Psyllid ID: psy14702
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 480 | 2.2.26 [Sep-21-2011] | |||||||
| Q8QGV2 | 595 | Wee1-like protein kinase | N/A | N/A | 0.572 | 0.462 | 0.439 | 2e-67 | |
| Q63802 | 646 | Wee1-like protein kinase | yes | N/A | 0.583 | 0.433 | 0.430 | 3e-66 | |
| P47810 | 646 | Wee1-like protein kinase | yes | N/A | 0.595 | 0.442 | 0.426 | 2e-65 | |
| Q8AYK6 | 571 | Wee1-like protein kinase | N/A | N/A | 0.570 | 0.479 | 0.434 | 9e-65 | |
| A4PES0 | 565 | Wee1-like protein kinase | no | N/A | 0.577 | 0.490 | 0.424 | 2e-64 | |
| P30291 | 646 | Wee1-like protein kinase | yes | N/A | 0.570 | 0.424 | 0.428 | 3e-64 | |
| E2RSS3 | 567 | Wee1-like protein kinase | yes | N/A | 0.579 | 0.490 | 0.425 | 1e-63 | |
| A4QNA8 | 562 | Wee1-like protein kinase | no | N/A | 0.556 | 0.475 | 0.426 | 2e-63 | |
| D2HHP1 | 565 | Wee1-like protein kinase | no | N/A | 0.579 | 0.492 | 0.416 | 1e-62 | |
| P54350 | 609 | Wee1-like protein kinase | yes | N/A | 0.633 | 0.499 | 0.391 | 4e-61 |
| >sp|Q8QGV2|WEE1B_XENLA Wee1-like protein kinase 1-B OS=Xenopus laevis GN=wee1-b PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 256 bits (655), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 128/291 (43%), Positives = 188/291 (64%), Gaps = 16/291 (5%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRYA EF E E +GSG+FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 242 SRYATEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 301
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSE 228
L + PH+V Y+S+W++ + +Q EYCNGG+L ++I E FTE LK LL QV+
Sbjct: 302 LGQHPHVVRYYSAWAEDDHMLIQNEYCNGGSLSDVISENYRTMQYFTEPELKDLLLQVAR 361
Query: 229 GLRCMHEMRMIHMDIKPANILIVKA-------QGELNEPMNTEKLHYKLGDFGHVIADND 281
GL+ +H M ++HMDIKP+NI I + + +E + K+ YK+GD GHV +
Sbjct: 362 GLKYIHSMSLVHMDIKPSNIFISRTTLPNTAVEEADDEECGSGKVIYKIGDLGHVTRVSS 421
Query: 282 FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIE 341
+VEEGD R+L E+L N+ +L+K DIFAL LT++ A+G P P NG WH IR G +
Sbjct: 422 PQVEEGDSRFLANEVLQENYTHLAKADIFALALTVWSAAGAEPFPTNGDQWHEIRQGKLP 481
Query: 342 KLSN-VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL----ARNYPQLKVE 387
++ +S + LIKLMI DP KRPS+ +L + + L ++ QL++E
Sbjct: 482 RVPQLLSQEFVDLIKLMISPDPEKRPSSVALVKHSVLLSASRKSAEQLRIE 532
|
Acts as a zygotic negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed cdk1 before the onset of mitosis by mediating phosphorylation of cdk1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed cdk1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-cdk1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric cdk1 does not occur. Xenopus laevis (taxid: 8355) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2 |
| >sp|Q63802|WEE1_RAT Wee1-like protein kinase OS=Rattus norvegicus GN=Wee1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (645), Expect = 3e-66, Method: Compositional matrix adjust.
Identities = 134/311 (43%), Positives = 194/311 (62%), Gaps = 31/311 (9%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EF E E +GSG+FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 292 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 351
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSE 228
L + PH+V YFS+W++ + +Q EYCNGG+L + + E FTE LK LL QV
Sbjct: 352 LGQHPHVVRYFSAWAEDDHMLIQNEYCNGGSLADAVSENYRVMSYFTEAELKDLLLQVGR 411
Query: 229 GLRCMHEMRMIHMDIKPANILI--------VKAQGELNEPMNTEKLHYKLGDFGHVIADN 280
GLR +H M ++HMDIKP+NI I V +G+ ++ + + K+ +K+GD GHV +
Sbjct: 412 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAVSEEGDEDDWI-SNKVMFKIGDLGHVTRIS 470
Query: 281 DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNI 340
+VEEGD R+L E+L N+ +L K DIFAL LT+ A+G PLP+NG WH IR G +
Sbjct: 471 SPQVEEGDSRFLANEVLQENYSHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 530
Query: 341 EKLSNV-SDDLHTLIKLMIDKDPTKRPST----------SSLRRSAQLARNYPQLKVE-N 388
++ V S +L L+K+MI DP +RPS S+ R+SA+ QL++E N
Sbjct: 531 PRIPQVLSQELTELLKVMIHPDPERRPSAMVLVKHSVLLSASRKSAE------QLRIELN 584
Query: 389 IRGNLNTRLKK 399
N+ L+K
Sbjct: 585 AEKFKNSLLQK 595
|
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P47810|WEE1_MOUSE Wee1-like protein kinase OS=Mus musculus GN=Wee1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 250 bits (638), Expect = 2e-65, Method: Compositional matrix adjust.
Identities = 130/305 (42%), Positives = 193/305 (63%), Gaps = 19/305 (6%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EF E E +GSG+FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 292 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 351
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSE 228
L + PH+V YFS+W++ + +Q EYCNGG+L + I E TE+ LK LL QV
Sbjct: 352 LGQHPHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRVMSYLTEVELKDLLLQVGR 411
Query: 229 GLRCMHEMRMIHMDIKPANILI--------VKAQGELNEPMNTEKLHYKLGDFGHVIADN 280
GLR +H M ++HMDIKP+NI I V +G+ ++ + + K+ +K+GD GHV +
Sbjct: 412 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAVSEEGDEDDWI-SNKVMFKIGDLGHVTRIS 470
Query: 281 DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNI 340
+VEEGD R+L E+L N+ +L K DIFAL LT+ A+G PLP+NG WH IR G +
Sbjct: 471 SPQVEEGDSRFLANEVLQENYSHLPKADIFALALTVVCAAGAEPLPRNGEQWHEIRQGRL 530
Query: 341 EKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL----ARNYPQLKVE-NIRGNLN 394
++ V S ++ L+++MI DP +RPS L + + L ++ QL++E N N
Sbjct: 531 PRIPQVLSQEVTELLRVMIHPDPERRPSAMELVKHSVLLSASRKSAEQLRIELNAEKFKN 590
Query: 395 TRLKK 399
+ L+K
Sbjct: 591 SLLQK 595
|
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q8AYK6|WEE1A_XENLA Wee1-like protein kinase 1-A OS=Xenopus laevis GN=wee1-a PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 127/292 (43%), Positives = 187/292 (64%), Gaps = 18/292 (6%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRYA EF E E +GSG+FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 218 SRYATEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPMAGSVDEQNALREVYAHAV 277
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSE 228
L + PH+V Y+S+W++ + +Q EYCNGG+L + I E FTE LK LL QV+
Sbjct: 278 LGQHPHVVRYYSAWAEDDHMLIQNEYCNGGSLADAISENYRTMQYFTEPELKDLLLQVAR 337
Query: 229 GLRCMHEMRMIHMDIKPANILIVK--------AQGELNEPMNTEKLHYKLGDFGHVIADN 280
GL+ +H M ++HMDIKP+NI I + +G+ +E + + YK+GD GHV +
Sbjct: 338 GLKYIHSMSLVHMDIKPSNIFISRITVPNTGVEEGD-DEDCGSGNVVYKIGDLGHVTRVS 396
Query: 281 DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNI 340
+VEEGD R+L E+L ++ +L+K DIFAL LT++ A+G P P NG WH IR G +
Sbjct: 397 SPQVEEGDSRFLANEVLQEDYTHLAKADIFALALTVWCAAGAEPFPTNGDQWHEIRQGKL 456
Query: 341 EKLSN-VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL----ARNYPQLKVE 387
++ +S + LIKLMI D KRPS+ +L + + L +N QL++E
Sbjct: 457 PRVPQLLSQEFVDLIKLMISPDSEKRPSSMALVKHSVLLSASRKNAEQLRIE 508
|
Acts as a zygotic negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed cdk1 before the onset of mitosis by mediating phosphorylation of cdk1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed cdk1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-cdk1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric cdk1 does not occur. Involved in convergent extension of the paraxial mesoderm during neurulation by inhibiting the cell cycle. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|A4PES0|WEE2_PIG Wee1-like protein kinase 2 OS=Sus scrofa GN=WEE2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 246 bits (629), Expect = 2e-64, Method: Compositional matrix adjust.
Identities = 127/299 (42%), Positives = 186/299 (62%), Gaps = 22/299 (7%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY EFLE E +G G+FG V+KC+K +DG YA+KR+ +PV+ + E + E++AH++L
Sbjct: 209 RYEKEFLEVEKIGVGEFGTVYKCIKRLDGCVYAIKRSTKPVSGLSDENLAMHEVYAHSVL 268
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSEG 229
PH+V Y+SSW++ + +Q EYCNGG+L+ I E F E LK +L Q+S G
Sbjct: 269 GHHPHVVRYYSSWAEDDHMMIQNEYCNGGSLQAAISENAKSGNHFQEPKLKDILLQISLG 328
Query: 230 LRCMHEMRMIHMDIKPANILIV------------KAQGELNEPMNTEKLHYKLGDFGHVI 277
L+ +H M+HMDIKP+NI I +A+ E + ++ + YK+GD GHV
Sbjct: 329 LKYIHNYGMVHMDIKPSNIFICHKIPSDSPVVPEEAENEADWFLSA-NVTYKIGDLGHVT 387
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ ++ +VEEGD R+L KE+L N+ +L K DIFALGLT+ A+G LP NG WHHIR+
Sbjct: 388 SISEPQVEEGDSRFLAKEILQENYQHLPKADIFALGLTIAVAAGAEALPTNGTSWHHIRE 447
Query: 338 GNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL-KVENIRGNLN 394
G + + ++S + + L+K MID DP RPS ++L RS L P L + E ++ LN
Sbjct: 448 GQLPNIPQDLSKEFYNLLKDMIDPDPVARPSAAALTRSRVLC---PSLGRTEELQQQLN 503
|
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits CDK1 and acts as a key regulator of meiosis during both prophase I and metaphase II. Required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, by phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity and prevent meiotic reentry. Also required for metaphase II exit during egg activation by phosphorylating CDK1 at 'Tyr-15', to ensure exit from meiosis in oocytes and promote pronuclear formation. Sus scrofa (taxid: 9823) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P30291|WEE1_HUMAN Wee1-like protein kinase OS=Homo sapiens GN=WEE1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 246 bits (628), Expect = 3e-64, Method: Compositional matrix adjust.
Identities = 125/292 (42%), Positives = 184/292 (63%), Gaps = 18/292 (6%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EF E E +GSG+FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 293 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 352
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSE 228
L + H+V YFS+W++ + +Q EYCNGG+L + I E F E LK LL QV
Sbjct: 353 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 412
Query: 229 GLRCMHEMRMIHMDIKPANILIVKA--------QGELNEPMNTEKLHYKLGDFGHVIADN 280
GLR +H M ++HMDIKP+NI I + +G+ ++ + K+ +K+GD GHV +
Sbjct: 413 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD-WASNKVMFKIGDLGHVTRIS 471
Query: 281 DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNI 340
+VEEGD R+L E+L N+ +L K DIFAL LT+ A+G PLP+NG WH IR G +
Sbjct: 472 SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRL 531
Query: 341 EKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL----ARNYPQLKVE 387
++ V S + L+K+MI DP +RPS +L + + L ++ QL++E
Sbjct: 532 PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRKSAEQLRIE 583
|
Acts as a negative regulator of entry into mitosis (G2 to M transition) by protecting the nucleus from cytoplasmically activated cyclin B1-complexed CDK1 before the onset of mitosis by mediating phosphorylation of CDK1 on 'Tyr-15'. Specifically phosphorylates and inactivates cyclin B1-complexed CDK1 reaching a maximum during G2 phase and a minimum as cells enter M phase. Phosphorylation of cyclin B1-CDK1 occurs exclusively on 'Tyr-15' and phosphorylation of monomeric CDK1 does not occur. Its activity increases during S and G2 phases and decreases at M phase when it is hyperphosphorylated. A correlated decrease in protein level occurs at M/G1 phase, probably due to its degradation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|E2RSS3|WEE2_CANFA Wee1-like protein kinase 2 OS=Canis familiaris GN=WEE2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 244 bits (623), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 128/301 (42%), Positives = 186/301 (61%), Gaps = 23/301 (7%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EFLE E +G G+FG V+KC+K +DG YA+KR+ +PVA + E + E++AHA+
Sbjct: 209 SRYEKEFLEVEKIGVGEFGTVYKCIKRLDGCVYAIKRSMKPVAGLSNENLALHEVYAHAV 268
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSE 228
L PH+V Y+S+W++ + +Q EYCNGG+L+ I E F E+ LK +L Q+S
Sbjct: 269 LGHHPHVVRYYSAWAEDDHMIIQNEYCNGGSLQTAISENTKSGNHFPELKLKDILLQISL 328
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH------------YKL-GDFGH 275
GL+ +H M+H+DIKP+NI I + + P+ E++ YK+ GD GH
Sbjct: 329 GLKYIHNSGMVHLDIKPSNIFICHKM-QCDSPVVPEEIENEADWFLSANVMYKIAGDLGH 387
Query: 276 VIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHI 335
V + + +VEEGD R+L E+L ++ +L K DIFALGLT+ A+G LP NG WHHI
Sbjct: 388 VTSISKPKVEEGDSRFLANEILQEDYQHLPKADIFALGLTIAVAAGAESLPANGAKWHHI 447
Query: 336 RDGNIEKLSN-VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL-KVENIRGNL 393
R+GN+ + +S++ H L+K MI DP++RPS + L RS L P L K E ++ L
Sbjct: 448 REGNLPDIPQKLSEEFHNLLKNMIHPDPSERPSAAGLARSRVL---RPSLRKAEELQQQL 504
Query: 394 N 394
N
Sbjct: 505 N 505
|
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits CDK1 and acts as a key regulator of meiosis during both prophase I and metaphase II. Required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, by phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity and prevent meiotic reentry. Also required for metaphase II exit during egg activation by phosphorylating CDK1 at 'Tyr-15', to ensure exit from meiosis in oocytes and promote pronuclear formation. Canis familiaris (taxid: 9615) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|A4QNA8|WEE2_XENTR Wee1-like protein kinase 2 OS=Xenopus tropicalis GN=wee2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (621), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 119/279 (42%), Positives = 180/279 (64%), Gaps = 12/279 (4%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EFLE E +G+G+FG VFKC+K +DG YA+KR+K+P+A + E++ +E++AHA+
Sbjct: 211 SRYKTEFLEIEKIGAGEFGSVFKCVKRLDGCFYAIKRSKKPLAGSTDEQLALREVYAHAV 270
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSE 228
L PH+V Y+S+W++ + +Q EYCNGG+L+++I E E LK++L QVS
Sbjct: 271 LGHHPHVVRYYSAWAEDDHMIIQNEYCNGGSLQDLIMENKKEGRFVPEQELKEILLQVSM 330
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNE-------PMNTEKLHYKLGDFGHVIADND 281
GL+ +H ++HMDIKP+NI I + Q E+ + +++ + YK+GD GHV + +
Sbjct: 331 GLKYIHSSGLVHMDIKPSNIFICRKQTEVGQDESDGEDDLSSASVLYKIGDLGHVTSILN 390
Query: 282 FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIE 341
+VEEGD R+L E+L ++ L K DIFALGLT+ A+G PLP N WHHIR GN+
Sbjct: 391 PQVEEGDSRFLANEILQEDYRQLPKADIFALGLTITLAAGAGPLPCNEDSWHHIRKGNLP 450
Query: 342 KLSN-VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379
+ ++ L+KL++ DP RP SL +++ L R
Sbjct: 451 HIPQPLTPAFLALLKLLVHPDPVMRPPAVSLAKNSLLRR 489
|
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits cdk1 and acts as a regulator of meiosis. Required to maintain meiotic arrest in oocytes by phosphorylating cdk1 at 'Tyr-15', leading to inhibit cdk1 activity and prevent meiotic reentry. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|D2HHP1|WEE2_AILME Wee1-like protein kinase 2 OS=Ailuropoda melanoleuca GN=WEE2 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 1e-62, Method: Compositional matrix adjust.
Identities = 125/300 (41%), Positives = 183/300 (61%), Gaps = 22/300 (7%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EFLE E +G G+FG V+KC+K +DG YA+KR+ +P A + E + E++AHA+
Sbjct: 208 SRYEKEFLEVEKIGVGEFGTVYKCIKRLDGCVYAIKRSTKPFAGLSNENLALHEVYAHAV 267
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSE 228
L PH+V Y+S+W++ + +Q EYCNGG+L+ I E F E LK +L Q+S
Sbjct: 268 LGHHPHVVRYYSAWAEDDHMIIQNEYCNGGSLQTAISENTKSGNHFQEPKLKDILLQISL 327
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH------------YKLGDFGHV 276
GL+ +H M+H+DIKP+NI I + + P+ E++ YK+GD GHV
Sbjct: 328 GLKYIHSSGMVHLDIKPSNIFICHKM-QSDSPVVPEEIENEADWFLSANVMYKIGDLGHV 386
Query: 277 IADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIR 336
+ + +VEEGD R+L E+L ++ +L K DIFALGLT+ A+G LP NG WHHIR
Sbjct: 387 TSISKPKVEEGDSRFLANEILQEDYQHLPKADIFALGLTIAVAAGAESLPTNGAAWHHIR 446
Query: 337 DGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL-KVENIRGNLN 394
+G + + +S++ + L+K MI DP +RPS ++L RS L P L K E ++ LN
Sbjct: 447 EGKLPDIPQKLSEEFYNLLKNMIHPDPRERPSAAALARSRVL---RPSLGKAEELQQQLN 503
|
Oocyte-specific protein tyrosine kinase that phosphorylates and inhibits CDK1 and acts as a key regulator of meiosis during both prophase I and metaphase II. Required to maintain meiotic arrest in oocytes during the germinal vesicle (GV) stage, a long period of quiescence at dictyate prophase I, by phosphorylating CDK1 at 'Tyr-15', leading to inhibit CDK1 activity and prevent meiotic reentry. Also required for metaphase II exit during egg activation by phosphorylating CDK1 at 'Tyr-15', to ensure exit from meiosis in oocytes and promote pronuclear formation. Ailuropoda melanoleuca (taxid: 9646) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P54350|WEE1_DROME Wee1-like protein kinase OS=Drosophila melanogaster GN=wee PE=1 SV=2 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 4e-61, Method: Compositional matrix adjust.
Identities = 130/332 (39%), Positives = 199/332 (59%), Gaps = 28/332 (8%)
Query: 65 RDALILNKKWSGKTLATLPSGSVIDEDSGDD----HHPVFDIKSISSTSIDHSRYALEFL 120
R+ L LN K L + + E++GD H ++ T+I SR+ EF+
Sbjct: 183 RENLNLNVNAMQKYLLSDACDDDVTEEAGDSMREIHQQAPKRLALHDTNI--SRFKREFM 240
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
+ ++G G+FG VF+C+ +DG YA+K++K+PVA ++ EK E+ AHA+L + ++V
Sbjct: 241 QVNVIGVGEFGVVFQCVNRLDGCIYAIKKSKKPVAGSSFEKRALNEVWAHAVLGKHDNVV 300
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
Y+S+W++ + +Q E+C+GG+L IQ+ C E LK +L V EGLR +H ++H
Sbjct: 301 RYYSAWAEDDHMLIQNEFCDGGSLHARIQDHC-LGEAELKIVLMHVIEGLRYIHSNDLVH 359
Query: 241 MDIKPANIL---------IVKAQGE-----------LNEPMNTEKL-HYKLGDFGHVIAD 279
MD+KP NI +V+ Q + E ++E L YK+GD GHV +
Sbjct: 360 MDLKPENIFSTMNPNAHKLVEVQPQQTKDDDGMDSVYEELRHSENLVTYKIGDLGHVTSV 419
Query: 280 NDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGN 339
+ VEEGDCRYLPKE+L+ ++ NL K DIF+LG+TL+EA+G PLPKNGP WH++RDG
Sbjct: 420 KEPYVEEGDCRYLPKEILHEDYSNLFKADIFSLGITLFEAAGGGPLPKNGPEWHNLRDGK 479
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ L ++S D + LI M+ P KRP++ S+
Sbjct: 480 VPILPSLSRDFNELIAQMMHPYPDKRPTSQSI 511
|
Could act as a negative regulator of entry into mitosis (G2 to M transition). This kinase specifically phosphorylates and inactivates cyclin B1-complexed CDC2. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 480 | ||||||
| 345479564 | 620 | PREDICTED: wee1-like protein kinase-like | 0.739 | 0.572 | 0.419 | 9e-74 | |
| 332022970 | 593 | Wee1-like protein kinase [Acromyrmex ech | 0.658 | 0.532 | 0.426 | 5e-69 | |
| 328780087 | 577 | PREDICTED: Wee1-like protein kinase [Api | 0.537 | 0.447 | 0.474 | 1e-68 | |
| 307207659 | 586 | Wee1-like protein kinase [Harpegnathos s | 0.618 | 0.506 | 0.435 | 2e-68 | |
| 307188284 | 579 | Wee1-like protein kinase [Camponotus flo | 0.645 | 0.535 | 0.405 | 3e-68 | |
| 350403645 | 487 | PREDICTED: wee1-like protein kinase-like | 0.537 | 0.529 | 0.470 | 8e-68 | |
| 350403648 | 571 | PREDICTED: wee1-like protein kinase-like | 0.537 | 0.451 | 0.470 | 8e-68 | |
| 340722831 | 571 | PREDICTED: wee1-like protein kinase-like | 0.537 | 0.451 | 0.470 | 9e-68 | |
| 322792811 | 511 | hypothetical protein SINV_05401 [Solenop | 0.589 | 0.553 | 0.440 | 1e-67 | |
| 383857251 | 589 | PREDICTED: wee1-like protein kinase-like | 0.537 | 0.438 | 0.463 | 2e-67 |
| >gi|345479564|ref|XP_001607455.2| PREDICTED: wee1-like protein kinase-like [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 284 bits (726), Expect = 9e-74, Method: Compositional matrix adjust.
Identities = 163/389 (41%), Positives = 236/389 (60%), Gaps = 34/389 (8%)
Query: 33 QSVDFIVHSLKDLPTE-----LPSGLSLGAILEREDPRDALILNKKWSGKTLATLPSGSV 87
++V H+ D P+ P+G+ L A +R + +LI G +P +
Sbjct: 168 KAVPTCYHNKSDKPSANINPFTPNGMLLTA-RKRSRSKRSLI------GSPELRIPKFDL 220
Query: 88 IDEDSGDD--HHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTY 145
+D + D+ P K ++ + SRY EFLE ELLGSG+FG V+KC +DG Y
Sbjct: 221 VDSEESDNDLEQPT---KRVALQESNISRYYQEFLELELLGSGEFGSVYKCTHRLDGCNY 277
Query: 146 AVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLE 205
AVK++ +PVA +A EK E++AHA+L + H+V Y+S+W++ + +Q EYCNGG+L
Sbjct: 278 AVKKSIKPVAGSASEKNALNEVYAHAVLGKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLA 337
Query: 206 NII----QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL---- 257
+ I QE+ ++E L+QLL V+EGLR +H M+++HMDIKP NI I + + +L
Sbjct: 338 DAISKMRQEKRHYSEAELRQLLLHVAEGLRYIHSMQLVHMDIKPGNIFISREKSQLRVNY 397
Query: 258 -------NEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIF 310
+E E++ YK+GD GHV + N+ +VEEGDCRYLP E+L+ +F +L+K DIF
Sbjct: 398 DSADDGFDEEETEEEITYKIGDLGHVTSINNPQVEEGDCRYLPTEILHEDFMHLTKADIF 457
Query: 311 ALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSS 370
ALGLT+YEA G PLPKNGP WH IR+GN+ +L S D + L+KLMI +P RPS S
Sbjct: 458 ALGLTMYEAGGGGPLPKNGPEWHDIRNGNLAELPQYSRDFNELLKLMIHPNPEMRPSAVS 517
Query: 371 LRRSAQLARNYPQLKVENIRGNLNT-RLK 398
L + L+ N + K + +R LN RLK
Sbjct: 518 LIQHRVLSPNGNKTKAQ-LRRELNAERLK 545
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332022970|gb|EGI63236.1| Wee1-like protein kinase [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 268 bits (685), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 145/340 (42%), Positives = 212/340 (62%), Gaps = 24/340 (7%)
Query: 50 PSGLSLGAILEREDPRDALILNKKWSGKTLATLPSGSVID-EDSGDDHHPVFDIKSISST 108
P+G+ + A ++ R LN S +P ++D EDS +++ V ++ +
Sbjct: 174 PTGMLITA---KKRSRSKRSLNGSNSSSPDMQVPKFDLVDSEDSDNEYEHVTKRVALQDS 230
Query: 109 SIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
+I SRY EF E L+G G+FG V+KC+ +DG TYA+K++ +PVA + EK E++
Sbjct: 231 NI--SRYHKEFHELGLIGIGEFGSVYKCINRLDGCTYAIKKSIKPVAGSINEKNALNEVY 288
Query: 169 AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII-----QERCTFTEMALKQLL 223
AHA+L + H+V Y+S+W++ + +Q EYCNGG+L + I Q++C F++ ++QLL
Sbjct: 289 AHAVLGKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADTILLMQKQKQC-FSQAEMRQLL 347
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQ------------GELNEPMNTEKLHYKLG 271
V+EGLR +H M+++HMDIKP NI I K + G +E E++ YK+G
Sbjct: 348 LHVAEGLRYIHSMQLVHMDIKPGNIFITKEKKLRAINYDSADDGFDDEENIDEEITYKIG 407
Query: 272 DFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPM 331
D GHV + N+ +VEEGDCRYL E+L +F++L K DIFALGLT+YEA G LPKNGPM
Sbjct: 408 DLGHVTSINNPQVEEGDCRYLTTEILQEDFNHLPKADIFALGLTVYEAGGGGLLPKNGPM 467
Query: 332 WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
WH IR G + L + S DL+ L+KLMI +P RPS SL
Sbjct: 468 WHDIRQGKLPDLPHCSRDLNNLLKLMIHPNPEMRPSAMSL 507
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328780087|ref|XP_624069.2| PREDICTED: Wee1-like protein kinase [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 266 bits (681), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 130/274 (47%), Positives = 184/274 (67%), Gaps = 16/274 (5%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY EF E L+G+G+FG V+KC+ +DG TYA+K++ +PVA + EK E++AHA+L
Sbjct: 228 RYHQEFHELGLIGTGEFGSVYKCINRLDGCTYAIKKSIKPVAGSINEKNALNEVYAHAVL 287
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII----QERCTFTEMALKQLLFQVSEG 229
+ H+V Y+S+W++ + +Q EYCNGG+L + I +E+ FTE ++QLL V+EG
Sbjct: 288 GKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADAIINLEKEKKHFTEAEMRQLLLHVAEG 347
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTE------------KLHYKLGDFGHVI 277
LR +H M+++HMDIKP NI I K + L ++ ++ YK+GD GHV
Sbjct: 348 LRYIHSMQLVHMDIKPGNIFISKEKRLLAVNYDSADDGFDEEETIEEEITYKIGDLGHVT 407
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ N+ +VEEGDCRYLP E+L +F +L K DIFA GLT+YEA G PLPKNGP WH IR+
Sbjct: 408 SVNNPQVEEGDCRYLPTEILREDFSHLPKADIFAFGLTVYEAGGGGPLPKNGPEWHDIRN 467
Query: 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
GN+++LS+ S DL+ L+KLMI +P RPS L
Sbjct: 468 GNLKELSHYSRDLNELLKLMIHPNPEMRPSAICL 501
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307207659|gb|EFN85297.1| Wee1-like protein kinase [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 266 bits (680), Expect = 2e-68, Method: Compositional matrix adjust.
Identities = 142/326 (43%), Positives = 203/326 (62%), Gaps = 29/326 (8%)
Query: 90 EDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR 149
EDS +D V ++ ++I +RY EF E L+GSG+FG V+KC+ +DG TYA+K+
Sbjct: 204 EDSDNDIEQVTKRMALQDSNI--TRYHQEFHELGLIGSGEFGSVYKCINRLDGCTYAIKK 261
Query: 150 TKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII- 208
+ +PVA + EK E++AHA+L + H+V Y+S+W++ + +Q EYCNGG+L ++I
Sbjct: 262 SIKPVAGSINEKNALNEVYAHAVLGKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADVIA 321
Query: 209 ---QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQ----------- 254
++ +E L+QLL ++EGLR +H M+++HMDIKP NI I K +
Sbjct: 322 RLQTQKTHLSEPELRQLLLHIAEGLRYIHSMQLVHMDIKPGNIFISKEKRLLALNYDSAD 381
Query: 255 -GELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALG 313
G E E++ YK+GD GHV + N+ +VEEGDCRYLP E+L +F +LSK DIFALG
Sbjct: 382 DGFDEEETVEEEITYKIGDLGHVTSINNPQVEEGDCRYLPTEILREDFSHLSKADIFALG 441
Query: 314 LTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL-- 371
LT+YEA G PLPKNG WH IR+G +++L + S D + L+KLMI +P RPS SL
Sbjct: 442 LTVYEAGGGGPLPKNGAAWHEIREGYLQELPHYSHDFNGLLKLMIHSNPEMRPSAISLIQ 501
Query: 372 ---------RRSAQLARNYPQLKVEN 388
+ AQL R KV+N
Sbjct: 502 HRVLCPLGNKTKAQLRRELNAEKVKN 527
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307188284|gb|EFN73076.1| Wee1-like protein kinase [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 265 bits (678), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 139/343 (40%), Positives = 207/343 (60%), Gaps = 33/343 (9%)
Query: 90 EDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR 149
EDS +++ ++ ++I SRY EF E L+GSG FG VFKC+ +DG TYAVKR
Sbjct: 210 EDSDNEYEHATKRMALQDSNI--SRYHKEFHELGLIGSGTFGSVFKCINRLDGCTYAVKR 267
Query: 150 TKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII- 208
+++P+A E E++AHA+L + H+V Y+S+W++ + +Q EYCNGG+L ++I
Sbjct: 268 SRKPIAGVVSESNALNEVYAHAVLGKHQHVVRYYSAWAEDSHMIIQNEYCNGGSLADVIA 327
Query: 209 ---QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK-----------AQ 254
+E+ F++ ++QLL V+EGL+ +H M+++HMDIKPANI I + A
Sbjct: 328 NLEKEKKQFSKAEMRQLLLHVAEGLKYIHSMQLVHMDIKPANIFISREGKLPSSNYDSAD 387
Query: 255 GELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGL 314
E +++ YK+GD GHV + N+ VEEGDCRYLP E+L + + +L K DIFALGL
Sbjct: 388 DGFEEDETVDEITYKIGDLGHVTSINNPHVEEGDCRYLPMEVLQDEYSHLPKADIFALGL 447
Query: 315 TLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL--- 371
T YEA G P+PKNG WH +R+GN+ L DL+ L+K+M DP RPS + L
Sbjct: 448 TAYEAGGAGPMPKNGFEWHRLREGNVPDLPLYGRDLNNLLKIMTHPDPQIRPSATCLTQH 507
Query: 372 --------RRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVF 406
+ AQL R +L +E ++ + T K+L + +F
Sbjct: 508 RALLPLGNKTKAQLRR---ELSLEKLKNEILT--KRLKDAAIF 545
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350403645|ref|XP_003486863.1| PREDICTED: wee1-like protein kinase-like isoform 1 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 264 bits (674), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 129/274 (47%), Positives = 183/274 (66%), Gaps = 16/274 (5%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY EF E L+G+G+FG V+KC+ +DG YA+K++ +PVA + EK E++AHA+L
Sbjct: 125 RYHQEFHELGLIGTGEFGSVYKCINRLDGCIYAIKKSIKPVAGSINEKNALNEVYAHAVL 184
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLE----NIIQERCTFTEMALKQLLFQVSEG 229
+ H+V Y+S+W++ + +Q EYCNGG+L N+ +E+ FTE ++QLL V+EG
Sbjct: 185 GKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADGIINLEKEKKHFTEAEMRQLLLHVAEG 244
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTE------------KLHYKLGDFGHVI 277
LR +H M+++HMDIKP NI I K + L ++ ++ YK+GD GHV
Sbjct: 245 LRYIHSMQLVHMDIKPGNIFISKEKRLLAVNYDSADDGFDEEETVEEEITYKIGDLGHVT 304
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ N+ +VEEGDCRYLP E+L +F +L K DIFALGLT+YEA G PLPKNGP WH IR+
Sbjct: 305 SVNNPQVEEGDCRYLPTEILREDFSHLPKADIFALGLTVYEAGGGGPLPKNGPEWHDIRN 364
Query: 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
GN+++L + S DL+ L+KLMI +P RPS L
Sbjct: 365 GNLKELPHYSRDLNELLKLMIHPNPEMRPSAICL 398
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350403648|ref|XP_003486864.1| PREDICTED: wee1-like protein kinase-like isoform 2 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 264 bits (674), Expect = 8e-68, Method: Compositional matrix adjust.
Identities = 129/274 (47%), Positives = 183/274 (66%), Gaps = 16/274 (5%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY EF E L+G+G+FG V+KC+ +DG YA+K++ +PVA + EK E++AHA+L
Sbjct: 209 RYHQEFHELGLIGTGEFGSVYKCINRLDGCIYAIKKSIKPVAGSINEKNALNEVYAHAVL 268
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLE----NIIQERCTFTEMALKQLLFQVSEG 229
+ H+V Y+S+W++ + +Q EYCNGG+L N+ +E+ FTE ++QLL V+EG
Sbjct: 269 GKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADGIINLEKEKKHFTEAEMRQLLLHVAEG 328
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTE------------KLHYKLGDFGHVI 277
LR +H M+++HMDIKP NI I K + L ++ ++ YK+GD GHV
Sbjct: 329 LRYIHSMQLVHMDIKPGNIFISKEKRLLAVNYDSADDGFDEEETVEEEITYKIGDLGHVT 388
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ N+ +VEEGDCRYLP E+L +F +L K DIFALGLT+YEA G PLPKNGP WH IR+
Sbjct: 389 SVNNPQVEEGDCRYLPTEILREDFSHLPKADIFALGLTVYEAGGGGPLPKNGPEWHDIRN 448
Query: 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
GN+++L + S DL+ L+KLMI +P RPS L
Sbjct: 449 GNLKELPHYSRDLNELLKLMIHPNPEMRPSAICL 482
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340722831|ref|XP_003399804.1| PREDICTED: wee1-like protein kinase-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 264 bits (674), Expect = 9e-68, Method: Compositional matrix adjust.
Identities = 129/274 (47%), Positives = 183/274 (66%), Gaps = 16/274 (5%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY EF E L+G+G+FG V+KC+ +DG YA+K++ +PVA + EK E++AHA+L
Sbjct: 209 RYHQEFHELGLIGTGEFGSVYKCINRLDGCIYAIKKSIKPVAGSINEKNALNEVYAHAVL 268
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLE----NIIQERCTFTEMALKQLLFQVSEG 229
+ H+V Y+S+W++ + +Q EYCNGG+L N+ +E+ FTE ++QLL V+EG
Sbjct: 269 GKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADGIINLEKEKKHFTEAEMRQLLLHVAEG 328
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTE------------KLHYKLGDFGHVI 277
LR +H M+++HMDIKP NI I K + L ++ ++ YK+GD GHV
Sbjct: 329 LRYIHSMQLVHMDIKPGNIFISKEKRLLAVNYDSADDGFDEEETVEEEITYKIGDLGHVT 388
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ N+ +VEEGDCRYLP E+L +F +L K DIFALGLT+YEA G PLPKNGP WH IR+
Sbjct: 389 SVNNPQVEEGDCRYLPTEILREDFSHLPKADIFALGLTVYEAGGGGPLPKNGPEWHDIRN 448
Query: 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
GN+++L + S DL+ L+KLMI +P RPS L
Sbjct: 449 GNLKELPHYSRDLNELLKLMIHPNPEMRPSAICL 482
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|322792811|gb|EFZ16644.1| hypothetical protein SINV_05401 [Solenopsis invicta] | Back alignment and taxonomy information |
|---|
Score = 263 bits (673), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 133/302 (44%), Positives = 192/302 (63%), Gaps = 19/302 (6%)
Query: 88 IDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAV 147
+D+ D+ K I+ + SRY EFLE L+G+G+FG V KC+ +DG TYA+
Sbjct: 126 LDDSEDSDNEYEHATKRIALQDSNISRYHEEFLELCLIGTGEFGSVHKCINRLDGCTYAI 185
Query: 148 KRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENI 207
K++ +PVA + EK E++AH++L + P++V Y+S+W++ + +Q EYCNGG+L +
Sbjct: 186 KKSIKPVAGSTTEKNALNEVYAHSVLGKHPYVVRYYSAWAENNHMLIQNEYCNGGSLADT 245
Query: 208 IQERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQG-------- 255
I T F++ ++QLL V+EGLR +H M+++HMDIKP NI I K +
Sbjct: 246 IALMRTQNQHFSQAEMRQLLLHVAEGLRYIHSMQLVHMDIKPGNIFITKEKKLRAINYDS 305
Query: 256 ------ELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDI 309
+++E ++ E++ YK+GD GHV + ++ +VEEGDCRYLP E+L NF +L K DI
Sbjct: 306 ADDGFDDIDETVD-EEITYKIGDLGHVTSISNPQVEEGDCRYLPTEILRENFTHLPKADI 364
Query: 310 FALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTS 369
FALGLT+YEA G LPKNGP WH IR G + L + + DL L+KLMI DP RPS
Sbjct: 365 FALGLTVYEAGGGGSLPKNGPAWHDIRHGKLADLPHCTRDLINLLKLMISYDPEMRPSAE 424
Query: 370 SL 371
SL
Sbjct: 425 SL 426
|
Source: Solenopsis invicta Species: Solenopsis invicta Genus: Solenopsis Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383857251|ref|XP_003704118.1| PREDICTED: wee1-like protein kinase-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 263 bits (671), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 127/274 (46%), Positives = 183/274 (66%), Gaps = 16/274 (5%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY EF E L+G+G+FG V+KC+ +DG YA+K++ +PVA + EK E++AHA+L
Sbjct: 228 RYHQEFHELGLIGTGEFGSVYKCINRLDGCIYAIKKSIKPVAGSINEKNALNEVYAHAVL 287
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII----QERCTFTEMALKQLLFQVSEG 229
+ H+V Y+S+W++ + +Q EYCNGG+L + I +E+ FTE ++QLL V+EG
Sbjct: 288 GKHQHVVRYYSAWAEDNHMIIQNEYCNGGSLADAIVNLEKEKKQFTEAEIRQLLLHVAEG 347
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTE------------KLHYKLGDFGHVI 277
LR +H M+++HMDIKP NI I K + L ++ ++ YK+GD GHV
Sbjct: 348 LRYIHSMQLVHMDIKPGNIFISKEKRLLAVNYDSADDGFDEEETIEEEITYKIGDLGHVT 407
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ N+ +VEEGDCRYLP E+L +F +L K DIFALGLT+YEA G PLPKNGP WH IR+
Sbjct: 408 SVNNPQVEEGDCRYLPTEILREDFSHLPKADIFALGLTVYEAGGGGPLPKNGPEWHDIRN 467
Query: 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
GN+++L + S D++ L+KLM+ +P RPS L
Sbjct: 468 GNLKELPHYSRDVNELLKLMVHPNPEMRPSAVCL 501
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 480 | ||||||
| ZFIN|ZDB-GENE-030131-5268 | 612 | wee1 "WEE1 homolog (S. pombe)" | 0.585 | 0.459 | 0.443 | 5.5e-61 | |
| RGD|1307895 | 646 | Wee1 "wee 1 homolog (S. pombe) | 0.616 | 0.458 | 0.411 | 8.1e-60 | |
| MGI|MGI:103075 | 646 | Wee1 "WEE 1 homolog 1 (S. pomb | 0.616 | 0.458 | 0.405 | 4.5e-59 | |
| UNIPROTKB|A7E332 | 422 | WEE1 "Uncharacterized protein" | 0.618 | 0.703 | 0.412 | 7.3e-59 | |
| UNIPROTKB|A7MBC3 | 646 | WEE1 "Uncharacterized protein" | 0.618 | 0.459 | 0.412 | 7.3e-59 | |
| UNIPROTKB|F1S6U8 | 646 | WEE1 "Uncharacterized protein" | 0.618 | 0.459 | 0.415 | 7.3e-59 | |
| UNIPROTKB|E2RIU0 | 665 | WEE1 "Uncharacterized protein" | 0.618 | 0.446 | 0.412 | 9.3e-59 | |
| UNIPROTKB|P30291 | 646 | WEE1 "Wee1-like protein kinase | 0.618 | 0.459 | 0.409 | 4e-58 | |
| UNIPROTKB|P47817 | 555 | wee2-a "Wee1-like protein kina | 0.591 | 0.511 | 0.401 | 8.4e-58 | |
| UNIPROTKB|F1MZD1 | 566 | WEE2 "Uncharacterized protein" | 0.581 | 0.492 | 0.411 | 1.7e-57 |
| ZFIN|ZDB-GENE-030131-5268 wee1 "WEE1 homolog (S. pombe)" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 5.5e-61, P = 5.5e-61
Identities = 130/293 (44%), Positives = 179/293 (61%)
Query: 113 SRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRYA GSG FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 259 SRYASEFHELEKNGSGQFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 318
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE---RCTF-TEMALKQLLFQVSE 228
L + PH+V Y+S+W++ + +Q EYCNGG L ++I E R F +E+ LK LL QVS
Sbjct: 319 LGQHPHVVRYYSAWAEDDHMLIQNEYCNGGTLSDVIAENNRRMHFLSELELKDLLLQVSR 378
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQG------ELNEPMNTEKLHYKLGDFGHVIADNDF 282
GL+ +H ++HMDIKP+NI I + E E T + YK+GD GHV +
Sbjct: 379 GLKYIHSTALVHMDIKPSNIFISRKPAASVEEFEDEEDGPTTNVVYKIGDLGHVTTVTNP 438
Query: 283 EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEK 342
+VEEGD R+L E+L ++ NL K DIFAL LT+ ASG PLP NG WH IR G +
Sbjct: 439 QVEEGDSRFLANEVLQEDYSNLKKADIFALALTVVSASGAEPLPTNGDKWHKIRQGILPH 498
Query: 343 LSNV-SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLN 394
+ V S + +L+KLMI DPT+RPSTS L R L ++ + +R LN
Sbjct: 499 IPQVLSQEFLSLLKLMIHPDPTRRPSTSELVRHPVLL-TASRMSADQLRVELN 550
|
|
| RGD|1307895 Wee1 "wee 1 homolog (S. pombe)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
Identities = 130/316 (41%), Positives = 195/316 (61%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 270 DYEFEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK 327
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + PH+V YFS+W++ + +Q EYCNGG+L + +
Sbjct: 328 RSKKPLAGSVDEQNALREVYAHAVLGQHPHVVRYFSAWAEDDHMLIQNEYCNGGSLADAV 387
Query: 209 QERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILI--------VKAQGE 256
E FTE LK LL QV GLR +H M ++HMDIKP+NI I V +G+
Sbjct: 388 SENYRVMSYFTEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAVSEEGD 447
Query: 257 LNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTL 316
++ ++ K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 448 EDDWISN-KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYSHLPKADIFALALTV 506
Query: 317 YEASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRS 374
A+G PLP+NG WH IR G + ++ V S +L L+K+MI DP +RPS L + S
Sbjct: 507 VCAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQELTELLKVMIHPDPERRPSAMVLVKHS 566
Query: 375 AQLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 567 VLLSASRKSAEQLRIE 582
|
|
| MGI|MGI:103075 Wee1 "WEE 1 homolog 1 (S. pombe)" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 606 (218.4 bits), Expect = 4.5e-59, P = 4.5e-59
Identities = 128/316 (40%), Positives = 195/316 (61%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 270 DYEFEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK 327
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + PH+V YFS+W++ + +Q EYCNGG+L + I
Sbjct: 328 RSKKPLAGSVDEQNALREVYAHAVLGQHPHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 387
Query: 209 QERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILI--------VKAQGE 256
E TE+ LK LL QV GLR +H M ++HMDIKP+NI I V +G+
Sbjct: 388 SENYRVMSYLTEVELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAVSEEGD 447
Query: 257 LNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTL 316
++ ++ K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 448 EDDWISN-KVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYSHLPKADIFALALTV 506
Query: 317 YEASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRS 374
A+G PLP+NG WH IR G + ++ V S ++ L+++MI DP +RPS L + S
Sbjct: 507 VCAAGAEPLPRNGEQWHEIRQGRLPRIPQVLSQEVTELLRVMIHPDPERRPSAMELVKHS 566
Query: 375 AQLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 567 VLLSASRKSAEQLRIE 582
|
|
| UNIPROTKB|A7E332 WEE1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 130/315 (41%), Positives = 192/315 (60%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 57 DYEFEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCVYAIK 114
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + H+V YFS+W++ + +Q EYCNGG+L + I
Sbjct: 115 RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 174
Query: 209 QERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK------AQGELN 258
E FTE LK LL QV GLR +H M ++HMDIKP+NI I + A E +
Sbjct: 175 SENYRSMSYFTEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 234
Query: 259 EP-MNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLY 317
E + K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 235 EDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 294
Query: 318 EASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRSA 375
A+G PLP+NG WH IR G + ++ V S + L+K+MI DP +RPS +L + S
Sbjct: 295 CAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 354
Query: 376 QLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 355 LLSASRKSAEQLRIE 369
|
|
| UNIPROTKB|A7MBC3 WEE1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 130/315 (41%), Positives = 192/315 (60%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 271 DYEFEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCVYAIK 328
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + H+V YFS+W++ + +Q EYCNGG+L + I
Sbjct: 329 RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 388
Query: 209 QERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK------AQGELN 258
E FTE LK LL QV GLR +H M ++HMDIKP+NI I + A E +
Sbjct: 389 SENYRSMSYFTEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 448
Query: 259 EP-MNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLY 317
E + K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 449 EDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 508
Query: 318 EASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRSA 375
A+G PLP+NG WH IR G + ++ V S + L+K+MI DP +RPS +L + S
Sbjct: 509 CAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 568
Query: 376 QLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 569 LLSASRKSAEQLRIE 583
|
|
| UNIPROTKB|F1S6U8 WEE1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 604 (217.7 bits), Expect = 7.3e-59, P = 7.3e-59
Identities = 131/315 (41%), Positives = 194/315 (61%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 271 DYEFEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK 328
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + H+V YFS+W++ + +Q EYCNGG+L + I
Sbjct: 329 RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 388
Query: 209 QE---RCT-FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK------AQGELN 258
E R + FTE LK LL QV GLR +H M ++HMDIKP+NI I + A E +
Sbjct: 389 SENYRRMSYFTEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 448
Query: 259 EP-MNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLY 317
E + K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 449 EDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 508
Query: 318 EASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRSA 375
A+G PLP+NG WH IR G + ++ V S + L+K+MI DP +RPS +L + S
Sbjct: 509 CAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 568
Query: 376 QLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 569 LLSASRKSAEQLRIE 583
|
|
| UNIPROTKB|E2RIU0 WEE1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 603 (217.3 bits), Expect = 9.3e-59, P = 9.3e-59
Identities = 130/315 (41%), Positives = 192/315 (60%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 272 DYELEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK 329
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + H+V YFS+W++ + +Q EYCNGG+L + I
Sbjct: 330 RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 389
Query: 209 QERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK------AQGELN 258
E FTE LK LL QV GLR +H M ++HMDIKP+NI I + A E +
Sbjct: 390 SENYRSMSYFTEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 449
Query: 259 EP-MNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLY 317
E + K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 450 EDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 509
Query: 318 EASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRSA 375
A+G PLP+NG WH IR G + ++ V S + L+K+MI DP +RPS +L + S
Sbjct: 510 CAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 569
Query: 376 QLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 570 LLSASRKSAEQLRIE 584
|
|
| UNIPROTKB|P30291 WEE1 "Wee1-like protein kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 597 (215.2 bits), Expect = 4.0e-58, P = 4.0e-58
Identities = 129/315 (40%), Positives = 191/315 (60%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVK 148
D + D+ P I +I+ +++ SRY GSG+FG VFKC+K +DG YA+K
Sbjct: 271 DYELEDETRPAKRI-TITESNMK-SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIK 328
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
R+K+P+A + E+ +E++AHA+L + H+V YFS+W++ + +Q EYCNGG+L + I
Sbjct: 329 RSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 388
Query: 209 QERCT----FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK------AQGELN 258
E F E LK LL QV GLR +H M ++HMDIKP+NI I + A E +
Sbjct: 389 SENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 448
Query: 259 EP-MNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLY 317
E + K+ +K+GD GHV + +VEEGD R+L E+L N+ +L K DIFAL LT+
Sbjct: 449 EDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVV 508
Query: 318 EASGVTPLPKNGPMWHHIRDGNIEKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSL-RRSA 375
A+G PLP+NG WH IR G + ++ V S + L+K+MI DP +RPS +L + S
Sbjct: 509 CAAGAEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 568
Query: 376 QLA---RNYPQLKVE 387
L+ ++ QL++E
Sbjct: 569 LLSASRKSAEQLRIE 583
|
|
| UNIPROTKB|P47817 wee2-a "Wee1-like protein kinase 2-A" [Xenopus laevis (taxid:8355)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
Identities = 120/299 (40%), Positives = 185/299 (61%)
Query: 95 DHHPVFDIKS--ISSTSIDHSRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVKRTKR 152
+H VF K + T++ SRY G+G+FG VFKC+K +DG YA+KR+K+
Sbjct: 185 EHPAVFQSKRFVLRETNMG-SRYKTEFLEIEKIGAGEFGSVFKCIKRLDGCFYAIKRSKK 243
Query: 153 PVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII---- 208
P+A + E++ +E++AHA+L PH+V Y+S+W++ + +Q EYCNGG+L+++I
Sbjct: 244 PLAGSTDEQLALREVYAHAVLGHHPHVVRYYSAWAEDDHMIIQNEYCNGGSLQDLIVDNN 303
Query: 209 QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP-------M 261
+E E LK++L QVS GL+ +H ++HMDIKP+NI I + Q EL + +
Sbjct: 304 KEGQFVLEQELKEILLQVSMGLKYIHGSGLVHMDIKPSNIFICRKQTELGQEESDGEDDL 363
Query: 262 NTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG 321
++ + YK+GD GHV + + +VEEGD R+L E+L ++ L K DIFALGLT+ A+G
Sbjct: 364 SSGSVLYKIGDLGHVTSILNPQVEEGDSRFLANEILQEDYSQLPKADIFALGLTIALAAG 423
Query: 322 VTPLPKNGPMWHHIRDGNIEKLSNVSDDLH-TLIKLMIDKDPTKRPSTSSLRRSAQLAR 379
PLP N WHHIR GN+ + + + L+KL++ DP RP +SL +++ L R
Sbjct: 424 AAPLPCNEDSWHHIRKGNLPHVPQLLTPIFLALLKLLVHPDPVMRPPAASLAKNSVLRR 482
|
|
| UNIPROTKB|F1MZD1 WEE2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 1.7e-57, P = 1.7e-57
Identities = 123/299 (41%), Positives = 180/299 (60%)
Query: 113 SRYAXXXXXXXXXGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY G GDFG V+KC+K +DG YA+KR+ +P+ + E + E++AHA+
Sbjct: 209 SRYEKEFLEVEKIGVGDFGTVYKCIKRLDGCVYAIKRSTKPLGGLSDETLAMHEVYAHAV 268
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSE 228
L + PH+V Y+S+W++ + +Q EYCNGG+L+ + E F E LK +L Q+S
Sbjct: 269 LGQHPHVVRYYSAWAEDDYMIIQNEYCNGGSLQAAVTENTKSGSHFPEPRLKDILLQISL 328
Query: 229 GLRCMHEMRMIHMDIKPANILIV-KAQGE----LNEPMN------TEKLHYKLGDFGHVI 277
GL+ +H M+H+DIKP+NI I K Q + L E N + + YK+GD GHV
Sbjct: 329 GLKYIHSSGMVHLDIKPSNIFICHKMQSDSPVVLEEAENEADWFFSADVMYKIGDLGHVT 388
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD 337
+ ++ +VEEGD R+L E+L N+ +L K DIFALGLT+ A+G LP NG WHHIR+
Sbjct: 389 SISNPKVEEGDSRFLANEILQENYQHLPKADIFALGLTIAVAAGAELLPTNGTEWHHIRE 448
Query: 338 GNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL-KVENIRGNLN 394
GN+ + +S + H L++ MI DP +RPS ++L +S L P L K E ++ LN
Sbjct: 449 GNLPDIPQELSKEFHQLLESMIHPDPAERPSAAALAKSRVLC---PSLGKTEELQHQLN 504
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.5.1.61 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.5.1 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 480 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-38 | |
| pfam01379 | 213 | pfam01379, Porphobil_deam, Porphobilinogen deamina | 5e-38 | |
| PRK00072 | 295 | PRK00072, hemC, porphobilinogen deaminase; Reviewe | 5e-38 | |
| cd00494 | 292 | cd00494, HMBS, Hydroxymethylbilane synthase (HMBS) | 1e-36 | |
| COG0181 | 307 | COG0181, HemC, Porphobilinogen deaminase [Coenzyme | 4e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-30 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-29 | |
| TIGR00212 | 292 | TIGR00212, hemC, porphobilinogen deaminase | 6e-29 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-26 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-24 | |
| PRK00072 | 295 | PRK00072, hemC, porphobilinogen deaminase; Reviewe | 6e-24 | |
| cd00494 | 292 | cd00494, HMBS, Hydroxymethylbilane synthase (HMBS) | 6e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-24 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-24 | |
| pfam01379 | 213 | pfam01379, Porphobil_deam, Porphobilinogen deamina | 1e-23 | |
| PLN02691 | 351 | PLN02691, PLN02691, porphobilinogen deaminase | 1e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-23 | |
| COG0181 | 307 | COG0181, HemC, Porphobilinogen deaminase [Coenzyme | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-19 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-18 | |
| TIGR00212 | 292 | TIGR00212, hemC, porphobilinogen deaminase | 1e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-15 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| PLN02691 | 351 | PLN02691, PLN02691, porphobilinogen deaminase | 3e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-13 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-12 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-12 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-11 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-10 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-10 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-10 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 8e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-09 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-08 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-08 | |
| PRK01066 | 231 | PRK01066, PRK01066, porphobilinogen deaminase; Pro | 3e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-06 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-06 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| PRK01066 | 231 | PRK01066, PRK01066, porphobilinogen deaminase; Pro | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-05 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-04 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-04 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-04 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.001 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 0.001 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 0.003 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 0.003 | |
| pfam03900 | 72 | pfam03900, Porphobil_deamC, Porphobilinogen deamin | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 5e-47
Identities = 76/263 (28%), Positives = 121/263 (46%), Gaps = 27/263 (10%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
+ LGSG FG V+K G AVK K+ + +++ ++EI LS P+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH-PN 59
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
IV ++ D+ LYL +EYC GG+L + + +E K++ Q+ GL +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPK 294
IH D+KP NIL+ E K+ DFG + + + G Y+
Sbjct: 120 IHRDLKPENILLD------------ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 295 ELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLP---KNGPMWHHIRDG------NIEKLS 344
E+L KVD+++LG+ LYE +G P + R + K S
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 345 NVSDDLHTLIKLMIDKDPTKRPS 367
+ S++ LIK ++KDP+KRP+
Sbjct: 228 SGSEEAKDLIKKCLNKDPSKRPT 250
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-46
Identities = 71/248 (28%), Positives = 109/248 (43%), Gaps = 46/248 (18%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG G FG V+ G A+K K+ +++ E+ +EI L+ P+IV +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE-LLREIEILKKLNH-PNIVKLYG 58
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDI 243
+ D+ LYL +EYC GG+L+++++E +E + ++L Q+ EGL +H +IH D+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR----YLPKELLNN 299
KP NIL+ G KL DFG + Y+ E+L
Sbjct: 119 KPENILLDSDNG-----------KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167
Query: 300 NFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMID 359
K DI++LG+ LYE +L LI+ M+
Sbjct: 168 KGYYSEKSDIWSLGVILYEL----------------------------PELKDLIRKMLQ 199
Query: 360 KDPTKRPS 367
KDP KRPS
Sbjct: 200 KDPEKRPS 207
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 4e-45
Identities = 74/269 (27%), Positives = 124/269 (46%), Gaps = 37/269 (13%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
+ E LG G FG+V+ G A+K K+ +E+I +EI L + P+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERI-LREIKILKKL-KHPN 58
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
IV + + D+ LYL +EYC GG+L +++++R +E + L Q+ L +H +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR-------- 290
+H D+KP NIL+ E H KL DFG +A +++ G+
Sbjct: 119 VHRDLKPENILL------------DEDGHVKLADFG--LAR---QLDPGEKLTTFVGTPE 161
Query: 291 YLPKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPKNGP---MWHHIRDGNIEKLS- 344
Y+ E+L + VDI++LG+ LYE +G P P + ++ I
Sbjct: 162 YMAPEVLLGKGYG--KAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP 219
Query: 345 --NVSDDLHTLIKLMIDKDPTKRPSTSSL 371
++S + LI+ ++ KDP KR +
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-38
Identities = 73/275 (26%), Positives = 128/275 (46%), Gaps = 46/275 (16%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIF-KKEIHAHALLSRV 176
+ + +G G FG+V+ + DG Y +K ++N + +E+ E+ +L ++
Sbjct: 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEVK---ILKKL 56
Query: 177 --PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC----TFTEMALKQLLFQVSEGL 230
P+I+ Y+ S+ ++G L + +EY +GG+L I+++ F E + Q+ L
Sbjct: 57 NHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA---DNDFEVEE- 286
+ +H +++H DIKP NI + T KLGDFG I+ + ++ +
Sbjct: 117 KYLHSRKILHRDIKPQNIFL------------TSNGLVKLGDFG--ISKVLSSTVDLAKT 162
Query: 287 --GDCRYLPKELLNN---NFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWH----HIRD 337
G YL EL N N+ K DI++LG LYE + P G I
Sbjct: 163 VVGTPYYLSPELCQNKPYNY----KSDIWSLGCVLYELCTLKH-PFEGENLLELALKILK 217
Query: 338 GNIEKLSN-VSDDLHTLIKLMIDKDPTKRPSTSSL 371
G + + S +L L+ ++ KDP +RPS + +
Sbjct: 218 GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|216465 pfam01379, Porphobil_deam, Porphobilinogen deaminase, dipyromethane cofactor binding domain | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 5e-38
Identities = 57/88 (64%), Positives = 67/88 (76%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
+ TTGD ILDK L KIG K LFTKELE AL N +D VHSLKD+PTELP GL LGAI +
Sbjct: 37 IKTTGDKILDKPLAKIGGKGLFTKELEEALLNNEIDIAVHSLKDVPTELPEGLVLGAIPK 96
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRDAL+ + +GK+L LP+GSV+
Sbjct: 97 REDPRDALVSS---NGKSLEDLPAGSVV 121
|
Length = 213 |
| >gnl|CDD|234612 PRK00072, hemC, porphobilinogen deaminase; Reviewed | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 5e-38
Identities = 51/88 (57%), Positives = 58/88 (65%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
+ T GD ILD L KIG K LF KELE AL +D VHSLKD+PTELP GL L AI E
Sbjct: 40 IKTKGDKILDVPLAKIGGKGLFVKELEEALLEGEIDIAVHSLKDVPTELPEGLVLAAIPE 99
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRDAL+ K+L LP G+V+
Sbjct: 100 REDPRDALVSRD---YKSLDDLPEGAVV 124
|
Length = 295 |
| >gnl|CDD|238276 cd00494, HMBS, Hydroxymethylbilane synthase (HMBS), also known as porphobilinogen deaminase (PBGD), is an intermediate enzyme in the biosynthetic pathway of tetrapyrrolic ring systems, such as heme, chlorophylls, and vitamin B12 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 56/88 (63%), Positives = 63/88 (71%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
+ TTGD ILDK L KIG K LFTKELE AL N +D VHSLKD+PTELP GL LGAI +
Sbjct: 36 IKTTGDKILDKPLAKIGGKGLFTKELEEALLNGEIDLAVHSLKDVPTELPEGLVLGAIPK 95
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRDAL+ S L LP+GSV+
Sbjct: 96 REDPRDALVSRNGSS---LEDLPAGSVV 120
|
HMBS catalyzes the conversion of porphobilinogen (PBG) into hydroxymethylbilane (HMB). HMBS consists of three domains, and is believed to bind substrate through a hinge-bending motion of domains I and II. HMBS is found in all organisms except viruses. Length = 292 |
| >gnl|CDD|223259 COG0181, HemC, Porphobilinogen deaminase [Coenzyme metabolism] | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 4e-33
Identities = 53/88 (60%), Positives = 59/88 (67%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
+ T GD ILDK L KIG K LFTKELE AL +D VHSLKD+PTELP GL L AI E
Sbjct: 39 IKTKGDRILDKPLSKIGGKGLFTKELEQALLEGEIDIAVHSLKDVPTELPEGLVLAAIPE 98
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRDAL+ G L LP G+V+
Sbjct: 99 REDPRDALVSRD---GYDLEELPEGAVV 123
|
Length = 307 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-31
Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 36/267 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--FKKEIHAHALLSRV--PH 178
ELLG G FG V+ L G AVK + ++ ++E++ ++EI +LS + P+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE--LSGDSEEELEALEREI---RILSSLQHPN 60
Query: 179 IVNYF-SSWS-DQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
IV Y+ S ++ L + LEY +GG+L +++++ E +++ Q+ EGL +H
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCR---- 290
++H DIK ANIL+ KL DFG + D + G R
Sbjct: 121 GIVHRDIKGANILV------------DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHI-RDGNIEKLSNVSD 348
++ E++ + DI++LG T+ E A+G P + G + + G+ + + +
Sbjct: 169 WMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227
Query: 349 DLHTLIKLMIDK----DPTKRPSTSSL 371
L K + K DP KRP+ L
Sbjct: 228 HLSEEAKDFLRKCLRRDPKKRPTADEL 254
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 76/265 (28%), Positives = 120/265 (45%), Gaps = 38/265 (14%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E +G G FGEV+K G A+K K +EKI EI P+IV Y
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIIN-EIQILKKCKH-PNIVKY 62
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ S+ + L++ +E+C+GG+L+++++ T TE + + ++ +GL +H +IH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHR 122
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR--------YLP 293
DIK ANIL+ T KL DFG ++ + R ++
Sbjct: 123 DIKAANILL------------TSDGEVKLIDFGLSA-----QLSDTKARNTMVGTPYWMA 165
Query: 294 KELLNN-NFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKL---SNV 346
E++N +D K DI++LG+T E A G P + PM I L
Sbjct: 166 PEVINGKPYD--YKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKW 223
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSL 371
SD+ +K + K+P KRP+ L
Sbjct: 224 SDEFKDFLKKCLQKNPEKRPTAEQL 248
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 72/263 (27%), Positives = 117/263 (44%), Gaps = 28/263 (10%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG G G V+K G YA+K+ + K +E+ P++V +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKT-LRSCESPYVVKCYG 66
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH-EMRMIHMDI 243
++ +G + + LEY +GG+L +++++ E L + Q+ +GL +H + +IH DI
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126
Query: 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE--GDCRYLPKELLNN 299
KP+N+LI +GE+ K+ DFG V+ + + G Y+ E +
Sbjct: 127 KPSNLLINS-KGEV-----------KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 300 NFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP-----MWHHIRDGNIEKL--SNVSDDLH 351
+ DI++LGLTL E A G P G + I DG L S +
Sbjct: 175 ESYS-YAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 352 TLIKLMIDKDPTKRPSTSSLRRS 374
I + KDP KRPS + L +
Sbjct: 234 DFISACLQKDPKKRPSAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 69/268 (25%), Positives = 120/268 (44%), Gaps = 32/268 (11%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVN 181
LG G +G V+K + D YA+K + + + EI +L+ V P+I++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR---ILASVNHPNIIS 63
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSEGLRCMHEMR 237
Y ++ D L + +EY G+L I +R E + ++ Q+ GL+ +HE +
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYLPKE 295
++H D+K ANIL+V +L K+GD G V+ N + + G Y+ E
Sbjct: 124 ILHRDLKSANILLV--ANDL----------VKIGDLGISKVLKKNMAKTQIGTPHYMAPE 171
Query: 296 LLNNN-FDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHHIRDGNIEKLSNV-SDD 349
+ + K DI++LG LYE + P P + + ++ G + + S D
Sbjct: 172 VWKGRPYS--YKSDIWSLGCLLYEMATFAP-PFEARSMQDLRYKVQRGKYPPIPPIYSQD 228
Query: 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQL 377
L I+ M+ P RP+ + S +
Sbjct: 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|232876 TIGR00212, hemC, porphobilinogen deaminase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 47/88 (53%), Positives = 59/88 (67%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
+ TTGD I DK L IG K LFTKELE AL + +D VHSLKD+PT LP GL + A+L+
Sbjct: 36 IKTTGDKIQDKPLYDIGGKGLFTKELEQALLDGEIDLAVHSLKDVPTVLPEGLEIAAVLK 95
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRD L+ K +L +LP G+ +
Sbjct: 96 REDPRDVLVSRK---YLSLDSLPQGAKV 120
|
Alternate name hydroxymethylbilane synthase Biosynthesis of cofactors, prosthetic groups, and carriers: Heme and porphyrin [Biosynthesis of cofactors, prosthetic groups, and carriers, Heme, porphyrin, and cobalamin]. Length = 292 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 78/269 (28%), Positives = 121/269 (44%), Gaps = 39/269 (14%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL--SRV 176
F E LG G +G V+K + G A+K PV QE KEI ++L
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQE--IIKEI---SILKQCDS 57
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHE 235
P+IV Y+ S+ L++ +EYC G++ +I++ T TE + +L+Q +GL +H
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEEGDC 289
+ IH DIK NIL+ E+ KL DFG +A + + G
Sbjct: 118 NKKIHRDIKAGNILL------------NEEGQAKLADFGVSGQLTDTMAKRNTVI--GTP 163
Query: 290 RYL-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGN-----IEK 342
++ P+ + ++N K DI++LG+T E A G P PM N +
Sbjct: 164 FWMAPEVIQEIGYNN--KADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD 221
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
S + + +K + KDP +RPS L
Sbjct: 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 4e-28
Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 44/277 (15%)
Query: 123 ELLGSGDFGEVFKC-LKYMDGMTY--AVKRTKRPVANTAQEKIFKKEIHAHALLSRV--P 177
+ LG G FGEV+K LK DG T AVK K A+ + K F KE ++ ++ P
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-ASEEERKDFLKEA---RVMKKLGHP 56
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLEN-IIQERCTF-----TEMALKQLL---FQVSE 228
++V +++ LYL LEY GG+L + + + R F + ++LK LL Q+++
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE 286
G+ + + +H D+ N L+ E L K+ DFG + D+D+ ++
Sbjct: 117 GMEYLASKKFVHRDLAARNCLV------------GEDLVVKISDFGLSRDVYDDDYYRKK 164
Query: 287 GDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRD 337
R++ E L + F SK D+++ G+ L+E G TP P N + ++R
Sbjct: 165 TGGKLPIRWMAPESLKDGIFT--SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
G + K D+L+ L+ DP RP+ S L
Sbjct: 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 72/253 (28%), Positives = 110/253 (43%), Gaps = 30/253 (11%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA---LLSRVPH--I 179
LG G FG+V K G YA+K V + K+ H +LSR+ H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMK-----VLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMI 239
V ++ + LYL LEY GG L + + + F+E + ++ L +H + +I
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVE-EGDCRYLPKE 295
+ D+KP NIL+ A G H KL DFG + ++ G YL E
Sbjct: 116 YRDLKPENILL-DADG-----------HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPE 163
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNIEKLSNVSDDLHT 352
+L + VD ++LG+ LYE +G P ++ I + +S +
Sbjct: 164 VLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARD 222
Query: 353 LIKLMIDKDPTKR 365
LI ++ KDPTKR
Sbjct: 223 LISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (279), Expect = 4e-27
Identities = 76/286 (26%), Positives = 121/286 (42%), Gaps = 46/286 (16%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI-FKKEIHAHALLSRV 176
+ LG G FGEV+ D A+K + + + ++E F +EI A L+
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER---CTFTEMALKQLLFQVSEGLRCM 233
P+IV + + D+G LYL +EY +GG+LE+++++ +E +L Q+ L +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----------HVIADNDFE 283
H +IH DIKP NIL+ + + KL DFG
Sbjct: 118 HSKGIIHRDIKPENILL-----------DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPS 166
Query: 284 VEEGDCRYLPKELLNNNFDNL--SKVDIFALGLTLYEA-SGVTPLPKNGP------MWHH 334
G Y+ E+L S DI++LG+TLYE +G+ P
Sbjct: 167 TSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKI 226
Query: 335 IRDGNIEKLSN---------VSDDLHTLIKLMIDKDPTKRPSTSSL 371
I + L++ +S L+K ++ KDP R S+SS
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272
|
Length = 384 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-26
Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
+F +G G FG VFK ++ D YA+K+ N + + E A L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-S 59
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENII--QERCTFTEMALKQLLFQVSEGLRCMHE 235
+I+ Y+ S+ D+G L + +EY G+L ++ Q E + + Q+ GL +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE--GDCRY 291
+++H DIK N+ + + K+GD G +++DN G Y
Sbjct: 120 KKILHRDIKSLNLFL------------DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYY 167
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKN--GPMWHHIRDGNIEKLSN-VS 347
L EL + N K D++ALG+ LYE +G P N G + I G +S S
Sbjct: 168 LSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYS 226
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377
L LI + KD +RP T L R+ L
Sbjct: 227 QQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 4e-26
Identities = 66/298 (22%), Positives = 107/298 (35%), Gaps = 54/298 (18%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRV 176
+F +++G G F V + YA+K KR + + K K E L+
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P I+ + ++ D+ LY LEY G L I++ + E + ++ L +H
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC------- 289
+IH D+KP NIL+ + +H K+ DFG + E +
Sbjct: 122 GIIHRDLKPENILL------------DKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 290 -----------------RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP- 330
Y+ ELLN D++ALG +Y+ +G P G
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPF--RGSN 226
Query: 331 ---MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
+ I N D LI+ ++ DP R + Y +LK
Sbjct: 227 EYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE---------GYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 77/275 (28%), Positives = 120/275 (43%), Gaps = 47/275 (17%)
Query: 118 EFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL--S 174
E + E +G G GEV+K G A+K+ + + +E I EI ++
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR--LRKQNKELIIN-EI---LIMKDC 72
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF---QVSEGLR 231
+ P+IV+Y+ S+ L++ +EY +GG+L +II F M Q+ + +V +GL
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII--TQNFVRMNEPQIAYVCREVLQGLE 130
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR- 290
+H +IH DIK NIL+ K G + KL DFG +E R
Sbjct: 131 YLHSQNVIHRDIKSDNILLSK-DGSV-----------KLADFGFAAQLT----KEKSKRN 174
Query: 291 -------YLPKEL-LNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGN 339
++ E+ ++ KVDI++LG+ E A G P + P+ I
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGP--KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG 232
Query: 340 IEKLSN---VSDDLHTLIKLMIDKDPTKRPSTSSL 371
I L N S + + + KDP KRPS L
Sbjct: 233 IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 81/278 (29%), Positives = 123/278 (44%), Gaps = 53/278 (19%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV------ 176
E +G G FG V K + DG K EK +K+ L+S V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDY---GNMTEK--EKQ----QLVSEVNILREL 56
Query: 177 --PHIVNYFSSWSD--QGVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSE 228
P+IV Y+ D LY+ +EYC GG+L +IQ ER E + ++L Q+
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 229 GL-RCMH-----EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN 280
L C H ++H D+KPANI + + KLGDFG ++ +
Sbjct: 117 ALYEC-HNRSDPGNTVLHRDLKPANIFL------------DANNNVKLGDFGLAKILGHD 163
Query: 281 DFEVEE--GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHH 334
+ G Y+ E LN+ + K DI++LG +YE ++P P +
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDE-KSDIWSLGCLIYELCALSP-PFTARNQLQLASK 221
Query: 335 IRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
I++G ++ S +L+ +IK M++ DP KRPST L
Sbjct: 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 75/270 (27%), Positives = 111/270 (41%), Gaps = 38/270 (14%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
+ +L+G G FG V+K L G A+K+ K +EI LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEID---LLKNLK 57
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P+IV Y S LY+ LEY G+L II++ F E + ++QV +GL +HE
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIA-DNDFEVEEGDCRY 291
+IH DIK ANIL K KL DFG + D G +
Sbjct: 118 QGVIHRDIKAANILTTKDG------------VVKLADFGVATKLNDVSKDDASVVGTPYW 165
Query: 292 LPKELLNNNFDNLS-KVDIFALGLTLYEASGVTPLPKNGP---------MWHHIRDGNIE 341
+ E++ S DI++LG T+ E L N P ++ ++D +
Sbjct: 166 MAPEVIEM--SGASTASDIWSLGCTVIEL-----LTGNPPYYDLNPMAALFRIVQDDHPP 218
Query: 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+S +L + KDP RP+ L
Sbjct: 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQL 248
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 77/261 (29%), Positives = 126/261 (48%), Gaps = 26/261 (9%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTK-RPVANTAQEKIFKKEIHAH-ALLSRVPH-- 178
ELLGSG FG V++ L DG +AVK T QE + K++ ALLS++ H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAV--KQLEQEIALLSKLQHPN 63
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
IV Y + ++ LY+ LE GG+L ++++ +F E ++ Q+ GL +H+
Sbjct: 64 IVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNT 123
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKE 295
+H DIK ANIL V G + KL DFG V+ + + +G ++ E
Sbjct: 124 VHRDIKGANIL-VDTNGVV-----------KLADFGMAKQVVEFSFAKSFKGSPYWMAPE 171
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTP---LPKNGPMWHHIRDGNIEKL-SNVSDDL 350
++ DI++LG T+ E A+G P L ++ R + + ++SD+
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 351 HTLIKLMIDKDPTKRPSTSSL 371
I + +DP+ RP+ + L
Sbjct: 232 KDFILKCLQRDPSLRPTAAEL 252
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 36/270 (13%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTY----AVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
+ LG G FGEV+K G AVK K A+ Q + F +E ++ ++
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-ASEQQIEEFLREA---RIMRKLD 59
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMH 234
P++V +++ LY+ +EY GG+L + +++ R + L Q++ G+ +
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADND-FEVEEGDC-- 289
IH D+ N L+ E L K+ DFG + D+D + G
Sbjct: 120 SKNFIHRDLAARNCLV------------GENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 290 RYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDGN-IEKL 343
R++ E L F SK D+++ G+ L+E G P P N + ++++G + +
Sbjct: 168 RWMAPESLKEGKFT--SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQP 225
Query: 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
N +L+ L+ +DP RP+ S L
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 81/264 (30%), Positives = 129/264 (48%), Gaps = 37/264 (14%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVN 181
++G G FG YA+K + P +++A E K+ + LL+++ P+IV
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAV----LLAKMKHPNIVA 62
Query: 182 YFSSWSDQGVLYLQLEYCNGGNL-ENIIQERCT-FTEMALKQLLFQVSEGLRCMHEMRMI 239
+ S+ G LY+ +EYC+GG+L + I +R F E + Q Q+ G++ +HE R++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVL 122
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEEGDCRYLP 293
H DIK NI + T+ KLGDFG A V G Y+P
Sbjct: 123 HRDIKSKNIFL------------TQNGKVKLGDFGSARLLTSPGAYACTYV--GTPYYVP 168
Query: 294 KELLNNNFDNLSKVDIFALGLTLYEASGVT-PLPKNGPMWHH----IRDGNIEKL-SNVS 347
E+ N N +K DI++LG LYE + P N W + + G+ + L S+ S
Sbjct: 169 PEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANS--WKNLILKVCQGSYKPLPSHYS 225
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSL 371
+L +LIK M ++P RPS +++
Sbjct: 226 YELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 70/259 (27%), Positives = 117/259 (45%), Gaps = 31/259 (11%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRV 176
+F + LG+G FG V G YA+K +K + Q + E +L +
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKR---ILQSI 58
Query: 177 --PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF---QVSEGLR 231
P +VN + S+ D LYL +EY GG L + +++ F E F QV L
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE---PVARFYAAQVVLALE 115
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDC 289
+H + +++ D+KP N+L+ + G + K+ DFG + + + G
Sbjct: 116 YLHSLDIVYRDLKPENLLL-DSDG-----------YIKITDFGFAKRVKGRTYTL-CGTP 162
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNV 346
YL E++ + + VD +ALG+ +YE +G P + P+ + I +G + S
Sbjct: 163 EYLAPEIILSKGYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFF 221
Query: 347 SDDLHTLIKLMIDKDPTKR 365
S D LI+ ++ D TKR
Sbjct: 222 SPDAKDLIRNLLQVDLTKR 240
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 37/271 (13%)
Query: 122 EELLGSGDFGEVFKC-LKYMDGMTY---AVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
+ LG G FGEV+K LK AVK K A+ Q + F +E ++ ++
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-ASEQQIEEFLREA---RIMRKLD 59
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMA-LKQLLFQVSEGLRCM 233
P+IV +++ L + +EY GG+L + +++ R ++ L Q++ G+ +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADND-FEVEEGDC- 289
IH D+ N L+ E L K+ DFG + D+D ++V+ G
Sbjct: 120 ESKNFIHRDLAARNCLV------------GENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 290 -RYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLPKNGP--MWHHIRDGN-IEK 342
R++ E L F SK D+++ G+ L+E G P P + +++ G + K
Sbjct: 168 IRWMAPESLKEGKFT--SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPK 225
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
N +L+ L+ +DP RP+ S L
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|234612 PRK00072, hemC, porphobilinogen deaminase; Reviewed | Back alignment and domain information |
|---|
Score = 100 bits (253), Expect = 6e-24
Identities = 33/63 (52%), Positives = 44/63 (69%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRR AQL P L+++ +RGN++TRL+KLDEG +D IILA AG+ R+ +DRI
Sbjct: 126 TSSLRRQAQLLALRPDLEIKPLRGNVDTRLRKLDEGE-YDAIILAAAGLKRLGLEDRITE 184
Query: 428 VFS 430
Sbjct: 185 YLD 187
|
Length = 295 |
| >gnl|CDD|238276 cd00494, HMBS, Hydroxymethylbilane synthase (HMBS), also known as porphobilinogen deaminase (PBGD), is an intermediate enzyme in the biosynthetic pathway of tetrapyrrolic ring systems, such as heme, chlorophylls, and vitamin B12 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 37/63 (58%), Positives = 45/63 (71%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRR AQL R P LK E +RGN++TRL+KLDEG +D IILA AG+ R+ +DRI
Sbjct: 122 TSSLRRQAQLKRKRPDLKFEPLRGNVDTRLRKLDEGE-YDAIILAAAGLKRLGLEDRITQ 180
Query: 428 VFS 430
S
Sbjct: 181 YLS 183
|
HMBS catalyzes the conversion of porphobilinogen (PBG) into hydroxymethylbilane (HMB). HMBS consists of three domains, and is believed to bind substrate through a hinge-bending motion of domains I and II. HMBS is found in all organisms except viruses. Length = 292 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 74/265 (27%), Positives = 121/265 (45%), Gaps = 34/265 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
+ G +G VF K G YA+K K+ A+ ++ + + +LS+ P++V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKK--ADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ S+ + LYL +EY GG+L ++++ + E + + ++ L +H +IH D
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG--------HVIADNDFEVEEGDC----R 290
+KP NILI + G H KL DFG I ND E E+
Sbjct: 119 LKPDNILI-DSNG-----------HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIE--KLSN 345
Y+ E++ + + VD ++LG LYE G+ P P + +I +G IE +
Sbjct: 167 YIAPEVILGQGHSKT-VDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVE 225
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSS 370
VSD+ LI ++ DP KR S
Sbjct: 226 VSDEAIDLISKLLVPDPEKRLGAKS 250
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 99.9 bits (250), Expect = 7e-24
Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 39/276 (14%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDG----MTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
LE ++ LG G FGEV+K DG AVK K + +E+ F +E ++
Sbjct: 1 LELGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEA---SI 54
Query: 173 LSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEG 229
+ ++ P+IV + LY+ EY GG+L + +++ T L Q+ Q+++G
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEG 287
+ + +H D+ N L+ TE L K+ DFG I ++D+ + G
Sbjct: 115 MEYLESKNFVHRDLAARNCLV------------TENLVVKISDFGLSRDIYEDDYYRKRG 162
Query: 288 DC----RYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDG 338
+++ E L + F SK D+++ G+ L+E G P P N + + DG
Sbjct: 163 GGKLPIKWMAPESLKDGKFT--SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
Query: 339 N-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + N D+L+ L+ DP RP+ S L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|216465 pfam01379, Porphobil_deam, Porphobilinogen deaminase, dipyromethane cofactor binding domain | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 1e-23
Identities = 38/63 (60%), Positives = 47/63 (74%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRRSAQL R P LK E++RGN++TRL+KLDEG +D IILA AG+ R+ +DRI
Sbjct: 123 TSSLRRSAQLKRKRPDLKFESLRGNVDTRLRKLDEGE-YDAIILAAAGLKRLGLEDRITQ 181
Query: 428 VFS 430
S
Sbjct: 182 SLS 184
|
Length = 213 |
| >gnl|CDD|215373 PLN02691, PLN02691, porphobilinogen deaminase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 47/88 (53%), Positives = 58/88 (65%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
+ TTGD ILD+ L IG K LFTKE++ AL + +D VHS+KD+PT LP G L L
Sbjct: 83 IKTTGDKILDQPLADIGGKGLFTKEIDDALLSGRIDIAVHSMKDVPTYLPEGTILPCNLP 142
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
RED RDA I K K+LA LP+GSV+
Sbjct: 143 REDVRDAFISLK---AKSLAELPAGSVV 167
|
Length = 351 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 43/275 (15%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK-EIHAHALLSR 175
LE+L E LG+G+ G V K L G AVK + + Q++I ++ +I
Sbjct: 3 LEYLGE--LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK---CN 57
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMH 234
P+IV ++ ++ + G + + +EY +GG+L+ I++E + E L ++ V +GL +H
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 235 EMR-MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEEG 287
E +IH D+KP+NIL+ ++G++ KL DFG + +A G
Sbjct: 118 EKHKIIHRDVKPSNILV-NSRGQI-----------KLCDFGVSGQLVNSLAKTFV----G 161
Query: 288 DCRYL-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMW-------HHIRDG 338
Y+ P+ + N++ S DI++LGL+L E A+G P P +I +
Sbjct: 162 TSSYMAPERIQGNDYSVKS--DIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNE 219
Query: 339 NIEKLSN--VSDDLHTLIKLMIDKDPTKRPSTSSL 371
+L + S D + L + KDP +RPS L
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 3e-23
Identities = 83/285 (29%), Positives = 122/285 (42%), Gaps = 69/285 (24%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA------NTAQEKIF--KKEIHA 169
F E +G G FGEV+K KRT + VA A+++I ++EI
Sbjct: 2 LFTLLECIGKGSFGEVYKA---------IDKRTNQVVAIKVIDLEEAEDEIEDIQQEI-- 50
Query: 170 HALLS--RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVS 227
LS R P+I Y+ S+ L++ +EYC GG+ +++ + E + +L +V
Sbjct: 51 -QFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVL 108
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-------HVIADN 280
GL +HE IH DIK ANIL+ +G++ KL DFG + N
Sbjct: 109 LGLEYLHEEGKIHRDIKAANILL-SEEGDV-----------KLADFGVSGQLTSTMSKRN 156
Query: 281 DF---------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP 330
F EV + + +D K DI++LG+T E A G PL P
Sbjct: 157 TFVGTPFWMAPEV-----------IKQSGYD--EKADIWSLGITAIELAKGEPPLSDLHP 203
Query: 331 M--WHHIRDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
M I N L + S + L ++KDP +RPS L
Sbjct: 204 MRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKEL 248
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 5e-23
Identities = 79/264 (29%), Positives = 125/264 (47%), Gaps = 29/264 (10%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IV 180
+ +G G FG+++ D +K +++ KKE+ LL+++ H IV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEV---ILLAKMKHPNIV 62
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRM 238
+F+S+ + G L++ +EYC+GG+L I + F+E + Q+S GL+ +H+ ++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKI 122
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND-FEVEE---GDCRYLPK 294
+H DIK NI + K + KLGDFG ND E+ G YL
Sbjct: 123 LHRDIKSQNIFLSK-----------NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 295 ELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHH----IRDGNIEKLS-NVSDD 349
E+ N N +K DI++LG LYE + P G H I G +S N S D
Sbjct: 172 EICQNRPYN-NKTDIWSLGCVLYELCTLKH-PFEGNNLHQLVLKICQGYFAPISPNFSRD 229
Query: 350 LHTLIKLMIDKDPTKRPSTSSLRR 373
L +LI + P RPS +S+ +
Sbjct: 230 LRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|223259 COG0181, HemC, Porphobilinogen deaminase [Coenzyme metabolism] | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 34/63 (53%), Positives = 45/63 (71%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRR AQL P LK+E +RGN++TRL+KLDEG +D IILA AG+ R+ ++RI
Sbjct: 125 TSSLRRQAQLKALRPDLKIEPLRGNVDTRLRKLDEGE-YDAIILAAAGLKRLGLENRITE 183
Query: 428 VFS 430
+
Sbjct: 184 ILD 186
|
Length = 307 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 7e-22
Identities = 86/290 (29%), Positives = 124/290 (42%), Gaps = 74/290 (25%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS--R 175
E ++ +GSG +G+V+K G A+K K + +I ++EI +L R
Sbjct: 6 ELIQR--IGSGTYGDVYKARDIATGELVAIKVIK--LEPGDDFEIIQQEIS---MLKECR 58
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL-----FQVSEGL 230
P+IV YF S+ + L++ +EYC GG+L++I Q T L +L + +GL
Sbjct: 59 HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV----TRGPLSELQIAYVCRETLKGL 114
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIAD-NDF- 282
+HE IH DIK ANIL+ TE KL DFG IA F
Sbjct: 115 AYLHETGKIHRDIKGANILL------------TEDGDVKLADFGVSAQLTATIAKRKSFI 162
Query: 283 --------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMW-- 332
EV +D K DI+ALG+T E + + P PM+
Sbjct: 163 GTPYWMAPEVAA--------VERKGGYD--GKCDIWALGITAIELAELQP-----PMFDL 207
Query: 333 HHIR--------DGNIEKLSNV---SDDLHTLIKLMIDKDPTKRPSTSSL 371
H +R + KL + S H IK + KDP KRP+ + L
Sbjct: 208 HPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKL 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 6e-20
Identities = 73/263 (27%), Positives = 114/263 (43%), Gaps = 36/263 (13%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVNY 182
LG G FGE + D K + + + EI +LS + H I+ Y
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEI---VILSLLQHPNIIAY 64
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENII--QERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
++ + D L +++EY NGG L + I Q+ F E + LFQ+ + +H+ ++H
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILH 124
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-HVIADNDFEVEE---GDCRYLPKEL 296
DIK NI + KA KLGDFG I +++ + E G Y+ EL
Sbjct: 125 RDIKTLNIFLTKAG------------LIKLGDFGISKILGSEYSMAETVVGTPYYMSPEL 172
Query: 297 LNN-NFDNLSKVDIFALGLTLYE------ASGVTPLPKNGPMWHHIRDGNIE-KLSNVSD 348
++ K DI+ALG LYE T + I GN +S S
Sbjct: 173 CQGVKYNF--KSDIWALGCVLYELLTLKRTFDATNPLN---LVVKIVQGNYTPVVSVYSS 227
Query: 349 DLHTLIKLMIDKDPTKRPSTSSL 371
+L +L+ ++ +DP KRP+ +
Sbjct: 228 ELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 36/267 (13%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTK--RPVANTAQEKIFKKEIHAHALLSRV--P 177
E+ +G G F V+K + +DG A+K+ + + A++ K EI LL ++ P
Sbjct: 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EI---DLLKQLDHP 62
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSEGLRCM 233
+++ Y +S+ + L + LE + G+L +I+ ++ E + + Q+ L M
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD--FGHVIADNDFEVEE--GDC 289
H R++H DIKPAN+ I A G + KLGD G + G
Sbjct: 123 HSKRIMHRDIKPANVFI-TATGVV-----------KLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNG----PMWHHIRDGNIEKLS 344
Y+ E ++ N N K DI++LG LYE A+ +P + + I + L
Sbjct: 171 YYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP 229
Query: 345 N--VSDDLHTLIKLMIDKDPTKRPSTS 369
S++L L+ I+ DP KRP S
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDIS 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 2e-19
Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 34/267 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVK--RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
+G G FG+V+ + G AVK R + T +E E+ LL P++V Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKE--IADEMKVLELLKH-PNLVKY 64
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ + +Y+ +EYC+GG LE +++ E ++ Q+ EGL +H ++H D
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRD 124
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN------DFEVEEGDCRYL-P 293
IKPANI + G + KLGDFG + +N + + G Y+ P
Sbjct: 125 IKPANIFLDH-NGVI-----------KLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
Query: 294 KELLNNNFD-NLSKVDIFALGLTLYE-ASGVTPLPKNGPMW---HHIRDGN---IEKLSN 345
+ + + DI++LG + E A+G P + + H+ G+ I
Sbjct: 173 EVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQ 232
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+S + + ++ DP KRP+ S L
Sbjct: 233 LSPEGKDFLDRCLESDPKKRPTASELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 77/270 (28%), Positives = 121/270 (44%), Gaps = 46/270 (17%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
+G G FG+ DG Y +K + + + +KE+ A+LS + P+IV Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEV---AVLSNMKHPNIVQY 64
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENII--QERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
S+ + G LY+ ++YC GG+L I Q F E + Q+ L+ +H+ +++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILH 124
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFEVEE---GDCRYLPKEL 296
DIK NI + K G + KLGDFG + ++ E+ G YL E+
Sbjct: 125 RDIKSQNIFLTK-DGTI-----------KLGDFGIARVLNSTVELARTCIGTPYYLSPEI 172
Query: 297 LNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKL------------- 343
N N +K DI+ALG LYE + H GN++ L
Sbjct: 173 CENRPYN-NKSDIWALGCVLYEMCTLK---------HAFEAGNMKNLVLKIIRGSYPPVS 222
Query: 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
S+ S DL L+ + ++P RPS +S+
Sbjct: 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 69/285 (24%), Positives = 108/285 (37%), Gaps = 56/285 (19%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVNY 182
+G G +G V+K + G A+K+ K + K +EI LL + H I+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREI---KLLKELNHPNIIKL 63
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ +G LYL E+ + +L +I++R E +K L+Q+ +GL H ++H
Sbjct: 64 LDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHR 122
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCR-YLPKELL 297
D+KP N+LI +G L KL DFG + R Y ELL
Sbjct: 123 DLKPENLLI-NTEGVL-----------KLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGV--------------------TPLPKNGP-MWHHI 335
+ + VDI+++G E S TP P+ P
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230
Query: 336 RDGNI-----------EKLSNVSDDLHTLIKLMIDKDPTKRPSTS 369
R+ + N S L+ M+ DP KR +
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAE 275
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 64/258 (24%), Positives = 105/258 (40%), Gaps = 40/258 (15%)
Query: 126 GSGDFGEVF----KCLKYMDGMTYAVKR---TKRPVANTAQEKIFKKEIHAHALLSRVPH 178
G G FG+V + K M M Y K+ K V N E+ +L + H
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNER---------RILQELNH 59
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+VN + S+ D+ +YL ++ GG+L + ++ F+E +K + ++ L +H
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLP 293
+IH DIKP NIL+ E+ H + DF V D G Y+
Sbjct: 120 GIIHRDIKPDNILL------------DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMA 167
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWH----HIRDGNIEKLSNV-S 347
E+L + VD ++LG+T YE G P + ++ S
Sbjct: 168 PEVLCRQGYS-VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWS 226
Query: 348 DDLHTLIKLMIDKDPTKR 365
+ I ++++DP KR
Sbjct: 227 TEAIDAINKLLERDPQKR 244
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 74/282 (26%), Positives = 121/282 (42%), Gaps = 56/282 (19%)
Query: 123 ELLGSGDFGEVFK--CLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
E++G G V+ CL A+KR T+ +++ +KE+ A + + P++V
Sbjct: 7 EVIGVGATAVVYAAICLPN--NEKVAIKRIDLEKCQTSVDEL-RKEVQAMSQCNH-PNVV 62
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQ---ERCTFTEMALKQLLFQVSEGLRCMHEMR 237
Y++S+ L+L + Y +GG+L +I++ R E + +L +V +GL +H
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG 122
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR------- 290
IH DIK NIL+ G + K+ DFG V A + GD
Sbjct: 123 QIHRDIKAGNILL-GEDGSV-----------KIADFG-VSA---SLADGGDRTRKVRKTF 166
Query: 291 -----YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKLS 344
++ E++ K DI++ G+T E A+G P K PM + L
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM-----KVLMLTLQ 221
Query: 345 NVSDDLHT-------------LIKLMIDKDPTKRPSTSSLRR 373
N L T +I L + KDP+KRP+ L +
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 74/267 (27%), Positives = 125/267 (46%), Gaps = 40/267 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS--RVPHIVNY 182
LG G FG+V+K G+ A K + + + + + F EI +LS + P+IV
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ--IESEEELEDFMVEID---ILSECKHPNIVGL 67
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ ++ + L++ +E+C+GG L++I+ E TE ++ + Q+ E L +H ++IH
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKEL 296
D+K NIL+ G++ KL DFG V A N +++ G ++ E+
Sbjct: 128 DLKAGNILLTL-DGDV-----------KLADFG-VSAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 297 LN------NNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNV- 346
+ N +D K DI++LG+TL E A P + PM I L
Sbjct: 175 VACETFKDNPYD--YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPS 232
Query: 347 --SDDLHTLIKLMIDKDPTKRPSTSSL 371
S + +K + KDP RP+ + L
Sbjct: 233 KWSSSFNDFLKSCLVKDPDDRPTAAEL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 81/285 (28%), Positives = 126/285 (44%), Gaps = 54/285 (18%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
+ +E LG G G V KC GM +A+K Q++I ++ + S P
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS--P 59
Query: 178 HIVNYFSSWSD--QGVLYLQLEYCNGGNLENIIQE------RCTFTEMALKQLLFQVSEG 229
+IV Y+ ++ D + + +EYC GG+L++I ++ R E L ++ V +G
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG--EKVLGKIAESVLKG 117
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD--NDFEVE-E 286
L +H ++IH DIKP+NIL+ T K KL DFG V + N
Sbjct: 118 LSYLHSRKIIHRDIKPSNILL------------TRKGQVKLCDFG-VSGELVNSLAGTFT 164
Query: 287 GDCRYL-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKLS 344
G Y+ P+ + + S D+++LGLTL E A P P G G IE LS
Sbjct: 165 GTSFYMAPERIQGKPYSITS--DVWSLGLTLLEVAQNRFPFPPEGEP----PLGPIELLS 218
Query: 345 NV------------------SDDLHTLIKLMIDKDPTKRPSTSSL 371
+ S++ IK ++KDPT+RP+ +
Sbjct: 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDM 263
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|232876 TIGR00212, hemC, porphobilinogen deaminase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 35/63 (55%), Positives = 43/63 (68%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRR AQL P LK+E +RGN++TRL+KLDEG D IILA AG+ R+ +D I
Sbjct: 122 TSSLRRKAQLKAIRPDLKIEPLRGNIDTRLRKLDEGEY-DAIILAEAGLKRLGLEDVITE 180
Query: 428 VFS 430
V
Sbjct: 181 VLD 183
|
Alternate name hydroxymethylbilane synthase Biosynthesis of cofactors, prosthetic groups, and carriers: Heme and porphyrin [Biosynthesis of cofactors, prosthetic groups, and carriers, Heme, porphyrin, and cobalamin]. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 73/277 (26%), Positives = 130/277 (46%), Gaps = 42/277 (15%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
+E L+E LG G++G V+K L G+T A+K + + + +I + H +S
Sbjct: 3 IEVLDE--LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-- 58
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT---EMALKQLLFQVSEGLRCM 233
P+IV+++ ++ +G +Y+ +EY + G+L+ + E L+++ + V +GL+ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 234 HE-MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEE 286
E +IH D+KP N+L V G++ KL DFG +A +
Sbjct: 119 KEEHNIIHRDVKPTNVL-VNGNGQV-----------KLCDFGVSGNLVASLAKTNI---- 162
Query: 287 GDCRYLPKELLN--NNFDNLS---KVDIFALGLTLYE-ASGVTPLPKNG-----PMWHHI 335
G Y+ E + N + + D+++LGL++ E A G P P I
Sbjct: 163 GCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222
Query: 336 RDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
DG+ L S SDD + ++K P +RP+ + L
Sbjct: 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-17
Identities = 73/260 (28%), Positives = 111/260 (42%), Gaps = 28/260 (10%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYF 183
++G G FG V C + D +K+ + + E LLS P+I+ Y+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYY 65
Query: 184 SSWSDQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ + L + +EY GG L IQ+RC E + Q+ L +H ++H
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHR 125
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELLN 298
D+K NIL ++ K+ K+GDFG + + + G Y+ EL
Sbjct: 126 DLKTQNIL-----------LDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCE 174
Query: 299 NNFDNLSKVDIFALGLTLYE------ASGVTPLPKNGPMWHHIRDGNIEKLSN-VSDDLH 351
N K DI+ALG LYE A LP + I G +S+ S DL
Sbjct: 175 GKPYN-QKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMSGTFAPISDRYSPDLR 230
Query: 352 TLIKLMIDKDPTKRPSTSSL 371
LI M++ DP+KRP S +
Sbjct: 231 QLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-17
Identities = 73/256 (28%), Positives = 117/256 (45%), Gaps = 33/256 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRP--VANTAQEKIF-KKEIHAHALLSRVPHIVN 181
LG G FG V T+A+K K+ V QE IF +KEI P IV
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC---NHPFIVK 57
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ ++ D+ +Y+ +EYC GG L I+++R F E + + V +H +I+
Sbjct: 58 LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKEL 296
D+KP N+L+ + G + KL DFG A ++ G Y+ E+
Sbjct: 118 DLKPENLLL-DSNGYV-----------KLVDFG--FAKKLKSGQKTWTFCGTPEYVAPEI 163
Query: 297 LNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPM--WHHIRDGN--IEKLSNVSDD 349
+ N + S VD ++LG+ LYE +G P PM ++ I GN +E + +
Sbjct: 164 ILNKGYDFS-VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKA 222
Query: 350 LHTLIKLMIDKDPTKR 365
LIK ++ ++P +R
Sbjct: 223 AKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-17
Identities = 72/262 (27%), Positives = 125/262 (47%), Gaps = 29/262 (11%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
+G G +GEV DG Y +K+ A+ + K ++E LLS++ P+IV Y
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ---LLSQLKHPNIVAY 64
Query: 183 FSSWS-DQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMI 239
SW + G+LY+ + +C GG+L + ++E+ E + + Q++ L+ +HE ++
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFEVEE---GDCRYLPKE 295
H D+K N+ + + K+GD G + +N ++ G Y+ E
Sbjct: 125 HRDLKTQNVFLTRTN------------IIKVGDLGIARVLENQCDMASTLIGTPYYMSPE 172
Query: 296 LLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPM---WHHIRDGNIEKL-SNVSDDLH 351
L +N N K D++ALG +YE + + M + I +G + + + S +L
Sbjct: 173 LFSNKPYNY-KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELG 231
Query: 352 TLIKLMIDKDPTKRPSTSSLRR 373
LI M+ K P KRPS S+ R
Sbjct: 232 ELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 82/298 (27%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG G FG V+ G A+K+ K+ + +E + +E+ + L+ P+IV
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ + LY EY G NL ++++R F+E ++ +++Q+ +GL +H+ H D
Sbjct: 66 VFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRD 124
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYL------- 292
+KP N+L+ E + K+ DFG + + + Y+
Sbjct: 125 LKPENLLV----------SGPEVV--KIADFGLAREIRSRPPYTD------YVSTRWYRA 166
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEASGVTPL-------------------PKNGPMW- 332
P+ LL + + S VDI+ALG + E + PL P W
Sbjct: 167 PEILLRSTSYS-SPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD-WP 224
Query: 333 ---------------------HHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTS 369
H + + N S + LIK M+ DP KRP+ S
Sbjct: 225 EGYKLASKLGFRFPQFAPTSLHQL-------IPNASPEAIDLIKDMLRWDPKKRPTAS 275
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 67/249 (26%), Positives = 106/249 (42%), Gaps = 27/249 (10%)
Query: 128 GDFGEVFKCLKYMDGMTYAVKRTKRP-VANTAQEKIFKKEIHAHALLSRVPHIVNYFSSW 186
G FG V+ K G +A+K K+ + Q K E + P++ + S+
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 187 SDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPA 246
+ LYL +EY NGG+ ++I+ E KQ + +V G+ +H+ +IH DIKP
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126
Query: 247 NILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELLNNNFDN 303
N+LI + H KL DFG + + + F G YL E + D+
Sbjct: 127 NLLI------------DQTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGDD 171
Query: 304 LSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNI----EKLSNVSDDLHTLIKL 356
D ++LG ++E G P P ++ +I I E S + LI
Sbjct: 172 -KMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230
Query: 357 MIDKDPTKR 365
++ DP KR
Sbjct: 231 LLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 51/272 (18%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN---TAQEKIFKKEIHAHALLSRVPHIVN 181
+GSG +G+V+K G AVK K + Q++IF + H +IV
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC------NIVA 70
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
YF S+ + L++ +EYC GG+L++I +E+ + + + +GL +H +H
Sbjct: 71 YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHR 130
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKEL 296
DIK ANIL+ T+ KL DFG V A + + G ++ E+
Sbjct: 131 DIKGANILL------------TDNGDVKLADFG-VAAKITATIAKRKSFIGTPYWMAPEV 177
Query: 297 L----NNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMW--HHIRDGNIEKLSNV---- 346
N ++ L DI+A+G+T E + + P PM+ H +R + SN
Sbjct: 178 AAVEKNGGYNQL--CDIWAVGITAIELAELQP-----PMFDLHPMRALFLMSKSNFQPPK 230
Query: 347 -------SDDLHTLIKLMIDKDPTKRPSTSSL 371
S H +K+ + K+P KRP+ L
Sbjct: 231 LKDKTKWSSTFHNFVKISLTKNPKKRPTAERL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 9e-16
Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
F + E +G G FGEVFK + A+K A E I ++EI +LS+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDI-QQEI---TVLSQCDS 61
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P++ Y+ S+ L++ +EY GG+ ++++ F E + +L ++ +GL +H
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSE 120
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----GDCRYL 292
+ IH DIK AN+L+ +E+ KL DFG D +++ G ++
Sbjct: 121 KKIHRDIKAANVLL------------SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 293 PKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLS-NVS 347
E++ + +D SK DI++LG+T E A G P PM I N L+ S
Sbjct: 169 APEVIQQSAYD--SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFS 226
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380
I ++KDP+ RP+ L + + +N
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 73/273 (26%), Positives = 120/273 (43%), Gaps = 53/273 (19%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTK----RPVANTAQEKIFKKEIHAHALLSRVPHIV 180
+GSG +G+V+K G A+K K A QE I K+ + +IV
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKD-------CKHSNIV 69
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
YF S+ + L++ +E+C GG+L++I +E + + + +GL +H +H
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMH 129
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKE 295
DIK ANIL+ T+ H KL DFG V A + + G ++ E
Sbjct: 130 RDIKGANILL------------TDNGHVKLADFG-VSAQITATIAKRKSFIGTPYWMAPE 176
Query: 296 LL----NNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMW--HHIRDGNIEKLSNV--- 346
+ ++ L DI+A+G+T E + + P PM+ H +R + SN
Sbjct: 177 VAAVERKGGYNQL--CDIWAVGITAIELAELQP-----PMFDLHPMRALFLMTKSNFQPP 229
Query: 347 --------SDDLHTLIKLMIDKDPTKRPSTSSL 371
S+ H +K+ + K+P KRP+ L
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKL 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 51/157 (32%), Positives = 73/157 (46%), Gaps = 24/157 (15%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFK--KEIHAHALLSRVPHIV 180
++G G FGEV+ G YA+K K + Q + ++I A A P IV
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA---DSPWIV 64
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCMHEMR 237
+ S+ D+ LYL +EY GG+L N++ + F E + F ++E L +H++
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETAR---FYIAELVLALDSVHKLG 121
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
IH DIKP NILI H KL DFG
Sbjct: 122 FIHRDIKPDNILI------------DADGHIKLADFG 146
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 32/268 (11%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
F E+ +G G F EV++ +DG+ A+K+ + + + K I LL ++
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ--IFDLMDAKARADCIKEIDLLKQLNH 61
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENII----QERCTFTEMALKQLLFQVSEGLRC 232
P+++ Y++S+ + L + LE + G+L +I +++ E + + Q+ L
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD--FGHVIADNDFEVEE--GD 288
MH R++H DIKPAN+ I A G + KLGD G + G
Sbjct: 122 MHSRRVMHRDIKPANVFIT-ATGVV-----------KLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKL----- 343
Y+ E ++ N N K DI++LG LYE + + M + IE+
Sbjct: 170 PYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 228
Query: 344 --SNVSDDLHTLIKLMIDKDPTKRPSTS 369
+ S++L L+ + I+ DP KRP +
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-15
Identities = 76/273 (27%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
F + E +G G FGEVFK + A+K A E I ++EI +LS+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEI---TVLSQCDS 61
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P++ Y+ S+ L++ +EY GG+ +++ E E + +L ++ +GL +H
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSE 120
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----GDCRYL 292
+ IH DIK AN+L+ +E KL DFG D +++ G ++
Sbjct: 121 KKIHRDIKAANVLL------------SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 293 PKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLS-NVS 347
E++ + +D SK DI++LG+T E A G P + PM I N L N S
Sbjct: 169 APEVIKQSAYD--SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYS 226
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380
L ++ ++K+P+ RP+ L + + R
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 76/272 (27%), Positives = 128/272 (47%), Gaps = 42/272 (15%)
Query: 124 LLGSGDFGEVFK-CLKYMDG-----MTYAVKRTKRPVANTAQEKI-FKKEIHAHALLSRV 176
LGSG FGEV++ + G + AVK ++ T QEK F KE H L+S
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAH---LMSNF 56
Query: 177 --PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLL---FQVS 227
P+IV Y+ +E GG+L + ++ ER + LK+LL V+
Sbjct: 57 NHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--IADNDFEVE 285
+G + +M IH D+ N L+ + + + + K+GDFG I +D+ +
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVV-------KIGDFGLARDIYKSDYYRK 169
Query: 286 EGD----CRYL-PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIR 336
EG+ R++ P+ LL+ F S D+++ G+ ++E G P P N + H+
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQS--DVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227
Query: 337 D-GNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
G ++K N D ++ L+ +DP++RP+
Sbjct: 228 AGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 70/275 (25%), Positives = 114/275 (41%), Gaps = 47/275 (17%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA----LLSRVPH 178
+LLG G FG V+ C G AVK+ P + E KKE++A LL + H
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPET--KKEVNALECEIQLLKNLQH 63
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
IV Y+ D L + +EY GG++++ ++ TE ++ Q+ EG+ +H
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR------ 290
++H DIK ANIL + G + KLGDFG +
Sbjct: 124 MIVHRDIKGANIL-RDSAGNV-----------KLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 291 -YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHI-----------RDG 338
++ E+++ K D++++G T+ E + P W +
Sbjct: 172 YWMSPEVISGEGYG-RKADVWSVGCTVVE------MLTEKPPWAEFEAMAAIFKIATQPT 224
Query: 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
N + S+VS D ++ ++ KRPS L R
Sbjct: 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
++G G +G V KC G A+K+ K + +K +E+ L R +IVN
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNL 65
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
++ +G LYL EY LE + A++ ++Q+ + + H +IH D
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRD 125
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
IKP NIL+ ++ G L KL DFG
Sbjct: 126 IKPENILVSES-GVL-----------KLCDFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 70/284 (24%), Positives = 129/284 (45%), Gaps = 42/284 (14%)
Query: 122 EELLGSGDFGEVFKCLKYMDG--MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
E+++G G+FG+V + + DG M A+K K A+ + F E+ L P+I
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNI 65
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENII-------------QERCTFTEMALKQLL--- 223
+N + ++G LY+ +EY GNL + + +E T + + +QLL
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF- 282
V+ G++ + E + IH D+ N+L+ E L K+ DFG + +
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLV------------GENLASKIADFGLSRGEEVYV 173
Query: 283 --EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHHIR 336
+ R++ E LN + +K D+++ G+ L+E + P G ++ +
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP 232
Query: 337 DG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379
G +EK N D+++ L++ P +RP + + S QL+R
Sbjct: 233 QGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI--SVQLSR 274
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 68/279 (24%), Positives = 121/279 (43%), Gaps = 38/279 (13%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
F E+ +G G F EV++ +D A+K+ + + K + + LL ++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ--IFEMMDAKARQDCVKEIDLLKQLN 60
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENII----QERCTFTEMALKQLLFQVSEGLR 231
P+++ Y S+ + L + LE + G+L +I +++ E + + Q+ +
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----- 286
MH R++H DIKPAN+ I A G + KLGD G F +
Sbjct: 121 HMHSRRVMHRDIKPANVFIT-ATGVV-----------KLGDLG---LGRFFSSKTTAAHS 165
Query: 287 --GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGV-TPLPKNG----PMWHHIRDGN 339
G Y+ E ++ N N K DI++LG LYE + + +P + + I +
Sbjct: 166 LVGTPYYMSPERIHENGYNF-KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD 224
Query: 340 IEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376
L + S+ L L+ + I DP +RP + + A+
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 68/276 (24%), Positives = 121/276 (43%), Gaps = 51/276 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-----VP 177
EL+G G +G V++ G A+K + I ++E+ ALLS+ P
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDI-QREV---ALLSQLRQSQPP 62
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENI-----IQERCTFTEMALKQLLFQVSEGLRC 232
+I Y+ S+ L++ +EY GG++ + I E+ + ++++L L+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYI--SVIIREVLV----ALKY 116
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR-- 290
+H++ +IH DIK ANIL+ T + KL DFG V A + + +
Sbjct: 117 IHKVGVIHRDIKAANILV------------TNTGNVKLCDFG-VAA----LLNQNSSKRS 159
Query: 291 -------YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI 340
++ E++ +K DI++LG+T+YE A+G P I
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP 219
Query: 341 EKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374
+L + S L + +D++P +R S L +S
Sbjct: 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 38/266 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG G FG+V+K G A K + ++ + + EI A P+IV
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC---NHPYIVKLLG 76
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDI 243
++ G L++ +E+C GG ++ I+ E TE ++ + Q+ E L+ +H M++IH D+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC-----RYLPKELL- 297
K N+L+ G++ KL DFG V A N ++ D ++ E++
Sbjct: 137 KAGNVLLTL-DGDI-----------KLADFG-VSAKNVKTLQRRDSFIGTPYWMAPEVVM 183
Query: 298 -----NNNFDNLSKVDIFALGLTLYEASGVTPLPKN--GPMWHHIRDGNIE-----KLSN 345
+ +D K DI++LG+TL E + + P P + PM ++ E + S
Sbjct: 184 CETMKDTPYD--YKADIWSLGITLIEMAQIEP-PHHELNPMRVLLKIAKSEPPTLSQPSK 240
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSL 371
S + +K +DK P RPS + L
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 67/270 (24%), Positives = 131/270 (48%), Gaps = 41/270 (15%)
Query: 125 LGSGDFGEVFKCLKYMDG-----MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
LG+G FG+V + Y M AVK K P A++++ + E+ + L +I
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK-PTAHSSEREALMSELKIMSHLGNHENI 101
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENII-QERCTFTEMALKQLL---FQVSEGLRCMHE 235
VN + + G + + EYC G+L N + ++R +F + L+ LL +QV++G+ +
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF--LTLEDLLSFSYQVAKGMAFLAS 159
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCR-- 290
IH D+ N+L+ G++ K+ DFG ++ D+++ V +G+ R
Sbjct: 160 KNCIHRDLAARNVLL--THGKI----------VKICDFGLARDIMNDSNY-VVKGNARLP 206
Query: 291 ---YLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTP---LPKNGPMWHHIRDG-NIE 341
P+ + N + S D+++ G+ L+E + G P +P + + I++G +
Sbjct: 207 VKWMAPESIFNCVYTFES--DVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMA 264
Query: 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ + +++ ++K D DP KRP+ +
Sbjct: 265 QPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 77/288 (26%), Positives = 122/288 (42%), Gaps = 36/288 (12%)
Query: 108 TSIDHSRYALEFLE-EELLGSGDFGEVFKCLKYMDGMTYAVKRTKR-------PVANTAQ 159
T D S + L E E LG+G FG V G YA+K K+ V + AQ
Sbjct: 8 TKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ 67
Query: 160 EKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMAL 219
EK E+ +H P IVN S+ D+ +Y LE+ GG L +++ F
Sbjct: 68 EKSILMEL-SH------PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 220 KQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--I 277
K ++ +H +I+ D+KP N+L+ +G H K+ DFG +
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLL-DNKG-----------HVKVTDFGFAKKV 168
Query: 278 ADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHH 334
D F + G YL E++ + VD + +G+ LYE +G P + P +
Sbjct: 169 PDRTFTL-CGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK 226
Query: 335 IRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
I G ++ + L+K ++ D TKR +L+ +N+P
Sbjct: 227 ILAGRLKFPNWFDGRARDLVKGLLQTDHTKR--LGTLKGGVADVKNHP 272
|
Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 80/290 (27%), Positives = 126/290 (43%), Gaps = 41/290 (14%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI-FKKEIHAH---ALLSRVPH- 178
+G+G FG V + YA+K P E I K+E H H +L V H
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIP------EVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 179 -IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT-EMALKQLLFQVSE---GLRCM 233
I+ F + DQ LY+ +EY GG L + ++ F+ LF SE L +
Sbjct: 62 FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCALEYL 117
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--IADNDFEVEEGDCRY 291
H +++ D+KP NIL+ K +G H KL DFG + D + + G Y
Sbjct: 118 HSKEIVYRDLKPENILLDK-EG-----------HIKLTDFGFAKKLRDRTWTL-CGTPEY 164
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348
L E++ + N VD +ALG+ +YE G P + P ++ I G +E ++
Sbjct: 165 LAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDL 223
Query: 349 DLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLK 398
LIK ++ D T+R +++ A +N+ K + +LK
Sbjct: 224 YAKDLIKKLLVVDRTRR--LGNMKNGADDVKNHRWFKSVDWDDVPQRKLK 271
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 70/268 (26%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH----ALLSRV--P 177
L+GSG FG V+ + G AVK+ + P + + + + + A ALL +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+IV Y S D L + LEY GG++ ++ F E ++ + Q+ +GL +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCR----- 290
+IH DIK ANIL V +G + K+ DFG + N + R
Sbjct: 127 IIHRDIKGANIL-VDNKGGI-----------KISDFGISKKLEANSLSTKTNGARPSLQG 174
Query: 291 ---YLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHHIRDGNI---EKL 343
++ E++ K DI++LG + E +G P P + + G E
Sbjct: 175 SVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIP 233
Query: 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
SN+S + ++ + D KRP+ + L
Sbjct: 234 SNISSEAIDFLEKTFEIDHNKRPTAAEL 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 69/287 (24%), Positives = 123/287 (42%), Gaps = 58/287 (20%)
Query: 123 ELLGSGDFGEVFK-----CLKYMDGMTYAVKRTKRPVANTAQEKIFK---KEIHAHALLS 174
+ LG G FG+V K + T AVK K + A EK E+ ++
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK----DDATEKDLSDLVSEMEMMKMIG 73
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----------------CTFTEMA 218
+ +I+N + +G LY+ +EY GNL + ++ R T T+
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-- 276
L +QV+ G+ + + IH D+ N+L+ TE K+ DFG
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLV------------TEDHVMKIADFGLARD 181
Query: 277 IADNDFEVEEGDCR----YLPKELLNNNFDNL--SKVDIFALGLTLYE--ASGVTPLPKN 328
I D+ + + R ++ E L FD + + D+++ G+ L+E G +P P
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEAL---FDRVYTHQSDVWSFGVLLWEIFTLGGSPYP-G 237
Query: 329 GPMWH---HIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
P+ +++G +EK N + +L+ L++ + P++RP+ L
Sbjct: 238 IPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|215373 PLN02691, PLN02691, porphobilinogen deaminase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 30/63 (47%), Positives = 42/63 (66%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
T+SLRR +Q+ YP LKV N RGN+ TRL+KL EG V D +LA+AG+ R+ + +
Sbjct: 169 TASLRRQSQILHKYPHLKVVNFRGNVQTRLRKLQEGVV-DATLLALAGLKRLDMTEHATS 227
Query: 428 VFS 430
+ S
Sbjct: 228 ILS 230
|
Length = 351 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 69/256 (26%), Positives = 114/256 (44%), Gaps = 31/256 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKR-------TKRPVANTAQEKIFKKEIHAHALLSRVP 177
+G G FG+V++ K YA+K K+ VA+T E+ I LL P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGER----NILVRTLLDESP 56
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
IV S+ LYL +Y +GG L +Q+ F+E K + ++ L +H+
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLP 293
+++ D+KP NIL+ A G H L DFG ++ + G YL
Sbjct: 117 IVYRDLKPENILL-DATG-----------HIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNIEKLSNV-SDD 349
E+L + VD ++LG+ ++E G +P M+ +I G + NV SD+
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDE 224
Query: 350 LHTLIKLMIDKDPTKR 365
+K +++++P R
Sbjct: 225 GRQFVKGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (171), Expect = 4e-13
Identities = 71/293 (24%), Positives = 114/293 (38%), Gaps = 65/293 (22%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK---KEIHAHALLSR 175
+ + E LG G +G V+K G A+K+ + + +E I +EI +LL
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR---LDNEEEGIPSTALREI---SLLKE 54
Query: 176 V--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSEGLRC 232
+ P+IV + LYL EYC+ +L+ + +R + +K +++Q+ GL
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGD 288
H R++H D+KP NILI + G L KL DFG I + E
Sbjct: 114 CHSHRILHRDLKPQNILINRD-GVL-----------KLADFGLARAFGIPLRTYTHEVVT 161
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYEA----------------------------- 319
Y E+L + + VDI+++G E
Sbjct: 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEE 221
Query: 320 --SGVTPLP---KNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
GVT LP P + + L + + L+ M+ +P KR S
Sbjct: 222 SWPGVTKLPDYKPTFPKFPPKDLE--KVLPRLDPEGIDLLSKMLQYNPAKRIS 272
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 72/255 (28%), Positives = 117/255 (45%), Gaps = 29/255 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPH--I 179
+++G G FG+V + YAVK K+ + +EK E + LL V H +
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE--RNVLLKNVKHPFL 58
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
V S+ LY L+Y NGG L +Q ERC F E + +++ L +H + +
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRERC-FLEPRARFYAAEIASALGYLHSLNI 117
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPK 294
++ D+KP NIL+ +QG H L DFG ++ + G YL
Sbjct: 118 VYRDLKPENILL-DSQG-----------HIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
Query: 295 ELLNNN-FDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLSNVSDDL 350
E+L+ +D VD + LG LYE G+ P M+ +I + ++ N+++
Sbjct: 166 EVLHKQPYDR--TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSA 223
Query: 351 HTLIKLMIDKDPTKR 365
L++ ++ KD TKR
Sbjct: 224 RHLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 4e-13
Identities = 75/294 (25%), Positives = 126/294 (42%), Gaps = 47/294 (15%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----L 173
F + +LG G FGEV C G YA K+ ++ ++I K++ + AL L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK-------KRIKKRKGESMALNEKQIL 54
Query: 174 SRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSE- 228
+V +V+ ++ + L L L NGG+L+ I F E + +F +E
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEI 111
Query: 229 --GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFE 283
GL +H+ R+++ D+KP NIL+ + H ++ D G HV +
Sbjct: 112 CCGLEDLHQERIVYRDLKPENILL------------DDHGHIRISDLGLAVHVPEGQTIK 159
Query: 284 VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLP------KNGPMWHHIR 336
G Y+ E++ N S D +ALG LYE +G +P K + ++
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 218
Query: 337 DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIR 390
+ E S D +L K+++ KDP +R A+ + +P K N +
Sbjct: 219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQG--GGAREVKEHPLFKQINFK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 42/283 (14%)
Query: 123 ELLGSGDFGEVFKCLKYMDG--MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
+++G G+FG+V K DG M A+KR K A+ + F E+ L P+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENII-------------QERCTFTEMALKQLLFQVS 227
N + +G LYL +EY GNL + + T + ++ +QLL +
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 228 E---GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF-- 282
+ G+ + + + IH D+ NIL+ E K+ DFG +
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILV------------GENYVAKIADFGLSRGQEVYVK 167
Query: 283 -EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHHIRD 337
+ R++ E LN + + D+++ G+ L+E + P G ++ +
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 226
Query: 338 G-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379
G +EK N D+++ L++ + P +RPS + + L R
Sbjct: 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI--LVSLNR 267
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 29/255 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA--HALLSRVPH-- 178
+++G G FG+V + +DG YAVK ++ + +E+ K I A + LL V H
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ---KHIMAERNVLLKNVKHPF 57
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
+V S+ LY L++ NGG L +Q +F E + +++ L +H + +
Sbjct: 58 LVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEE-GDCRYLPK 294
++ D+KP NIL+ +QG H L DFG IA +D G YL
Sbjct: 118 VYRDLKPENILL-DSQG-----------HVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAP 165
Query: 295 ELLNNN-FDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLSNVSDDL 350
E++ +DN VD + LG LYE G+ P M+ +I + S
Sbjct: 166 EVIRKQPYDN--TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTA 223
Query: 351 HTLIKLMIDKDPTKR 365
++++ +++KD +R
Sbjct: 224 WSILEELLEKDRQRR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 58/199 (29%), Positives = 95/199 (47%), Gaps = 43/199 (21%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA-----LLSRV- 176
+++G G FGEV K G YA+K+ ++ ++ +KE AH +L+
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRK-------SEMLEKEQVAHVRAERDILAEAD 59
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRC 232
P +V + S+ D+ LYL +EY GG++ ++ ++ TFTE ++ F ++E +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTE---EETRFYIAETILAIDS 116
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-----HVIADNDFEVEEG 287
+H++ IH DIKP N+L+ A+G H KL DFG +F
Sbjct: 117 IHKLGYIHRDIKPDNLLL-DAKG-----------HIKLSDFGLCTGLKKSHRTEFY---- 160
Query: 288 DCRYLPKELLNNNFDNLSK 306
R L L +N D +SK
Sbjct: 161 --RILSHALPSNFLDFISK 177
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 46/280 (16%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
F + E +G G FGEV+K + A+K A E I ++EI +LS+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDI-QQEI---TVLSQCDS 61
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P+I Y+ S+ L++ +EY GG+ ++++ E + +L ++ +GL +H
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSE 120
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----GDCRYL 292
R IH DIK AN+L+ + QG++ KL DFG D +++ G ++
Sbjct: 121 RKIHRDIKAANVLLSE-QGDV-----------KLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTP------------LPKNGPMWHHIRDGN 339
E++ + + K DI++LG+T E A G P +PKN P
Sbjct: 169 APEVIKQSAYDF-KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------PT 220
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379
+E S ++ ++KDP RP+ L + + R
Sbjct: 221 LE--GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 73/270 (27%), Positives = 116/270 (42%), Gaps = 34/270 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
+G G FG+V + K YA+K ++ A+ + +L++V P IV
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
S+ LYL L + NGG L + +Q F + ++ L +H+ +I+ D
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPKELLN 298
+KP NIL+ QG H L DFG ++ D+ G YL ELL
Sbjct: 119 LKPENILL-DYQG-----------HIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLL 166
Query: 299 NNFDNLSK-VDIFALGLTLYEASGVTPLP----KNGP-MWHHIRDGNIEKLSNVSDDLHT 352
+ +K VD + LG+ LYE +T LP +N M+ I + D
Sbjct: 167 GH--GYTKAVDWWTLGVLLYEM--LTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKD 222
Query: 353 LIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
L+ ++ +DPT+R + AQ +N+P
Sbjct: 223 LLIGLLSRDPTRRLGYN----GAQEIKNHP 248
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 70/285 (24%), Positives = 114/285 (40%), Gaps = 41/285 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-------P 177
LG G FGEV C G YA K+ + +++ K++ AL +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDK-------KRLKKRKGEQMALNEKKILEKVSSR 53
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRCMHE 235
IV+ ++ + L L + NGG+L+ I F E Q+ GL +H+
Sbjct: 54 FIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYL 292
R+++ D+KP N+L+ + + ++ D G + + G Y+
Sbjct: 114 RRIVYRDLKPENVLL------------DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYM 161
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLP------KNGPMWHHIRDGNIEKLSN 345
E+L + S VD FALG TLYE +G +P + + + +E
Sbjct: 162 APEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK 220
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIR 390
S + L + ++ KDP KR SA R +P K N R
Sbjct: 221 FSPEAKDLCEALLQKDPEKR--LGCRGGSADEVREHPLFKDLNWR 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 67/264 (25%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 125 LGSGDFGEVF---KCLKYMDGMTYAVKRTKRPV----ANTAQEKIFKKEIHAHALLSRVP 177
LG+G +G+VF K + G YA+K K+ A TA+ ++++ + R P
Sbjct: 8 LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA--VRRCP 65
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+V ++ L+L L+Y NGG L + +R FTE ++ + ++ L +H++
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD-----C--- 289
+I+ DIK NIL+ + H L DFG +F EE + C
Sbjct: 126 IIYRDIKLENILL------------DSEGHVVLTDFG---LSKEFLAEEEERAYSFCGTI 170
Query: 290 RYLPKELLNNNFDNLSK-VDIFALGLTLYE-ASGVTPLPKNGP------MWHHIRDGNIE 341
Y+ E++ K VD ++LG+ +E +G +P +G + I
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230
Query: 342 KLSNVSDDLHTLIKLMIDKDPTKR 365
+S + I+ +++KDP KR
Sbjct: 231 FPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 67/251 (26%), Positives = 115/251 (45%), Gaps = 23/251 (9%)
Query: 124 LLGSGDFGEVFKC-LKYMDGMTYAVKRTKRPVANTAQE-KIFKKEIHAHALLSRVPHIVN 181
+LG G FG+V LK D + YAVK K+ V + + E AL + P +
Sbjct: 2 VLGKGSFGKVLLAELKGTDEL-YAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
S + + L+ +EY NGG+L IQ F E + ++ GL+ +HE +I+
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPKELL 297
D+K N+L+ ++G H K+ DFG ++ G Y+ E+L
Sbjct: 121 DLKLDNVLL-DSEG-----------HIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEIL 168
Query: 298 NNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLHTLI 354
+ + VD +ALG+ LYE +G +P + ++ I + + +S + +++
Sbjct: 169 SYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSIL 227
Query: 355 KLMIDKDPTKR 365
K + K+P KR
Sbjct: 228 KSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 73/283 (25%), Positives = 122/283 (43%), Gaps = 50/283 (17%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMT-YAVKRTK----RPVANTAQEKIFK 164
I LE LG+G FGEV+ +G T AVK K P A + +I K
Sbjct: 3 IPRESLKLE----RKLGAGQFGEVWM--GTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMK 56
Query: 165 KEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF 224
K H +V ++ S++ +Y+ EY + G+L + ++ ++ L QL+
Sbjct: 57 KLRH--------DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSG-EGKKLRLPQLVD 107
Query: 225 ---QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIAD 279
Q++EG+ + IH D+ NIL+ E L K+ DFG +I D
Sbjct: 108 MAAQIAEGMAYLESRNYIHRDLAARNILV------------GENLVCKIADFGLARLIED 155
Query: 280 NDFEVEEGDCRY-----LPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGP 330
+++ EG ++ P+ F K D+++ G+ L E G P P N
Sbjct: 156 DEYTAREG-AKFPIKWTAPEAANYGRFT--IKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212
Query: 331 MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ + G + + N ++L+ L+ DKDP +RP+ L+
Sbjct: 213 VLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQ 255
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 2e-12
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 50/277 (18%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYF 183
+LGSG G V + DG +AVK + ++ + + LL+ ++F
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVD--MEGMSEADKNRAQAEVCCLLN-----CDFF 91
Query: 184 S--------SWSDQG------VLYLQLEYCNGGNLENIIQERC----TFTEMALKQLLFQ 225
S + D ++ L L+Y N G+L I+ R TF E L Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIAD 279
V + +H MIH DIK ANIL+ + G + KLGDFG ++D
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLC-SNGLV-----------KLGDFGFSKMYAATVSD 199
Query: 280 NDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD-- 337
+ G Y+ E+ K D+F+LG+ LYE + P +G +
Sbjct: 200 DVGRTFCGTPYYVAPEIWRRK-PYSKKADMFSLGVLLYELLTLKR-PFDGENMEEVMHKT 257
Query: 338 --GNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
G + L ++S ++ ++ ++ DP +RPS+S L
Sbjct: 258 LAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294
|
Length = 496 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR------- 175
+++G G FGEV K G YA+K + ++FKK+ AH R
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLK-------SEMFKKDQLAHVKAERDVLAESD 59
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P +V+ + S+ D LYL +E+ GG+L ++ + TF+E + + + + +H+
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ IH DIKP NILI + H KL DFG
Sbjct: 120 LGFIHRDIKPDNILIDR------------GGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 74/296 (25%), Positives = 118/296 (39%), Gaps = 65/296 (21%)
Query: 125 LGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--P 177
+G G FG VF+ L Y AVK K A+ + F++E AL++ P
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREA---ALMAEFDHP 68
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENII----------------------QERCTFT 215
+IV + + L EY G+L + +
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
+ QV+ G+ + E + +H D+ N L+ E + K+ DFG
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV------------GENMVVKIADFGL 176
Query: 275 -HVIADNDF-EVEEGDC---RYLPKE-LLNNNFDNLSKVDIFALGLTLYEASGVTPLPKN 328
I D+ + E D R++P E + N + S D++A G+ L+E P
Sbjct: 177 SRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTES--DVWAYGVVLWEIFSYGMQPYY 234
Query: 329 GPMWH-----HIRDGNIEKLS---NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376
G M H ++RDGN+ LS N +L+ L++L K P+ RPS +S+ R Q
Sbjct: 235 G-MAHEEVIYYVRDGNV--LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV------ 176
EL+G G +G V+ L G AVK+ + P + +K++ AL S +
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVK-ALRSEIETLKDL 65
Query: 177 --PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
+IV Y + + L + LEY GG++ + ++ F E ++ QV EGL +H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-----IADNDFEVE-EGD 288
++H D+K N+L V A G K+ DFG I DND + +G
Sbjct: 126 SKGILHRDLKADNLL-VDADGIC-----------KISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 289 CRYLPKELLNNNFDNLS-KVDIFALGLTLYE 318
++ E++++ S KVDI++LG + E
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLE 204
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 68/276 (24%), Positives = 113/276 (40%), Gaps = 45/276 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E++G G +G+V+K G A+K + +E+I K+E + S P+I +
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEI-KEEYNILRKYSNHPNIATF 68
Query: 183 F------SSWSDQGVLYLQLEYCNGGN----LENIIQERCTFTEMALKQLLFQVSEGLRC 232
+ + + L+L +E C GG+ ++ + ++ E + +L + GL
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-GDCRY 291
+HE ++IH DIK NIL+ T+ KL DFG V A D +
Sbjct: 129 LHENKVIHRDIKGQNILL------------TKNAEVKLVDFG-VSAQLDSTLGRRNTFIG 175
Query: 292 LP----------KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDG 338
P E + ++D + D+++LG+T E A G PL PM I
Sbjct: 176 TPYWMAPEVIACDEQPDASYDA--RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN 233
Query: 339 NIEKLS---NVSDDLHTLIKLMIDKDPTKRPSTSSL 371
L N S + I + K+ +RP L
Sbjct: 234 PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 61/208 (29%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSEGLRCMH 234
IV +F + L L +EY +GG+L I+ E F E + L +Q+ L +H
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH 186
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND---FEVEEGDC-- 289
+M+H D+K ANI + M T + KLGDFG +D +V C
Sbjct: 187 SRKMMHRDLKSANIFL----------MPTGII--KLGDFGFSKQYSDSVSLDVASSFCGT 234
Query: 290 -RYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD----GNIEKLS 344
YL EL + K D+++LG+ LYE + P GP I G +
Sbjct: 235 PYYLAPELWERKRYS-KKADMWSLGVILYELLTLHR-PFKGPSQREIMQQVLYGKYDPFP 292
Query: 345 -NVSDDLHTLIKLMIDKDPTKRPSTSSL 371
VS + L+ ++ K+P RP+T L
Sbjct: 293 CPVSSGMKALLDPLLSKNPALRPTTQQL 320
|
Length = 478 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 62/217 (28%), Positives = 104/217 (47%), Gaps = 27/217 (12%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
+F + LG+G+ G V K L G+ A K + + +I ++ H S P
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS--P 59
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+IV ++ ++ G + + +E+ +GG+L+ ++++ E L ++ V GL + E
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 238 MI-HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-----HVIADNDFEVEEGDCRY 291
I H D+KP+NIL V ++GE+ KL DFG N F G Y
Sbjct: 120 KIMHRDVKPSNIL-VNSRGEI-----------KLCDFGVSGQLIDSMANSF---VGTRSY 164
Query: 292 L-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLP 326
+ P+ L ++ S DI++LGL+L E A G P+P
Sbjct: 165 MSPERLQGTHYTVQS--DIWSLGLSLVEMAIGRYPIP 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 9e-12
Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 33/270 (12%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-AQEKIFKKEIHAHALLSRVPH--I 179
E+LG G +G V+ C G AVK+ + +N A EK ++K LL + H I
Sbjct: 6 EVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMI 239
V Y + D + + +E+ GG++ +I+ E + Q+ +G+ +H ++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----------HVIADNDFEVEEGDC 289
H DIK N++++ P KL DFG H N + G
Sbjct: 125 HRDIKGNNVMLM--------PNGI----IKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKLSNVSD 348
++ E++N + K DI+++G T++E A+G PL + G L
Sbjct: 173 YWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLP 231
Query: 349 DLHT-----LIKLMIDKDPTKRPSTSSLRR 373
D + + + +D +RPS L R
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 9e-12
Identities = 67/270 (24%), Positives = 106/270 (39%), Gaps = 29/270 (10%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEK---IFKKEIHAHALLSRVPHIVN 181
+G G FG V+ A+K+ + EK I K+ L R P+ +
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQL--RHPNTIE 79
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
Y + + +L +EYC G + + + E+ + + +GL +H IH
Sbjct: 80 YKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELL---- 297
DIK NIL+ TE KL DFG + G ++ E++
Sbjct: 140 DIKAGNILL------------TEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMD 187
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNV--SDDLHT 352
+D KVD+++LG+T E A PL M +HI + LS+ SD
Sbjct: 188 EGQYDG--KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRN 245
Query: 353 LIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
+ + K P RPS+ L + + R P
Sbjct: 246 FVDSCLQKIPQDRPSSEELLKHRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 66/283 (23%), Positives = 117/283 (41%), Gaps = 53/283 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK------RTKRPVANTAQEKIFKKEIHAHALLSRV 176
+LLG GD G VF G +A+K KR N + + ++EI L+ +
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEI-----LATL 58
Query: 177 PH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRC 232
H + ++S+ + L L ++YC GG L ++Q + +E + +V L
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTE-KLHYKLGDFGHVIAD------------ 279
+H + +++ D+KP NIL+ G + M ++ L + ++
Sbjct: 119 LHLLGIVYRDLKPENILL-HESGHI---MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 280 ---NDFEVEEGDCR---------YLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL- 325
++ EE R Y+ E+++ + S VD + LG+ LYE G TP
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHG-SAVDWWTLGILLYEMLYGTTPFK 233
Query: 326 -PKNGPMWHHIRDGNIE--KLSNVSDDLHTLIKLMIDKDPTKR 365
+ +I + VS LI+ ++ KDP+KR
Sbjct: 234 GSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKR 276
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 40/212 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV------ 176
+++G G FG+V + DG YAVK ++ I KK+ H + R
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT-------ILKKKEQNHIMAERNVLLKNL 53
Query: 177 --PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCM 233
P +V S+ LY L+Y NGG L +Q ERC F E + +V+ + +
Sbjct: 54 KHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC-FLEPRARFYAAEVASAIGYL 112
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE------G 287
H + +I+ D+KP NIL+ +QG H L DFG + E EE G
Sbjct: 113 HSLNIIYRDLKPENILL-DSQG-----------HVVLTDFG--LCKEGVEPEETTSTFCG 158
Query: 288 DCRYLPKELLNNN-FDNLSKVDIFALGLTLYE 318
YL E+L +D VD + LG LYE
Sbjct: 159 TPEYLAPEVLRKEPYDR--TVDWWCLGAVLYE 188
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 46/276 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E +G G +G+VFK L +G AVK P+ + +E + E + LS P++V +
Sbjct: 24 ETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEE--IEAEYNILKALSDHPNVVKF 80
Query: 183 FSSWSDQGV-----LYLQLEYCNGGNLENIIQ------ERCTFTEMALKQLLFQVSEGLR 231
+ + + V L+L LE CNGG++ ++++ ER E + +L + GL+
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER--MEEPIIAYILHEALMGLQ 138
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRY 291
+H + IH D+K NIL+ G KL DFG +
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGG------------VKLVDFGVSAQLTSTRLRRNTSVG 186
Query: 292 LP----------KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIR---- 336
P ++ L++ +D ++ D+++LG+T E G PL PM +
Sbjct: 187 TPFWMAPEVIACEQQLDSTYD--ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244
Query: 337 -DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ + S++ + I+ + KD KRP+ S L
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 74/288 (25%), Positives = 110/288 (38%), Gaps = 55/288 (19%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
+G G F EV K G YA+K K+ + Q + EI A LS P+I+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIE 65
Query: 185 SWSDQ--GVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSEGLRCMHEMRMIHM 241
D+ G L L E + NL +I+ R E +K ++Q+ + L MH + H
Sbjct: 66 VLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHR 124
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--IADNDFEVEEGDCRYL--PKELL 297
DIKP NILI + KL DFG I E R+ P+ LL
Sbjct: 125 DIKPENILI-------------KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLL 171
Query: 298 NNNFDNLSKVDIFALGLTLYEASGVTPL---------------------PKNGPMWHHIR 336
+ + K+DI+A+G +E + PL + + R
Sbjct: 172 TDGYYG-PKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230
Query: 337 DGN----------IEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
N + KL N S + L+K ++ DP +R + R
Sbjct: 231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 73/254 (28%), Positives = 111/254 (43%), Gaps = 31/254 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVN 181
+G G FG+V DG YAVK K+ + ++K E + LL V H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE--RNVLLKNVKHPFLVG 60
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
S+ LY L+Y NGG L +Q +F E + +++ L +H + +I+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE------GDCRYL-PK 294
D+KP NIL+ +QG H L DFG + E + G YL P+
Sbjct: 121 DLKPENILL-DSQG-----------HVVLTDFG--LCKEGIEHSKTTSTFCGTPEYLAPE 166
Query: 295 ELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLSNVSDDLH 351
L +D VD + LG LYE G+ P M+ +I + + N+S
Sbjct: 167 VLRKQPYDR--TVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSAR 224
Query: 352 TLIKLMIDKDPTKR 365
L++ ++ KD TKR
Sbjct: 225 HLLEGLLQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 71/291 (24%), Positives = 130/291 (44%), Gaps = 46/291 (15%)
Query: 122 EELLGSGDFGEVFKCLKYMDG--MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
++++G G+FG+V K DG M A+KR K A+ + F E+ L P+I
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-------------RCTFTEMALKQLLF-- 224
+N + +G LYL +EY GNL + +++ T + ++ +QLL
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 225 -QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFE 283
V+ G+ + + + IH D+ NIL+ E K+ DFG + +
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILV------------GENYVAKIADFG-LSRGQEVY 177
Query: 284 VEEG----DCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHHI 335
V++ R++ E LN + + D+++ G+ L+E + P G ++ +
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
Query: 336 RDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTS----SLRRSAQLARNY 381
G +EK N D+++ L++ + P +RPS + SL R + + Y
Sbjct: 237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 67/256 (26%), Positives = 114/256 (44%), Gaps = 29/256 (11%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSR--VPHIV 180
++G G FGEV+ C K G YA+K K+ + E + E +L+S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
++ L L+ NGG+L + + F+E ++ ++ GL MH +++
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKE 295
D+KPANIL+ E H ++ D G DF ++ G Y+ E
Sbjct: 121 RDLKPANILL------------DEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPE 165
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDG-----NIEKLSNVSDD 349
+L S D F+LG L++ G +P ++ H D N+E + S +
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPE 225
Query: 350 LHTLIKLMIDKDPTKR 365
L +L++ ++ +D +KR
Sbjct: 226 LKSLLEGLLQRDVSKR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 3e-11
Identities = 58/235 (24%), Positives = 89/235 (37%), Gaps = 30/235 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
+G G G VFK G T A+K+ +EI A L P++V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA---LQACQHPYVVKL 64
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ L +EY E + E E +K + + +G+ MH ++H D
Sbjct: 65 LDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRD 124
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG-HVIADNDFEV----EEGDCRYLPKELL 297
+KPAN+LI A G L K+ DFG + + + Y ELL
Sbjct: 125 LKPANLLIS-ADGVL-----------KIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172
Query: 298 NNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHT 352
VD++A+G E L P++ + +IE+L+ V L T
Sbjct: 173 YGARKYDPGVDLWAVGCIFAE------LLNGSPLFPG--ENDIEQLAIVFRTLGT 219
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 73/281 (25%), Positives = 117/281 (41%), Gaps = 54/281 (19%)
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
+ +G G FG V K L G AVKR + V Q K ++ S P+IV
Sbjct: 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSDCPYIV 66
Query: 181 NYFSSWSDQGVLYLQLE-------------YCNG-GNL-ENIIQERCTFTEMALKQLLFQ 225
++ + +G ++ +E Y + E I+ + T AL L
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYL--- 123
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF---GHVIADNDF 282
E+++IH D+KP+NIL+ + KL DF G ++ D+
Sbjct: 124 -------KEELKIIHRDVKPSNILL------------DRNGNIKLCDFGISGQLV-DSIA 163
Query: 283 EVEEGDCR-YLPKELLNNNFDNLSKV--DIFALGLTLYE-ASGVTPLPKNGPMWHHIR-- 336
+ + CR Y+ E ++ + + V D+++LG+TLYE A+G P PK ++ +
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQV 223
Query: 337 -DGNIEKLSN-----VSDDLHTLIKLMIDKDPTKRPSTSSL 371
G+ LSN S I L + KD +KRP L
Sbjct: 224 VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKEL 264
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 42/161 (26%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTA--QEKIFKKEIHAHALLSR 175
E+L+ + LG+G F ++ G AVK+ V NT+ QE++ + L++R
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTY-VRNTSSEQEEVVEALRKEIRLMAR 59
Query: 176 V--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
+ PHI+ + + L +E+ GG++ +++ + F E + Q+ GL +
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
HE ++IH D+K AN+L + + G+ ++ DFG
Sbjct: 120 HENQIIHRDVKGANLL-IDSTGQ----------RLRIADFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 73/292 (25%), Positives = 130/292 (44%), Gaps = 56/292 (19%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL--S 174
LE + + LG+G+ G V K G A K+ V A+ + K+ + ++
Sbjct: 7 LETISD--LGAGNGGSVSKVKHIPTGTVMA----KKVVHIGAKSSVRKQILRELQIMHEC 60
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
R P+IV+++ ++ ++ + + +E+ + G+L+ I ++ L ++ V EGL ++
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 235 -EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEEG 287
R++H DIKP+NIL V ++G++ KL DFG + IAD G
Sbjct: 121 NVHRIMHRDIKPSNIL-VNSRGQI-----------KLCDFGVSGELINSIADTFV----G 164
Query: 288 DCRYLPKELLNNNFDNLS-KVDIFALGLTLYE-ASGVTPLPKN--------GPM-----W 332
Y+ E + + K D+++LG+++ E A G P + PM
Sbjct: 165 TSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222
Query: 333 HHIRDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
I +L S+ +DL + + KDPT+RP+ QL P
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT------PQQLCAMPP 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 32/271 (11%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKR-PVANTAQEKIFKKEIHAHALLSRVP 177
++ ++ LG G FG V+ +K K PV + + A LLS++
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQ-LLSKLD 60
Query: 178 H--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLR 231
H IV + +S+ ++ + EYC G +L+ ++E T +E + + Q+ G+
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVE-EG 287
MH+ R++H D+K NI + + K+GDFG ++ D G
Sbjct: 121 YMHQRRILHRDLKAKNIFL-------------KNNLLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 288 DCRYL-PKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWH---HIRDGNIEKL 343
Y+ P+ L + +D SK DI++LG LYE + + I +G L
Sbjct: 168 TPYYMSPEALKHQGYD--SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSL 225
Query: 344 SNV-SDDLHTLIKLMIDKDPTKRPSTSSLRR 373
S L+++++ M++KDP+ RPS + + R
Sbjct: 226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 54/193 (27%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
+G G +G VFKC G A+K+ + +KI +EI L P++VN
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIE 67
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIK 244
+ + L+L EYC+ L + + E +K++++Q + + H+ IH D+K
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127
Query: 245 PANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR----YLPKELLNNN 300
P NILI K QG++ KL DFG + D Y ELL +
Sbjct: 128 PENILITK-QGQI-----------KLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 301 FDNLSKVDIFALG 313
VD++A+G
Sbjct: 176 TQYGPPVDVWAIG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
+F + L+G G FGEV + G YA+K K+ V + F +E +S P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEM 236
I ++ D+ LYL +EY GG+L +++ F E + L ++ + +H+M
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H DIKP N+LI + H KL DFG
Sbjct: 122 GYVHRDIKPENVLIDRTG------------HIKLADFG 147
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG+G+ G VFK G+ A K + + +I ++ H S P+IV ++
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS--PYIVGFYG 70
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDI 243
++ G + + +E+ +GG+L+ ++++ E L ++ V +GL + E +++H D+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDV 130
Query: 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYLPKELLNNNF 301
KP+NIL V ++GE+ KL DFG + D+ G Y+ E L
Sbjct: 131 KPSNIL-VNSRGEI-----------KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 302 DNLSKVDIFALGLTLYE-ASGVTPLP 326
++ DI+++GL+L E A G P+P
Sbjct: 179 YSVQS-DIWSMGLSLVEMAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 41/165 (24%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKR-------PVANTAQE-KIFKKEIHAHALLSRV 176
+G G +G+V+K G A+K+ + P+ +E K+ +K H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPIT-AIREIKLLQKLRH-------- 57
Query: 177 PHIVN----YFSSWSDQGVLYLQLEYCN---GGNLENIIQERCTFTEMALKQLLFQVSEG 229
P+IV S +G +Y+ EY + G L++ FTE +K + Q+ EG
Sbjct: 58 PNIVRLKEIVTSK--GKGSIYMVFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEG 112
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
L+ +H ++H DIK +NILI G L KL DFG
Sbjct: 113 LQYLHSNGILHRDIKGSNILI-NNDGVL-----------KLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 74/302 (24%), Positives = 124/302 (41%), Gaps = 63/302 (20%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----L 173
F +LG G FGEV C G YA K+ ++ ++I K++ A AL L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK-------KRIKKRKGEAMALNEKQIL 54
Query: 174 SRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSE- 228
+V +V+ ++ + L L L NGG+L+ I F E ++ +F +E
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE---ERAVFYAAEI 111
Query: 229 --GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFEVE 285
GL +H R+++ D+KP NIL L D+GH+ I+D VE
Sbjct: 112 TCGLEDLHRERIVYRDLKPENIL--------------------LDDYGHIRISDLGLAVE 151
Query: 286 --EGD--------CRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLP------KN 328
EG+ Y+ E++ N S D + LG +YE G +P K
Sbjct: 152 IPEGETIRGRVGTVGYMAPEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKR 210
Query: 329 GPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVEN 388
+ +++ E S+ ++ + ++ KDP R A+ + +P + N
Sbjct: 211 EEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCR--GEGAEEVKAHPFFRTAN 268
Query: 389 IR 390
+
Sbjct: 269 FK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 65/258 (25%), Positives = 123/258 (47%), Gaps = 36/258 (13%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVNY 182
LG+G FGEV+ + Y + T +T +P + Q F +E + L+ + H +V
Sbjct: 14 LGAGQFGEVW--MGYYNNSTKVAVKTLKPGTMSVQA--FLEEAN---LMKTLQHDKLVRL 66
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF--QVSEGLRCMHEMRMIH 240
++ + + +Y+ EY G+L + ++ + K + F Q++EG+ + IH
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIH 126
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEG---DCRYLPKE 295
D++ AN+L+ +E L K+ DFG VI DN++ EG ++ E
Sbjct: 127 RDLRAANVLV------------SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPE 174
Query: 296 LLNNNFDNLS-KVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDG-NIEKLSNVSDD 349
+ NF + + K D+++ G+ LYE G P P N + ++ G + ++ N D+
Sbjct: 175 AI--NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDE 232
Query: 350 LHTLIKLMIDKDPTKRPS 367
L+ ++K + +RP+
Sbjct: 233 LYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 67/267 (25%), Positives = 114/267 (42%), Gaps = 28/267 (10%)
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
E +LG G +G V+ + A+K P ++ + +EI H+ L +IV
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEI--PERDSRYVQPLHEEIALHSYLKH-RNIV 68
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQER---CTFTEMALKQLLFQVSEGLRCMHEMR 237
Y S S+ G + +E GG+L +++ + E + Q+ EGL+ +H+ +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDF-EVEEGDCRYLP 293
++H DIK N+L+ NT K+ DFG + N E G +Y+
Sbjct: 129 IVHRDIKGDNVLV-----------NTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMA 177
Query: 294 KELLNNNFDNLSK-VDIFALGLTLYE-ASGVTPLPKNG-PMWHHIRDGNIEKLSNVSDDL 350
E+++ DI++LG T+ E A+G P + G P + G + + + L
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237
Query: 351 HTLIKLMIDK----DPTKRPSTSSLRR 373
K I + DP KR S L +
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 68/257 (26%), Positives = 108/257 (42%), Gaps = 34/257 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-SRV----- 176
+LLG G FG+V + G YA+K K+ V I K+ AH L SRV
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV-------IIAKDEVAHTLTESRVLQNTR 53
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P + S+ L +EY NGG L + F+E + ++ L +H
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHS 113
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND-FEVEEGDCRY 291
+++ D+K N+++ K H K+ DFG I+D + G Y
Sbjct: 114 CDVVYRDLKLENLMLDKDG------------HIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLSNVSD 348
L E+L +N D VD + LG+ +YE G P + ++ I I +S
Sbjct: 162 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSP 220
Query: 349 DLHTLIKLMIDKDPTKR 365
+ +L+ ++ KDP +R
Sbjct: 221 EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 66/302 (21%), Positives = 124/302 (41%), Gaps = 43/302 (14%)
Query: 119 FLEEELLGSGDFGEVFKC-------LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
F + +G G FG V+ + + M+Y+ K++ + +E F +++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL---- 72
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231
R P+ + Y + + +L +EYC G + + + E+ + + +GL
Sbjct: 73 ---RHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH---VIADNDFEVEEGD 288
+H MIH D+K NIL+ +E KLGDFG + N F G
Sbjct: 130 YLHSHNMIHRDVKAGNILL------------SEPGLVKLGDFGSASIMAPANXF---VGT 174
Query: 289 CRYLPKELL----NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHI--RDGN 339
++ E++ +D KVD+++LG+T E A PL M +HI +
Sbjct: 175 PYWMAPEVILAMDEGQYD--GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKK 399
+ + S+ + + K P RP++ L + + R P + ++ +++
Sbjct: 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 292
Query: 400 LD 401
LD
Sbjct: 293 LD 294
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 72/305 (23%), Positives = 145/305 (47%), Gaps = 63/305 (20%)
Query: 125 LGSGDFGEVFKC----LKYMDGMT-YAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--P 177
LG G+FG+V K LK G T AVK K A++++ + E + LL +V P
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFN---LLKQVNHP 63
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----CTFTE----------------- 216
H++ + + S G L L +EY G+L + ++E ++
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 217 MALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273
+ + L+ +Q+S G++ + EM+++H D+ N+L+ A+G K+ DF
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV--AEGRK----------MKISDF 171
Query: 274 G--HVIADNDFEVEEGDCRYLPKEL-LNNNFDNL--SKVDIFALGLTLYE--ASGVTPLP 326
G + + D V+ R K + + + FD++ ++ D+++ G+ L+E G P P
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231
Query: 327 KNGP--MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
P +++ ++ G +E+ N S++++ L+ ++P KRP+ A +++ +
Sbjct: 232 GIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTF------ADISKELEK 285
Query: 384 LKVEN 388
+ V++
Sbjct: 286 MMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 24/161 (14%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E +G G +G+V+K DG AVK P+++ +E + E + L P++V +
Sbjct: 28 ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEE--IEAEYNILQSLPNHPNVVKF 84
Query: 183 FSSW--SDQ---GVLYLQLEYCNGGNLENIIQE--RC--TFTEMALKQLLFQVSEGLRCM 233
+ + +D+ G L+L LE CNGG++ +++ C E + +L+ GL+ +
Sbjct: 85 YGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL 144
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
H R+IH D+K NIL+ G KL DFG
Sbjct: 145 HNNRIIHRDVKGNNILLTTEGG------------VKLVDFG 173
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 2e-10
Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 42/275 (15%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
EL+G+G +G+V+K G A+K V +E+I K+EI+ S +I Y
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEEEEI-KQEINMLKKYSHHRNIATY 68
Query: 183 FSSW--------SDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRC 232
+ ++ DQ L+L +E+C G++ ++I+ T E + + ++ GL
Sbjct: 69 YGAFIKKNPPGMDDQ--LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----G 287
+H+ ++IH DIK N+L+ TE KL DFG V A D V G
Sbjct: 127 LHQHKVIHRDIKGQNVLL------------TENAEVKLVDFG-VSAQLDRTVGRRNTFIG 173
Query: 288 DCRYLPKELL--NNNFDNLS--KVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI 340
++ E++ + N D K D+++LG+T E A G PL PM I
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA 233
Query: 341 EKLSNV--SDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+L + S + I+ + K+ ++RP+T L +
Sbjct: 234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 65/253 (25%), Positives = 113/253 (44%), Gaps = 27/253 (10%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---NTAQEKIFKKEIHAHALLSRVPHIV 180
+LG G FG+V + YA+K K+ V + + + +K + A L + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA--LQDKPPFLT 64
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
S + LY +EY NGG+L IQ+ F E ++S GL +H +I+
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIY 124
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPKEL 296
D+K N++ +++E H K+ DFG H++ G Y+ E+
Sbjct: 125 RDLKLDNVM-----------LDSEG-HIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
Query: 297 LNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHHIRDGNIEKLSNVSDDLHT 352
+ S VD +A G+ LYE P P +G ++ I + N+ ++S + +
Sbjct: 173 IAYQPYGKS-VDWWAYGVLLYEMLAGQP-PFDGEDEDELFQSIMEHNVSYPKSLSKEAVS 230
Query: 353 LIKLMIDKDPTKR 365
+ K ++ K P+KR
Sbjct: 231 ICKGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-10
Identities = 70/314 (22%), Positives = 109/314 (34%), Gaps = 105/314 (33%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTK---RPVAN-----TAQEKI-FKKEIHA 169
+ + + LG G + V+K G A+K+ K R A TA +I +E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK- 60
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSE 228
H P+I+ + + + L E+ +LE +I+++ T +K +
Sbjct: 61 H------PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLR 113
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-------------- 274
GL +H ++H D+KP N+LI + G L KL DFG
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLI-ASDGVL-----------KLADFGLARSFGSPNRKMTH 161
Query: 275 HVIADNDFEVEEGDCR-YLPKELL-------------------------------NNNFD 302
V+ R Y ELL +++ D
Sbjct: 162 QVVT-----------RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID 210
Query: 303 NLSKVDIF-ALGL-TLYEASGVTPLP-------KNGPMWHHIRDGNIEKLSNVSDDLHTL 353
L K IF ALG T GVT LP I SDD L
Sbjct: 211 QLGK--IFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQI-------FPAASDDALDL 261
Query: 354 IKLMIDKDPTKRPS 367
++ ++ +P KR +
Sbjct: 262 LQRLLTLNPNKRIT 275
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 123 ELLGSGDFGEVFKCLKYM---DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH- 178
++LG G FG+VF K G YA+K K+ K E +L+ V H
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKME---RDILAEVNHP 58
Query: 179 -IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
IV ++ +G LYL L++ GG+L + + FTE +K L +++ L +H +
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----GDCRYLP 293
+I+ D+KP NIL+ E+ H KL DFG D E + G Y+
Sbjct: 119 IIYRDLKPENILL------------DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE 318
E++N S D ++ G+ ++E
Sbjct: 167 PEVVNRRGHTQS-ADWWSFGVLMFE 190
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 65/258 (25%), Positives = 110/258 (42%), Gaps = 37/258 (14%)
Query: 124 LLGSGDFGEVFKCLKYMDGMT--YAVKRTKRPVA-------NTAQEKIFKKEIHAHALLS 174
+LG G FG+V L + G +A+K K+ V T E+ AL
Sbjct: 2 VLGKGSFGKVM--LAELKGTNEFFAIKALKKDVVLEDDDVECTMVER------RVLALAW 53
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
P + + F ++ + L+ +EY NGG+L IQ F E + ++ GL+ +H
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCR 290
+ +I+ D+K N+L+ K G H K+ DFG ++ + G
Sbjct: 114 KKGIIYRDLKLDNVLLDK-DG-----------HIKIADFGMCKENMNGEGKASTFCGTPD 161
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVS 347
Y+ E+L N S VD ++ G+ LYE G +P ++ I + +S
Sbjct: 162 YIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWIS 220
Query: 348 DDLHTLIKLMIDKDPTKR 365
+ + + ++DPTKR
Sbjct: 221 KEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 7e-10
Identities = 71/268 (26%), Positives = 111/268 (41%), Gaps = 52/268 (19%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVNY 182
LG G FGEV C G YA K+ + + K ++ + +L++V IV+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNK--KRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 183 FSSWSDQGVLYLQLEYCNGGNLE----NIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
++ + L L + NGG+L N+ +E F E Q+ GL +H+ R+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFEVEEGDCR------- 290
I+ D+KP N+L L + G+V I+D VE D +
Sbjct: 119 IYRDLKPENVL--------------------LDNDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 291 ----YLPKELLNNNFDNLSKVDIFALGLTLYE---ASGVTPLPKNG------PMWHHIRD 337
++ ELL + S VD FALG+TLYE A G P G + I +
Sbjct: 159 GTPGFMAPELLQGEEYDFS-VDYFALGVTLYEMIAARG--PFRARGEKVENKELKQRILN 215
Query: 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
++ S + + ++ KDP KR
Sbjct: 216 DSVTYPDKFSPASKSFCEALLAKDPEKR 243
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 74/283 (26%), Positives = 114/283 (40%), Gaps = 54/283 (19%)
Query: 125 LGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
LG G FG+V C L G AVK F++EI L +IV
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDH-ENIV 69
Query: 181 NYFSSWSDQGVLYLQL--EYCNGGNLENIIQERCTFTEMALKQLL---FQVSEGLRCMHE 235
Y G L+L EY G+L + +Q ++ LK+LL Q+ +G+ +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEV--EEGDCR 290
R IH D+ NIL+ +E K+ DFG + D D+ E G+
Sbjct: 128 QRYIHRDLAARNILV-----------ESED-LVKISDFGLAKVLPEDKDYYYVKEPGESP 175
Query: 291 ---YLPKELLNNNFDNLSKVDIFALGLTLYEA-----SGVTPLPKNGPMWHHIRDGNI-- 340
Y P+ L + F S D+++ G+TLYE +P + M + I
Sbjct: 176 IFWYAPECLRTSKFS--SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233
Query: 341 ---------EKLS---NVSDDLHTLIKLMIDKDPTKRPSTSSL 371
E+L + D+++ L+KL + +P RPS + L
Sbjct: 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 69/263 (26%), Positives = 109/263 (41%), Gaps = 46/263 (17%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-------VP 177
+G G +G+VF K G A+KR K+ + +FK H L R
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSL-------LFKLNEVRHVLTERDILTTTKSE 61
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+V ++ D LYL +EY GG+ ++ +E + + ++ E + +HE+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE---GDCRYLPK 294
IH D+KP N LI H KL DFG ++ G Y+
Sbjct: 122 YIHRDLKPENFLIDA------------SGHIKLTDFG--LSKGIVTYANSVVGSPDYMAP 167
Query: 295 ELLNN-NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHI--------RDGNIEK 342
E+L +D VD ++LG LYE G P + P W ++ R +
Sbjct: 168 EVLRGKGYDF--TVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDP 225
Query: 343 LSNVSDDLHTLIKLMIDKDPTKR 365
N+SD+ LI +I+ DP++R
Sbjct: 226 RFNLSDEAWDLITKLIN-DPSRR 247
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 51/160 (31%), Positives = 77/160 (48%), Gaps = 24/160 (15%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH----ALLSRVPH 178
+LLG G FGEV+ C G AVK+ P +QE KE++A LL + H
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQV--PFDPDSQET--SKEVNALECEIQLLKNLRH 63
Query: 179 --IVNYFSSWSD--QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
IV Y+ D + L + +EY GG++++ ++ TE ++ Q+ +G+ +H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++H DIK ANIL A + KLGDFG
Sbjct: 124 SNMIVHRDIKGANILRDSAG------------NVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 68/268 (25%), Positives = 123/268 (45%), Gaps = 42/268 (15%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
LG G FG+V+K G+ A K V +T E+ + + +L+ P+IV
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAK-----VIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ + L++ +E+C GG ++ ++ E TE ++ + Q E L +HE ++IH
Sbjct: 68 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHR 127
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC-----RYLPKEL 296
D+K NIL G++ KL DFG V A N ++ D ++ E+
Sbjct: 128 DLKAGNILFT-LDGDI-----------KLADFG-VSAKNTRTIQRRDSFIGTPYWMAPEV 174
Query: 297 L------NNNFDNLSKVDIFALGLTLYEASGVTPLPKN--GPMWHHIRDGNIE-----KL 343
+ + +D K D+++LG+TL E + + P P + PM ++ E +
Sbjct: 175 VMCETSKDRPYD--YKADVWSLGITLIEMAQIEP-PHHELNPMRVLLKIAKSEPPTLAQP 231
Query: 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
S S + +K ++K+ R +T+ L
Sbjct: 232 SRWSSEFKDFLKKCLEKNVDARWTTTQL 259
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 50/169 (29%), Positives = 71/169 (42%), Gaps = 35/169 (20%)
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-----TAQE--KIFKKEIHAHALL 173
LG G FGEV+K + G A+K+ TA KI KK H + +
Sbjct: 12 ILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVV- 70
Query: 174 SRVPHIVNYFSSWSDQ-----GVLYLQLEYCN---GGNLENIIQERCTFTEMALKQLLFQ 225
+++ D+ G +Y+ Y + G LEN TE +K + Q
Sbjct: 71 ----PLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQ 123
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ EG+ +HE ++H DIK ANILI QG L K+ DFG
Sbjct: 124 LLEGINYLHENHILHRDIKAANILIDN-QGIL-----------KIADFG 160
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 9e-10
Identities = 75/306 (24%), Positives = 127/306 (41%), Gaps = 54/306 (17%)
Query: 104 SISSTSIDHSRYALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI 162
S +S S + +L LE +GSG G V+K + G YA+K +T + +I
Sbjct: 60 SSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQI 119
Query: 163 FKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALK 220
+EI +L V P++V + G + + LE+ +GG+LE E L
Sbjct: 120 -CREI---EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG----THIADEQFLA 171
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIA 278
+ Q+ G+ +H ++H DIKP+N+LI N+ K + K+ DFG ++A
Sbjct: 172 DVARQILSGIAYLHRRHIVHRDIKPSNLLI-----------NSAK-NVKIADFGVSRILA 219
Query: 279 D--NDFEVEEGDCRYLPKELLNNN-----FDNLSKVDIFALGLTLYEAS-GVTPLPKNGP 330
+ G Y+ E +N + +D + DI++LG+++ E G P
Sbjct: 220 QTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAG-DIWSLGVSILEFYLGRFPFGVG-- 276
Query: 331 MWHHIRDGNIEKL-------------SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377
R G+ L + S + I + ++P KR S L + +
Sbjct: 277 -----RQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFI 331
Query: 378 ARNYPQ 383
R P
Sbjct: 332 LRAQPG 337
|
Length = 353 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 18/159 (11%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVP 177
F++ + LG G FGEV K YA+K K+ V N Q K E +L+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAE---RDILAEAD 59
Query: 178 H--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
+ +V + S+ D+ LY ++Y GG++ +++ F E+ + + +++ + +H+
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
M IH DIKP NILI +L+ H KL DFG
Sbjct: 120 MGFIHRDIKPDNILI-----DLDG-------HIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 46/153 (30%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKE--IHAHALLSRVPHIVN 181
+G G FGEV K YA+K K V Q K E I A A +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA---DNEWVVK 65
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ S+ D+ LY ++Y GG++ +++ F E + + +++ + +H+M IH
Sbjct: 66 LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHR 125
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
DIKP NILI + H KL DFG
Sbjct: 126 DIKPDNILIDRDG------------HIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 64/285 (22%), Positives = 126/285 (44%), Gaps = 41/285 (14%)
Query: 123 ELLGSGDFGEVF---KCLKYMDGMTYAVKRTKRPV----ANTAQEKIFKKEIHAHALLSR 175
++LG+G +G+VF K + G YA+K ++ A T + ++ + H + +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH--VRQ 63
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P +V ++ + L+L L+Y +GG + + +R F+E ++ ++ L +H+
Sbjct: 64 SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK 123
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE--------G 287
+ +++ DIK NIL+ ++G H L DFG +F EE G
Sbjct: 124 LGIVYRDIKLENILL-DSEG-----------HVVLTDFG---LSKEFLSEEKERTYSFCG 168
Query: 288 DCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNG------PMWHHIRDGNI 340
Y+ E++ + VD ++LG+ ++E +G +P G + I +
Sbjct: 169 TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228
Query: 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
S + + L+ ++ KDP KR + + A + +P K
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKDPKKR--LGAGPQGASEIKEHPFFK 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 66/263 (25%), Positives = 118/263 (44%), Gaps = 34/263 (12%)
Query: 123 ELLGSGDFGEVF---KCLKYMDGMTYAVKRTKRPV----ANTAQEKIFKKEIHAHALLSR 175
++LG+G +G+VF K + G YA+K K+ A T + ++++ H + +
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH--IRQ 63
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P +V ++ L+L L+Y NGG L + +R F E ++ ++ L +H+
Sbjct: 64 SPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK 123
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCR 290
+ +I+ DIK NIL+ + G H L DFG ++ EVE G
Sbjct: 124 LGIIYRDIKLENILL-DSNG-----------HVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 291 YLPKELLNNNFDNLSK-VDIFALGLTLYE-ASGVTPLPKNGPMWHH--IRDGNIEKLSNV 346
Y+ +++ K VD +++G+ +YE +G +P +G I ++
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231
Query: 347 SDDLHTLIKLMID----KDPTKR 365
++ L K +I KDP KR
Sbjct: 232 PQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG+G+ G V K G+ A K + + +I ++ H S P+IV ++
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS--PYIVGFYG 70
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMI-HMDI 243
++ G + + +E+ +GG+L+ +++E E L ++ V GL + E I H D+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYLPKELLNNNF 301
KP+NIL V ++GE+ KL DFG + D+ G Y+ E L
Sbjct: 131 KPSNIL-VNSRGEI-----------KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTH 178
Query: 302 DNLSKVDIFALGLTLYE-ASGVTPLP 326
++ DI+++GL+L E A G P+P
Sbjct: 179 YSVQS-DIWSMGLSLVELAIGRYPIP 203
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 79/310 (25%), Positives = 130/310 (41%), Gaps = 78/310 (25%)
Query: 117 LEFLEEELLGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
L+F++ LG G+FG V C L+ G AVK+ + A ++ F++EI +
Sbjct: 6 LKFIQ--QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD--FEREIE---I 58
Query: 173 LSRVPH--IVNYFSSWSDQGVLY--------LQLEYCNGGNLENIIQ---ERCTFTEMAL 219
L + H IV Y +GV Y L +EY G+L + +Q ER ++
Sbjct: 59 LKSLQHDNIVKY------KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKL-- 110
Query: 220 KQLLF--QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--H 275
LL+ Q+ +G+ + R +H D+ NIL+ + K+GDFG
Sbjct: 111 --LLYASQICKGMEYLGSKRYVHRDLATRNILV------------ESENRVKIGDFGLTK 156
Query: 276 VI-ADNDFEV--EEGDCR---YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG 329
V+ D ++ E G+ Y P+ L + F S D+++ G+ LYE + +
Sbjct: 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVAS--DVWSFGVVLYELFTYSDKSCSP 214
Query: 330 PMWHHIRDGN-----------IEKLSNVS---------DDLHTLIKLMIDKDPTKRPSTS 369
P GN IE L N +++ ++K + DP++RPS S
Sbjct: 215 PAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
Query: 370 SLRRSAQLAR 379
L + R
Sbjct: 275 ELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 71/269 (26%), Positives = 122/269 (45%), Gaps = 34/269 (12%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
EF E LGSG FGEV++ L + + + A+K K + +++ F+KE+ A L R
Sbjct: 7 EFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKS--DDLLKQQDFQKEVQALKRL-RHK 62
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQLLFQVSEGLRCMHE 235
H+++ F+ S +Y+ E G+L ++ E +L + QV+EG+ + E
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRY-- 291
IH D+ NIL+ E L K+ DFG +I ++ + + Y
Sbjct: 123 QNSIHRDLAARNILV------------GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW 170
Query: 292 -LPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDGNIEKLSNV 346
P+ + F K D+++ G+ LYE G P P N ++ I G ++
Sbjct: 171 TAPEAASHGTFST--KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG--YRMPCP 226
Query: 347 SDDLHTLIKLMID---KDPTKRPSTSSLR 372
+ + K+M++ +P RPS +LR
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 26/164 (15%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
+F +++G G FGEV K G YA+K ++ + +KE AH R
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRK-------ADMLEKEQVAHIRAERDI 54
Query: 177 ------PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+V F S+ D+ LYL +E+ GG++ ++ ++ T +E A + + + +
Sbjct: 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAI 114
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H++ IH DIKP N+L+ A+G H KL DFG
Sbjct: 115 DAIHQLGFIHRDIKPDNLLL-DAKG-----------HVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTK-RPVANTAQEKIFKKEIHAHALLSRVPH--I 179
+LLG G FG V+ C G A K+ + P + +++ E LL + H I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQ-LLKNLQHERI 66
Query: 180 VNYFSSWSDQG--VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
V Y+ D+ L + +EY GG++++ ++ TE ++ Q+ EG+ +H
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++H DIK ANIL A + KLGDFG
Sbjct: 127 IVHRDIKGANILRDSAG------------NVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 70/262 (26%), Positives = 111/262 (42%), Gaps = 42/262 (16%)
Query: 124 LLGSGDFGEVFKCLKYM---DGMTYAVKRTKRPVANTAQEKIFKKEIHAHA---LLSRVP 177
+LG G +G+VF+ K G +A+K K+ Q K H A +L V
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQ----KDTAHTKAERNILEAVK 58
Query: 178 H--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
H IV+ ++ G LYL LEY +GG L ++ F E L ++S L +H+
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRY 291
+I+ D+KP NIL+ AQG H KL DFG + G Y
Sbjct: 119 QGIIYRDLKPENILL-DAQG-----------HVKLTDFGLCKESIHEGTVTHTFCGTIEY 166
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKL-------- 343
+ E+L + VD ++LG +Y+ P P R I+K+
Sbjct: 167 MAPEILMRSGHG-KAVDWWSLGALMYDMLTGAP-----PFTAENRKKTIDKILKGKLNLP 220
Query: 344 SNVSDDLHTLIKLMIDKDPTKR 365
++ + L+K ++ ++P+ R
Sbjct: 221 PYLTPEARDLLKKLLKRNPSSR 242
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 59/273 (21%), Positives = 103/273 (37%), Gaps = 56/273 (20%)
Query: 146 AVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLE 205
AVK+ + K+ ++EI L + P+I+ Y +S+ LY+ G+ E
Sbjct: 29 AVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87
Query: 206 NIIQERCT--FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILI-----VKAQG--E 256
++++ E+A+ +L V L +H IH +K ++IL+ V G
Sbjct: 88 DLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRY 147
Query: 257 LNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLS-KVDIFALGLT 315
+ K + DF N +L E+L N + K DI+++G+T
Sbjct: 148 SVSMIKHGKRQRVVHDFPKSSVKN--------LPWLSPEVLQQNLQGYNEKSDIYSVGIT 199
Query: 316 LYE-ASGVTP----------LPK-NGPMWHHI--------------------RDGNIEKL 343
E A+G P L K G + + N + +
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSV 259
Query: 344 SNV-----SDDLHTLIKLMIDKDPTKRPSTSSL 371
+ S+ H ++L + +DP RPS S L
Sbjct: 260 DHPYTRTFSEHFHQFVELCLQRDPESRPSASQL 292
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 46/285 (16%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
LE +EE LG G +G V K G AVKR + V N+ ++K ++
Sbjct: 3 LEVIEE--LGRGAYGVVDKMRHVPTGTIMAVKRIRATV-NSQEQKRLLMDLDISMRSVDC 59
Query: 177 PHIVNYFSSWSDQGVLYLQLEY---CNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
P+ V ++ + +G +++ +E + + + T E L ++ + + L +
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119
Query: 234 HE-MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF---GHVIADNDFEVEEGDC 289
H + +IH D+KP+N+LI G KL DF G+++ ++ G C
Sbjct: 120 HSKLSVIHRDVKPSNVLI-NRNG-----------QVKLCDFGISGYLVDSVAKTIDAG-C 166
Query: 290 R-YLPKELLNNNFDNLS---KVDIFALGLTLYE-ASGVTPLPKNGPMWHHIR---DGNIE 341
+ Y+ E +N + K D+++LG+T+ E A+G P + ++ +
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSP 226
Query: 342 KLSN--VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL 384
+L S + + + K+ +RP NYP+L
Sbjct: 227 QLPAEKFSPEFQDFVNKCLKKNYKERP-------------NYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 63/280 (22%), Positives = 117/280 (41%), Gaps = 37/280 (13%)
Query: 119 FLEEELLGSGDFGEVFKC-------LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
F+ +G G FG V+ + + M+Y+ K+T + +E F +++
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL---- 78
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231
+ P+ + Y + + +L +EYC G + + + E+ + + +GL
Sbjct: 79 ---KHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLA 135
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRY 291
+H MIH DIK NIL+ TE KL DFG + G +
Sbjct: 136 YLHSHNMIHRDIKAGNILL------------TEPGQVKLADFGSASKSSPANSFVGTPYW 183
Query: 292 LPKELL----NNNFDNLSKVDIFALGLTLYEASGVTPLPKN----GPMWHHIRDGNIEKL 343
+ E++ +D KVD+++LG+T E + P N ++H ++ +
Sbjct: 184 MAPEVILAMDEGQYD--GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ 241
Query: 344 SNV-SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
SN +D + + K P +RP+++ L R + R+ P
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 45/270 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IV 180
E++G G+FG V + +Y G AVK K V TAQ F +E A+++++ H +V
Sbjct: 12 EIIGEGEFGAVLQG-EYT-GQKVAVKNIKCDV--TAQA--FLEET---AVMTKLHHKNLV 62
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---FQVSEGLRCMHEMR 237
G LY+ +E + GNL N ++ R +++ QLL V+EG+ + +
Sbjct: 63 RLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESKK 120
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYL----- 292
++H D+ NIL+ +E K+ DFG D L
Sbjct: 121 LVHRDLAARNILV------------SEDGVAKVSDFGLARV----GSMGVDNSKLPVKWT 164
Query: 293 -PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNG--PMWHHIRDG-NIEKLSNV 346
P+ L + F SK D+++ G+ L+E + G P PK + + G +E
Sbjct: 165 APEALKHKKFS--SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGC 222
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376
D++ L+ + +P KRPS LR +
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 68/273 (24%), Positives = 122/273 (44%), Gaps = 51/273 (18%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKR----PVANTAQEKIFKKEIHA-----HAL 172
+ LG+G FGEV+ Y A+K K+ P A A+ + K+ H +A+
Sbjct: 11 VKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQLLFQVSEGL 230
+++ P +Y+ EY G+L + ++ E T L + Q++EG+
Sbjct: 70 VTQEP--------------IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEG- 287
+ IH D++ ANIL+ +E L K+ DFG +I DN++ EG
Sbjct: 116 AFIERKNYIHRDLRAANILV------------SETLCCKIADFGLARLIEDNEYTAREGA 163
Query: 288 --DCRYLPKELLNNNFDNLS-KVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDG-N 339
++ E + N+ + K D+++ G+ L E G P P N + ++ G
Sbjct: 164 KFPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR 221
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ + N ++L+ L++L + P +RP+ LR
Sbjct: 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLR 254
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 49/154 (31%), Positives = 76/154 (49%), Gaps = 26/154 (16%)
Query: 128 GDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA-----HAL-LSRVPHIVN 181
G FG+V+ K + YAVK K+ + I K +H AL LS+ P IV+
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKK------ADMINKNMVHQVQAERDALALSKSPFIVH 68
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTE-MALKQLLFQVSEGLRCMHEMRMIH 240
+ S +YL +EY GG++++++ F E MA+K + +V+ L +H +IH
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVK-YISEVALALDYLHRHGIIH 127
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
D+KP N+LI + + H KL DFG
Sbjct: 128 RDLKPDNMLI------------SNEGHIKLTDFG 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 65/256 (25%), Positives = 112/256 (43%), Gaps = 29/256 (11%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSR--VPHIV 180
++G G FGEV+ C K G YA+K K+ + E + E +L+S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
++ L L+ NGG+L + + F+E ++ ++ GL MH +++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKE 295
D+KPANIL+ E H ++ D G DF ++ G Y+ E
Sbjct: 121 RDLKPANILL------------DEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPE 165
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDG-----NIEKLSNVSDD 349
+L S D F+LG L++ G +P ++ H D +E + S +
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE 225
Query: 350 LHTLIKLMIDKDPTKR 365
L +L++ ++ +D +R
Sbjct: 226 LRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 66/257 (25%), Positives = 110/257 (42%), Gaps = 34/257 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-------SR 175
+LLG G FG+V + G YA+K K+ V I K+ AH L +R
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-------IIAKDEVAHTLTESRVLKNTR 53
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P + + S+ + L +EY NGG L + F+E + ++ L +H
Sbjct: 54 HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS 113
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRY 291
++++ D+K N+++ K H K+ DFG + + G Y
Sbjct: 114 GKIVYRDLKLENLMLDKDG------------HIKITDFGLCKEGITDAATMKTFCGTPEY 161
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNIEKLSNVSD 348
L E+L +N D VD + LG+ +YE G P + ++ I +I+ +S
Sbjct: 162 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSA 220
Query: 349 DLHTLIKLMIDKDPTKR 365
D +L+ ++ KDP KR
Sbjct: 221 DAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-- 175
+F +++G G FGEV K G YA+K ++ + +KE H R
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA-------DMLEKEQVGHIRAERDI 54
Query: 176 -----VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+V F S+ D+ LYL +E+ GG++ ++ ++ T TE + + + +
Sbjct: 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAI 114
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H++ IH DIKP N+L+ K H KL DFG
Sbjct: 115 DSIHQLGFIHRDIKPDNLLL------------DSKGHVKLSDFG 146
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 36/266 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMD----GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
+G G FG+V++ + YM + AVK K + + +EK A + R
Sbjct: 12 RCIGEGQFGDVYQGV-YMSPENEKIAVAVKTCKNCTSPSVREKFL-----QEAYIMRQFD 65
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMA-LKQLLFQVSEGLRCMH 234
PHIV ++ V ++ +E G L + +Q ++A L +Q+S L +
Sbjct: 66 HPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPK 294
R +H DI N+L+ KLGDFG D + LP
Sbjct: 125 SKRFVHRDIAARNVLVSSPDC------------VKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 295 ELL---NNNFDNLSKV-DIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDGN-IEKLSN 345
+ + + NF + D++ G+ ++E GV P KN + I +G + N
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPN 232
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSL 371
L++L+ DP+KRP + L
Sbjct: 233 CPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 69/274 (25%), Positives = 107/274 (39%), Gaps = 51/274 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTY-----------AVKRTKR----PVANTAQEKIFKKEI 167
E LGSG FG V+K K +G A + KR + + E KE
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 168 HAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNG---GNLENIIQERC-TFTEMALKQLL 223
H P+IV Y+ ++ + LY+ ++ G G N ++E+ FTE + +
Sbjct: 66 LRH------PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 224 FQVSEGLRCMH-EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF 282
Q+ LR +H E R++H D+ P NI M E + DFG +A
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNI------------MLGEDDKVTITDFG--LAKQKQ 165
Query: 283 EVEE-----GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWH---H 334
+ G Y E++ N K D++A G LY+ + P + M
Sbjct: 166 PESKLTSVVGTILYSCPEIV-KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK 224
Query: 335 IRDGNIEKLSN--VSDDLHTLIKLMIDKDPTKRP 366
I + E L S+D+ +I + D RP
Sbjct: 225 IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 64/266 (24%), Positives = 104/266 (39%), Gaps = 31/266 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
+G G+FG+V G AVK K + AQ F E L R P++V
Sbjct: 12 ATIGKGEFGDVMLGD--YRGQKVAVKCLKD-DSTAAQA--FLAEASVMTTL-RHPNLVQL 65
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
LY+ EY G+L + ++ R T V EG+ + E +H
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVH 125
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRY---LPKELL 297
D+ N+L+ +E L K+ DFG + + + G P+ L
Sbjct: 126 RDLAARNVLV------------SEDLVAKVSDFG-LAKEASQGQDSGKLPVKWTAPEALR 172
Query: 298 NNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNG--PMWHHIRDG-NIEKLSNVSDDLHT 352
F K D+++ G+ L+E + G P P+ + H+ G +E +++
Sbjct: 173 EKKFST--KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230
Query: 353 LIKLMIDKDPTKRPSTSSLRRSAQLA 378
++K + DP KRP+ LR L
Sbjct: 231 VMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 42/227 (18%)
Query: 125 LGSGDFGEVFKCL-KYMDG----MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH- 178
LG G FGEV++ L + DG + AVK T + E F E ++S+ H
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVK-TLPESCSEQDESDFLMEA---LIMSKFNHQ 69
Query: 179 -IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTE----MALKQLLF---QVSEGL 230
IV ++ ++ LE GG+L++ ++E E + +K LLF V++G
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 231 RCMHEMRMIHMDIKPANILIV-KAQGELNEPMNTEKLHYKLGDFGHV--IADNDFEVEEG 287
+ + E IH DI N L+ K G + K+ DFG I + +G
Sbjct: 130 KYLEENHFIHRDIAARNCLLTCKGPGRV----------AKIADFGMARDIYRASY-YRKG 178
Query: 288 DCRYL------PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP 326
L P+ L+ F SK D+++ G+ L+E + G P P
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFT--SKTDVWSFGVLLWEIFSLGYMPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 6e-09
Identities = 72/314 (22%), Positives = 123/314 (39%), Gaps = 56/314 (17%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV-------ANTAQEKIFKKEIHAHALLSR 175
+LG G FG+V G YAVK K+ V T EK H L++
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
+ + + L+ +E+ NGG+L IQ+ F E + +++ L +H+
Sbjct: 61 L------YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR----- 290
+I+ D+K N+L+ + H KL DFG +EG
Sbjct: 115 KGIIYRDLKLDNVLL------------DHEGHCKLADFGM--------CKEGIFNGKTTS 154
Query: 291 -------YLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI 340
Y+ E+L S VD +A+G+ LYE G P ++ I + +
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213
Query: 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR-------NYPQLKVENIRGNL 393
+ +S D ++K + K+PT R + +L + R ++ +L I
Sbjct: 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPF 273
Query: 394 NTRLKKLDEGNVFD 407
R+K ++ + FD
Sbjct: 274 RPRIKSREDVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 66/257 (25%), Positives = 108/257 (42%), Gaps = 35/257 (13%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-------NTAQEKIFKKEIHAHALLSRV 176
+LG G FG+V + YA+K K+ V T EK AL +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEK------RVLALPGKP 60
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P + S + LY +EY NGG+L IQ+ F E +++ GL +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYL 292
+I+ D+K N++ + A+G H K+ DFG ++ G Y+
Sbjct: 121 GIIYRDLKLDNVM-LDAEG-----------HIKIADFGMCKENIFGGKTTRTFCGTPDYI 168
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG----PMWHHIRDGNIEKLSNVSD 348
E++ S VD +A G+ LYE P P +G ++ I + N+ ++S
Sbjct: 169 APEIIAYQPYGKS-VDWWAFGVLLYEMLAGQP-PFDGEDEDELFQSIMEHNVSYPKSLSK 226
Query: 349 DLHTLIKLMIDKDPTKR 365
+ ++ K ++ K P KR
Sbjct: 227 EAVSICKGLLTKHPAKR 243
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 9e-09
Identities = 66/265 (24%), Positives = 114/265 (43%), Gaps = 45/265 (16%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-----NTAQEKIFKKEIHAHALLSRV--- 176
LGSG+FG V K GM Y +K++++ VA N + K E+ A + +
Sbjct: 3 LGSGNFGTVKK------GM-YKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN 55
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P+IV + + L +E G L +Q+ TE + +L+ QVS G++ + E
Sbjct: 56 PYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET 114
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHY-KLGDFG---HVIADNDFEVEEGDCR-- 290
+H D+ N+L+V HY K+ DFG + AD ++ + +
Sbjct: 115 NFVHRDLAARNVLLVTQ-------------HYAKISDFGLSKALGADENYYKAKTHGKWP 161
Query: 291 ---YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLP----KNGPMWHHIRDGN-IEK 342
Y P+ + N + SK D+++ G+ ++EA P K + I G +E
Sbjct: 162 VKWYAPECM--NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC 219
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPS 367
+++ L+KL +RP
Sbjct: 220 PQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 44/278 (15%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
R +++ L + LG+G FGEV++ L + + AVK K T K F E
Sbjct: 4 DRTSIQLLRK--LGAGQFGEVWEGL-WNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKK 57
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---FQVSEG 229
L R P ++ ++ + + +Y+ E G+L +Q + L QL+ QV+ G
Sbjct: 58 L-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG-AGRALKLPQLIDMAAQVASG 115
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEG 287
+ + IH D+ N+L+ GE N K+ DFG VI ++ +E EG
Sbjct: 116 MAYLEAQNYIHRDLAARNVLV----GENNI--------CKVADFGLARVIKEDIYEAREG 163
Query: 288 DCRY-----LPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDG 338
++ P+ L N F K D+++ G+ L E G P P N + + G
Sbjct: 164 -AKFPIKWTAPEAALYNRFS--IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
Query: 339 -NIEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLR 372
+ +L+ +M+D +DP RP+ +L+
Sbjct: 221 YRMPCPPGCPKELY---DIMLDCWKEDPDDRPTFETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 35/216 (16%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMT-YAVKR-TKRPVANTAQEKIFKKE--IHAHALL 173
+F +++G G FGEV + +++ YA+K +K + + F +E I AHA
Sbjct: 44 DFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-- 100
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF---QVSEGL 230
IV ++ D LY+ +EY GG+L N++ + ++ K F +V L
Sbjct: 101 -NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKWARFYTAEVVLAL 155
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI-ADNDFEVEE--- 286
+H M IH D+KP N+L+ K+ H KL DFG + D + V
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSG------------HLKLADFGTCMKMDANGMVRCDTA 203
Query: 287 -GDCRYL-PKELLNNNFDNL--SKVDIFALGLTLYE 318
G Y+ P+ L + D + D +++G+ LYE
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 42/231 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E++G+G +G+V+K G A+K V +E+I K EI+ S +I Y
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTEDEEEEI-KLEINMLKKYSHHRNIATY 78
Query: 183 FSSW--------SDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRC 232
+ ++ DQ L+L +E+C G++ ++++ E + + ++ GL
Sbjct: 79 YGAFIKKSPPGHDDQ--LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----G 287
+H ++IH DIK N+L+ TE KL DFG V A D V G
Sbjct: 137 LHAHKVIHRDIKGQNVLL------------TENAEVKLVDFG-VSAQLDRTVGRRNTFIG 183
Query: 288 DCRYLPKELL------NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM 331
++ E++ + +D S DI++LG+T E A G PL PM
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRS--DIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 33/256 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG G FGEV+ + +G T +T +P T + F +E L R +V ++
Sbjct: 14 LGQGCFGEVW--MGTWNGTTKVAIKTLKP--GTMMPEAFLQEAQIMKKL-RHDKLVPLYA 68
Query: 185 SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---FQVSEGLRCMHEMRMIHM 241
S++ + Y+ E+ G+L + ++E + L QL+ Q+++G+ + M IH
Sbjct: 69 VVSEEPI-YIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNYIHR 126
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRY-----LPK 294
D++ ANIL+ + L K+ DFG +I DN++ +G ++ P+
Sbjct: 127 DLRAANILV------------GDNLVCKIADFGLARLIEDNEYTARQG-AKFPIKWTAPE 173
Query: 295 ELLNNNFDNLSKVDIFALGLTLYEASGVTPLPK--NGPMWHHIRDG-NIEKLSNVSDDLH 351
L F S V F + LT G P P N + + G + + LH
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLH 233
Query: 352 TLIKLMIDKDPTKRPS 367
L+KL KDP +RP+
Sbjct: 234 ELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 45/157 (28%), Positives = 73/157 (46%), Gaps = 18/157 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTK-RPVANTAQEKIFKKEIHAHALLSRVPH--I 179
+LLG G FG V+ C G AVK+ + P + +++ E LL + H I
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQ-LLKNLLHERI 66
Query: 180 VNYFSSWSD--QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
V Y+ D + L + +E+ GG++++ ++ TE ++ Q+ EG+ +H
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++H DIK ANIL + KLGDFG
Sbjct: 127 IVHRDIKGANILRDSVG------------NVKLGDFG 151
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 55/274 (20%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----L 173
F + +LG G FGEV C G YA KR ++ ++I K++ + AL L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEK-------KRIKKRKGESMALNEKQIL 54
Query: 174 SRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSE- 228
+V +VN ++ + L L L NGG+L+ I F E ++ LF +E
Sbjct: 55 EKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEI 111
Query: 229 --GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE 286
GL +H ++ D+KP NIL+ + H ++ D G + ++ E
Sbjct: 112 LCGLEDLHRENTVYRDLKPENILL------------DDYGHIRISDLGLAV-----KIPE 154
Query: 287 GD--------CRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLP------KNGPM 331
G+ Y+ E+LNN LS D + LG +YE G +P K +
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQRYTLSP-DYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
Query: 332 WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+ + + S++ ++ K+++ KDP +R
Sbjct: 214 DRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQR 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 68/281 (24%), Positives = 109/281 (38%), Gaps = 48/281 (17%)
Query: 125 LGSGDFGEVFKCLKYMDG---MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
LG G+FG V K + M + AVK T + A +K F +E A L P IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVK-TLKQEHIAAGKKEFLREASVMAQLDH-PCIVR 60
Query: 182 YFSSWSDQGV-----LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
GV L L +E G L +++R LK+L QV+ G+ +
Sbjct: 61 LI------GVCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHY-KLGDFG---HVIADNDFEVEEGDCR-- 290
+H D+ N+L+V H K+ DFG + A +D+ R
Sbjct: 115 HFVHRDLAARNVLLVNR-------------HQAKISDFGMSRALGAGSDYYRATTAGRWP 161
Query: 291 ---YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLP---KNGPMWHHIRDGN--IEK 342
Y P+ + F SK D+++ G+TL+EA P G + + + +
Sbjct: 162 LKWYAPECINYGKFS--SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPR 219
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
++++++ P RP+ S L R P+
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSEL---ESTFRRDPE 257
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 5/130 (3%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IV 180
L+G G +G V KC G A+K+ + +KI +EI +L ++ H +V
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR---MLKQLRHENLV 63
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
N + + LYL E+ + L+++ + E +++ LFQ+ G+ H +IH
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH 123
Query: 241 MDIKPANILI 250
DIKP NIL+
Sbjct: 124 RDIKPENILV 133
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 63/272 (23%), Positives = 111/272 (40%), Gaps = 39/272 (14%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV-----ANTAQE-KIFKKEIHAHALLSRV 176
E +G G+FGEVF D AVK + + A QE +I K+ H
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-------- 52
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEM-ALKQLLFQVSEGLRCMHE 235
P+IV + + +Y+ +E GG+ ++ ++ L Q++ + G+ +
Sbjct: 53 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND-FEVEEGDCRYLP- 293
IH D+ N L+ TEK K+ DFG + D G + +P
Sbjct: 113 KHCIHRDLAARNCLV------------TEKNVLKISDFGMSREEEDGVYASTGGMKQIPV 160
Query: 294 ----KELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRD-----GNIEKLS 344
E LN + S+ D+++ G+ L+EA + +P R+ +
Sbjct: 161 KWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPE 219
Query: 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376
D ++ L++ + DP +RPS S++ + Q
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 66/269 (24%), Positives = 117/269 (43%), Gaps = 45/269 (16%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----L 173
F +LG G FGEV C G YA K+ ++ ++I K++ A AL L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEK-------KRIKKRKGEAMALNEKRIL 54
Query: 174 SRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSE- 228
+V +V+ ++ + L L L NGG+L+ I F E ++ +F +E
Sbjct: 55 EKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDE---QRAIFYAAEL 111
Query: 229 --GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEV-- 284
GL + R+++ D+KP NIL+ ++ H ++ D G + + E
Sbjct: 112 CCGLEDLQRERIVYRDLKPENILL------------DDRGHIRISDLGLAVQIPEGETVR 159
Query: 285 -EEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG------PMWHHIR 336
G Y+ E++NN S D + LG +YE G +P K + ++
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSP-DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK 218
Query: 337 DGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+ E S+D ++ ++++ K+P +R
Sbjct: 219 EDQEEYSEKFSEDAKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 65/288 (22%), Positives = 115/288 (39%), Gaps = 27/288 (9%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNY 182
+G G FG V+ A+K+ + ++ ++ I L R+ P+ + Y
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK--WQDIIKEVKFLQRIKHPNSIEY 90
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ + +L +EYC G + + + E+ + + +GL +H MIH D
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELL----N 298
IK NIL+ TE KL DFG + G ++ E++
Sbjct: 151 IKAGNILL------------TEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDE 198
Query: 299 NNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNV--SDDLHTL 353
+D KVD+++LG+T E A PL M +HI L + SD
Sbjct: 199 GQYD--GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 256
Query: 354 IKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLD 401
+ + K P RP++ L + + R P+ + ++ +++LD
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLIQRTKDAVRELD 304
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 41/167 (24%), Positives = 70/167 (41%), Gaps = 30/167 (17%)
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV---- 176
E +G G +G V+K G A+K+ + P ++E I + ALL ++
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP---LSEEGIPLSTLREIALLKQLESFE 59
Query: 177 -PHIVN-----YFSSWSDQGVLYLQLEYCNGGNLENIIQERCT---FTEMALKQLLFQVS 227
P+IV + + L L E+ + +L + +C +K L+ Q+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDLMRQLL 117
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
G+ +H R++H D+KP NIL+ T K+ DFG
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILV------------TSDGQVKIADFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 3e-08
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 31/162 (19%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK----EIHAHALLSRV--P 177
+GSG +G V + G A+K+ ++N + I K EI LL +
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKK----ISNVFDDLIDAKRILREI---KLLRHLRHE 59
Query: 178 HIVNYFS-----SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRC 232
+I+ S D +Y+ E +L +I+ T+ ++ L+Q+ GL+
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H +IH D+KP+NIL V + +L K+ DFG
Sbjct: 119 LHSANVIHRDLKPSNIL-VNSNCDL-----------KICDFG 148
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|167150 PRK01066, PRK01066, porphobilinogen deaminase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 21/58 (36%), Positives = 33/58 (56%), Gaps = 1/58 (1%)
Query: 362 PTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRM 419
R +SSLRR L +P + +IRG + RLK L+E +D I++A A ++R+
Sbjct: 131 RRPRIGSSSLRREELLKLLFPSGIILDIRGTIEERLKLLEEKK-YDAIVVAKAAVLRL 187
|
Length = 231 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL----SRVPH 178
E +G G G V+ + G A+K+ N Q+ KKE+ + +L ++ P+
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQM-----NLQQQP--KKELIINEILVMRENKHPN 77
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
IVNY S+ L++ +EY GG+L +++ E C E + + + + L +H ++
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 136
Query: 239 IHMDIKPANILI 250
IH DIK NIL+
Sbjct: 137 IHRDIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 39/132 (29%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL----SRVPH 178
E +G G G V+ + G A+K+ N Q+ KKE+ + +L ++ P+
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQM-----NLQQQP--KKELIINEILVMRENKNPN 77
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
IVNY S+ L++ +EY GG+L +++ E C E + + + + L +H ++
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALDFLHSNQV 136
Query: 239 IHMDIKPANILI 250
IH DIK NIL+
Sbjct: 137 IHRDIKSDNILL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 45/153 (29%), Positives = 68/153 (44%), Gaps = 15/153 (9%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+++G G FGEV YA+K +K + + F +E A + P +V
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSPWVVQ 107
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
F ++ D LY+ +EY GG+L N++ E K +V L +H M +IH
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHR 166
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
D+KP N+L+ K H KL DFG
Sbjct: 167 DVKPDNMLLDKHG------------HLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP---VANTAQEKIFKKEIHAHALLSR 175
F++ + LG G FGEV K YA+K ++ + N +++I A A
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA---D 59
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
+V + S+ D+ LY ++Y GG++ +++ F E + + +++ + +H+
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
M IH DIKP NILI + H KL DFG
Sbjct: 120 MGFIHRDIKPDNILIDRDG------------HIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 71/303 (23%), Positives = 126/303 (41%), Gaps = 33/303 (10%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---NTAQEKIFKKEIHAHALLSRVPHI 179
++LG G FG+V YA+K K+ V + + +K I A L ++ P +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILA--LAAKHPFL 58
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMI 239
+ + L+ +EY NGG+L IQ F E + +V+ L +H +I
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPKE 295
+ D+K NIL+ A+G H KL DFG ++ G Y+ E
Sbjct: 119 YRDLKLDNILL-DAEG-----------HCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLHT 352
+L + VD +ALG+ +YE +G P + ++ I ++ +S + +
Sbjct: 167 IL-QELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVS 225
Query: 353 LIKLMIDKDPTKRPSTSSLRRSAQLARNYP--------QLKVENIRGNLNTRLKKLDEGN 404
++K + K+P KR + + + +P L+ I+ ++K + N
Sbjct: 226 ILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVN 285
Query: 405 VFD 407
FD
Sbjct: 286 NFD 288
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 68/270 (25%), Positives = 111/270 (41%), Gaps = 34/270 (12%)
Query: 125 LGSGDFGEV-FKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV------- 176
LG+G FG V K D A+KR ++ KI K++ H R
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEK-------SKIIKQKQVDHVFSERKILNYINH 90
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P VN + S+ D+ LYL LE+ GG ++ F Q+ + +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL 150
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFEVEEGDCRYLPKE 295
+++ D+KP N+L+ K K+ DFG + D G Y+ E
Sbjct: 151 NIVYRDLKPENLLLDKDG------------FIKMTDFGFAKVVDTRTYTLCGTPEYIAPE 198
Query: 296 LLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDGNIEKLSNVSDDLHT 352
+L N + D + LG+ +YE G P N P+ + I +G I + ++
Sbjct: 199 IL-LNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKH 257
Query: 353 LIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
L+K ++ D TKR +L++ AQ + +P
Sbjct: 258 LMKKLLSHDLTKR--YGNLKKGAQNVKEHP 285
|
Length = 340 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 22/161 (13%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
F + E +G G +G V+K + G A+K+ + +T E + I +LL +
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNH 58
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMAL---KQLLFQVSEGLRCM 233
P+IV + LYL E+ + +L+ + + + + L K LFQ+ +GL
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFC 116
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
H R++H D+KP N+LI +G + KL DFG
Sbjct: 117 HSHRVLHRDLKPQNLLI-NTEGAI-----------KLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 6e-08
Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 44/226 (19%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMD------GMTYAVKRTKRPVANTAQEKIFKK 165
H RY L+ + LG G FG+V L D G AVK KR +KK
Sbjct: 2 HKRY-LKKIRV--LGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSG-WKK 55
Query: 166 EIHAHALLSRVPHIVNYFSSWSDQG--VLYLQLEYCNGGNLENIIQERCTFTEMALKQLL 223
EI+ L +IV Y S+QG L L +EY G+L + + + ++ L QLL
Sbjct: 56 EINILKTLYH-ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNLAQLL 110
Query: 224 F---QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVI 277
Q+ EG+ +H IH D+ N+L+ + ++L K+GDFG V
Sbjct: 111 LFAQQICEGMAYLHSQHYIHRDLAARNVLL-----------DNDRL-VKIGDFGLAKAVP 158
Query: 278 ADNDFE--VEEGDCR---YLPKELLNNNFDNLSKVDIFALGLTLYE 318
+++ E+GD Y + L N F S D+++ G+TLYE
Sbjct: 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYAS--DVWSFGVTLYE 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 58/278 (20%), Positives = 106/278 (38%), Gaps = 50/278 (17%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRT--------KRPVANTAQEKIFKKEIHAHALLSR 175
LG G+FGEVF G+ T K N E F++E+ LS
Sbjct: 12 TLGRGEFGEVFLA--KAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSH 67
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ------ERCTFTEMALKQLL---FQV 226
++V + Y+ LEY + G+L+ ++ E+ ++ KQ + Q+
Sbjct: 68 -KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 227 SEGLRCMHEMRMIHMDIKPANILI-------VKAQGELNEPMNTEKLHYKLGDFGHVIAD 279
+ G+ + R +H D+ N L+ V + N+E + +I
Sbjct: 127 ALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR----NALIP- 181
Query: 280 NDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPK--NGPMWHHI 335
R+L E + + D +K D+++ G+ ++E G P + + + +
Sbjct: 182 ---------LRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL 231
Query: 336 RDGNIE--KLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ G +E L+ L+ +P RPS S L
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 66/267 (24%), Positives = 118/267 (44%), Gaps = 39/267 (14%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
E LG G FGEV+ +G T +T +P T + F +E L R +V
Sbjct: 11 EVKLGQGCFGEVWM--GTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKL-RHEKLVQ 65
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---FQVSEGLRCMHEMRM 238
++ S++ + Y+ EY + G+L + ++ + L QL+ Q++ G+ + M
Sbjct: 66 LYAVVSEEPI-YIVTEYMSKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRY----- 291
+H D++ ANIL+ E L K+ DFG +I DN++ +G ++
Sbjct: 124 VHRDLRAANILV------------GENLVCKVADFGLARLIEDNEYTARQG-AKFPIKWT 170
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEK------LSN 345
P+ L F K D+++ G+ L E + +P G + + D +E+
Sbjct: 171 APEAALYGRFT--IKSDVWSFGILLTELTTKGRVPYPGMVNREVLD-QVERGYRMPCPPE 227
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ LH L+ K+P +RP+ L+
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 9e-08
Identities = 38/132 (28%), Positives = 67/132 (50%), Gaps = 12/132 (9%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL----SRVPH 178
E +G G G V+ + G A+++ N Q+ KKE+ + +L ++ P+
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM-----NLQQQP--KKELIINEILVMRENKNPN 78
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
IVNY S+ L++ +EY GG+L +++ E C E + + + + L +H ++
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQV 137
Query: 239 IHMDIKPANILI 250
IH DIK NIL+
Sbjct: 138 IHRDIKSDNILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 62/256 (24%), Positives = 116/256 (45%), Gaps = 31/256 (12%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---NTAQEKIFKKEIHAHALLSRVPHI 179
++LG G FG+V G +AVK K+ V + + + +K + A L P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLA--LAWENPFL 58
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCMHEM 236
+ + ++ + L+ +E+ NGG+L IQ++ F L + F +E GL+ +H
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD---LYRATFYAAEIVCGLQFLHSK 115
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYL 292
+I+ D+K N+++ + H K+ DFG +V DN G Y+
Sbjct: 116 GIIYRDLKLDNVMLDRDG------------HIKIADFGMCKENVFGDNRASTFCGTPDYI 163
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKN--GPMWHHIRDGNIEKLSNVSDD 349
E+L S VD ++ G+ LYE G +P + ++ IR ++ +
Sbjct: 164 APEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKE 222
Query: 350 LHTLIKLMIDKDPTKR 365
+++ + ++DPT+R
Sbjct: 223 SKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 65/257 (25%), Positives = 106/257 (41%), Gaps = 34/257 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-SRV----- 176
+LLG G FG+V + G YA+K ++ V I K+ AH + SRV
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV-------IIAKDEVAHTVTESRVLQNTR 53
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P + ++ L +EY NGG L + FTE + ++ L +H
Sbjct: 54 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 113
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRY 291
+++ DIK N+++ K H K+ DFG + + G Y
Sbjct: 114 RDVVYRDIKLENLMLDKDG------------HIKITDFGLCKEGISDGATMKTFCGTPEY 161
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNIEKLSNVSD 348
L E+L +N D VD + LG+ +YE G P + ++ I I +S
Sbjct: 162 LAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 220
Query: 349 DLHTLIKLMIDKDPTKR 365
+ +L+ ++ KDP +R
Sbjct: 221 EAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 51/274 (18%)
Query: 123 ELLGSGDFGEVFK-CLKYMDGMTYAVKRTKRPVANT------AQEKIFKKEIHAHALLSR 175
ELLG G+FGEVFK LK D AVK K + ++ +I K+ H
Sbjct: 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH------- 51
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---FQVSEGLRC 232
P+IV + + +Y+ +E GG+ + ++++ E+ KQL+ + G+
Sbjct: 52 -PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAY 108
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYL 292
+ IH D+ N L+ GE N K+ DFG ++D + +
Sbjct: 109 LESKNCIHRDLAARNCLV----GENNV--------LKISDFGMSRQEDDGIYSSSGLKQI 156
Query: 293 P-----KELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGPMWHHIRDGNIEKLSN 345
P E LN + S+ D+++ G+ L+E + GV P P G R+ +EK
Sbjct: 157 PIKWTAPEALNYGRYS-SESDVWSYGILLWETFSLGVCPYP--GMTNQQARE-QVEKGYR 212
Query: 346 VS------DDLHTLIKLMIDKDPTKRPSTSSLRR 373
+S DD++ +++ D P RP S L++
Sbjct: 213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 2e-07
Identities = 57/216 (26%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
F + E LG G + V+K G A+K A+E I +L+ + H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHL----DAEEGTPSTAIREISLMKELKH 57
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ---ERCTFTEMALKQLLFQVSEGLRCM 233
IV + L L EY + +L+ + R +K +Q+ +G+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV----IADNDFEVEEGDC 289
HE R++H D+KP N+LI K +GEL KL DFG I N F E
Sbjct: 117 HENRVLHRDLKPQNLLINK-RGEL-----------KLADFGLARAFGIPVNTFSNEVVTL 164
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPL 325
Y ++L + + +DI+++G + E PL
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPL 200
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 26/211 (12%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK-EIHAHALLSRVPHIV 180
+E+LG G+ G V+K + AVK + Q++I + EI P+I+
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEI---LYKCDSPYII 62
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
++ ++ + + + E+ +GG+L+ + E L ++ V +GL + ++++H
Sbjct: 63 GFYGAFFVENRISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLKILH 118
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYL-PKELL 297
D+KP+N+L+ NT + KL DFG + ++ + G Y+ P+ +
Sbjct: 119 RDVKPSNMLV-----------NT-RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERIS 166
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGVTPLPK 327
+ S D+++LG++ E A G P P+
Sbjct: 167 GEQYGIHS--DVWSLGISFMELALGRFPYPQ 195
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 76/297 (25%), Positives = 133/297 (44%), Gaps = 61/297 (20%)
Query: 118 EFLEEEL-----LGSGDFGEVFKCLKY-MD------GMTYAVKRTKRPVANTAQEKIFK- 164
EF + L LG G FG+V + Y +D +T AVK K + A +K
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK----DNATDKDLAD 63
Query: 165 --KEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER------CTF-- 214
E+ L+ + +I+N + +G LY+ +EY GNL ++ R TF
Sbjct: 64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123
Query: 215 TEMALKQLLF--------QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266
T++ +QL F QV+ G+ + R IH D+ N+L+ TE
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV------------TEDN 171
Query: 267 HYKLGDFGHV--IADNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE- 318
K+ DFG + D D+ + + R P+ L + + + S D+++ G+ ++E
Sbjct: 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS--DVWSFGILMWEI 229
Query: 319 -ASGVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
G +P P ++ +R+G+ ++K SN + +L+ L++ PT+RP+ L
Sbjct: 230 FTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 30/216 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+++G G FGEV YA+K +K + + F +E A + P +V
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-ANSPWVVQ 107
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCMHEMRM 238
F ++ D LY+ +EY GG+L N++ ++ K F +E L +H M
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMGF 163
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND-----FEVEEGDCRYLP 293
IH D+KP N+L+ K+ H KL DFG + N + G Y+
Sbjct: 164 IHRDVKPDNMLLDKSG------------HLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211
Query: 294 KELLNNNFDN---LSKVDIFALGLTLYEA-SGVTPL 325
E+L + + + D +++G+ LYE G TP
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 27/101 (26%), Positives = 54/101 (53%), Gaps = 3/101 (2%)
Query: 151 KRPVANTAQEKIFKK-EIHAHALLSRVPHIVN-YFSSWSDQGVLYLQLEYCNGGNLENII 208
K V + K F E H L+ P+ + Y+S + +G + + ++Y G+L +++
Sbjct: 42 KLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI-MDYIKDGDLFDLL 100
Query: 209 QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANIL 249
++ +E +K+++ Q+ E L +H+ +IH DIK N+L
Sbjct: 101 KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141
|
Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 62/260 (23%), Positives = 115/260 (44%), Gaps = 32/260 (12%)
Query: 124 LLGSGDFGEVFKC-LKYMDGMTYAVKRTKRPVANTAQE-KIFKKEIHAHALLSRVPHIVN 181
++G G + +V LK + + YA+K K+ + N ++ + E H S P +V
Sbjct: 2 VIGRGSYAKVLLVRLKKTERI-YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
S + + L+ +EY NGG+L +Q + E + ++S L +HE +I+
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH----VIADNDFEVEEGDCRYLPKELL 297
D+K N+L+ ++G H KL D+G + + G Y+ E+L
Sbjct: 121 DLKLDNVLL-DSEG-----------HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP-----------MWHHIRDGNIEKLSN 345
D VD +ALG+ ++E +G +P G ++ I + I +
Sbjct: 169 RGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 227
Query: 346 VSDDLHTLIKLMIDKDPTKR 365
+S +++K ++KDP +R
Sbjct: 228 LSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 4e-07
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 19/153 (12%)
Query: 102 IKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEK 161
I SI ++RY E +G G G VF + G A+K+ +K
Sbjct: 11 IVSIGDPKKKYTRY-------EKIGQGASGTVFTAIDVATGQEVAIKQIN-------LQK 56
Query: 162 IFKKEIHAHALLS----RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEM 217
KKE+ + +L + P+IVN+ S+ L++ +EY GG+L +++ E C E
Sbjct: 57 QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC-MDEA 115
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILI 250
+ + + + L +H ++IH DIK N+L+
Sbjct: 116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 72/307 (23%), Positives = 128/307 (41%), Gaps = 47/307 (15%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV------ 176
++LG G FG+VF +A+K K+ V + ++ + RV
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV------LMDDDVECTMVEKRVLSLAWE 54
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRC 232
P + + + ++ + L+ +EY NGG+L IQ F L + F +E GL+
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD---LPRATFYAAEIICGLQF 111
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGD 288
+H +++ D+K NIL+ H K+ DFG +++ D G
Sbjct: 112 LHSKGIVYRDLKLDNILLDTDG------------HIKIADFGMCKENMLGDAKTCTFCGT 159
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGN---IEK 342
Y+ E+L N S VD ++ G+ LYE G +P ++ IR N
Sbjct: 160 PDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRW 218
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR--NYPQLKVENIRGNLNTRLKKL 400
L+ + D+ L+KL + ++P +R R R ++ L+ I ++K
Sbjct: 219 LTREAKDI--LVKLFV-REPERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSA 275
Query: 401 DEGNVFD 407
++ + FD
Sbjct: 276 NDCSNFD 282
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 36/167 (21%)
Query: 126 GSGDFGEVFKC--LKYMDGMTYAVKRTKRPVANTA---QEKIFKKEIHAHALLSRVPH-- 178
G G +G V+K DG YA+K+ K Q +EI ALL + H
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSAC--REI---ALLRELKHEN 63
Query: 179 ---IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-----ERCTFTEMALKQLLFQVSEGL 230
+V F +D+ V YL +Y +L II+ +R + +K LL+Q+ G+
Sbjct: 64 VVSLVEVFLEHADKSV-YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV 121
Query: 231 RCMHEMRMIHMDIKPANILIV---KAQGELNEPMNTEKLHYKLGDFG 274
+H ++H D+KPANIL++ +G + K+GD G
Sbjct: 122 HYLHSNWVLHRDLKPANILVMGEGPERGVV-----------KIGDLG 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 55/216 (25%), Positives = 86/216 (39%), Gaps = 22/216 (10%)
Query: 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR 175
A +L E LG G + V+K + ++G A+K ++ +E + I +LL
Sbjct: 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALK----VISMKTEEGVPFTAIREASLLKG 59
Query: 176 VPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
+ H IV + L EY + + +IQ ++ +FQ+ GL +
Sbjct: 60 LKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYI 119
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDC 289
H ++H D+KP N+LI GEL KL DFG I + E
Sbjct: 120 HGQHILHRDLKPQNLLI-SYLGEL-----------KLADFGLARAKSIPSQTYSSEVVTL 167
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPL 325
Y P ++L D S +DI+ G E P
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYA---VKRTKRPVANTAQEKIFKKEIHAHAL 172
A+ F+EE LG FG+++K Y+ GM +A +T + + N Q F++E A
Sbjct: 6 AVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALK------------ 220
L P+IV + + + + EY N G+L + R +++
Sbjct: 64 LHH-PNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLD 122
Query: 221 -----QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
+ Q++ G+ + +H D+ NILI E+LH K+ D G
Sbjct: 123 HGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI------------GEQLHVKISDLGL 170
Query: 275 --HVIADNDFEVEEGD---CRYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
+ + + + V+ R++P E ++ F + S DI++ G+ L+E
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDS--DIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 39/264 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKR---PVANTAQEKIFKKEIHAHALLSRVPHIVN 181
LG G +GEV++ + +T AVK K V +E KEI H P++V
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-H------PNLVQ 66
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRCMHEMRMI 239
+ + Y+ E+ GNL + ++E R + L + Q+S + + + I
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRY-----L 292
H D+ N L+ E K+ DFG ++ + + G ++
Sbjct: 127 HRDLAARNCLV------------GENHLVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTA 173
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRDG-NIEKLSNVS 347
P+ L N F K D++A G+ L+E + G++P P ++ + G +E+
Sbjct: 174 PESLAYNKFS--IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCP 231
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSL 371
++ L++ +P+ RPS + +
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 63/270 (23%), Positives = 112/270 (41%), Gaps = 33/270 (12%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
L FL+E LGSG FG V K+ + A+K + + E F +E LS
Sbjct: 6 LTFLKE--LGSGQFG-VVHLGKWRGKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSH- 58
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMA-LKQLLFQVSEGLRCMHE 235
P++V + + Q +++ EY G L N ++ER L + V E + +
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES 118
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGD---CR 290
IH D+ N L+ GE N K+ DFG + D+ + +G +
Sbjct: 119 NGFIHRDLAARNCLV----GEDNV--------VKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 291 YLPKELLN-NNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDG-NIEKLS 344
+ P E+ + + F SK D+++ G+ ++E + G P N + + G + +
Sbjct: 167 WAPPEVFDYSRFS--SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPK 224
Query: 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374
+++T++ + P RP+ L
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 27/86 (31%), Positives = 45/86 (52%), Gaps = 18/86 (20%)
Query: 192 LYLQLEYCN---GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANI 248
++L +EYC L+N+ F+E +K L+ Q+ GL+ +HE +IH D+K +N+
Sbjct: 83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139
Query: 249 LIVKAQGELNEPMNTEKLHYKLGDFG 274
L+ T+K K+ DFG
Sbjct: 140 LL------------TDKGCLKIADFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 67/268 (25%), Positives = 114/268 (42%), Gaps = 46/268 (17%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH--AHALLSRVPHIVNY 182
+GSG +G V G+ AVK+ RP + K +E+ H V +++
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 183 FS---SWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRM 238
F+ S + +YL + + G +L NI+ +C T+ ++ L++Q+ GL+ +H +
Sbjct: 85 FTPARSLEEFNDVYL-VTHLMGADLNNIV--KCQKLTDDHVQFLIYQILRGLKYIHSADI 141
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR-YLPKELL 297
IH D+KP+N+ + E K+ DFG +D R Y E++
Sbjct: 142 IHRDLKPSNLAV------------NEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 189
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKL 356
N VDI+++G + E +G T P HI D L +++L
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT----DHI------------DQLKLILRL 233
Query: 357 MIDKDPTKRPSTSSLRR-SAQLARNYPQ 383
P L++ S++ ARNY Q
Sbjct: 234 ------VGTPGAELLKKISSESARNYIQ 255
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 68/274 (24%), Positives = 124/274 (45%), Gaps = 39/274 (14%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
R +L+ +++ LG+G FGEV+ + +G T +T +P T + F +E ++
Sbjct: 5 RESLQLIKK--LGNGQFGEVW--MGTWNGNTKVAVKTLKP--GTMSPESFLEEAQ---IM 55
Query: 174 SRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---FQVSE 228
++ H +V ++ S++ + Y+ EY + G+L + +++ + L L+ QV+
Sbjct: 56 KKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAA 113
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE 286
G+ + M IH D++ ANIL+ + L K+ DFG +I DN++ +
Sbjct: 114 GMAYIERMNYIHRDLRSANILV------------GDGLVCKIADFGLARLIEDNEYTARQ 161
Query: 287 GDCRY-----LPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLP--KNGPMWHHIRDG- 338
G ++ P+ L F S V F + LT G P P N + + G
Sbjct: 162 G-AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY 220
Query: 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ + LH L+ KDP +RP+ L+
Sbjct: 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 42/213 (19%)
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---- 274
+K LFQ+ GL H +++H D+KP N+LI +GEL KL DFG
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI-NERGEL-----------KLADFGLARA 153
Query: 275 HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHH 334
I + E Y P ++L + D +++D++ +G YE S PL
Sbjct: 154 KSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG------ 207
Query: 335 IRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLN 394
S V + LH + +++ PT+ L + NYP+ + + L+
Sbjct: 208 ---------STVEEQLHFIFRIL--GTPTEETWPGILSNEEFKSYNYPKYRAD----CLH 252
Query: 395 TRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
+LD DG L ++ +++ + + RI A
Sbjct: 253 NHAPRLDS----DGAEL-LSKLLQFEGRKRISA 280
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 8e-07
Identities = 66/271 (24%), Positives = 113/271 (41%), Gaps = 31/271 (11%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
L FL+E LG+G FG V K K+ A+K K + E F +E LS
Sbjct: 6 LTFLKE--LGTGQFG-VVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMKLSH- 58
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHE 235
+V + + Q +Y+ EY + G L N ++E F L ++ V EG+ +
Sbjct: 59 EKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGD---CR 290
+ IH D+ N L V QG + K+ DFG + D+++ G R
Sbjct: 119 KQFIHRDLAARNCL-VDDQGCV-----------KVSDFGLSRYVLDDEYTSSVGSKFPVR 166
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLP----KNGPMWHHIRDG-NIEKLSN 345
+ P E+L SK D++A G+ ++E + +P N + G + +
Sbjct: 167 WSPPEVL-LYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHL 225
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376
S+ ++ ++ + +RP+ L S +
Sbjct: 226 ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 44/154 (28%), Positives = 62/154 (40%), Gaps = 17/154 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IV 180
E +G G +G VFK A+KR + + +EI LL + H IV
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI---CLLKELKHKNIV 62
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
+ L L EYC+ + +K +FQ+ +GL H ++H
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH 122
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
D+KP N+LI K GEL KL DFG
Sbjct: 123 RDLKPQNLLINK-NGEL-----------KLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 63/268 (23%), Positives = 107/268 (39%), Gaps = 32/268 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS-RVPHIVN 181
E +G G+FG+V+K AVK + + + K F +E A L P+IV
Sbjct: 1 EKIGKGNFGDVYKG-VLKGNTEVAVKTCRSTLPPDLKRK-FLQE--AEILKQYDHPNIVK 56
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
+ +Y+ +E GG+L ++ ++ T L Q+ + G+ + IH
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIH 116
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND--FEVEEGDCRYLP----- 293
D+ N L+ E K+ DFG + + V +G + +P
Sbjct: 117 RDLAARNCLV------------GENNVLKISDFGMSREEEGGIYTVSDG-LKQIPIKWTA 163
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRDG-NIEKLSNVSD 348
E LN S+ D+++ G+ L+E + G TP P N I G + +
Sbjct: 164 PEALNYG-RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPE 222
Query: 349 DLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376
+++ L+ DP RPS S + Q
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 56/233 (24%), Positives = 91/233 (39%), Gaps = 48/233 (20%)
Query: 114 RYALEFLEEELLGSGDFGEVFK--CLKYM---DGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R + E LG G FG+VF C D AVK K +N A++ F++E
Sbjct: 4 RDTIVLKRE--LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAE 60
Query: 169 AHALLSRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLEN-----------IIQERCTFT 215
LL+ H IV ++ ++ + EY G+L +
Sbjct: 61 ---LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 216 EMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272
E+ L QLL Q++ G+ + +H D+ N L+ L K+GD
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV------------GYDLVVKIGD 165
Query: 273 FGHV--IADNDFEVEEGD----CRYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
FG + D+ G R++P E ++ F S D+++ G+ L+E
Sbjct: 166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTES--DVWSFGVVLWE 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 25/171 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRT----KRPVANTAQE-KIFKKEIHA------HALL 173
LG G G VF + AVK+ + V + +E KI ++ H L
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
+ S ++ +Y+ EY +L N++ E+ +E + ++Q+ GL+ +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGLKYI 130
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFE 283
H ++H D+KPAN+ I NTE L K+GDFG I D +
Sbjct: 131 HSANVLHRDLKPANVFI-----------NTEDLVLKIGDFGLARIVDPHYS 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 63/254 (24%), Positives = 113/254 (44%), Gaps = 29/254 (11%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---NTAQEKIFKKEIHAHALLSRVPHIV 180
+LG G FG+V + YA+K K+ V + + + +K + A L + P +
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA--LSGKPPFLT 64
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
S + LY +EY NGG+L IQ+ F E +++ GL +H +I+
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYLPKE 295
D+K N+++ ++G H K+ DFG + +N ++ G Y+ E
Sbjct: 125 RDLKLDNVML-DSEG-----------HIKIADFG-MCKENMWDGVTTKTFCGTPDYIAPE 171
Query: 296 LLNNNFDNLSK-VDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLSNVSDDLH 351
++ + K VD +A G+ LYE +G P ++ I + N+ ++S +
Sbjct: 172 II--AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAV 229
Query: 352 TLIKLMIDKDPTKR 365
+ K ++ K P KR
Sbjct: 230 AICKGLMTKHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 62/255 (24%), Positives = 108/255 (42%), Gaps = 32/255 (12%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+++G G FGEV YA+K K + A+ F++E + + I
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNV-LVNGDCQWITT 65
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
++ D+ LYL ++Y GG+L ++ + E + + ++ + +H++ +H
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH 125
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND-----FEVEEGDCRYLPKE 295
DIKP N+L+ MN H +L DFG + N V G Y+ E
Sbjct: 126 RDIKPDNVLL---------DMNG---HIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 296 LLNNNFDNLSK----VDIFALGLTLYEA-SGVTPLPKNG-------PMWHHIRDGNIEKL 343
+L D + K D ++LG+ +YE G TP M H R +
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHI 233
Query: 344 SNVSDDLHTLIKLMI 358
++VS++ LI+ +I
Sbjct: 234 TDVSEEAKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 65/248 (26%), Positives = 90/248 (36%), Gaps = 69/248 (27%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRT-----KRPVANTAQEKIFKKEIHAHALLSRVPH- 178
+G G FGEVFK A+K+ K TA +I +L + H
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREI--------KILQLLKHE 71
Query: 179 -IVNYFSSWS--------DQGVLYLQLEYCN---GGNLENIIQERCTFTEMALKQLLFQV 226
+VN +G YL E+C G L N FT +K+++ +
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMKML 128
Query: 227 SEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE 286
GL +H +++H D+K ANILI K G L KL DFG A F + +
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKD-GIL-----------KLADFGLARA---FSLSK 173
Query: 287 GDCR-----------YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMW--H 333
Y P ELL D +D++ G + E MW
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAE------------MWTRS 221
Query: 334 HIRDGNIE 341
I GN E
Sbjct: 222 PIMQGNTE 229
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 68/258 (26%), Positives = 107/258 (41%), Gaps = 35/258 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-------SR 175
+LLG G FG+V + G YA+K K+ V I K+ AH L SR
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-------IVAKDEVAHTLTENRVLQNSR 53
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH- 234
P + S+ L +EY NGG L + F+E + ++ L +H
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 113
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADN-DFEVEEGDCR 290
E +++ D+K N+++ K H K+ DFG I D + G
Sbjct: 114 EKNVVYRDLKLENLMLDKDG------------HIKITDFGLCKEGIKDGATMKTFCGTPE 161
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNIEKLSNVS 347
YL E+L +N D VD + LG+ +YE G P + ++ I I +S
Sbjct: 162 YLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLS 220
Query: 348 DDLHTLIKLMIDKDPTKR 365
+ +L+ ++ KDP +R
Sbjct: 221 PEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 63/285 (22%), Positives = 125/285 (43%), Gaps = 56/285 (19%)
Query: 125 LGSGDFGEVFKCL-------KYMDGMTYAVKRTKRPVANTAQEKIFK---KEIHAHALLS 174
LG G FG+V K + +T AVK K + A EK E+ ++
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK----DDATEKDLSDLVSEMEMMKMIG 78
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-------------ERCTFTEMALKQ 221
+ +I+N + + G LY+ +EY + GNL ++ R +M K
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 222 LL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-- 276
L+ +QV+ G+ + + IH D+ N+L+ TE K+ DFG
Sbjct: 139 LVSCTYQVARGMEYLASQKCIHRDLAARNVLV------------TENNVMKIADFGLARD 186
Query: 277 IADNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--K 327
+ + D+ + + R P+ L + + + S D+++ G+ ++E G +P P
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLMWEIFTLGGSPYPGIP 244
Query: 328 NGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
++ +++G+ ++K +N +++L+ +++ P+ RP+ L
Sbjct: 245 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 60/287 (20%), Positives = 123/287 (42%), Gaps = 60/287 (20%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK------------KEIHAHAL 172
LG G FG+V + + + +PV T K+ K E+ +
Sbjct: 20 LGEGCFGQVVMA----EAIGIDKDKPNKPV--TVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-----------CTFTE--MAL 219
+ + +I+N + + G LY+ +EY + GNL ++ R C E +
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF 133
Query: 220 KQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276
K L+ +QV+ G+ + + IH D+ N+L+ TE K+ DFG
Sbjct: 134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV------------TEDNVMKIADFGLA 181
Query: 277 --IADNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG 329
+ + D+ + + R P+ L + + + S D+++ G+ L+E + P G
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS--DVWSFGVLLWEIFTLGGSPYPG 239
Query: 330 ----PMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
++ +++G+ ++K +N + +L+ +++ P++RP+ L
Sbjct: 240 IPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQL 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 14/134 (10%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH-----I 179
+GSG G V + G+ AVK+ RP N K +E+ LL V H +
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYREL---VLLKCVNHKNIISL 85
Query: 180 VNYFS---SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+N F+ S + +YL +E + NL +I M+ LL+Q+ G++ +H
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSY--LLYQMLCGIKHLHSA 142
Query: 237 RMIHMDIKPANILI 250
+IH D+KP+NI++
Sbjct: 143 GIIHRDLKPSNIVV 156
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 32/167 (19%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E +G G +G+V+K G A+K+T+ + +EI +LS +IV
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRL 66
Query: 183 FS-----SWSDQGVLYLQLEYC----------NGGNLENIIQERCTFTEMALKQLLFQVS 227
+ + LYL EY NG + + +K ++Q+
Sbjct: 67 LDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAK------TIKSFMYQLL 120
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+G+ H+ ++H D+KP N+L+ K +G L K+ D G
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLL-----------KIADLG 156
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 49/224 (21%)
Query: 125 LGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH- 178
LG G FG+VF Y D M AVK K P A K F++E LL+ + H
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAE---LLTNLQHE 67
Query: 179 -IVNYFSSWSDQGVLYLQLEYCNGGNLENII-------------QERCTFTEMALKQLLF 224
IV ++ D L + EY G+L + Q R E+ L Q+L
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 225 ---QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--IAD 279
Q++ G+ + +H D+ N L+ L K+GDFG +
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLV------------GANLLVKIGDFGMSRDVYS 175
Query: 280 NDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
D+ G R++P E ++ F S D+++ G+ L+E
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTES--DVWSFGVILWE 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF---QVSEGLRCM 233
P+IV +SS+ L++ +E+ GG L +I+ T T M +Q+ V + L +
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLAVLKALSFL 131
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GD 288
H +IH DIK +IL+ + G + KL DFG A EV G
Sbjct: 132 HAQGVIHRDIKSDSILL-TSDGRV-----------KLSDFGFC-AQVSKEVPRRKSLVGT 178
Query: 289 CRYLPKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLS 344
++ E+++ + ++VDI++LG+ + E G P P+ IRD KL
Sbjct: 179 PYWMAPEVISRLPYG--TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLK 236
Query: 345 N---VSDDLHTLIKLMIDKDPTKRPSTSSL 371
N VS L + + M+ +DP +R + + L
Sbjct: 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 44/221 (19%)
Query: 125 LGSGDFGEVF--KC---LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
LG G FG+VF +C L D M AVK K + Q+ F++E +L HI
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTVLQH-QHI 69
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQ------------ERCTFTEMALKQLLF--- 224
V ++ ++ L + EY G+L ++ E ++ L Q+L
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 225 QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--IADNDF 282
Q++ G+ + + +H D+ N L+ + L K+GDFG I D+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLV------------GQGLVVKIGDFGMSRDIYSTDY 177
Query: 283 EVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
G R++P E +L F S DI++ G+ L+E
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTES--DIWSFGVVLWE 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 48/224 (21%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP----------VANTAQEKIFKKEIHAHA 171
E+ LG+G FGEV+ Y AVK T +P AN + K + HA
Sbjct: 11 EKKLGAGQFGEVWMA-TYNKHTKVAVK-TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF--QVSEG 229
++++ P +Y+ E+ G+L + ++ + K + F Q++EG
Sbjct: 69 VVTKEP--------------IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEG 287
+ + + IH D++ ANIL+ + L K+ DFG VI DN++ EG
Sbjct: 115 MAFIEQRNYIHRDLRAANILVSAS------------LVCKIADFGLARVIEDNEYTAREG 162
Query: 288 ---DCRYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP 326
++ E +N + K D+++ G+ L E G P P
Sbjct: 163 AKFPIKWTAPEAINFGSFTI-KSDVWSFGILLMEIVTYGRIPYP 205
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 57/224 (25%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYA--VKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
+G+G FG+V + GM+ A V + R A ++ +F +E+ + L+ P+++
Sbjct: 3 IGNGWFGKVLLGEAH-RGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQC 60
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLF----QVSEGLRCMHEMR 237
+ L LE+C G+L+N ++ R +MA K +L +V+ GL +H+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDC-----R 290
IH D+ N + T L K+GD+G D+ DC R
Sbjct: 121 FIHSDLALRNCQL------------TADLSVKIGDYGLALEQYPEDY-YITKDCHAVPLR 167
Query: 291 YLPKELLNNNFDNLSKVD------IFALGLTLYEAS--GVTPLP 326
+L EL+ +L D I++LG+T++E P P
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYP 211
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 43/161 (26%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTK-----RPVANTAQEKIFKKEIHAHALLSRVP 177
E +G G +G V+K + G A+K+ + V +TA +I +LL +
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREI--------SLLKELN 56
Query: 178 H--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRCM 233
H IV + LYL E+ + +L+ + +K L+Q+ +G+
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
H R++H D+KP N+LI + +G L KL DFG
Sbjct: 116 HSHRVLHRDLKPQNLLIDR-EGAL-----------KLADFG 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (117), Expect = 4e-06
Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 47/279 (16%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-------- 176
+G+G FGEVF +K+ KRT+ A KE L+ V
Sbjct: 21 IGNGRFGEVF-LVKH--------KRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71
Query: 177 PHIVNYFSSWSDQG--VLYLQLEYCNGGNLENIIQERC-----TFTEMALKQLLFQVSEG 229
+IV Y + ++ LY+ +E+C+ G+L IQ +C E A+ + Q+
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAIVDITRQLLHA 130
Query: 230 LRCMHEM-------RMIHMDIKPANILI---VKAQGELNEPMN--TEKLHYKLGDFGHVI 277
L H + R++H D+KP NI + ++ G++ N + K+GDFG +
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG-LS 189
Query: 278 ADNDFEVEEGDC-----RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKN--- 328
+ E C + P+ LL+ K D++ALG +YE SG TP K
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249
Query: 329 GPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ ++ G + S +L+ LIK +++ +RPS
Sbjct: 250 SQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 51/207 (24%), Positives = 94/207 (45%), Gaps = 30/207 (14%)
Query: 125 LGSGDFGEVFKCLKYMDG--MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
LGSG+FG V K + M + A+K K + ++++ ++ H L + P+IV
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN--PYIVRM 60
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ L L +E +GG L + ++ T + +L+ QVS G++ + +H
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHY-KLGDFG---HVIADNDFEVEEGDCR-----YL 292
D+ N+L+V HY K+ DFG + AD+ + + Y
Sbjct: 120 DLAARNVLLVNQ-------------HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA 166
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEA 319
P+ + F S+ D+++ G+T++EA
Sbjct: 167 PECINFRKFS--SRSDVWSYGITMWEA 191
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 31/213 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEK--IFKKEIHAHALLSRV--PHI 179
LG G FGEV G YA K+ K+ + + EK + +KEI L +V P I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF---QVSEGLRCMHEM 236
VN ++ + L L + NGG+L+ I + +++++ Q++ G+ +H M
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM 114
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEV---EEGDCRYLP 293
+++ D+KP N+L+ QG +L D G + D + G Y+
Sbjct: 115 DIVYRDMKPENVLL-DDQGNC-----------RLSDLGLAVELKDGKTITQRAGTNGYMA 162
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL 325
E+L + VD FA+G ++YE +G TP
Sbjct: 163 PEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQL---LFQVSEGLRCMH 234
++V ++S+ L++ +E+ GG L +I+ T T M +Q+ V + L +H
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAVCLAVLKALSVLH 133
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDC 289
+IH DIK +IL+ T KL DFG A EV G
Sbjct: 134 AQGVIHRDIKSDSILL------------THDGRVKLSDFGFC-AQVSKEVPRRKSLVGTP 180
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSN- 345
++ EL+ + +VDI++LG+ + E G P P+ IRD KL N
Sbjct: 181 YWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNL 239
Query: 346 --VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
VS L + ++ +DP +R + + L + LA+ P
Sbjct: 240 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 53/208 (25%), Positives = 93/208 (44%), Gaps = 32/208 (15%)
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQL---LFQVSEGLRCMH 234
++V+ ++S+ L++ +E+ GG L +I+ T T M +Q+ V L +H
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIATVCLSVLRALSYLH 135
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDC 289
+IH DIK +IL+ T KL DFG A EV + G
Sbjct: 136 NQGVIHRDIKSDSILL------------TSDGRIKLSDFGFC-AQVSKEVPKRKSLVGTP 182
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDG---NIEKL 343
++ E+++ ++VDI++LG+ + E G P P+ IRD ++
Sbjct: 183 YWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS 241
Query: 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
VS L + LM+ ++P++R + L
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQEL 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 26/162 (16%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTK----RPVANTAQEKIFKKEIHAHALLSRVPHIV 180
LG G +G+V K + G A+K+ K ++ + IH L R I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL--RELKIM 74
Query: 181 NYFSSWSDQGV--LYLQLEYCN------GGNLENIIQERCTFTEMALKQLLFQVSEGLRC 232
N + G+ +Y++ ++ N +L+ ++ + TE +K +L Q+ GL
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNV 134
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H+ +H D+ PANI I +G K+ DFG
Sbjct: 135 LHKWYFMHRDLSPANIFINS-KGIC-----------KIADFG 164
|
Length = 335 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 11/117 (9%)
Query: 159 QEKIFKKEIHAHALLSRVPHIVNYFSSW-SDQGVLYLQLEYCNGGNLENIIQERCTFTEM 217
Q F++E A L P+IV S + G+L+ EY G L ++
Sbjct: 21 QRARFRRETALCARLYH-PNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+L+ QV + L C H ++H D+KP NI++ + H K+ DFG
Sbjct: 80 ETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVR---------PHAKVLDFG 127
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 5e-06
Identities = 43/171 (25%), Positives = 72/171 (42%), Gaps = 33/171 (19%)
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA 278
+K L+Q+ GL H +++H D+KP N+LI +GEL KL DFG A
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI-NERGEL-----------KLADFGLARA 153
Query: 279 DN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHH 334
+ + E Y P ++L + + +++D++ +G +E + PL
Sbjct: 154 KSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG------ 207
Query: 335 IRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
S V D+LH + +L+ P SS N+P+ K
Sbjct: 208 ---------STVEDELHLIFRLLGTPTEETWPGISSNDEFKNY--NFPKYK 247
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 37/178 (20%), Positives = 65/178 (36%), Gaps = 12/178 (6%)
Query: 196 LEYCNGGNLENIIQERCTFTEMALK-QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQ 254
EY G L+ + + K + Q++ L + + +++H ++ NIL+ +
Sbjct: 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARY- 137
Query: 255 GELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSK-VDIFALG 313
KL D G I E ++ E + N +L+ D ++ G
Sbjct: 138 ----GLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFG 193
Query: 314 LTLYEASGVTPLP----KNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
TL E P + +D + + + +L LI DPTKRPS
Sbjct: 194 TTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD-CAELANLINQCWTYDPTKRPS 250
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 60/257 (23%), Positives = 109/257 (42%), Gaps = 28/257 (10%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE-KIFKKEIHAHALLSRVPHIVNY 182
++G G + +V + YA+K K+ + + ++ + E H S P +V
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
S + L+L +EY NGG+L +Q + E + ++ L +HE +I+ D
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFGH----VIADNDFEVEEGDCRYLPKELLN 298
+K N+L+ A G H KL D+G + + G Y+ E+L
Sbjct: 122 LKLDNVLL-DADG-----------HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILR 169
Query: 299 NNFDNLSKVDIFALGLTLYE-ASGVTPLP--KNGP-------MWHHIRDGNIEKLSNVSD 348
S VD +ALG+ ++E +G +P + P ++ I + I +S
Sbjct: 170 GEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSV 228
Query: 349 DLHTLIKLMIDKDPTKR 365
++K ++KDP +R
Sbjct: 229 KASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 26/156 (16%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVN- 181
+G G FG V + G A+K+ +P + K +E+ LL + H I++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK---LLKHLRHENIISL 74
Query: 182 ---YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
+ S D +Y E G +L ++ R + + L+Q+ GL+ +H +
Sbjct: 75 SDIFISPLED---IYFVTELL-GTDLHRLLTSRPLEKQFI-QYFLYQILRGLKYVHSAGV 129
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H D+KP+NILI E K+ DFG
Sbjct: 130 VHRDLKPSNILI------------NENCDLKICDFG 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|167150 PRK01066, PRK01066, porphobilinogen deaminase; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 30/93 (32%), Positives = 44/93 (47%), Gaps = 9/93 (9%)
Query: 2 NTTGDNILDKALP-KIGEKS-LFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAIL 59
T GD LD+ P + E + FT +++ + + D +HS KDLP P L++ AI
Sbjct: 54 TTQGD--LDQKTPLHLVENTGFFTDDVDFLVLSGQCDLAIHSAKDLPE--PPKLTVVAIT 109
Query: 60 EREDPRDALILNKKWSGKTLATLPSGSVIDEDS 92
DPRD L+ +K+ LP I S
Sbjct: 110 AGLDPRDLLVYAEKY---LSQPLPRRPRIGSSS 139
|
Length = 231 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 35/274 (12%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
L ++E +GSG FG V+ +++ A+K T R A + ++ F +E LS
Sbjct: 6 LTLVQE--IGSGQFGLVWLG-YWLEKRKVAIK-TIREGAMSEED--FIEEAQVMMKLSH- 58
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHE 235
P +V + +++ + L E+ G L + ++ +R F++ L + V EG+ +
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGD---CR 290
+IH D+ N L+ E K+ DFG + D+ + G +
Sbjct: 119 SNVIHRDLAARNCLV------------GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVK 166
Query: 291 YLPKELLNNNFDNLS-KVDIFALGLTLYE--ASGVTPLPK--NGPMWHHIRDG-NIEKLS 344
+ E+ +F S K D+++ G+ ++E + G TP N + I G + K
Sbjct: 167 WSSPEVF--SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224
Query: 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378
S ++ L++ + P RPS S L QLA
Sbjct: 225 LASQSVYELMQHCWKERPEDRPSFSLLLH--QLA 256
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 30/211 (14%)
Query: 125 LGSGDFGEVFKCLKYMD-GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYF 183
+G+G FG+V Y D G+ V + + A++ ++ F ++ + +L P+I+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCL 61
Query: 184 SSWSDQGVLYLQLEYCNGGNLENII-QERCTFTE---MALKQLLFQVSEGLRCMHEMRMI 239
+ L EYC G+L++ + QE+ + L+++ +++ G+ MH+ +
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL 121
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDC---RYLP 293
H D+ N + T L K+GD+G ++ E E+ C R+L
Sbjct: 122 HSDLALRNCFL------------TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLA 169
Query: 294 KELLNNNFDNLSKVD------IFALGLTLYE 318
EL+ L + ++ALG+TL+E
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 43/156 (27%), Positives = 71/156 (45%), Gaps = 22/156 (14%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRP--VANTAQEKIF-KKEIHAHALLSRVPHIVN 181
LG G FG+V G YA+K K+ +A E + +K I A R P +VN
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCMHEMRM 238
F+ + + + +EY GG+L I F+E + +F + GL+ +HE ++
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD-VFSE---PRAVFYAACVVLGLQYLHENKI 122
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++ D+K N+L+ +G K+ DFG
Sbjct: 123 VYRDLKLDNLLL-DTEG-----------FVKIADFG 146
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 43/176 (24%), Positives = 76/176 (43%), Gaps = 35/176 (19%)
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA 278
+K +FQ+ GL H+ +++H D+KP N+LI +GEL KL DFG A
Sbjct: 105 VKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI-NEKGEL-----------KLADFGLARA 152
Query: 279 DN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWH 333
+ + E Y P ++L + + + +D++ +G LYE A+G P
Sbjct: 153 KSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG------ 206
Query: 334 HIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENI 389
S V ++LH + +L+ PT+ + +PQ + + +
Sbjct: 207 ----------STVKEELHLIFRLL--GTPTEETWPGITSNEEFRSYLFPQYRAQPL 250
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 55/205 (26%)
Query: 196 LEYCNGG-NLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQ 254
++ C GG ++ N+ + LFQ+ GL H+ R++H D+KP N+LI +
Sbjct: 93 MDDCGGGLSMHNV------------RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI-SER 139
Query: 255 GELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIF 310
GEL KL DFG + + E Y P ++L + + + +D++
Sbjct: 140 GEL-----------KLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMW 188
Query: 311 ALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLM----------ID 359
+G YE A+G P ++V D LH + +++ +
Sbjct: 189 GVGCIFYEMATGRPLFP---------------GSTDVEDQLHKIFRVLGTPTEETWPGVS 233
Query: 360 KDPTKRPSTSSLRRSAQLARNYPQL 384
+P +P + L + P+L
Sbjct: 234 SNPEFKPYSFPFYPPRPLINHAPRL 258
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 44/185 (23%), Positives = 89/185 (48%), Gaps = 29/185 (15%)
Query: 201 GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP 260
+ +I E + M L +QV+ G+ + +H D+ N+LI +G+L
Sbjct: 223 RTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKL--- 277
Query: 261 MNTEKLHYKLGDFG---HVIADNDFEVEEGDC----RYL-PKELLNNNFDNLSKVDIFAL 312
K+ DFG ++ D+++ + +G +++ P+ + NN + LS D+++
Sbjct: 278 -------VKICDFGLARDIMRDSNY-ISKGSTFLPLKWMAPESIFNNLYTTLS--DVWSF 327
Query: 313 GLTLYE--ASGVTP---LPKNGPMWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRP 366
G+ L+E G TP LP N ++ I+ G + K ++ SD+++ +++ ++ RP
Sbjct: 328 GILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP 387
Query: 367 STSSL 371
S L
Sbjct: 388 DFSQL 392
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 41/169 (24%)
Query: 125 LGSGDFGEVFKCLKYMDGMTY-AVKRTKRPVANTAQEKIFKKEIHAHALLSRV-----PH 178
+G G +G+VFK +G + A+KR + T +E + I A+L + P+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 179 IVNYFS----SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMA---------LKQLLFQ 225
+V F S +D+ L L + E++ Q+ T+ + +K ++FQ
Sbjct: 66 VVRLFDVCTVSRTDRET-KLTLVF------EHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ GL +H R++H D+KP NIL V + G++ KL DFG
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNIL-VTSSGQI-----------KLADFG 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 27/154 (17%)
Query: 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIV 251
LY +L + L II+ T+ + ++Q+ GL+ +H ++H D+KP N+L V
Sbjct: 83 LYEELMEAD---LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL-V 138
Query: 252 KAQGELNEPMNTEKLHYKLGDFGHV--IADNDFEVEEGDCRYL-------PKELLNNNFD 302
A EL K+ DFG ++N E Y+ P+ +L +F
Sbjct: 139 NADCEL-----------KICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIML--SFQ 185
Query: 303 NLSK-VDIFALGLTLYEASGVTPLPKNGPMWHHI 335
+ +K +D++++G L E G P+ K +
Sbjct: 186 SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQL 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 12/74 (16%)
Query: 201 GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP 260
+L +II TE ++ L+Q+ GL+ +H +IH D+KP+N+L+
Sbjct: 91 ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---------- 140
Query: 261 MNTEKLHYKLGDFG 274
E ++GDFG
Sbjct: 141 --NEDCELRIGDFG 152
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 52/235 (22%), Positives = 108/235 (45%), Gaps = 44/235 (18%)
Query: 166 EIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER------------CT 213
E+ ++ + +I+N + + G LY+ +EY + GNL ++ R
Sbjct: 73 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132
Query: 214 FTE-MALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269
E ++ K L+ +QV+ G+ + + IH D+ N+L+ TE K
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV------------TEDNVMK 180
Query: 270 LGDFGHV--IADNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE--AS 320
+ DFG I D+ + + R P+ L + + + S D+++ G+ L+E
Sbjct: 181 IADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS--DVWSFGVLLWEIFTL 238
Query: 321 GVTPLPKNGPM---WHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
G +P P P+ + +++G+ ++K SN +++L+ +++ P++RP+ L
Sbjct: 239 GGSPYP-GVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 46/167 (27%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVK-------------RTKRPVANTAQEKIFKKEIHAHA 171
LG G +G V+K + A+K RT R E +F +E+ H
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-------EIMFLQELGDH- 66
Query: 172 LLSRVPHIV---NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQ-LLFQVS 227
P+IV N + +D+ +YL EY +L +I R E K+ +++Q+
Sbjct: 67 -----PNIVKLLNVIKAENDKD-IYLVFEYMET-DLHAVI--RANILEDVHKRYIMYQLL 117
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ L+ +H +IH D+KP+NIL+ N++ KL DFG
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILL-----------NSD-CRVKLADFG 152
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 39/142 (27%), Positives = 66/142 (46%), Gaps = 25/142 (17%)
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH------ALLS 174
+GSG +G+V G A+K+ RP F+ IHA LL
Sbjct: 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP---------FQSAIHAKRTYRELRLLK 69
Query: 175 RVPH-----IVNYF---SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQV 226
+ H +++ F SS D +YL G +L NI++ + ++ ++ L++Q+
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQI 127
Query: 227 SEGLRCMHEMRMIHMDIKPANI 248
GL+ +H +IH D+KP+NI
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNI 149
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 32/127 (25%), Positives = 59/127 (46%), Gaps = 1/127 (0%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYF 183
++G G +G V KC A+K+ K N ++ +E+ L + +IV
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ-ENIVELK 66
Query: 184 SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDI 243
++ +G LYL EY LE + + ++ ++Q+ + + H+ ++H DI
Sbjct: 67 EAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDI 126
Query: 244 KPANILI 250
KP N+LI
Sbjct: 127 KPENLLI 133
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 31/164 (18%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKR-------PVANTAQEKIFKKEIHAHALLSRVP 177
+G G +G+V+K G A+K+ + P+ + KI ++ H + + +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIV--NLK 72
Query: 178 HIV----NYFSSWSDQGVLYLQLEYCNG---GNLENIIQERCTFTEMALKQLLFQVSEGL 230
IV + D+G YL EY + G LE+ + F+E +K + Q+ EGL
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL---VHFSEDHIKSFMKQLLEGL 129
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
H+ +H DIK +NIL+ K KL DFG
Sbjct: 130 NYCHKKNFLHRDIKCSNILL------------NNKGQIKLADFG 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 38/134 (28%), Positives = 64/134 (47%), Gaps = 14/134 (10%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVNY 182
+GSG G V + A+K+ RP N K +E+ L+ V H I++
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL---VLMKCVNHKNIISL 81
Query: 183 FSSWSDQGVL------YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+ ++ Q L YL +E + NL +IQ M+ LL+Q+ G++ +H
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSY--LLYQMLCGIKHLHSA 138
Query: 237 RMIHMDIKPANILI 250
+IH D+KP+NI++
Sbjct: 139 GIIHRDLKPSNIVV 152
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 49/205 (23%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
++V + S+ L++ +E+ GG L +I+ + E + + V + L +H
Sbjct: 79 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG 137
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-----GDCRYL 292
+IH DIK +IL+ T KL DFG A +V + G ++
Sbjct: 138 VIHRDIKSDSILL------------TLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWM 184
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSN---V 346
E+++ ++VDI++LG+ + E G P + P+ +RD KL N +
Sbjct: 185 APEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKI 243
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSL 371
S L ++ M+ ++P +R + L
Sbjct: 244 SPVLRDFLERMLTREPQERATAQEL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 27/165 (16%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTK-----RPVANTAQEKI-FKKEIHAHA 171
++ + E +G G +G V+K + T A+K+ + V +TA +I KE+ H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HG 61
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTE--MALKQLLFQVSEG 229
+ R+ +V+ S++ LYL EY + +L+ + F + +K L+Q+ G
Sbjct: 62 NIVRLQDVVH-----SEK-RLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ H R++H D+KP N+LI + L KL DFG
Sbjct: 115 IAYCHSHRVLHRDLKPQNLLIDRRTNAL-----------KLADFG 148
|
Length = 294 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 63/274 (22%), Positives = 106/274 (38%), Gaps = 46/274 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTY---AVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
+ LG G FG V + G AVK K + + K+ H+L ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL--DHENL 58
Query: 180 VNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRC 232
+ + GV L + E G+L + +++ F L Q++ G+R
Sbjct: 59 IRLY------GVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRY 112
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA---DNDFEVEEGDC 289
+ R IH D+ NIL+ A + K+GDFG + A + D V E
Sbjct: 113 LESKRFIHRDLAARNILL--ASDDK----------VKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 290 R----YLPKELLNN-NFDNLSKVDIFALGLTLYE--ASGVTP-LPKNGPMWHHIRDGNIE 341
+ + E L F + S D++ G+TL+E G P +G D E
Sbjct: 161 KVPFAWCAPESLRTRTFSHAS--DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE 218
Query: 342 KLSNVSD---DLHTLIKLMIDKDPTKRPSTSSLR 372
+L D++ ++ +P RP+ ++LR
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 52/230 (22%), Positives = 89/230 (38%), Gaps = 44/230 (19%)
Query: 116 ALEFLEEELLGSGDFGEVFK----CLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
A+ FLEE LG G FG+V+K T +T + A ++ F++E +
Sbjct: 6 AVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII-----------QERCTFTEMALK 220
L + P+IV + + + EY G+L + + + +L
Sbjct: 64 DL-QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLD 122
Query: 221 QLLF-----QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
F Q++ G+ + +H D+ N L+ E L K+ DFG
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV------------GEGLTVKISDFGL 170
Query: 275 -HVIADNDFEVEEGD----CRYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
I D+ + R++P E +L F S DI++ G+ L+E
Sbjct: 171 SRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTES--DIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 21/163 (12%)
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL--GDF 273
MA+ Q++ G+ +H+ +IH DI N +I EL + L L D+
Sbjct: 121 HMAI-----QIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDY 172
Query: 274 GHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP- 330
H + DN E +++ E L N + S D+++ G+ L+E G TP + P
Sbjct: 173 -HCLGDN----ENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPF 226
Query: 331 -MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
M +++DG + + N D+L ++ DP +RPS S L
Sbjct: 227 EMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQL 269
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 57/288 (19%)
Query: 113 SRYALEFLEEELLGSGDFGEVFK-----CLKYMDGMTYAVKRTKRPVANTAQ------EK 161
R + + E LG G FG V++ +K A+K T A+ + E
Sbjct: 4 PREKITLIRE--LGQGSFGMVYEGLAKGVVKGEPETRVAIK-TVNENASMRERIEFLNEA 60
Query: 162 IFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-------CTF 214
KE + H H+V S + +E G+L++ ++ R
Sbjct: 61 SVMKEFNCH-------HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 215 TEMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
L++ + ++++G+ + + +H D+ N ++ E L K+G
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV------------AEDLTVKIG 161
Query: 272 DFGHV--IADNDFEVEEGD----CRYLPKELLNNN-FDNLSKVDIFALGLTLYEASGVTP 324
DFG I + D+ + G R++ E L + F +K D+++ G+ L+E + +
Sbjct: 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT--TKSDVWSFGVVLWEMATLAE 219
Query: 325 LP----KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
P N + + DG + N D L L+++ +P RP+
Sbjct: 220 QPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 28/163 (17%)
Query: 121 EEELLGSGDFGEVFKCLKYMDG---MTYAVKRTKRPVANTAQEKIFKKEIH-----AHAL 172
+++++G+G+FGEVF+ + M G + A+K T +P Q + F E +H
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIK-TLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLR 231
+ R+ +V F + EY G L+ +++ F+ L +L ++ G++
Sbjct: 68 IIRLEGVVTKFKP------AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ +M +H D+ NIL+ L K+ DFG
Sbjct: 122 YLSDMNYVHRDLAARNILV------------NSNLECKVSDFG 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 33/216 (15%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTK------RPVANTAQEKIFKKEIHAH-ALLSR 175
E LG G + V+K ++G A+K + P + + K HA+ LL
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
+ H + L L EY + + + + +K LFQ+ GL +H+
Sbjct: 71 IIHT---------KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRY 291
++H D+KP N+LI GEL KL DFG + + + E Y
Sbjct: 122 RYILHRDLKPQNLLISDT-GEL-----------KLADFGLARAKSVPSHTYSNEVVTLWY 169
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLP 326
P ++L + + + +D++ +G E GV P
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--FKKEIHAHALLSRVPHIVN 181
++G G + +V YA+K K+ + N E I + E H S P +V
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVND-DEDIDWVQTEKHVFETASNHPFLVG 60
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
S + + L+ +E+ +GG+L +Q + E + ++S L +HE +I+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV---IADNDFEVEE-GDCRYLPKELL 297
D+K N+L+ A+G H KL D+G I D G Y+ E+L
Sbjct: 121 DLKLDNVLL-DAEG-----------HIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 298 NNNFDNLSKVDIFALGLTLYE 318
S VD +ALG+ ++E
Sbjct: 169 RGEDYGFS-VDWWALGVLMFE 188
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 28/98 (28%), Positives = 45/98 (45%), Gaps = 18/98 (18%)
Query: 225 QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADN 280
Q+ EGLR +H R+IH D+K NI I ++ +GD G V+A
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFI--------NDVDQ----VCIGDLGAAQFPVVAPA 212
Query: 281 DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE 318
+ P+ L + ++ SK DI++ G+ L+E
Sbjct: 213 FLGLAGTVETNAPEVLARDKYN--SKADIWSAGIVLFE 248
|
Length = 357 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 31/134 (23%), Positives = 56/134 (41%), Gaps = 17/134 (12%)
Query: 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
+LL G V+ L D Y +K + + ++E+ LL+R V
Sbjct: 2 SIKLLKGGLTNRVYL-LGTKDE-DYVLKINP----SREKGADREREVAILQLLARKGLPV 55
Query: 181 -NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM- 238
+S G YL +E+ G L+ + +E + + Q++E L +H++ +
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 239 --IHMDIKPANILI 250
H D+ P NIL+
Sbjct: 109 VLCHGDLHPGNILV 122
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+++G G FGEV G YA+K K + A+ F++E R I N
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITN 65
Query: 182 YFSSWSDQGVLYLQLEYCNGGNL--------ENIIQERCTF--TEMALKQLLFQVSEGLR 231
++ D+ LYL ++Y GG+L + + ++ F EM L +
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVL---------AID 116
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADN--DFEVEE 286
+H++ +H DIKP N+L+ K G H +L DFG ++AD V
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDK-NG-----------HIRLADFGSCLRLLADGTVQSNVAV 164
Query: 287 GDCRYLPKELLNNNFDNLSK----VDIFALGLTLYEA-SGVTP 324
G Y+ E+L D + D ++LG+ +YE G TP
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 36/163 (22%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH-----I 179
+GSG G V + G A+K+ RP N K +E+ L+ V H +
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYREL---VLMKLVNHKNIIGL 80
Query: 180 VNYFS---SWSDQGVLYLQLEYCNGGNLENIIQ-----ERCTFTEMALKQLLFQVSEGLR 231
+N F+ S + +YL +E + NL +IQ ER ++ LL+Q+ G++
Sbjct: 81 LNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMSY-------LLYQMLCGIK 132
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+H +IH D+KP+NI +VK+ L K+ DFG
Sbjct: 133 HLHSAGIIHRDLKPSNI-VVKSDCTL-----------KILDFG 163
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 33/136 (24%), Positives = 60/136 (44%), Gaps = 16/136 (11%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH---------AHALLS 174
+GSG +G V + G A+K+ RP Q +IF K + H +
Sbjct: 22 QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF----QSEIFAKRAYRELTLLKHMQHENVI 77
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
+ + S + YL + Y +L+ I+ +E ++ L++Q+ GL+ +H
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQYLVYQMLCGLKYIH 134
Query: 235 EMRMIHMDIKPANILI 250
+IH D+KP N+ +
Sbjct: 135 SAGIIHRDLKPGNLAV 150
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 74/288 (25%), Positives = 115/288 (39%), Gaps = 58/288 (20%)
Query: 110 IDHSRYA-----LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK 164
ID +Y LE L E +GSG G+V+K G AVK+ +R N + K
Sbjct: 5 IDGQKYPADLNDLENLGE--IGSGTCGQVYKMRFKKTGHVMAVKQMRR-TGNKEENKRIL 61
Query: 165 KEIHAHALLSRVPHIVN---YFSSWSDQGVLYLQLEYC--------NGGNLENIIQERCT 213
++ P+IV YF + SD + + C G E+I+ +
Sbjct: 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK--- 118
Query: 214 FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273
T +K L + L+ H + IH D+KP+NIL+ A G + KL DF
Sbjct: 119 MTVAIVKALHY-----LKEKHGV--IHRDVKPSNILL-DASGNV-----------KLCDF 159
Query: 274 GHVIA----DNDFEVEEGDCR-YLPKELL--NNNFDNLS-KVDIFALGLTLYE-ASGVTP 324
G I+ D+ + C Y+ E + + + D+++LG++L E A+G P
Sbjct: 160 G--ISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
Query: 325 LPKNG---PMWHHIRDGNIEKLS---NVSDDLHTLIKLMIDKDPTKRP 366
+ I L S D + + L + KD KRP
Sbjct: 218 YKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 37/134 (27%), Positives = 64/134 (47%), Gaps = 14/134 (10%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH-----I 179
+GSG G V + A+K+ RP N K +E+ L+ V H +
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL---VLMKCVNHKNIIGL 88
Query: 180 VNYFS---SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+N F+ S + +Y+ +E + NL +IQ M+ LL+Q+ G++ +H
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSY--LLYQMLCGIKHLHSA 145
Query: 237 RMIHMDIKPANILI 250
+IH D+KP+NI++
Sbjct: 146 GIIHRDLKPSNIVV 159
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 16/127 (12%)
Query: 203 NLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMN 262
+L II+ T ++ + L+Q+ GL+ +H ++H D+KP+N+L + A +L
Sbjct: 94 DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL-LNANCDL----- 147
Query: 263 TEKLHYKLGDFGHVIADN---DFEVEEGDCR-YLPKELLNNNFDNLSKVDIFALGLTLYE 318
K+ DFG + DF E R Y ELL N + + +D++++G E
Sbjct: 148 ------KICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 319 ASGVTPL 325
G PL
Sbjct: 202 LLGRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 58/229 (25%)
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE---------RCTFTEMALKQLLFQVS 227
P +V+ F S+ + L + +EY GG+ +++ R F E L
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVL-------- 112
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------------- 274
L +H ++H D+KP N+LI T H KL DFG
Sbjct: 113 -ALEYLHNYGIVHRDLKPDNLLI------------TSMGHIKLTDFGLSKIGLMSLTTNL 159
Query: 275 ---HVIADNDFEVEEGDC---RYL-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLP 326
H+ D +++ C Y+ P+ +L + VD +A+G+ LYE G P
Sbjct: 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK--PVDWWAMGIILYEFLVGCVPFF 217
Query: 327 KNGP--MWHHIRDGNIEKLSN---VSDDLHTLIKLMIDKDPTKRPSTSS 370
+ P ++ + +IE + D LI ++ ++P +R T
Sbjct: 218 GDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGG 266
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 67/263 (25%), Positives = 110/263 (41%), Gaps = 48/263 (18%)
Query: 123 ELLGSGDFGEVFKC-LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+++G G FGEV LK D + K + A+ F++E +VN
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDV---------LVN 57
Query: 182 YFSSW--------SDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRC 232
+ W D+ LYL ++Y GG+L ++ + E + L ++ +
Sbjct: 58 GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDS 117
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFE--VEEG 287
+H++ +H DIKP NIL+ MN H +L DFG ++ D + V G
Sbjct: 118 VHQLHYVHRDIKPDNILM---------DMNG---HIRLADFGSCLKLMEDGTVQSSVAVG 165
Query: 288 DCRYLPKELLNNNFDNLSK----VDIFALGLTLYEA-SGVTPLPKNG-------PMWHHI 335
Y+ E+L D K D ++LG+ +YE G TP M H
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE 225
Query: 336 RDGNIEKLSNVSDDLHTLIKLMI 358
R ++++VS+D LI+ +I
Sbjct: 226 RFQFPAQVTDVSEDAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 27/159 (16%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH-ALLSRVPH----- 178
+GSG +G V L G A+K+ RP Q ++F K + LL + H
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPF----QSELFAKRAYRELRLLKHMKHENVIG 78
Query: 179 IVNYFS---SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
+++ F+ S YL + + G +L +++ +E ++ L++Q+ +GL+ +H
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA 136
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+IH D+KP N+ + E K+ DFG
Sbjct: 137 AGIIHRDLKPGNLAV------------NEDCELKILDFG 163
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 27/165 (16%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTK-----RPVANTAQEKI-FKKEIHAHA 171
++ + E +G G +G V+K G A+K+ + V +TA +I KE+ H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-H- 58
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEY--CNGGNLENIIQERCTFTEMALKQLLFQVSEG 229
P+IV + LYL E+ + + + + +K L+Q+ +G
Sbjct: 59 -----PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ H R++H D+KP N+LI K KL DFG
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLI------------DNKGVIKLADFG 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 59/252 (23%), Positives = 97/252 (38%), Gaps = 64/252 (25%)
Query: 111 DHSRYALEFLEEELLGSGDFGEVFKC-------LKYMD---------GMTYAVKRTKRPV 154
R L F E+ LG G FGEV C L + + AVK RP
Sbjct: 1 KFPRGHLLFKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPD 57
Query: 155 ANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC 212
AN F KE+ +LSR+ P+I+ D+ L + EY G+L +
Sbjct: 58 ANKNARNDFLKEVK---ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHH 114
Query: 213 -------------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKA 253
+ +L + Q++ G++ + + +H D+ N L+
Sbjct: 115 LDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV--- 171
Query: 254 QGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDC---RYLPKE-LLNNNFDNLSK 306
E L K+ DFG ++ A + + ++ R++ E +L F S
Sbjct: 172 ---------GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTAS- 221
Query: 307 VDIFALGLTLYE 318
D++A G+TL+E
Sbjct: 222 -DVWAFGVTLWE 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 43/183 (23%), Positives = 91/183 (49%), Gaps = 29/183 (15%)
Query: 200 NGGNLENIIQERCT--FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL 257
N ++N++ + + T + L +QV+ G+ + +H D+ N+L+ AQG++
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKI 275
Query: 258 NEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELL--NNNFDNLSKV--DIF 310
K+ DFG ++ D+++ V +G +LP + + + FDNL D++
Sbjct: 276 ----------VKICDFGLARDIMHDSNY-VSKGST-FLPVKWMAPESIFDNLYTTLSDVW 323
Query: 311 ALGLTLYE--ASGVTPLPK---NGPMWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTK 364
+ G+ L+E + G TP P + ++ I+ G + K + + +++ ++ + +P K
Sbjct: 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEK 383
Query: 365 RPS 367
RPS
Sbjct: 384 RPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 33/134 (24%), Positives = 66/134 (49%), Gaps = 13/134 (9%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH-----I 179
+GSG +G V AVK+ RP + + +E+ LL + H +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELR---LLKHMKHENVIGL 79
Query: 180 VNYFS---SWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
++ F+ S + +YL + G +L NI++ + ++ ++ L++Q+ GL+ +H
Sbjct: 80 LDVFTPATSIENFNEVYL-VTNLMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 237 RMIHMDIKPANILI 250
+IH D+KP+N+ +
Sbjct: 138 GIIHRDLKPSNVAV 151
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 57/233 (24%), Positives = 91/233 (39%), Gaps = 54/233 (23%)
Query: 122 EELLGSGDFGEVFKC-----LKYMDG-----------MTYAVKRTKRPVANTAQEKIFKK 165
+E LG G FGEV C K+MD + AVK R AN F K
Sbjct: 10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK-MLREDANKNARNDFLK 68
Query: 166 EIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL----------ENIIQERCT 213
EI ++SR+ P+I+ + L + EY G+L E +
Sbjct: 69 EIK---IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 214 FTEMA-LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272
+ L + Q++ G++ + + +H D+ N L+ K K+ D
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK------------NYTIKIAD 173
Query: 273 FG--HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
FG + D+ +G R++ E +L F S D++A G+TL+E
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTAS--DVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 59/232 (25%), Positives = 95/232 (40%), Gaps = 53/232 (22%)
Query: 122 EELLGSGDFGEVFKC----LKYMDGMT----------YAVKRTKRPVANTAQEKIFKKEI 167
+E LG G FGEV C L G AVK + V TA+ F KEI
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARND-FLKEI 68
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER---CTFTE------ 216
++SR+ P+I+ L + EY G+L + +R TFT
Sbjct: 69 K---IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 217 MALKQLLF---QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273
+++ LL+ Q++ G++ + + +H D+ N L+ K+ DF
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV------------GNHYTIKIADF 173
Query: 274 G--HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE 318
G + D+ +G R++ E +L F S D++A G+TL+E
Sbjct: 174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS--DVWAFGVTLWE 223
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 16/48 (33%), Positives = 27/48 (56%)
Query: 203 NLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILI 250
+L II + +K L+Q+ GL+ +H ++H DIKP N+L+
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|202802 pfam03900, Porphobil_deamC, Porphobilinogen deaminase, C-terminal domain | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.003
Identities = 13/48 (27%), Positives = 24/48 (50%), Gaps = 3/48 (6%)
Query: 427 AVFSEYKPGSLSMTGAVWSLDGRETLQDAMERSLDGEENEVDGGQEVG 474
++ K G+L + G V S DG + +E D E+ E + G+++
Sbjct: 23 GAYAVLKDGNLRLKGLVGSPDGTRVFE--IEVRGDIEDAE-ELGKKLA 67
|
Length = 72 |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 480 | ||||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-62 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-62 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-62 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-62 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-28 | ||
| 3ecr_A | 364 | Structure Of Human Porphobilinogen Deaminase Length | 2e-27 | ||
| 3ecr_A | 364 | Structure Of Human Porphobilinogen Deaminase Length | 4e-15 | ||
| 3eq1_A | 361 | The Crystal Structure Of Human Porphobilinogen Deam | 3e-27 | ||
| 3eq1_A | 361 | The Crystal Structure Of Human Porphobilinogen Deam | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-23 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-22 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-18 | ||
| 1pda_A | 313 | Structure Of Porphobilinogen Deaminase Reveals A Fl | 3e-18 | ||
| 1pda_A | 313 | Structure Of Porphobilinogen Deaminase Reveals A Fl | 2e-10 | ||
| 2ypn_A | 313 | Hydroxymethylbilane Synthase Length = 313 | 3e-18 | ||
| 2ypn_A | 313 | Hydroxymethylbilane Synthase Length = 313 | 2e-10 | ||
| 1ypn_A | 313 | Reduced Form Hydroxymethylbilane Synthase (K59q Mut | 6e-18 | ||
| 1ypn_A | 313 | Reduced Form Hydroxymethylbilane Synthase (K59q Mut | 2e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-18 | ||
| 1ah5_A | 313 | Reduced Form Selenomethionine-Labelled Hydroxymethy | 2e-17 | ||
| 1ah5_A | 313 | Reduced Form Selenomethionine-Labelled Hydroxymethy | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 4htg_A | 320 | Porphobilinogen Deaminase From Arabidopsis Thaliana | 1e-15 | ||
| 4htg_A | 320 | Porphobilinogen Deaminase From Arabidopsis Thaliana | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-15 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-15 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-14 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-14 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-14 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 9e-14 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 7e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-12 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-12 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-12 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 9e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-11 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 9e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 9e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-10 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-10 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-10 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-09 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-09 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-09 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-09 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-09 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 3e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-09 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 8e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-07 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-07 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-07 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-07 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-07 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-07 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 5e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 9e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 9e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 9e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-05 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 5e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 5e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-05 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-05 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 9e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-04 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-04 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-04 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-04 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-04 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-04 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-04 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-04 |
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3ECR|A Chain A, Structure Of Human Porphobilinogen Deaminase Length = 364 | Back alignment and structure |
|
| >pdb|3ECR|A Chain A, Structure Of Human Porphobilinogen Deaminase Length = 364 | Back alignment and structure |
|
| >pdb|3EQ1|A Chain A, The Crystal Structure Of Human Porphobilinogen Deaminase At 2.8a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|3EQ1|A Chain A, The Crystal Structure Of Human Porphobilinogen Deaminase At 2.8a Resolution Length = 361 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1PDA|A Chain A, Structure Of Porphobilinogen Deaminase Reveals A Flexible Multidomain Polymerase With A Single Catalytic Site Length = 313 | Back alignment and structure |
|
| >pdb|1PDA|A Chain A, Structure Of Porphobilinogen Deaminase Reveals A Flexible Multidomain Polymerase With A Single Catalytic Site Length = 313 | Back alignment and structure |
|
| >pdb|2YPN|A Chain A, Hydroxymethylbilane Synthase Length = 313 | Back alignment and structure |
|
| >pdb|2YPN|A Chain A, Hydroxymethylbilane Synthase Length = 313 | Back alignment and structure |
|
| >pdb|1YPN|A Chain A, Reduced Form Hydroxymethylbilane Synthase (K59q Mutant) Crystal Structure After 2 Hours In A Flow Cell Determined By Time-Resolved Laue Diffraction Length = 313 | Back alignment and structure |
|
| >pdb|1YPN|A Chain A, Reduced Form Hydroxymethylbilane Synthase (K59q Mutant) Crystal Structure After 2 Hours In A Flow Cell Determined By Time-Resolved Laue Diffraction Length = 313 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1AH5|A Chain A, Reduced Form Selenomethionine-Labelled Hydroxymethylbilane Synthase Determined By Mad Length = 313 | Back alignment and structure |
|
| >pdb|1AH5|A Chain A, Reduced Form Selenomethionine-Labelled Hydroxymethylbilane Synthase Determined By Mad Length = 313 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4HTG|A Chain A, Porphobilinogen Deaminase From Arabidopsis Thaliana Length = 320 | Back alignment and structure |
|
| >pdb|4HTG|A Chain A, Porphobilinogen Deaminase From Arabidopsis Thaliana Length = 320 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 4e-97
Identities = 119/271 (43%), Positives = 171/271 (63%), Gaps = 12/271 (4%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
SRY EF E E +GSG+FG VFKC+K +DG YA+KR+K+P+A + E+ +E++AHA+
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC----TFTEMALKQLLFQVSE 228
L + H+V YFS+W++ + +Q EYCNGG+L + I E F E LK LL QV
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 229 GLRCMHEMRMIHMDIKPANILI-------VKAQGELNEPMNTEKLHYKLGDFGHVIADND 281
GLR +H M ++HMDIKP+NI I ++ + + K+ +K+GD GHV +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 282 FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIE 341
+VEEGD R+L E+L N+ +L K DIFAL LT+ A+G PLP+NG WH IR G +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246
Query: 342 KL-SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
++ +S + L+K+MI DP +RPS +L
Sbjct: 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 2e-80
Identities = 80/267 (29%), Positives = 125/267 (46%), Gaps = 21/267 (7%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
S + F LG G +GEVFK DG YAVKR+ P E+ +H
Sbjct: 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLR 231
+ + P V +W + G+LYLQ E C G +L+ + + E + L L
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV--IADNDF-EVEEGD 288
+H ++H+D+KPANI + + KLGDFG + + EV+EGD
Sbjct: 172 HLHSQGLVHLDVKPANIFL------------GPRGRCKLGDFGLLVELGTAGAGEVQEGD 219
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNI--EKLSNV 346
RY+ ELL ++ D+F+LGLT+ E + LP G W +R G + E + +
Sbjct: 220 PRYMAPELLQGSYGT--AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSLRR 373
S +L +++ +M++ DP R + +L
Sbjct: 278 SSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-53
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 52/307 (16%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY +F + LG G FG VF+ +D YA+KR + P A+EK+ +E+ A A L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV-MREVKALAKL 60
Query: 174 SRVPHIVNYFSSWSD------------QGVLYLQLEYCNGGNLENIIQERCTFT---EMA 218
P IV YF++W + + LY+Q++ C NL++ + RCT
Sbjct: 61 -EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---- 274
+ Q++E + +H ++H D+KP+NI T K+GDFG
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF------------TMDDVVKVGDFGLVTA 167
Query: 275 ------------HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGV 322
+ A + G Y+ E ++ N + KVDIF+LGL L+E +
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFEL--L 224
Query: 323 TPLPKNGPM---WHHIRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378
P +R+ L + + +++ M+ P +RP ++ +A
Sbjct: 225 YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284
Query: 379 RNYPQLK 385
K
Sbjct: 285 DLDFPGK 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-52
Identities = 80/301 (26%), Positives = 139/301 (46%), Gaps = 50/301 (16%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
R+ ++F E EL+GSG FG+VFK +DG TY +KR EK ++E+ A A
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-----KYNNEKA-EREVKALAK 60
Query: 173 LSRVPHIVNYFSSWSDQ----------------GVLYLQLEYCNGGNLENIIQERC--TF 214
L +IV+Y W L++Q+E+C+ G LE I++R
Sbjct: 61 LDH-VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 215 TEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++ +L Q+++G+ +H ++I+ D+KP+NI + + K+GDFG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL------------VDTKQVKIGDFG 167
Query: 275 HVIA-----DNDFEVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPK 327
+ D +G RY+ E +++ + +VD++ALGL L E +
Sbjct: 168 --LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGK--EVDLYALGLILAELLHVCDTAFE 223
Query: 328 NGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVE 387
+ +RDG I TL++ ++ K P RP+TS + R+ + + P+
Sbjct: 224 TSKFFTDLRDGIIS--DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
Query: 388 N 388
+
Sbjct: 282 H 282
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 74/301 (24%), Positives = 124/301 (41%), Gaps = 57/301 (18%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
RYA +F E +LG G FG+V K +D YA+K+ + + E+ L
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEV---ML 55
Query: 173 LSRV--PHIVNYFSSWSDQGV-------------LYLQLEYCNGGNLENIIQER-CTFTE 216
L+ + ++V Y+++W ++ L++Q+EYC G L ++I
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR 115
Query: 217 MALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-- 274
+L Q+ E L +H +IH D+KP NI I E + K+GDFG
Sbjct: 116 DEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI------------DESRNVKIGDFGLA 163
Query: 275 --------HVIADNDFEVEEGDCR--------YLPKELLNNNFDNLSKVDIFALGLTLYE 318
+ D+ D Y+ E+L+ K+D+++LG+ +E
Sbjct: 164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
Query: 319 -ASGVTPLPKNGPMWHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + + +R +IE N +I+L+ID DP KRP +L
Sbjct: 224 MIYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
Query: 374 S 374
S
Sbjct: 284 S 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-45
Identities = 73/312 (23%), Positives = 132/312 (42%), Gaps = 38/312 (12%)
Query: 96 HHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA 155
H D+ + + +Y + +G G FG+ DG Y +K
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRL----QKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62
Query: 156 NTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC- 212
++ + + ++E+ +L+ + P+IV Y S+ + G LY+ ++YC GG+L I +
Sbjct: 63 SSKEREESRREVA---VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119
Query: 213 -TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
F E + Q+ L+ +H+ +++H DIK NI + T+ +LG
Sbjct: 120 VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL------------TKDGTVQLG 167
Query: 272 DFGHVIA---DNDFEVEEGDC---RYLPKELLNNN-FDNLSKVDIFALGLTLYE-ASGVT 323
DFG IA ++ E+ YL E+ N ++N K DI+ALG LYE +
Sbjct: 168 DFG--IARVLNSTVELARACIGTPYYLSPEICENKPYNN--KSDIWALGCVLYELCTLKH 223
Query: 324 PLPKNGPM--WHHIRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380
I G+ + + S DL +L+ + ++P RPS +S+ +A+
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283
Query: 381 YPQLKVENIRGN 392
+ +
Sbjct: 284 IEKFLSPQLIAE 295
|
| >3ecr_A Porphobilinogen deaminase; heme biosynthesis, porphobilinogen hinge, alternative splicing, cytoplasm, disease mutation, porphyrin biosynthesis; HET: DPM; 2.18A {Homo sapiens} PDB: 3eq1_A* Length = 364 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-44
Identities = 58/88 (65%), Positives = 69/88 (78%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
M+TTGD ILD AL KIGEKSLFTKELE ALE VD +VHSLKDLPT LP G ++GAI +
Sbjct: 59 MSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICK 118
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
RE+P DA++ + K+ GKTL TLP SV+
Sbjct: 119 RENPHDAVVFHPKFVGKTLETLPEKSVV 146
|
| >3ecr_A Porphobilinogen deaminase; heme biosynthesis, porphobilinogen hinge, alternative splicing, cytoplasm, disease mutation, porphyrin biosynthesis; HET: DPM; 2.18A {Homo sapiens} PDB: 3eq1_A* Length = 364 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 36/63 (57%), Positives = 45/63 (71%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRR+AQL R +P L+ +IRGNLNTRL+KLDE F IILA AG+ RM W +R+
Sbjct: 148 TSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQ 207
Query: 428 VFS 430
+
Sbjct: 208 ILH 210
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 78/325 (24%), Positives = 136/325 (41%), Gaps = 47/325 (14%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYALE-FLEEELLGSGDFGEVFKCLKYMDGMTYAV 147
++ G PV + + D L F E+ +G G F EV++ +DG+ A+
Sbjct: 3 EQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVAL 62
Query: 148 KRTKRPVANTAQEKIF-KKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL 204
K+ + A+ + KEI LL ++ P+++ Y++S+ + L + LE + G+L
Sbjct: 63 KKVQIFDLMDAKARADCIKEI---DLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119
Query: 205 ENIIQE----RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP 260
+I+ + E + + Q+ L MH R++H DIKPAN+ I
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---------- 169
Query: 261 MNTEKLHYKLGDFG---HVIADNDFEVEEGDCR-------YLPKELLNNNFDNLSKVDIF 310
T KLGD G + Y+ E ++ N N K DI+
Sbjct: 170 --TATGVVKLGDLGLGRFFSSKTTA------AHSLVGTPYYMSPERIHENGYN-FKSDIW 220
Query: 311 ALGLTLYE-ASGVTPLPKNGP----MWHHIRDGNIEKL--SNVSDDLHTLIKLMIDKDPT 363
+LG LYE A+ +P + + I + L + S++L L+ + I+ DP
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 280
Query: 364 KRPSTSSLRRSAQLARNYPQLKVEN 388
KRP + + A+ +E+
Sbjct: 281 KRPDVTYVYDVAKRMHACTASSLEH 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-43
Identities = 63/282 (22%), Positives = 97/282 (34%), Gaps = 44/282 (15%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
+L + LG G F V DG YA+KR + ++E H L + P+
Sbjct: 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREADMHRLFNH-PN 87
Query: 179 IVNYFSSWSDQGV----LYLQLEYCNGGNLENIIQERCT----FTEMALKQLLFQVSEGL 230
I+ + + +L L + G L N I+ TE + LL + GL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-------HVIADNDFE 283
+H H D+KP NIL+ ++ L D G HV
Sbjct: 148 EAIHAKGYAHRDLKPTNILL------------GDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 284 VEEGDCR------YLPKELLNN--NFDNLSKVDIFALGLTLYE-ASGVTP---LPKNGPM 331
+ Y EL + + + D+++LG LY G P + + G
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255
Query: 332 WHHIRDGN--IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
I + S L L+ M+ DP +RP L
Sbjct: 256 VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297
|
| >1gtk_A Porphobilinogen deaminase; lyase, biosynthesis of linear tetrapyrrole, all alpha/beta; HET: DPM; 1.66A {Escherichia coli} SCOP: c.94.1.1 d.50.2.1 PDB: 1ah5_A* 2ypn_A* 1ypn_A* 1pda_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-41
Identities = 46/88 (52%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
M T GD ILD L K+G K LF KELE+AL D VHS+KD+P E P GL L I E
Sbjct: 41 MVTRGDVILDTPLAKVGGKGLFVKELEVALLENRADIAVHSMKDVPVEFPQGLGLVTICE 100
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRDA + N +L LP+GS++
Sbjct: 101 REDPRDAFVSNN---YDSLDALPAGSIV 125
|
| >1gtk_A Porphobilinogen deaminase; lyase, biosynthesis of linear tetrapyrrole, all alpha/beta; HET: DPM; 1.66A {Escherichia coli} SCOP: c.94.1.1 d.50.2.1 PDB: 1ah5_A* 2ypn_A* 1ypn_A* 1pda_A* Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 33/63 (52%), Positives = 41/63 (65%), Gaps = 1/63 (1%)
Query: 368 TSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMA 427
TSSLRR QLA P L + ++RGN+ TRL KLD G +D IILAVAG+ R+ + RI A
Sbjct: 127 TSSLRRQCQLAERRPDLIIRSLRGNVGTRLSKLDNGE-YDAIILAVAGLKRLGLESRIRA 185
Query: 428 VFS 430
Sbjct: 186 ALP 188
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-39
Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 41/281 (14%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIV 180
+G+G +G K + DG K A++++ E++ LL + P+IV
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVN---LLRELKHPNIV 68
Query: 181 NYFSSWSDQ--GVLYLQLEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLRCMH 234
Y+ D+ LY+ +EYC GG+L ++I + R E + +++ Q++ L+ H
Sbjct: 69 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 128
Query: 235 EMR-----MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA---DNDFEVEE 286
++H D+KPAN+ + K + KLGDFG +A ++D +
Sbjct: 129 RRSDGGHTVLHRDLKPANVFL------------DGKQNVKLGDFG--LARILNHDTSFAK 174
Query: 287 GDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLP-KNGP-MWHHIRDGNI 340
Y+ E +N N K DI++LG LYE + + P + + IR+G
Sbjct: 175 TFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
Query: 341 EKLSNV-SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380
++ SD+L+ +I M++ RPS + + + +
Sbjct: 234 RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-37
Identities = 70/342 (20%), Positives = 130/342 (38%), Gaps = 53/342 (15%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
+ F +++LG G G + + D AVKR +E+
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILP-----ECFSFADREVQLLRESDEH 77
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHE 235
P+++ YF + D+ Y+ +E C L+ ++++ + LL Q + GL +H
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDC-- 289
+ ++H D+KP NIL ++ P K+ + DFG + + F G
Sbjct: 137 LNIVHRDLKPHNIL-------ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 290 -RYLPKELLNNNFDNL--SKVDIFALGLTLYE--ASGVTPLPKNGPMWHHIRDGN----- 339
++ E+L+ + VDIF+ G Y + G P K+ +I G
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPS----------TSSLRRSAQLARNYPQLKVENI 389
+ + LI+ MI DP KRPS S ++ +++ E++
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESL 309
Query: 390 RGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMAVFSE 431
G + +L++ +V+M W++ I
Sbjct: 310 DGPIVKQLER------------GGRAVVKMDWRENITVPLQT 339
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 61/299 (20%), Positives = 109/299 (36%), Gaps = 49/299 (16%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+L G F V++ G YA+KR + + +E+ LS P+IV
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90
Query: 182 YFSSWS--------DQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLR 231
+ S+ S Q L E C G +E + + + + ++ +Q ++
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ 150
Query: 232 CMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----------HVIAD 279
MH + +IH D+K N+L+ + + KL DFG + +
Sbjct: 151 HMHRQKPPIIHRDLKVENLLL------------SNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 280 NDFEVEEGDCR------YLPKELLN--NNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP 330
+ E + Y E+++ +NF K DI+ALG LY P
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258
Query: 331 MWHHIRDGNIE--KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVE 387
+ I +G H+LI+ M+ +P +R S + + Q + +
Sbjct: 259 L--RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPK 315
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-36
Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 42/294 (14%)
Query: 103 KSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI 162
S S+ Y++ + +GSG +VF+ L YA+K A+
Sbjct: 18 LYFQSMSVKGRIYSIL----KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDS 72
Query: 163 FKKEIHAHALLS-RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQ 221
++ EI L I+ + +Y+ +E C +L + ++++ + K
Sbjct: 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKS 131
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIA 278
+ E + +H+ ++H D+KPAN LIV G L KL DFG +
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GML-----------KLIDFGIANQMQP 178
Query: 279 DNDFEVEEGDC---RYLPKELLNNNFDNLS----------KVDIFALGLTLYE-ASGVTP 324
D V++ Y+P E + + + K D+++LG LY G TP
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 325 LPKNGPMWHHIR-----DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + + IE DL ++K + +DP +R S L
Sbjct: 239 FQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 67/288 (23%), Positives = 113/288 (39%), Gaps = 42/288 (14%)
Query: 109 SIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
S+ Y++ + +GSG +VF+ L YA+K A+ ++ EI
Sbjct: 5 SVKGRIYSIL----KQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIA 59
Query: 169 AHALLS-RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVS 227
L I+ + +Y+ +E C +L + ++++ + K +
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML 118
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEV 284
E + +H+ ++H D+KPAN LIV G L KL DFG + D V
Sbjct: 119 EAVHTIHQHGIVHSDLKPANFLIVD--GML-----------KLIDFGIANQMQPDTTSVV 165
Query: 285 EEGDC---RYLPKELLNNNFDNL----------SKVDIFALGLTLYE-ASGVTP---LPK 327
++ Y+P E + + + K D+++LG LY G TP +
Sbjct: 166 KDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN 225
Query: 328 NGPMWHHIRDGN--IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
H I D N IE DL ++K + +DP +R S L
Sbjct: 226 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 66/306 (21%), Positives = 115/306 (37%), Gaps = 42/306 (13%)
Query: 91 DSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRT 150
D G D + S+ Y++ + +GSG +VF+ L YA+K
Sbjct: 34 DLGTDDDDKASSSANECISVKGRIYSIL----KQIGSGGSSKVFQVLN-EKKQIYAIKYV 88
Query: 151 KRPVANTAQEKIFKKEIHAHALLS-RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ 209
A+ ++ EI L I+ + +Y+ +E C +L + ++
Sbjct: 89 NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLK 147
Query: 210 ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269
++ + K + E + +H+ ++H D+KPAN LIV G L K
Sbjct: 148 KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD--GML-----------K 194
Query: 270 LGDFG---HVIADNDFEVEEGDC---RYLPKELLNNNFDNLS----------KVDIFALG 313
L DFG + D V++ Y+P E + + + K D+++LG
Sbjct: 195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 254
Query: 314 LTLYE-ASGVTPLPKNGPMWHHIR-----DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
LY G TP + + + IE DL ++K + +DP +R S
Sbjct: 255 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 314
Query: 368 TSSLRR 373
L
Sbjct: 315 IPELLA 320
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 56/270 (20%), Positives = 106/270 (39%), Gaps = 35/270 (12%)
Query: 126 GSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSS 185
+ K + MD + + T P+++ + +I S + V
Sbjct: 71 NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFST-KNTVGQLQP 129
Query: 186 WSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF---QVSEGLRCMHEMRMIHMD 242
S + LY+Q++ C NL++ + RC+ + L Q++E + +H ++H D
Sbjct: 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRD 189
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG----------------HVIADNDFEVEE 286
+KP+NI T K+GDFG + A +
Sbjct: 190 LKPSNIFF------------TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237
Query: 287 GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKL-S 344
G Y+ E ++ N + KVDIF+LGL L+E + + + +R+ L +
Sbjct: 238 GTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFT 296
Query: 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374
H +++ M+ PT+RP + + +
Sbjct: 297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN 326
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-34
Identities = 53/265 (20%), Positives = 101/265 (38%), Gaps = 32/265 (12%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIV 180
+G G F V+K L + A + ++ + FK+E +L + P+IV
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE---MLKGLQHPNIV 88
Query: 181 NYFSSWSD----QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
++ SW + + L E G L+ ++ L+ Q+ +GL+ +H
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR 148
Query: 237 RM--IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADNDFEVEEGDCRYL 292
IH D+K NI I G + K+GD G + + + G ++
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSV-----------KIGDLGLATLKRASFAKAVIGTPEFM 197
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM---WHHIRDGNIEKL--SNV 346
E+ +D VD++A G+ + E A+ P + + + G
Sbjct: 198 APEMYEEKYD--ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSL 371
++ +I+ I ++ +R S L
Sbjct: 256 IPEVKEIIEGCIRQNKDERYSIKDL 280
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 9e-34
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 48/287 (16%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
+ E++LG G G V + G AVKR I EI P+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPN 70
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTF-------TEMALKQLLFQVSEGLR 231
++ Y+ S + LY+ LE C NL+++++ + E LL Q++ G+
Sbjct: 71 VIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 232 CMHEMRMIHMDIKPANILI-VKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE-- 286
+H +++IH D+KP NIL+ ++ ++ E L + DFG +
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 287 ----GDCRYLPKELLNNNFDNL------SKVDIFALGLTLYE--ASGVTPLPKNGPMWHH 334
G + ELL + + +DIF++G Y + G P +
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK-----Y 244
Query: 335 IRDGNIEK------------LSNVSDDLHTLIKLMIDKDPTKRPSTS 369
R+ NI + ++ + LI MID DP KRP+
Sbjct: 245 SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAM 291
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-33
Identities = 61/293 (20%), Positives = 111/293 (37%), Gaps = 37/293 (12%)
Query: 100 FDIKSISSTSIDHSRYAL---EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN 156
K +I RY + +GSG G+V+K G AVK+ +R
Sbjct: 5 SSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK 64
Query: 157 TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTE 216
++I ++ P+IV F ++ +++ +E + + + E
Sbjct: 65 EENKRI-LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 217 MALKQLLFQVSEGLRCMHEMR-MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
L ++ + + L + E +IH D+KP+NIL+ +G++ KL DFG
Sbjct: 124 RILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL-DERGQI-----------KLCDFGI 171
Query: 275 -----HVIADNDFEVEEGDCRYLPKELLNNNFDNLS----KVDIFALGLTLYE-ASGVTP 324
A + G Y+ E ++ + D+++LG++L E A+G P
Sbjct: 172 SGRLVDDKAKDRS---AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
Query: 325 LPKNGPMW---HHIRDGNIEKLSNV---SDDLHTLIKLMIDKDPTKRPSTSSL 371
+ + L S D + +K + KD KRP + L
Sbjct: 229 YKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKL 281
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-32
Identities = 67/326 (20%), Positives = 118/326 (36%), Gaps = 42/326 (12%)
Query: 64 PRDALILNKKWSGKTLATLPSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEE 123
L K WS + G +++ G +K + + + +
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTE--KLKPVDYEYREEVHW---MTHQP 64
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYF 183
+G G FGEV + G AVK+ + E +E+ A A LS P IV +
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSS-PRIVPLY 116
Query: 184 SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDI 243
+ + + + +E GG+L +I++ E L Q EGL +H R++H D+
Sbjct: 117 GAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176
Query: 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADNDFEVEEGDCRYL--------P 293
K N+L+ +++ L DFGH + + Y+ P
Sbjct: 177 KADNVLL-----------SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKL---SNVS 347
+ ++ D +KVDI++ + +G P + I + +
Sbjct: 226 EVVMGKPCD--AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA 283
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSLRR 373
I+ + K+P R S LRR
Sbjct: 284 PLTAQAIQEGLRKEPVHRASAMELRR 309
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 63/263 (23%), Positives = 104/263 (39%), Gaps = 34/263 (12%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
LG G FG V+ + A+K K + E ++E+ + L R P+I+
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRL 74
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ + D +YL LEY G + +Q+ F E + +++ L H R+IH D
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRD 134
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR---------YLP 293
IKP N+L+ K+ DFG + V R YLP
Sbjct: 135 IKPENLLL------------GSAGELKIADFG-------WSVHAPSSRRTDLCGTLDYLP 175
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDL 350
E++ + KVD+++LG+ YE G P N + I V++
Sbjct: 176 PEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 351 HTLIKLMIDKDPTKRPSTSSLRR 373
LI ++ +P++RP +
Sbjct: 235 RDLISRLLKHNPSQRPMLREVLE 257
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-30
Identities = 46/317 (14%), Positives = 88/317 (27%), Gaps = 58/317 (18%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHA 171
+ +LG D + G ++ V + K K+E+
Sbjct: 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 128
Query: 172 LLSRV------------------------PHIVNYFSSWSDQGVL--YLQLEYCN----- 200
LL + ++ D VL +
Sbjct: 129 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 188
Query: 201 -GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNE 259
G L + + A QL QV L +H ++H ++P +I++ +G +
Sbjct: 189 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-DQRGGV-- 245
Query: 260 PMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLS----------KVDI 309
L F H++ D V + P EL D
Sbjct: 246 ---------FLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296
Query: 310 FALGLTLYEA-SGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPST 368
+ALGL +Y P+ K+ + + N+ + L++ + R
Sbjct: 297 WALGLVIYWIWCADLPITKDAAL--GGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP 354
Query: 369 SSLRRSAQLARNYPQLK 385
+ + + +L
Sbjct: 355 LQAMETPEYEQLRTELS 371
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 48/310 (15%), Positives = 85/310 (27%), Gaps = 58/310 (18%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALL------- 173
E L GD VF +A+K T + ++ + + A A L
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 174 ----------------SRVPHIVNYFSSWSDQGV--LYLQLEYCNG------GNLENIIQ 209
P D V L + + L+ +
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 210 ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269
R +AL L Q+ + ++H P N+ I G L
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI-MPDGRL-----------M 234
Query: 270 LGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLS-KVDIFALGLTLYEA-SGVTPLP 326
LGD + Y P+E LN + + ++ + LGL++Y P
Sbjct: 235 LGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294
Query: 327 KNGPMWH-----------HIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375
P + + D + TLI ++ D +R +
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETP 354
Query: 376 QLARNYPQLK 385
+ + ++
Sbjct: 355 EFLQLQNEIS 364
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-30
Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 30/285 (10%)
Query: 95 DHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV 154
HH +++ RY + +LG G FGEV KC + YAVK +
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIV----CMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 155 ANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC 212
A +E+ LL ++ P+I+ F D Y+ E GG L + I +R
Sbjct: 60 AKNKDTSTILREV---ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116
Query: 213 TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272
F+E +++ QV G+ MH+ ++H D+KP NIL+ + K+ D
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES---------KEKDCDIKIID 167
Query: 273 FG---HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--P 326
FG + + G Y+ E+L +D K D+++ G+ LY SG P
Sbjct: 168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDE--KCDVWSAGVILYILLSGTPPFYGK 225
Query: 327 KNGPMWHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
+ + G +SDD LI+ M+ P+ R +
Sbjct: 226 NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 75/301 (24%), Positives = 139/301 (46%), Gaps = 38/301 (12%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
+S Y + E LG G FG+V KC + G+ A K K ++ K EI +
Sbjct: 86 NSFYTVSKTEI--LGGGRFGQVHKCEETATGLKLAAKIIK--TRGMKDKEEVKNEI---S 138
Query: 172 LLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL-ENIIQERCTFTEMALKQLLFQVSE 228
+++++ +++ + ++ + + L +EY +GG L + II E TE+ + Q+ E
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE 198
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVE 285
G+R MH+M ++H+D+KP NIL V N + K+ DFG +V
Sbjct: 199 GIRHMHQMYILHLDLKPENILCV----------NRDAKQIKIIDFGLARRYKPREKLKVN 248
Query: 286 EGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNI-- 340
G +L E++N +F + D++++G+ Y SG++P + ++I
Sbjct: 249 FGTPEFLAPEVVNYDFVSF-PTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDL 307
Query: 341 --EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLK 398
E+ ++S++ I ++ K+ + R SA A +P L + L+ + K
Sbjct: 308 EDEEFQDISEEAKEFISKLLIKEKSWRI-------SASEALKHPWLSDHKLHSRLSAQKK 360
Query: 399 K 399
K
Sbjct: 361 K 361
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 72/269 (26%), Positives = 123/269 (45%), Gaps = 31/269 (11%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAH 170
RY + +LG G FGEV C + G AVK +KR V ++ +E+
Sbjct: 25 SDRYKGQ----RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREV--- 77
Query: 171 ALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE 228
LL ++ P+I+ + + D+G YL E GG L + I R F+E+ +++ QV
Sbjct: 78 QLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVE 285
G+ MH+ +++H D+KP N+L+ ++ + ++ DFG H A + +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLES---------KSKDANIRIIDFGLSTHFEASKKMKDK 188
Query: 286 EGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNI-- 340
G Y+ E+L+ +D K D+++ G+ LY SG P + + G
Sbjct: 189 IGTAYYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTF 246
Query: 341 --EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ VS+ LI+ M+ P+ R S
Sbjct: 247 ELPQWKKVSESAKDLIRKMLTYVPSMRIS 275
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 67/279 (24%), Positives = 116/279 (41%), Gaps = 43/279 (15%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
L+ L E +G G +G V K + G AVKR + V Q+++ ++ S
Sbjct: 24 LKDLGE--IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLL-MDLDVVMRSSDC 80
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-----TFTEMALKQLLFQVSEGLR 231
P+IV ++ + +G ++ +E + + + E L ++ + L
Sbjct: 81 PYIVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 232 CMH-EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEV 284
+ +++IH DIKP+NIL+ + KL DFG IA
Sbjct: 140 HLKENLKIIHRDIKPSNILL------------DRSGNIKLCDFGISGQLVDSIAKTRD-- 185
Query: 285 EEGDCRYLPKELLNNNFDNLS---KVDIFALGLTLYE-ASGVTPLPKNGPMW---HHIRD 337
G Y+ E ++ + + D+++LG+TLYE A+G P PK ++ +
Sbjct: 186 -AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 338 GNIEKLSNV-----SDDLHTLIKLMIDKDPTKRPSTSSL 371
G+ +LSN S + L + KD +KRP L
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKEL 283
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 84/472 (17%), Positives = 164/472 (34%), Gaps = 64/472 (13%)
Query: 30 LENQSVDFIVHSLKDLPTELPSGLSLGAILEREDPRDALILNKKWSGKTLATLPSGSVID 89
+ +F + + P + ++ ++ + + GK + + S
Sbjct: 73 RAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNY 132
Query: 90 EDSGDDHHPVFDIKSISSTSID-HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK 148
++ D + + + Y + E LG+G FG V + + G +A K
Sbjct: 133 DNYVFDIWKQYYPQPVEIKHDHVLDHYDIH----EELGTGAFGVVHRVTERATGNNFAAK 188
Query: 149 --RTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL 204
T + ++ +KEI +S + P +VN ++ D + + E+ +GG L
Sbjct: 189 FVMTPHE----SDKETVRKEI---QTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 205 -ENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263
E + E +E + + QV +GL MHE +H+D+KP NI+
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT----------TK 291
Query: 264 EKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELLNNNFDNLSK-VDIFALGLTLYE- 318
KL DFG H+ +V G + E+ + D++++G+ Y
Sbjct: 292 RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA--EGKPVGYYTDMWSVGVLSYIL 349
Query: 319 ASGVTP-LPKNGP-MWHHIRDGNI----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
SG++P +N +++ + S +S+D I+ ++ DP R
Sbjct: 350 LSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM------ 403
Query: 373 RSAQLARNYPQLKVENIRGNLN----TRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMAV 428
+ A +P L N G + +R K+ + + K+ +
Sbjct: 404 -TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSI-------------KTKYDAWPEPL 449
Query: 429 FSEYKPGSLSMTGAVWSLDGRETLQDAMERSLDGEENEVDGGQEVGSGEPAR 480
+ + S + G EVG G+ A
Sbjct: 450 PPLGRISNYSSLRKHRPQEYSIRDAFWDRSEAQPRFIVKPYGTEVGEGQSAN 501
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 64/268 (23%), Positives = 114/268 (42%), Gaps = 30/268 (11%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
Y + LGSG +GEV C + + A+K ++ +T+ +E+ A
Sbjct: 36 SEMYQRV----KKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV---A 88
Query: 172 LLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEG 229
+L + P+I+ + + D+ YL +E GG L + I R F E+ ++ QV G
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEE 286
+ +H+ ++H D+KP N+L+ + K+ DFG +
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLES---------KEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 287 GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI--- 340
G Y+ E+L +D K D++++G+ L+ +G P + + G
Sbjct: 200 GTAYYIAPEVLRKKYD--EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 341 -EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ NVS+ LIK M+ D +R S
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRIS 285
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 75/302 (24%), Positives = 120/302 (39%), Gaps = 56/302 (18%)
Query: 104 SISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIF 163
S SI+ Y L+ E++GSG V A+KR T+ +++
Sbjct: 6 SALPWSINRDDYELQ----EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL- 60
Query: 164 KKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC--------TFT 215
KEI A + P+IV+Y++S+ + L+L ++ +GG++ +II+
Sbjct: 61 LKEIQAMSQCHH-PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275
E + +L +V EGL +H+ IH D+K NIL+ E ++ DFG
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL------------GEDGSVQIADFG- 166
Query: 276 VIADNDFEVEEGDCRYLPK-------------ELLNNNFDNLSKVDIFALGLTLYE-ASG 321
V A F GD E++ K DI++ G+T E A+G
Sbjct: 167 VSA---FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223
Query: 322 VTPL------------PKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTS 369
P +N P + E L +I L + KDP KRP+ +
Sbjct: 224 AAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAA 283
Query: 370 SL 371
L
Sbjct: 284 EL 285
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 48/272 (17%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
LG G F + F+ +A K K + Q + EI H L H+V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVG 79
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ + D +++ LE C +L + + R TE + L Q+ G + +H R+IH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCR-------- 290
D+K N+ LNE + K+GDFG V D G+ +
Sbjct: 140 DLKLGNLF-------LNEDLEV-----KIGDFGLATKVEYD-------GERKKVLCGTPN 180
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLY---------EASGVTPLPKNGPMWHHIRDGNIE 341
Y+ E+L+ + +VD++++G +Y E S + I+
Sbjct: 181 YIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKNEYS 233
Query: 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+++ +LI+ M+ DPT RP+ + L
Sbjct: 234 IPKHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 32/286 (11%)
Query: 95 DHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRP 153
HH +++ RY + +LG G FGEV KC + YAVK K
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIV----CMLGKGSFGEVLKCKDRITQQEYAVKVINKAS 59
Query: 154 VANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER 211
N I +E+ LL ++ P+I+ F D Y+ E GG L + I +R
Sbjct: 60 AKNKDTSTI-LREV---ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 212 CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
F+E +++ QV G+ MH+ ++H D+KP NIL+ + K+
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES---------KEKDCDIKII 166
Query: 272 DFG---HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPK 327
DFG + + G Y+ E+L +D K D+++ G+ LY SG P
Sbjct: 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYD--EKCDVWSAGVILYILLSGTPPFYG 224
Query: 328 NGP--MWHHIRDGNI----EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ + G + +SDD LI+ M+ P+ R +
Sbjct: 225 KNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT 270
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 61/274 (22%), Positives = 114/274 (41%), Gaps = 37/274 (13%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
LE + E LG G +G V K G AVKR + V + Q+++ ++
Sbjct: 9 LEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRL-LMDLDISMRTVDC 65
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGN---LENIIQERCTFTEMALKQLLFQVSEGLRCM 233
P V ++ + +G +++ +E + + +I + T E L ++ + + L +
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 234 H-EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEE 286
H ++ +IH D+KP+N+LI A G++ K+ DFG +A +
Sbjct: 126 HSKLSVIHRDVKPSNVLI-NALGQV-----------KMCDFGISGYLVDDVAKDID---A 170
Query: 287 GDCRYLPKELLNNNFDNLS---KVDIFALGLTLYE-ASGVTPLPKNGPMW---HHIRDGN 339
G Y+ E +N + K DI++LG+T+ E A P G + + +
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP 230
Query: 340 IEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+L S + + K+ +RP+ L
Sbjct: 231 SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPEL 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 64/294 (21%), Positives = 119/294 (40%), Gaps = 35/294 (11%)
Query: 106 SSTSIDHSRYALEFLE-EELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIF 163
+ + ++ ++ + LG G FG V+ + + A+K K + E
Sbjct: 2 ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 164 KKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL 223
++EI + L R P+I+ ++ + D+ +YL LE+ G L +Q+ F E +
Sbjct: 62 RREIEIQSHL-RHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFE 283
++++ L HE ++IH DIKP N+L+ K K+ DFG +
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLM------------GYKGELKIADFG-------WS 161
Query: 284 VEEGDCR---------YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--M 331
V R YLP E++ + KVD++ G+ YE G+ P
Sbjct: 162 VHAPSLRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTET 220
Query: 332 WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
I + +++ +SD LI ++ P +R + + N ++
Sbjct: 221 HRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-29
Identities = 58/339 (17%), Positives = 115/339 (33%), Gaps = 75/339 (22%)
Query: 105 ISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK 164
+ S S + + L ++LG G VF+ G +A+K +
Sbjct: 1 MGSQSTSNHLWLLS----DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-M 55
Query: 165 KEIHAHALLSRV--PHIVNYFSSWSDQG--VLYLQLEYCNGGNLENIIQER---CTFTEM 217
+E +L ++ +IV F+ + L +E+C G+L +++E E
Sbjct: 56 REFE---VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--H 275
+L V G+ + E ++H +IKP NI+ V + + YKL DFG
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE--------DGQSVYKLTDFGAAR 164
Query: 276 VIADNDF-------------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASG 321
+ D++ ++ E + ++ + + VD++++G+T Y A+G
Sbjct: 165 ELEDDEQFVSLYGTEEYLHPDMYERA---VLRKDHQKKYG--ATVDLWSIGVTFYHAATG 219
Query: 322 VTP-LPKNGP-----MWHHIRDGNIEKL-------------------------SNVSDDL 350
P P GP + + I G + L
Sbjct: 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL 279
Query: 351 HTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENI 389
++ +++ D K + +
Sbjct: 280 TPVLANILEADQEKCWGFDQFFAETSDILHRGNSHHHHH 318
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-29
Identities = 62/296 (20%), Positives = 100/296 (33%), Gaps = 51/296 (17%)
Query: 104 SISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIF 163
S+ S + + E+LG G FG+ K G +K R + ++ F
Sbjct: 1 SMPHRIFRPS----DLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTF 54
Query: 164 KKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALK 220
KE+ ++ + P+++ + L EY GG L II+ +
Sbjct: 55 LKEV---KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRV 111
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIA 278
++ G+ +H M +IH D+ N L+ E + + DFG ++
Sbjct: 112 SFAKDIASGMAYLHSMNIIHRDLNSHNCLV------------RENKNVVVADFGLARLMV 159
Query: 279 DNDFEVEEGDCRYLPK----------------ELLNNN-FDNLSKVDIFALGLTLYE-AS 320
D + E P E++N +D KVD+F+ G+ L E
Sbjct: 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD--EKVDVFSFGIVLCEIIG 217
Query: 321 GVTPLPKNGPMWHHIRDGNIEKL-----SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
V P P L N + D DP KRPS L
Sbjct: 218 RVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 63/316 (19%), Positives = 131/316 (41%), Gaps = 29/316 (9%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK----RTKRPVANTAQEKIFKKEIHAHALLSRV- 176
E LGSG F V KC + G+ YA K R R + ++E+ ++L +V
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV---SILRQVL 73
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
+++ + ++ + L LE +GG L + + ++ + +E + Q+ +G+ +H
Sbjct: 74 HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYL 292
++ H D+KP NI+++ ++ + + KL DFG + +F+ G ++
Sbjct: 134 KKIAHFDLKPENIMLL------DKNIPIPHI--KLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNI----EKLSN 345
E++N L + D++++G+ Y SG +P +I + E S+
Sbjct: 186 APEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNT-RLKKLDEGN 404
S+ I+ ++ K+ KR + R + Q + +N +K
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRR 304
Query: 405 VFDGIILAVAGIVRMK 420
+ V+ +
Sbjct: 305 RWKLSFSIVSLCNHLT 320
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/269 (23%), Positives = 110/269 (40%), Gaps = 42/269 (15%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
LG G F + F+ +A K K + Q + EI H L H+V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVG 105
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ + D +++ LE C +L + + R TE + L Q+ G + +H R+IH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 165
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCR-------- 290
D+K N+ LNE + K+GDFG V D G+ +
Sbjct: 166 DLKLGNLF-------LNEDLEV-----KIGDFGLATKVEYD-------GERKKVLCGTPN 206
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTP-----LPKNGPMWHHIRDGNIEKLS 344
Y+ E+L+ + +VD++++G +Y G P L + + I+
Sbjct: 207 YIAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYSIPK 262
Query: 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+++ +LI+ M+ DPT RP+ + L
Sbjct: 263 HINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 67/276 (24%), Positives = 120/276 (43%), Gaps = 33/276 (11%)
Query: 104 SISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKI 162
S+ +T+I + E+LGSG F EVF + + G +A+K K P +
Sbjct: 1 SMQTTNI-RKTFIFM----EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSS 52
Query: 163 FKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALK 220
+ EI A+L ++ +IV + YL ++ +GG L + I ER +TE
Sbjct: 53 LENEI---AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS 109
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIA 278
++ QV ++ +HE ++H D+KP N+L + E + DFG +
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLT---------PEENSKIMITDFGLSKMEQ 160
Query: 279 DNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHI 335
+ G Y+ E+L + VD +++G+ Y G P ++ I
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219
Query: 336 RDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
++G E S ++S+ I +++KDP +R +
Sbjct: 220 KEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT 255
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 58/273 (21%), Positives = 115/273 (42%), Gaps = 33/273 (12%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
LLG G F V++ G+ A+K K+ + + + E+ H L + P I+
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILEL 76
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ + D +YL LE C+ G + ++ R F+E + + Q+ G+ +H ++H
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDC---RYLPKE 295
D+ +N+L+ T ++ K+ DFG + ++ C Y+ E
Sbjct: 137 DLTLSNLLL------------TRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPE 182
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTP-----LPKNGPMWHHIRDGNIEKLSNVSDD 349
+ + + D+++LG Y G P + + + + E S +S +
Sbjct: 183 IATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYEMPSFLSIE 238
Query: 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
LI ++ ++P R S SS+ ++RN
Sbjct: 239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 66/301 (21%), Positives = 123/301 (40%), Gaps = 38/301 (12%)
Query: 106 SSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK 165
S +++ E + +LG G +G V+ + + A+K P ++ + +
Sbjct: 11 ESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--PERDSRYSQPLHE 68
Query: 166 EIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC---TFTEMALK 220
EI AL + +IV Y S+S+ G + + +E GG+L +++ + E +
Sbjct: 69 EI---ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADN 280
Q+ EGL+ +H+ +++H DIK N+LI G L K+ DFG
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL-----------KISDFGTSKRLA 174
Query: 281 DFEVEEGDCR----YLPKELLNNNFDNLS-KVDIFALGLTLYE-ASGVTPLPKNGPMW-- 332
Y+ E+++ DI++LG T+ E A+G P + G
Sbjct: 175 GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA 234
Query: 333 -HHIRDGNI--EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL------RRSAQLARNYPQ 383
+ + E ++S + I + DP KR + L + S++ + P+
Sbjct: 235 MFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPK 294
Query: 384 L 384
L
Sbjct: 295 L 295
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 62/315 (19%), Positives = 112/315 (35%), Gaps = 71/315 (22%)
Query: 105 ISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK 164
+ S S + + L ++LG G VF+ G +A+K +
Sbjct: 1 MGSQSTSNHLWLLS----DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-M 55
Query: 165 KEIHAHALLSRV--PHIVNYFSSWSDQG--VLYLQLEYCNGGNLENIIQER---CTFTEM 217
+E +L ++ +IV F+ + L +E+C G+L +++E E
Sbjct: 56 REFE---VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI 277
+L V G+ + E ++H +IKP NI+ V + + YKL DFG
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE--------DGQSVYKLTDFG--- 161
Query: 278 ADNDFEVEE------GDCRYLPKELLNNNFDNL-------SKVDIFALGLTLYE-ASGVT 323
A + E +E G YL ++ + VD++++G+T Y A+G
Sbjct: 162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221
Query: 324 P-LPKNGP-----MWHHIRDGNIEKL-------------------------SNVSDDLHT 352
P P GP + + I G + L
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281
Query: 353 LIKLMIDKDPTKRPS 367
++ +++ D K
Sbjct: 282 VLANILEADQEKCWG 296
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 75/275 (27%), Positives = 119/275 (43%), Gaps = 36/275 (13%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAH 170
+ Y L+ ++ L G G F KC+ +AVK +KR ANT +KEI A
Sbjct: 7 YQHYDLDLKDKPL-GEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEITAL 59
Query: 171 ALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
L P+IV + DQ +L +E NGG L I+++ F+E ++ ++ +
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-HVIADNDFEVEEGDC 289
MH++ ++H D+KP N+L + L K+ DFG + D + + C
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTD---------ENDNLEIKIIDFGFARLKPPDNQPLKTPC 170
Query: 290 ---RYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTP---------LPKNGPMWHHIR 336
Y ELLN N + D+++LG+ LY SG P + I+
Sbjct: 171 FTLHYAAPELLNQNGYDE-SCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK 229
Query: 337 DGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
G+ NVS + LI+ ++ DP KR
Sbjct: 230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK 264
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 74/274 (27%), Positives = 117/274 (42%), Gaps = 50/274 (18%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
F + E +G G FGEVFK + A+K A E I ++EI + P+
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDS-PY 81
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
+ Y+ S+ L++ +EY GG+ ++++ E + +L ++ +GL +H +
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKK 140
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD--------NDF-------- 282
IH DIK AN+L+ +E KL DFG V N F
Sbjct: 141 IHRDIKAANVLL------------SEHGEVKLADFG-VAGQLTDTQIKRNTFVGTPFWMA 187
Query: 283 -EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMW--HHIRDG 338
EV + + +D SK DI++LG+T E A G P + PM I
Sbjct: 188 PEV-----------IKQSAYD--SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN 234
Query: 339 NIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
N L N S L ++ ++K+P+ RP+ L
Sbjct: 235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKEL 268
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 70/300 (23%), Positives = 130/300 (43%), Gaps = 40/300 (13%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK--RTKRPVANTAQEKIFKKEIHAHALLSRV--P 177
E LGSG FG V +C++ G + K T P+ + K EI ++++++ P
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL----DKYTVKNEI---SIMNQLHHP 108
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNL-ENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
++N ++ D+ + L LE+ +GG L + I E +E + + Q EGL+ MHE
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLP 293
++H+DIKP NI+ + K+ DFG + D +V +
Sbjct: 169 SIVHLDIKPENIMCE----------TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAA 218
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNI----EKLSNV 346
E+++ D++A+G+ Y SG++P + +++ + + S+V
Sbjct: 219 PEIVDREPVGF-YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 347 SDDLHTLIKLMIDKDPTKRPSTS-SLR------RSAQLARNYPQLKVENIRGNLNTRLKK 399
S + IK ++ K+P KR + +L + L P + IR + +
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 64/286 (22%), Positives = 112/286 (39%), Gaps = 56/286 (19%)
Query: 99 VFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTA 158
V I +I ++LG G G+V + +A+K +
Sbjct: 4 VKSGLQIKKNAIIDDYKVTS----QVLGLGINGKVLQIFNKRTQEKFALKMLQD------ 53
Query: 159 QEKIFKKEIHAHALLSRVPHIVN----YFSSWSDQGVLYLQLEYCNGGNLENIIQER--C 212
++E+ H S+ PHIV Y + ++ + L + +E +GG L + IQ+R
Sbjct: 54 -CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ 112
Query: 213 TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272
FTE +++ + E ++ +H + + H D+KP N+L KL D
Sbjct: 113 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS---------KRPNAILKLTD 163
Query: 273 FGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP- 330
FG KE +D D+++LG+ +Y G P N
Sbjct: 164 FG-----------------FAKETTGEKYDK--SCDMWSLGVIMYILLCGYPPFYSNHGL 204
Query: 331 -----MWHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
M IR G E + VS+++ LI+ ++ +PT+R +
Sbjct: 205 AISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT 250
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-28
Identities = 71/288 (24%), Positives = 120/288 (41%), Gaps = 70/288 (24%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--FKKEIHAHALLSRV 176
+ LG G FG+V+K G A K + ++E++ + EI +L+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKV----IETKSEEELEDYIVEI---EILATC 73
Query: 177 --PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCM 233
P+IV ++ G L++ +E+C GG ++ I+ E TE ++ + Q+ E L +
Sbjct: 74 DHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD--------NDF--- 282
H R+IH D+K N+L+ T + +L DFG V A + F
Sbjct: 134 HSKRIIHRDLKAGNVLM------------TLEGDIRLADFG-VSAKNLKTLQKRDSFIGT 180
Query: 283 ------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL---------- 325
EV + + + + +D K DI++LG+TL E A P
Sbjct: 181 PYWMAPEV------VMCETMKDTPYD--YKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232
Query: 326 --PKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
K+ P + S S + +K+ +DK+P RPS + L
Sbjct: 233 KIAKSDP-------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-28
Identities = 69/291 (23%), Positives = 114/291 (39%), Gaps = 42/291 (14%)
Query: 97 HPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN 156
+F ++ Y L +++LG G G+V +C G A+K
Sbjct: 13 EVLFQGPEPKKYAV-TDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKLLYD---- 64
Query: 157 TAQEKIFKKEIHAHALLSRVPHIVN----YFSSWSDQGVLYLQLEYCNGGNLENIIQER- 211
++E+ H S PHIV Y + + L + +E GG L + IQER
Sbjct: 65 ---SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG 121
Query: 212 -CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270
FTE +++ + ++ +H + H D+KP N+L + KL
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTS---------KEKDAVLKL 172
Query: 271 GDFG--HVIADNDFEVEEGDCRYLPKELLN-NNFDNLSKVDIFALGLTLYEA-SGVTP-- 324
DFG N + Y+ E+L +D D+++LG+ +Y G P
Sbjct: 173 TDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDK--SCDMWSLGVIMYILLCGFPPFY 230
Query: 325 ----LPKNGPMWHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
+ M IR G + VS+D LI+L++ DPT+R +
Sbjct: 231 SNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT 281
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 70/309 (22%), Positives = 120/309 (38%), Gaps = 34/309 (11%)
Query: 82 LPSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMD 141
L + S I + VF ++ S+ E++ + LGSG GEV +
Sbjct: 100 LNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT 159
Query: 142 GMTYAVKR-TKRPVANTAQEKI-----FKKEIHAHALLSRV--PHIVNYFSSWSDQGVLY 193
A++ +KR A + + + EI +L ++ P I+ + + + Y
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEI---EILKKLNHPCIIKIKNFFDAEDY-Y 215
Query: 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKA 253
+ LE GG L + + E K +Q+ ++ +HE +IH D+KP N+L+
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS- 274
Query: 254 QGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC---RYLPKELLNNNFDNL--SKVD 308
E K+ DFGH + + C YL E+L + VD
Sbjct: 275 --------QEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVD 326
Query: 309 IFALGLTLYE-ASGVTP-LPKNGP--MWHHIRDGNIEKLS----NVSDDLHTLIKLMIDK 360
++LG+ L+ SG P + I G + VS+ L+K ++
Sbjct: 327 CWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV 386
Query: 361 DPTKRPSTS 369
DP R +T
Sbjct: 387 DPKARFTTE 395
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 67/310 (21%), Positives = 126/310 (40%), Gaps = 38/310 (12%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK----RTKRPVANTAQEKIFKKEIHAHALLSRV- 176
E LGSG F V KC + G+ YA K R + + ++E+ ++L +
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV---SILKEIQ 72
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P+++ + ++ + L LE GG L + + E+ + TE + L Q+ G+ +H
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYL 292
+++ H D+KP NI+++ K+ DFG + N+F+ G ++
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRI--------KIIDFGLAHKIDFGNEFKNIFGTPEFV 184
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNI----EKLSN 345
E++N L + D++++G+ Y SG +P ++ N E SN
Sbjct: 185 APEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243
Query: 346 VSDDLHTLIKLMIDKDPTKRPST---------SSLRRSAQLARNYPQLKVENIRG-NLNT 395
S I+ ++ KDP KR + L+R + +E +
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARK 303
Query: 396 RLKKLDEGNV 405
+ G +
Sbjct: 304 KSNNGSGGGL 313
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 61/282 (21%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 102 IKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK----RTKRPVANT 157
+++ + Y + E LGSG F V KC + G+ YA K R R
Sbjct: 2 METFKQQKV-EDFYDIG----EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG 56
Query: 158 AQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT 215
+ ++E+ ++L +V P+I+ + ++ + L LE +GG L + + ++ + +
Sbjct: 57 VCREEIEREV---SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS 113
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
E + Q+ +G+ +H ++ H D+KP NI+++ ++ + + KL DFG
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL------DKNIPIPHI--KLIDFGL 165
Query: 275 --HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNG 329
+ +F+ G ++ E++N L + D++++G+ Y SG +P
Sbjct: 166 AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 330 PMWHHIRDGNI----EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+I + E S S+ I+ ++ K+ KR +
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLT 266
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 64/260 (24%), Positives = 108/260 (41%), Gaps = 22/260 (8%)
Query: 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
L + LG G F V +C+ G YA K K+ EI L P +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNL-ENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMR 237
+N + + + L LEY GG + + E +E + +L+ Q+ EG+ +H+
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPK 294
++H+D+KP NIL+ K+ DFG + + G YL
Sbjct: 152 IVHLDLKPQNILLSS---------IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202
Query: 295 ELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNI----EKLSNVS 347
E+LN + D++ +G+ Y + +P N + +I N+ E S+VS
Sbjct: 203 EILNYDPITT-ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS 261
Query: 348 DDLHTLIKLMIDKDPTKRPS 367
I+ ++ K+P KRP+
Sbjct: 262 QLATDFIQSLLVKNPEKRPT 281
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (280), Expect = 3e-27
Identities = 44/327 (13%), Positives = 85/327 (25%), Gaps = 62/327 (18%)
Query: 103 KSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEK 161
+ S R + +LG D + G ++ V + K
Sbjct: 65 QPFRVESELGERPRT-LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 162 IFKKEIHAHALLSRVPHIVN----------------------------YFSSWSDQGVLY 193
K+E+ LL + + W
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 194 LQLEYCN----GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANIL 249
N G L + + A QL QV L +H ++H ++P +I+
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIV 243
Query: 250 IVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELL---------NNN 300
+ ++ L F H++ D V + P E ++
Sbjct: 244 L------------DQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHP 291
Query: 301 FDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDGNIEKLSNVSDDLHTLIKLM 357
D + LGL +Y P + + I N+ + L++
Sbjct: 292 TLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSCK----NIPQPVRALLEGF 347
Query: 358 IDKDPTKRPSTSSLRRSAQLARNYPQL 384
+ R + + + +L
Sbjct: 348 LRYPKEDRLLPLQAMETPEYEQLRTEL 374
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 34/285 (11%)
Query: 97 HPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN 156
H + +S Y ++ E +G G + +C+ M +AVK + +
Sbjct: 7 HSIVQQLHRNSIQF-TDGYEVK----EDIGVGSYSVCKRCIHKATNMEFAVK-----IID 56
Query: 157 TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTE 216
++ +EI + P+I+ + D +Y+ E GG L + I + F+E
Sbjct: 57 KSKRDP-TEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE 115
Query: 217 MALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-H 275
+LF +++ + +H ++H D+KP+NIL V +E N E + ++ DFG
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV------DESGNPESI--RICDFGFA 167
Query: 276 VIADNDFEVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM 331
+ + C ++ E+L + DI++LG+ LY +G TP
Sbjct: 168 KQLRAENGLLMTPCYTANFVAPEVLERQGYDA-ACDIWSLGVLLYTMLTGYTPFANGPDD 226
Query: 332 WHH-----IRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
I G +VSD L+ M+ DP +R +
Sbjct: 227 TPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-27
Identities = 64/296 (21%), Positives = 107/296 (36%), Gaps = 43/296 (14%)
Query: 92 SGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTK 151
G HH + I + + +GSG FG V+K K+ AVK
Sbjct: 3 KGHHHHHHGSRDAADDWEIPDG----QITVGQRIGSGSFGTVYKG-KWHG--DVAVKMLN 55
Query: 152 RPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ 209
Q + FK E+ +L + +I+ F +S L + ++C G +L + +
Sbjct: 56 VTAPTPQQLQAFKNEV---GVLRKTRHVNILL-FMGYSTAPQLAIVTQWCEGSSLYHHLH 111
Query: 210 ER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268
F L + Q + G+ +H +IH D+K NI + E
Sbjct: 112 ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL------------HEDNTV 159
Query: 269 KLGDFG------HVIADNDFEVEEGDCRYLPKELLNNNFDNL--SKVDIFALGLTLYE-A 319
K+GDFG + FE G ++ E++ N + D++A G+ LYE
Sbjct: 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELM 219
Query: 320 SGVTPLPKNGPM--------WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+G P + + SN + L+ + K +RPS
Sbjct: 220 TGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS 275
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 60/308 (19%), Positives = 131/308 (42%), Gaps = 61/308 (19%)
Query: 94 DDHHPVFDIKSISSTSIDHSRYALEFLE----------EELLGSGDFGEVFKCLKYMDGM 143
HHP+ D I +T + + A++ + +E +G+G FG V + ++ G
Sbjct: 5 HHHHPMSD-YDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRA-EW-HGS 61
Query: 144 TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNG 201
AVK + + F +E+ A++ R+ P+IV + + + L + EY +
Sbjct: 62 DVAVKILMEQDFHAERVNEFLREV---AIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSR 118
Query: 202 GNLENIIQERCTFTEMALKQLL---FQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGE 256
G+L ++ + ++ ++ L + V++G+ +H ++H ++K N+L+
Sbjct: 119 GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV------ 172
Query: 257 LNEPMNTEKLHYKLGDFGHV-IADNDFEVEEGDC---RYLPKELLNNN-FDNLSKVDIFA 311
+K K+ DFG + + F + ++ E+L + + K D+++
Sbjct: 173 ------DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE--KSDVYS 224
Query: 312 LGLTLYE-ASGVTPLPKNGPMWHHIRDGNI------EKL-----SNVSDDLHTLIKLMID 359
G+ L+E A+ P W ++ + + N++ + +I+
Sbjct: 225 FGVILWELATLQQP-------WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 360 KDPTKRPS 367
+P KRPS
Sbjct: 278 NEPWKRPS 285
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 75/286 (26%), Positives = 112/286 (39%), Gaps = 73/286 (25%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL--SRV 176
F E LG G +G V+K + G A+K+ V + + KEI ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ----VPVESDLQEIIKEIS---IMQQCDS 83
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHE 235
PH+V Y+ S+ L++ +EYC G++ +II+ R T TE + +L +GL +H
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD--------NDF----- 282
MR IH DIK NIL+ + H KL DFG V N
Sbjct: 144 MRKIHRDIKAGNILL------------NTEGHAKLADFG-VAGQLTDTMAKRNTVIGTPF 190
Query: 283 ----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPL------------ 325
EV + ++ DI++LG+T E A G P
Sbjct: 191 WMAPEV-----------IQEIGYN--CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237
Query: 326 PKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
P N P K SD+ +K + K P +R + + L
Sbjct: 238 PTNPP-------PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQL 276
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 64/269 (23%), Positives = 113/269 (42%), Gaps = 31/269 (11%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAH 170
Y ++ E LG G F V +C+ G+ +A K + ++ +K+ ++E
Sbjct: 5 SDNYDVK----EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-EREA--- 56
Query: 171 ALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE 228
+ ++ P+IV S ++ YL + GG L I R ++E + Q+ E
Sbjct: 57 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE 286
+ H ++H ++KP N+L L + KL DFG + D++
Sbjct: 117 SIAYCHSNGIVHRNLKPENLL-------LASKAKGAAV--KLADFGLAIEVNDSEAWHGF 167
Query: 287 -GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEK 342
G YL E+L + + VDI+A G+ LY G P ++ I+ G +
Sbjct: 168 AGTPGYLSPEVLKKDPYSK-PVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 343 LS----NVSDDLHTLIKLMIDKDPTKRPS 367
S V+ + +LI M+ +P KR +
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT 255
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 37/269 (13%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK-----------RTKRPVANTAQEKIFKKEIHAH 170
LGSG +GEV C + A+K + + EI
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI--- 97
Query: 171 ALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE 228
+LL + P+I+ F + D+ YL E+ GG L I R F E ++ Q+
Sbjct: 98 SLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVE 285
G+ +H+ ++H DIKP NIL+ L+ K+ DFG D
Sbjct: 158 GICYLHKHNIVHRDIKPENILLEN---------KNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 286 EGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI-- 340
G Y+ E+L ++ K D+++ G+ +Y G P + + G
Sbjct: 209 LGTAYYIAPEVLKKKYN--EKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266
Query: 341 --EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
N+SD+ LIKLM+ D KR +
Sbjct: 267 DFNDWKNISDEAKELIKLMLTYDYNKRCT 295
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 72/283 (25%), Positives = 118/283 (41%), Gaps = 54/283 (19%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
F EL+G+G +G+V+K G A+K +E+ K+EI+ S +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRN 82
Query: 179 IVNYFSSW------SDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGL 230
I Y+ ++ L+L +E+C G++ ++I+ T E + + ++ GL
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD--------NDF 282
+H+ ++IH DIK N+L+ TE KL DFG V A N F
Sbjct: 143 SHLHQHKVIHRDIKGQNVLL------------TENAEVKLVDFG-VSAQLDRTVGRRNTF 189
Query: 283 ---------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMW 332
EV E + +D K D+++LG+T E A G PL PM
Sbjct: 190 IGTPYWMAPEV------IACDENPDATYDF--KSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 333 --HHIRDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
I +L S + I+ + K+ ++RP+T L
Sbjct: 242 ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQL 284
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 81/373 (21%), Positives = 139/373 (37%), Gaps = 55/373 (14%)
Query: 76 GKTLATLPSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFK 135
G +A++ G + S + Y ++ E LG G F V +
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSD---------NYDVK----EELGKGAFSVVRR 47
Query: 136 CLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVL 192
C+ G+ +A K + ++ +K+ ++E + ++ P+IV S ++
Sbjct: 48 CVHKTTGLEFAAKIINTKKLSARDFQKL-EREA---RICRKLQHPNIVRLHDSIQEESFH 103
Query: 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK 252
YL + GG L I R ++E + Q+ E + H ++H ++KP N+L
Sbjct: 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLL--- 160
Query: 253 AQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC---RYLPKELLNNNFDNLSKVDI 309
L + KL DFG I ND E G YL E+L + + VDI
Sbjct: 161 ----LASKAKGAAV--KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK-PVDI 213
Query: 310 FALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDP 362
+A G+ LY G P ++ I+ G + S V+ + +LI M+ +P
Sbjct: 214 WACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNP 273
Query: 363 TKRPSTSSLRRSAQLARNYPQLKVEN------IRGNLNTRLKKLDEGNVFDGIILAVAGI 416
KR +A A P + R + LKK + G IL +
Sbjct: 274 KKRI-------TADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTT--M 324
Query: 417 VRMKWKDRIMAVF 429
+ + +
Sbjct: 325 IATRNLSNLGRNL 337
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 60/270 (22%), Positives = 109/270 (40%), Gaps = 41/270 (15%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL--SRV 176
+G G G V + G AVK + + ++ E+ ++ +
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEV---VIMRDYQH 101
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
++V + S+ L++ +E+ GG L +I+ + E + + V + L +H
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRY----- 291
+IH DIK +IL+ T KL DFG A +V + R
Sbjct: 161 GVIHRDIKSDSILL------------TLDGRVKLSDFG-FCAQISKDVPK---RKSLVGT 204
Query: 292 ----LPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLS 344
P+ + + + ++VDI++LG+ + E G P + P+ +RD KL
Sbjct: 205 PYWMAPEVISRSLYA--TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLK 262
Query: 345 N---VSDDLHTLIKLMIDKDPTKRPSTSSL 371
N VS L ++ M+ +DP +R + L
Sbjct: 263 NSHKVSPVLRDFLERMLVRDPQERATAQEL 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 32/272 (11%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK----RTKRPVANTAQEKIFKKEI 167
Y + E LGSG F V KC + G YA K R + ++E+
Sbjct: 4 EDHYEMG----EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREV 59
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQ 225
+L + P+I+ + ++ + L LE +GG L + + E+ + TE Q L Q
Sbjct: 60 ---NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQ 116
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDF 282
+ +G+ +H R+ H D+KP NI+++ KL DFG + A N+F
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR--------IKLIDFGIAHKIEAGNEF 168
Query: 283 EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGN 339
+ G ++ E++N L + D++++G+ Y SG +P +I N
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGL-EADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227
Query: 340 I----EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
E SN S+ I+ ++ KDP +R +
Sbjct: 228 YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT 259
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 59/267 (22%), Positives = 113/267 (42%), Gaps = 34/267 (12%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKI------FKKEIHAHALLSR 175
E+LG G V +C+ YAVK + + E++ KE+ +S
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P+I+ ++ +L + G L + + E+ T +E ++++ + E + +H+
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK 142
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE-GDCRYL 292
+ ++H D+KP NIL+ + ++ KL DFG + + E G YL
Sbjct: 143 LNIVHRDLKPENILLD------------DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYL 190
Query: 293 PKELLNNNFDNLSK-----VDIFALGLTLYE-ASGVTPL--PKNGPMWHHIRDGNIEKLS 344
E++ + ++ VD+++ G+ +Y +G P K M I GN + S
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 250
Query: 345 ----NVSDDLHTLIKLMIDKDPTKRPS 367
+ SD + L+ + P KR +
Sbjct: 251 PEWDDYSDTVKDLVSRFLVVQPQKRYT 277
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 61/270 (22%), Positives = 108/270 (40%), Gaps = 41/270 (15%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL--SRV 176
+ E +G G G V+ + G A++ + + ++++ EI ++ ++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIR--QMNLQQQPKKELIINEI---LVMRENKN 76
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P+IVNY S+ L++ +EY GG+L +++ E C E + + + + L +H
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSN 135
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRY----- 291
++IH DIK NIL+ KL DFG A E + R
Sbjct: 136 QVIHRDIKSDNILL------------GMDGSVKLTDFG-FCAQITPEQSK---RSTMVGT 179
Query: 292 ----LPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKL- 343
P+ + + KVDI++LG+ E G P P+ + I +L
Sbjct: 180 PYWMAPEVVTRKAYG--PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 344 --SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+S + ++ D KR S L
Sbjct: 238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKEL 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 63/289 (21%), Positives = 111/289 (38%), Gaps = 36/289 (12%)
Query: 95 DHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRP 153
HH +++ + + LGSG FG+V + G+ +K K
Sbjct: 4 HHHHSSGRENLYFQGTIDDLFIFK----RKLGSGAFGDVHLVEERSSGLERVIKTINKDR 59
Query: 154 VANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL-ENIIQE 210
+ + EI +L + P+I+ F + D +Y+ +E C GG L E I+
Sbjct: 60 SQV--PMEQIEAEI---EVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSA 114
Query: 211 RCT---FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267
+ +E + +L+ Q+ L H ++H D+KP NIL +
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQD---------TSPHSP 165
Query: 268 YKLGDFG---HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVT 323
K+ DFG +D G Y+ E+ + K DI++ G+ +Y +G
Sbjct: 166 IKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTF--KCDIWSAGVVMYFLLTGCL 223
Query: 324 P-LPKNGP-MWHHIRDGNI---EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
P + + + ++ L+K M+ KDP +RPS
Sbjct: 224 PFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 33/278 (11%)
Query: 104 SISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKI 162
+I+ T Y L E LG G F V +C+K + G YA + ++ +K+
Sbjct: 3 TITCTRF-TEEYQLF----EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL 57
Query: 163 FKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALK 220
++E + + P+IV S S++G YL + GG L I R ++E
Sbjct: 58 -EREA---RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS 113
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-HVIAD 279
+ Q+ E + H+M ++H ++KP N+L L + + KL DFG + +
Sbjct: 114 HCIQQILEAVLHCHQMGVVHRNLKPENLL-------LASKLKGAAV--KLADFGLAIEVE 164
Query: 280 NDFEVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWH 333
+ + G YL E+L + VD++A G+ LY G P ++
Sbjct: 165 GEQQAWFGFAGTPGYLSPEVLRKDPYGK-PVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223
Query: 334 HIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
I+ G + S V+ + LI M+ +P+KR +
Sbjct: 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT 261
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 58/286 (20%), Positives = 107/286 (37%), Gaps = 50/286 (17%)
Query: 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVPH 178
L+E++LG G V C+ + YAVK K+P + ++F+ E+ +
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI--RSRVFR-EVEMLYQCQGHRN 72
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
++ + ++ YL E GG++ + I +R F E+ ++ V+ L +H +
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGI 132
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCR------ 290
H D+KP NIL P + K+ DF I N
Sbjct: 133 AHRDLKPENIL-------CEHPNQVSPV--KICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 291 ---YLPKELLNNNFDNLS----KVDIFALGLTLY------------------EASGVTPL 325
Y+ E++ + S + D+++LG+ LY G
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243
Query: 326 PKNGPMWHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPS 367
++ I++G E ++S LI ++ +D +R S
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS 289
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 52/315 (16%), Positives = 100/315 (31%), Gaps = 74/315 (23%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEIH 168
+Y L+ +G G +G V ++ A+K + K N + K E+
Sbjct: 25 QKKYHLK----GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVR 80
Query: 169 AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----------------- 211
L P+I + + D+ + L +E C+GG+L + +
Sbjct: 81 LMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 212 -----------------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANI 248
E + ++ Q+ L +H + H DIKP N
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 249 LIVKAQGELNEPMNTEKLHYKLGDFG-HVIADNDFEVEEGDCR-------YLPKELLNNN 300
L + KL DFG E ++ E+LN
Sbjct: 200 LFS----------TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 301 FDNLS-KVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNI----EKLSNVSDDLHT 352
++ K D ++ G+ L+ G P P + + + + +S
Sbjct: 250 NESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARD 309
Query: 353 LIKLMIDKDPTKRPS 367
L+ +++++ +R
Sbjct: 310 LLSNLLNRNVDERFD 324
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 47/274 (17%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE-KIFKKEIHAHALLS--R 175
F + +G G FG V+ + A+K+ + ++ + KE+ L R
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR---FLQKLR 112
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P+ + Y + + +L +EYC G + + + E+ + + +GL +H
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD----NDF--------- 282
MIH D+K NIL+ +E KLGDFG + N F
Sbjct: 173 HNMIHRDVKAGNILL------------SEPGLVKLGDFG-SASIMAPANSFVGTPYWMAP 219
Query: 283 EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGN 339
EV +D KVD+++LG+T E A PL M +HI
Sbjct: 220 EVILAMDE--------GQYD--GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 269
Query: 340 IEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
L + S+ + + K P RP++ L
Sbjct: 270 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 303
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 58/268 (21%), Positives = 108/268 (40%), Gaps = 32/268 (11%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
+ Y LE +G G +GEV ++ + A K+ + FK+EI
Sbjct: 8 NQYYTLE----NTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEI---E 58
Query: 172 LLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEG 229
++ + P+I+ + ++ D +YL +E C GG L + + F E +++ V
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEE 286
+ H++ + H D+KP N L + ++ KL DFG +
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLT---------DSPDSPLKLIDFGLAARFKPGKMMRTKV 169
Query: 287 GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTP-LPKNGP-MWHHIRDGNIEKL 343
G Y+ ++L + + D ++ G+ +Y G P + IR+G
Sbjct: 170 GTPYYVSPQVLEGLYGP--ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFP 227
Query: 344 S----NVSDDLHTLIKLMIDKDPTKRPS 367
NVS +LI+ ++ K P +R +
Sbjct: 228 EKDWLNVSPQAESLIRRLLTKSPKQRIT 255
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 70/312 (22%), Positives = 121/312 (38%), Gaps = 45/312 (14%)
Query: 72 KKWSGKTLATLPSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFG 131
+ S T + P + + D D + + +E LG G
Sbjct: 21 QSMSSVTASAAPGTASLVPDYWIDGSNRDALSD---------FFEVE----SELGRGATS 67
Query: 132 EVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQ 189
V++C + YA+K K+ T +KI + EI +L R+ P+I+ +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKK----TVDKKIVRTEI---GVLLRLSHPNIIKLKEIFETP 120
Query: 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANIL 249
+ L LE GG L + I E+ ++E + Q+ E + +HE ++H D+KP N+L
Sbjct: 121 TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
Query: 250 IVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYL-PKELLNNNFDNLS 305
K+ DFG V + G Y P+ L +
Sbjct: 181 YAT---------PAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGP-- 229
Query: 306 KVDIFALGLTLY-EASGVTPL---PKNGPMWHHIRDGNIEKLS----NVSDDLHTLIKLM 357
+VD++++G+ Y G P + M+ I + +S VS + L++ +
Sbjct: 230 EVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKL 289
Query: 358 IDKDPTKRPSTS 369
I DP KR +T
Sbjct: 290 IVLDPKKRLTTF 301
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 64/289 (22%), Positives = 116/289 (40%), Gaps = 59/289 (20%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+E LG+G FG V + + G A+K+ ++ ++ +E+ EI L P++V+
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW-CLEIQIMKKL-NHPNVVS 76
Query: 182 YF------SSWSDQGVLYLQLEYCNGGNLENIIQER---CTFTEMALKQLLFQVSEGLRC 232
+ + L +EYC GG+L + + C E ++ LL +S LR
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE------ 286
+HE R+IH D+KP NI++ ++L +K+ D G + + E
Sbjct: 137 LHENRIIHRDLKPENIVLQP---------GPQRLIHKIIDLG---YAKELDQGELCTEFV 184
Query: 287 GDCRYLPKELLNN-NFDNLSKVDIFALGLTLYE-ASGVTPLPKNG--------------- 329
G +YL ELL + VD ++ G +E +G P N
Sbjct: 185 GTLQYLAPELLEQKKYT--VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242
Query: 330 -PMWHHIRDGNIE---------KLSNV-SDDLHTLIKLMIDKDPTKRPS 367
+ + G ++ LS + + L ++ M+ +R +
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 72/327 (22%), Positives = 126/327 (38%), Gaps = 45/327 (13%)
Query: 113 SRYALEFLEE----ELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKI----- 162
S Y +E + LGSG GEV + A+K +KR A + +
Sbjct: 2 SVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALN 61
Query: 163 FKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALK 220
+ EI +L ++ P I+ + + + Y+ LE GG L + + E K
Sbjct: 62 VETEI---EILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCK 117
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADN 280
+Q+ ++ +HE +IH D+KP N+L+ E K+ DFGH
Sbjct: 118 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSS---------QEEDCLIKITDFGHSKILG 168
Query: 281 DFEVEEGDC---RYLPKELLNNNFDN--LSKVDIFALGLTLYEA-SGVTPL-PKNGP--M 331
+ + C YL E+L + VD ++LG+ L+ SG P +
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228
Query: 332 WHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVE 387
I G + VS+ L+K ++ DP R + + A +P L+ E
Sbjct: 229 KDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF-------TTEEALRHPWLQDE 281
Query: 388 NIRGNLNTRLKKLDEGNVFDGIILAVA 414
+++ L + +E ++ +
Sbjct: 282 DMKRKFQDLLSEENESTALPQVLAQPS 308
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 68/323 (21%), Positives = 127/323 (39%), Gaps = 45/323 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEIHAHALLSRV--P 177
E++G G F V +C+ G +AVK K + + K+E ++ + P
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA---SICHMLKHP 86
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSEGLRCM 233
HIV ++S G+LY+ E+ +G +L I +R ++E + Q+ E LR
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE--GDC 289
H+ +IH D+KP +L L N+ + KLG FG + ++ G
Sbjct: 147 HDNNIIHRDVKPHCVL-------LASKENSAPV--KLGGFGVAIQLGESGLVAGGRVGTP 197
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTP-LPKNGPMWHHIRDGNIEKLS--- 344
++ E++ VD++ G+ L+ SG P ++ I G +
Sbjct: 198 HFMAPEVVKREPYGK-PVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQW 256
Query: 345 -NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA------RNYPQLKVENIRGNLNTRL 397
++S+ L++ M+ DP +R + A + + + +L
Sbjct: 257 SHISESAKDLVRRMLMLDPAERI-------TVYEALNHPWLKERDRYAYKIHLPETVEQL 309
Query: 398 KKLDEGNVFDGIILAVAGIVRMK 420
+K + G +LA +
Sbjct: 310 RKFNARRKLKGAVLAAVSSHKFN 332
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 70/310 (22%), Positives = 123/310 (39%), Gaps = 44/310 (14%)
Query: 81 TLPSGSVIDEDSGDDHHPVFDIKSISS--TSIDHSRYALEFLEEELLGSGDFGEVFKCLK 138
LP P F +KS + Y + ++LG G G+V +
Sbjct: 27 ALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDY---KVTSQVLGLGINGKVLQIFN 83
Query: 139 YMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN----YFSSWSDQGVLYL 194
+A+K + ++E+ H S+ PHIV Y + ++ + L +
Sbjct: 84 KRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 195 QLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK 252
+E +GG L + IQ+R FTE +++ + E ++ +H + + H D+KP N+L
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTS 196
Query: 253 AQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELLN-NNFDNLSKVD 308
KL DFG + N Y+ E+L +D D
Sbjct: 197 ---------KRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDK--SCD 245
Query: 309 IFALGLTLYEA-SGVTPLPKNGP------MWHHIRDGNIEKLS----NVSDDLHTLIKLM 357
+++LG+ +Y G P N M IR G E + VS+++ LI+ +
Sbjct: 246 MWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNL 305
Query: 358 IDKDPTKRPS 367
+ +PT+R +
Sbjct: 306 LKTEPTQRMT 315
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 55/270 (20%), Positives = 109/270 (40%), Gaps = 36/270 (13%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAH 170
+ +Y + E LG G+FG V +C++ TY K + + + KKEI
Sbjct: 4 YEKYMIA----EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEI--- 52
Query: 171 ALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL-ENIIQERCTFTEMALKQLLFQVS 227
++L+ +I++ S+ L + E+ +G ++ E I E + + QV
Sbjct: 53 SILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEV 284
E L+ +H + H DI+P NI+ K+ +FG + ++F +
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQ----------TRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 285 EEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNI- 340
Y E+ ++ + D+++LG +Y SG+ P N + +I +
Sbjct: 163 LFTAPEYYAPEVHQHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYT 221
Query: 341 ---EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
E +S + + ++ K+ R +
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMT 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 57/324 (17%), Positives = 107/324 (33%), Gaps = 28/324 (8%)
Query: 94 DDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLK-----YMDGMTYAVK 148
+ + IK + + + LLG G F +V++ + + + +K
Sbjct: 46 EWQCKLPAIKPKTEFQLGSKLVYVH----HLLGEGAFAQVYEATQGDLNDAKNKQKFVLK 101
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
K + I + + + + ++S+ Q L E + G L N I
Sbjct: 102 VQKPANPW--EFYIGTQLMERLKPSMQ-HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAI 158
Query: 209 QERCTFTEMALKQLL-----FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263
E + Q L ++ + +H+ +IH DIKP N ++ E ++ +
Sbjct: 159 NLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDL 218
Query: 264 EKLHYKLGDFGHVIADNDFEVEE---GDCR---YLPKELLNNNFDNLSKVDIFALGLTLY 317
L D G I F C + E+L+N N ++D F + T+Y
Sbjct: 219 SA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY-QIDYFGVAATVY 276
Query: 318 EASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377
T + + + + D + +M++ + L R Q
Sbjct: 277 CMLFGTYMKVKNE-GGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR--QK 333
Query: 378 ARNYPQLKVENIRGNLNTRLKKLD 401
+ Q N L RL L
Sbjct: 334 LKKVFQQHYTNKIRALRNRLIVLL 357
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-25
Identities = 58/276 (21%), Positives = 109/276 (39%), Gaps = 37/276 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--FKKEI 167
ID + E EE++G G FG+V++ + G AVK + + I ++E
Sbjct: 4 IDFA----ELTLEEIIGIGGFGKVYRA-FW-IGDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQ 225
L + + P+I+ + L L +E+ GG L ++ + L Q
Sbjct: 58 ---KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQ 113
Query: 226 VSEGLRCMHEMR---MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN 280
++ G+ +H+ +IH D+K +NILI + E + K+ DFG
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILI----LQKVENGDLSNKILKITDFGLAREWHRT 169
Query: 281 DFEVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM------- 331
G ++ E++ + F D+++ G+ L+E +G P +
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFS--KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA 227
Query: 332 WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ + + S + L++ + DP RPS
Sbjct: 228 MNKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPS 260
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 44/274 (16%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
ID+ E EE++G G FG V K K+ A+K+ + ++ K F E+
Sbjct: 5 IDYK----EIEVEEVVGRGAFGVVCKA-KW-RAKDVAIKQIESE----SERKAFIVEL-- 52
Query: 170 HALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL---F 224
LSRV P+IV + + + + L +EY GG+L N++ +
Sbjct: 53 -RQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 225 QVSEGLRCMHEMR---MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADN 280
Q S+G+ +H M+ +IH D+KP N+L+V K+ DFG
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVA-----------GGTVLKICDFGTACDIQT 158
Query: 281 DFEVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDG 338
+G ++ E+ + + K D+F+ G+ L+E + P + G I
Sbjct: 159 HMTNNKGSAAWMAPEVFEGSNYSE--KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216
Query: 339 NIEKL-----SNVSDDLHTLIKLMIDKDPTKRPS 367
N+ + +L+ KDP++RPS
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPS 250
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 46/287 (16%), Positives = 98/287 (34%), Gaps = 56/287 (19%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTY----AVKRTKRPVANTAQEKIFKK 165
I + EL+G G FG+V+ + A++ N Q K FK+
Sbjct: 30 IPFE----QLEIGELIGKGRFGQVYHG-------RWHGEVAIRLIDIERDNEDQLKAFKR 78
Query: 166 EIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQL 222
E+ + ++V + + L + C G L ++++ + +Q+
Sbjct: 79 EV---MAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI 135
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-------- 274
++ +G+ +H ++H D+K N+ + + DFG
Sbjct: 136 AQEIVKGMGYLHAKGILHKDLKSKNVFY-------------DNGKVVITDFGLFSISGVL 182
Query: 275 -HVIADNDFEVEEGDCRYLPKELLNNNFDNLS--------KVDIFALGLTLYE-ASGVTP 324
++ ++ G +L E++ + D+FALG YE + P
Sbjct: 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
Query: 325 LPKNGPMW--HHIRDGNIEKLS--NVSDDLHTLIKLMIDKDPTKRPS 367
+ G LS + ++ ++ + +RP+
Sbjct: 243 FKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPT 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 56/266 (21%), Positives = 107/266 (40%), Gaps = 33/266 (12%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQ-----EKIFKKEIHAHALLSRV 176
+++G G V +C+ G +AVK + + + ++E H ++
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
PHI+ S+ ++L + G L + + E+ +E + ++ + E + +H
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLP 293
++H D+KP NIL+ + + +L DFG H+ G YL
Sbjct: 220 NIVHRDLKPENILLD------------DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267
Query: 294 KELLNNNFDNLSK-----VDIFALGLTLYEA-SGVTPL--PKNGPMWHHIRDGNIEKLS- 344
E+L + D VD++A G+ L+ +G P + M I +G + S
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSP 327
Query: 345 ---NVSDDLHTLIKLMIDKDPTKRPS 367
+ S + LI ++ DP R +
Sbjct: 328 EWDDRSSTVKDLISRLLQVDPEARLT 353
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 67/310 (21%), Positives = 122/310 (39%), Gaps = 77/310 (24%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
+F + LG+G+ G VFK G+ A K + + +I + E+ +L
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-EL---QVLHECN 89
Query: 177 -PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH- 234
P+IV ++ ++ G + + +E+ +GG+L+ ++++ E L ++ V +GL +
Sbjct: 90 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG------HVIADNDFEVEEGD 288
+ +++H D+KP+NIL V ++GE+ KL DFG +A N F G
Sbjct: 150 KHKIMHRDVKPSNIL-VNSRGEI-----------KLCDFGVSGQLIDSMA-NSFV---GT 193
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP----------------- 330
Y+ E L + + DI+++GL+L E A G P+P
Sbjct: 194 RSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 331 ----------------MWHHIRDGNIEKLSNV-------------SDDLHTLIKLMIDKD 361
M E L + S + + + K+
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312
Query: 362 PTKRPSTSSL 371
P +R L
Sbjct: 313 PAERADLKQL 322
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 62/267 (23%), Positives = 107/267 (40%), Gaps = 51/267 (19%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRV-- 176
++G G FGEV+ C K G YA+K + ++I K+ AL LS V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDK-------KRIKMKQGETLALNERIMLSLVST 248
Query: 177 ---PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
P IV ++ L L+ NGG+L + + F+E ++ ++ GL M
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR--- 290
H +++ D+KPANIL+ G H ++ D G + +
Sbjct: 309 HNRFVVYRDLKPANILL-DEHG-----------HVRISDLG-------LACDFSKKKPHA 349
Query: 291 ------YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTP-----LPKNGPMWHHIRDG 338
Y+ E+L S D F+LG L++ G +P +
Sbjct: 350 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 339 NIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+E + S +L +L++ ++ +D +R
Sbjct: 410 AVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 66/299 (22%), Positives = 116/299 (38%), Gaps = 42/299 (14%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN--TAQEKIFKKEIHAHA 171
RY + + LG G V+ + + A+K P ++ F++E+H +
Sbjct: 12 RYKIV----DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSS 66
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231
LS +IV+ + YL +EY G L I+ + Q+ +G++
Sbjct: 67 QLSH-QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----- 286
H+MR++H DIKP NILI K+ DFG A ++ + +
Sbjct: 126 HAHDMRIVHRDIKPQNILI------------DSNKTLKIFDFGIAKALSETSLTQTNHVL 173
Query: 287 GDCRYL-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM---WHHIRDGNIE 341
G +Y P++ D + DI+++G+ LYE G P + HI+D
Sbjct: 174 GTVQYFSPEQAKGEATDECT--DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN 231
Query: 342 KLS----NVSDDLHTLIKLMIDKDPTKRPSTSS-----LRRSAQLAR-NYPQLKVENIR 390
+ ++ L +I +KD R T L R N +++ ++
Sbjct: 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMK 290
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 54/282 (19%), Positives = 106/282 (37%), Gaps = 45/282 (15%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI-----FK 164
+ + E E+ +G G FG V K D A+K + E I F+
Sbjct: 16 LADN----EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQ 71
Query: 165 KEIHAHALLSRV--PHIVNYFSSWSDQGV----LYLQLEYCNGGNLENIIQER-CTFTEM 217
+E+ ++S + P+IV + G+ + +E+ G+L + + ++
Sbjct: 72 REV---FIMSNLNHPNIVKLY------GLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 218 ALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275
+L+ ++ G+ M ++H D++ NI L + K+ DFG
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIF-------LQSLDENAPVCAKVADFGL 175
Query: 276 V-IADNDFEVEEGDCRYLPKELLNNNFDNLS-KVDIFALGLTLYE-ASGVTPLP--KNGP 330
+ + G+ +++ E + ++ + K D ++ + LY +G P G
Sbjct: 176 SQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
Query: 331 MWHHIRDGNIEKL-----SNVSDDLHTLIKLMIDKDPTKRPS 367
+ E L + L +I+L DP KRP
Sbjct: 236 IKFINMIRE-EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 68/260 (26%), Positives = 111/260 (42%), Gaps = 45/260 (17%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRVPH 178
LG+G FG V G YA+K + +K+ K + H L L V
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDK-------QKVVKLKQIEHTLNEKRILQAVNF 100
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+V S+ D LY+ +EY GG + + ++ F+E + Q+ +H +
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD-----C-- 289
+I+ D+KP N+LI QG + ++ DFG F C
Sbjct: 161 DLIYRDLKPENLLI-DQQG-----------YIQVTDFG-------FAKRVKGRTWTLCGT 201
Query: 290 -RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSN 345
L E++ + N + VD +ALG+ +YE A+G P + P ++ I G + S+
Sbjct: 202 PEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
Query: 346 VSDDLHTLIKLMIDKDPTKR 365
S DL L++ ++ D TKR
Sbjct: 261 FSSDLKDLLRNLLQVDLTKR 280
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-23
Identities = 60/256 (23%), Positives = 100/256 (39%), Gaps = 26/256 (10%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK-----RTKRPVANTAQEKIFKKEIHAHALLS-R 175
LLGSG FG V+ ++ D + A+K R ++ E+ +S
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV-PMEVVLLKKVSSG 106
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNG-GNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
++ + L LE +L + I ER E + +QV E +R H
Sbjct: 107 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYL 292
++H DIK NILI + + KL DFG ++ D + +G Y
Sbjct: 167 NCGVLHRDIKDENILI-----------DLNRGELKLIDFGSGALLKDTVYTDFDGTRVYS 215
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLH 351
P E + + + +++LG+ LY+ G +P I G + VS +
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD--IPFEHD--EEIIRGQVFFRQRVSSECQ 271
Query: 352 TLIKLMIDKDPTKRPS 367
LI+ + P+ RP+
Sbjct: 272 HLIRWCLALRPSDRPT 287
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 59/267 (22%), Positives = 107/267 (40%), Gaps = 51/267 (19%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVK-------RTKRPVANTAQEKIFKKEIHAHALLSRV 176
+G G FG+V K YA+K + V N +E ++ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKEL---------QIMQGL 72
Query: 177 PH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
H +VN + S+ D+ +++ ++ GG+L +Q+ F E +K + ++ L +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD-----C 289
R+IH D+KP NIL+ G H + DF IA +
Sbjct: 133 NQRIIHRDMKPDNILL-DEHG-----------HVHITDFN--IAA---MLPRETQITTMA 175
Query: 290 ---RYLPKELLNNNFDNL-SK-VDIFALGLTLYE-ASGVTPLPKNGP-----MWHHIRDG 338
Y+ E+ ++ S VD ++LG+T YE G P + H
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
Query: 339 NIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+ S S ++ +L+K +++ +P +R
Sbjct: 236 VVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 58/343 (16%), Positives = 108/343 (31%), Gaps = 86/343 (25%)
Query: 96 HHPVFDIKSISSTSIDHSRYALEFLEEELLGSG--DFGEVFKCLKYMDGMTYAVKRTKRP 153
H + +SS + Y L ++G G D V G V+R
Sbjct: 8 HMENLYFQGMSSFLPEGGCYELL----TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLE 63
Query: 154 VANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT 213
+ + E+H L + P+IV Y +++ L++ + G+ +++I
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM 122
Query: 214 --FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
E+A+ +L V + L +H M +H +K ++ILI + L
Sbjct: 123 DGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI------------SVDGKVYLS 170
Query: 272 DFGHVIADNDFEVEEGDCRYLPK-----------ELLNNN---FDNLSKVDIFALGLTLY 317
++ + PK E+L N +D +K DI+++G+T
Sbjct: 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD--AKSDIYSVGITAC 228
Query: 318 E-ASGVTPL------------PKNGP---------------------------------- 330
E A+G P
Sbjct: 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTS 288
Query: 331 --MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ + S H ++ + ++P RPS S+L
Sbjct: 289 TPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL 331
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 61/266 (22%), Positives = 104/266 (39%), Gaps = 30/266 (11%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK---RTK-RPVANTAQEKIFKKEIH 168
+ Y L LLG G FG VF + D + A+K R + + + E+
Sbjct: 31 AEYRLG----PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 169 AHALLS---RVPHIVNYFSSWSDQGVLYLQLEY-CNGGNLENIIQERCTFTEMALKQLLF 224
+ P ++ + Q L LE +L + I E+ E +
Sbjct: 87 LLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 225 QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDF 282
QV ++ H ++H DIK NILI + + KL DFG ++ D +
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILI-----------DLRRGCAKLIDFGSGALLHDEPY 195
Query: 283 EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIE 341
+G Y P E ++ + + +++LG+ LY+ G +P I + +
Sbjct: 196 TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD--IPFERD--QEILEAELH 251
Query: 342 KLSNVSDDLHTLIKLMIDKDPTKRPS 367
++VS D LI+ + P+ RPS
Sbjct: 252 FPAHVSPDCCALIRRCLAPKPSSRPS 277
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 58/261 (22%), Positives = 99/261 (37%), Gaps = 42/261 (16%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRVPH 178
+LG G F V + YA+K ++ I K+ + +SR+ H
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEK-------RHIIKENKVPYVTRERDVMSRLDH 89
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCM 233
V + ++ D LY L Y G L I++ +F E + F +E L +
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR---FYTAEIVSALEYL 146
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDC- 289
H +IH D+KP NIL+ H ++ DFG + ++
Sbjct: 147 HGKGIIHRDLKPENILL-NEDM-----------HIQITDFGTAKVLSPESKQARANSFVG 194
Query: 290 --RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLS 344
+Y+ ELL S D++ALG +Y+ +G+ P ++ I +
Sbjct: 195 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 345 NVSDDLHTLIKLMIDKDPTKR 365
L++ ++ D TKR
Sbjct: 254 KFFPKARDLVEKLLVLDATKR 274
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 2e-21
Identities = 64/269 (23%), Positives = 115/269 (42%), Gaps = 52/269 (19%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRVPH 178
+LG G FGEVF C G YA K+ + +++ K++ + A+ L++V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNK-------KRLKKRKGYQGAMVEKKILAKVHS 244
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNL----ENIIQERCTFTEMALKQLLFQVSE---G 229
IV+ ++ + L L + NGG++ N+ ++ F E + +F ++ G
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAIFYTAQIVSG 301
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEE 286
L +H+ +I+ D+KP N+L+ G + ++ D G + A +
Sbjct: 302 LEHLHQRNIIYRDLKPENVLL-DDDG-----------NVRISDLGLAVELKAGQT--KTK 347
Query: 287 GDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTP------LPKNGPMWHHIR 336
G ++ ELL + S VD FALG+TLYE + P +N + +
Sbjct: 348 GYAGTPGFMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVL 406
Query: 337 DGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+ + S + ++ KDP KR
Sbjct: 407 EQAVTYPDKFSPASKDFCEALLQKDPEKR 435
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 60/286 (20%), Positives = 105/286 (36%), Gaps = 37/286 (12%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN--TAQEKIFKKEIHAHA 171
Y L L+G G G+V++ + A+K +++ + + ++E
Sbjct: 35 PYRLR----RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAG 89
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231
L PH+V G LY+ + NG +L +++ + ++ Q+ L
Sbjct: 90 RLQE-PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE----- 286
H H D+KP NIL+ + L DFG A D ++ +
Sbjct: 149 AAHAAGATHRDVKPENILV------------SADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 287 GDCRYL-PKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK 342
G Y+ P+ ++ + DI+AL LYE +G P + M HI I +
Sbjct: 197 GTLYYMAPERFSESHAT--YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPR 253
Query: 343 LS----NVSDDLHTLIKLMIDKDPTKR-PSTSSLRRSAQLARNYPQ 383
S + +I + K+P R + L +A A
Sbjct: 254 PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 4e-21
Identities = 45/281 (16%), Positives = 97/281 (34%), Gaps = 53/281 (18%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
ID + L GE++K ++ G VK K +T + + F +E
Sbjct: 7 IDFK----QLNFLTKLNENHSGELWKG-RW-QGNDIVVKVLKVRDWSTRKSRDFNEEC-- 58
Query: 170 HALLSRV--PHIVNYFSSWSDQGVLYLQL--EYCNGGNLENIIQERCTFTEMALKQLL-- 223
L P+++ + + L + G+L N++ E T + Q +
Sbjct: 59 -PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKF 116
Query: 224 -FQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADN 280
++ G+ +H + + + +++I E + ++ +
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMI------------DEDMTARISMAD--VK-- 160
Query: 281 DFEVEEGDCRYLPK----ELLNNNFDNLS--KVDIFALGLTLYE-ASGVTPLPKNGPM-- 331
F + Y P E L ++ + D+++ + L+E + P M
Sbjct: 161 -FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219
Query: 332 -----WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+R +S + L+K+ +++DP KRP
Sbjct: 220 GMKVALEGLR---PTIPPGISPHVSKLMKICMNEDPAKRPK 257
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 4e-21
Identities = 62/266 (23%), Positives = 113/266 (42%), Gaps = 47/266 (17%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL----- 172
+ L LG+G FG V +G YA+K K+ E + + + H
Sbjct: 9 QILR--TLGTGSFGRVHLIRSRHNGRYYAMKVLKK-------EIVVRLKQVEHTNDERLM 59
Query: 173 LSRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
LS V H I+ + ++ D +++ ++Y GG L +++++ F K +V L
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD-- 288
+H +I+ D+KP NIL+ G H K+ DFG F D
Sbjct: 120 EYLHSKDIIYRDLKPENILL-DKNG-----------HIKITDFG-------FAKYVPDVT 160
Query: 289 ---C---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGN 339
C Y+ E+++ N S +D ++ G+ +YE +G TP + + I +
Sbjct: 161 YTLCGTPDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE 219
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKR 365
+ ++D+ L+ +I +D ++R
Sbjct: 220 LRFPPFFNEDVKDLLSRLITRDLSQR 245
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 55/296 (18%), Positives = 110/296 (37%), Gaps = 71/296 (23%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVK---------------RTKRPVANTAQEKIFKKEIHA 169
L G F ++ C K D YA+K ++ ++ FK E+
Sbjct: 39 LNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ- 95
Query: 170 HALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--------ERCTFTEMAL 219
+++ + + + ++ +Y+ EY ++ + C +
Sbjct: 96 --IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 220 KQLLFQVSEGLRCMH-EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HV 276
K ++ V +H E + H D+KP+NIL+ + KL DFG
Sbjct: 154 KCIIKSVLNSFSYIHNEKNICHRDVKPSNILM------------DKNGRVKLSDFGESEY 201
Query: 277 IADNDFEVEEGDCRYLPKELLNN--NFDNLSKVDIFALGLTLYE-ASGVTP--------- 324
+ D + G ++P E +N +++ +KVDI++LG+ LY V P
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNG-AKVDIWSLGICLYVMFYNVVPFSLKISLVE 260
Query: 325 -------------LPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
L +N ++ + + +S++ +KL + K+P +R +
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 72/281 (25%), Positives = 117/281 (41%), Gaps = 51/281 (18%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN--TAQEKIFKKEIHAHA 171
RY L E+LG G EV D AVK + +A + + F++E A
Sbjct: 13 RYELG----EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAA 67
Query: 172 LLSRVPHIVNYFSSWSDQG--------VLYLQLEYCNGGNLENIIQERCTFTEMALKQLL 223
L+ P IV + D G + Y+ +EY +G L +I+ T +++
Sbjct: 68 ALNH-PAIVAVY----DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVI 122
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFE 283
+ L H+ +IH D+KPANI+I + K+ DFG A D
Sbjct: 123 ADACQALNFSHQNGIIHRDVKPANIMI------------SATNAVKVMDFGIARAIADSG 170
Query: 284 VEE-------GDCRYL-PKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--- 331
G +YL P++ ++ D S D+++LG LYE +G P + P+
Sbjct: 171 NSVTQTAAVIGTAQYLSPEQARGDSVDARS--DVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 332 WHHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPST 368
+ H+R+ + S +S DL ++ + K+P R T
Sbjct: 229 YQHVRE-DPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 67/266 (25%), Positives = 110/266 (41%), Gaps = 49/266 (18%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRVPH 178
+LG G FGEV C G YA K+ ++ ++I K++ A AL L +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEK-------KRIKKRKGEAMALNEKQILEKVNS 243
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRCMH 234
+V+ ++ + L L L NGG+L+ I + F E ++ GL +H
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD-----C 289
R+++ D+KP NIL+ G H ++ D G + V EG
Sbjct: 304 RERIVYRDLKPENILL-DDHG-----------HIRISDLGLAV-----HVPEGQTIKGRV 346
Query: 290 ---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP------MWHHIRDGN 339
Y+ E++ N S D +ALG LYE +G +P + + +++
Sbjct: 347 GTVGYMAPEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKR 365
E S +L ++ KDP +R
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 63/283 (22%), Positives = 108/283 (38%), Gaps = 44/283 (15%)
Query: 106 SSTSIDHSRYALE-FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK 164
+ I R E + +++G G FGEV YA+K + ++ K
Sbjct: 57 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSK-------FEMIK 109
Query: 165 KEIHAHAL-----LSRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEM 217
+ A ++ +V F ++ D LY+ +EY GG+L N++ E
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEK 168
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI 277
+ +V L +H M IH D+KP N+L+ G H KL DFG +
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL-DKSG-----------HLKLADFGTCM 216
Query: 278 ADNDFEVEE-----GDCRYLPKELLNNNFDNLS---KVDIFALGLTLYE-ASGVTPLPKN 328
N + G Y+ E+L + + + D +++G+ LYE G TP +
Sbjct: 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 329 GP--MWHHIRDGNIE----KLSNVSDDLHTLIKLMIDKDPTKR 365
+ I + +++S + LI + D R
Sbjct: 277 SLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVR 318
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 53/261 (20%), Positives = 101/261 (38%), Gaps = 32/261 (12%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
+Y ++ + G G ++ L + ++G +K + + + E A
Sbjct: 81 QYEVK----GCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAMAMAERQFLAE 135
Query: 173 LSRVPHIVNYF-----SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVS 227
+ P IV F + V Y+ +EY G +L+ ++ E L ++
Sbjct: 136 VVH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAI--AYLLEIL 192
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEG 287
L +H + +++ D+KP NI++ + Q KL D G V N F G
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEEQ-------------LKLIDLGAVSRINSFGYLYG 239
Query: 288 DCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVS 347
+ E++ + DI+ +G TL + P +NG + + + +
Sbjct: 240 TPGFQAPEIVRTGPTVAT--DIYTVGRTLAALTLDLP-TRNGRYVDGLPED--DPVLKTY 294
Query: 348 DDLHTLIKLMIDKDPTKRPST 368
D L++ ID DP +R +T
Sbjct: 295 DSYGRLLRRAIDPDPRQRFTT 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 59/318 (18%), Positives = 104/318 (32%), Gaps = 74/318 (23%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
+ E+ G FG V+K + AVK Q + E+++ + +
Sbjct: 24 MPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIFP---IQDKQSWQNEYEVYSLPGM-KH 77
Query: 177 PHIVNYF----SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRC 232
+I+ + S L+L + G+L + ++ + L + ++ GL
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAY 136
Query: 233 MHEM----------RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG-------- 274
+HE + H DIK N+L+ L + DFG
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLL------------KNNLTACIADFGLALKFEAG 184
Query: 275 HVIADNDFEVEEGDCRYLPKELL----NNNFDNLSKVDIFALGLTLYE-ASGVTPL---- 325
D +V G RY+ E+L N D ++D++A+GL L+E AS T
Sbjct: 185 KSAGDTHGQV--GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 326 --------------PKNGPMWHHI----RDGNIEKLSNVSDDLHTLIKLMI---DKDPTK 364
P M + + + + L + + D D
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 365 RPSTSSLRRS-AQLARNY 381
R S + Q+ R
Sbjct: 303 RLSAGCVGERITQMQRLT 320
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-20
Identities = 63/343 (18%), Positives = 119/343 (34%), Gaps = 85/343 (24%)
Query: 90 EDSGDDHHPVFDIKSISSTSID----HSRYALEFLEE----------ELLGSGDFGEVFK 135
ED D + + ++ D S L L + E +G G FGEV++
Sbjct: 1 EDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWR 60
Query: 136 CLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS-RVPHIVNYFSSWSDQGVLYL 194
G AVK + ++ +E+ + +E + + R +I+ + ++ + +
Sbjct: 61 GK--WRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113
Query: 195 QL----EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE--------MRMIHMD 242
QL +Y G+L + + T T + +L + GL +H + H D
Sbjct: 114 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG-----HVIADNDFEVEEGDC---RYLPK 294
+K NIL+ + + D G D RY+
Sbjct: 173 LKSKNILV------------KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 295 ELLNN-----NFDNLSKVDIFALGLTLYE-ASGVTP-------------LPKNGPMWHHI 335
E+L++ +F++ + DI+A+GL +E A + L + P +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 336 RDG--------NIEKLSNVSDDLHTLIKLMI---DKDPTKRPS 367
R NI + L + K+M + R +
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 63/277 (22%), Positives = 109/277 (39%), Gaps = 33/277 (11%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++H L E +G G+FGEVF D AVK + R + F +E
Sbjct: 111 LNHEDLVLG----EQIGRGNFGEVFSGRLRADNTLVAVK-SCRETLPPDLKAKFLQEARI 165
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSE 228
S P+IV + + +Y+ +E GG+ ++ L Q++ +
Sbjct: 166 LKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE 286
G+ + IH D+ N L+ TEK K+ DFG AD +
Sbjct: 225 GMEYLESKCCIHRDLAARNCLV------------TEKNVLKISDFGMSREEADGVYAASG 272
Query: 287 GDC----RYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRD 337
G ++ E LN + S+ D+++ G+ L+E + G +P P N +
Sbjct: 273 GLRQVPVKWTAPEALNYGRYS--SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
G + D + L++ +P +RPS S++ +
Sbjct: 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 72/296 (24%), Positives = 126/296 (42%), Gaps = 55/296 (18%)
Query: 114 RYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R L F + LG+G FG+V + +K MT AVK +P A+ + + E+
Sbjct: 22 RNRLSFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVK-MLKPSAHLTEREALMSELK 78
Query: 169 AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMA---------- 218
+ L +IVN + + G + EYC G+L N ++ + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 219 -----LKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270
L+ LL +QV++G+ + IH D+ NIL+ T K+
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL------------THGRITKI 186
Query: 271 GDFG--HVIADNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDIFALGLTLYEAS-- 320
DFG I ++ V +G+ R LP K E + N + S D+++ G+ L+E
Sbjct: 187 CDFGLARDIKNDSNYVVKGNAR-LPVKWMAPESIFNCVYTFES--DVWSYGIFLWELFSL 243
Query: 321 GVTP---LPKNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
G +P +P + + I++G + +++ ++K D DP KRP+ +
Sbjct: 244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 62/297 (20%), Positives = 109/297 (36%), Gaps = 71/297 (23%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-LSRVPHIV 180
E +G G +GEV++ G AVK + ++ EK + +E + + R +I+
Sbjct: 13 LECVGKGRYGEVWRGS--WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENIL 65
Query: 181 NYF----SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+ +S L+L Y G+L + +Q T ++ +++ ++ GL +H
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 237 R--------MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEEG 287
+ H D+K NIL VK G+ + D G V+ +
Sbjct: 125 IFGTQGKPAIAHRDLKSKNIL-VKKNGQC-----------CIADLGLAVMHSQSTNQLDV 172
Query: 288 DC-------RYLPKELLNN-----NFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP---- 330
RY+ E+L+ FD+ +VDI+A GL L+E A +
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP 232
Query: 331 -------------MWHHIRDGN----IEKLSNVSDDLHTLIKLMI---DKDPTKRPS 367
M + I L +L KLM ++P+ R +
Sbjct: 233 FYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT 289
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 58/265 (21%), Positives = 100/265 (37%), Gaps = 32/265 (12%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK---RTK----RPVANTAQEKIFKKEIHAHALLS 174
LGSG FG V+ + VK + K + + K+ EI + +
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV-TLEIAILSRV- 86
Query: 175 RVPHIVNYFSSWSDQGVLYLQLE-YCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
+I+ + +QG L +E + +G +L I E + Q+ + +
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCR 290
+IH DIK NI+I E KL DFG ++ F G
Sbjct: 147 RLKDIIHRDIKDENIVI------------AEDFTIKLIDFGSAAYLERGKLFYTFCGTIE 194
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348
Y E+L N ++++++LG+TLY T + + P + I VS
Sbjct: 195 YCAPEVLMGNPYRGPELEMWSLGVTLY-----TLVFEENPFCELEETVEAAIHPPYLVSK 249
Query: 349 DLHTLIKLMIDKDPTKRPSTSSLRR 373
+L +L+ ++ P +R + L
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 60/289 (20%), Positives = 107/289 (37%), Gaps = 47/289 (16%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKC-LKYMDG--MTYAVKRTKRPVANTAQEKIFKKE 166
I S + F E +G G FG V+ L DG + AVK + + + + F E
Sbjct: 20 IGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTE 76
Query: 167 IHAHALLSRV--PHIVN-YFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQL 222
++ P++++ +G + L Y G+L N I+ E T L
Sbjct: 77 G---IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADN 280
QV++G++ + + +H D+ N ++ EK K+ DFG + D
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCML------------DEKFTVKVADFGLARDMYDK 181
Query: 281 DFEVEEGDCRYL-------PKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNG 329
++ + L F +K D+++ G+ L+E G P P
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFT--TKSDVWSFGVLLWELMTRGAPPYPDVNTF 239
Query: 330 PMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS 374
+ ++ G + D L+ ++M+ RPS S L
Sbjct: 240 DITVYLLQGRRLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSR 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 56/296 (18%), Positives = 105/296 (35%), Gaps = 69/296 (23%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+ +G G +GEV+ G AVK + EI+ L+ R +I+
Sbjct: 42 VKQIGKGRYGEVWMGK--WRGEKVAVKVFF---TTEEASWFRETEIYQTVLM-RHENILG 95
Query: 182 YFSSWSDQGVLYLQL----EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+ ++ + QL +Y G+L + ++ T ++ +L + GL +H
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 238 --------MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEEGD 288
+ H D+K NIL+ + + D G V +D +
Sbjct: 155 FSTQGKPAIAHRDLKSKNILV------------KKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 289 C-------RYLPKELLN-----NNFDNLSKVDIFALGLTLYE-ASGVTP----------- 324
RY+P E+L+ N+F + D+++ GL L+E A
Sbjct: 203 PNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262
Query: 325 --LPKNGPMWHHIRDG--------NIEKLSNVSDDLHTLIKLMI---DKDPTKRPS 367
L + P + +R+ + + + L + KLM +P R +
Sbjct: 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT 318
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 69/284 (24%), Positives = 118/284 (41%), Gaps = 42/284 (14%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
+LLG G +G+V + L AVK + K + + KKEI L R +
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV-KKEIQLLRRL-RHKN 67
Query: 179 IVNYFSSWSDQ--GVLYLQLEYCNGGNLE---NIIQERCTFTEMALKQLLFQVSEGLRCM 233
++ ++ +Y+ +EYC G E ++ ++R F Q+ +GL +
Sbjct: 68 VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--FPVCQAHGYFCQLIDGLEYL 125
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR--- 290
H ++H DIKP N+L+ T K+ G V + CR
Sbjct: 126 HSQGIVHKDIKPGNLLL------------TTGGTLKISALG-VAEALHPFAADDTCRTSQ 172
Query: 291 ----YLPKELLNNN--FDNLSKVDIFALGLTLYE-ASGVTPLPKNGP----MWHHIRDGN 339
+ P E+ N F KVDI++ G+TLY +G+ P G ++ +I G+
Sbjct: 173 GSPAFQPPEIANGLDTFSG-FKVDIWSAGVTLYNITTGL--YPFEGDNIYKLFENIGKGS 229
Query: 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
+ L L+K M++ +P KR S +R+ + + +P
Sbjct: 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 7e-19
Identities = 35/308 (11%), Positives = 83/308 (26%), Gaps = 54/308 (17%)
Query: 90 EDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR 149
E + P D++ + I + RY L G + ++ L A+
Sbjct: 8 EPDRESSAPPDDVQLVPGARIANGRYRLL----IFHGGVPPLQFWQALDTALDRQVALTF 63
Query: 150 TKRPVANTAQEKI-FKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
+ + + P + + + E+ GG+L+ +
Sbjct: 64 VDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA 122
Query: 209 QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268
+ + + ++ H + P+ + + G++
Sbjct: 123 DTSPSPVGAI--RAMQSLAAAADAAHRAGVALSIDHPSRVRV-SIDGDV----------- 168
Query: 269 KLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPK 327
L + D + + DI +G +LY PLP+
Sbjct: 169 VLAYPA-TMPDAN-----------------------PQDDIRGIGASLYALLVNRWPLPE 204
Query: 328 NGPMW-----HHIRDGNIEKLS----NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378
G G + + ++ + + + D R +++ L Q
Sbjct: 205 AGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQAT 264
Query: 379 RNYPQLKV 386
+ +V
Sbjct: 265 AVADRTEV 272
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 55/277 (19%), Positives = 114/277 (41%), Gaps = 35/277 (12%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++ + ++ LG G +GEV++ + +T AVK K E+ F KE
Sbjct: 217 MERTDITMK----HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEE-FLKEAAV 269
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQLLFQVS 227
+ P++V + + Y+ E+ GNL + ++ R + + L + Q+S
Sbjct: 270 MKEIKH-PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
+ + + IH ++ N L+ E K+ DFG ++ + +
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLV------------GENHLVKVADFGLSRLMTGDTYTAH 376
Query: 286 EGDC---RYLPKELLN-NNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRD 337
G ++ E L N F K D++A G+ L+E G++P P ++ +
Sbjct: 377 AGAKFPIKWTAPESLAYNKFS--IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+E+ + ++ L++ +P+ RPS + + +
Sbjct: 435 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 59/307 (19%), Positives = 115/307 (37%), Gaps = 59/307 (19%)
Query: 117 LEFLEEE------LLGSGDFGEVFKCLKYMDGMTY----AVKRTKRPVANTAQEKIFKKE 166
L L+E +LGSG FG V+K L +G A+K R + K E
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDE 67
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERC-TFTEMALK 220
+ A + PH+ G+ + L + G L + ++E L
Sbjct: 68 AYVMASVDN-PHVCRLL------GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIA 278
Q+++G+ + + R++H D+ N+L+ H K+ DFG ++
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLV------------KTPQHVKITDFGLAKLLG 168
Query: 279 DNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNG 329
+ E + + +L+ + + D+++ G+T++E G P
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESILHRIYT--HQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 330 PMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS-AQLARNYPQL 384
+ + G + + + D++ +M D RP L +++AR+ +
Sbjct: 227 EISSILEKGERLPQPPICTIDVY---MIMRKCWMIDADSRPKFRELIIEFSKMARDPQRY 283
Query: 385 KVENIRG 391
V I+G
Sbjct: 284 LV--IQG 288
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 57/271 (21%), Positives = 103/271 (38%), Gaps = 53/271 (19%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRVPH 178
++G G FGEV +A+K + ++ K+ A L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNK-------WEMLKRAETACFREERDVLVNGDS 133
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHE 235
I ++ D LYL ++Y GG+L ++ E + L ++ + +H+
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR----- 290
+ +H DIKP NIL+ G H +L DFG + +E+G +
Sbjct: 194 LHYVHRDIKPDNILM-DMNG-----------HIRLADFGSCLKL----MEDGTVQSSVAV 237
Query: 291 ----YLPKELLNNNFDNLSK----VDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGN 339
Y+ E+L + D ++LG+ +YE G TP + I +
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297
Query: 340 I-----EKLSNVSDDLHTLIKLMIDKDPTKR 365
++++VS++ LI+ +I R
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLI-CSREHR 327
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 62/332 (18%), Positives = 110/332 (33%), Gaps = 85/332 (25%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV- 176
EL+G G +G V+K +D AVK V + A + F E + + + +
Sbjct: 14 NLKLLELIGRGRYGAVYKGS--LDERPVAVK-----VFSFANRQNFINEKNIY-RVPLME 65
Query: 177 -PHIVNYF-----SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+I + + + L +EY G+L + T ++ +L V+ GL
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGL 124
Query: 231 RCMHEM---------RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADN 280
+H + H D+ N+L VK G + DFG +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVL-VKNDGTC-----------VISDFGLSMRLTG 172
Query: 281 DFEVEEGDC-----------RYLPKELLNNNFD------NLSKVDIFALGLTLYE-ASGV 322
+ V G+ RY+ E+L + L +VD++ALGL +E
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 323 TPLPKNGPM--------WHHIRDGNIEKLSNV-----------------SDDLHTLIKLM 357
T L + E + + S + +L + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 358 I---DKDPTKRPSTSSLRRS-AQLARNYPQLK 385
D+D R + A+L + + K
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 67/350 (19%), Positives = 125/350 (35%), Gaps = 51/350 (14%)
Query: 49 LPSGLSLGAILEREDPRDALILNKKWSGKTLATLPSGSVIDEDSGDDHHPVFDIKSISST 108
+P G + + + K S + ID + + ++++
Sbjct: 27 VPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPEL----VQAVQHV 82
Query: 109 SIDHSRYALEFLEEELLGSGDFGEVFKC-LKYMDG--MTYAVKRTKRPVANTAQEKIFKK 165
I S + F E +G G FG V+ L DG + AVK + + + + F
Sbjct: 83 VIGPSSLIVHFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLT 139
Query: 166 EIHAHALLSRV--PHIVN-YFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQ 221
E ++ P++++ +G + L Y G+L N I+ E T L
Sbjct: 140 EG---IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIAD 279
QV++G++ + + +H D+ N ++ EK K+ DFG + D
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCML------------DEKFTVKVADFGLARDMYD 244
Query: 280 NDFEVEEGDCRYL-------PKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KN 328
+F+ + L F +K D+++ G+ L+E G P P
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFT--TKSDVWSFGVLLWELMTRGAPPYPDVNT 302
Query: 329 GPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS 374
+ ++ G + D L+ ++M+ RPS S L
Sbjct: 303 FDITVYLLQGRRLLQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSR 349
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 64/284 (22%), Positives = 119/284 (41%), Gaps = 36/284 (12%)
Query: 104 SISSTSIDHSR---YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANT 157
SI+S + + Y L + +G G+F +V + G A+K +T+ + T
Sbjct: 3 SIASCADEQPHIGNYRLL----KTIGKGNFAKVKLARHILTGREVAIKIIDKTQ--LNPT 56
Query: 158 AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEM 217
+ +K+ +E+ +L P+IV F + LYL +EY +GG + + + E
Sbjct: 57 SLQKL-FREVRIMKIL-NHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK 114
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI 277
+ Q+ ++ H+ R++H D+K N+L+ ++ K+ DFG
Sbjct: 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL------------DADMNIKIADFGFSN 162
Query: 278 ADNDFEVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--- 330
+ C Y EL + +VD+++LG+ LY SG LP +G
Sbjct: 163 EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS--LPFDGQNLK 220
Query: 331 -MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + G +S D L+K + +P KR + + +
Sbjct: 221 ELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 56/289 (19%), Positives = 102/289 (35%), Gaps = 47/289 (16%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKC-LKYMDG--MTYAVKRTKRPVANTAQEKIFKKE 166
I H R +G G FG V+ + A+K + + Q + F +E
Sbjct: 16 IPHERVVTHSDRV--IGKGHFGVVYHGEYIDQAQNRIQCAIK-SLSRITEMQQVEAFLRE 72
Query: 167 IHAHALLSRV--PHIVN-YFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQL 222
L+ + P+++ +G+ ++ L Y G+L I+ + T L
Sbjct: 73 G---LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN 280
QV+ G+ + E + +H D+ N ++ E K+ DFG I D
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCML------------DESFTVKVADFGLARDILDR 177
Query: 281 DFEVEEGDCRYL-------PKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNG 329
++ + + L F +K D+++ G+ L+E G P
Sbjct: 178 EYYSVQQHRHARLPVKWTALESLQTYRFT--TKSDVWSFGVLLWELLTRGAPPYRHIDPF 235
Query: 330 PMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS 374
+ H + G + D L+ ++M DP RP+ L
Sbjct: 236 DLTHFLAQGRRLPQPEYCPDSLY---QVMQQCWEADPAVRPTFRVLVGE 281
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 6e-18
Identities = 71/304 (23%), Positives = 123/304 (40%), Gaps = 66/304 (21%)
Query: 114 RYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R LEF + LGSG FG+V K + AVK + A++++ + E+
Sbjct: 44 RENLEFGKV--LGSGAFGKVMNATAYGISKTGVSIQVAVK-MLKEKADSSEREALMSELK 100
Query: 169 AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNL--------------------ENII 208
L +IVN + + G +YL EYC G+L + +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 209 QERCTFTEMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEK 265
+E + + LL +QV++G+ + +H D+ N+L+ T
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV------------THG 208
Query: 266 LHYKLGDFG--HVIADNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDIFALGLTLY 317
K+ DFG I + V G+ R LP K E L + K D+++ G+ L+
Sbjct: 209 KVVKICDFGLARDIMSDSNYVVRGNAR-LPVKWMAPESLFEGIYT--IKSDVWSYGILLW 265
Query: 318 EAS--GVTP---LPKNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPST 368
E GV P +P + + I++G ++ +++++ +M D KRPS
Sbjct: 266 EIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY---IIMQSCWAFDSRKRPSF 322
Query: 369 SSLR 372
+L
Sbjct: 323 PNLT 326
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 61/294 (20%), Positives = 109/294 (37%), Gaps = 63/294 (21%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK-------------------------RTKRPVANT 157
+ +G G +G V D YA+K
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 158 AQEKIFKKEIHAHALLSRVPHIVNYFSSWSD--QGVLYLQLEYCNGGNLENIIQERCTFT 215
E++ +EI L P++V D + LY+ E N G + + + +
Sbjct: 79 PIEQV-YQEIAILKKL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LS 135
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275
E + + +G+ +H ++IH DIKP+N+L+ E H K+ DFG
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV------------GEDGHIKIADFG- 182
Query: 276 VIADNDFEVEEGDCR-------YLPKELLNNNFDNLS--KVDIFALGLTLYE-ASGVTPL 325
N+F+ + ++ E L+ S +D++A+G+TLY G
Sbjct: 183 --VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ--C 238
Query: 326 PKNGP----MWHHIRDGNIE--KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
P + I+ +E ++++DL LI M+DK+P R ++
Sbjct: 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-18
Identities = 59/296 (19%), Positives = 101/296 (34%), Gaps = 59/296 (19%)
Query: 118 EFLEEEL-----LGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
F + L LG G FG+V G AVK + A +K+EI
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK-ALKADAGPQHRSGWKQEID 85
Query: 169 AHALLSRV--PHIVNYF--SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF 224
+L + HI+ Y + L L +EY G+L + + + L
Sbjct: 86 ---ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQ 141
Query: 225 QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND 281
Q+ EG+ +H IH D+ N+L+ K+GDFG V ++
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLL------------DNDRLVKIGDFGLAKAVPEGHE 189
Query: 282 FEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE----------------AS 320
+ D Y P+ L F D+++ G+TLYE
Sbjct: 190 YYRVREDGDSPVFWYAPECLKEYKFY--YASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 321 GVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + G + + +++ L+K + + + RP+ +L
Sbjct: 248 IGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 57/273 (20%), Positives = 92/273 (33%), Gaps = 55/273 (20%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL-----LSRVPH 178
++G G F EV G YA+K + + K+ + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNK-------WDMLKRGEVSCFREERDVLVNGDR 120
Query: 179 --IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHE 235
I ++ D+ LYL +EY GG+L ++ + L ++ + +H
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR----- 290
+ +H DIKP NIL+ G H +L DFG + +G R
Sbjct: 181 LGYVHRDIKPDNILL-DRCG-----------HIRLADFGSCLKLR----ADGTVRSLVAV 224
Query: 291 ----YLPKELLNNNFDNLSK------VDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRD 337
YL E+L D +ALG+ YE G TP + + I
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVH 284
Query: 338 GNIE-----KLSNVSDDLHTLIKLMIDKDPTKR 365
V ++ I+ ++ P R
Sbjct: 285 YKEHLSLPLVDEGVPEEARDFIQRLL-CPPETR 316
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 7e-18
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 37/271 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
I LE LG G FGEV+ + A+K K + E F +E
Sbjct: 181 IPRESLRLE----VKLGQGCFGEVWMG-TWNGTTRVAIKTLKP--GTMSPEA-FLQEAQV 232
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVS 227
L R +V ++ S++ + Y+ EY + G+L + ++ L + Q++
Sbjct: 233 MKKL-RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
G+ + M +H D++ ANIL+ E L K+ DFG +I DN++
Sbjct: 291 SGMAYVERMNYVHRDLRAANILV------------GENLVCKVADFGLARLIEDNEYTAR 338
Query: 286 EGD---CRYLPKELLN-NNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRD 337
+G ++ E F K D+++ G+ L E G P P N + +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFT--IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
G + + LH L+ K+P +RP+
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPT 427
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 7e-18
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 37/271 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
I LE LG G FGEV+ + A+K K + E F +E
Sbjct: 264 IPRESLRLE----VKLGQGCFGEVWMG-TWNGTTRVAIKTLKP--GTMSPEA-FLQEAQV 315
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVS 227
L R +V ++ S++ + Y+ EY + G+L + ++ L + Q++
Sbjct: 316 MKKL-RHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
G+ + M +H D++ ANIL+ E L K+ DFG +I DN++
Sbjct: 374 SGMAYVERMNYVHRDLRAANILV------------GENLVCKVADFGLARLIEDNEYTAR 421
Query: 286 EGD---CRYLPKELLN-NNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIRD 337
+G ++ E F K D+++ G+ L E G P P N + +
Sbjct: 422 QGAKFPIKWTAPEAALYGRFT--IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
G + + LH L+ K+P +RP+
Sbjct: 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPT 510
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 65/309 (21%), Positives = 127/309 (41%), Gaps = 59/309 (19%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R L+F + LG+G FG+V + K + AVK + A+ +++ E+
Sbjct: 45 RNNLQFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVK-MLKSTAHADEKEALMSELK 101
Query: 169 AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMA---------- 218
+ L + +IVN + + G + + EYC G+L N ++ + E
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTA 161
Query: 219 -LKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ LL QV++G+ + IH D+ N+L+ T K+GDFG
Sbjct: 162 STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL------------TNGHVAKIGDFG 209
Query: 275 --HVIADNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDIFALGLTLYEAS--GVTP 324
I ++ + +G+ R LP K E + + + + D+++ G+ L+E G+ P
Sbjct: 210 LARDIMNDSNYIVKGNAR-LPVKWMAPESIFDCVYT--VQSDVWSYGILLWEIFSLGLNP 266
Query: 325 ---LPKNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS--A 375
+ N + ++DG + + +++ +M +PT RP+ +
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIY---SIMQACWALEPTHRPTFQQICSFLQE 323
Query: 376 QLARNYPQL 384
Q + +
Sbjct: 324 QAQEDRRER 332
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 64/307 (20%), Positives = 116/307 (37%), Gaps = 62/307 (20%)
Query: 118 EFLEEEL-----LGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
+F E L LG G+FG V C L+ G AVK+ + ++ F++EI
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIE 63
Query: 169 AHALLSRV--PHIVNYF--SSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLL 223
+L + +IV Y + + L L +EY G+L + +Q+ + L Q
Sbjct: 64 ---ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADN 280
Q+ +G+ + R IH D+ NIL+ + K+GDFG + D
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILV------------ENENRVKIGDFGLTKVLPQDK 168
Query: 281 DFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE----------------- 318
+F + Y P+ L + F D+++ G+ LYE
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFS--VASDVWSFGVVLYELFTYIEKSKSPPAEFMR 226
Query: 319 ASGVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS- 374
G + +++ + + D+++ ++ + + +RPS L
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286
Query: 375 AQLARNY 381
Q+ N
Sbjct: 287 DQIRDNM 293
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 65/299 (21%), Positives = 123/299 (41%), Gaps = 60/299 (20%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R L+ + LG G FG+V + K T AVK + A ++ + E+
Sbjct: 26 RDRLKLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVK-MLKEGATHSEHRALMSELK 82
Query: 169 AHALLSRVPHIVNYFSSWSDQGV-LYLQLEYCNGGNL-------------ENIIQERCTF 214
+ ++VN + + G L + +E+C GNL + E
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 142
Query: 215 TEMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
+ L+ L+ FQV++G+ + + IH D+ NIL+ +EK K+
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL------------SEKNVVKIC 190
Query: 272 DFG--HVIADNDFEVEEGDCRYLP------KELLNNNFDNLSKVDIFALGLTLYEAS--G 321
DFG I + V +GD R LP + + + + S D+++ G+ L+E G
Sbjct: 191 DFGLARDIYKDPDYVRKGDAR-LPLKWMAPETIFDRVYTIQS--DVWSFGVLLWEIFSLG 247
Query: 322 VTP---LPKNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRR 373
+P + + +++G + + +++ + M+D +P++RP+ S L
Sbjct: 248 ASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY---QTMLDCWHGEPSQRPTFSELVE 303
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 70/295 (23%), Positives = 110/295 (37%), Gaps = 56/295 (18%)
Query: 118 EFLEEEL-----LGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
F E L LG G+FG V C L G AVK+ + + Q++ F++EI
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQ--HSGPDQQRDFQREIQ 76
Query: 169 AHALLSRVPHIVNYF--SSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQ 225
L IV Y S + L L +EY G L + +Q L Q
Sbjct: 77 ILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDF 282
+ +G+ + R +H D+ NIL+ + H K+ DFG + D D+
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILV------------ESEAHVKIADFGLAKLLPLDKDY 183
Query: 283 EVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE------------------A 319
V + Y P+ L +N F + D+++ G+ LYE
Sbjct: 184 YVVREPGQSPIFWYAPESLSDNIFS--RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241
Query: 320 SGVTPLPKNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+P + + +G + ++H L+KL P RPS S+L
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 46/268 (17%)
Query: 122 EELLGSGDFGEVFK-CLKYMDG--MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-- 176
+G G FG+V + + M A+K T + + + + F +E + +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK-TCKNCTSDSVREKFLQE---ALTMRQFDH 450
Query: 177 PHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGL 230
PHIV GV +++ +E C G L + +Q + + +L +Q+S L
Sbjct: 451 PHIVKLI------GVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGD 288
+ R +H DI N+L+ + KLGDFG + D+ +
Sbjct: 505 AYLESKRFVHRDIAARNVLV------------SSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 289 ---CRYLPKELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRDGNI 340
+++ E +N F S D++ G+ ++E GV P KN + I +G
Sbjct: 553 KLPIKWMAPESINFRRFT--SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 610
Query: 341 -EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
N L++L+ DP++RP
Sbjct: 611 LPMPPNCPPTLYSLMTKCWAYDPSRRPR 638
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 61/298 (20%), Positives = 113/298 (37%), Gaps = 61/298 (20%)
Query: 118 EFLEEEL-----LGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
+F E L LG G+FG V C L+ G AVK+ + ++ F++EI
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIE 94
Query: 169 AHALLSRV--PHIVNYF--SSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLL 223
+L + +IV Y + + L L +EY G+L + +Q+ + L Q
Sbjct: 95 ---ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 151
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADN 280
Q+ +G+ + R IH D+ NIL+ + K+GDFG + D
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILV------------ENENRVKIGDFGLTKVLPQDK 199
Query: 281 DFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE----------------- 318
++ + Y P+ L + F D+++ G+ LYE
Sbjct: 200 EYYKVKEPGESPIFWYAPESLTESKFS--VASDVWSFGVVLYELFTYIEKSKSPPAEFMR 257
Query: 319 ASGVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
G + +++ + + D+++ ++ + + +RPS L
Sbjct: 258 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 32/277 (11%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+ LG G +GEV + + AVK A E I KKEI + +L ++V
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKML-NHENVVK 69
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ + + YL LEYC+GG L + I+ E ++ Q+ G+ +H + + H
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD------C---RYL 292
DIKP N+L L+E N K+ DFG F + C Y+
Sbjct: 130 DIKPENLL-------LDERDNL-----KISDFG---LATVFRYNNRERLLNKMCGTLPYV 174
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTP---LPKNGPMWHHIRDGNIEKL--SNV 346
ELL + VD+++ G+ L +G P + + ++ +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
L+ ++ ++P+ R + +++ + +
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 57/287 (19%), Positives = 113/287 (39%), Gaps = 55/287 (19%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEI 167
+R + E LG G FG V++ +K A+K T A+ + F E
Sbjct: 23 AREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIK-TVNEAASMRERIEFLNEA 79
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-------CTFTEMA 218
+++ H+V S + +E G+L++ ++ +
Sbjct: 80 ---SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 219 LKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
L +++ ++++G+ ++ + +H D+ N ++ E K+GDFG
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV------------AEDFTVKIGDFGM 184
Query: 275 -HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS-GVTPLP 326
I + D+ + G R++ E L + F + D+++ G+ L+E A+ P
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT--TYSDVWSFGVVLWEIATLAEQPYQ 242
Query: 327 --KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS 367
N + + +G + +K N D L +LM +P RPS
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPDMLF---ELMRMCWQYNPKMRPS 286
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 50/303 (16%), Positives = 111/303 (36%), Gaps = 55/303 (18%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTY----AVKRTKRPVANTAQEKIFKK 165
+ ++LGSG FG V K + +G + +K + +
Sbjct: 10 FKETELRKL----KVLGSGVFGTVHKGVWIPEGESIKIPVCIK-VIEDKSGRQSFQAVTD 64
Query: 166 EIHAHALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERC-TFTEMAL 219
+ A L HIV G+ L L +Y G+L + +++ L
Sbjct: 65 HMLAIGSLDH-AHIVRLL------GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL 117
Query: 220 KQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVI 277
Q+++G+ + E M+H ++ N+L+ ++ DFG ++
Sbjct: 118 LNWGVQIAKGMYYLEEHGMVHRNLAARNVLL------------KSPSQVQVADFGVADLL 165
Query: 278 ADNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KN 328
+D ++ + + + + + + D+++ G+T++E G P +
Sbjct: 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYT--HQSDVWSYGVTVWELMTFGAEPYAGLRL 223
Query: 329 GPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS-AQLARNYPQ 383
+ + G + + + D++ +M+ D RP+ L ++AR+ P+
Sbjct: 224 AEVPDLLEKGERLAQPQICTIDVY---MVMVKCWMIDENIRPTFKELANEFTRMARDPPR 280
Query: 384 LKV 386
V
Sbjct: 281 YLV 283
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 57/297 (19%), Positives = 113/297 (38%), Gaps = 59/297 (19%)
Query: 118 EFLEEEL-----LGSGDFGEVFKC----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
F + L LG G FG+V C G AVK + +P + KKEI
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVK-SLKPESGGNHIADLKKEIE 75
Query: 169 AHALLSRV--PHIVNYFSSWSDQGV--LYLQLEYCNGGNLENIIQE-RCTFTEMALKQLL 223
+L + +IV Y ++ G + L +E+ G+L+ + + + +
Sbjct: 76 ---ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYA 132
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADN 280
Q+ +G+ + + +H D+ N+L+ + K+GDFG + D
Sbjct: 133 VQICKGMDYLGSRQYVHRDLAARNVLV------------ESEHQVKIGDFGLTKAIETDK 180
Query: 281 DFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYE----------ASGVTPL 325
++ + D Y P+ L+ + F D+++ G+TL+E +
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFY--IASDVWSFGVTLHELLTYCDSDSSPMALFLK 238
Query: 326 PKNGPMW--------HHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ +++G + N D+++ L++ + P+ R S +L
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 65/293 (22%), Positives = 126/293 (43%), Gaps = 60/293 (20%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-------KYMDGMTYAVKRTKRPVANTAQEKIFKKE 166
R L + LG G FG+V K + +T AVK + A E
Sbjct: 80 RDKLTLGKP--LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVSE 136
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT----------- 215
+ ++ + +I+N + + G LY+ +EY + GNL ++ R
Sbjct: 137 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 216 --EMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270
+M K L+ +Q++ G+ + + IH D+ N+L+ TE K+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------------TENNVMKI 244
Query: 271 GDFG--HVIADNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDIFALGLTLYEAS-- 320
DFG I + D+ + + R LP K E L + + + D+++ G+ ++E
Sbjct: 245 ADFGLARDINNIDYYKKTTNGR-LPVKWMAPEALFDRVYT--HQSDVWSFGVLMWEIFTL 301
Query: 321 GVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPS 367
G +P P ++ +++G+ ++K +N +++L+ +M D P++RP+
Sbjct: 302 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY---MMMRDCWHAVPSQRPT 351
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 68/322 (21%), Positives = 129/322 (40%), Gaps = 61/322 (18%)
Query: 93 GDDHHPVFDIKSISSTSIDHSRYALEFLE--------EELLGSGDFGEVFKC-LKYMDG- 142
G HH + + + LE + ++LG G+FG V + LK DG
Sbjct: 2 GSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 143 -MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVN-----YFSSWSDQGVLYL 194
+ AVK K ++ + + F E A + P+++ S +
Sbjct: 62 SLKVAVKTMKLDNSSQREIEEFLSEA---ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118
Query: 195 QLEYCNGGNLENIIQERCTFTE---MALKQLL---FQVSEGLRCMHEMRMIHMDIKPANI 248
L + G+L + T + L+ LL ++ G+ + +H D+ N
Sbjct: 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 249 LIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYLP-K----E-LLNNN 300
++ + + + DFG I D+ + + +P K E L +
Sbjct: 179 ML------------RDDMTVCVADFGLSKKIYSGDYYRQGRIAK-MPVKWIAIESLADRV 225
Query: 301 FDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIK 355
+ SK D++A G+T++E + G+TP P +N M+ ++ G+ +++ + D+L+ +
Sbjct: 226 YT--SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELY---E 280
Query: 356 LMID---KDPTKRPSTSSLRRS 374
+M DP RP+ S LR
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQ 302
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 72/300 (24%), Positives = 117/300 (39%), Gaps = 48/300 (16%)
Query: 88 IDEDSGDDHHPVFDIKSISSTSIDHSRYALE-FLEEELLGSGDFGEVFKCLKYMDGMTYA 146
I + + + S + + R L F +LG G FG+V + YA
Sbjct: 311 IGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYA 370
Query: 147 VKRTKRP-------VANTAQEK-IFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEY 198
VK K+ V T EK + AL + P + S + LY +EY
Sbjct: 371 VKILKKDVVIQDDDVECTMVEKRVL-------ALPGKPPFLTQLHSCFQTMDRLYFVMEY 423
Query: 199 CNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELN 258
NGG+L IQ+ F E +++ GL + +I+ D+K N+++ ++G
Sbjct: 424 VNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML-DSEG--- 479
Query: 259 EPMNTEKLHYKLGDFG---HVIADND----FEVEEGDC---RYLPKELLNNNFDNLSKVD 308
H K+ DFG I D F C Y+ E++ S VD
Sbjct: 480 --------HIKIADFGMCKENIWDGVTTKTF------CGTPDYIAPEIIAYQPYGKS-VD 524
Query: 309 IFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+A G+ LYE +G P ++ I + N+ ++S + + K ++ K P KR
Sbjct: 525 WWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 59/294 (20%), Positives = 113/294 (38%), Gaps = 54/294 (18%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKC-LKYMDG--MTYAVKRTKRPVANTAQEKIFKKEIHA 169
LG G+FG V + LK DG + AVK K + ++ + F +E
Sbjct: 21 PEQQFTLGRM--LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA-- 76
Query: 170 HALLSRV--PHIVNYF------SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTE---MA 218
A + PH+ + + + L + G+L + +
Sbjct: 77 -ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 219 LKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
L+ L+ ++ G+ + IH D+ N ++ E + + DFG
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML------------AEDMTVCVADFGL 183
Query: 275 -HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP 326
I D+ + ++L E L +N + D++A G+T++E G TP
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYT--VHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 327 --KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS 374
+N +++++ GN +++ ++++ LM DP +RPS + LR
Sbjct: 242 GIENAEIYNYLIGGNRLKQPPECMEEVY---DLMYQCWSADPKQRPSFTCLRME 292
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 66/300 (22%), Positives = 127/300 (42%), Gaps = 60/300 (20%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-------KYMDGMTYAVKRTKRPVANTAQEKIFKKE 166
R L + LG G FG+V K + +T AVK + A E
Sbjct: 34 RDKLTLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK-MLKDDATEKDLSDLVSE 90
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT----------- 215
+ ++ + +I+N + + G LY+ +EY + GNL ++ R
Sbjct: 91 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 216 --EMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270
+M K L+ +Q++ G+ + + IH D+ N+L+ TE K+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV------------TENNVMKI 198
Query: 271 GDFG--HVIADNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDIFALGLTLYEAS-- 320
DFG I + D+ + + R LP K E L + + + D+++ G+ ++E
Sbjct: 199 ADFGLARDINNIDYYKKTTNGR-LPVKWMAPEALFDRVYT--HQSDVWSFGVLMWEIFTL 255
Query: 321 GVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS 374
G +P P ++ +++G+ ++K +N +++L+ +M D P++RP+ L
Sbjct: 256 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY---MMMRDCWHAVPSQRPTFKQLVED 312
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 39/279 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
ID S + +GSG FG V +++ A+K + E+ F +E
Sbjct: 5 IDPSELTFV----QEIGSGQFGLVHLG-YWLNKDKVAIKTIR---EGAMSEEDFIEEA-- 54
Query: 170 HALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQV 226
++ ++ P +V + +Q + L E+ G L + ++ R F L + V
Sbjct: 55 -EVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 227 SEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEV 284
EG+ + E +IH D+ N L+ E K+ DFG + D+ +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLV------------GENQVIKVSDFGMTRFVLDDQYTS 161
Query: 285 EEGD---CRYLPKELLN-NNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWHHIR 336
G ++ E+ + + + SK D+++ G+ ++E + G P N + I
Sbjct: 162 STGTKFPVKWASPEVFSFSRYS--SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
Query: 337 DGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374
G + K S ++ ++ + P RP+ S L R
Sbjct: 220 TGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 47/263 (17%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-------VANTAQEK-IFKKEIHAHALLSR 175
+LG G FG+VF +A+K K+ V T EK + H
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE-H----- 77
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P + + F ++ + L+ +EY NGG+L IQ F ++ GL+ +H
Sbjct: 78 -PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 136
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGD 288
+++ D+K NIL+ G H K+ DFG + + F
Sbjct: 137 KGIVYRDLKLDNILL-DKDG-----------HIKIADFGMCKENMLGDAKTNTF------ 178
Query: 289 C---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEK 342
C Y+ E+L N S VD ++ G+ LYE G +P ++H IR N
Sbjct: 179 CGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY 237
Query: 343 LSNVSDDLHTLIKLMIDKDPTKR 365
+ + L+ + ++P KR
Sbjct: 238 PRWLEKEAKDLLVKLFVREPEKR 260
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 57/281 (20%), Positives = 115/281 (40%), Gaps = 45/281 (16%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++ + ++ LG G +GEV++ + +T AVK K +T + + F KE
Sbjct: 10 MERTDITMK----HKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAV 62
Query: 170 -----HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQL 222
H P++V + + Y+ E+ GNL + ++ R + + L +
Sbjct: 63 MKEIKH------PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN 280
Q+S + + + IH D+ N L+ E K+ DFG ++ +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLV------------GENHLVKVADFGLSRLMTGD 164
Query: 281 DFEVEEGD---CRYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMW 332
+ G ++ E L N F K D++A G+ L+E G++P P ++
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFS--IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222
Query: 333 HHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ +E+ + ++ L++ +P+ RPS + +
Sbjct: 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 58/304 (19%)
Query: 89 DEDSGDDHHPVFDIKSISSTSIDHSRYAL---EFLEEELLGSGDFGEVFKCLKYMDGMTY 145
+ + + P + I+ + FL+ ++G G FG+V + + Y
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK--VIGKGSFGKVLLARHKAEEVFY 66
Query: 146 AVK-------RTKRPVANTAQEK-IFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197
AVK K+ + E+ + K + H P +V S+ LY L+
Sbjct: 67 AVKVLQKKAILKKKEEKHIMSERNVLLKNVK-H------PFLVGLHFSFQTADKLYFVLD 119
Query: 198 YCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCMHEMRMIHMDIKPANILIVKAQ 254
Y NGG L +Q F E + F +E L +H + +++ D+KP NIL+ +Q
Sbjct: 120 YINGGELFYHLQRERCFLE---PRARFYAAEIASALGYLHSLNIVYRDLKPENILL-DSQ 175
Query: 255 GELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGDC---RYLPKELLNNNFDNL 304
G H L DFG I N F C YL E+L+ +
Sbjct: 176 G-----------HIVLTDFGLCKENIEHNSTTSTF------CGTPEYLAPEVLHKQPYDR 218
Query: 305 SKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKD 361
+ VD + LG LYE G+ P M+ +I + ++ N+++ L++ ++ KD
Sbjct: 219 T-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 362 PTKR 365
TKR
Sbjct: 278 RTKR 281
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 52/286 (18%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFK-CLKYMDGMTY--AVKRTKRPVANTAQEKIFKKE 166
I R L +G G FG+V + + A+K T + + + + F +E
Sbjct: 12 IQRERIELG----RCIGEGQFGDVHQGIYMSPENPALAVAIK-TCKNCTSDSVREKFLQE 66
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERC-TFTEMALK 220
PHIV GV +++ +E C G L + +Q R + +L
Sbjct: 67 ALTMRQF-DHPHIVKLI------GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLI 119
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIA 278
+Q+S L + R +H DI N+L+ + KLGDFG +
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLV------------SSNDCVKLGDFGLSRYME 167
Query: 279 DNDFEVEEGD---CRYLPKELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGP 330
D+ + +++ E +N F S D++ G+ ++E GV P KN
Sbjct: 168 DSTYYKASKGKLPIKWMAPESINFRRFT--SASDVWMFGVCMWEILMHGVKPFQGVKNND 225
Query: 331 MWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLR 372
+ I +G + N L+ LM DP++RP + L+
Sbjct: 226 VIGRIENGERLPMPPNCPPTLY---SLMTKCWAYDPSRRPRFTELK 268
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 48/263 (18%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-------VANTAQEK-IFKKEIHAHALLSR 175
LLG G FG+V + G YA+K ++ VA+T E + + H
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH------- 64
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P + ++ L +EY NGG L + FTE + ++ L +H
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGD 288
+++ DIK N+++ G H K+ DFG I+D F
Sbjct: 124 RDVVYRDIKLENLML-DKDG-----------HIKITDFGLCKEGISDGATMKTF------ 165
Query: 289 C---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEK 342
C YL E+L +N + VD + LG+ +YE G P ++ I I
Sbjct: 166 CGTPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF 224
Query: 343 LSNVSDDLHTLIKLMIDKDPTKR 365
+S + +L+ ++ KDP +R
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQR 247
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 61/284 (21%), Positives = 105/284 (36%), Gaps = 49/284 (17%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKC-LKYMDGMTY----AVKRTKRPVANTAQEKIFKKEI 167
R + + LG G FGEV++ + M AVK T V + E F E
Sbjct: 28 PRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLMEA 84
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLEN-------IIQERCTFTEMA 218
++S+ +IV ++ +E GG+L++ + + +
Sbjct: 85 ---LIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HV 276
L + ++ G + + E IH DI N L + G K+GDFG
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCL-LTCPG--------PGRVAKIGDFGMARD 192
Query: 277 IADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS-GVTPLP--K 327
I + + G +++P E + F SK D ++ G+ L+E S G P P
Sbjct: 193 IYRASYYRKGGCAMLPVKWMPPEAFMEGIFT--SKTDTWSFGVLLWEIFSLGYMPYPSKS 250
Query: 328 NGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS 367
N + + G + N ++ ++M P RP+
Sbjct: 251 NQEVLEFVTSGGRMDPPKNCPGPVY---RIMTQCWQHQPEDRPN 291
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 60/323 (18%), Positives = 123/323 (38%), Gaps = 53/323 (16%)
Query: 117 LEFLEE------ELLGSGDFGEVFKCLKYMDGMTY----AVKRTKRPVANTAQEKIFKKE 166
L L+E ++LGSG FG V+K L +G A+K R + K E
Sbjct: 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-ELREATSPKANKEILDE 67
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERC-TFTEMALK 220
+ A + PH+ G+ + L + G L + ++E L
Sbjct: 68 AYVMASVDN-PHVCRLL------GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLL 120
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIA 278
Q+++G+ + + R++H D+ N+L+ H K+ DFG ++
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLV------------KTPQHVKITDFGLAKLLG 168
Query: 279 DNDFEVEEGDCR-----YLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNG 329
+ E + + +L+ + + D+++ G+T++E G P
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESILHRIYT--HQSDVWSYGVTVWELMTFGSKPYDGIPAS 226
Query: 330 PMWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS-AQLARNYPQLKVE 387
+ + G + + + D++ ++ D RP L +++AR+ + V
Sbjct: 227 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV- 285
Query: 388 NIRGNLNTRLKKLDEGNVFDGII 410
I+G+ L + N + ++
Sbjct: 286 -IQGDERMHLPSPTDSNFYRALM 307
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 22/270 (8%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIHAHALLSRVPHIV 180
+ LG G FG+V + G AVK ++ + + K+EI L R PHI+
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHII 74
Query: 181 NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
+ S ++ +EY +GG L + I + EM ++L Q+ + H ++H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVH 134
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDF-EVEEGDCRYLPKELL 297
D+KP N+L+ ++ K+ DFG ++++D +F G Y E++
Sbjct: 135 RDLKPENVLL------------DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182
Query: 298 NNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP----MWHHIRDGNIEKLSNVSDDLHTL 353
+ +VDI++ G+ LY A LP + ++ IR G ++ + TL
Sbjct: 183 SGRLYAGPEVDIWSCGVILY-ALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATL 241
Query: 354 IKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
+ M+ DP KR + +R ++ P
Sbjct: 242 LMHMLQVDPLKRATIKDIREHEWFKQDLPS 271
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 55/305 (18%)
Query: 83 PSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDG 142
++SG + V K +++ E+L+ LLG G FG+V + G
Sbjct: 120 FRSGSPSDNSGAEEMEVSLAKPKHRVTMNE----FEYLK--LLGKGTFGKVILVKEKATG 173
Query: 143 MTYAVKRTKRP-------VANTAQEK-IFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194
YA+K K+ VA+T E + + H P + S+ L
Sbjct: 174 RYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH--------PFLTALKYSFQTHDRLCF 225
Query: 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR-MIHMDIKPANILIVKA 253
+EY NGG L + F+E + ++ L +H + +++ D+K N+++
Sbjct: 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML-DK 284
Query: 254 QGELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGDC---RYLPKELLNNNFDN 303
G H K+ DFG I D F C YL E+L +N
Sbjct: 285 DG-----------HIKITDFGLCKEGIKDGATMKTF------CGTPEYLAPEVLEDNDYG 327
Query: 304 LSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLHTLIKLMIDK 360
+ VD + LG+ +YE G P ++ I I + + +L+ ++ K
Sbjct: 328 RA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKK 386
Query: 361 DPTKR 365
DP +R
Sbjct: 387 DPKQR 391
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 73/320 (22%), Positives = 127/320 (39%), Gaps = 67/320 (20%)
Query: 83 PSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYAL---EFLEEELLGSGDFGEVFKCLKY 139
S D G+ V ++ + + + E L+ +LG+G +G+VF K
Sbjct: 19 AGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK--VLGTGAYGKVFLVRKI 76
Query: 140 MDGMT---YAVK--------RTKRPVANTAQEK-IFKKEIHAHALLSRVPHIVNYFSSWS 187
T YA+K + + +T E+ + + + P +V ++
Sbjct: 77 SGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL-------EHIRQSPFLVTLHYAFQ 129
Query: 188 DQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE---GLRCMHEMRMIHMDIK 244
+ L+L L+Y NGG L + +R FTE ++ V E L +H++ +I+ DIK
Sbjct: 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQ---IYVGEIVLALEHLHKLGIIYRDIK 186
Query: 245 PANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADND----FEVEEGDC---RYLP 293
NIL+ + G H L DFG V + + F C Y+
Sbjct: 187 LENILL-DSNG-----------HVVLTDFGLSKEFVADETERAYDF------CGTIEYMA 228
Query: 294 KELLNNNFDNLSK-VDIFALGLTLYE-ASGVTPLPKNGP------MWHHIRDGNIEKLSN 345
+++ K VD ++LG+ +YE +G +P +G + I
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE 288
Query: 346 VSDDLHTLIKLMIDKDPTKR 365
+S LI+ ++ KDP KR
Sbjct: 289 MSALAKDLIQRLLMKDPKKR 308
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 60/276 (21%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMT---YAVK--------RTKRPVANTAQEK-IFKK 165
E L +LG G +G+VF+ K T +A+K R + A+T E+ I ++
Sbjct: 20 ELLR--VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 166 EIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQ 225
H P IV+ ++ G LYL LEY +GG L ++ F E F
Sbjct: 78 VKH--------PFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTAC---FY 126
Query: 226 VSE---GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIAD 279
++E L +H+ +I+ D+KP NI++ QG H KL DFG I D
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIML-NHQG-----------HVKLTDFGLCKESIHD 174
Query: 280 ND----FEVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP- 330
F C Y+ E+L + N + VD ++LG +Y+ +G P
Sbjct: 175 GTVTHTF------CGTIEYMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRK 227
Query: 331 -MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
I + ++ + L+K ++ ++ R
Sbjct: 228 KTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 47/277 (16%)
Query: 120 LEEELLGSGDFGEVFK-CLKYMDGMTY-AVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
LE++ LGSG+FG V K + + AVK K + A + E + L P
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP 78
Query: 178 HIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRC 232
+IV G+ L +E G L +Q+ + + +L+ QVS G++
Sbjct: 79 YIVRMI------GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDC 289
+ E +H D+ N+L+V + + K+ DFG + AD ++ +
Sbjct: 133 LEESNFVHRDLAARNVLLV------------TQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 290 R-----YLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRDGN- 339
+ Y P+ + F SK D+++ G+ ++EA G P K + + G
Sbjct: 181 KWPVKWYAPECINYYKFS--SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 238
Query: 340 IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRR 373
+ + +++ LM D RP +++
Sbjct: 239 MGCPAGCPREMY---DLMNLCWTYDVENRPGFAAVEL 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 67/263 (25%), Positives = 107/263 (40%), Gaps = 47/263 (17%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-------VANTAQEK-IFKKEIHAHALLSR 175
+LG G FG+V + YAVK K+ V T EK + AL +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL-------ALPGK 79
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P + S + LY +EY NGG+L IQ+ F E +++ GL +
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS 139
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGD 288
+I+ D+K N+++ ++G H K+ DFG I D F
Sbjct: 140 KGIIYRDLKLDNVML-DSEG-----------HIKIADFGMCKENIWDGVTTKTF------ 181
Query: 289 C---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEK 342
C Y+ E++ S VD +A G+ LYE +G P ++ I + N+
Sbjct: 182 CGTPDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY 240
Query: 343 LSNVSDDLHTLIKLMIDKDPTKR 365
++S + + K ++ K P KR
Sbjct: 241 PKSMSKEAVAICKGLMTKHPGKR 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 5e-16
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
+ L + LGSG FG V K+ AVK K + E F +E
Sbjct: 5 LKREEITLL----KELGSGQFGVVKLG-KWKGQYDVAVKMIK---EGSMSEDEFFQEAQT 56
Query: 170 -----HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLL 223
H P +V ++ S + +Y+ EY + G L N ++ L ++
Sbjct: 57 MMKLSH------PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADND 281
+ V EG+ + + IH D+ N L+ L K+ DFG + D+
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLV------------DRDLCVKVSDFGMTRYVLDDQ 158
Query: 282 FEVEEGD---CRYLPKELLN-NNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWH 333
+ G ++ E+ + + SK D++A G+ ++E + G P N +
Sbjct: 159 YVSSVGTKFPVKWSAPEVFHYFKYS--SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216
Query: 334 HIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPS 367
+ G+ + + SD ++ ++M + P KRP+
Sbjct: 217 KVSQGHRLYRPHLASDTIY---QIMYSCWHELPEKRPT 251
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 60/278 (21%), Positives = 108/278 (38%), Gaps = 51/278 (18%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
ID + LG+G FG V K+ A+K + + + E F +E
Sbjct: 21 IDPKDLTFL----KELGTGQFGVVKYG-KWRGQYDVAIK-MIKEGSMSEDE--FIEEAKV 72
Query: 170 -----HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLL 223
H +V + + Q +++ EY G L N ++E R F L ++
Sbjct: 73 MMNLSH------EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADND 281
V E + + + +H D+ N L+ ++ K+ DFG + D++
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLV------------NDQGVVKVSDFGLSRYVLDDE 174
Query: 282 FEVEEGD---CRYLPKE-LLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWH 333
+ G R+ P E L+ + F SK DI+A G+ ++E + G P N
Sbjct: 175 YTSSVGSKFPVRWSPPEVLMYSKFS--SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232
Query: 334 HIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPS 367
HI G + + S+ ++ +M + +RP+
Sbjct: 233 HIAQGLRLYRPHLASEKVY---TIMYSCWHEKADERPT 267
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-16
Identities = 66/272 (24%), Positives = 111/272 (40%), Gaps = 54/272 (19%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMT---YAVKRTKRPVANTAQEKIFKKEIHAHA--- 171
E L+ +LG G FG+VF K YA+K K+ + +
Sbjct: 27 ELLK--VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL------KVRDRVRTKMERD 78
Query: 172 LLSRVPH--IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE- 228
+L V H IV ++ +G LYL L++ GG+L + + FTE +K F ++E
Sbjct: 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK---FYLAEL 135
Query: 229 --GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND-- 281
L +H + +I+ D+KP NIL+ +G H KL DFG I
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILL-DEEG-----------HIKLTDFGLSKESIDHEKKA 183
Query: 282 --FEVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWH 333
F C Y+ E++N S D ++ G+ ++E +G P
Sbjct: 184 YSF------CGTVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236
Query: 334 HIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
I + +S + +L++++ ++P R
Sbjct: 237 MILKAKLGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-16
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 32/277 (11%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+ LG G +GEV + + AVK A E I KKEI + +L ++V
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKML-NHENVVK 69
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ + + YL LEYC+GG L + I+ E ++ Q+ G+ +H + + H
Sbjct: 70 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGD------C---RYL 292
DIKP N+L L+E N K+ DFG F + C Y+
Sbjct: 130 DIKPENLL-------LDERDNL-----KISDFG---LATVFRYNNRERLLNKMCGTLPYV 174
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTP---LPKNGPMWHHIRDGNIEKL--SNV 346
ELL + VD+++ G+ L +G P + + ++ +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
L+ ++ ++P+ R + +++ + +
Sbjct: 235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 63/284 (22%), Positives = 108/284 (38%), Gaps = 49/284 (17%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKC-LKYMDG----MTYAVKRTKRPVANTAQEKIFKKEI 167
R + + LG G FGEV++ + M + AVK T V + E F E
Sbjct: 69 PRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVK-TLPEVCSEQDELDFLMEA 125
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-------TFTEMA 218
++S+ +IV ++ LE GG+L++ ++E + +
Sbjct: 126 ---LIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HV 276
L + ++ G + + E IH DI N L + G K+GDFG
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCL-LTCPG--------PGRVAKIGDFGMARD 233
Query: 277 IADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS-GVTPLP--K 327
I + + G +++P E + F SK D ++ G+ L+E S G P P
Sbjct: 234 IYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT--SKTDTWSFGVLLWEIFSLGYMPYPSKS 291
Query: 328 NGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS 367
N + + G + N ++ ++M P RP+
Sbjct: 292 NQEVLEFVTSGGRMDPPKNCPGPVY---RIMTQCWQHQPEDRPN 332
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 68/269 (25%), Positives = 109/269 (40%), Gaps = 49/269 (18%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-------VANTAQEK-IFKKEIHA 169
EF+ +LG G FG+V G YAVK K+ V T EK I
Sbjct: 26 EFIR--VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRIL------ 77
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEG 229
+L P + F + L+ +E+ NGG+L IQ+ F E + ++
Sbjct: 78 -SLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISA 136
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND----F 282
L +H+ +I+ D+K N+L+ +G H KL DFG I + F
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLL-DHEG-----------HCKLADFGMCKEGICNGVTTATF 184
Query: 283 EVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIR 336
C Y+ E+L + VD +A+G+ LYE G P ++ I
Sbjct: 185 ------CGTPDYIAPEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237
Query: 337 DGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
+ + + + +D ++K + K+PT R
Sbjct: 238 NDEVVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 68/300 (22%), Positives = 124/300 (41%), Gaps = 60/300 (20%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-------KYMDGMTYAVKRTKRPVANTAQEKIFKKE 166
R L + LG G FG+V K AVK + A E
Sbjct: 68 RDRLVLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK-MLKSDATEKDLSDLISE 124
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT----------- 215
+ ++ + +I+N + + G LY+ +EY + GNL +Q R
Sbjct: 125 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 216 --EMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270
+++ K L+ +QV+ G+ + + IH D+ N+L+ TE K+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV------------TEDNVMKI 232
Query: 271 GDFG--HVIADNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDIFALGLTLYE-AS- 320
DFG I D+ + + R LP K E L + + + D+++ G+ L+E +
Sbjct: 233 ADFGLARDIHHIDYYKKTTNGR-LPVKWMAPEALFDRIYT--HQSDVWSFGVLLWEIFTL 289
Query: 321 GVTPLP--KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS 374
G +P P ++ +++G+ +K SN +++L+ +M D P++RP+ L
Sbjct: 290 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELY---MMMRDCWHAVPSQRPTFKQLVED 346
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 62/293 (21%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEI 167
R + E LG G FG+VF D M AVK K A K F++E
Sbjct: 13 KRRDIVLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREA 68
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL----------------ENIIQ 209
LL+ + HIV ++ D L + EY G+L Q
Sbjct: 69 E---LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 210 ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269
+ + + Q++ G+ + +H D+ N L+ L K
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV------------GANLLVK 173
Query: 270 LGDFG--HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS- 320
+GDFG + D+ G R++P E ++ F ++ D+++ G+ L+E +
Sbjct: 174 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT--TESDVWSFGVILWEIFTY 231
Query: 321 GVTPLP--KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS 367
G P N + I G + E+ +++ +M+ ++P +R +
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY---DVMLGCWQREPQQRLN 281
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 56/272 (20%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVK-------RTKRPVANTAQEK-IFKKEIHAHALLSR 175
++G G + +V YA+K + EK +F S
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF-------EQASN 68
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P +V S + + L+ +EY NGG+L +Q + E + ++S L +HE
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 128
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGD 288
+I+ D+K N+L+ ++G H KL D+G + D F
Sbjct: 129 RGIIYRDLKLDNVLL-DSEG-----------HIKLTDYGMCKEGLRPGDTTSTF------ 170
Query: 289 C---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP-----------MWH 333
C Y+ E+L S VD +ALG+ ++E +G +P G ++
Sbjct: 171 CGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229
Query: 334 HIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
I + I ++S +++K ++KDP +R
Sbjct: 230 VILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 1e-15
Identities = 64/293 (21%), Positives = 104/293 (35%), Gaps = 71/293 (24%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-----VANTAQEKI-FKKEIHAHALLSRV 176
+G G +G VFKC G A+K+ + A +I K++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-H------ 61
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSEGLRCMHE 235
P++VN + + L+L EYC+ + + + E +K + +Q + + H+
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDF--------- 282
IH D+KP NILI K + KL DFG + +
Sbjct: 121 HNCIHRDVKPENILITK-HSVI-----------KLCDFGFARLLTGPSDYYDDEVATRWY 168
Query: 283 ---EVEEGDCRYLPK-----------ELLN--------NNFDNLSKVDIF-ALGLTLYEA 319
E+ GD +Y P ELL+ ++ D L I LG L
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL--IRKTLG-DLIPR 225
Query: 320 S--GVTPLP--KNGPMWHHIRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPS 367
+ + +E N+S L+K + DPT+R +
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 66/307 (21%), Positives = 112/307 (36%), Gaps = 50/307 (16%)
Query: 91 DSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFK-CLKYMDGMTY-AVK 148
D+ P D + + + R L + EL G G+FG V + + A+K
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIK 369
Query: 149 RTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGN 203
+ A + +E L P+IV GV L L +E GG
Sbjct: 370 -VLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLI------GVCQAEALMLVMEMAGGGP 421
Query: 204 LENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMN 262
L + + + +LL QVS G++ + E +H ++ N+L+V
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV----------- 470
Query: 263 TEKLHYKLGDFG--HVIADNDFEVEEGDCRYLP-----KELLN-NNFDNLSKVDIFALGL 314
+ + K+ DFG + +D P E +N F S+ D+++ G+
Sbjct: 471 -NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS--SRSDVWSYGV 527
Query: 315 TLYEAS--GVTPLP--KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRP 366
T++EA G P K + I G +E +L+ LM D RP
Sbjct: 528 TMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY---ALMSDCWIYKWEDRP 584
Query: 367 STSSLRR 373
++ +
Sbjct: 585 DFLTVEQ 591
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 1e-15
Identities = 60/293 (20%), Positives = 114/293 (38%), Gaps = 61/293 (20%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEI 167
S A+ F+EE LG FG+V+K A+K T + A + F+ E
Sbjct: 7 SLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIK-TLKDKAEGPLREEFRHEA 63
Query: 168 HAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL----------------ENIIQ 209
L +R+ P++V + L + YC+ G+L ++
Sbjct: 64 ---MLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 210 ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269
+ L+ Q++ G+ + ++H D+ N+L+ +KL+ K
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV------------YDKLNVK 168
Query: 270 LGDFG--HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS- 320
+ D G + D+ G+ R++ E ++ F DI++ G+ L+E S
Sbjct: 169 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS--IDSDIWSYGVVLWEVFSY 226
Query: 321 GVTPLP--KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS 367
G+ P N + IR+ + + ++ LMI+ + P++RP
Sbjct: 227 GLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVY---ALMIECWNEFPSRRPR 276
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 64/289 (22%), Positives = 105/289 (36%), Gaps = 40/289 (13%)
Query: 111 DHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEI 167
D RY + +GSG+FG + AVK R E + ++EI
Sbjct: 18 DSDRYDFV----KDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENV-QREI 67
Query: 168 HAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVS 227
H L R P+IV + L + +EY +GG L I F+E + Q+
Sbjct: 68 INHRSL-RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEV 284
G+ H M++ H D+K N L+ + + K+ DFG + + +
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLL-----DGSPAPRL-----KICDFGYSKSSVLHSQPKS 176
Query: 285 EEGDCRYLPKELLNNNFDNLSKVDIFALGLTLY---------EASGVTPLPKNGPMWHHI 335
G Y+ E+L + D+++ G+TLY E + I
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRI 234
Query: 336 RDGN--IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
I +S + LI + DP R S ++ + +N P
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 62/295 (21%), Positives = 97/295 (32%), Gaps = 75/295 (25%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-----VANTAQ-E-KIFKKEIHAHALLSR 175
L+G G +G V KC G A+K+ V A E K+ K+ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH------- 83
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSEGLRCMH 234
++VN + YL E+ + + + ++ +++ LFQ+ G+ H
Sbjct: 84 -ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDF-------- 282
+IH DIKP NIL+ + G + KL DFG +
Sbjct: 142 SHNIIHRDIKPENILVSQ-SGVV-----------KLCDFGFARTLAAPGEVYDDEVATRW 189
Query: 283 ----EVEEGDCRYLPK-----------ELLN--------NNFDNLSKVDIF-ALGLTLYE 318
E+ GD +Y E+ ++ D L I LG L
Sbjct: 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYH--IMMCLG-NLIP 246
Query: 319 AS--GVTPLP----KNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
P P + +S+ + L K + DP KRP
Sbjct: 247 RHQELFNKNPVFAGVRLPEIKEREPLE-RRYPKLSEVVIDLAKKCLHIDPDKRPF 300
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 68/283 (24%), Positives = 114/283 (40%), Gaps = 51/283 (18%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
+ L E LG+G FGEV+ Y AVK K + F E +
Sbjct: 10 VPRETLKLV----ERLGAGQFGEVWMG-YYNGHTKVAVKSLK---QGSMSPDAFLAEANL 61
Query: 170 HALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQ--ERCTFTEMALKQL 222
L + +V + V +Y+ EY G+L + ++ T L +
Sbjct: 62 MKQL-QHQRLVRLY------AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN 280
Q++EG+ + E IH D++ ANIL+ ++ L K+ DFG +I DN
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILV------------SDTLSCKIADFGLARLIEDN 162
Query: 281 DFEVEEGDCRYL------PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP--KNGP 330
++ EG P+ + F K D+++ G+ L E G P P N
Sbjct: 163 EYTAREG--AKFPIKWTAPEAINYGTFT--IKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218
Query: 331 MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ ++ G + + N ++L+ L++L + P RP+ LR
Sbjct: 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 65/298 (21%), Positives = 121/298 (40%), Gaps = 44/298 (14%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFK-CLKYMDGMTY--AVKRTKRPVANTAQEKIFKKE 166
+D + +++ +++G+G+FGEV LK A+K T + Q + F E
Sbjct: 42 LDATNISID----KVVGAGEFGEVCSGRLKLPSKKEISVAIK-TLKVGYTEKQRRDFLGE 96
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQ 225
P+I+ + + + EY G+L++ +++ FT + L +L
Sbjct: 97 ASIMGQF-DHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRG 155
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADNDFE 283
++ G++ + +M +H D+ NILI L K+ DFG V+ D+
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILI------------NSNLVCKVSDFGLGRVLEDDPEA 203
Query: 284 VEEGDCRYLP-K----ELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWH 333
+P + E + F S D+++ G+ L+E G P N +
Sbjct: 204 AYTTRGGKIPIRWTSPEAIAYRKFT--SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIK 261
Query: 334 HIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLRRS-AQLARNYPQLKV 386
+ +G + + L+ +LM+D KD RP + +L RN LK+
Sbjct: 262 AVDEGYRLPPPMDCPAALY---QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 60/272 (22%), Positives = 108/272 (39%), Gaps = 56/272 (20%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVK-------RTKRPVANTAQEK-IFKKEIHAHALLSR 175
++G G + +V YA++ + EK +F S
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVF-------EQASN 111
Query: 176 VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
P +V S + + L+ +EY NGG+L +Q + E + ++S L +HE
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 171
Query: 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADND----FEVEEGD 288
+I+ D+K N+L+ ++G H KL D+G + D F
Sbjct: 172 RGIIYRDLKLDNVLL-DSEG-----------HIKLTDYGMCKEGLRPGDTTSTF------ 213
Query: 289 C---RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP-----------MWH 333
C Y+ E+L S VD +ALG+ ++E +G +P G ++
Sbjct: 214 CGTPNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272
Query: 334 HIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKR 365
I + I ++S +++K ++KDP +R
Sbjct: 273 VILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 64/271 (23%), Positives = 113/271 (41%), Gaps = 37/271 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
I LE + LG+G FGEV+ Y AVK K + + F E +
Sbjct: 185 IPRESLKLE----KKLGAGQFGEVWMA-TYNKHTKVAVKTMK---PGSMSVEAFLAEANV 236
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQLLFQVS 227
L + +V + + + + Y+ E+ G+L + ++ E L Q++
Sbjct: 237 MKTL-QHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
EG+ + + IH D++ ANIL+ + L K+ DFG VI DN++
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILV------------SASLVCKIADFGLARVIEDNEYTAR 342
Query: 286 EGDC---RYLPKELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRD 337
EG ++ E +N +F K D+++ G+ L E G P P N + +
Sbjct: 343 EGAKFPIKWTAPEAINFGSFT--IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
G + + N ++L+ ++ P +RP+
Sbjct: 401 GYRMPRPENCPEELYNIMMRCWKNRPEERPT 431
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 61/291 (20%)
Query: 114 RYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R + E LG G FG+VF L D M AVK K A+ + + F++E
Sbjct: 40 RRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQREA- 94
Query: 169 AHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL---------------ENIIQER 211
LL+ + HIV +F ++ L + EY G+L
Sbjct: 95 --ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 212 CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
L + QV+ G+ + + +H D+ N L+ + L K+G
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV------------GQGLVVKIG 200
Query: 272 DFG--HVIADNDFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS-GV 322
DFG I D+ G R++P E +L F ++ D+++ G+ L+E + G
Sbjct: 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT--TESDVWSFGVVLWEIFTYGK 258
Query: 323 TPLP--KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS 367
P N I G E+ +++ +M ++P +R S
Sbjct: 259 QPWYQLSNTEAIDCITQGRELERPRACPPEVY---AIMRGCWQREPQQRHS 306
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-15
Identities = 79/361 (21%), Positives = 137/361 (37%), Gaps = 80/361 (22%)
Query: 78 TLATLPSGSVIDEDSGDDHHPVFDIKSISSTSIDH----SRYALEFLEEELLGSGDFGEV 133
TL TLPS ++D + P++ + R +E++ + +G G FG V
Sbjct: 9 TLTTLPSELLLDRLHPN---PMYQRMPLLLNPKLLSLEYPRNNIEYVRD--IGEGAFGRV 63
Query: 134 FKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSW 186
F+ L Y AVK + A+ + F++E AL++ P+IV
Sbjct: 64 FQARAPGLLPYEPFTMVAVK-MLKEEASADMQADFQREA---ALMAEFDNPNIVKLLGVC 119
Query: 187 SDQGVLYLQLEYCNGGNL------------------------ENIIQERCTFTEMALKQL 222
+ + L EY G+L + +
Sbjct: 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADN 280
QV+ G+ + E + +H D+ N L+ E + K+ DFG I
Sbjct: 180 ARQVAAGMAYLSERKFVHRDLATRNCLV------------GENMVVKIADFGLSRNIYSA 227
Query: 281 DFEVEEGDC----RYLPKE-LLNNNFDNLSKVDIFALGLTLYE-AS-GVTPLP--KNGPM 331
D+ +G+ R++P E + N + ++ D++A G+ L+E S G+ P + +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYT--TESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 285
Query: 332 WHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRPS----TSSLRRSAQLARNYPQ 383
+++RDGNI N +L+ LM K P RPS L+R + A
Sbjct: 286 IYYVRDGNILACPENCPLELY---NLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVG 342
Query: 384 L 384
+
Sbjct: 343 V 343
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 63/283 (22%), Positives = 110/283 (38%), Gaps = 43/283 (15%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFK-CLKYMDGMTY--AVKRTKRPVANTAQEKIFKKE 166
I+ SR +E +++GSGD GEV L+ A+K + Q + F E
Sbjct: 46 IEASRIHIE----KIIGSGDSGEVCYGRLRVPGQRDVPVAIK-ALKAGYTERQRRDFLSE 100
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQ 225
P+I+ + + + EY G+L+ ++ FT M L +L
Sbjct: 101 ASIMGQFDH-PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADNDFE 283
V G+R + ++ +H D+ N+L+ L K+ DFG V+ D+
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLV------------DSNLVCKVSDFGLSRVLEDDPDA 207
Query: 284 VEEGDCRYLP-K----ELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWH 333
+P + E + F S D+++ G+ ++E G P N +
Sbjct: 208 AYTTTGGKIPIRWTAPEAIAFRTFS--SASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS 265
Query: 334 HIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLR 372
+ +G + LH +LM+D KD +RP S +
Sbjct: 266 SVEEGYRLPAPMGCPHALH---QLMLDCWHKDRAQRPRFSQIV 305
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 3e-15
Identities = 59/286 (20%), Positives = 100/286 (34%), Gaps = 62/286 (21%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFK-CLKYMDGMTY--AVKRTKRPVANTAQEKIFKKE 166
I L +LG G FGEV++ G AVK T + ++ F E
Sbjct: 9 IAREDVVLN----RILGEGFFGEVYEGVYTNHKGEKINVAVK-TCKKDCTLDNKEKFMSE 63
Query: 167 IHA-----HALLSRVPHIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQE-RCTFT 215
H PHIV G+ ++ +E G L + ++ + +
Sbjct: 64 AVIMKNLDH------PHIVKLI------GIIEEEPTWIIMELYPYGELGHYLERNKNSLK 111
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG- 274
+ L Q+ + + + + +H DI NIL+ KLGDFG
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV------------ASPECVKLGDFGL 159
Query: 275 -HVIADNDFEVEEGD---CRYLPKELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP- 326
I D D+ +++ E +N F + D++ + ++E G P
Sbjct: 160 SRYIEDEDYYKASVTRLPIKWMSPESINFRRFT--TASDVWMFAVCMWEILSFGKQPFFW 217
Query: 327 -KNGPMWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPS 367
+N + + G+ + K L+ LM DP+ RP
Sbjct: 218 LENKDVIGVLEKGDRLPKPDLCPPVLY---TLMTRCWDYDPSDRPR 260
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-15
Identities = 73/313 (23%), Positives = 124/313 (39%), Gaps = 58/313 (18%)
Query: 95 DHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDG--MTYAVKRTKR 152
HH + +D + + +++G G+FG+V K DG M A+KR K
Sbjct: 7 HHHGKNNPDPTIYPVLDWNDIKFQ----DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK- 61
Query: 153 PVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNL-------- 204
A+ + F E+ L P+I+N + +G LYL +EY GNL
Sbjct: 62 EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 205 --------ENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE 256
T + L V+ G+ + + + IH D+ NIL+
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV------ 175
Query: 257 LNEPMNTEKLHYKLGDFGHVIA-DNDFEVEEGDCRYLP-K----E-LLNNNFDNLSKVDI 309
E K+ DFG ++ + V++ R LP + E L + + + D+
Sbjct: 176 ------GENYVAKIADFG--LSRGQEVYVKKTMGR-LPVRWMAIESLNYSVYT--TNSDV 224
Query: 310 FALGLTLYE-AS-GVTPLP--KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KD 361
++ G+ L+E S G TP ++ + G EK N D+++ LM +
Sbjct: 225 WSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY---DLMRQCWREK 281
Query: 362 PTKRPSTSSLRRS 374
P +RPS + + S
Sbjct: 282 PYERPSFAQILVS 294
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 60/277 (21%), Positives = 101/277 (36%), Gaps = 49/277 (17%)
Query: 120 LEEELLGSGDFGEVFK-CLKYMDGMTY-AVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
+ + LG G+FG V + + A+K + A + +E L P
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIK-VLKQGTEKADTEEMMREAQIMHQL-DNP 70
Query: 178 HIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLR 231
+IV GV L L +E GG L + + + +LL QVS G++
Sbjct: 71 YIVRLI------GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDC 289
+ E +H D+ N+L+ + + K+ DFG + +D
Sbjct: 125 YLEEKNFVHRDLAARNVLL------------VNRHYAKISDFGLSKALGADDSYYTARSA 172
Query: 290 RYLP-----KELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRDGN 339
P E +N F S+ D+++ G+T++EA G P K + I G
Sbjct: 173 GKWPLKWYAPECINFRKFS--SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 230
Query: 340 -IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLR 372
+E +L+ LM D RP ++
Sbjct: 231 RMECPPECPPELY---ALMSDCWIYKWEDRPDFLTVE 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 51/273 (18%), Positives = 101/273 (36%), Gaps = 36/273 (13%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-------NTAQEKIFKKEIHAHALLS 174
E LG G F ++FK ++ G + T V + + F + ++S
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHET--EVLLKVLDKAHRNYSESFFEAAS---MMS 67
Query: 175 RV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLR 231
++ H+V + L E+ G+L+ +++ + + ++ Q++ +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADND---FEVEE 286
+ E +IH ++ NIL++ + KL D G + D +
Sbjct: 128 FLEENTLIHGNVCAKNILLI----REEDRKTGNPPFIKLSDPGISITVLPKDILQERI-- 181
Query: 287 GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHIRDGNI-E 341
++P E + N + D ++ G TL+E G PL + D +
Sbjct: 182 ---PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLP 238
Query: 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374
+L LI +D +P RPS ++ R
Sbjct: 239 APKA--AELANLINNCMDYEPDHRPSFRAIIRD 269
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 65/306 (21%), Positives = 130/306 (42%), Gaps = 71/306 (23%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIH 168
R L + LG G+FG+V K T AVK + A+ ++ + E
Sbjct: 22 RKNLVLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAVK-MLKENASPSELRDLLSEF- 77
Query: 169 AHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNL---------------------E 205
+L +V PH++ + + S G L L +EY G+L
Sbjct: 78 --NVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 206 NIIQERCTFTEMALKQLL---FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMN 262
+ + + + L+ +Q+S+G++ + EM+++H D+ NIL+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV------------ 183
Query: 263 TEKLHYKLGDFG--HVIADNDFEVEEGDCRYLP------KELLNNNFDNLSKVDIFALGL 314
E K+ DFG + + D V+ R +P + L ++ + ++ D+++ G+
Sbjct: 184 AEGRKMKISDFGLSRDVYEEDSYVKRSQGR-IPVKWMAIESLFDHIYT--TQSDVWSFGV 240
Query: 315 TLYEAS--GVTPLP--KNGPMWHHIRDGNI-EKLSNVSDDLHTLIKLMID---KDPTKRP 366
L+E G P P +++ ++ G+ E+ N S++++ +LM+ ++P KRP
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY---RLMLQCWKQEPDKRP 297
Query: 367 STSSLR 372
+ +
Sbjct: 298 VFADIS 303
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 55/283 (19%), Positives = 101/283 (35%), Gaps = 55/283 (19%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++ L + +G G+FG+V G AVK K N A + F E
Sbjct: 190 LNMKELKLL----QTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASV 239
Query: 170 -----HALLSRVPHIVN-YFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQ 221
H ++V ++G LY+ EY G+L + ++ R L +
Sbjct: 240 MTQLRH------SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND 281
V E + + +H D+ N+L+ +E K+ DFG +
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLV------------SEDNVAKVSDFG--LTKEA 339
Query: 282 FEVEEGD---CRYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWH 333
++ ++ E L F +K D+++ G+ L+E + G P P +
Sbjct: 340 SSTQDTGKLPVKWTAPEALREKKFS--TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 397
Query: 334 HIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPSTSSLR 372
+ G ++ ++ +M + D RP+ LR
Sbjct: 398 RVEKGYKMDAPDGCPPAVY---DVMKNCWHLDAATRPTFLQLR 437
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 59/281 (20%), Positives = 113/281 (40%), Gaps = 48/281 (17%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFK-CLKYMDG---MTYAVKRTKRPVANTAQEKIFKK 165
I S + +++G+G+FGEV+K LK G + A+K T + Q F
Sbjct: 41 IHPSCVTRQ----KVIGAGEFGEVYKGMLKTSSGKKEVPVAIK-TLKAGYTEKQRVDFLG 95
Query: 166 EIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQL 222
E ++ + +I+ S + + EY G L+ ++E F+ + L +
Sbjct: 96 EA---GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADN 280
L ++ G++ + M +H D+ NIL+ L K+ DFG V+ D+
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILV------------NSNLVCKVSDFGLSRVLEDD 200
Query: 281 DFEVEEGDCRYLP-K----ELLNNN-FDNLSKVDIFALGLTLYEAS--GVTPLP--KNGP 330
+P + E ++ F S D+++ G+ ++E G P N
Sbjct: 201 PEATYTTSGGKIPIRWTAPEAISYRKFT--SASDVWSFGIVMWEVMTYGERPYWELSNHE 258
Query: 331 MWHHIRDGN-IEKLSNVSDDLHTLIKLMID---KDPTKRPS 367
+ I DG + + ++ +LM+ ++ +RP
Sbjct: 259 VMKAINDGFRLPTPMDCPSAIY---QLMMQCWQQERARRPK 296
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 56/282 (19%), Positives = 101/282 (35%), Gaps = 49/282 (17%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++ L + +G G+FG+V G AVK K N A + F E
Sbjct: 18 LNMKELKLL----QTIGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASV 67
Query: 170 -----HALLSRVPHIVN-YFSSWSDQGVLYLQLEYCNGGNLENIIQ--ERCTFTEMALKQ 221
H ++V ++G LY+ EY G+L + ++ R L +
Sbjct: 68 MTQLRH------SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND 281
V E + + +H D+ N+L+ +E K+ DFG +
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLV------------SEDNVAKVSDFG--LTKEA 167
Query: 282 FEVEEGD---CRYLPKELLNNN-FDNLSKVDIFALGLTLYE--ASGVTPLP--KNGPMWH 333
++ ++ E L F +K D+++ G+ L+E + G P P +
Sbjct: 168 SSTQDTGKLPVKWTAPEALREKKFS--TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 225
Query: 334 HIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374
+ G ++ ++ ++K D RPS LR
Sbjct: 226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 267
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 26/272 (9%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
+ LG G FG+V + G AVK R K + KI ++EI L R PH
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKI-RSLDVVGKI-RREIQNLKLF-RHPH 77
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
I+ + S +++ +EY +GG L + I + E ++L Q+ G+ H +
Sbjct: 78 IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMV 137
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDF-EVEEGDCRYLPKE 295
+H D+KP N+L+ ++ K+ DFG ++++D +F G Y E
Sbjct: 138 VHRDLKPENVLL------------DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 185
Query: 296 LLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP----MWHHIRDGNIEKLSNVSDDLH 351
+++ +VDI++ G+ LY A LP + ++ I DG ++ +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILY-ALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVI 244
Query: 352 TLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
+L+K M+ DP KR + +R ++ P+
Sbjct: 245 SLLKHMLQVDPMKRATIKDIREHEWFKQDLPK 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 27/272 (9%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
E LG G FG+V Y A+K R + ++ ++EI LL R PH
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRV-EREISYLKLL-RHPH 70
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
I+ + + + + +EY GG L + I E+ TE ++ Q+ + H ++
Sbjct: 71 IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKI 129
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDF-EVEEGDCRYLPKE 295
+H D+KP N+L+ + L+ K+ DFG +++ D +F + G Y E
Sbjct: 130 VHRDLKPENLLL------------DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177
Query: 296 LLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP----MWHHIRDGNIEKLSNVSDDLH 351
++N +VD+++ G+ LY V LP + ++ + +S
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLY-VMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 352 TLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
+LI+ MI DP +R + +RR N P
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 45/192 (23%), Positives = 78/192 (40%), Gaps = 23/192 (11%)
Query: 90 EDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR 149
G S+S ++ + + LG G +GEV+K + + T A+KR
Sbjct: 7 HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66
Query: 150 TKRP-----VANTA-QE-KIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGG 202
+ V TA +E + K+ H +I+ S L+L EY
Sbjct: 67 IRLEHEEEGVPGTAIREVSLLKELQH--------RNIIELKSVIHHNHRLHLIFEYAEN- 117
Query: 203 NLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMN 262
+L+ + + + +K L+Q+ G+ H R +H D+KP N+L+ +
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL-------SVSDA 170
Query: 263 TEKLHYKLGDFG 274
+E K+GDFG
Sbjct: 171 SETPVLKIGDFG 182
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 39/177 (22%), Positives = 75/177 (42%), Gaps = 32/177 (18%)
Query: 109 SIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE-------- 160
++D A + + + LG G F V+K A+K+ K + A++
Sbjct: 2 ALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR 61
Query: 161 --KIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEM 217
K+ ++ H P+I+ ++ + + L ++ +LE II++ T
Sbjct: 62 EIKLLQELSH--------PNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS 112
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+K + +GL +H+ ++H D+KP N+L+ + G L KL DFG
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE-NGVL-----------KLADFG 157
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 65/286 (22%), Positives = 109/286 (38%), Gaps = 47/286 (16%)
Query: 122 EELLGSGDFGEVFK-CLKYMDGMTY--AVKRTKRPVANTAQEKI-FKKEIHAHALLSRVP 177
E LG G FG V + G T AVK K V + + F +E++A L
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHR 81
Query: 178 HIVNYFSSWSDQGV-----LYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLR 231
+++ + GV + + E G+L + +++ F L + QV+EG+
Sbjct: 82 NLIRLY------GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDC 289
+ R IH D+ N+L+ + K+GDFG + ND +
Sbjct: 136 YLESKRFIHRDLAARNLLL------------ATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 290 RYLP-----KELLN-NNFDNLSKVDIFALGLTLYEAS--GVTPLP--KNGPMWHHI-RDG 338
R +P E L F D + G+TL+E G P + H I ++G
Sbjct: 184 RKVPFAWCAPESLKTRTFS--HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241
Query: 339 N-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
+ + + D++ ++ P RP+ +LR L P
Sbjct: 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR--DFLLEAQPT 285
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 74/299 (24%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-----VANTA-QE-KIFKKEIHAH 170
++ + E +G G +G VFK A+KR + V ++A +E + K+ H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-- 60
Query: 171 ALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII-QERCTFTEMALKQLLFQVSEG 229
+IV L L E+C+ +L+ +K LFQ+ +G
Sbjct: 61 ------KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDF--- 282
L H ++H D+KP N+LI + GEL KL +FG I +
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINR-NGEL-----------KLANFGLARAFGIPVRCYSAE 161
Query: 283 ---------EVEEGDCRYLPK-----------ELLN---------NNFDNLSKVDIF-AL 312
+V G Y EL N + D L + IF L
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR--IFRLL 219
Query: 313 GLTLYEAS--GVTPLP--KNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
G T E +T LP K PM+ + ++ L++ ++ +P +R S
Sbjct: 220 G-TPTEEQWPSMTKLPDYKPYPMYPATTSLV-NVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 32/166 (19%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKR------PVANTA-QE-KIFKKEIHA 169
+++ + LG G + V+K + A+K + P TA +E + K H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLKH- 59
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSE 228
+IV + L L EY + +L+ + + +K LFQ+
Sbjct: 60 -------ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
GL H +++H D+KP N+LI + +GEL KL DFG
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINE-RGEL-----------KLADFG 145
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 36/179 (20%), Positives = 61/179 (34%), Gaps = 35/179 (19%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTK--------RPVANTAQEKIFK 164
S + +G G +G V+K G A+K + + +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV----- 59
Query: 165 KEIHAHALLSRVPH--IVN-----YFSSWSDQGVLYLQLEYCNGGNLENII--QERCTFT 215
+E+ L H +V S + + L E+ + +L +
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLP 118
Query: 216 EMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+K L+ Q GL +H ++H D+KP NIL+ G + KL DFG
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS-GGTV-----------KLADFG 165
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 5e-12
Identities = 38/152 (25%), Positives = 67/152 (44%), Gaps = 21/152 (13%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFS 184
LG G + EVF+ + + VK K PV ++K K+EI L P+I+
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-PV----KKKKIKREIKILENLRGGPNIITLAD 98
Query: 185 SWSDQ--GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
D L E+ N + + + Q T T+ ++ ++++ + L H M ++H D
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRD 155
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+KP N++I +L +L D+G
Sbjct: 156 VKPHNVMIDHEHRKL-----------RLIDWG 176
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 46/170 (27%), Positives = 72/170 (42%), Gaps = 45/170 (26%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKR-------PVANTAQEKIFKKEIHAHALLSRV- 176
+G G FGEVFK G A+K+ P+ TA +EI +L +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI--TAL-----REIK---ILQLLK 74
Query: 177 -PHIVN--------YFSSWSDQGVLYLQLEYCN---GGNLENIIQERCTFTEMALKQLLF 224
++VN +G +YL ++C G L N+ FT +K+++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQ 131
Query: 225 QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ GL +H +++H D+K AN+LI + G L KL DFG
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITR-DGVL-----------KLADFG 169
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 7e-12
Identities = 46/187 (24%), Positives = 81/187 (43%), Gaps = 34/187 (18%)
Query: 96 HHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-- 153
HH S ++ ++ + E +G G +G V+K K G A+KR +
Sbjct: 4 HHH----HSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAE 58
Query: 154 ---VANTA-QE-KIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENII 208
+ +TA +E + K+ H P+IV+ + L L E+ +L+ ++
Sbjct: 59 DEGIPSTAIREISLLKELHH--------PNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL 109
Query: 209 -QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267
+ + + +K L+Q+ G+ H+ R++H D+KP N+LI G L
Sbjct: 110 DENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS-DGAL---------- 158
Query: 268 YKLGDFG 274
KL DFG
Sbjct: 159 -KLADFG 164
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 34/169 (20%), Positives = 71/169 (42%), Gaps = 39/169 (23%)
Query: 125 LGSGDFGEVFK--CLKYMDGMTYAVKRTKR---PVANTAQEKIFKKEIHAHALLSRVPHI 179
+G G +G V+K D YA+K+ + ++ + + ++ H P++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKH--------PNV 80
Query: 180 VN---YFSSWSDQGVLYLQLEYC--------NGGNLENIIQERCTFTEMALKQLLFQVSE 228
++ F S +D+ ++L +Y ++ +K LL+Q+ +
Sbjct: 81 ISLQKVFLSHADRK-VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD 139
Query: 229 GLRCMHEMRMIHMDIKPANILIVKA---QGELNEPMNTEKLHYKLGDFG 274
G+ +H ++H D+KPANIL++ +G + K+ D G
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRV-----------KIADMG 177
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 41/212 (19%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK--RTKRPVANTAQEKIFKKEIHAHALLSRVP--- 177
+++G G FG+V K + A+K R ++ A +EI L +
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA-----EEIRILEHLRKQDKDN 157
Query: 178 --HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRCM 233
++++ +++ + + + E NL +I++ F+ +++ + + L +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYL- 292
H+ R+IH D+KP NIL+ + K+ DFG + + Y+
Sbjct: 217 HKNRIIHCDLKPENILLK----------QQGRSGIKVIDFG-----SSCYEHQRVYTYIQ 261
Query: 293 ------PKELLNNNFDNLSKVDIFALGLTLYE 318
P+ +L + +D+++LG L E
Sbjct: 262 SRFYRAPEVILGARYG--MPIDMWSLGCILAE 291
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 40/171 (23%), Positives = 75/171 (43%), Gaps = 35/171 (20%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFK-KEIHAHALLSR 175
+ + + +++G+G FG V++ G A+K+ Q+K FK +E+ ++ +
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-------QDKRFKNRELQ---IMRK 103
Query: 176 VPH--IV---NYFSSWSDQG---VLYLQLEYCNGGNLENII----QERCTFTEMALKQLL 223
+ H IV +F S ++ L L L+Y + + + + T + +K +
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+Q+ L +H + H DIKP N+L+ L KL DFG
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-----------KLCDFG 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 62.5 bits (153), Expect = 5e-11
Identities = 39/176 (22%), Positives = 67/176 (38%), Gaps = 52/176 (29%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK------------ 165
++ E +G G +G V+K A A KK
Sbjct: 3 KYHGLEKIGEGTYGVVYK----------AQNNYGETFA-------LKKIRLEKEDEGIPS 45
Query: 166 ----EIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYCNGGNLENII-QERCTFTEMA 218
EI ++L + +IV + + L L E+ + +L+ ++ +
Sbjct: 46 TTIREI---SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT 101
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
K L Q+ G+ H+ R++H D+KP N+LI + +GEL K+ DFG
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR-EGEL-----------KIADFG 145
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 39/212 (18%)
Query: 76 GKTLATLPSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFK 135
T++ P V D + + + S T + + + +++G+G FG VF+
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTG---EQREIAYTNCKVIGNGSFGVVFQ 58
Query: 136 CLKYMDGMTYAVKRTKRPVANTAQEKIFK-KEIHAHALLSRVPH--IV---NYFSSWSDQ 189
K ++ A+K+ Q+K FK +E+ ++ V H +V +F S D+
Sbjct: 59 A-KLVESDEVAIKKVL-------QDKRFKNRELQ---IMRIVKHPNVVDLKAFFYSNGDK 107
Query: 190 G---VLYLQLEYCNGGNLENII----QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
L L LEY + + + T + +K ++Q+ L +H + + H D
Sbjct: 108 KDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRD 166
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
IKP N+L+ G L KL DFG
Sbjct: 167 IKPQNLLLDPPSGVL-----------KLIDFG 187
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 37/171 (21%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKR------PVANTA-QE-KIFKKEIHA 169
+F + E LG+G + V+K L G+ A+K K P TA +E + K+ H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS--TAIREISLMKELKH- 62
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT------FTEMALKQLL 223
+IV + + L L E+ + +L+ + R +K
Sbjct: 63 -------ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+Q+ +GL HE +++H D+KP N+LI K +G+L KLGDFG
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINK-RGQL-----------KLGDFG 153
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 40/183 (21%), Positives = 65/183 (35%), Gaps = 55/183 (30%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK------------ 165
++ +G G +G+VFK +K R VA K+
Sbjct: 12 QYECVAEIGEGAYGKVFKARD--------LKNGGRFVA-------LKRVRVQTGEEGMPL 56
Query: 166 ----EIHAHALLSRVPH--IVN-----YFSSWSDQGVLYLQLEYCN---GGNLENIIQER 211
E+ L H +V S + L L E+ + L+ +
Sbjct: 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV--PE 114
Query: 212 CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271
+K ++FQ+ GL +H R++H D+KP NIL+ G++ KL
Sbjct: 115 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS-SGQI-----------KLA 162
Query: 272 DFG 274
DFG
Sbjct: 163 DFG 165
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 19/154 (12%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI--VNY 182
+G G FG +F+ ++ A+K R + + E + LL+ I V Y
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIH 240
F VL + L G +LE+++ C F+ + Q+ ++ +HE +++
Sbjct: 74 FGQEGLHNVLVIDLL---GPSLEDLLD-LCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 129
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
DIKP N LI + + N ++ + DFG
Sbjct: 130 RDIKPDNFLIGRPNSK-----NANMIY--VVDFG 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 27/163 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK--RTKRPVANTAQEKIFKKEIHAHALLSRVP--- 177
L+G G FG+V K ++ A+K + K+ N AQ E+ L+++
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ-----IEVRLLELMNKHDTEM 114
Query: 178 --HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCM 233
+IV+ + + L L E NL ++++ + ++ Q+ L +
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFL 173
Query: 234 H--EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
E+ +IH D+KP NIL+ N ++ K+ DFG
Sbjct: 174 ATPELSIIHCDLKPENILLC----------NPKRSAIKIVDFG 206
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 35/176 (19%), Positives = 68/176 (38%), Gaps = 32/176 (18%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH-- 170
S Y ++ + SG +G V + +G+ A+KR V++ I
Sbjct: 22 SPYTVQ----RFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRV 76
Query: 171 ----ALLSRVPH-----IVNYFSSWSDQGV--LYLQLEYCNGGNLENIIQ-ERCTFTEMA 218
LL+ H + + F + + + LYL E +L +I +R +
Sbjct: 77 LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQH 135
Query: 219 LKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++ ++ + GL +HE ++H D+ P NIL + ++ + DF
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNIL-LADNNDI-----------TICDFN 179
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 30/129 (23%), Positives = 49/129 (37%), Gaps = 10/129 (7%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI--VNY 182
+GSG FGE++ A+K + E + +L I V +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLLYESKIYRILQGGTGIPNVRW 70
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
F D VL + L G +LE++ + + L Q+ + +H +H
Sbjct: 71 FGVEGDYNVLVMDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
Query: 242 DIKPANILI 250
DIKP N L+
Sbjct: 128 DIKPDNFLM 136
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 3e-09
Identities = 48/271 (17%), Positives = 87/271 (32%), Gaps = 61/271 (22%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVK------------RTKRPVANTAQEKIFKK 165
+ E +G G FGEVF+ + D A+K ++ E I K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 166 EIHA--HALLSRVPHIVNYFSSWSDQGV------------------------------LY 193
E+ + +R + S QG L+
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 194 LQLEYCNGGN-LENIIQERCTFTEMALKQLLFQVSEGLRCMHE-MRMIHMDIKPANILIV 251
+ LE+ GG LE + + + K +L Q++ L +R H D+ N+L+
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 252 KAQGELNEPMNTEKLHYKLGDFGHVIADNDF----EVEEGDCRY----LPKELLNNNFDN 303
K + K + G ++ D+ +G + + ++L + D
Sbjct: 197 KTSLKKLHYTLNGK-SSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD- 254
Query: 304 LSKVDIFALGLTLYEASGVTPLPKNGPMWHH 334
+ DI+ L P + +W H
Sbjct: 255 -YQFDIYRLMKKENNNRWGEYHPYSNVLWLH 284
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 28/130 (21%), Positives = 53/130 (40%), Gaps = 12/130 (9%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI--VNY 182
+GSG FG+++ G A+K + E + ++ I + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIRW 72
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIH 240
+ D V+ ++L G +LE++ C F+ + L Q+ + +H IH
Sbjct: 73 CGAEGDYNVMVMELL---GPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128
Query: 241 MDIKPANILI 250
D+KP N L+
Sbjct: 129 RDVKPDNFLM 138
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-09
Identities = 45/172 (26%), Positives = 73/172 (42%), Gaps = 44/172 (25%)
Query: 119 FLEEELLGSGDFGEVFK-CLKYMDGMTYAVKRTKRPVANTAQ-EKIFKKEIHAHALLSRV 176
F + L+G G FG+V+K L+ DG A+KR ++Q + F+ EI LS
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLR--DGAKVALKRRTP---ESSQGIEEFETEIE---TLSFC 92
Query: 177 --PHIVN---YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFT---------EMALKQL 222
PH+V+ + ++ ++Y +Y GNL+ + T E+ +
Sbjct: 93 RHPHLVSLIGFCDERNEMILIY---KYMENGNLKRHLYGSDLPTMSMSWEQRLEICI--- 146
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ GL +H +IH D+K NIL+ E K+ DFG
Sbjct: 147 --GAARGLHYLHTRAIIHRDVKSINILL------------DENFVPKITDFG 184
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 35/172 (20%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK-EIHAHALLSRVP 177
F E + G G FG V + GM+ A+K+ Q+ F+ E+ L+ +
Sbjct: 25 FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-------QDPRFRNRELQIMQDLAVLH 77
Query: 178 H-----IVNYFSSWSDQGV----LYLQLEYCNGGNLENII----QERCTFTEMALKQLLF 224
H + +YF + ++ L + +EY L + + + +K LF
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 225 QVSEGLRCMHE--MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
Q+ + C+H + + H DIKP N+L+ +A G L KL DFG
Sbjct: 137 QLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL-----------KLCDFG 177
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 46/247 (18%), Positives = 87/247 (35%), Gaps = 38/247 (15%)
Query: 90 EDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK- 148
+ +HP +RY L LG G F V+ ++ A+K
Sbjct: 1 DYRPGGYHPA-----FKGEPYKDARYILV----RKLGWGHFSTVWLAKDMVNNTHVAMKI 51
Query: 149 -RTKRPVANTAQ------EKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYC-- 199
R + A+ +++ + + HI+ ++ +G + +
Sbjct: 52 VRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA-NHILKLLDHFNHKGPNGVHV--VMV 108
Query: 200 ---NGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMH-EMRMIHMDIKPANILIVKA 253
G NL +I++ + +KQ+ Q+ GL MH +IH DIKP N+L+
Sbjct: 109 FEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME-- 166
Query: 254 QGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYL--PKELLNNNFDNLSKVDIFA 311
+ K+ D G+ ++ R P+ LL + DI++
Sbjct: 167 ----IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG--CGADIWS 220
Query: 312 LGLTLYE 318
++E
Sbjct: 221 TACLIFE 227
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 40/173 (23%), Positives = 73/173 (42%), Gaps = 35/173 (20%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK----EIH 168
RY + L+G+G +G V + ++ A+K+ + ++ I K EI
Sbjct: 53 DRYEIR----HLIGTGSYGHVCEAYDKLEKRVVAIKK----ILRVFEDLIDCKRILREIA 104
Query: 169 AHALLSRVPH--IVN-----YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQ 221
+L+R+ H +V LY+ LE + + + + TE+ +K
Sbjct: 105 ---ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKT 160
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
LL+ + G++ +H ++H D+KPAN L V + K+ DFG
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCL-VNQDCSV-----------KVCDFG 201
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 40/173 (23%), Positives = 59/173 (34%), Gaps = 27/173 (15%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVK--RTKRPVANTAQEKIFKKEIHAHALLSRVP--- 177
+G G FG V C + YAVK R + +A K E +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-----KIEADILKKIQNDDINN 95
Query: 178 -HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRCMH 234
+IV Y + + L E G +L II F +K ++ + L +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR 154
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY-------------KLGDFG 274
+M + H D+KP NIL+ E + KL DFG
Sbjct: 155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 37/205 (18%), Positives = 67/205 (32%), Gaps = 41/205 (20%)
Query: 62 EDPRDALILNKKWSGKTLATLPSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLE 121
+ L + P G V+D+ G+ ++ L
Sbjct: 5 HHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGN-------------------QWVLG--- 42
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQ-------EKIFKKEIHAHALLS 174
+ +GSG FG ++ A K + K+ +
Sbjct: 43 -KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101
Query: 175 R-------VPHIVNYFSSWSDQGVLY--LQLEYCNGGNLENIIQERCTFTEMALKQLLFQ 225
R +P +G Y + +E G +L+ I + TF + + QL +
Sbjct: 102 RKQLDYLGIPLFY-GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIR 159
Query: 226 VSEGLRCMHEMRMIHMDIKPANILI 250
+ + L +HE +H DIK AN+L+
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLL 184
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 36/172 (20%), Positives = 69/172 (40%), Gaps = 29/172 (16%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTY-AVK--RTKRPVANTAQEKIFKKEIHAHALLSRV--- 176
+ LG G FG+V +C+ + G + AVK + A + EI +L +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-----RSEI---QVLEHLNTT 71
Query: 177 -----PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEG 229
V + G + + E G + + I+E F ++++ +Q+ +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY-------KLGDFG 274
+ +H ++ H D+KP NIL V++ ++ K+ DFG
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 23/169 (13%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTY-AVK--RTKRPVANTAQEKIFKKEIHAHALLSR---- 175
LG G FG+V +CL + G + A+K R A + EI+ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-----RLEINVLKKIKEKDKE 79
Query: 176 -VPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRC 232
V ++ G + + E G N ++E + ++ + +Q+ LR
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRF 138
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY-------KLGDFG 274
+HE ++ H D+KP NIL V ++ E + ++ DFG
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 4e-08
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 35/173 (20%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKK----EIH 168
Y ++ L+G G +G V+ A+K+ V ++ I K EI
Sbjct: 26 DNYIIK----HLIGRGSYGYVYLAYDKNTEKNVAIKK----VNRMFEDLIDCKRILREIT 77
Query: 169 AHALLSRVPH--IVNYF-----SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQ 221
+L+R+ I+ + LY+ LE +L+ + + TE +K
Sbjct: 78 ---ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKT 133
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+L+ + G +HE +IH D+KPAN L + + K+ DFG
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCL-LNQDCSV-----------KVCDFG 174
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 40/172 (23%)
Query: 119 FLEEELLGSGDFGEVFK-CLKYMDGMTYAVKRTKRPVANTAQ--EKIFKKEIHAHALLSR 175
F + +LG G FG+V+K L DG AVKR K Q E F+ E+ ++S
Sbjct: 32 FSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKE---ERTQGGELQFQTEV---EMISM 83
Query: 176 V--PHIVNY--FSSWSDQGVL-YLQLEYCNGGNLENIIQERCTFTEMAL-----KQLLFQ 225
+++ F + +L Y Y G++ + ++ER ++ L +++
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVY---PYMANGSVASCLRERPE-SQPPLDWPKRQRIALG 139
Query: 226 VSEGLRCMHE---MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ GL +H+ ++IH D+K ANIL+ E+ +GDFG
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILL------------DEEFEAVVGDFG 179
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 42/164 (25%), Positives = 71/164 (43%), Gaps = 38/164 (23%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH------ALLSRVPH 178
+GSG +G V + G A+K+ RP F+ EI A LL + H
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRP---------FQSEIFAKRAYRELLLLKHMQH 82
Query: 179 --------IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+ SS + YL + + +L+ I+ + F+E ++ L++Q+ +GL
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLKGL 139
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ +H ++H D+KP N+ V EL K+ DFG
Sbjct: 140 KYIHSAGVVHRDLKPGNLA-VNEDCEL-----------KILDFG 171
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 44/219 (20%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH------ALLSRVPH 178
+GSG G V + A+K+ RP F+ + HA L+ V H
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRP---------FQNQTHAKRAYRELVLMKCVNH 83
Query: 179 -----IVNYFSSWSDQGV---LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
++N F+ +Y+ +E NL +IQ + LL+Q+ G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 140
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGD 288
+ +H +IH D+KP+NI+ VK+ L K+ DFG +
Sbjct: 141 KHLHSAGIIHRDLKPSNIV-VKSDCTL-----------KILDFGLARTAGTSFMMTPYVV 188
Query: 289 CRYL--PKELLNNNFDNLSKVDIFALGLTLYEASGVTPL 325
RY P+ +L + VDI+++G + E L
Sbjct: 189 TRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMIKGGVL 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 56/216 (25%), Positives = 90/216 (41%), Gaps = 38/216 (17%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH------ALLSRVPH 178
+GSG +G V G+ AVK+ RP F+ IHA LL + H
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRP---------FQSIIHAKRTYRELRLLKHMKH 87
Query: 179 -----IVNYF---SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+++ F S + +YL G +L NI++ + T+ ++ L++Q+ GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGL 145
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR 290
+ +H +IH D+KP+N+ V EL K+ DFG D R
Sbjct: 146 KYIHSADIIHRDLKPSNLA-VNEDCEL-----------KILDFGLARHTADEMTGYVATR 193
Query: 291 -YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPL 325
Y E++ N VDI+++G + E L
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 229
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 44/166 (26%), Positives = 68/166 (40%), Gaps = 40/166 (24%)
Query: 124 LLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQ-EKIFKKEIHAHALLSRV--PHI 179
+G G FG V+K Y++ T AVK+ T + ++ F +EI ++++ ++
Sbjct: 38 KMGEGGFGVVYK--GYVNNTTVAVKKLAAMVDITTEELKQQFDQEI---KVMAKCQHENL 92
Query: 180 VNY--FSSWSDQGVL-YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQ--------VSE 228
V FSS D L Y Y G+L + + L + +
Sbjct: 93 VELLGFSSDGDDLCLVY---VYMPNGSLLDRL-----SCLDGTPPLSWHMRCKIAQGAAN 144
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
G+ +HE IH DIK ANIL L+E K+ DFG
Sbjct: 145 GINFLHENHHIHRDIKSANIL-------LDEAFTA-----KISDFG 178
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 63/432 (14%), Positives = 135/432 (31%), Gaps = 104/432 (24%)
Query: 33 QSVDFIVHSLKDLPTELPSGLSLGAILEREDPRDALILNKKWSG----------KTLATL 82
++ +HS++ L + + L+L + K L T
Sbjct: 221 SNIKLRIHSIQAELRRL--------LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 83 PSGSVIDEDSGDDHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDG 142
V D S + S+DH L +E+ + LKY+D
Sbjct: 273 RFKQVTDFLSAATTTHI---------SLDHHSMTLT--PDEVK------SLL--LKYLD- 312
Query: 143 MTYAVKRTKRPVANTAQEKIFKKEIH--AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCN 200
+ P + ++++ I + ++W ++ N
Sbjct: 313 ----CRPQDLPRE--------VLTTNPRRLSIIAES--IRDGLATWD-------NWKHVN 351
Query: 201 GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIK-PANIL-IVKAQGELN 258
L II E +L L + +E + + + P +L ++ +
Sbjct: 352 CDKLTTII-------ESSLNVL--EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402
Query: 259 EPMN-TEKLHYKLGDFGHVIADNDFEVEEGDCR----YLPKELLNNNFDNLSK--VDIFA 311
+ M KLH + + +E YL ++ N L + VD +
Sbjct: 403 DVMVVVNKLHKYS------LVEKQP--KESTISIPSIYLELKVKLENEYALHRSIVDHYN 454
Query: 312 LGLTLYEASGVTPLPKNGPMWHHI--------RDGNIEKLSNVSDDLHTLIKLMIDKDPT 363
+ T +++ + P + + HI + V D ++ I D T
Sbjct: 455 IPKT-FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFR-FLEQKIRHDST 512
Query: 364 KRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKD 423
++ S+ + Q + Y I N + ++ + D + ++ K+ D
Sbjct: 513 AWNASGSILNTLQQLKFYKPY----ICDNDPKYERLVNA--ILDFLPKIEENLICSKYTD 566
Query: 424 RI-MAVFSEYKP 434
+ +A+ +E +
Sbjct: 567 LLRIALMAEDEA 578
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 67/481 (13%), Positives = 129/481 (26%), Gaps = 156/481 (32%)
Query: 15 KIGEKSLFTKE-LEIALENQSVDFIVHSLKDLPTELPSGLSLGAILEREDP--------- 64
+ GE K+ L + + +F ++D+P + S + I+ +D
Sbjct: 10 ETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69
Query: 65 --------------RDALILNKKWSGKTLATLPSGSVIDEDSGDDHH-------PVFDIK 103
+ L +N K+ + T + + VF
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKY 129
Query: 104 SISSTS-IDHSRYALEFLEEE-------LLGSG-------------------------DF 130
++S R AL L +LGSG +
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 131 GEVFK-----------CLKYMDGMTYAVKRTKRPVANTAQEK-----IFKKEIHAHAL-- 172
+ T + + + K + + + L
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 173 LSRV--PHIVNYFS-------SWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQ 221
L V N F+ + + V ++ + +I + T T +K
Sbjct: 250 LLNVQNAKAWNAFNLSCKILLTTRFKQV----TDFLSAATTTHISLDHHSMTLTPDEVKS 305
Query: 222 LLFQV----SEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEK--LHYKLGDFGH 275
LL + + L E+ + P + I+ + + + T H
Sbjct: 306 LLLKYLDCRPQDLP--REVLTTN----PRRLSIIAE--SIRDGLATWDNWKHVNCDKLTT 357
Query: 276 VIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP----- 330
+I ++ V E P E FD LS +F P +
Sbjct: 358 II-ESSLNVLE------PAE-YRKMFDRLS---VF---------------PPSAHIPTIL 391
Query: 331 ---MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL----RRSAQLARNYPQ 383
+W + ++ V + LH +++K P + ST S+ N
Sbjct: 392 LSLIWFDVIKSDVM---VVVNKLHK--YSLVEKQP--KESTISIPSIYLELKVKLENEYA 444
Query: 384 L 384
L
Sbjct: 445 L 445
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 70/437 (16%), Positives = 115/437 (26%), Gaps = 148/437 (33%)
Query: 96 HHPVFDIKSISSTSIDHS-RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV 154
HH F+ + + L E+ F + F C D
Sbjct: 5 HHMDFET-----GEHQYQYKDILSVFED------AFVDNFDCKDVQDMP----------- 42
Query: 155 ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTF 214
+ I KE + HI+ S + G L L + E ++Q+ F
Sbjct: 43 -----KSILSKE--------EIDHIIM--SKDAVSGTLRLFWTLLSKQ--EEMVQK---F 82
Query: 215 TEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP-MNTEKL---HYKL 270
E L+ + L+ + E +P M T +L
Sbjct: 83 VEEVLRI--------------------NY---KFLMSPIKTEQRQPSMMTRMYIEQRDRL 119
Query: 271 GDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFAL------G---LTL--YEA 319
+ V A + V R P L L + G + L +
Sbjct: 120 YNDNQVFAK--YNV----SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS 173
Query: 320 SGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSS--------- 370
V W + N V + L L+ ID + T R SS
Sbjct: 174 YKVQCKMDFKIFW--LNLKNCNSPETVLEMLQKLL-YQIDPNWTSRSDHSSNIKLRIHSI 230
Query: 371 ---LRRSAQLARNYPQ--LKVENIRGNLNTRLKKLDEG----------NVFDGIILAVAG 415
LRR ++ Y L + N++ N + V D + A
Sbjct: 231 QAELRR-LLKSKPYENCLLVLLNVQ-NAKA-WNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 416 IVRMKW------KDRIMAVFSEY---------------KPGSLSMTGAV----------W 444
+ + D + ++ +Y P LS+ W
Sbjct: 288 HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNW 347
Query: 445 SLDGRETLQDAMERSLD 461
+ L +E SL+
Sbjct: 348 KHVNCDKLTTIIESSLN 364
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 40/218 (18%), Positives = 83/218 (38%), Gaps = 27/218 (12%)
Query: 168 HAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVS 227
L R + S + G + + + T L FQV+
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
+G+ + + IH D+ NIL+ +EK K+ DFG I + V
Sbjct: 204 KGMEFLASRKCIHRDLAARNILL------------SEKNVVKICDFGLARDIYKDPDYVR 251
Query: 286 EGDCRY-----LPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTP---LPKNGPMWHHI 335
+GD R P+ + + + + D+++ G+ L+E + G +P + + +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYT--IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
Query: 336 RDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
++G + + +++ + +P++RP+ S L
Sbjct: 310 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 347
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 26/130 (20%), Positives = 50/130 (38%), Gaps = 11/130 (8%)
Query: 122 EELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
+ LG G FG+V + K T AVK K A ++ + E+ +
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHH 85
Query: 177 PHIVNYFSSWSDQ-GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235
++VN + + G L + +E+C GNL ++ + + + +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR----NEFVPYKTKGARFRQGKDY 141
Query: 236 MRMIHMDIKP 245
+ I +D+K
Sbjct: 142 VGAIPVDLKR 151
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 32/136 (23%), Positives = 53/136 (38%), Gaps = 18/136 (13%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI-- 179
+ +G G+FGE+ A+K ++ E + L I
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPM----KSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALK---QLLFQVSEGLRCMH 234
V YF + L+L G +LE++ C TF+ LK + Q+ + +H
Sbjct: 70 VYYFGPCGKYNAMVLELL---GPSLEDLFD-LCDRTFS---LKTVLMIAIQLISRMEYVH 122
Query: 235 EMRMIHMDIKPANILI 250
+I+ D+KP N LI
Sbjct: 123 SKNLIYRDVKPENFLI 138
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 51/216 (23%), Positives = 85/216 (39%), Gaps = 38/216 (17%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH------ALLSRVPH 178
+GSG +G V + G A+K+ RP F+ E+ A LL + H
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRP---------FQSELFAKRAYRELRLLKHMRH 83
Query: 179 --------IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+ + D YL + + G +L +++ E ++ L++Q+ +GL
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE-KLGEDRIQFLVYQMLKGL 141
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR 290
R +H +IH D+KP N+ V EL K+ DFG + R
Sbjct: 142 RYIHAAGIIHRDLKPGNLA-VNEDCEL-----------KILDFGLARQADSEMTGYVVTR 189
Query: 291 -YLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPL 325
Y E++ N VDI+++G + E L
Sbjct: 190 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 51/219 (23%), Positives = 84/219 (38%), Gaps = 44/219 (20%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH------ALLSRVPH 178
+GSG G V + A+K+ RP F+ + HA L+ V H
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRP---------FQNQTHAKRAYRELVLMKCVNH 120
Query: 179 --------IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGL 230
+ + + +YL +E NL +IQ + LL+Q+ G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLCGI 177
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGD 288
+ +H +IH D+KP+NI+ VK+ L K+ DFG +
Sbjct: 178 KHLHSAGIIHRDLKPSNIV-VKSDCTL-----------KILDFGLARTAGTSFMMTPYVV 225
Query: 289 CRYL--PKELLNNNFDNLSKVDIFALGLTLYEASGVTPL 325
RY P+ +L + VDI+++G + E L
Sbjct: 226 TRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMVRHKIL 262
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 42/185 (22%), Positives = 67/185 (36%), Gaps = 52/185 (28%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI-FKKEIHAH- 170
SRY + LG G G VF + A+K KI
Sbjct: 11 SRYMDL----KPLGCGGNGLVFSAVDNDCDKRVAIK------------KIVLTDPQSVKH 54
Query: 171 -----ALLSRVPH-----IVNYFSSWSDQGV-----------LYLQLEYCNGGNLENIIQ 209
++ R+ H + Q +Y+ EY +L N+++
Sbjct: 55 ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLE 113
Query: 210 ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269
+ E + ++Q+ GL+ +H ++H D+KPAN+ I NTE L K
Sbjct: 114 QG-PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFI-----------NTEDLVLK 161
Query: 270 LGDFG 274
+GDFG
Sbjct: 162 IGDFG 166
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 20/147 (13%), Positives = 54/147 (36%), Gaps = 19/147 (12%)
Query: 122 EELLGSGDFGEVFK--------CLKYMDGMTYAVKRTKRPVANTAQEKIFKK-----EIH 168
+ + G +++ C +++K + ++ F++ +++
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 169 AHALLSRVPH--IVNYFSSWSDQGVL-YLQLEYCNGGNLENIIQE--RCTFTEMALKQLL 223
L P I Q +L L G +L++ + + +E ++ Q+
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 224 FQVSEGLRCMHEMRMIHMDIKPANILI 250
++ + L +HE +H ++ NI +
Sbjct: 166 CRLLDALEFLHENEYVHGNVTAENIFV 192
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 39/174 (22%), Positives = 75/174 (43%), Gaps = 40/174 (22%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAH-- 170
+Y L + LG G +G V+K + G AVK+ F+ A
Sbjct: 9 RKYELV----KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA---------FQNSTDAQRT 55
Query: 171 ----ALLSRV---PHIV---NYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALK 220
+L+ + +IV N + +D+ V YL +Y +L +I+ + +
Sbjct: 56 FREIMILTELSGHENIVNLLNVLRADNDRDV-YLVFDYM-ETDLHAVIRAN-ILEPVHKQ 112
Query: 221 QLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+++Q+ + ++ +H ++H D+KP+NIL + A+ + K+ DFG
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNIL-LNAECHV-----------KVADFG 154
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 28/149 (18%), Positives = 49/149 (32%), Gaps = 23/149 (15%)
Query: 122 EELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR- 175
+G G FG ++ VK E F + + +
Sbjct: 40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW 99
Query: 176 ----------VPHIVNYFSSWSDQGVLY--LQLEYCNGGNLENIIQERC--TFTEMALKQ 221
VP G Y + ++ G +L+ I E F+ + Q
Sbjct: 100 IRTRKLKYLGVPKYW-GSGLHDKNGKSYRFMIMDRF-GSDLQKIY-EANAKRFSRKTVLQ 156
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILI 250
L ++ + L +HE +H DIK +N+L+
Sbjct: 157 LSLRILDILEYIHEHEYVHGDIKASNLLL 185
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 31/188 (16%), Positives = 55/188 (29%), Gaps = 47/188 (25%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVK-------RTKR---------------------- 152
+ LG+G FG V + G +A+K R
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYT 71
Query: 153 --PVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE 210
+ H + + S L + +EY L +++
Sbjct: 72 TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKS 130
Query: 211 RC----TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266
+ + ++Q+ + +H + + H DIKP N+L+ L
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTL--------- 181
Query: 267 HYKLGDFG 274
KL DFG
Sbjct: 182 --KLCDFG 187
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 39/177 (22%), Positives = 69/177 (38%), Gaps = 45/177 (25%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--FKKEIHAH 170
S + L+ LLG G +G V G A+K KI F K + A
Sbjct: 11 SDFQLK----SLLGEGAYGVVCSATHKPTGEIVAIK------------KIEPFDKPLFAL 54
Query: 171 ------ALLSRVPH-----IVNYF--SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEM 217
+L H I N S+ + +Y+ E +L +I + ++
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDD 112
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
++ ++Q ++ +H +IH D+KP+N+L + + +L K+ DFG
Sbjct: 113 HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL-INSNCDL-----------KVCDFG 157
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 36/166 (21%), Positives = 60/166 (36%), Gaps = 44/166 (26%)
Query: 214 FTEMALKQLLFQVSEGLRCMH-EMRMIHMDIKPANILIV--------------------- 251
+K+++ QV +GL +H + R+IH DIKP NIL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 252 ----------------KAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEEGDCRYLPK 294
EP N EKL K+ D G+ F + +Y
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262
Query: 295 E-LLNNNFDNLSKVDIFALGLTLYEASGVTPL--PKNGPMWHHIRD 337
E L+ + ++ + DI++ +E + L P +G + D
Sbjct: 263 EVLIGSGYN--TPADIWSTACMAFELATGDYLFEPHSGEEYTRDED 306
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 31/165 (18%), Positives = 65/165 (39%), Gaps = 41/165 (24%)
Query: 125 LGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--FKKEIHAH------ALLSRV 176
+G G +G V ++ + A+K KI F+ + + +L R
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIK------------KISPFEHQTYCQRTLREIKILLRF 82
Query: 177 PH-----IVNYF--SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEG 229
H I + + +Y+ + +L +++ + + + L+Q+ G
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRG 140
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
L+ +H ++H D+KP+N+L + +L K+ DFG
Sbjct: 141 LKYIHSANVLHRDLKPSNLL-LNTTCDL-----------KICDFG 173
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 480 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 3ecr_A | 364 | Porphobilinogen deaminase; heme biosynthesis, porp | 99.95 | |
| 1gtk_A | 313 | Porphobilinogen deaminase; lyase, biosynthesis of | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.71 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.28 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.13 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.04 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.56 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.2 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.11 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.02 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.91 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.35 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.3 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.66 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.62 | |
| 3ecr_A | 364 | Porphobilinogen deaminase; heme biosynthesis, porp | 92.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.68 | |
| 1gtk_A | 313 | Porphobilinogen deaminase; lyase, biosynthesis of | 91.45 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.83 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-62 Score=468.22 Aligned_cols=253 Identities=24% Similarity=0.403 Sum_probs=212.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|++.+.||+|+||+||+|.++.+|+.||||++.+.... ......+.+|+.+++.+ +|||||++++++.+++.+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEEEE
Confidence 4688999999999999999999999999999999765332 23345689999999999 799999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||| +|+|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl------------~~~~~vkl~DFGl 158 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL------------DEHLNVKIADFGL 158 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE------------CTTCCEEECCSSC
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE------------CCCCCEEEeecCC
Confidence 9999 78999999988899999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHH
Q psy14702 276 VIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDD 349 (480)
Q Consensus 276 a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~ 349 (480)
|+.... ....+||+.|||||++.+..+++.++|||||||++|+| +|..||..... .+..+.++.+..+..+|++
T Consensus 159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~ 238 (275)
T 3hyh_A 159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPG 238 (275)
T ss_dssp C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 975443 23467999999999999887766799999999999996 78888876543 4567778888888889999
Q ss_pred HHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 350 ~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
+++||.+||++||++|||++|+++||||+...|.
T Consensus 239 ~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 239 AAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCG
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCcccccCCCh
Confidence 9999999999999999999999999999876653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-62 Score=480.61 Aligned_cols=251 Identities=27% Similarity=0.469 Sum_probs=216.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
++|++++.||+|+||+||+|+++.+|+.||||++.+........+.+.+|+.+++.| +|||||+++++|.+++.+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEECCEEEEEE
Confidence 478899999999999999999999999999999987766667778899999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 197 EYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 197 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl------------~~~g~vKl~DFG 170 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL------------TKDGTVQLGDFG 170 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE------------CTTCCEEECSTT
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE------------CCCCCEEEcccc
Confidence 999999999999754 357999999999999999999999999999999999999 567789999999
Q ss_pred cccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC-cCCCC
Q psy14702 275 HVIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE-KLSNV 346 (480)
Q Consensus 275 ~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~-~~~~~ 346 (480)
+|+..... ...+||+.|||||++.+..++ .++|||||||+|||| +|..||..... .+..+.++.++ .+..+
T Consensus 171 la~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T 4b9d_A 171 IARVLNSTVELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHY 249 (350)
T ss_dssp EESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred cceeecCCcccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccC
Confidence 99765432 245799999999999987665 799999999999996 77788876543 44566666654 45679
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
|+++++||.+||++||++|||+.|+++||||.+..
T Consensus 250 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999999999999999998643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-62 Score=474.26 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=217.1
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.+ +|||||+++++|++++.+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~yiv 110 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 110 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999875321 112245688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 111 mEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl------------~~~g~vKl~DFGl 178 (311)
T 4aw0_A 111 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL------------NEDMHIQITDFGT 178 (311)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE------------cCCCCEEEEEcCC
Confidence 9999999999999988899999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCC
Q psy14702 276 VIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNV 346 (480)
Q Consensus 276 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~ 346 (480)
|+.... ....+||+.|||||++.+..++ .++|||||||++|+| +|..||...+. .+..+.++.+..+..+
T Consensus 179 a~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~ 257 (311)
T 4aw0_A 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKF 257 (311)
T ss_dssp CEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTC
T ss_pred ceecCCCCCcccccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccc
Confidence 975432 2346899999999999988775 789999999999996 78888876543 5677888888888899
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
|+++++||.+||++||++|||+.|++.|+|+
T Consensus 258 s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i 288 (311)
T 4aw0_A 258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPL 288 (311)
T ss_dssp CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcChHHHcCCHHH
Confidence 9999999999999999999999986544444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-61 Score=476.78 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=217.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
...|.+.+.||+|+||+||+|.++.+|+.||||++....... .+.+.+|+.+|+.+ +|||||+++++|.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 456889999999999999999999999999999987543222 34578999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.+ ..+++.+++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl------------~~~g~vKl~DFGl 216 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL------------THDGRVKLSDFGF 216 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEECCCTT
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE------------CCCCCEEEecCcC
Confidence 999999999999976 579999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCC---CCcCCC
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGN---IEKLSN 345 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~---~~~~~~ 345 (480)
|+.... ....+||+.|||||++.+..++ .++|||||||++||| +|..||..... .+..+.... .+.+..
T Consensus 217 a~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 295 (346)
T 4fih_A 217 CAQVSKEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 295 (346)
T ss_dssp CEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGG
T ss_pred ceecCCCCCcccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCcccc
Confidence 875432 3456899999999999887775 799999999999996 77788876543 344555543 234456
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
+|+++++||.+||++||++|||+.|+++||||++..+.
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 89999999999999999999999999999999886654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-60 Score=458.07 Aligned_cols=246 Identities=21% Similarity=0.326 Sum_probs=210.3
Q ss_pred hhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----CCEEEEE
Q psy14702 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----QGVLYLQ 195 (480)
Q Consensus 120 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~~~~lv 195 (480)
...+.||+|+||+||+|.++.+++.||+|++..........+.|.+|+.+++.+ +|||||+++++|.+ +..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCcEEEEE
Confidence 456789999999999999999999999999987656666677899999999999 89999999999875 3568999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||+||+|.+++.+...+++..++.|+.||+.||+|||++| ||||||||+|||++ +.++.+||+||
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~-----------~~~g~vKl~DF 176 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-----------GPTGSVKIGDL 176 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES-----------STTSCEEECCT
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE-----------CCCCCEEEEeC
Confidence 999999999999998889999999999999999999999998 99999999999993 13568999999
Q ss_pred CcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCCC--cCCC
Q psy14702 274 GHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNIE--KLSN 345 (480)
Q Consensus 274 G~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~~--~~~~ 345 (480)
|+|+.... ....+||+.|||||++.+. ++ .++|||||||+|||| +|..||..... .+..+..+..+ .+..
T Consensus 177 Gla~~~~~~~~~~~~GTp~YmAPE~~~~~-y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 177 GLATLKRASFAKAVIGTPEFMAPEMYEEK-YD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTC-CC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred cCCEeCCCCccCCcccCccccCHHHcCCC-CC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 99975433 3456799999999999764 43 799999999999996 77888865443 33444444332 2345
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+++++++||.+||++||++|||+.|+++||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 7899999999999999999999999999999865
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-60 Score=477.83 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=217.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
...|.+.+.||+|+||+||+|.++.+|+.||||++....... .+.+.+|+.+|+.+ +|||||+++++|.+++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDY-QHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhC-CCCCCCceEEEEEECCEEEEE
Confidence 356889999999999999999999999999999997643332 34588999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.. ..+++.+++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl------------~~~g~vKl~DFGl 293 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL------------THDGRVKLSDFGF 293 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE------------CTTCCEEECCCTT
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE------------cCCCCEEEecCcc
Confidence 999999999999875 479999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCC---CCcCCC
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGN---IEKLSN 345 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~---~~~~~~ 345 (480)
|..... ....+||+.|||||++.+..|+ .++|||||||++||| +|..||..... .+..+.... ...+..
T Consensus 294 a~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 372 (423)
T 4fie_A 294 CAQVSKEVPRRKSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHK 372 (423)
T ss_dssp CEECCSSCCCBCCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTS
T ss_pred ceECCCCCccccccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCccccc
Confidence 875432 2356799999999999888775 799999999999996 77778766543 344555443 334567
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
+|+++++||.+||.+||++|||+.|+++||||.+..+.
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 99999999999999999999999999999999886554
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-61 Score=466.56 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=212.2
Q ss_pred hhhhhheeecccCceEEEEEEEe---eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKY---MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+|++.+.||+|+||+||+|++. .+++.||||++++..........+.+|+.++..+ +|||||+++++|.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEECCEEE
Confidence 46889999999999999999874 3678999999876432222233577899999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl------------~~~g~vKl~DF 170 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL------------DEEGHIKLTDF 170 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE------------CTTSCEEEESS
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE------------cCCCCEEeccc
Confidence 999999999999999988899999999999999999999999999999999999999 66778999999
Q ss_pred CcccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCC
Q psy14702 274 GHVIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNV 346 (480)
Q Consensus 274 G~a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~ 346 (480)
|+|+... .....+||+.|||||++.+..++ .++|||||||++||| +|..||...+. ....+.++.++.+..+
T Consensus 171 Gla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~ 249 (304)
T 3ubd_A 171 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249 (304)
T ss_dssp EEEEC-----CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred ccceeccCCCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcC
Confidence 9997532 23346799999999999988766 789999999999996 78888876543 4567778888888889
Q ss_pred CHHHHHHHHHhhccCCCCCCCh-----hHHHHHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPST-----SSLRRSAQLAR 379 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~-----~ell~h~~~~~ 379 (480)
|+++++||.+||++||++|||+ +|+++||||..
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 9999999999999999999995 79999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-58 Score=449.88 Aligned_cols=241 Identities=25% Similarity=0.320 Sum_probs=208.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
..|...++||+|+||+||+|+++.+|+.||||+++.... ..+|+.++..+ +|||||+++++|.+++.+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l-~HpnIV~l~~~~~~~~~~~ivm 129 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGL-SSPRIVPLYGAVREGPWVNIFM 129 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEE
Confidence 457778999999999999999999999999999986432 24699999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc-ceEeCccCc
Q psy14702 197 EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL-HYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~-~vkL~DFG~ 275 (480)
|||+||+|.+++++.+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++ .+||+|||+
T Consensus 130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl------------~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL------------SSDGSRAALCDFGH 197 (336)
T ss_dssp CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE------------CTTSCCEEECCCTT
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE------------eCCCCEEEEeeCCC
Confidence 999999999999988899999999999999999999999999999999999999 4444 699999999
Q ss_pred ccccCCC---------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCc--cchHHHhcCCCC--
Q psy14702 276 VIADNDF---------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG--PMWHHIRDGNIE-- 341 (480)
Q Consensus 276 a~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~--~~~~~i~~~~~~-- 341 (480)
|+..... ...+||+.|||||++.+..++ .++|||||||++||| +|..||.... .....+.....+
T Consensus 198 a~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~ 276 (336)
T 4g3f_A 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR 276 (336)
T ss_dssp CEEC------------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred CeEccCCCcccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch
Confidence 9754321 234799999999999988765 789999999999996 7888887543 345566665543
Q ss_pred -cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 342 -KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 342 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
.++.+|+++++||.+||++||.+|||+.|+++|.+..
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 4567999999999999999999999999999886543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-58 Score=448.64 Aligned_cols=249 Identities=29% Similarity=0.506 Sum_probs=201.7
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC---
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG--- 190 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--- 190 (480)
||..+|.+.+.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+++.| +|||||+++++|.+.+
T Consensus 2 R~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC---
T ss_pred CcchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCccc
Confidence 56778999999999999999999999999999999997643 344456789999999999 8999999999987544
Q ss_pred ---------EEEEEeeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCC
Q psy14702 191 ---------VLYLQLEYCNGGNLENIIQERCT---FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELN 258 (480)
Q Consensus 191 ---------~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~ 258 (480)
.+|||||||+||+|.+++..+.. .++..++.|+.||+.||+|||++|||||||||+|||+
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl-------- 151 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF-------- 151 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE--------
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE--------
Confidence 47999999999999999987654 4456788999999999999999999999999999999
Q ss_pred CCCCccccceEeCccCcccccCCC----------------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCC
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADNDF----------------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGV 322 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~ 322 (480)
+.++.+||+|||+|+..... ...+||+.|||||++.+..++ .++|||||||++|||+.
T Consensus 152 ----~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~- 225 (299)
T 4g31_A 152 ----TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY- 225 (299)
T ss_dssp ----CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS-
T ss_pred ----CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc-
Confidence 56778999999998654321 224699999999999987665 79999999999999973
Q ss_pred CCCCCCccc---hHHHhcCCCC-cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 323 TPLPKNGPM---WHHIRDGNIE-KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 323 ~p~~~~~~~---~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
||...... ...+.....+ .+...++.+.+||.+||++||.+|||+.|+++||||..
T Consensus 226 -Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 226 -PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp -CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred -CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 77543322 2334444443 22446778899999999999999999999999999854
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-57 Score=455.59 Aligned_cols=251 Identities=21% Similarity=0.311 Sum_probs=212.5
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee------CC
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------QG 190 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------~~ 190 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++++........+.+.+|+.+|+.+ +|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccCC
Confidence 478999999999999999999999999999999987766666677889999999999 79999999998763 36
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|||||||+ |+|.+++.+++.+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~------------~~~~~~Ki 199 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV------------NENCELKI 199 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTCCEEE
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc------------CCCCCEEE
Confidence 7999999995 6899999888899999999999999999999999999999999999999 66778999
Q ss_pred CccCcccccCC--------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcC-
Q psy14702 271 GDFGHVIADND--------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDG- 338 (480)
Q Consensus 271 ~DFG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~- 338 (480)
+|||+|+.... ....+||+.|||||++.+..+++.++||||+|||+||| +|..||...+. ....|...
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~ 279 (398)
T 4b99_A 200 GDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVL 279 (398)
T ss_dssp CCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhc
Confidence 99999864321 23467999999999998876656899999999999996 67777766543 11112110
Q ss_pred -C--------------------CC---------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 339 -N--------------------IE---------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 339 -~--------------------~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
. .+ .++.+|+++++||.+||.+||.+|||+.|+|+||||++..
T Consensus 280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0 00 1245789999999999999999999999999999998643
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=433.59 Aligned_cols=244 Identities=23% Similarity=0.379 Sum_probs=205.4
Q ss_pred hhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.+.||+|+||+||+|.+. .++..||||+++.. .....+.|.+|+.+++.+ +|||||++++++.+++.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~ 89 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNL-QHEHIVKFYGVCVEGDP 89 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCE
Confidence 46778899999999999999864 46889999999753 445567799999999999 89999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCC
Q psy14702 192 LYLQLEYCNGGNLENIIQER-------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELN 258 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~ 258 (480)
+|||||||++|+|.++|... ..+++.++..|+.||+.||.|||+++||||||||+|||+
T Consensus 90 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl-------- 161 (299)
T 4asz_A 90 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV-------- 161 (299)
T ss_dssp EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--------
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE--------
Confidence 99999999999999999753 369999999999999999999999999999999999999
Q ss_pred CCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP 330 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~ 330 (480)
+.++.+||+|||+|+..... ....||+.|||||++.+..++ .++|||||||+||||+ |..||.....
T Consensus 162 ----~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 162 ----GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp ----CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ----CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 67789999999999654322 123589999999999988765 7999999999999974 6778875443
Q ss_pred --chHHHhcCCC-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 331 --MWHHIRDGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 331 --~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
....+..+.. +.+..+|+++.+||.+||+.||++|||+.+|. .|+.
T Consensus 237 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~ 285 (299)
T 4asz_A 237 NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQ 285 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHH
Confidence 4455666654 45677999999999999999999999999994 4554
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-56 Score=443.72 Aligned_cols=248 Identities=17% Similarity=0.307 Sum_probs=203.4
Q ss_pred hhhhhhhhheeecccCceEEEEEEEe---eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKY---MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
....+|.+.+.||+|+||+||+|+++ .+++.||+|++..... ...+.+|+.++..+.+|||||+++++|.+.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 45567999999999999999999876 3578999999865422 2347789999999988999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
++|||||||+||+|.++++ .+++.+++.++.||+.||+|||++|||||||||+|||++. ..+.+||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~-----------~~~~~kl 159 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNR-----------RLKKYAL 159 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-----------TTTEEEE
T ss_pred EEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeC-----------CCCeEEE
Confidence 9999999999999999984 5999999999999999999999999999999999999942 2358999
Q ss_pred CccCcccccCC--------------------------------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHH
Q psy14702 271 GDFGHVIADND--------------------------------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE 318 (480)
Q Consensus 271 ~DFG~a~~~~~--------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilye 318 (480)
+|||+|+.... ....+||+.|+|||++.+...++.++||||+|||+||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e 239 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS 239 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence 99999864321 1234699999999999887655678999999999999
Q ss_pred H-hCCCCCCCCccchH---HHh--------------------------------------c----------------CCC
Q psy14702 319 A-SGVTPLPKNGPMWH---HIR--------------------------------------D----------------GNI 340 (480)
Q Consensus 319 l-~~~~p~~~~~~~~~---~i~--------------------------------------~----------------~~~ 340 (480)
| +|..||........ .|. . ...
T Consensus 240 ll~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 319 (361)
T 4f9c_A 240 LLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNL 319 (361)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--------------------
T ss_pred HHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccc
Confidence 6 67788865432110 000 0 011
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
..+..+|+++++||.+||++||++|||++|+++||||..
T Consensus 320 ~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 320 EGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp --CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred cccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 234568999999999999999999999999999999863
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=427.95 Aligned_cols=246 Identities=23% Similarity=0.368 Sum_probs=201.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.++.+.+.||+|+||+||+|+. ...||||+++.........+.|.+|+.+++.+ +|||||++++++.+ +.+||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~-~~~~iVm 110 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKW---HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK-DNLAIVT 110 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEES---SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEE---CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC-CeEEEEE
Confidence 3456789999999999999964 33699999987666666678899999999999 89999999998765 5689999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+||+|.+++... ..+++.++..|+.||+.||+|||+++||||||||+|||+ +.++.+||+|||+
T Consensus 111 Ey~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl------------~~~~~~Ki~DFGl 178 (307)
T 3omv_A 111 QWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL------------HEGLTVKIGDFGL 178 (307)
T ss_dssp ECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE------------ETTEEEEECCCSS
T ss_pred EcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE------------CCCCcEEEeeccC
Confidence 999999999999764 579999999999999999999999999999999999999 6678999999999
Q ss_pred ccccCC------CcccCCCcccchhhhhcccC--CCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCC---
Q psy14702 276 VIADND------FEVEEGDCRYLPKELLNNNF--DNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNI--- 340 (480)
Q Consensus 276 a~~~~~------~~~~~gt~~y~aPE~~~~~~--~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~--- 340 (480)
|+.... ....+||+.|||||++.+.. .++.++|||||||+|||| +|..||..... ....+..+..
T Consensus 179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 179 ATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp CBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCC
T ss_pred ceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 965432 23457999999999997532 234689999999999996 78888875443 2223333321
Q ss_pred --CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 341 --EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 341 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
..+.++|+++.+||.+||+.||++|||+.+|+++.+..+
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 123568999999999999999999999999999877544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=431.72 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=206.3
Q ss_pred hhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.+.||+|+||+||+|+.+ .+++.||||+++.. .....+.|.+|+.++..+ +|||||++++++.+.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~~~~ 117 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTML-QHQHIVRFFGVCTEGRP 117 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCE
Confidence 45777899999999999999854 46889999999753 455567799999999999 89999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC
Q psy14702 192 LYLQLEYCNGGNLENIIQER---------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE 256 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~ 256 (480)
+|||||||++|+|.++++.. .++++.++..|+.||+.||.|||+++||||||||+|||+
T Consensus 118 ~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl------ 191 (329)
T 4aoj_A 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV------ 191 (329)
T ss_dssp EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------
T ss_pred EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE------
Confidence 99999999999999999753 358999999999999999999999999999999999999
Q ss_pred CCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCC
Q psy14702 257 LNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKN 328 (480)
Q Consensus 257 ~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~ 328 (480)
+.++.+||+|||+++..... ....||+.|||||++.+..++ .++|||||||+||||+ |..||...
T Consensus 192 ------~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 192 ------GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp ------ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred ------CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCC
Confidence 66789999999999754221 235699999999999987665 7999999999999974 67788754
Q ss_pred cc--chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 329 GP--MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 329 ~~--~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
.. ....+..+. .+.+..+|+++.+||.+||+.||++|||+.||+++..-....|
T Consensus 265 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 265 SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred CHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 43 345555554 4566789999999999999999999999999998865544444
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=426.54 Aligned_cols=243 Identities=20% Similarity=0.324 Sum_probs=203.7
Q ss_pred hhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 119 FLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 119 y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
+.+.+.||+|+||+||+|... .+++.||||+++.... ....+.|.+|+.++..+ +|||||++++++.+++.+|
T Consensus 28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARL-QHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCE
T ss_pred CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhC-CCCCCCCcceEEEECCEEE
Confidence 445789999999999999753 4678999999975432 33346699999999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCC
Q psy14702 194 LQLEYCNGGNLENIIQER----------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL 257 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~ 257 (480)
||||||++|+|.++|..+ ..+++.++..|+.||+.||+|||+++||||||||+|||+
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl------- 178 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV------- 178 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-------
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE-------
Confidence 999999999999999643 358999999999999999999999999999999999999
Q ss_pred CCCCCccccceEeCccCcccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCc
Q psy14702 258 NEPMNTEKLHYKLGDFGHVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNG 329 (480)
Q Consensus 258 ~~~~~~~~~~vkL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~ 329 (480)
++++.+||+|||+++.... .....||+.|||||++.+..++ .++|||||||+||||+ |..||....
T Consensus 179 -----~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 -----YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp -----CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred -----CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 6778999999999864322 2335699999999999988665 7999999999999974 567876544
Q ss_pred c--chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 330 P--MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 330 ~--~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
. ....+..+. .+.+..+|+++.+||.+||+.||++|||+.+|+++..
T Consensus 253 ~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~ 302 (308)
T 4gt4_A 253 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302 (308)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3 445555554 4556789999999999999999999999999988753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-55 Score=462.38 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=211.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-HHHHHHHHH---HHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-AQEKIFKKE---IHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E---i~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
..+|.+.++||+|+||+||+|+++.+|+.||||++.+..... .....+.+| +.++..+ +|||||+++++|.+.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEECCE
Confidence 346889999999999999999999999999999986521110 111223344 4444455 79999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++++||+
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl------------d~~G~vKL~ 334 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL------------DEHGHVRIS 334 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE------------CTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE------------eCCCCEEec
Confidence 99999999999999999988899999999999999999999999999999999999999 677899999
Q ss_pred ccCcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHhcCCCCcC
Q psy14702 272 DFGHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIRDGNIEKL 343 (480)
Q Consensus 272 DFG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~~~~~~~~ 343 (480)
|||+|..... ....+||+.|||||++.++..++.++|||||||+|||| +|..||..... ....+....+..+
T Consensus 335 DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 335 DLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp CCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred ccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence 9999976543 34568999999999997654444789999999999996 78888864322 3345566777778
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCC-----hhHHHHHHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPS-----TSSLRRSAQLAR 379 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps-----~~ell~h~~~~~ 379 (480)
..+|+++++||.+||++||.+|++ ++||++||||..
T Consensus 415 ~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 415 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 889999999999999999999998 799999999964
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=428.02 Aligned_cols=246 Identities=22% Similarity=0.334 Sum_probs=207.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeC-----CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-C
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMD-----GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-Q 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~ 189 (480)
..+|.+.+.||+|+||+||+|.+..+ ++.||||+++.. ......+.|.+|+.++..+.+|||||+++++|.. +
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 35788899999999999999987654 368999999764 3344566799999999999888999999999866 4
Q ss_pred CEEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecc
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER----------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKA 253 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~ 253 (480)
+.+|||||||++|+|.++|+.. ..+++..+..|+.||+.||+|||+++||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl--- 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee---
Confidence 5789999999999999999753 248999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCC
Q psy14702 254 QGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPL 325 (480)
Q Consensus 254 ~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~ 325 (480)
+.++.+||+|||+|+..... ...+||+.|||||++.+..++ .++|||||||+||||+ |..||
T Consensus 219 ---------~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 219 ---------SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp ---------CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSS
T ss_pred ---------CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCC
Confidence 67789999999999754321 234589999999999988765 7999999999999984 67788
Q ss_pred CCCcc---chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 326 PKNGP---MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 326 ~~~~~---~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..... +...+..+. .+.+..+++++.+||.+||+.||++|||+.+|++|.
T Consensus 289 ~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L 342 (353)
T 4ase_A 289 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342 (353)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHH
Confidence 75432 334455554 455667999999999999999999999999999984
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-53 Score=451.48 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=219.1
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||+||+|.++.+|+.||+|++... .....+.+.+|+.+|+.| +|||||+++++|.+.+.+||
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEE
Confidence 446899999999999999999999999999999999764 344456789999999999 89999999999999999999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||+||+|.++|.. .+.+++.+++.|+.||+.||+|||++||+||||||+|||+.. +..+.+||+||
T Consensus 232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~----------~~~~~vKl~DF 301 (573)
T 3uto_A 232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT----------KRSNELKLIDF 301 (573)
T ss_dssp EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------SSCCCEEECCC
T ss_pred EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC----------CCCCCEEEeec
Confidence 9999999999999964 457999999999999999999999999999999999999943 23468999999
Q ss_pred CcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC----cC
Q psy14702 274 GHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE----KL 343 (480)
Q Consensus 274 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~----~~ 343 (480)
|+|+..... ...+||+.|||||++.+..+. .++|||||||++||| +|..||..... .+..+....+. .+
T Consensus 302 G~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 380 (573)
T 3uto_A 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 380 (573)
T ss_dssp SSCEECCTTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG
T ss_pred cceeEccCCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc
Confidence 999765433 346799999999999988765 789999999999996 77888876543 44556665543 33
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
..+|+++++||.+||+.||.+|||+.|+++||||....
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~ 418 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 418 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence 57899999999999999999999999999999998643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=407.74 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=225.1
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.+++.+ +||||+++++++...+.+|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCEEEEE
Confidence 4578899999999999999999999999999999987655666677789999999999 799999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll------------~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL------------DADMNIKIADFGF 160 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTSCEEECSTTC
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE------------cCCCCEEEeeccC
Confidence 9999999999999888899999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHH
Q psy14702 276 VIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDD 349 (480)
Q Consensus 276 a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~ 349 (480)
+..... ....+||+.|+|||++.+..+.+.++|||||||++|+| +|..||..... ....+..+.+..+..++++
T Consensus 161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 240 (328)
T 3fe3_A 161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240 (328)
T ss_dssp CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 865432 23457999999999999887766789999999999996 67778765543 4556677777777789999
Q ss_pred HHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 350 ~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+.+||.+||..||.+|||+.|+++||||....
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999997654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=422.75 Aligned_cols=291 Identities=26% Similarity=0.400 Sum_probs=235.6
Q ss_pred CcchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 111 DHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 111 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
...++..+|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++..+ +||||+++++++.+.+
T Consensus 5 ~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~ 83 (444)
T 3soa_A 5 TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEG 83 (444)
T ss_dssp --CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEECSS
T ss_pred ccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEECC
Confidence 345778899999999999999999999999999999999987665566667799999999999 8999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
..|+|||||.||+|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||+... ...+.+||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~---------~~~~~vkL 154 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK---------LKGAAVKL 154 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS---------STTCCEEE
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc---------CCCCcEEE
Confidence 999999999999999999988899999999999999999999999999999999999999532 23568999
Q ss_pred CccCcccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC--
Q psy14702 271 GDFGHVIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE-- 341 (480)
Q Consensus 271 ~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~-- 341 (480)
+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+..+...
T Consensus 155 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 233 (444)
T 3soa_A 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFP 233 (444)
T ss_dssp CCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred ccCceeEEecCCCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCC
Confidence 999998654432 235799999999999887665 789999999999996 67777765543 45556665443
Q ss_pred --cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHH
Q psy14702 342 --KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAV 413 (480)
Q Consensus 342 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~ 413 (480)
.+..+++++++||.+||+.||.+|||+.|+++|||+........ ..........++++...++++++++.+
T Consensus 234 ~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~-~~~~~~~~~~l~~~~~~~klk~~~~~~ 306 (444)
T 3soa_A 234 SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS-CMHRQETVDCLKKFNARRKLKGAILTV 306 (444)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSC-CCCCHHHHHHHHHHHHHHHHHTTCSCE
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccc-cchhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 33578999999999999999999999999999999976421111 111223345566666655555554443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=406.70 Aligned_cols=292 Identities=24% Similarity=0.375 Sum_probs=241.5
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+..+|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++..+ +||||+++++++.+.+..
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEE
Confidence 4567789999999999999999999999999999999987666666667799999999999 799999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|+|||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... .....+||+|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~---------~~~~~~kl~D 174 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK---------AKGAAVKLAD 174 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCS---------STTCCEEECC
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC---------CCCCCEEEee
Confidence 9999999999999999888889999999999999999999999999999999999999542 2245699999
Q ss_pred cCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc----
Q psy14702 273 FGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK---- 342 (480)
Q Consensus 273 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~---- 342 (480)
||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+..+.+..
T Consensus 175 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 253 (362)
T 2bdw_A 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 253 (362)
T ss_dssp CTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTG
T ss_pred cCcceEecCCcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 9998655432 235799999999999887655 789999999999996 67777765443 445555554432
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHHhhH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGI 416 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 416 (480)
+..+++++++||.+||..||.+|||+.++++|||+........ ..........++++...+.++++++.++..
T Consensus 254 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 326 (362)
T 2bdw_A 254 WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVAS-AIHRQDTVDCLKKFNARRKLKGAILTTMIA 326 (362)
T ss_dssp GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSC-CCCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCccccc-ccchhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3468999999999999999999999999999999975321111 111234456678888888888888776543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=402.18 Aligned_cols=241 Identities=20% Similarity=0.362 Sum_probs=183.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC----EE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG----VL 192 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----~~ 192 (480)
.+|.+.+.||+|+||+||+|+. +|+.||||+++.. ......+..|+..+..+ +|||||++++++..++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEE
Confidence 4577889999999999999974 7999999998642 22223344566655666 8999999999998653 68
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEeccCCCCCCCCCcc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM--------RMIHMDIKPANILIVKAQGELNEPMNTE 264 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~IvHrDlKp~NILl~~~~~~~~~~~~~~ 264 (480)
|||||||++|+|.++++.. ++++..+..++.|++.||+|||++ +||||||||+|||+ +.
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl------------~~ 143 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV------------KK 143 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE------------CT
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE------------CC
Confidence 9999999999999999764 699999999999999999999987 99999999999999 67
Q ss_pred ccceEeCccCcccccCCC--------cccCCCcccchhhhhcccCC-----CCCcccHHHHHHHHHHHhCCCCCCC-Cc-
Q psy14702 265 KLHYKLGDFGHVIADNDF--------EVEEGDCRYLPKELLNNNFD-----NLSKVDIFALGLTLYEASGVTPLPK-NG- 329 (480)
Q Consensus 265 ~~~vkL~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~-----~~~k~DiwSlGvilyel~~~~p~~~-~~- 329 (480)
++.+||+|||+++..... ...+||+.|||||++.+... .+.++|||||||+||||+++.|++. ..
T Consensus 144 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~ 223 (303)
T 3hmm_A 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc
Confidence 789999999998654321 12469999999999976431 2358999999999999855433221 10
Q ss_pred ------------cchH----HHhcCCC-CcCCC------CCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 330 ------------PMWH----HIRDGNI-EKLSN------VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 330 ------------~~~~----~i~~~~~-~~~~~------~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
+... .+..... +.++. .+..+.+|+.+||+.||++|||+.||++...
T Consensus 224 ~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred ccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 0111 1222221 11111 2346889999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=390.22 Aligned_cols=268 Identities=45% Similarity=0.824 Sum_probs=226.7
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
+++..+|.+.+.||+|+||.||+|.+..+++.||||++............+.+|+..+..+.+||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~ 86 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM 86 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence 46778999999999999999999999999999999999876666666677889999999988899999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCC-------CCCC
Q psy14702 193 YLQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL-------NEPM 261 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~-------~~~~ 261 (480)
|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+... ....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999999764 5799999999999999999999999999999999999996432100 0000
Q ss_pred CccccceEeCccCcccccCCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCCCCCCCCccchHHHhcCCCC
Q psy14702 262 NTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIE 341 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~~p~~~~~~~~~~i~~~~~~ 341 (480)
......+||+|||++..........||+.|+|||++.+....+.++|||||||++|+|+++.|++.....+..+..+..+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQGRLP 246 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHHHHTTCCC
T ss_pred cCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHHHHcCCCC
Confidence 02456799999999987776667789999999999987655556899999999999998888887777777777777665
Q ss_pred cC-CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 342 KL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 342 ~~-~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.. ..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 247 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 247 RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 44 5689999999999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=404.66 Aligned_cols=256 Identities=23% Similarity=0.371 Sum_probs=217.1
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHH----HHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTA----QEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~----~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
..+..+|.+.+.||+|+||.||+|.++.+|+.||+|+++....... ....+.+|+.++..+ +||||++++++|.+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEEe
Confidence 3456779999999999999999999999999999999876433211 235688999999999 79999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
...+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+ .....+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~--------~~~~~v 158 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN--------IPIPHI 158 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------SSSCCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCC--------CCccCE
Confidence 999999999999999999998888899999999999999999999999999999999999994322 112379
Q ss_pred EeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc
Q psy14702 269 KLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK 342 (480)
Q Consensus 269 kL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~ 342 (480)
||+|||++..... ....+||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..+.+..
T Consensus 159 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp EECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEEecCCceEcCCCCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 9999999865443 2345799999999999877665 789999999999996 67778765543 345565555433
Q ss_pred ----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 343 ----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 343 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
+..+++++++||.+||..||.+|||+.++++||||.
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~ 277 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence 357899999999999999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=403.09 Aligned_cols=250 Identities=25% Similarity=0.379 Sum_probs=215.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++++... .......+.+|..++..+.+||||+++++++.+.+.+|+|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 468889999999999999999999999999999875311 1122345778999999887899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl------------~~~g~ikL~DFG~ 170 (353)
T 3txo_A 103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL------------DHEGHCKLADFGM 170 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE------------CCCCCEEEccccc
Confidence 9999999999999988899999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
+..... ....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+..+....+..+++
T Consensus 171 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~ 249 (353)
T 3txo_A 171 CKEGICNGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHE 249 (353)
T ss_dssp CBCSCC---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred eeecccCCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Confidence 875322 2345799999999999887665 789999999999996 77788876543 566777787777788999
Q ss_pred HHHHHHHHhhccCCCCCCCh------hHHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPST------SSLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~------~ell~h~~~~~ 379 (480)
++.+||.+||.+||.+||++ .++++||||..
T Consensus 250 ~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence 99999999999999999999 89999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=415.37 Aligned_cols=311 Identities=23% Similarity=0.377 Sum_probs=248.6
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-----------HHHHHHHHHHHHHHhcCCCCceeE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-----------AQEKIFKKEIHAHALLSRVPHIVN 181 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-----------~~~~~~~~Ei~~l~~l~~hpnIv~ 181 (480)
.....+|.+.+.||+|+||+||+|.++.+++.||+|++....... .....+.+|+.++..+ +||||++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~ 110 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNIIK 110 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBCC
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCCe
Confidence 346678999999999999999999999999999999987643221 1235688999999999 7899999
Q ss_pred EeeEEeeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCC
Q psy14702 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPM 261 (480)
Q Consensus 182 l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~ 261 (480)
+++++.+...+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------- 183 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN------- 183 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTT-------
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCC-------
Confidence 9999999999999999999999999998888999999999999999999999999999999999999995321
Q ss_pred CccccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHH
Q psy14702 262 NTEKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHI 335 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i 335 (480)
....+||+|||++..... .....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+
T Consensus 184 --~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i 259 (504)
T 3q5i_A 184 --SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259 (504)
T ss_dssp --CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred --CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccC-C-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 234799999999865443 2345699999999998764 3 3689999999999996 67778765543 44555
Q ss_pred hcCCCCc----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCcccc--ccccHHHHhhhccCCCcchHH
Q psy14702 336 RDGNIEK----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVEN--IRGNLNTRLKKLDEGNVFDGI 409 (480)
Q Consensus 336 ~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~ 409 (480)
..+.+.. +..+|+++++||.+||..||.+|||+.++++||||.+......... .......+++++...+.++.+
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~~a 339 (504)
T 3q5i_A 260 EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQA 339 (504)
T ss_dssp HHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHHCCCCSHHHHH
T ss_pred HcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHHHHHHHHHHHH
Confidence 5555432 3678999999999999999999999999999999998765543211 123345567889999999888
Q ss_pred HHHHhhHH--HhcccccccccccccCCC
Q psy14702 410 ILAVAGIV--RMKWKDRIMAVFSEYKPG 435 (480)
Q Consensus 410 ~l~~~~~~--~~~~~~~~~~~~~~~~~~ 435 (480)
++.++... ......++...|..++..
T Consensus 340 ~l~~i~~~~~~~~~~~~l~~~F~~~D~d 367 (504)
T 3q5i_A 340 AILFIGSKLTTLEERKELTDIFKKLDKN 367 (504)
T ss_dssp HHHHHHHHTSCHHHHHHHHHHHHHHCTT
T ss_pred HHHHhhccCCcHHHHHHHHHHHHeeCCC
Confidence 88776432 444556677778777643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=415.83 Aligned_cols=313 Identities=21% Similarity=0.356 Sum_probs=246.7
Q ss_pred CcchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 111 DHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 111 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
....+..+|.+.+.||+|+||+||+|.+..++..||+|++............+.+|+.++..+ +||||+++++++.+..
T Consensus 31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 109 (494)
T 3lij_A 31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFEDKR 109 (494)
T ss_dssp CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEECSS
T ss_pred CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCC
Confidence 334567789999999999999999999999999999999886543333345688999999999 8899999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||
T Consensus 110 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---------~~~~~~kl 180 (494)
T 3lij_A 110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK---------EKDALIKI 180 (494)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS---------STTCCEEE
T ss_pred EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC---------CCCCcEEE
Confidence 999999999999999999888899999999999999999999999999999999999999532 23456999
Q ss_pred CccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC---
Q psy14702 271 GDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE--- 341 (480)
Q Consensus 271 ~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~--- 341 (480)
+|||++..... .....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+..+.+.
T Consensus 181 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 258 (494)
T 3lij_A 181 VDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDS 258 (494)
T ss_dssp CCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTC-B-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCS
T ss_pred EECCCCeECCCCccccccCCCcCeeCHHHHccc-C-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence 99999865443 2345699999999998754 3 3689999999999996 67777765543 34455555433
Q ss_pred -cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCC---ccccccccHHHHhhhccCCCcchHHHHHHhhHH
Q psy14702 342 -KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL---KVENIRGNLNTRLKKLDEGNVFDGIILAVAGIV 417 (480)
Q Consensus 342 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 417 (480)
.+..+|+++++||.+||+.||.+|||+.++++||||....... .......+...+++++...+.++.+++..+...
T Consensus 259 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~qa~l~~ia~~ 338 (494)
T 3lij_A 259 PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLAQAALLYMASK 338 (494)
T ss_dssp GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHTTTTCCHHHHHHHHHHHHH
T ss_pred hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHHHHHhHHHHHHHHHHHHHh
Confidence 3457899999999999999999999999999999998743211 111223456677889999888988888776432
Q ss_pred --HhcccccccccccccCCC
Q psy14702 418 --RMKWKDRIMAVFSEYKPG 435 (480)
Q Consensus 418 --~~~~~~~~~~~~~~~~~~ 435 (480)
......++.+.|..++..
T Consensus 339 ~~~~~~~~~l~~~F~~~D~d 358 (494)
T 3lij_A 339 LTSQEETKELTDIFRHIDKN 358 (494)
T ss_dssp SCCHHHHHHHHHHHHHHCTT
T ss_pred cccHHHHHHHHHHHHHhCcC
Confidence 334455677777776643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=401.22 Aligned_cols=289 Identities=24% Similarity=0.388 Sum_probs=222.7
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV---ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
.+..+|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.++..+ +||||+++++++.+.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCC
Confidence 35678999999999999999999999999999999986421 1111235688999999999 7999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 191 VLYLQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... ....
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~---------~~~~ 170 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK---------ENSA 170 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSS---------STTC
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecC---------CCCC
Confidence 999999999999999887543 258999999999999999999999999999999999999542 2234
Q ss_pred ceEeCccCcccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-chHHHhcCCC
Q psy14702 267 HYKLGDFGHVIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-MWHHIRDGNI 340 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-~~~~i~~~~~ 340 (480)
.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+..+..
T Consensus 171 ~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~ 249 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY 249 (351)
T ss_dssp CEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC
T ss_pred cEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC
Confidence 6999999998655432 235699999999999887665 789999999999996 67778765432 3445555544
Q ss_pred CcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHHh
Q psy14702 341 EKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVA 414 (480)
Q Consensus 341 ~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~ 414 (480)
... ..+++++++||.+||..||.+|||+.++++||||........... ......+++++...+.++.++++++
T Consensus 250 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~ 326 (351)
T 3c0i_A 250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIH-LPETVEQLRKFNARRKLKGAVLAAV 326 (351)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSC-CHHHHHHHHHHHHHHC---------
T ss_pred CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCcccccccc-chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 332 578999999999999999999999999999999985321111011 1223455666666666776666654
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=416.93 Aligned_cols=312 Identities=22% Similarity=0.374 Sum_probs=249.9
Q ss_pred cchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 112 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
...+..+|.+.+.||+|+||+||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++.+...
T Consensus 17 ~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 95 (486)
T 3mwu_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS 95 (486)
T ss_dssp CCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSE
T ss_pred cCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEcCCE
Confidence 34678899999999999999999999999999999999864322222245688999999999 89999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~---------~~~~~~kl~ 166 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK---------EKDCDIKII 166 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS---------STTCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC---------CCCCCEEEE
Confidence 99999999999999999888899999999999999999999999999999999999999532 235679999
Q ss_pred ccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCC----C
Q psy14702 272 DFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI----E 341 (480)
Q Consensus 272 DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~----~ 341 (480)
|||++..... .....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+..+.+ +
T Consensus 167 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp SCSCTTTBCCC----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred ECCcCeECCCCCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 9999865433 2345699999999999875 3 3689999999999996 67777765543 3445555543 3
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccc---cccccHHHHhhhccCCCcchHHHHHHhhHH-
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVE---NIRGNLNTRLKKLDEGNVFDGIILAVAGIV- 417 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~- 417 (480)
.+..+|+++++||.+||..||.+|||+.++++||||.......... ........+++++...+.++.+++..+...
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ia~~l 324 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKL 324 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHHHHHSCHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3467899999999999999999999999999999999865433211 112234456778888888888887766432
Q ss_pred -HhcccccccccccccCCC
Q psy14702 418 -RMKWKDRIMAVFSEYKPG 435 (480)
Q Consensus 418 -~~~~~~~~~~~~~~~~~~ 435 (480)
......++...|..++..
T Consensus 325 ~~~~~~~~l~~~F~~~D~d 343 (486)
T 3mwu_A 325 TTLDETKQLTEIFRKLDTN 343 (486)
T ss_dssp CCHHHHHHHHHHHHHHCTT
T ss_pred ccHHHHHHHHHHHHHhCCC
Confidence 344556677778777643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=395.52 Aligned_cols=249 Identities=24% Similarity=0.338 Sum_probs=215.7
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|.++.+|+.||+|++++... .......+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeCCEEEEE
Confidence 468889999999999999999999999999999875311 111234578899999998 799999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------~~~g~vkL~DFG~ 151 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML------------DKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE------------CCCCCEEEeeccc
Confidence 9999999999999988889999999999999999999999999999999999999 5677899999999
Q ss_pred ccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
+.... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... ....+.......+..+++
T Consensus 152 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 230 (337)
T 1o6l_A 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred hhhcccCCCcccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Confidence 86532 22345799999999999887665 789999999999996 67778765443 455666677777778999
Q ss_pred HHHHHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
++++||.+||+.||.+|| ++.++++||||..
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999999999999999999 9999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=401.06 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=216.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.++||+|+||+||+|+++.+++.||+|++++.... ......+.+|..++..+.+||||++++++|.+.+.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 35688899999999999999999999999999998764322 22234577899999888789999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||+||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl------------~~~g~ikL~DFG 198 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL------------DSEGHIKLTDYG 198 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCT
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE------------CCCCCEEEeecc
Confidence 99999999999999988899999999999999999999999999999999999999 667789999999
Q ss_pred cccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCc-----------cchHHHhcC
Q psy14702 275 HVIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG-----------PMWHHIRDG 338 (480)
Q Consensus 275 ~a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~-----------~~~~~i~~~ 338 (480)
+++... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||.... ..+..+...
T Consensus 199 la~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp TCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred eeeecccCCCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 986422 23446799999999999987665 789999999999996 7777875321 134556677
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCCCh------hHHHHHHHHHH
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPST------SSLRRSAQLAR 379 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~ell~h~~~~~ 379 (480)
....+..++.++++||.+||+.||.+||++ .++++||||..
T Consensus 278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 777778899999999999999999999996 79999999964
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=385.29 Aligned_cols=252 Identities=21% Similarity=0.305 Sum_probs=207.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||+||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEeCCEEEEEE
Confidence 368889999999999999999999999999999987655555566788999999999 7899999999999999999999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||.+ +|.+.+. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~------------~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI------------NRNGELKLANFGL 147 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE------------cCCCCEEEeeccc
Confidence 99976 5555554 45689999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCccch---HHHhc----C-----
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGPMW---HHIRD----G----- 338 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~~~---~~i~~----~----- 338 (480)
+..... .....||+.|+|||++.+....+.++|||||||++|+|+ |+.|+....... ..+.. .
T Consensus 148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTC
T ss_pred ceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhh
Confidence 865432 234568999999999987765557999999999999985 777865443211 11110 0
Q ss_pred --------------------CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 339 --------------------NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 339 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
.....+.+++++++||.+||+.||++|||++|+++||||....|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p 291 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence 00112357899999999999999999999999999999986544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=393.49 Aligned_cols=250 Identities=23% Similarity=0.362 Sum_probs=216.8
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|+++.+++.||+|++++... .......+.+|..++..+.+||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 468889999999999999999999999999999976432 3444566889999999887899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------~~~g~~kL~DFG~ 156 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL------------DSEGHIKLTDYGM 156 (345)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCGGG
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE------------CCCCCEEEEeccc
Confidence 9999999999999888889999999999999999999999999999999999999 5677899999999
Q ss_pred ccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCc-----------cchHHHhcCC
Q psy14702 276 VIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG-----------PMWHHIRDGN 339 (480)
Q Consensus 276 a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~-----------~~~~~i~~~~ 339 (480)
+.... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||.... ..+..+....
T Consensus 157 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 157 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp CBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred cccccCCCCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence 87432 23345799999999999887664 789999999999996 6777775311 1344566666
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCCCCCh------hHHHHHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPST------SSLRRSAQLAR 379 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~------~ell~h~~~~~ 379 (480)
...+..++.++++||.+||+.||.+||++ .++++||||..
T Consensus 236 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 236 IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 67777899999999999999999999996 79999999953
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-50 Score=397.78 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=216.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++...+.+|+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeCCEEEE
Confidence 457889999999999999999999999999999986421111 1124588999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||+ +|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll------------~~~~~~kl~DFG 153 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL------------DDNLNVKIADFG 153 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE------------CTTCCEEECCSS
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE------------cCCCCEEEEEec
Confidence 99999 78999999888899999999999999999999999999999999999999 567789999999
Q ss_pred cccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCc--cchHHHhcCCCCcCCCCCH
Q psy14702 275 HVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG--PMWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 275 ~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~--~~~~~i~~~~~~~~~~~s~ 348 (480)
++..... ....+||+.|+|||++.+..+.+.++|||||||++|+| +|..||.... .....+..+....+..+|+
T Consensus 154 ~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 233 (336)
T 3h4j_B 154 LSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233 (336)
T ss_dssp CTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCH
T ss_pred cceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCH
Confidence 9865433 23457999999999998877655789999999999996 6777876542 2333444455556677999
Q ss_pred HHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
++.+||.+||..||.+|||+.|+++||||....+.
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence 99999999999999999999999999999876654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=389.14 Aligned_cols=249 Identities=23% Similarity=0.403 Sum_probs=216.8
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|++..+|+.||+|++++.... ......+.+|+.++..+ +||||+++++++.+...+|+|
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEeCCEEEEE
Confidence 4688899999999999999999999999999998753111 11234577899999988 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------~~~g~~kL~Dfg~ 152 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL------------DKNGHIKITDFGF 152 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE------------CTTSCEEECCCSS
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE------------cCCCCEEEeecCc
Confidence 9999999999999988889999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCC-cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHHH
Q psy14702 276 VIADNDF-EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLH 351 (480)
Q Consensus 276 a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~~ 351 (480)
+...... ...+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+.......+..++++++
T Consensus 153 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 231 (318)
T 1fot_A 153 AKYVPDVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVK 231 (318)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ceecCCccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 8765443 346799999999999887665 689999999999996 67778765543 455667777777788999999
Q ss_pred HHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 352 TLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 352 ~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
+||.+||..||.+|| +++++++||||..
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 999999999999999 9999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-49 Score=383.18 Aligned_cols=252 Identities=24% Similarity=0.373 Sum_probs=212.8
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
....+|.+.+.||+|+||+||+|.+..+|+.||||++....... .+.+.+|+.++..+ +||||+++++++...+.+|
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 93 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLDSYLVGDELW 93 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcC-CCCCCCeEeEEEEECCEEE
Confidence 34567899999999999999999999999999999987543322 34578899999998 8899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||+||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~------------~~~~~~kl~Df 160 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL------------GMDGSVKLTDF 160 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEECCC
T ss_pred EEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE------------CCCCCEEEeeC
Confidence 999999999999999765 69999999999999999999999999999999999999 56678999999
Q ss_pred CcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHHhc-C--CCCcC
Q psy14702 274 GHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHIRD-G--NIEKL 343 (480)
Q Consensus 274 G~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i~~-~--~~~~~ 343 (480)
|++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||....... ..+.. . ....+
T Consensus 161 g~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (297)
T 3fxz_A 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239 (297)
T ss_dssp TTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCG
T ss_pred CCceecCCcccccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCc
Confidence 98865432 2335699999999999887665 789999999999996 6777876554321 11221 1 23344
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
..+++.+.+||.+||+.||.+|||+.++++||||....+
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 668999999999999999999999999999999976543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=388.21 Aligned_cols=253 Identities=21% Similarity=0.332 Sum_probs=215.4
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
+..+|.+.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhC-CCCCCCeEeEEEecCCEEEE
Confidence 346788999999999999999999999999999998743 33445688999999999 79999999999999999999
Q ss_pred EeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. ..++.+||+||
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~----------~~~~~~kl~Df 148 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT----------RRSSTIKIIEF 148 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------SSCCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc----------CCCCCEEEEEC
Confidence 99999999999999765 37999999999999999999999999999999999999943 12578999999
Q ss_pred CcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc----C
Q psy14702 274 GHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK----L 343 (480)
Q Consensus 274 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~----~ 343 (480)
|++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..+.... +
T Consensus 149 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (321)
T 1tki_A 149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF 227 (321)
T ss_dssp TTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred CCCeECCCCCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh
Confidence 998765432 335699999999999877554 789999999999996 67778765443 344555555443 2
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
+.+|.++++||.+||..||.+|||+.|+++||||.....
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 578999999999999999999999999999999987543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=396.04 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=215.8
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|+++.+|+.||||++++... .......+..|..++..+.+||||+++++++.+.+.+|+|
T Consensus 17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv 96 (345)
T 1xjd_A 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 96 (345)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence 468889999999999999999999999999999875311 0112344677888888777899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 97 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 97 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL------------DKDGHIKIADFGM 164 (345)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE------------CCCCCEEEeEChh
Confidence 9999999999999988889999999999999999999999999999999999999 5677899999999
Q ss_pred ccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
+.... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+.......+..+++
T Consensus 165 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 243 (345)
T 1xjd_A 165 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 243 (345)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred hhhcccCCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCH
Confidence 86532 23446799999999999887665 789999999999996 67778765543 456677777666778999
Q ss_pred HHHHHHHHhhccCCCCCCChh-HHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTS-SLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~-ell~h~~~~~ 379 (480)
++++||.+||..||.+||++. ++++||||..
T Consensus 244 ~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 244 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275 (345)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence 999999999999999999998 9999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=411.92 Aligned_cols=311 Identities=22% Similarity=0.370 Sum_probs=249.8
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
..+..+|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCE
Confidence 35677899999999999999999999999999999998754322 23345688999999999 89999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~---------~~~~~~kl~ 171 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK---------SKDANIRII 171 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS---------STTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC---------CCCCcEEEE
Confidence 99999999999999999988899999999999999999999999999999999999999432 345689999
Q ss_pred ccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCC----C
Q psy14702 272 DFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI----E 341 (480)
Q Consensus 272 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~----~ 341 (480)
|||++...... ....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+..+.+ +
T Consensus 172 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 249 (484)
T 3nyv_A 172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-Y-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP 249 (484)
T ss_dssp CTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred eeeeeEEcccccccccCCCCccccCceeecCC-C-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99998654432 335699999999999874 3 3689999999999996 67778766543 3445555543 3
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCcc--ccccccHHHHhhhccCCCcchHHHHHHhhH--H
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKV--ENIRGNLNTRLKKLDEGNVFDGIILAVAGI--V 417 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~l~~~~~--~ 417 (480)
.+..+|+++++||.+||+.||.+|||+.++++||||......... .....+...+++++...+.++.+++..++. .
T Consensus 250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~qa~l~~i~~~~~ 329 (484)
T 3nyv_A 250 QWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLT 329 (484)
T ss_dssp GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHHhhhhHHHHHHHHHHHhccC
Confidence 346789999999999999999999999999999999876542211 111233445677777777788877776643 3
Q ss_pred HhcccccccccccccCCC
Q psy14702 418 RMKWKDRIMAVFSEYKPG 435 (480)
Q Consensus 418 ~~~~~~~~~~~~~~~~~~ 435 (480)
......++...|..++..
T Consensus 330 ~~~~~~~l~~~F~~~D~d 347 (484)
T 3nyv_A 330 SQDETKELTAIFHKMDKN 347 (484)
T ss_dssp HHHHHHHHHHHHHHHCTT
T ss_pred cHHHHHHHHHHHHHhCcC
Confidence 455666777778777643
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=391.60 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=213.3
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+..+|.+.+.||+|+||.||+|.++.+|+.||||++.+.... ..+|+.++..+.+||||+++++++.+...+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~ 92 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVY 92 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence 4677899999999999999999999999999999999765332 3457888888878999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+ .....+||+||
T Consensus 93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~--------~~~~~~kl~Df 164 (342)
T 2qr7_A 93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES--------GNPESIRICDF 164 (342)
T ss_dssp EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS--------CSGGGEEECCC
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC--------CCcCeEEEEEC
Confidence 9999999999999999888899999999999999999999999999999999999995432 23356999999
Q ss_pred CcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCc-----cchHHHhcCCCCc-
Q psy14702 274 GHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG-----PMWHHIRDGNIEK- 342 (480)
Q Consensus 274 G~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~-----~~~~~i~~~~~~~- 342 (480)
|++..... ....+||+.|+|||++.+..+. .++|||||||++|+| +|..||.... .....+..+.+..
T Consensus 165 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 243 (342)
T 2qr7_A 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS 243 (342)
T ss_dssp TTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC
T ss_pred CCcccCcCCCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC
Confidence 99865432 2345789999999999876554 689999999999996 6777776432 2345555555443
Q ss_pred ---CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 343 ---LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 343 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+..+|+++++||.+||..||.+|||+.++++||||..
T Consensus 244 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 244 GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 3568999999999999999999999999999999965
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=393.04 Aligned_cols=254 Identities=24% Similarity=0.307 Sum_probs=205.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||+||+|.+..+++.||||++....... ..+.+|+.+++.+ +||||+++++++.+.+.+|+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhC-CCCCCCcEEEEEeeCCEEEEE
Confidence 457888999999999999999999999999999997643322 3477899999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+.. +....+||+|||+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~----------~~~~~~kl~Dfg~ 164 (361)
T 3uc3_A 95 MEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG----------SPAPRLKICDFGY 164 (361)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS----------SSSCCEEECCCCC
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC----------CCCceEEEeecCc
Confidence 999999999999988888999999999999999999999999999999999999943 2234599999998
Q ss_pred ccccC---CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------chHHHhcCCC--CcC
Q psy14702 276 VIADN---DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MWHHIRDGNI--EKL 343 (480)
Q Consensus 276 a~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------~~~~i~~~~~--~~~ 343 (480)
+.... ......||+.|+|||++.+..+.+.++|||||||++|+| +|..||..... ....+..... +..
T Consensus 165 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (361)
T 3uc3_A 165 SKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244 (361)
T ss_dssp C---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT
T ss_pred cccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc
Confidence 86332 223456999999999998876664559999999999996 67778765432 1223333333 333
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
..+++++++||.+||..||.+|||+.++++||||.+..+.
T Consensus 245 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~ 284 (361)
T 3uc3_A 245 IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA 284 (361)
T ss_dssp SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence 4689999999999999999999999999999999887654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=394.86 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=216.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|.++.+|+.||||++++... .......+..|..++..+.+||||+++++++.+.+.+|+|
T Consensus 20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 99 (353)
T 2i0e_A 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 99 (353)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence 468889999999999999999998999999999875311 1112345778999998887899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll------------~~~g~vkL~DFG~ 167 (353)
T 2i0e_A 100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML------------DSEGHIKIADFGM 167 (353)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE------------cCCCcEEEEeCCc
Confidence 9999999999999988889999999999999999999999999999999999999 6677899999999
Q ss_pred ccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
+.... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+.......+..++.
T Consensus 168 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 246 (353)
T 2i0e_A 168 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 246 (353)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccccccCCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence 87532 23346799999999999887665 789999999999996 67778765543 456677777777788999
Q ss_pred HHHHHHHHhhccCCCCCCC-----hhHHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPS-----TSSLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps-----~~ell~h~~~~~ 379 (480)
++++||.+||..||.+||+ +.++++||||..
T Consensus 247 ~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999999995 699999999863
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=382.88 Aligned_cols=252 Identities=32% Similarity=0.551 Sum_probs=212.0
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+..+|.+.++||+|+||+||+|.+..+|+.||||++............+..|+..+..+.+||||+++++++.+.+.+
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 45667899999999999999999999999999999998876666666666777887777777899999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 193 YLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll------------~~~~~~kl~ 199 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL------------GPRGRCKLG 199 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CGGGCEEEC
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE------------CCCCCEEEc
Confidence 9999999 67998888764 469999999999999999999999999999999999999 667789999
Q ss_pred ccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCCCCCCCCccchHHHhcCCCC--cCCCC
Q psy14702 272 DFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIE--KLSNV 346 (480)
Q Consensus 272 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~~p~~~~~~~~~~i~~~~~~--~~~~~ 346 (480)
|||++...... ....||+.|+|||++.+. + +.++|||||||++|||+++.+++.....+..+..+..+ .+..+
T Consensus 200 DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (311)
T 3p1a_A 200 DFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-Y-GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGL 277 (311)
T ss_dssp CCTTCEECC------CCCCCGGGCCGGGGGTC-C-STHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTS
T ss_pred cceeeeecccCCCCcccCCCccccCHhHhcCC-C-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCC
Confidence 99998655432 334699999999999874 3 36899999999999975444444444455556555433 23568
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
++++.+||.+||+.||++|||+.++++||||.+
T Consensus 278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999999999853
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=392.68 Aligned_cols=284 Identities=23% Similarity=0.329 Sum_probs=221.5
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
....+|.+.+.||+|+||.||+|.+..+++.||||+++... ..+.+.+|+.++..+ +||||+++++++.....+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRL-SHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhC-CCCCCcceeeeEecCCeEE
Confidence 45567899999999999999999999999999999997542 234578899999999 7899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+||
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~---------~~~~~~kl~Df 195 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP---------APDAPLKIADF 195 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS---------STTCCEEECCC
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC---------CCCCCEEEccC
Confidence 999999999999999888889999999999999999999999999999999999999431 23678999999
Q ss_pred CcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCCC----c
Q psy14702 274 GHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNIE----K 342 (480)
Q Consensus 274 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~~----~ 342 (480)
|++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+...... .
T Consensus 196 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~ 274 (349)
T 2w4o_A 196 GLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPW 274 (349)
T ss_dssp C----------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTT
T ss_pred ccccccCcccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCch
Confidence 998654332 345699999999999887654 789999999999996 67788765433 34445554432 2
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHHhh
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAG 415 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 415 (480)
+..++.++.+||.+||..||++|||+.++++||||......... .......++++...+.++.++.++..
T Consensus 275 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (349)
T 2w4o_A 275 WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVH---MDTAQKKLQEFNARRKLKAAVKAVVA 344 (349)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSC---CHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhh---hcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 35689999999999999999999999999999999876544321 23445667778777777777766553
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=384.62 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=215.3
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
.....+|.+.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.++..+ +||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 345678999999999999999999999999999999987643221 1245688999999999 79999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
...+|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+ .....+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~--------~~~~~~ 157 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN--------VPKPRI 157 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS--------SSSCCE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC--------CCCCCE
Confidence 999999999999999999998878899999999999999999999999999999999999994432 123479
Q ss_pred EeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc
Q psy14702 269 KLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK 342 (480)
Q Consensus 269 kL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~ 342 (480)
||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......
T Consensus 158 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 236 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236 (326)
T ss_dssp EECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCC
T ss_pred EEEECCCCeECCCCCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCc
Confidence 9999999865432 3345699999999999877655 789999999999996 67777765432 333444443332
Q ss_pred ----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 343 ----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 343 ----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+..++..+++||.+||..||.+|||+.++++||||..
T Consensus 237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 2568999999999999999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-49 Score=391.07 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=218.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.++..+ +||||+++++++.+...+|+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEcCCEEEE
Confidence 3578889999999999999999999999999999865211 111234578899999998 89999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll------------~~~g~~kL~DFg 186 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI------------DQQGYIQVTDFG 186 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCT
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE------------CCCCCEEEcccc
Confidence 99999999999999988889999999999999999999999999999999999999 567789999999
Q ss_pred cccccCCC-cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHH
Q psy14702 275 HVIADNDF-EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDL 350 (480)
Q Consensus 275 ~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~ 350 (480)
++...... ...+||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+..+....+..++.++
T Consensus 187 ~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 265 (350)
T 1rdq_E 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265 (350)
T ss_dssp TCEECSSCBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHH
T ss_pred cceeccCCcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHH
Confidence 98765433 345799999999999887665 789999999999996 67777765543 45667777777778899999
Q ss_pred HHHHHHhhccCCCCCCC-----hhHHHHHHHHHH
Q psy14702 351 HTLIKLMIDKDPTKRPS-----TSSLRRSAQLAR 379 (480)
Q Consensus 351 ~~li~~~L~~dP~~Rps-----~~ell~h~~~~~ 379 (480)
.+||.+||+.||.+||+ +.++++||||..
T Consensus 266 ~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999999999999998 999999999863
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=373.10 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=219.9
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+..+|.+.+.||+|+||.||+|.+..+|+.||+|++............+.+|+.++..+ +||||+++++++...+..|
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEcCCEEE
Confidence 456789999999999999999999999999999999987655666667789999999999 7899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... .....+||+||
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~---------~~~~~~kl~Df 152 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK---------AKGAAVKLADF 152 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS---------STTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecC---------CCCCcEEEeec
Confidence 999999999999999888889999999999999999999999999999999999999532 22346999999
Q ss_pred CcccccCCCc---ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC----cC
Q psy14702 274 GHVIADNDFE---VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE----KL 343 (480)
Q Consensus 274 G~a~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~----~~ 343 (480)
|++....... ...||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..+... .+
T Consensus 153 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T 3kk8_A 153 GLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW 231 (284)
T ss_dssp TTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred eeeEEcccCccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh
Confidence 9986554332 35699999999999887664 789999999999996 67777765443 33444444332 23
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
..+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 232 DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 56899999999999999999999999999999998653
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=405.72 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=221.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.+++.+ +||||+++++++...+.+|+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~~~~~l 93 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTPSDIFM 93 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 35688899999999999999999999999999998652111 11234688999999998 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||+||+|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll------------~~~~~vkL~DFG 161 (476)
T 2y94_A 94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL------------DAHMNAKIADFG 161 (476)
T ss_dssp EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE------------CTTCCEEECCCS
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE------------ecCCCeEEEecc
Confidence 99999999999999888889999999999999999999999999999999999999 567789999999
Q ss_pred cccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 275 HVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 275 ~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
++..... ....+||+.|+|||++.+..+.+.++|||||||++|+| +|..||..... ....+..+....+..+++
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 241 (476)
T 2y94_A 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNP 241 (476)
T ss_dssp SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCH
T ss_pred chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCH
Confidence 9875433 23457999999999999876655789999999999996 67778765432 456677777777778999
Q ss_pred HHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
++.+||.+||..||.+|||+.++++||||....+.
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 276 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPK 276 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCT
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCcc
Confidence 99999999999999999999999999999986553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=404.95 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=195.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-----C
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-----Q 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-----~ 189 (480)
...+|.+.+.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.++..+ +|||||++++++.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccC
Confidence 34679999999999999999999999999999999987666777778899999999999 89999999999843 3
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
..+|+||||+ +++|.+++.....+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+|
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl------------~~~~~~k 196 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV------------NQDCSVK 196 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTCCEE
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE------------CCCCCEe
Confidence 5799999998 57999999888889999999999999999999999999999999999999 6677899
Q ss_pred eCccCcccccCC-------------------------------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHH
Q psy14702 270 LGDFGHVIADND-------------------------------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE 318 (480)
Q Consensus 270 L~DFG~a~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilye 318 (480)
|+|||+++.... ....+||+.|+|||++.....++.++||||||||+||
T Consensus 197 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~e 276 (458)
T 3rp9_A 197 VCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAE 276 (458)
T ss_dssp ECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred ecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHH
Confidence 999999865431 1234689999999987554444579999999999999
Q ss_pred Hh------------CCCCCCCCccc----------------------hHHHh-----------------------cC---
Q psy14702 319 AS------------GVTPLPKNGPM----------------------WHHIR-----------------------DG--- 338 (480)
Q Consensus 319 l~------------~~~p~~~~~~~----------------------~~~i~-----------------------~~--- 338 (480)
|+ +..+|++.... +..+. ..
T Consensus 277 lltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 356 (458)
T 3rp9_A 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPK 356 (458)
T ss_dssp HHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCC
T ss_pred HHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCC
Confidence 86 33344332210 00000 00
Q ss_pred -----CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 339 -----NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 339 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
....++.+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 357 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 357 REGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp CCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 001234578999999999999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=379.76 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=208.2
Q ss_pred chhhhhhhhh-eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 113 SRYALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 113 ~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.++..+|.+. +.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++..+.+||||+++++++.+.+.
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 3566678774 7899999999999999999999999999765332 234588999999987789999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+ ....+||+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~---------~~~~~kl~ 156 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPN---------QVSPVKIC 156 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSS---------SSCSEEEC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCC---------CcCceEEE
Confidence 999999999999999998888899999999999999999999999999999999999994321 22359999
Q ss_pred ccCcccccCC-----------CcccCCCcccchhhhhcc-----cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc----
Q psy14702 272 DFGHVIADND-----------FEVEEGDCRYLPKELLNN-----NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---- 330 (480)
Q Consensus 272 DFG~a~~~~~-----------~~~~~gt~~y~aPE~~~~-----~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---- 330 (480)
|||++..... .....||+.|+|||++.+ ..+. .++|||||||++|+| +|..||.....
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 235 (316)
T 2ac3_A 157 DFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCG 235 (316)
T ss_dssp CTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHT-TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred EccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCC-cccccHhHHHHHHHHHHCCCCCccccccccc
Confidence 9998754321 123459999999999875 2233 689999999999996 67777765421
Q ss_pred -------------chHHHhcCCCCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 331 -------------MWHHIRDGNIEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 331 -------------~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
....+..+....+ ..+++++++||.+||..||.+|||+.++++||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 236 WDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp C----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 2344555544433 46899999999999999999999999999999997643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=387.70 Aligned_cols=253 Identities=22% Similarity=0.396 Sum_probs=211.1
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
+..+|.+.+.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeEEE
Confidence 44678899999999999999999999999999999875432 22235578999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll------------~~~~~~kl~Dfg 150 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL------------DERDNLKISDFG 150 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCCEEECCCT
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE------------eCCCCEEEEEee
Confidence 99999999999999877789999999999999999999999999999999999999 566789999999
Q ss_pred cccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc---hHHHhcCC--CCc
Q psy14702 275 HVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM---WHHIRDGN--IEK 342 (480)
Q Consensus 275 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~---~~~i~~~~--~~~ 342 (480)
++..... .....||+.|+|||++.+..+.+.++|||||||++|+| +|..||...... +..+.... ...
T Consensus 151 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (323)
T 3tki_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230 (323)
T ss_dssp TCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTT
T ss_pred ccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCc
Confidence 9864321 22456999999999998876655689999999999996 677787654432 22222222 233
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+..+++++.+||.+||..||.+|||+.|+++||||....
T Consensus 231 ~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 456899999999999999999999999999999997644
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=389.34 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=208.3
Q ss_pred hhhhhhheeeccc--CceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 116 ALEFLEEELLGSG--DFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 116 ~~~y~~~~~LG~G--~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
..+|.+.+.||+| +||.||+|.+..+|+.||||++............+.+|+.+++.+ +|||||++++++.+.+.+|
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIADNELW 102 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEECCEEE
Confidence 4578899999999 999999999999999999999987655666677889999999999 7899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 194 LQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll------------~~~~~~kl~ 170 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI------------SVDGKVYLS 170 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEEC
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE------------cCCCCEEEc
Confidence 999999999999999875 579999999999999999999999999999999999999 567789999
Q ss_pred ccCcccccC-----------CCcccCCCcccchhhhhccc-CCCCCcccHHHHHHHHHHH-hCCCCCCCCccchH--HHh
Q psy14702 272 DFGHVIADN-----------DFEVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWH--HIR 336 (480)
Q Consensus 272 DFG~a~~~~-----------~~~~~~gt~~y~aPE~~~~~-~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~--~i~ 336 (480)
|||.+.... ......||+.|+|||++.+. ...+.++|||||||++|+| +|..||........ .+.
T Consensus 171 dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp CGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred ccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999764321 11224689999999999873 2334789999999999996 67777765432111 111
Q ss_pred cCC----------------------------------------------CCcCCCCCHHHHHHHHHhhccCCCCCCChhH
Q psy14702 337 DGN----------------------------------------------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSS 370 (480)
Q Consensus 337 ~~~----------------------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 370 (480)
.+. .+.+..+++++.+||.+||+.||.+|||+.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 330 (389)
T 3gni_B 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330 (389)
T ss_dssp -------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred cCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHH
Confidence 100 0123457889999999999999999999999
Q ss_pred HHHHHHHHHh
Q psy14702 371 LRRSAQLARN 380 (480)
Q Consensus 371 ll~h~~~~~~ 380 (480)
+++||||...
T Consensus 331 ll~hp~f~~~ 340 (389)
T 3gni_B 331 LLNHSFFKQI 340 (389)
T ss_dssp HTTSGGGGGC
T ss_pred HhcCHHHHHH
Confidence 9999999754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=394.83 Aligned_cols=253 Identities=23% Similarity=0.305 Sum_probs=207.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC-----
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ----- 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~----- 189 (480)
...+|.+.+.||+|+||.||+|.+..+++.||||++..........+.+.+|+.++..+ +||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 45678999999999999999999999999999999987666677778899999999999 789999999999766
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
..+|+|||||. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl------------~~~~~~k 169 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL------------NQDCSVK 169 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEE
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE------------CCCCCEE
Confidence 57999999995 6999999988889999999999999999999999999999999999999 5677899
Q ss_pred eCccCcccccCC--------------------------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC--
Q psy14702 270 LGDFGHVIADND--------------------------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG-- 321 (480)
Q Consensus 270 L~DFG~a~~~~~--------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~-- 321 (480)
|+|||++..... ....+||+.|+|||++......+.++|||||||++|||++
T Consensus 170 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 170 VCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred EccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 999999865432 2345799999999997655445579999999999999863
Q ss_pred ---------CCCCC-CCccc-------------------------------------------hHHHhcCCCC-------
Q psy14702 322 ---------VTPLP-KNGPM-------------------------------------------WHHIRDGNIE------- 341 (480)
Q Consensus 322 ---------~~p~~-~~~~~-------------------------------------------~~~i~~~~~~------- 341 (480)
+.|++ ..... ...+......
T Consensus 250 ~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (432)
T 3n9x_A 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329 (432)
T ss_dssp TTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHH
T ss_pred cccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHH
Confidence 33433 22100 0000000000
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.++.+++++.+||.+||..||.+|||+.|+++||||....
T Consensus 330 ~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 369 (432)
T 3n9x_A 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR 369 (432)
T ss_dssp HSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred HCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence 1246899999999999999999999999999999998643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=380.25 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=205.1
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+..+|.+.+.||+|+||+||+|.+. +|+.||+|++............+.+|+.++..+ +||||+++++++.+...+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCEeeeeeEEccCCEE
Confidence 345568999999999999999999874 699999999976544444456688999999999 799999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 193 YLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
|+|||||++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~------------~~~~~~kl~ 161 (311)
T 3niz_A 95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI------------NSDGALKLA 161 (311)
T ss_dssp EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEEC
T ss_pred EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE------------CCCCCEEEc
Confidence 999999975 888888754 459999999999999999999999999999999999999 566789999
Q ss_pred ccCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc-------
Q psy14702 272 DFGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD------- 337 (480)
Q Consensus 272 DFG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~------- 337 (480)
|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+..
T Consensus 162 Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 241 (311)
T 3niz_A 162 DFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNP 241 (311)
T ss_dssp CCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCT
T ss_pred cCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCCh
Confidence 9999875432 23346899999999998755455799999999999996 677777654321 111110
Q ss_pred --------------CCCC---------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 338 --------------GNIE---------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 338 --------------~~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
.... ..+.+++++.+||.+||+.||.+|||+.|+++||||....++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 242 REWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp TTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred HHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 0000 123478899999999999999999999999999999865443
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=391.64 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=213.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.++..+ +|||||+++++|.+...+|+|
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCEEEEE
Confidence 468889999999999999999999999999999864211 111234578899999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll------------~~~g~vkL~DFG~ 161 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL------------DEHGHVHITDFNI 161 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE------------CCCCCEEEeccce
Confidence 9999999999999988889999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC---CcccCCCcccchhhhhccc--CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHhcCCCCcCC
Q psy14702 276 VIADND---FEVEEGDCRYLPKELLNNN--FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIRDGNIEKLS 344 (480)
Q Consensus 276 a~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~~~~~~~~~ 344 (480)
+..... ....+||+.|+|||++.+. ...+.++|||||||++|+| +|..||..... ....+.......+.
T Consensus 162 a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~ 241 (384)
T 4fr4_A 162 AAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241 (384)
T ss_dssp CEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT
T ss_pred eeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC
Confidence 875432 3456799999999999742 2234689999999999996 67788864322 23445556666777
Q ss_pred CCCHHHHHHHHHhhccCCCCCCC-hhHHHHHHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPS-TSSLRRSAQLAR 379 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps-~~ell~h~~~~~ 379 (480)
.++.++.+||.+||..||.+||+ ++++++||||..
T Consensus 242 ~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 89999999999999999999998 899999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=380.09 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=206.9
Q ss_pred hhhhhhheeecccCceEEEEEEEe---eCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY---MDGMTYAVKRTKRPVA--NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|++. .+|+.||+|++++... .......+.+|+.++..+ +||||+++++++...+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQTGG 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEcCC
Confidence 357888999999999999999875 6899999999976432 222345578899999999 7999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill------------~~~~~~kl 162 (327)
T 3a62_A 95 KLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML------------NHQGHVKL 162 (327)
T ss_dssp CEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE------------CTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE------------CCCCcEEE
Confidence 999999999999999999988889999999999999999999999999999999999999 56678999
Q ss_pred CccCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcC
Q psy14702 271 GDFGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKL 343 (480)
Q Consensus 271 ~DFG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~ 343 (480)
+|||++..... ....+||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......+
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p 241 (327)
T 3a62_A 163 TDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP 241 (327)
T ss_dssp CCCSCC----------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC
T ss_pred EeCCcccccccCCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 99999864322 2345699999999999877654 789999999999996 67778765443 4456666777777
Q ss_pred CCCCHHHHHHHHHhhccCCCCCC-----ChhHHHHHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRP-----STSSLRRSAQLA 378 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~h~~~~ 378 (480)
..++.++++||.+||..||.+|| ++.++++||||.
T Consensus 242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~ 281 (327)
T 3a62_A 242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281 (327)
T ss_dssp TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence 88999999999999999999999 888999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=389.35 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=207.9
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|+++.+++.||||++++.... ......+.+|..++....+||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 45788999999999999999999999999999998764322 22334456676664333389999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll------------~~~g~ikL~DFG 184 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL------------DSQGHIVLTDFG 184 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEECCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE------------CCCCCEEEeeCc
Confidence 99999999999999988889999999999999999999999999999999999999 667789999999
Q ss_pred cccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCC
Q psy14702 275 HVIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVS 347 (480)
Q Consensus 275 ~a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s 347 (480)
++.... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+.......++.++
T Consensus 185 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 263 (373)
T 2r5t_A 185 LCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263 (373)
T ss_dssp BCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSC
T ss_pred cccccccCCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 987532 23346799999999999887665 789999999999996 67778765543 45667777777778899
Q ss_pred HHHHHHHHHhhccCCCCCCCh----hHHHHHHHHHH
Q psy14702 348 DDLHTLIKLMIDKDPTKRPST----SSLRRSAQLAR 379 (480)
Q Consensus 348 ~~~~~li~~~L~~dP~~Rps~----~ell~h~~~~~ 379 (480)
.++++||.+||+.||.+||++ .++++||||..
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 999999999999999999997 59999999863
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=382.23 Aligned_cols=251 Identities=28% Similarity=0.434 Sum_probs=194.3
Q ss_pred hhhhhh---heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 116 ALEFLE---EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 116 ~~~y~~---~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
-.+|.+ .+.||+|+||.||+|.+..+++.||||++... ....+.+|+.++..+.+||||+++++++.+....
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 344544 37899999999999999999999999998652 2345778999999997799999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +....+||+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~---------~~~~~~kl~D 152 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE---------NDNLEIKIID 152 (325)
T ss_dssp EEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-------------CEEEECC
T ss_pred EEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC---------CCcccEEEec
Confidence 9999999999999999988899999999999999999999999999999999999999542 2234799999
Q ss_pred cCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---------chHHHhcC
Q psy14702 273 FGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---------MWHHIRDG 338 (480)
Q Consensus 273 FG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---------~~~~i~~~ 338 (480)
||++..... ....+||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..+
T Consensus 153 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231 (325)
T ss_dssp CTTCEECCC----------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTT
T ss_pred cccceecCCCCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcC
Confidence 999865432 2345689999999999877655 789999999999996 67778765332 33445555
Q ss_pred CCCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 339 NIEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 339 ~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.+... ..+++++++||.+||..||.+|||+.++++||||....
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 54433 35899999999999999999999999999999997654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=370.05 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=216.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..++..||+|++....... .....+.+|+.++..+ +||||+++++++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEecCCEEEE
Confidence 457888999999999999999999999999999986421111 1235588899999999 68999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili------------~~~~~~~l~Dfg 154 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL------------GSAGELKIADFG 154 (279)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE------------CTTSCEEECSCC
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE------------cCCCCEEEEecc
Confidence 99999999999999888889999999999999999999999999999999999999 567789999999
Q ss_pred cccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHH
Q psy14702 275 HVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDD 349 (480)
Q Consensus 275 ~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~ 349 (480)
++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......+..++++
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (279)
T 3fdn_A 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 233 (279)
T ss_dssp EESCC--------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred ccccCCcccccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHH
Confidence 8854433 2345699999999999877654 689999999999996 67777765442 3455666666667779999
Q ss_pred HHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCC
Q psy14702 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL 384 (480)
Q Consensus 350 ~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~ 384 (480)
+.+||.+||..||.+|||+.++++||||.......
T Consensus 234 ~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 234 ARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred HHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 99999999999999999999999999999875443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=380.25 Aligned_cols=259 Identities=23% Similarity=0.352 Sum_probs=215.5
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
....|...+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++...+..|
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCeEE
Confidence 345688899999999999999999999999999998765333 33346788999999999 7899999999999999999
Q ss_pred EEeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
+|||||. |+|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 131 lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll------------~~~~~~kL~D 197 (348)
T 1u5q_A 131 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL------------SEPGLVKLGD 197 (348)
T ss_dssp EEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE------------ETTTEEEECC
T ss_pred EEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE------------CCCCCEEEee
Confidence 9999997 58888775 44679999999999999999999999999999999999999 5567899999
Q ss_pred cCcccccCCCcccCCCcccchhhhhcc--cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC--cCCC
Q psy14702 273 FGHVIADNDFEVEEGDCRYLPKELLNN--NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE--KLSN 345 (480)
Q Consensus 273 FG~a~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~--~~~~ 345 (480)
||++..........||+.|+|||++.+ ....+.++|||||||++||| +|..||..... ....+.....+ ....
T Consensus 198 fG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (348)
T 1u5q_A 198 FGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277 (348)
T ss_dssp CTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred ccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCC
Confidence 999987766667789999999999853 22233689999999999996 66677765443 12233333332 2346
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccc
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVE 387 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~ 387 (480)
+++.+.+||.+||+.||.+|||+.++++|||+....+.....
T Consensus 278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~ 319 (348)
T 1u5q_A 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 319 (348)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHH
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhh
Confidence 899999999999999999999999999999998876655443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=377.42 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=202.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH------------------------HHHHHHHHHHHHHHh
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT------------------------AQEKIFKKEIHAHAL 172 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~------------------------~~~~~~~~Ei~~l~~ 172 (480)
.+|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+.+|+.++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 46888999999999999999999999999999987543211 113458899999999
Q ss_pred cCCCCceeEEeeEEee--CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy14702 173 LSRVPHIVNYFSSWSD--QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILI 250 (480)
Q Consensus 173 l~~hpnIv~l~~~~~~--~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl 250 (480)
+ +||||+++++++.+ ...+|+|||||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 93 l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 93 L-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp C-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred C-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9 79999999999986 678999999999999988653 3579999999999999999999999999999999999999
Q ss_pred eccCCCCCCCCCccccceEeCccCcccccCCC----cccCCCcccchhhhhcccCC--CCCcccHHHHHHHHHHH-hCCC
Q psy14702 251 VKAQGELNEPMNTEKLHYKLGDFGHVIADNDF----EVEEGDCRYLPKELLNNNFD--NLSKVDIFALGLTLYEA-SGVT 323 (480)
Q Consensus 251 ~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~--~~~k~DiwSlGvilyel-~~~~ 323 (480)
+.++.+||+|||++...... ....||+.|+|||++.+... .+.++|||||||++|+| +|..
T Consensus 171 ------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 171 ------------GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp ------------CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred ------------CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 56678999999998654432 23569999999999976542 24679999999999996 6777
Q ss_pred CCCCCcc--chHHHhcCCC--CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 324 PLPKNGP--MWHHIRDGNI--EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 324 p~~~~~~--~~~~i~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
||..... ....+..... +....+++++.+||.+||+.||.+|||+.++++||||.+
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 8765443 2233443333 334578999999999999999999999999999999963
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=382.19 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=202.1
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
....+|.+.+.||+|+||+||+|.+..+++.||||+++...........+.+|+.++..+ +||||+++++++.+.+.+|
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEecCCEEE
Confidence 345578899999999999999999999999999999986655444456678999999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||. |+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+. +..+.+||+||
T Consensus 110 lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-------~~~~~~kl~Df 181 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA-------SETPVLKIGDF 181 (329)
T ss_dssp EEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC------------CCEEEECCT
T ss_pred EEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC-------CccceEEECcC
Confidence 9999997 599999998888999999999999999999999999999999999999964321 34567999999
Q ss_pred CcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhcC-CC-----
Q psy14702 274 GHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDG-NI----- 340 (480)
Q Consensus 274 G~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~~-~~----- 340 (480)
|++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+... ..
T Consensus 182 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 182 GLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp THHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 99865432 23346899999999998765455799999999999996 666777654431 1111110 00
Q ss_pred --------------Cc----------CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 341 --------------EK----------LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 341 --------------~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
+. ...+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 00 01167899999999999999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=365.70 Aligned_cols=256 Identities=22% Similarity=0.376 Sum_probs=217.6
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+..+|.+.+.||+|+||.||+|.+..++..||+|++....... ...+.+|+.++..+ +||||+++++++.+....|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSL-DHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhC-CCCCEeeEEEEEecCCeEE
Confidence 45678999999999999999999999999999999987643332 34588999999999 8899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~~~~~~~l~Df 153 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD---------SPDSPLKLIDF 153 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS---------STTCCEEECCC
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC---------CCCCcEEEEec
Confidence 999999999999999888889999999999999999999999999999999999999432 34668999999
Q ss_pred CcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcC----
Q psy14702 274 GHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKL---- 343 (480)
Q Consensus 274 G~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~---- 343 (480)
|++..... .....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+..+....+
T Consensus 154 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (277)
T 3f3z_A 154 GLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW 231 (277)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH
T ss_pred ccceeccCccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh
Confidence 99865432 2345699999999999765 3 3689999999999996 67777765443 3444555554443
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
..+++++.+||.+||+.||.+|||+.++++||||.+....
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 232 LNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred hcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 3689999999999999999999999999999999886543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=390.47 Aligned_cols=253 Identities=22% Similarity=0.342 Sum_probs=200.9
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--E
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG--V 191 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--~ 191 (480)
....+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.++..+.+||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45568999999999999999999999999999999998766666777788899999999977999999999997544 7
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|+|||||. ++|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll------------~~~~~~kl~ 151 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL------------NAECHVKVA 151 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEEC
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE------------cCCCCEEec
Confidence 999999996 599999876 479999999999999999999999999999999999999 667789999
Q ss_pred ccCcccccCC-------------------------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCC
Q psy14702 272 DFGHVIADND-------------------------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPL 325 (480)
Q Consensus 272 DFG~a~~~~~-------------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~ 325 (480)
|||+++.... ....+||+.|+|||++.+...++.++|||||||++||| +|..||
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 9999864321 12346999999999998754555799999999999996 677777
Q ss_pred CCCccc--hHHHhc--C-------------------------------C--------------CCcCCCCCHHHHHHHHH
Q psy14702 326 PKNGPM--WHHIRD--G-------------------------------N--------------IEKLSNVSDDLHTLIKL 356 (480)
Q Consensus 326 ~~~~~~--~~~i~~--~-------------------------------~--------------~~~~~~~s~~~~~li~~ 356 (480)
+..... ...+.. + . ......+++++.+||.+
T Consensus 232 ~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 311 (388)
T 3oz6_A 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK 311 (388)
T ss_dssp CCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence 654421 111110 0 0 00122678999999999
Q ss_pred hhccCCCCCCChhHHHHHHHHHHh
Q psy14702 357 MIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 357 ~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
||+.||.+|||+.|+++||||...
T Consensus 312 ~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 312 LLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp HCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred hhccCcccCCCHHHHhCCHHHHHh
Confidence 999999999999999999999754
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=388.72 Aligned_cols=250 Identities=24% Similarity=0.406 Sum_probs=203.1
Q ss_pred hhhhhhhh-eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----C
Q psy14702 115 YALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----Q 189 (480)
Q Consensus 115 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~ 189 (480)
...+|.+. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++..+.+||||++++++|.. .
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 34456665 7899999999999999999999999998642 2366788888777799999999999875 6
Q ss_pred CEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
..+|||||||+||+|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.. ..++.
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~---------~~~~~ 202 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK---------RPNAI 202 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS---------STTCC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC---------CCCcc
Confidence 67999999999999999998653 59999999999999999999999999999999999999432 12678
Q ss_pred eEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------chHHHhc
Q psy14702 268 YKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MWHHIRD 337 (480)
Q Consensus 268 vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------~~~~i~~ 337 (480)
+||+|||++..... ....+||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..
T Consensus 203 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~ 281 (400)
T 1nxk_A 203 LKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 281 (400)
T ss_dssp EEECCCTTCEECC-----------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred EEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence 99999999875443 2345789999999999877665 789999999999996 67778765432 2345555
Q ss_pred CCCCc----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 338 GNIEK----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 338 ~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+.+.. +..+++++++||.+||..||.+|||+.++++||||....
T Consensus 282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 54432 357899999999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=383.22 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=203.1
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG-- 190 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 190 (480)
+++..+|.+.+.||+|+||.||+|.+..+|+.||||+++... .....+.+.+|+.++..+ +||||++++++|.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSC
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccc
Confidence 567889999999999999999999999999999999997643 233456689999999999 7999999999986543
Q ss_pred -------------------------------------------------------EEEEEeeccCCCCHHHHHHhcC---
Q psy14702 191 -------------------------------------------------------VLYLQLEYCNGGNLENIIQERC--- 212 (480)
Q Consensus 191 -------------------------------------------------------~~~lv~E~~~gg~L~~~l~~~~--- 212 (480)
.+|+|||||++|+|.+++....
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 3899999999999999998754
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccCCC----------
Q psy14702 213 TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF---------- 282 (480)
Q Consensus 213 ~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~---------- 282 (480)
..++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~ 227 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF------------TMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 227 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEECCCTTCEECSCC----------
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE------------eCCCCEEEeecCcccccccchhhccccccc
Confidence 35666789999999999999999999999999999999 55678999999998654332
Q ss_pred ------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCCC-CCCCCccchHHHhcCCCCc-CCCCCHHHHHHH
Q psy14702 283 ------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVT-PLPKNGPMWHHIRDGNIEK-LSNVSDDLHTLI 354 (480)
Q Consensus 283 ------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~~-p~~~~~~~~~~i~~~~~~~-~~~~s~~~~~li 354 (480)
....||+.|+|||++.+..+. .++|||||||++|+|+.+. |+.........+.....+. +...++++.+||
T Consensus 228 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 306 (332)
T 3qd2_B 228 PAYATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMV 306 (332)
T ss_dssp ----CCCSCC-CGGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHH
T ss_pred cccccccccCCCcCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHH
Confidence 224699999999999887654 7899999999999986432 2211112223333333332 234678899999
Q ss_pred HHhhccCCCCCCChhHHHHHHHHH
Q psy14702 355 KLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 355 ~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
.+||+.||.+|||+.++++||||.
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~~~f~ 330 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIENAIFE 330 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHSTTCC
T ss_pred HHHccCCCCcCCCHHHHhhchhhh
Confidence 999999999999999999999985
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=395.18 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=209.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||+||+|+++.+++.||+|++++.... ......+.+|+.++..+ +|||||+++++|.+...+|+
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEE
Confidence 35788899999999999999999999999999998642100 00112367899999988 89999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 147 V~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl------------~~~g~ikL~DFG 213 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL------------DKSGHLKLADFG 213 (410)
T ss_dssp EECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCT
T ss_pred EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE------------CCCCCEEEeccc
Confidence 9999999999999976 479999999999999999999999999999999999999 667789999999
Q ss_pred cccccCCC-----cccCCCcccchhhhhcccCC---CCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcC----C
Q psy14702 275 HVIADNDF-----EVEEGDCRYLPKELLNNNFD---NLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDG----N 339 (480)
Q Consensus 275 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~---~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~----~ 339 (480)
++...... ...+||+.|+|||++.+... .+.++|||||||++||| +|..||..... .+..+... .
T Consensus 214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~ 293 (410)
T 3v8s_A 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293 (410)
T ss_dssp TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc
Confidence 98654432 24679999999999986541 33689999999999996 77788876543 33444432 3
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCC--CCChhHHHHHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTK--RPSTSSLRRSAQLAR 379 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~h~~~~~ 379 (480)
++....+|+++++||.+||..+|.+ ||++.++++||||..
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence 4455679999999999999999988 999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=386.85 Aligned_cols=256 Identities=26% Similarity=0.402 Sum_probs=216.0
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
....+|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.++..+ +||||+++++++.+...+|
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEeCCEEE
Confidence 34567999999999999999999999999999999987542 33455688999999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
+|||||.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|
T Consensus 125 lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~----------~~~~~vkL~D 194 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET----------KKASSVKIID 194 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------TTCCCEEECC
T ss_pred EEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec----------CCCCceEEEe
Confidence 9999999999999987543 7999999999999999999999999999999999999942 2346799999
Q ss_pred cCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC----c
Q psy14702 273 FGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE----K 342 (480)
Q Consensus 273 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~----~ 342 (480)
||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+...... .
T Consensus 195 FG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 273 (387)
T 1kob_A 195 FGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDA 273 (387)
T ss_dssp CTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSST
T ss_pred cccceecCCCcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccc
Confidence 9998765432 335799999999999887665 689999999999996 67777765543 23344444332 3
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
+..+++++++||.+||..||.+|||+.++++||||......
T Consensus 274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 35689999999999999999999999999999999875543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=370.24 Aligned_cols=257 Identities=25% Similarity=0.407 Sum_probs=214.9
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+..+|.+.+.||+|+||.||+|.+..+|+.||+|+++.... .....+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKI-KHENIVTLEDIYESTTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHC-CCTTBCCEEEEEECSSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhC-CCCCeeehhhhcccCCEE
Confidence 3456789999999999999999999999999999999975422 2335588999999999 789999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~---------~~~~~~kl~D 152 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP---------EENSKIMITD 152 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS---------STTCCEEBCS
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC---------CCCCCEEEcc
Confidence 9999999999999999888889999999999999999999999999999999999999432 3466899999
Q ss_pred cCcccccCCC--cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC----cC
Q psy14702 273 FGHVIADNDF--EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE----KL 343 (480)
Q Consensus 273 FG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~----~~ 343 (480)
||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..+... .+
T Consensus 153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 231 (304)
T 2jam_A 153 FGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW 231 (304)
T ss_dssp CSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT
T ss_pred CCcceecCCCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc
Confidence 9998654432 234599999999999877554 789999999999996 67777765432 34445554432 33
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
..+++++.+||.+||..||.+|||+.++++||||....+
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 568999999999999999999999999999999987543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=383.29 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=214.8
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTA------QEKIFKKEIHAHALLSRVPHIVNYFSSW 186 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~------~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 186 (480)
..+..+|.+.+.||+|+||.||+|.+..+++.||||+++....... ....+.+|+.++..+ +||||+++++++
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~ 98 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIF 98 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence 4577899999999999999999999999999999999876432211 223467799999999 899999999999
Q ss_pred eeCCEEEEEeeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccc
Q psy14702 187 SDQGVLYLQLEYCNGG-NLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEK 265 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~ 265 (480)
.+.+.+|+||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll------------~~~ 166 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI------------AED 166 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTT
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE------------cCC
Confidence 9999999999999776 999999988889999999999999999999999999999999999999 566
Q ss_pred cceEeCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchHHHhcCCCC
Q psy14702 266 LHYKLGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHHIRDGNIE 341 (480)
Q Consensus 266 ~~vkL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~~i~~~~~~ 341 (480)
+.+||+|||++...... ....||+.|+|||++.+..+.+.++|||||||++|+| +|..||..... .......
T Consensus 167 ~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~~ 242 (335)
T 3dls_A 167 FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----TVEAAIH 242 (335)
T ss_dssp SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----GTTTCCC
T ss_pred CcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----HHhhccC
Confidence 78999999998754432 3456999999999998877655789999999999996 67777754322 2333444
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 243 ~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 243 PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 556689999999999999999999999999999999753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=375.26 Aligned_cols=250 Identities=28% Similarity=0.389 Sum_probs=207.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++..+ +||||+++++++...+..|+||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeecCCeEEEEE
Confidence 468889999999999999999999999999999987666666677788999999999 7899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 197 EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
|||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~------------~~~~~~kl~Dfg~~ 149 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI------------TKHSVIKLCDFGFA 149 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCTTC
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE------------cCCCCEEEeeCCCc
Confidence 999999999998887889999999999999999999999999999999999999 56678999999998
Q ss_pred cccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHHhc------------
Q psy14702 277 IADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHIRD------------ 337 (480)
Q Consensus 277 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i~~------------ 337 (480)
..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||....... ..+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 150 RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp EECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 65442 23346899999999998755555799999999999996 6777776544211 00100
Q ss_pred ---------CCCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 338 ---------GNIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 338 ---------~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
...+ ..+.++.++.+||.+||..||.+|||+.++++||||..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 290 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFEN 290 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHh
Confidence 0111 12467889999999999999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=373.29 Aligned_cols=247 Identities=22% Similarity=0.339 Sum_probs=200.8
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E 197 (480)
+|.+.+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.++..+ +||||+++++++.+.+.+|+|||
T Consensus 3 ~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred cchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccCCeEEEEEE
Confidence 688899999999999999987 6799999999876543333335578899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 198 YCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 198 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~------------~~~~~~kl~Dfg~~ 147 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI------------NREGELKIADFGLA 147 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTSCEEECCTTHH
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE------------cCCCCEEEeECccc
Confidence 9975 999998764 579999999999999999999999999999999999999 56678999999988
Q ss_pred cccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc----C-------
Q psy14702 277 IADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD----G------- 338 (480)
Q Consensus 277 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~----~------- 338 (480)
..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+.. .
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchh
Confidence 65432 23346899999999998755445799999999999996 667777654321 111110 0
Q ss_pred ---------CC---------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 339 ---------NI---------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 339 ---------~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.. ..+..+++++.+||.+||+.||++|||+.++++||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00 012357899999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=397.47 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=208.8
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||+++.... .......+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEETTEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeCCEEEE
Confidence 4578899999999999999999999999999999875321 222334577889888888 79999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE-MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||++|+|.+++.....+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+||
T Consensus 226 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll------------~~~~~~kl~DF 293 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML------------DKDGHIKITDF 293 (446)
T ss_dssp EECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE------------CSSSCEEECCC
T ss_pred EEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE------------CCCCCEEEccC
Confidence 99999999999999888899999999999999999999998 999999999999999 56778999999
Q ss_pred CcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCC
Q psy14702 274 GHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNV 346 (480)
Q Consensus 274 G~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~ 346 (480)
|++..... ....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... ....+.......+..+
T Consensus 294 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 372 (446)
T 4ejn_A 294 GLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 372 (446)
T ss_dssp CCCCTTCC-----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTS
T ss_pred CCceeccCCCcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Confidence 99865322 2345799999999999877665 799999999999996 67778865543 4556666677777889
Q ss_pred CHHHHHHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
++++.+||.+||+.||.+|| |+.++++||||..
T Consensus 373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 99999999999999999999 9999999999964
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=382.56 Aligned_cols=251 Identities=25% Similarity=0.350 Sum_probs=208.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-VPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+. +++.||||++............+.+|+.++..+.+ ||||+++++++...+.+||
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 346889999999999999999875 49999999998766666667789999999999975 7999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||| |.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-------------~~~~kl~DFG 199 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-------------DGMLKLIDFG 199 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-------------SSCEEECCCS
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-------------CCeEEEEecC
Confidence 999 55889999999888899999999999999999999999999999999999992 2479999999
Q ss_pred cccccCCC------cccCCCcccchhhhhccc----------CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHH
Q psy14702 275 HVIADNDF------EVEEGDCRYLPKELLNNN----------FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHH 334 (480)
Q Consensus 275 ~a~~~~~~------~~~~gt~~y~aPE~~~~~----------~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~ 334 (480)
++...... ...+||+.|+|||++.+. ...+.++|||||||++|+| +|..||..... ....
T Consensus 200 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~ 279 (390)
T 2zmd_A 200 IANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 279 (390)
T ss_dssp SSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH
T ss_pred ccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHH
Confidence 98654322 235699999999998752 1234689999999999996 67778765432 2223
Q ss_pred HhcCC--CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 335 IRDGN--IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 335 i~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+.... ...+...+.++.+||.+||..||.+|||+.++++||||....
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 280 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 33332 233445688999999999999999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=373.32 Aligned_cols=257 Identities=21% Similarity=0.336 Sum_probs=214.8
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
.....+|.+.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.++..+ +||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEec
Confidence 346678999999999999999999999999999999987643221 1245688999999999 78999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
...+|+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+ .....+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~--------~~~~~~ 158 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN--------IPIPHI 158 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTT--------SSSCCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCC--------CCcCCE
Confidence 999999999999999999999888899999999999999999999999999999999999994322 112279
Q ss_pred EeCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc
Q psy14702 269 KLGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK 342 (480)
Q Consensus 269 kL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~ 342 (480)
||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......
T Consensus 159 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 237 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237 (321)
T ss_dssp EECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred EEccCccceecCccccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccccc
Confidence 99999998654432 335699999999999877654 789999999999996 67778765433 334444444332
Q ss_pred C----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 343 L----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 343 ~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
. ..++..+.+||.+||..||.+|||+.++++||||..
T Consensus 238 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 238 DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence 2 568999999999999999999999999999999853
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.02 Aligned_cols=252 Identities=24% Similarity=0.329 Sum_probs=206.8
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-CceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-PHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+ .+++.||||++............+.+|+.++..+.+| |||+++++++.....+|+
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 34688899999999999999976 5789999999987666666667899999999999654 999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||+ .+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||
T Consensus 87 v~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-------------~~~~kl~DFG 152 (343)
T 3dbq_A 87 VMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-------------DGMLKLIDFG 152 (343)
T ss_dssp EECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-------------TTEEEECCCS
T ss_pred EEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-------------CCcEEEeecc
Confidence 9995 5889999999888999999999999999999999999999999999999993 3469999999
Q ss_pred cccccCCC------cccCCCcccchhhhhccc----------CCCCCcccHHHHHHHHHHH-hCCCCCCCCccc---hHH
Q psy14702 275 HVIADNDF------EVEEGDCRYLPKELLNNN----------FDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM---WHH 334 (480)
Q Consensus 275 ~a~~~~~~------~~~~gt~~y~aPE~~~~~----------~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~---~~~ 334 (480)
++...... ....||+.|+|||++.+. ...+.++|||||||++|+| +|..||...... ...
T Consensus 153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~ 232 (343)
T 3dbq_A 153 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 232 (343)
T ss_dssp SSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred cccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHH
Confidence 98654322 234699999999998651 2334689999999999996 677787654322 122
Q ss_pred HhcC--CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 335 IRDG--NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 335 i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
+... ....+...+.++.+||.+||+.||.+|||+.++++||||.....
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 2222 23344557789999999999999999999999999999986543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=376.27 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=193.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.+..+|+.||+|+++..... .....+.+|+.++..+ +||||+++++++..++.+|+||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKEL-KHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTC-CBTTBCCEEEEECCTTEEEEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhc-CCCCcceEEEEEEECCeEEEEE
Confidence 4688899999999999999999999999999998754321 1224577899999999 7899999999999999999999
Q ss_pred eccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 197 EYCNGGNLENIIQER------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 197 E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
|||+ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~------------~~~~~~kl 149 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI------------NKRGQLKL 149 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEE
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE------------cCCCCEEE
Confidence 9997 5999998754 358999999999999999999999999999999999999 56678999
Q ss_pred CccCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--CC--
Q psy14702 271 GDFGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD--GN-- 339 (480)
Q Consensus 271 ~DFG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~--~~-- 339 (480)
+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+.. +.
T Consensus 150 ~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 229 (317)
T 2pmi_A 150 GDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN 229 (317)
T ss_dssp CCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99999865432 23456899999999998754445799999999999996 677777654321 111110 00
Q ss_pred ------------------------------CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 340 ------------------------------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 340 ------------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
......++.++.+||.+||+.||.+|||+.|+++||||......
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 230 ESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp TTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 00112578899999999999999999999999999999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=365.66 Aligned_cols=254 Identities=25% Similarity=0.416 Sum_probs=217.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..+ +||||+++++++.+.+..|+|
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEcCCEEEEE
Confidence 4688899999999999999999999999999998642111 11134688999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~~kl~Dfg~ 160 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM------------GYKGELKIADFGW 160 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE------------CTTCCEEECCCTT
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE------------cCCCCEEEecccc
Confidence 9999999999999888889999999999999999999999999999999999999 5567899999998
Q ss_pred ccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHH
Q psy14702 276 VIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDL 350 (480)
Q Consensus 276 a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~ 350 (480)
+..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......+..++.++
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 2vgo_A 161 SVHAPSLRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239 (284)
T ss_dssp CEECSSSCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred cccCcccccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHH
Confidence 865443 2345699999999999887655 689999999999996 67777765432 34455666666677899999
Q ss_pred HHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCC
Q psy14702 351 HTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL 384 (480)
Q Consensus 351 ~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~ 384 (480)
++||.+||..||.+|||+.++++||||.......
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~ 273 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV 273 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence 9999999999999999999999999999865443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=370.92 Aligned_cols=249 Identities=23% Similarity=0.336 Sum_probs=209.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
...|...+.||+|+||.||+|.+..+|+.||||++....... .+.+.+|+.++..+ +||||+++++++...+..|+|
T Consensus 44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDY-QHFNVVEMYKSYLVGEELWVL 120 (321)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhC-CCCCcceEEEEEEECCEEEEE
Confidence 345667789999999999999998899999999987643332 34578999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 121 ~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll------------~~~~~~kl~Dfg~ 187 (321)
T 2c30_A 121 MEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL------------TLDGRVKLSDFGF 187 (321)
T ss_dssp ECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEECCCTT
T ss_pred EecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE------------CCCCcEEEeeeee
Confidence 999999999998864 479999999999999999999999999999999999999 5567899999998
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc---CCC
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK---LSN 345 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~---~~~ 345 (480)
+..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.....+. ...
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2c30_A 188 CAQISKDVPKRKSLVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK 266 (321)
T ss_dssp CEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGG
T ss_pred eeecccCccccccccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCcccc
Confidence 865432 2335699999999999877655 689999999999996 67777765543 233344433322 245
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 889999999999999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=371.96 Aligned_cols=254 Identities=24% Similarity=0.420 Sum_probs=219.9
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV-ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++..+ +||||+++++++.+.+.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEecCCeE
Confidence 34567889999999999999999999999999999987542 3345566789999999999 899999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|+|||||.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~------------~~~~~~kl~D 184 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL------------NEDLEVKIGD 184 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------CTTCCEEECC
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE------------cCCCCEEEee
Confidence 9999999999999999888889999999999999999999999999999999999999 5667899999
Q ss_pred cCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCC
Q psy14702 273 FGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSN 345 (480)
Q Consensus 273 FG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~ 345 (480)
||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+.......+..
T Consensus 185 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 263 (335)
T 2owb_A 185 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH 263 (335)
T ss_dssp CTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccCceecccCcccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCcc
Confidence 999865432 2335699999999999877654 689999999999996 67777765432 344555666666778
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
++.++.+||.+||+.||++|||+.++++|+||....
T Consensus 264 ~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 264 INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 999999999999999999999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=411.18 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=218.8
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|.++.+++.||||++++... .......+..|..++..+.+||||+++++++.+.+.+|||
T Consensus 341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV 420 (674)
T 3pfq_A 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV 420 (674)
T ss_dssp TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence 468899999999999999999999999999999875211 1112345778899998888999999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl------------~~~g~ikL~DFGl 488 (674)
T 3pfq_A 421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML------------DSEGHIKIADFGM 488 (674)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE------------CSSSCEEECCCTT
T ss_pred EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE------------cCCCcEEEeecce
Confidence 9999999999999988899999999999999999999999999999999999999 6677999999999
Q ss_pred ccccC----CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADN----DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
++... .....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..|.......+..+++
T Consensus 489 a~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 567 (674)
T 3pfq_A 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 567 (674)
T ss_dssp CEECCCTTCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCH
T ss_pred eeccccCCcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Confidence 87532 23346799999999999887665 789999999999996 67778876543 567788888888889999
Q ss_pred HHHHHHHHhhccCCCCCCCh-----hHHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPST-----SSLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~-----~ell~h~~~~~ 379 (480)
++++||.+||+.||.+||++ .+|++||||..
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999999999998 99999999964
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=391.87 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=207.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.++||+|+||+||+|+++.+++.||+|++++.... ......+.+|+.++..+ +||||++++++|.+.+.+||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeCCEEEE
Confidence 45788999999999999999999999999999998642110 01112377899999988 89999999999999999999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||+||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+||
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl------------~~~g~vkL~DF 219 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM------------DMNGHIRLADF 219 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCC
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE------------cCCCCEEEcch
Confidence 9999999999999987 4689999999999999999999999999999999999999 66779999999
Q ss_pred CcccccCCC-----cccCCCcccchhhhhcc----cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcC---
Q psy14702 274 GHVIADNDF-----EVEEGDCRYLPKELLNN----NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDG--- 338 (480)
Q Consensus 274 G~a~~~~~~-----~~~~gt~~y~aPE~~~~----~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~--- 338 (480)
|++...... ...+||+.|+|||++.. ....+.++|||||||++||| +|..||..... .+..+...
T Consensus 220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 998654322 23579999999999972 22234789999999999996 77778876543 33344321
Q ss_pred -CCC-cCCCCCHHHHHHHHHhhccCCCC--CCChhHHHHHHHHHH
Q psy14702 339 -NIE-KLSNVSDDLHTLIKLMIDKDPTK--RPSTSSLRRSAQLAR 379 (480)
Q Consensus 339 -~~~-~~~~~s~~~~~li~~~L~~dP~~--Rps~~ell~h~~~~~ 379 (480)
.++ .+..+|+++++||.+||..+|++ ||+++++++||||..
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 222 23568999999999999998888 999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=364.81 Aligned_cols=255 Identities=25% Similarity=0.426 Sum_probs=210.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.++..+ +||||+++++++...+..|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCeEEE
Confidence 3578889999999999999999988999999999864211 111234688999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~~~l~dfg 156 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL------------DAHMNAKIADFG 156 (276)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE------------CTTSCEEECCCC
T ss_pred EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE------------CCCCCEEEeecc
Confidence 99999999999999888889999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 275 HVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 275 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
++...... ....||+.|+|||++.+..+.+.++|||||||++|+| +|..||..... ....+..+....+..++.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (276)
T 2h6d_A 157 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNR 236 (276)
T ss_dssp GGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred cccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCH
Confidence 98655432 2346899999999998776544689999999999996 67777765432 345556666666677899
Q ss_pred HHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
++.++|.+||+.||.+|||+.++++||||.+..+.
T Consensus 237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 99999999999999999999999999999887654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=379.72 Aligned_cols=245 Identities=27% Similarity=0.470 Sum_probs=203.1
Q ss_pred hheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeeccC
Q psy14702 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCN 200 (480)
Q Consensus 121 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~~~ 200 (480)
..+.||+|+||.||+|.+..+|+.||+|+++.. .....+.+.+|+.++..+ +||||+++++++...+.+|+|||||+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 367899999999999999999999999999864 234456789999999999 89999999999999999999999999
Q ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCccccc
Q psy14702 201 GGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD 279 (480)
Q Consensus 201 gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 279 (480)
+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||++...
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~----------~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN----------RDAKQIKIIDFGLARRY 239 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE----------TTTTEEEECCCSSCEEC
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec----------CCCCcEEEEeCCCceec
Confidence 99999988654 46999999999999999999999999999999999999953 23568999999998754
Q ss_pred CCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC----cCCCCCHH
Q psy14702 280 NDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE----KLSNVSDD 349 (480)
Q Consensus 280 ~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~----~~~~~s~~ 349 (480)
... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+....+. .+..++++
T Consensus 240 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 318 (373)
T 2x4f_A 240 KPREKLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEE 318 (373)
T ss_dssp CTTCBCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHH
T ss_pred CCccccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHH
Confidence 432 334699999999999876554 689999999999996 67777765543 33445444432 23568999
Q ss_pred HHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 350 ~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+++||.+||+.||.+|||+.++++||||..
T Consensus 319 ~~~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 319 AKEFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 999999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=374.21 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=210.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++..+ +||||+++++++...+..|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeecCCEEEEE
Confidence 4578899999999999999999999999999999987666666677788999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~------------~~~~~~kl~Dfg~ 170 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV------------SQSGVVKLCDFGF 170 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE------------cCCCcEEEEeCCC
Confidence 9999999999988777789999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHHhc-----------
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHIRD----------- 337 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i~~----------- 337 (480)
+..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||....... ..+..
T Consensus 171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp C------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence 865432 23456899999999998765555789999999999996 6777776554211 11100
Q ss_pred ----------CCCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 ----------GNIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 ----------~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
...+ ..+.+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0001 123578999999999999999999999999999999763
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=363.66 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=219.0
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV-ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.++..+ +||||+++++++.+.+..|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCEEE
Confidence 3457888999999999999999999999999999987543 3345566788999999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~~kl~df 159 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL------------NEDLEVKIGDF 159 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEECCC
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE------------cCCCCEEEEec
Confidence 999999999999999888889999999999999999999999999999999999999 56678999999
Q ss_pred CcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCC
Q psy14702 274 GHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNV 346 (480)
Q Consensus 274 G~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~ 346 (480)
|++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+.......+..+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (294)
T 2rku_A 160 GLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI 238 (294)
T ss_dssp TTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTS
T ss_pred cCceecccCccccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcccc
Confidence 99865432 2335689999999999876554 689999999999996 67777765432 3445556666667789
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
++.+.++|.+||+.||++|||+.++++||||....
T Consensus 239 ~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 239 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 99999999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=400.69 Aligned_cols=250 Identities=24% Similarity=0.366 Sum_probs=213.1
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.+... .......+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEeeCCEEEE
Confidence 3468889999999999999999999999999999864211 111234578899999999 88999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 262 VmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl------------d~~g~vKL~D 329 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL------------DDHGHIRISD 329 (576)
T ss_dssp EECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTSCEEECC
T ss_pred EEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE------------eCCCCeEEEe
Confidence 999999999999998654 49999999999999999999999999999999999999 6677899999
Q ss_pred cCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------chHHHhcCCCCc
Q psy14702 273 FGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MWHHIRDGNIEK 342 (480)
Q Consensus 273 FG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------~~~~i~~~~~~~ 342 (480)
||++...... ...+||+.|+|||++.+..+. .++|||||||++||| +|..||..... ....+.......
T Consensus 330 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~ 408 (576)
T 2acx_A 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY 408 (576)
T ss_dssp CTTCEECCTTCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC
T ss_pred cccceecccCccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC
Confidence 9999755332 345799999999999887655 789999999999996 67778765432 334455555556
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
+..+|+++++||.+||..||.+|| ++.++++||||..
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 678999999999999999999999 7899999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=374.72 Aligned_cols=254 Identities=21% Similarity=0.412 Sum_probs=213.8
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC--H----HHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN--T----AQEKIFKKEIHAHALLSRVPHIVNYFSSW 186 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 186 (480)
..+..+|.+.+.||+|+||.||+|.+..+|+.||||++...... . .....+.+|+.++..+.+||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 44567899999999999999999999889999999998764321 1 22456789999999997899999999999
Q ss_pred eeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 187 SDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
......|+|||||+|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~------------~~~~ 237 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL------------DDNM 237 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE------------CCCC
Confidence 9999999999999999999999888889999999999999999999999999999999999999 5677
Q ss_pred ceEeCccCcccccCC---CcccCCCcccchhhhhcccC-----CCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHH
Q psy14702 267 HYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNF-----DNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHI 335 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~-----~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i 335 (480)
.+||+|||++..... .....||+.|+|||++.+.. ..+.++|||||||++|+| +|..||..... ....+
T Consensus 238 ~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i 317 (365)
T 2y7j_A 238 QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI 317 (365)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 899999998865433 23457999999999987431 233689999999999996 67777765443 23344
Q ss_pred hcCCCC----cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 336 RDGNIE----KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 336 ~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
..+... .+..++.++.+||.+||..||.+|||+.++++||||.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp HHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred HhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 444433 2357899999999999999999999999999999985
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=369.25 Aligned_cols=252 Identities=21% Similarity=0.254 Sum_probs=197.3
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC---HHHHHHHHHHHHHHHhcC--CCCceeEEeeEEeeC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN---TAQEKIFKKEIHAHALLS--RVPHIVNYFSSWSDQ 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~---~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~~ 189 (480)
...+|.+.+.||+|+||+||+|.+..+|+.||||++...... ......+.+|+.++..+. +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 456788999999999999999999999999999998643211 111223556777776664 599999999999875
Q ss_pred C-----EEEEEeeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCC
Q psy14702 190 G-----VLYLQLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMN 262 (480)
Q Consensus 190 ~-----~~~lv~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~ 262 (480)
. .+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~------------ 153 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV------------ 153 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE------------
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE------------
Confidence 5 5899999996 599999987643 9999999999999999999999999999999999999
Q ss_pred ccccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHh
Q psy14702 263 TEKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIR 336 (480)
Q Consensus 263 ~~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~ 336 (480)
+.++.+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+.
T Consensus 154 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 154 TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5667899999999865432 2345699999999999877665 789999999999997 455566544321 11111
Q ss_pred cC----C---C--------------------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 337 DG----N---I--------------------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 337 ~~----~---~--------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.. . + ...+.+++++.+||.+||+.||.+|||+.|+++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 10 0 0 0123578999999999999999999999999999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=360.42 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=212.5
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||+|+++...... ...+.+.+|+.++..+ +||||+++++++.+..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecCCC
Confidence 4567899999999999999999999999999999987643221 1245688999999999 7899999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
..|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+...+ .....+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~--------~~~~~~kl 153 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN--------VPNPRIKL 153 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS--------SSSCCEEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC--------CCCCceEE
Confidence 9999999999999999998888899999999999999999999999999999999999995432 22347999
Q ss_pred CccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc--
Q psy14702 271 GDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK-- 342 (480)
Q Consensus 271 ~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~-- 342 (480)
+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......
T Consensus 154 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T 3bhy_A 154 IDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDE 232 (283)
T ss_dssp CCCTTCEECC--------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCH
T ss_pred EecccceeccCCCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcc
Confidence 99999865433 2334689999999999877554 789999999999996 67777765443 233344443322
Q ss_pred --CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 343 --LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 343 --~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
+..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus 233 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 233 EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 25688999999999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=364.54 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=205.9
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
+.+..+|.+.+.||+|+||.||+|.+..++..||+|++...... .....+.+|+.++..+ +||||+++++++.+....
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhC-CCchHHhHHHheecCCeE
Confidence 34667899999999999999999999999999999998764322 2235588999999999 789999999999999999
Q ss_pred EEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 193 YLQLEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~---------~~~~~~ 166 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT---------SPHSPI 166 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS---------STTCCE
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC---------CCCCCE
Confidence 999999999999998854 3579999999999999999999999999999999999999432 335679
Q ss_pred EeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC-
Q psy14702 269 KLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE- 341 (480)
Q Consensus 269 kL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~- 341 (480)
||+|||++..... .....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+......
T Consensus 167 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (285)
T 3is5_A 167 KIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRD-V-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY 244 (285)
T ss_dssp EECCCCCCCC----------CTTGGGCCHHHHTTC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred EEEeeecceecCCcccCcCcccccCcCChHHhccC-C-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence 9999999865432 2345699999999998754 3 3689999999999996 67777765432 12222222221
Q ss_pred --cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 342 --KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 342 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
....+++++.+||.+||+.||.+|||+.|+++||||.+
T Consensus 245 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 245 AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 22347899999999999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=388.19 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=205.8
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||+||+|+++.+|+.||||++++.... ......+.+|..++..+ +||||++++++|.+.+.+|+
T Consensus 60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEECSSEEEE
T ss_pred hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeCCEEEE
Confidence 45788999999999999999999999999999998642111 11123477899999888 88999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 139 VmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl------------d~~g~vkL~DF 206 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL------------DRCGHIRLADF 206 (412)
T ss_dssp EECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCC
T ss_pred EEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee------------cCCCCEEEeec
Confidence 999999999999998754 79999999999999999999999999999999999999 66779999999
Q ss_pred CcccccCCC-----cccCCCcccchhhhhcc------cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcC-
Q psy14702 274 GHVIADNDF-----EVEEGDCRYLPKELLNN------NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDG- 338 (480)
Q Consensus 274 G~a~~~~~~-----~~~~gt~~y~aPE~~~~------~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~- 338 (480)
|++...... ...+||+.|+|||++.. ....+.++|||||||++||| +|..||..... .+..+...
T Consensus 207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~ 286 (412)
T 2vd5_A 207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286 (412)
T ss_dssp TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 998654332 23579999999999973 12234789999999999996 77788876543 33344432
Q ss_pred ---CCCc-CCCCCHHHHHHHHHhhccCCCCC---CChhHHHHHHHHHH
Q psy14702 339 ---NIEK-LSNVSDDLHTLIKLMIDKDPTKR---PSTSSLRRSAQLAR 379 (480)
Q Consensus 339 ---~~~~-~~~~s~~~~~li~~~L~~dP~~R---ps~~ell~h~~~~~ 379 (480)
..+. ...+|+++++||.+||. +|.+| |+++++++||||..
T Consensus 287 ~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 287 EHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred cCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 2222 25689999999999999 99998 59999999999965
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=392.80 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=199.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC------
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ------ 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~------ 189 (480)
..+|.+.+.||+|+||+||+|.+..+|+.||||++..........+.+.+|+.+++.+ +||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCccccC
Confidence 4678999999999999999999999999999999987655666677889999999999 899999999999654
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
..+|||||||.+ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll------------~~~~~~k 204 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV------------KSDCTLK 204 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEE
T ss_pred CeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE------------eCCCCEE
Confidence 468999999975 57776643 59999999999999999999999999999999999999 5677899
Q ss_pred eCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcC-----
Q psy14702 270 LGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDG----- 338 (480)
Q Consensus 270 L~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~----- 338 (480)
|+|||++..... ....+||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+...
T Consensus 205 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 205 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 283 (464)
T ss_dssp ECCCCCC-----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred EEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999999876543 2345799999999999987665 789999999999996 67777765432 11111110
Q ss_pred ----------------CCCcC---------CC------------CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 339 ----------------NIEKL---------SN------------VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 339 ----------------~~~~~---------~~------------~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
..+.. +. .++++++||.+||..||.+|||+.|+++||||...+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 00000 00 156799999999999999999999999999998543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=378.11 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=204.1
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC------
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ------ 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~------ 189 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++..+ +||||+++++++...
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCccccC
Confidence 4578899999999999999999999999999999977666666677889999999999 799999999999765
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll------------~~~~~~k 168 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV------------NEDCELK 168 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEE
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE------------cCCCCEE
Confidence 3469999999 8899999876 579999999999999999999999999999999999999 5677899
Q ss_pred eCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--C-----
Q psy14702 270 LGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD--G----- 338 (480)
Q Consensus 270 L~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~--~----- 338 (480)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+.. +
T Consensus 169 l~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 169 ILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp ECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred EEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999999876543 33457999999999998744445789999999999996 667777654321 111110 0
Q ss_pred -----------------------CC-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 339 -----------------------NI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 339 -----------------------~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.+ ..++.+++++.+||.+||..||.+|||+.++++||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 00 12346789999999999999999999999999999997643
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=363.21 Aligned_cols=251 Identities=20% Similarity=0.303 Sum_probs=210.3
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----CC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----QG 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~ 190 (480)
....|.+.+.||+|+||.||+|.+..++..||+|.+............+.+|+.++..+ +||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeeccccCCCc
Confidence 34457788999999999999999999999999999987666666677899999999999 79999999998875 46
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
.+|+|||||++++|.+++.....+++..++.++.||+.||.|||++| |+||||||+|||++ ..++.+
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~-----------~~~~~~ 171 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-----------GPTGSV 171 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-----------STTSCE
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE-----------CCCCCE
Confidence 78999999999999999998888999999999999999999999999 99999999999993 146689
Q ss_pred EeCccCcccccCCC--cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCCC-
Q psy14702 269 KLGDFGHVIADNDF--EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNIE- 341 (480)
Q Consensus 269 kL~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~~- 341 (480)
||+|||++...... ....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+..+..+
T Consensus 172 kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (290)
T 1t4h_A 172 KIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp EECCTTGGGGCCTTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred EEeeCCCcccccccccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcc
Confidence 99999998654432 345699999999998765 3 3689999999999996 67778765433 22233333222
Q ss_pred -cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 342 -KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 342 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.....++++.+||.+||..||.+|||+.++++||||..
T Consensus 250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 23457789999999999999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=377.19 Aligned_cols=262 Identities=19% Similarity=0.294 Sum_probs=209.2
Q ss_pred cCcchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy14702 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV---ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSW 186 (480)
Q Consensus 110 ~~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 186 (480)
.+...+..+|.+.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.++..+ +||||+++++++
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~ 97 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVY 97 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhh
Confidence 344567889999999999999999999999999999999986421 1223346689999999999 799999999999
Q ss_pred eeCCEEEEEeeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHH
Q psy14702 187 SDQGVLYLQLEYCNGGNLENIIQE----------------------------------------RCTFTEMALKQLLFQV 226 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi 226 (480)
.+.+..|+|||||+||+|.+++.. ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 999999999999999999998842 1124678888999999
Q ss_pred HHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccCC--------CcccCCCcccchhhhhc
Q psy14702 227 SEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND--------FEVEEGDCRYLPKELLN 298 (480)
Q Consensus 227 ~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~~gt~~y~aPE~~~ 298 (480)
+.||.|||++||+||||||+|||+.. +....+||+|||++..... .....||+.|+|||++.
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 247 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFST----------NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLN 247 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESC----------SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHT
T ss_pred HHHHHHHHHCCccccCCChhhEEEec----------CCCceEEEeeccccccccccCccccccccccCCCccccCchhhc
Confidence 99999999999999999999999943 2234799999999864322 23456999999999997
Q ss_pred cc-CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCC----CcCCCCCHHHHHHHHHhhccCCCCCCChhH
Q psy14702 299 NN-FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSS 370 (480)
Q Consensus 299 ~~-~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 370 (480)
+. ...+.++|||||||++|+| +|..||..... ....+..... +.+..+++++.+||.+||..||.+|||+.+
T Consensus 248 ~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 248 TTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp CSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred cCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 52 3334799999999999996 67778765443 2233333332 222358999999999999999999999999
Q ss_pred HHHHHHHHHhCC
Q psy14702 371 LRRSAQLARNYP 382 (480)
Q Consensus 371 ll~h~~~~~~~~ 382 (480)
+++||||.....
T Consensus 328 ~l~hp~~~~~~~ 339 (345)
T 3hko_A 328 ALQHPWISQFSD 339 (345)
T ss_dssp HHHSHHHHTTSS
T ss_pred HhcChhhccChH
Confidence 999999987543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=381.00 Aligned_cols=249 Identities=17% Similarity=0.167 Sum_probs=190.7
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCCceeEEe-------eEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLS-RVPHIVNYF-------SSWSD 188 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~-~hpnIv~l~-------~~~~~ 188 (480)
.|.+.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.++..+. +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 47789999999999999999999999999999987644 3344566788877666664 599988865 44433
Q ss_pred C-----------------CEEEEEeeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceecCCC
Q psy14702 189 Q-----------------GVLYLQLEYCNGGNLENIIQER-CTFTEMAL------KQLLFQVSEGLRCMHEMRMIHMDIK 244 (480)
Q Consensus 189 ~-----------------~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~------~~i~~qi~~aL~yLH~~~IvHrDlK 244 (480)
. ..+|||||||+ |+|.+++... ..+++... ..++.||+.||.|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 2 34899999998 8999999764 24455555 5777999999999999999999999
Q ss_pred CCcEEEeccCCCCCCCCCccccceEeCccCcccccCCCc-ccCCCcccchhhhhcc--cCCCCCcccHHHHHHHHHHH-h
Q psy14702 245 PANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFE-VEEGDCRYLPKELLNN--NFDNLSKVDIFALGLTLYEA-S 320 (480)
Q Consensus 245 p~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~-~~~gt~~y~aPE~~~~--~~~~~~k~DiwSlGvilyel-~ 320 (480)
|+|||+ +.++.+||+|||++....... ...+|+.|+|||++.+ ..+ +.++|||||||++|+| +
T Consensus 222 p~NIll------------~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI------------MPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE------------CTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE------------CCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHh
Confidence 999999 566789999999998766554 5567899999999976 444 4799999999999996 7
Q ss_pred CCCCCCCCccc----hHH---Hh----cCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 321 GVTPLPKNGPM----WHH---IR----DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 321 ~~~p~~~~~~~----~~~---i~----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
|..||....+. +.. .. ....+.+..+++++.+||.+||+.||++|||+.++++||||...
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 77888655321 111 00 11123335789999999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=365.20 Aligned_cols=243 Identities=22% Similarity=0.371 Sum_probs=200.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||+||+|.+ +|..||||++............+.+|+.++..+ +||||+++++++.+...+|+|
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSTTCCEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEECCceEEE
Confidence 45788899999999999999964 789999999987666666677899999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 196 LEYCNGGNLENIIQERCT---FTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
||||++|+|.+++..... +++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll------------~~~~~~kL 180 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV------------DKKYTVKV 180 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE------------CTTCCEEE
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE------------eCCCcEEE
Confidence 999999999999986543 999999999999999999999999 9999999999999 56778999
Q ss_pred CccCcccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHH--hcCCCC
Q psy14702 271 GDFGHVIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHI--RDGNIE 341 (480)
Q Consensus 271 ~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i--~~~~~~ 341 (480)
+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+ ......
T Consensus 181 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 3p86_A 181 CDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE 259 (309)
T ss_dssp CCCC-----------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred CCCCCCccccccccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence 999998644322 335699999999999887664 789999999999996 677777654431 2222 223445
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
.+..+++++.+||.+||..||.+|||+.++++.
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~ 292 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567799999999999999999999999999984
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=373.43 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=209.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++..+ +||||+++++++...+.+|+|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEECCEEEEE
Confidence 457889999999999999999999999999999998643 445566789999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~-~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++++|.+++.....+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||
T Consensus 110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~------------~~~~~~kl~Dfg 177 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV------------NSRGEIKLCDFG 177 (360)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE------------CTTCCEEECCCC
T ss_pred EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE------------CCCCCEEEEECC
Confidence 99999999999999888899999999999999999999996 99999999999999 566789999999
Q ss_pred cccccC--CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--------------------
Q psy14702 275 HVIADN--DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM-------------------- 331 (480)
Q Consensus 275 ~a~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~-------------------- 331 (480)
++.... ......||+.|+|||++.+..+. .++|||||||++|+| +|..||......
T Consensus 178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (360)
T 3eqc_A 178 VSGQLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256 (360)
T ss_dssp CCHHHHHHC----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------
T ss_pred CCcccccccccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCC
Confidence 885432 23345799999999999887554 789999999999996 677787653321
Q ss_pred ------------------------hHHHhcCCCCcC--CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 332 ------------------------WHHIRDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 332 ------------------------~~~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
...+.....+.. ..++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp -----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 011111222211 2478999999999999999999999999999999874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=375.48 Aligned_cols=259 Identities=24% Similarity=0.380 Sum_probs=214.0
Q ss_pred Ccchhhhhhhhh-eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC
Q psy14702 111 DHSRYALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ 189 (480)
Q Consensus 111 ~~~~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 189 (480)
....+..+|.+. +.||+|+||.||+|.+..+++.||+|++............+.+|+.++..+.+||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345677788887 8999999999999999999999999998764443333456889999999998899999999999999
Q ss_pred CEEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
+.+|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... ...+.
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~---------~~~~~ 172 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI---------YPLGD 172 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB---------TTBCC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC---------CCCCc
Confidence 9999999999999999998543 579999999999999999999999999999999999999431 12568
Q ss_pred eEeCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCC-
Q psy14702 268 YKLGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI- 340 (480)
Q Consensus 268 vkL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~- 340 (480)
+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.....
T Consensus 173 ~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 251 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVD 251 (327)
T ss_dssp EEECCGGGCEEC---------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred EEEeeCccccccCCccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccc
Confidence 999999998755432 335699999999999877655 789999999999996 67777765543 2223333322
Q ss_pred ---CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 341 ---EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 341 ---~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
..+..+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~ 293 (327)
T 3lm5_A 252 YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293 (327)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCC
T ss_pred cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcc
Confidence 234568999999999999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=378.58 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=201.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-------
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------- 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------- 188 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccccc
Confidence 4578899999999999999999999999999999876544433344577899999999 78999999999886
Q ss_pred -CCEEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 189 -QGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 189 -~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
.+.+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~------------~~~~ 161 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI------------TRDG 161 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTS
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE------------cCCC
Confidence 4578999999975 777777644 579999999999999999999999999999999999999 5667
Q ss_pred ceEeCccCcccccCC--------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHH
Q psy14702 267 HYKLGDFGHVIADND--------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHI 335 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i 335 (480)
.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+
T Consensus 162 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i 241 (351)
T 3mi9_A 162 VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241 (351)
T ss_dssp CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 899999999864331 22346899999999998755555799999999999996 566666554321 1111
Q ss_pred hc--CCC--CcCCC----------------------------CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 336 RD--GNI--EKLSN----------------------------VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 336 ~~--~~~--~~~~~----------------------------~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.. +.. ..++. .++++.+||.+||+.||.+|||+.|+++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred HHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 11 100 01111 267899999999999999999999999999997643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=395.01 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=212.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|+++.+|+.||+|++.+..... .....+.+|+.++..+ +||||++++++|.+...+|+|
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEeeCCEEEEE
Confidence 46888899999999999999999999999999986531111 1134578899999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 196 LEYCNGGNLENIIQER----CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl------------~~~g~vkL~ 331 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL------------DDDGNVRIS 331 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTSCEEEC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE------------eCCCCEEEe
Confidence 9999999999999763 369999999999999999999999999999999999999 667789999
Q ss_pred ccCcccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCc------cchHHHhcCCC
Q psy14702 272 DFGHVIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNG------PMWHHIRDGNI 340 (480)
Q Consensus 272 DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~------~~~~~i~~~~~ 340 (480)
|||++...... ...+||+.|+|||++.+..+. .++|||||||++||| +|..||.... .....+.....
T Consensus 332 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp CCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred ecceeeeccCCCcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 99998754332 234799999999999887665 789999999999996 6777886542 23445566666
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCC-----hhHHHHHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPS-----TSSLRRSAQLAR 379 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps-----~~ell~h~~~~~ 379 (480)
..+..+|+++++||.+||+.||.+||+ +.++++||||..
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 677889999999999999999999996 489999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=374.05 Aligned_cols=262 Identities=23% Similarity=0.250 Sum_probs=206.2
Q ss_pred cchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC----CCCceeEEeeEEe
Q psy14702 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS----RVPHIVNYFSSWS 187 (480)
Q Consensus 112 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hpnIv~l~~~~~ 187 (480)
......+|.+.+.||+|+||+||+|.+..+++.||||+++. .......+..|+.++..+. +||||+++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 33456789999999999999999999999999999999874 2344456778999999885 4999999999999
Q ss_pred eCCEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCC--------
Q psy14702 188 DQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL-------- 257 (480)
Q Consensus 188 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~-------- 257 (480)
..+.+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.......
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 999999998654 599999999999999999999999999999999999995311000
Q ss_pred -----CCCCCccccceEeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc
Q psy14702 258 -----NEPMNTEKLHYKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP 330 (480)
Q Consensus 258 -----~~~~~~~~~~vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~ 330 (480)
........+.+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||.....
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 000001267899999999875543 3345799999999999887665 789999999999996 67777765432
Q ss_pred c--hHHHhcCCCC--------------------------cC--------------------CCCCHHHHHHHHHhhccCC
Q psy14702 331 M--WHHIRDGNIE--------------------------KL--------------------SNVSDDLHTLIKLMIDKDP 362 (480)
Q Consensus 331 ~--~~~i~~~~~~--------------------------~~--------------------~~~s~~~~~li~~~L~~dP 362 (480)
. ...+.....+ .+ ...++.+.+||.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 1 1111100000 00 0124678899999999999
Q ss_pred CCCCChhHHHHHHHHH
Q psy14702 363 TKRPSTSSLRRSAQLA 378 (480)
Q Consensus 363 ~~Rps~~ell~h~~~~ 378 (480)
.+|||+.|+++||||+
T Consensus 345 ~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 345 TLRPSPAELLKHKFLE 360 (360)
T ss_dssp GGSCCHHHHTTSGGGC
T ss_pred hhCCCHHHHhcCcccC
Confidence 9999999999999973
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=361.44 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=192.9
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||+|+++...........+.++...+..+ +||||+++++++.+.+..|+|
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEEE
Confidence 4578889999999999999999999999999999976544333333344444445555 899999999999999999999
Q ss_pred eeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 196 LEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~-~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
||||+ |+|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~------------~~~~~~kl 151 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI------------NALGQVKM 151 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE------------CTTCCEEB
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE------------CCCCCEEE
Confidence 99997 588777653 45799999999999999999999998 99999999999999 55678999
Q ss_pred CccCcccccCCC---cccCCCcccchhhhhc---ccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch---HH-HhcCC
Q psy14702 271 GDFGHVIADNDF---EVEEGDCRYLPKELLN---NNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW---HH-IRDGN 339 (480)
Q Consensus 271 ~DFG~a~~~~~~---~~~~gt~~y~aPE~~~---~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~---~~-i~~~~ 339 (480)
+|||++...... ....||+.|+|||++. .....+.++|||||||++|+| +|..||....... .. +....
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (290)
T 3fme_A 152 CDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231 (290)
T ss_dssp CCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCC
T ss_pred eecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCC
Confidence 999998654332 2346999999999973 222334689999999999996 7777876533221 22 22222
Q ss_pred CCc-CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 340 IEK-LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 340 ~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
... ...+++++.+||.+||+.||.+|||+.++++||||....
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 222 246899999999999999999999999999999998753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=359.73 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=216.0
Q ss_pred cchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 112 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
...+..+|.+.+.||+|+||.||+|.+..+++.||+|++............+.+|+.++..+ +||||+++++++...+.
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeCCCe
Confidence 45667889999999999999999999988999999999876433333345688999999999 88999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +....+||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~---------~~~~~~kL~ 166 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK---------EKDCDIKII 166 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS---------STTCCEEEC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC---------CCcccEEEe
Confidence 99999999999999999887889999999999999999999999999999999999999532 224579999
Q ss_pred ccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCC----C
Q psy14702 272 DFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNI----E 341 (480)
Q Consensus 272 DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~----~ 341 (480)
|||++...... ....||+.|+|||++.+. + +.++|||||||++|+| +|..||..... ....+..+.. +
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T 2wei_A 167 DFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (287)
T ss_dssp STTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred ccCcceeecCCCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch
Confidence 99988654432 223588999999999875 3 3689999999999996 66777765433 3344444443 2
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+..+++++.+||.+||..||.+|||+.++++||||.+.
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 335789999999999999999999999999999999875
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=364.49 Aligned_cols=251 Identities=23% Similarity=0.433 Sum_probs=190.2
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..+ +||||+++++++.+.+..|+|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEccCCeEEEE
Confidence 4688899999999999999999899999999998642111 11135688999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili------------~~~~~~kl~dfg 157 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL------------TRNMNIKIADFG 157 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE------------CTTCCEEECCCT
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE------------cCCCCEEEEeec
Confidence 9999999999999865 579999999999999999999999999999999999999 566789999999
Q ss_pred cccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCC
Q psy14702 275 HVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVS 347 (480)
Q Consensus 275 ~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s 347 (480)
++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.......+..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (278)
T 3cok_A 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236 (278)
T ss_dssp TCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSC
T ss_pred ceeeccCCCCcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccC
Confidence 9865432 2234689999999999876554 689999999999996 67777754332 22233333444556789
Q ss_pred HHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 348 ~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.++.+||.+||+.||.+|||+.++++||||....
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 9999999999999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=361.58 Aligned_cols=253 Identities=22% Similarity=0.392 Sum_probs=213.0
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
+..+|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.++..+ +||||+++++++.+.+..|+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKML-NHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhc-CCCCceeeeeEEEcCCEEEE
Confidence 456899999999999999999999999999999998753322 2345688999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~~kl~dfg 150 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL------------DERDNLKISDFG 150 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCCEEECCCT
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE------------ccCCCEEEeeCC
Confidence 99999999999999877789999999999999999999999999999999999999 556789999999
Q ss_pred cccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCC--CCc
Q psy14702 275 HVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGN--IEK 342 (480)
Q Consensus 275 ~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~--~~~ 342 (480)
++..... .....||+.|+|||++.+..+.+.++|||||||++|+| +|..||..... .+..+.... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 230 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 230 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTT
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCc
Confidence 8864321 23456899999999998766545689999999999996 67778765433 222333322 233
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+..+++.+.+||.+||..||.+|||+.++++||||....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 231 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 456899999999999999999999999999999987643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=375.19 Aligned_cols=256 Identities=20% Similarity=0.299 Sum_probs=210.4
Q ss_pred hhhhhhheeecccCceEEEEEE-----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||+||+|. +..+++.||||+++.. ........+.+|+.++..+ +||||+++++++.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSL 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEecCC
Confidence 4578889999999999999998 4567889999998753 3445556788999999999 8999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC-------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
..|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--------- 218 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--------- 218 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---------
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC---------
Confidence 9999999999999999998643 489999999999999999999999999999999999994321
Q ss_pred cccceEeCccCccccc------CCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chH
Q psy14702 264 EKLHYKLGDFGHVIAD------NDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWH 333 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~ 333 (480)
....+||+|||++... .......||+.|+|||++.+..+. .++|||||||++|||+ |..||..... ...
T Consensus 219 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~ 297 (367)
T 3l9p_A 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 297 (367)
T ss_dssp TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 3446999999998532 122334588999999999877655 7899999999999974 6667765443 334
Q ss_pred HHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 334 HIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 334 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
.+..+. ...+..++..+.+||.+||+.||.+|||+.+++++++.....+.
T Consensus 298 ~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 298 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 444443 44556789999999999999999999999999999998876543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=384.62 Aligned_cols=256 Identities=25% Similarity=0.350 Sum_probs=204.5
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA------NTAQEKIFKKEIHAHALLSRVPHIVNYFSSW 186 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 186 (480)
..+..+|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..+ +||||+++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~ 209 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 209 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence 4556789999999999999999999999999999999875321 111223478899999999 899999999997
Q ss_pred eeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 187 SDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
. ...+|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... +...
T Consensus 210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~---------~~~~ 279 (419)
T 3i6u_A 210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ---------EEDC 279 (419)
T ss_dssp E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS---------SSSC
T ss_pred e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC---------CCcc
Confidence 5 45689999999999999999888889999999999999999999999999999999999999542 2345
Q ss_pred ceEeCccCcccccCCC---cccCCCcccchhhhhcc--cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhc
Q psy14702 267 HYKLGDFGHVIADNDF---EVEEGDCRYLPKELLNN--NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRD 337 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~ 337 (480)
.+||+|||++...... ...+||+.|+|||++.+ ....+.++|||||||++|+| +|..||..... ....+..
T Consensus 280 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~ 359 (419)
T 3i6u_A 280 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 359 (419)
T ss_dssp CEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT
T ss_pred eEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc
Confidence 7999999998765432 34569999999999864 22233689999999999996 67777765432 3445555
Q ss_pred CCCCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 338 GNIEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 338 ~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+..... ..+++++.+||.+||+.||.+|||+.++++||||..
T Consensus 360 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 360 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 554432 568999999999999999999999999999999853
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=378.02 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=209.2
Q ss_pred hhhhhhheeecccCceEEEEEEEe---eCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY---MDGMTYAVKRTKRPVA--NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+. .+++.||||+++.... .......+.+|+.++..+.+||||+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 357889999999999999999874 4899999999864321 11112336678889998878999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll------------~~~~~~kl 200 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL------------DSNGHVVL 200 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE------------CCCCcEEE
Confidence 999999999999999999988889999999999999999999999999999999999999 56778999
Q ss_pred CccCcccccCC-----CcccCCCcccchhhhhccc-CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------chHHHhc
Q psy14702 271 GDFGHVIADND-----FEVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MWHHIRD 337 (480)
Q Consensus 271 ~DFG~a~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------~~~~i~~ 337 (480)
+|||++..... ....+||+.|+|||++.+. ...+.++|||||||++|+| +|..||..... ....+..
T Consensus 201 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 280 (355)
T 1vzo_A 201 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 280 (355)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc
Confidence 99999864322 1234699999999999863 2334689999999999996 67778764321 2233444
Q ss_pred CCCCcCCCCCHHHHHHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 338 GNIEKLSNVSDDLHTLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 338 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
...+.+..++..+.+||.+||..||.+|| |+.++++||||..
T Consensus 281 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 281 SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 55566678999999999999999999999 9999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=384.08 Aligned_cols=246 Identities=17% Similarity=0.208 Sum_probs=197.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHHhcC--CCCceeEEe-------eE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV-ANTAQEKIFKKEIHAHALLS--RVPHIVNYF-------SS 185 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~-------~~ 185 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.++..+. +|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 356888999999999999999998999999999987532 23334567889996666654 799999998 66
Q ss_pred EeeCC-----------------EEEEEeeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceec
Q psy14702 186 WSDQG-----------------VLYLQLEYCNGGNLENIIQERCTFTE-------MALKQLLFQVSEGLRCMHEMRMIHM 241 (480)
Q Consensus 186 ~~~~~-----------------~~~lv~E~~~gg~L~~~l~~~~~l~~-------~~~~~i~~qi~~aL~yLH~~~IvHr 241 (480)
+...+ ..||||||| +|+|.+++.....+++ ..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 65543 389999999 6899999987555555 7788899999999999999999999
Q ss_pred CCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccCCC-cccCCCcccchhhhhccc-----------CCCCCcccH
Q psy14702 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF-EVEEGDCRYLPKELLNNN-----------FDNLSKVDI 309 (480)
Q Consensus 242 DlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~k~Di 309 (480)
||||+|||+ +.++.+||+|||++...... ....| +.|+|||++.+. .+. .++||
T Consensus 231 Dikp~NIll------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL------------DQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDA 296 (377)
T ss_dssp CCCGGGEEE------------CTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHH
T ss_pred CCCHHHEEE------------cCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCC-hhhhH
Confidence 999999999 55678999999999765443 33457 999999999876 444 79999
Q ss_pred HHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 310 FALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 310 wSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
|||||++||| +|..||..... ....+ ...+..+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 9999999996 67777754332 11112 22346789999999999999999999999999999999763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.44 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=206.7
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG-- 190 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 190 (480)
.+..+|.+.+.||+|+||.||+|.+..+++.||||+++.... .......+.+|+.++..+ +||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCC
Confidence 456689999999999999999999999999999999976533 334456788999999988 8899999999987543
Q ss_pred --EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 191 --VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 191 --~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
..|+|||||+|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~------------~~~~~~ 155 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI------------SATNAV 155 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------ETTSCE
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE------------cCCCCE
Confidence 459999999999999999988889999999999999999999999999999999999999 556689
Q ss_pred EeCccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc---hHHHhc
Q psy14702 269 KLGDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM---WHHIRD 337 (480)
Q Consensus 269 kL~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~---~~~i~~ 337 (480)
||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... +..+..
T Consensus 156 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 234 (311)
T 3ork_A 156 KVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 234 (311)
T ss_dssp EECCCSCC------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred EEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence 99999998644321 224589999999999887654 789999999999996 677787665432 122222
Q ss_pred CCCC---cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 GNIE---KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 ~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
...+ ....+++++.+||.+||+.||.+||++.+++.|+|+...
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 2221 234689999999999999999999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-46 Score=365.65 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=202.8
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--CCEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD--QGVLY 193 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~ 193 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||+++... .+.+.+|+.++..+.+||||+++++++.+ ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 467999999999999999999999999999999987432 24588999999999779999999999987 67899
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++. ....+||+||
T Consensus 110 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~-----------~~~~~kl~Df 175 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-----------EHRKLRLIDW 175 (330)
T ss_dssp EEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-----------TTTEEEECCC
T ss_pred EEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcC-----------CCCEEEEEeC
Confidence 9999999999999875 4899999999999999999999999999999999999942 2337999999
Q ss_pred CcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch----------------H
Q psy14702 274 GHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW----------------H 333 (480)
Q Consensus 274 G~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~----------------~ 333 (480)
|++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||....... .
T Consensus 176 g~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 255 (330)
T 3nsz_A 176 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 255 (330)
T ss_dssp TTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred CCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhh
Confidence 99865432 23456899999999998744445799999999999996 6777885443211 1
Q ss_pred HHhcCCCC------------------------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 334 HIRDGNIE------------------------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 334 ~i~~~~~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+...... ....+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 11111110 112278999999999999999999999999999999754
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=372.20 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=199.2
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E 197 (480)
+|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++..+ +||||+++++++.+.+.+|+|||
T Consensus 3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDL-KHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCC-CCTTBCCEEEEEECSSCEEEEEE
T ss_pred ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhc-CCCCCCeeeeEEeeCCEEEEEec
Confidence 68889999999999999999999999999999875322 11112345799999999 78999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 198 YCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 198 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI------------NERGELKLADFGLA 147 (324)
T ss_dssp CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE------------CTTCCEEECSSSEE
T ss_pred ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE------------CCCCCEEEccCccc
Confidence 996 59999887654 59999999999999999999999999999999999999 56678999999998
Q ss_pred cccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc------------
Q psy14702 277 IADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD------------ 337 (480)
Q Consensus 277 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~------------ 337 (480)
..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+..
T Consensus 148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 148 RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchh
Confidence 65432 22346899999999998755555799999999999996 677777654321 111110
Q ss_pred ---------CCC---------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 338 ---------GNI---------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 338 ---------~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
... ...+.+++++.+||.+||+.||.+|||+.|+++||||......
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 000 1123578999999999999999999999999999999876543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=373.37 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=197.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC-----
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG----- 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----- 190 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||++............+.+|+.+++.+ +||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeeccccccccc
Confidence 4578899999999999999999999999999999987666666677789999999999 8999999999997654
Q ss_pred -EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 191 -VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 191 -~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
.+|+|||||. |+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~------------~~~~~~k 167 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV------------KSDCTLK 167 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTSCEE
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE------------cCCCCEE
Confidence 7899999996 47888886 358999999999999999999999999999999999999 5667899
Q ss_pred eCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCC----
Q psy14702 270 LGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGN---- 339 (480)
Q Consensus 270 L~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~---- 339 (480)
|+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+....
T Consensus 168 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 168 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246 (371)
T ss_dssp ECCCCC----------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCC
T ss_pred EEEeecccccccccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 9999998755432 335699999999999887655 789999999999996 67778765443 122221110
Q ss_pred -----------------CCcCC---------------------CCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 340 -----------------IEKLS---------------------NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 340 -----------------~~~~~---------------------~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+... ..+.++++||.+||..||.+|||+.++++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 00000 015678999999999999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=358.47 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=206.4
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV-ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
...+|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.++..+ +||||+++++++...+.+|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEECSSEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeeeCCeEE
Confidence 4567899999999999999999999999999999986543 3344557789999999999 7899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||+|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~------------~~~~~~kl~Df 155 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI------------DSNKTLKIFDF 155 (294)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE------------CCCCCEEEEeC
Confidence 999999999999999988899999999999999999999999999999999999999 56678999999
Q ss_pred CcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchH--HHhcCCCC----
Q psy14702 274 GHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWH--HIRDGNIE---- 341 (480)
Q Consensus 274 G~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~--~i~~~~~~---- 341 (480)
|++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||........ .......+
T Consensus 156 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T 4eqm_A 156 GIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTT 234 (294)
T ss_dssp SSSTTC-------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHH
T ss_pred CCccccccccccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcch
Confidence 998654322 234699999999999887664 789999999999996 67778866543221 12222222
Q ss_pred -cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 342 -KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 342 -~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
....+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus 235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 2356899999999999999999999766666666643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.66 Aligned_cols=255 Identities=22% Similarity=0.374 Sum_probs=212.5
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC---C----HHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---N----TAQEKIFKKEIHAHALLSRVPHIVNYFSSW 186 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---~----~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 186 (480)
.+..+|.+.+.||+|+||.||+|.+..+|+.||||++..... . ......+.+|+.++..+.+||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 345678899999999999999999999999999999875431 1 123456889999999997799999999999
Q ss_pred eeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 187 SDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
...+..|+||||+++++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~ 161 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL------------DDDM 161 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE------------cCCC
Confidence 9999999999999999999999988889999999999999999999999999999999999999 5667
Q ss_pred ceEeCccCcccccCC---CcccCCCcccchhhhhcc-----cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHH
Q psy14702 267 HYKLGDFGHVIADND---FEVEEGDCRYLPKELLNN-----NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHI 335 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i 335 (480)
.+||+|||++..... .....||+.|+|||++.+ ....+.++|||||||++|+| +|..||..... ....+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 241 (298)
T 1phk_A 162 NIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 241 (298)
T ss_dssp CEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH
Confidence 899999998865432 233568999999999862 22234689999999999996 67777765433 23334
Q ss_pred hcCCCC----cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 336 RDGNIE----KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 336 ~~~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..+... .+..++.++.+||.+||..||.+|||+.++++||||...
T Consensus 242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 242 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred hcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 444332 224689999999999999999999999999999998653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=369.57 Aligned_cols=247 Identities=23% Similarity=0.401 Sum_probs=206.5
Q ss_pred hhhhhhheeecccCceEEEEEEEe-------eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY-------MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
..+|.+.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.++..+.+||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 467889999999999999999875 34568999999764 3444556789999999999889999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERC----------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK 252 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~ 252 (480)
.+.+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-- 236 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-- 236 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE--
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE--
Confidence 999999999999999999998643 47899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCC
Q psy14702 253 AQGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTP 324 (480)
Q Consensus 253 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p 324 (480)
+.++.+||+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|||+ |..|
T Consensus 237 ----------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p 305 (370)
T 2psq_A 237 ----------TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSP 305 (370)
T ss_dssp ----------CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCS
T ss_pred ----------CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCC
Confidence 56778999999998754322 223477899999999877655 7899999999999974 6667
Q ss_pred CCCCcc--chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 325 LPKNGP--MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 325 ~~~~~~--~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
|..... ....+..+. ...+..++.++.+||.+||+.||.+|||+.+++++..
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~ 360 (370)
T 2psq_A 306 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360 (370)
T ss_dssp STTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 765432 334444443 3445678999999999999999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=380.97 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=203.3
Q ss_pred CcchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----CCCceeEEeeE
Q psy14702 111 DHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS-----RVPHIVNYFSS 185 (480)
Q Consensus 111 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~hpnIv~l~~~ 185 (480)
.......+|.+.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.++..+. +|+||++++++
T Consensus 91 ~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~ 167 (429)
T 3kvw_A 91 PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLEN 167 (429)
T ss_dssp TTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEE
T ss_pred CCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEee
Confidence 3445567899999999999999999999999999999999752 344455777888887763 57899999999
Q ss_pred EeeCCEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 186 WSDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 186 ~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
+...+.+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.
T Consensus 168 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~------------ 234 (429)
T 3kvw_A 168 FTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK------------ 234 (429)
T ss_dssp EEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES------------
T ss_pred cccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc------------
Confidence 999999999999995 69999997654 599999999999999999999999999999999999994
Q ss_pred cccc--eEeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc
Q psy14702 264 EKLH--YKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD 337 (480)
Q Consensus 264 ~~~~--vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~ 337 (480)
.++. +||+|||++..... .....||+.|+|||++.+..+. .++|||||||++||| +|..||...... ...+..
T Consensus 235 ~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~ 313 (429)
T 3kvw_A 235 QQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIE 313 (429)
T ss_dssp STTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 3333 99999999865443 3345799999999999887665 789999999999996 666676654321 110000
Q ss_pred ----------------------CCCC-------------------------------------cCCCCCHHHHHHHHHhh
Q psy14702 338 ----------------------GNIE-------------------------------------KLSNVSDDLHTLIKLMI 358 (480)
Q Consensus 338 ----------------------~~~~-------------------------------------~~~~~s~~~~~li~~~L 358 (480)
...+ .....++++.+||.+||
T Consensus 314 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L 393 (429)
T 3kvw_A 314 LLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCL 393 (429)
T ss_dssp HHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHT
T ss_pred HcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHC
Confidence 0000 00123778999999999
Q ss_pred ccCCCCCCChhHHHHHHHHHHhCCCC
Q psy14702 359 DKDPTKRPSTSSLRRSAQLARNYPQL 384 (480)
Q Consensus 359 ~~dP~~Rps~~ell~h~~~~~~~~~~ 384 (480)
+.||.+|||+.|+++||||.+..+..
T Consensus 394 ~~dP~~Rpta~e~L~Hpw~~~~~~~~ 419 (429)
T 3kvw_A 394 EWDPAVRMTPGQALRHPWLRRRLPKP 419 (429)
T ss_dssp CSSTTTSCCHHHHHTSTTTC------
T ss_pred CCChhhCCCHHHHhCChhhccCCCCC
Confidence 99999999999999999998876544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.14 Aligned_cols=242 Identities=24% Similarity=0.376 Sum_probs=202.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.++..+ +||||+++++++.+.+..|+|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKDKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecCCeeEEE
Confidence 3568889999999999999999999999999999864 3455567799999999999 799999999999999999999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~------------~~~~~~kl~Dfg 153 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV------------RENKNVVVADFG 153 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE------------CTTSCEEECCCT
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE------------CCCCCEEEeecc
Confidence 999999999999987 4579999999999999999999999999999999999999 567789999999
Q ss_pred cccccCCCc------------------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCccc----
Q psy14702 275 HVIADNDFE------------------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGPM---- 331 (480)
Q Consensus 275 ~a~~~~~~~------------------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~~---- 331 (480)
++....... ...||+.|+|||++.+..+. .++|||||||++|+|+ |..|+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TCEECC--------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred cceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 986442211 34699999999999887655 7899999999999974 55555432221
Q ss_pred ---hHHHhcCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 332 ---WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 332 ---~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
...... ...+..+++.+.++|.+||+.||.+|||+.++++..
T Consensus 233 ~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L 277 (310)
T 3s95_A 233 GLNVRGFLD--RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277 (310)
T ss_dssp SBCHHHHHH--HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hhhhhcccc--ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 011111 122467889999999999999999999999998743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=364.51 Aligned_cols=256 Identities=25% Similarity=0.353 Sum_probs=207.8
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCCceeEEeeEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA------NTAQEKIFKKEIHAHALLSRVPHIVNYFSSW 186 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~------~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~ 186 (480)
.....+|.+.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.++..+ +||||+++++++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEE
Confidence 4466789999999999999999999999999999999875422 112234578899999999 899999999998
Q ss_pred eeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 187 SDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
.... .|+|||||++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+... ....
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~---------~~~~ 154 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ---------EEDC 154 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS---------SSSC
T ss_pred cCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC---------CCCC
Confidence 7665 89999999999999999887889999999999999999999999999999999999999532 2244
Q ss_pred ceEeCccCcccccCCCc---ccCCCcccchhhhhcc--cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhc
Q psy14702 267 HYKLGDFGHVIADNDFE---VEEGDCRYLPKELLNN--NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRD 337 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~~~---~~~gt~~y~aPE~~~~--~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~ 337 (480)
.+||+|||++....... ...||+.|+|||++.+ ....+.++|||||||++|+| +|..||..... ....+..
T Consensus 155 ~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 234 (322)
T 2ycf_A 155 LIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS 234 (322)
T ss_dssp CEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH
T ss_pred eEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh
Confidence 69999999987654432 3459999999999852 22334689999999999996 67777764332 3344555
Q ss_pred CCCCc----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 338 GNIEK----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 338 ~~~~~----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+.... +..++.++.+||.+||..||.+|||+.++++||||..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 54433 2568999999999999999999999999999999853
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=368.97 Aligned_cols=248 Identities=22% Similarity=0.336 Sum_probs=205.3
Q ss_pred hhhhhhhheeecccCceEEEEEE-----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 189 (480)
...+|.+.+.||+|+||.||+|. +..+++.||||+++.. ......+.+.+|+.++..+.+||||+++++++...
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~ 98 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 98 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence 35678899999999999999998 4456789999999764 34445567899999999998999999999998875
Q ss_pred C-EEEEEeeccCCCCHHHHHHhcCC-------------------------------------------------------
Q psy14702 190 G-VLYLQLEYCNGGNLENIIQERCT------------------------------------------------------- 213 (480)
Q Consensus 190 ~-~~~lv~E~~~gg~L~~~l~~~~~------------------------------------------------------- 213 (480)
+ .+|+|||||++|+|.+++.....
T Consensus 99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (359)
T 3vhe_A 99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 178 (359)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence 4 48999999999999999976532
Q ss_pred -----------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccCCC
Q psy14702 214 -----------FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF 282 (480)
Q Consensus 214 -----------l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~ 282 (480)
+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll------------~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL------------SEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CGGGCEEECCCGGGSCTTSC
T ss_pred cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE------------cCCCcEEEEeccceeeeccc
Confidence 8999999999999999999999999999999999999 56778999999998644221
Q ss_pred ------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc---chHHHhcC-CCCcCCCCCHHH
Q psy14702 283 ------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP---MWHHIRDG-NIEKLSNVSDDL 350 (480)
Q Consensus 283 ------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~---~~~~i~~~-~~~~~~~~s~~~ 350 (480)
....||+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+ ....+..+++++
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 325 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 325 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHH
Confidence 223578899999999877655 7899999999999985 6777765432 22333333 334456689999
Q ss_pred HHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 351 HTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 351 ~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.++|.+||..||.+|||+.++++|.-
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~ 351 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLG 351 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHH
Confidence 99999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=358.03 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=212.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
...|.+.+.||+|+||.||+|.+..+++.||||++...... .....+.+|+.++..+ +||||+++++++.....+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQC-DSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCCeEEEE
Confidence 45688899999999999999999999999999998764332 2345688999999999 889999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~~kl~Dfg~ 165 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL------------SEHGEVKLADFGV 165 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE------------CCCCCEEEeeccc
Confidence 999999999999865 579999999999999999999999999999999999999 5567899999999
Q ss_pred ccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC-cCCCCC
Q psy14702 276 VIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE-KLSNVS 347 (480)
Q Consensus 276 a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~-~~~~~s 347 (480)
+...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.....+ ....++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (303)
T 3a7i_A 166 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYS 244 (303)
T ss_dssp CEECBTTBCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCC
T ss_pred ceecCccccccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccC
Confidence 8654332 234689999999999877655 689999999999996 66677655433 22233333332 345789
Q ss_pred HHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 348 ~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
..+.+||.+||..||.+|||+.++++||||......
T Consensus 245 ~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 280 (303)
T 3a7i_A 245 KPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK 280 (303)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc
Confidence 999999999999999999999999999999987654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=360.75 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=209.2
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe--eCC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA--NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS--DQG 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~~ 190 (480)
...+|.+.+.||+|+||.||+|.+..+++.||+|+++.... .......+.+|+.++..+ +||||+++++++. +..
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 34578899999999999999999999999999999865311 112346689999999999 7999999999984 456
Q ss_pred EEEEEeeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 191 VLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
..|+|||||.++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~------------~~~~~~ 148 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL------------TTGGTL 148 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCCE
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE------------cCCCcE
Confidence 899999999876 7777765 3479999999999999999999999999999999999999 556789
Q ss_pred EeCccCcccccCC------CcccCCCcccchhhhhcccC-CCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcC
Q psy14702 269 KLGDFGHVIADND------FEVEEGDCRYLPKELLNNNF-DNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDG 338 (480)
Q Consensus 269 kL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~ 338 (480)
||+|||++..... .....||+.|+|||++.+.. ..+.++|||||||++|+| +|..||..... ....+..+
T Consensus 149 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~ 228 (305)
T 2wtk_C 149 KISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG 228 (305)
T ss_dssp EECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC
T ss_pred EeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC
Confidence 9999999865432 12345899999999997642 223589999999999996 67777765432 34556667
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCC
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL 384 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~ 384 (480)
....+..+++++.+||.+||..||.+|||+.++++||||....+..
T Consensus 229 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 274 (305)
T 2wtk_C 229 SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274 (305)
T ss_dssp CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCc
Confidence 7777778999999999999999999999999999999999866543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=363.86 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=200.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--EE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG--VL 192 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--~~ 192 (480)
...+|.+.+.||+|+||+||+|.+..+++.||||++..... ......+.+|+.++..+ +||||+++++++.... .+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCceE
Confidence 34578899999999999999999999999999999875322 12234578899999999 7899999999988655 78
Q ss_pred EEEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 193 YLQLEYCNGGNLENIIQERC---TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
|+|||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.... +..+.+|
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~--------~~~~~~k 156 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE--------DGQSVYK 156 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT--------TSCEEEE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC--------CCCceEE
Confidence 99999999999999998643 399999999999999999999999999999999999984432 4566899
Q ss_pred eCccCcccccCCC---cccCCCcccchhhhhcc-------cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------ch
Q psy14702 270 LGDFGHVIADNDF---EVEEGDCRYLPKELLNN-------NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MW 332 (480)
Q Consensus 270 L~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------~~ 332 (480)
|+|||++...... ....||+.|+|||++.. ....+.++|||||||++|+| +|..||..... ..
T Consensus 157 L~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 236 (319)
T 4euu_A 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (319)
T ss_dssp ECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred EccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence 9999998654332 33569999999999863 12334689999999999996 67777753221 12
Q ss_pred HHHhcCCC---------------------CcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 333 HHIRDGNI---------------------EKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 333 ~~i~~~~~---------------------~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..+..+.. +.. ..++..+.+||.+||+.||++|||++|+++||-
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 22222211 111 123467899999999999999999999999996
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=358.05 Aligned_cols=253 Identities=26% Similarity=0.420 Sum_probs=212.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe--eCCEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS--DQGVLY 193 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~~~~~ 193 (480)
..+|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.++..+ +||||+++++++. ....+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCceEE
Confidence 3578889999999999999999999999999999987666666677899999999999 7999999999875 467899
Q ss_pred EEeeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEeccCCCCCCCCCcc
Q psy14702 194 LQLEYCNGGNLENIIQER----CTFTEMALKQLLFQVSEGLRCMHEMR-----MIHMDIKPANILIVKAQGELNEPMNTE 264 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~-----IvHrDlKp~NILl~~~~~~~~~~~~~~ 264 (480)
+|||||++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ +.
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~------------~~ 151 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL------------DG 151 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE------------CS
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE------------cC
Confidence 999999999999999753 24999999999999999999999999 9999999999999 56
Q ss_pred ccceEeCccCcccccCCCc----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhc
Q psy14702 265 KLHYKLGDFGHVIADNDFE----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRD 337 (480)
Q Consensus 265 ~~~vkL~DFG~a~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~ 337 (480)
++.+||+|||++....... ...||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+..
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~ 230 (279)
T 2w5a_A 152 KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 230 (279)
T ss_dssp SSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEEecCchheeeccccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh
Confidence 6789999999986554322 24589999999999877554 789999999999996 66777765432 3445555
Q ss_pred CCCC-cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 338 GNIE-KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 338 ~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
+..+ .+..++.++.++|.+||+.||.+|||+.++++|+|+....+
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 231 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred cccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 5553 34578999999999999999999999999999999876544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=375.44 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=193.2
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC-----
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ----- 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~----- 189 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++..........+.+.+|+.++..+ +||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGG
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCcccc
Confidence 34678999999999999999999999999999999987666666677889999999999 799999999998654
Q ss_pred -CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 190 -GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 190 -~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll------------~~~~~~ 171 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV------------NEDCEL 171 (367)
T ss_dssp CCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTCCE
T ss_pred CCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE------------CCCCCE
Confidence 5689999999 7899998875 579999999999999999999999999999999999999 567789
Q ss_pred EeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc-------
Q psy14702 269 KLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD------- 337 (480)
Q Consensus 269 kL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~------- 337 (480)
||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+..
T Consensus 172 kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 172 KILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp EECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9999999875443 33457999999999998744445789999999999996 677777655421 111110
Q ss_pred ----------------C--CCC------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 338 ----------------G--NIE------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 338 ----------------~--~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
. ..+ .++.+++++.+||.+||..||.+|||+.++++||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0 000 1235688999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=368.23 Aligned_cols=251 Identities=19% Similarity=0.311 Sum_probs=205.9
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC-----C
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ-----G 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-----~ 190 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.++..+ +||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccc
Confidence 35788999999999999999999999999999998753 3444556788999999999 799999999998754 4
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------~~~~~~kl 169 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL------------NTTCDLKI 169 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEE
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE------------CCCCCEEE
Confidence 7899999996 599999876 479999999999999999999999999999999999999 56778999
Q ss_pred CccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--C
Q psy14702 271 GDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD--G 338 (480)
Q Consensus 271 ~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~--~ 338 (480)
+|||++...... ....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+.. +
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 249 (364)
T 3qyz_A 170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 249 (364)
T ss_dssp CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHC
T ss_pred EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhC
Confidence 999998654322 2346999999999987665455799999999999996 677777654321 111110 0
Q ss_pred --------------------CC---------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 339 --------------------NI---------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 339 --------------------~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
.. ...+.+++++.+||.+||+.||.+|||+.++++||||.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 00 012467899999999999999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.97 Aligned_cols=254 Identities=18% Similarity=0.228 Sum_probs=206.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCC-------cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDG-------MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
..+|.+.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.++..+ +||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKL-SHKHLVLNYGVCVC 83 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTS-CCTTBCCEEEEECC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEe
Confidence 457888999999999999999988877 479999986532 23345688999999999 79999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
.+..|+|||||++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++..+... ......
T Consensus 84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~----~~~~~~ 159 (289)
T 4fvq_A 84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRK----TGNPPF 159 (289)
T ss_dssp TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGG----GTBCCE
T ss_pred CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccc----ccccce
Confidence 9999999999999999999987653 99999999999999999999999999999999999996543110 012234
Q ss_pred eEeCccCcccccCCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC-CCCCCCCccc--hHHHhcCCCCcCC
Q psy14702 268 YKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG-VTPLPKNGPM--WHHIRDGNIEKLS 344 (480)
Q Consensus 268 vkL~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~-~~p~~~~~~~--~~~i~~~~~~~~~ 344 (480)
+||+|||++..........||+.|+|||++.+....+.++|||||||++|+|++ +.|+...... ...+.......+.
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (289)
T 4fvq_A 160 IKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239 (289)
T ss_dssp EEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC
T ss_pred eeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC
Confidence 999999998776665666789999999999874444579999999999999754 5555443321 2223333444556
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..++++.+||.+||+.||.+|||+.+++++..
T Consensus 240 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~ 271 (289)
T 4fvq_A 240 PKAAELANLINNCMDYEPDHRPSFRAIIRDLN 271 (289)
T ss_dssp CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 67889999999999999999999999998753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=371.67 Aligned_cols=246 Identities=17% Similarity=0.246 Sum_probs=197.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-------
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------- 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------- 188 (480)
..+|.+.+.||+|+||+||+|.+..+|+.||||++...... ..+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTC-CCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHc-CCCCccchhheeeecCccccc
Confidence 45788999999999999999999999999999998754222 23689999999 89999999999843
Q ss_pred -------------------------------CCEEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHH
Q psy14702 189 -------------------------------QGVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSEGLRCM 233 (480)
Q Consensus 189 -------------------------------~~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~yL 233 (480)
...+|+|||||+ |+|.+.+. ....+++..++.++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345899999997 57777664 346799999999999999999999
Q ss_pred HhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHH
Q psy14702 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIF 310 (480)
Q Consensus 234 H~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~Diw 310 (480)
|++||+||||||+|||++. .++.+||+|||++..... .....||+.|+|||++.+....+.++|||
T Consensus 158 H~~gi~H~Dikp~Nil~~~-----------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNS-----------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HTTTEECSCCCGGGEEEET-----------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHCcCccCccCHHHEEEcC-----------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 9999999999999999932 356899999999875432 23456899999999998765555799999
Q ss_pred HHHHHHHHH-hCCCCCCCCccc--hHHHhc--------------C-----CCC----------cCCCCCHHHHHHHHHhh
Q psy14702 311 ALGLTLYEA-SGVTPLPKNGPM--WHHIRD--------------G-----NIE----------KLSNVSDDLHTLIKLMI 358 (480)
Q Consensus 311 SlGvilyel-~~~~p~~~~~~~--~~~i~~--------------~-----~~~----------~~~~~s~~~~~li~~~L 358 (480)
||||++|+| +|..||...... ...+.. . .++ .+..+++++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 999999996 677777654421 111110 0 011 12347889999999999
Q ss_pred ccCCCCCCChhHHHHHHHHHHh
Q psy14702 359 DKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 359 ~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..||.+|||+.|+++||||...
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHH
Confidence 9999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.35 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=197.8
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHH---HHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTA---QEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
....+|.+.+.||+|+||.||+|.+..+|+.||||++........ ....+.+|+.++..+ +||||+++++++...+
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKS 85 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTT
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEeeCC
Confidence 345678899999999999999999999999999999875322221 123578899999999 7999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 191 VLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
..|+|||||++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~------------~~~~~~k 152 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL------------DENGVLK 152 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTCCEE
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE------------cCCCCEE
Confidence 99999999975 898888754 368999999999999999999999999999999999999 5667899
Q ss_pred eCccCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhc--CC-
Q psy14702 270 LGDFGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRD--GN- 339 (480)
Q Consensus 270 L~DFG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~--~~- 339 (480)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||..... ....+.. +.
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 153 LADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 232 (346)
T ss_dssp ECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred EEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 999999865432 23356899999999997655445789999999999997 45455544332 1111111 00
Q ss_pred ----CC---------------------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 340 ----IE---------------------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 340 ----~~---------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
++ .+..+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 00 014567899999999999999999999999999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=357.81 Aligned_cols=248 Identities=30% Similarity=0.529 Sum_probs=201.8
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-----
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----- 188 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----- 188 (480)
++..+|.+.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.++..+ +||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchh
Confidence 567889999999999999999999999999999999864 234456788999999999 79999999998865
Q ss_pred --------CCEEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCC
Q psy14702 189 --------QGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 189 --------~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
...+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~--------- 149 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI--------- 149 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---------
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---------
Confidence 457899999999999999998643 68899999999999999999999999999999999999
Q ss_pred CCCccccceEeCccCcccccCC------------------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC
Q psy14702 260 PMNTEKLHYKLGDFGHVIADND------------------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG 321 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~------------------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~ 321 (480)
+.++.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+|+.
T Consensus 150 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 150 ---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp ---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred ---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 5567899999998864431 1234589999999999865444579999999999999875
Q ss_pred CCCCCCCcc---chHHHhcCCCCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 322 VTPLPKNGP---MWHHIRDGNIEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 322 ~~p~~~~~~---~~~~i~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
||..... ....+.......+ ...+..+++||.+||+.||.+|||+.++++||||..
T Consensus 227 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 227 --PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp --CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred --ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 5543321 2333443333222 346778999999999999999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=356.15 Aligned_cols=249 Identities=29% Similarity=0.419 Sum_probs=203.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||+|.+..... ...+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQC-DSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhC-CCCCCccEEEEEEeCCEEEE
Confidence 34568889999999999999999999999999999876432 23478899999999 88999999999999999999
Q ss_pred EeeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~~kl~df 169 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL------------NTEGHAKLADF 169 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEECCC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE------------CCCCCEEEeec
Confidence 999999999999997 34679999999999999999999999999999999999999 55678999999
Q ss_pred CcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHHhcCC---CCcC
Q psy14702 274 GHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHIRDGN---IEKL 343 (480)
Q Consensus 274 G~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i~~~~---~~~~ 343 (480)
|++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||....... ..+.... ...+
T Consensus 170 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T 3com_A 170 GVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP 248 (314)
T ss_dssp TTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSG
T ss_pred ccchhhhhhccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCc
Confidence 98865432 2234689999999999877655 689999999999996 6777776544321 1222222 2233
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
..++.++.+||.+||..||.+|||+.++++||||....
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 45789999999999999999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=358.59 Aligned_cols=248 Identities=23% Similarity=0.317 Sum_probs=205.4
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGM---TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
...+|.+.+.||+|+||.||+|.+..+++ .||||+++.. ......+.+.+|+.++..+ +||||+++++++.+.+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRGRL 124 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGGGC
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeCCc
Confidence 34578889999999999999999876554 5999999764 3445566789999999999 79999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll------------~~~~~~kl 192 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV------------DSNLVCKV 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCCEEE
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE------------CCCCCEEE
Confidence 99999999999999999754 579999999999999999999999999999999999999 56778999
Q ss_pred CccCcccccCCCc-------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-
Q psy14702 271 GDFGHVIADNDFE-------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG- 338 (480)
Q Consensus 271 ~DFG~a~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~- 338 (480)
+|||++....... ...+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+
T Consensus 193 ~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~ 271 (325)
T 3kul_A 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY 271 (325)
T ss_dssp CCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred CCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 9999987543321 22367789999999877555 6899999999999964 6777755432 33334443
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
..+.+..+++++.+||.+||..||.+|||+.++++...-
T Consensus 272 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~ 310 (325)
T 3kul_A 272 RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA 310 (325)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 344556799999999999999999999999999976543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=360.88 Aligned_cols=251 Identities=19% Similarity=0.317 Sum_probs=187.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGM---TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+|.+.+.||+|+||.||+|.+..++. .||||+++.........+.+.+|+.+++.+ +||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC---
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccccc
Confidence 4568889999999999999998877765 899999987654555667799999999999 899999999999877655
Q ss_pred ------EEEeeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCC
Q psy14702 193 ------YLQLEYCNGGNLENIIQERC------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP 260 (480)
Q Consensus 193 ------~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~ 260 (480)
|+|||||.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---------- 170 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---------- 170 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----------
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE----------
Confidence 99999999999999996432 59999999999999999999999999999999999999
Q ss_pred CCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--
Q psy14702 261 MNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP-- 330 (480)
Q Consensus 261 ~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~-- 330 (480)
+.++.+||+|||++...... ....+++.|+|||++.+..+. .++|||||||++|+| + |..||.....
T Consensus 171 --~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 171 --AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp --CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred --cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 56678999999998654322 123467889999999887655 789999999999996 4 5666654432
Q ss_pred chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCC-------hhHHHHHHHHHHh
Q psy14702 331 MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPS-------TSSLRRSAQLARN 380 (480)
Q Consensus 331 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps-------~~ell~h~~~~~~ 380 (480)
....+..+ ....+..+++++.+||.+||..||.+||| +.++++|+|+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 248 IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 33344443 34556779999999999999999999999 5555667776653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=364.87 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=211.6
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCC-CCceeEEeeEEee
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLSR-VPHIVNYFSSWSD 188 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~ 188 (480)
....+|.+.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++..+.+ ||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34567889999999999999999999999999999987532211 112336678899998863 7999999999999
Q ss_pred CCEEEEEeeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 189 QGVLYLQLEYCNG-GNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 189 ~~~~~lv~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
.+..++|||++.+ ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++. ..+.
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~-----------~~~~ 188 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-----------NRGE 188 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-----------TTTE
T ss_pred CCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeC-----------CCCC
Confidence 9999999999976 899999998889999999999999999999999999999999999999931 4568
Q ss_pred eEeCccCcccccCCC--cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchHHHhcCCCCcCC
Q psy14702 268 YKLGDFGHVIADNDF--EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHHIRDGNIEKLS 344 (480)
Q Consensus 268 vkL~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~~i~~~~~~~~~ 344 (480)
+||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+| +|..||... ..+.........
T Consensus 189 ~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~~~~~~~~~~~~ 264 (320)
T 3a99_A 189 LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFFRQ 264 (320)
T ss_dssp EEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHHCCCCCSS
T ss_pred EEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----hhhhcccccccc
Confidence 999999998655432 3356999999999998776655689999999999996 666776543 234444555567
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+++++.+||.+||..||.+|||+.++++||||...
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 799999999999999999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=357.33 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=202.8
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee------
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------ 188 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------ 188 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++...... ...+.+|+.++..+.+||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 456788999999999999999999899999999998754332 24578899999999889999999999986
Q ss_pred CCEEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
.+.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~------------~~~~ 166 (326)
T 2x7f_A 99 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL------------TENA 166 (326)
T ss_dssp CCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE------------CTTC
T ss_pred cceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE------------cCCC
Confidence 56899999999999999999864 479999999999999999999999999999999999999 5567
Q ss_pred ceEeCccCcccccCC----CcccCCCcccchhhhhcc----cCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHH
Q psy14702 267 HYKLGDFGHVIADND----FEVEEGDCRYLPKELLNN----NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHI 335 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~----~~~~~gt~~y~aPE~~~~----~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i 335 (480)
.+||+|||++..... .....||+.|+|||++.. ....+.++|||||||++|+| +|..||...... ...+
T Consensus 167 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246 (326)
T ss_dssp CEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred CEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence 899999998865432 233469999999999873 22234689999999999996 677777654432 1222
Q ss_pred hcCCCC--cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 336 RDGNIE--KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 336 ~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.....+ ....++..+.+||.+||..||.+|||+.++++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 232222 235689999999999999999999999999999999754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=374.30 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=188.2
Q ss_pred hhhhhhhh-heeecccCceEEEEEEEe--eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--
Q psy14702 114 RYALEFLE-EELLGSGDFGEVFKCLKY--MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-- 188 (480)
Q Consensus 114 ~~~~~y~~-~~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-- 188 (480)
++...|.+ .++||+|+||+||+|.++ .+++.||||++....... .+.+|+.++..+ +||||+++++++..
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~----~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 91 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM----SACREIALLREL-KHPNVISLQKVFLSHA 91 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH----HHHHHHHHHHHC-CCTTBCCCCEEEEETT
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH----HHHHHHHHHHhc-CCCCeeeEeeEEecCC
Confidence 44556665 458999999999999866 568899999997643332 367899999999 79999999999954
Q ss_pred CCEEEEEeeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCC
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQER---------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
...+|+|||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~----- 165 (405)
T 3rgf_A 92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG----- 165 (405)
T ss_dssp TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS-----
T ss_pred CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC-----
Confidence 778999999996 5888887532 1499999999999999999999999999999999999995432
Q ss_pred CCCccccceEeCccCcccccCC-------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc
Q psy14702 260 PMNTEKLHYKLGDFGHVIADND-------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM 331 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~ 331 (480)
+..+.+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+| +|..||......
T Consensus 166 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 242 (405)
T 3rgf_A 166 ---PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242 (405)
T ss_dssp ---TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred ---CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccc
Confidence 4567899999999865432 23356899999999998765455789999999999996 677777533210
Q ss_pred -----------hHHHhc--C--CCCc----------------------------------CCCCCHHHHHHHHHhhccCC
Q psy14702 332 -----------WHHIRD--G--NIEK----------------------------------LSNVSDDLHTLIKLMIDKDP 362 (480)
Q Consensus 332 -----------~~~i~~--~--~~~~----------------------------------~~~~s~~~~~li~~~L~~dP 362 (480)
...+.. + .... ....++++.+||.+||..||
T Consensus 243 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP 322 (405)
T 3rgf_A 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322 (405)
T ss_dssp ----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSG
T ss_pred ccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCc
Confidence 011100 0 0000 01226789999999999999
Q ss_pred CCCCChhHHHHHHHHHHh
Q psy14702 363 TKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 363 ~~Rps~~ell~h~~~~~~ 380 (480)
.+|||+.|+++||||...
T Consensus 323 ~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 323 IKRITSEQAMQDPYFLED 340 (405)
T ss_dssp GGSCCHHHHHTSGGGTSS
T ss_pred ccCCCHHHHhcChhhccC
Confidence 999999999999999764
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=358.05 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=203.0
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATC-DHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHC-CCTTBCCEEEEEECC-CEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcC-CCCCEeeeeeeeeeCCeEEE
Confidence 456788999999999999999999999999999998754322 235588899999999 89999999999999999999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~------------~~~~~~kl~Df 161 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM------------TLEGDIRLADF 161 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE------------CTTSCEEECCC
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE------------CCCCCEEEEEC
Confidence 9999999999999875 4579999999999999999999999999999999999999 55678999999
Q ss_pred Cccccc----CCCcccCCCcccchhhhhc----ccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC-
Q psy14702 274 GHVIAD----NDFEVEEGDCRYLPKELLN----NNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE- 341 (480)
Q Consensus 274 G~a~~~----~~~~~~~gt~~y~aPE~~~----~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~- 341 (480)
|++... .......||+.|+|||++. .....+.++|||||||++|+| +|..||..... ....+.....+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 162 GVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241 (302)
T ss_dssp HHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC
T ss_pred CCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcc
Confidence 987432 1223456999999999984 222334689999999999996 66667665433 22233333322
Q ss_pred --cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 342 --KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 342 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.+..++.++.+||.+||..||.+|||+.++++||||....
T Consensus 242 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 2356889999999999999999999999999999997644
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=368.49 Aligned_cols=250 Identities=20% Similarity=0.330 Sum_probs=204.8
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE--
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL-- 192 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~-- 192 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCccc
Confidence 45678899999999999999999999999999999987766666677889999999999 789999999999876654
Q ss_pred ----EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 193 ----YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 193 ----~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
|+||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll------------~~~~~~ 183 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV------------NEDCEL 183 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCE
T ss_pred ceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE------------CCCCCE
Confidence 99999996 68988874 359999999999999999999999999999999999999 567789
Q ss_pred EeCccCcccccCCC-cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc-------
Q psy14702 269 KLGDFGHVIADNDF-EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD------- 337 (480)
Q Consensus 269 kL~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~------- 337 (480)
||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+..
T Consensus 184 kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 184 KILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp EECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred EEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 99999998755433 3457899999999998744445789999999999996 677777654321 111100
Q ss_pred --------------------CCC----CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 --------------------GNI----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 --------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
... ..++.+++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 000 1124578999999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=363.74 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=207.8
Q ss_pred hhhhhhheeecccCceEEEEEEEeeC-------CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMD-------GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~-------~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
..+|.+.+.||+|+||.||+|.+..+ +..||||+++.. ........+.+|+.++..+.+||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 45788899999999999999987643 357999999764 3445556789999999999889999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERC----------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK 252 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~ 252 (480)
.+.+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 224 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 224 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--
Confidence 999999999999999999998653 49999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccceEeCccCcccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCC
Q psy14702 253 AQGELNEPMNTEKLHYKLGDFGHVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTP 324 (480)
Q Consensus 253 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p 324 (480)
+.++.+||+|||++..... .....+|+.|+|||++.+..+. .++|||||||++|+|+ |..|
T Consensus 225 ----------~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p 293 (382)
T 3tt0_A 225 ----------TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSP 293 (382)
T ss_dssp ----------CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCS
T ss_pred ----------cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCC
Confidence 5667899999999865432 2233578899999999877554 7899999999999974 6667
Q ss_pred CCCCcc--chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 325 LPKNGP--MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 325 ~~~~~~--~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
|..... ....+..+ ....+..+++++.+||.+||+.||.+|||+.+++++..-
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 349 (382)
T 3tt0_A 294 YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349 (382)
T ss_dssp STTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 765432 33444444 334556789999999999999999999999999998653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=351.58 Aligned_cols=248 Identities=32% Similarity=0.577 Sum_probs=207.0
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD---- 188 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~---- 188 (480)
..+..+|.+.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++..+ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 79 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKL-DHVNIVHYNGCWDGFDYD 79 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhC-CCCCEEEEeeeEeccccC
Confidence 467788999999999999999999998899999999987642 2366899999999 78999999998864
Q ss_pred ------------CCEEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccC
Q psy14702 189 ------------QGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQ 254 (480)
Q Consensus 189 ------------~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~ 254 (480)
...+|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---- 155 (284)
T 2a19_B 80 PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---- 155 (284)
T ss_dssp ---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----
T ss_pred cccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE----
Confidence 45689999999999999999754 579999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCcc
Q psy14702 255 GELNEPMNTEKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGP 330 (480)
Q Consensus 255 ~~~~~~~~~~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~ 330 (480)
+.++.+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+|+ +..|+.....
T Consensus 156 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~ 226 (284)
T 2a19_B 156 --------VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSK 226 (284)
T ss_dssp --------EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHHHH
T ss_pred --------cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhHHH
Confidence 5566899999998865433 2345699999999999877554 7899999999999975 4445433333
Q ss_pred chHHHhcCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 331 MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 331 ~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
.+..+..+.. ...++.++.+||.+||..||.+|||+.+++++++.....+
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~ 276 (284)
T 2a19_B 227 FFTDLRDGII--SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP 276 (284)
T ss_dssp HHHHHHTTCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred HHHHhhcccc--cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence 3444444433 3568899999999999999999999999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=344.02 Aligned_cols=243 Identities=22% Similarity=0.314 Sum_probs=203.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.++..+ +||||+++++++.+.+..|+||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCH---HHHHHHHHHHHhC-CCCCEeeEEEEEecCCceEEEE
Confidence 46888999999999999999875 67889999998654333 4588999999999 7899999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~------------~~~~~~kl~Dfg~ 152 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV------------GENQVIKVSDFGM 152 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CGGGCEEECCTTG
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE------------cCCCCEEeccccc
Confidence 999999999999754 468999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCcCCC
Q psy14702 276 VIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEKLSN 345 (480)
Q Consensus 276 a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~~~~ 345 (480)
+...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+ ....+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 231 (269)
T 4hcu_A 153 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 231 (269)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cccccccccccccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCc
Confidence 8654332 233467789999999877655 7899999999999974 5666654432 33344444 3334556
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
+++++.++|.+||+.||.+|||+.+++++..-
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~ 263 (269)
T 4hcu_A 232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE 263 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence 89999999999999999999999999998653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=361.63 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=203.3
Q ss_pred cchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC---CCCceeEEee
Q psy14702 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLS---RVPHIVNYFS 184 (480)
Q Consensus 112 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~---~hpnIv~l~~ 184 (480)
...+..+|.+.+.||+|+||.||+|.+..+++.||||++....... .....+.+|+.++..+. +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 3456678999999999999999999998999999999987643322 12234567888888774 6899999999
Q ss_pred EEeeCCEEEEEeec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 185 SWSDQGVLYLQLEY-CNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 185 ~~~~~~~~~lv~E~-~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
++...+..++|||| +.+++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~----------- 174 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL----------- 174 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEET-----------
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeC-----------
Confidence 99999999999999 789999999998888999999999999999999999999999999999999931
Q ss_pred cccceEeCccCcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchHHHhcCCC
Q psy14702 264 EKLHYKLGDFGHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHHIRDGNI 340 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~~i~~~~~ 340 (480)
.++.+||+|||++..... .....||+.|+|||++.+..+.+.++|||||||++|+| +|..||... ..+.....
T Consensus 175 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~~~~~~~~ 250 (312)
T 2iwi_A 175 RRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----QEILEAEL 250 (312)
T ss_dssp TTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHHTCC
T ss_pred CCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----HHHhhhcc
Confidence 456899999999865443 23456899999999998776654589999999999996 666676543 23444555
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
..+..++.++.+||.+||..||++|||+.++++||||.....
T Consensus 251 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 566789999999999999999999999999999999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=358.02 Aligned_cols=245 Identities=25% Similarity=0.322 Sum_probs=205.7
Q ss_pred hhhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.++..+ +||||+++++++.+.+
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 123 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEF-DNPNIVKLLGVCAVGK 123 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEccCC
Confidence 457888999999999999999887 355899999997643 344556789999999999 8999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy14702 191 VLYLQLEYCNGGNLENIIQER------------------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPA 246 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~ 246 (480)
.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 999999999999999999763 46899999999999999999999999999999999
Q ss_pred cEEEeccCCCCCCCCCccccceEeCccCcccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh
Q psy14702 247 NILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS 320 (480)
Q Consensus 247 NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~ 320 (480)
|||+ +.++.+||+|||++..... .....+|+.|+|||++.+..+. .++|||||||++|+|+
T Consensus 204 NIl~------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~ 270 (343)
T 1luf_A 204 NCLV------------GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIF 270 (343)
T ss_dssp GEEE------------CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred eEEE------------CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHH
Confidence 9999 5677899999998864322 2234578899999999877654 7899999999999975
Q ss_pred --CCCCCCCCcc--chHHHhcCCC-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 321 --GVTPLPKNGP--MWHHIRDGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 321 --~~~p~~~~~~--~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
|..||..... ....+..+.. ..+..++.++.+||.+||..||.+|||+.+++++.
T Consensus 271 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 271 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred hcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 5667765432 3344555544 34567899999999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=360.44 Aligned_cols=251 Identities=26% Similarity=0.380 Sum_probs=186.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.++..+ +||||+++++++...+..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCC-CCTTBCCEEEEEESSSCEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhc-CCCCEeeEEEEEeecCCcEEE
Confidence 4568889999999999999999888999999998865322 22345578899998888 799999999999999999999
Q ss_pred eeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 196 LEYCNGGNLENIIQE--------RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~------------~~~~~ 159 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL------------GEDGS 159 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE------------CTTCC
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE------------cCCCC
Confidence 999999999999874 3469999999999999999999999999999999999999 56678
Q ss_pred eEeCccCcccccCC---------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHH
Q psy14702 268 YKLGDFGHVIADND---------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHI 335 (480)
Q Consensus 268 vkL~DFG~a~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i 335 (480)
+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||....... ...
T Consensus 160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 239 (303)
T 2vwi_A 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT 239 (303)
T ss_dssp EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH
Confidence 99999998754322 12346899999999997633334789999999999996 6777776543321 111
Q ss_pred hcCCC----------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 336 RDGNI----------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 336 ~~~~~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..... ..+..++.++.+||.+||+.||.+|||+.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 11111 1234678999999999999999999999999999999764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=353.04 Aligned_cols=251 Identities=24% Similarity=0.348 Sum_probs=204.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-VPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+. +++.||||++............+.+|+.++..+.+ ||||+++++++...+.+|+
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 456888999999999999999874 68999999998765666667789999999999965 7999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+. ++.+||+|||
T Consensus 106 v~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-------------~~~~kL~Dfg 171 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-------------DGMLKLIDFG 171 (313)
T ss_dssp EEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-------------TTEEEECCCS
T ss_pred EEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-------------CCeEEEeecc
Confidence 999 55889999999888899999999999999999999999999999999999993 2579999999
Q ss_pred cccccCCC------cccCCCcccchhhhhccc----------CCCCCcccHHHHHHHHHHH-hCCCCCCCCccc---hHH
Q psy14702 275 HVIADNDF------EVEEGDCRYLPKELLNNN----------FDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM---WHH 334 (480)
Q Consensus 275 ~a~~~~~~------~~~~gt~~y~aPE~~~~~----------~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~---~~~ 334 (480)
++...... ....||+.|+|||++.+. ...+.++|||||||++|+| +|..||...... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 251 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHA 251 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHH
Confidence 98654322 234689999999998752 1233689999999999996 677777654322 122
Q ss_pred HhcC--CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 335 IRDG--NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 335 i~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
+... ....+...+.++.+||.+||..||.+|||+.++++||||....
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 2222 2233455789999999999999999999999999999998654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=360.27 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=180.4
Q ss_pred hhhhhhhh-eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----C
Q psy14702 115 YALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----Q 189 (480)
Q Consensus 115 ~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~ 189 (480)
...+|.+. ++||+|+||.||+|.+..+|+.||||++... .. ..+|+..+..+.+||||+++++++.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 45577775 4699999999999999999999999998652 21 23344444444489999999999876 5
Q ss_pred CEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
..+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+... +..+.
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~---------~~~~~ 169 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK---------EKDAV 169 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS---------STTCC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec---------CCCce
Confidence 56899999999999999998653 69999999999999999999999999999999999999532 23557
Q ss_pred eEeCccCcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc------hHHHhcC
Q psy14702 268 YKLGDFGHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM------WHHIRDG 338 (480)
Q Consensus 268 vkL~DFG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~------~~~i~~~ 338 (480)
+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+...
T Consensus 170 ~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 170 LKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp EEECCCTTCEEC----------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred EEEeccccceeccccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence 99999999865443 2345689999999999766554 689999999999996 677777544321 1112222
Q ss_pred C----CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 339 N----IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 339 ~----~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
. .+.+..+++++.+||.+||..||.+|||+.++++||||....
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 1 123356899999999999999999999999999999998753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=348.05 Aligned_cols=247 Identities=23% Similarity=0.363 Sum_probs=196.1
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
....+|.+.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+.+|+.++..+ +||||+++++++. ++
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~ 88 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-EN 88 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhC-CCCccceEEEEEc-cC
Confidence 3456788999999999999999988653 567999998764 3445566789999999999 7999999999985 56
Q ss_pred EEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
..|+|||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~------------~~~~~~k 156 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV------------SSNDCVK 156 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------EETTEEE
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE------------CCCCCEE
Confidence 7899999999999999998654 69999999999999999999999999999999999999 5566899
Q ss_pred eCccCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-
Q psy14702 270 LGDFGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN- 339 (480)
Q Consensus 270 L~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~- 339 (480)
|+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+.
T Consensus 157 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~ 235 (281)
T 1mp8_A 157 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER 235 (281)
T ss_dssp ECC-------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ECccccccccCcccccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC
Confidence 9999998654332 223467889999999876554 6899999999999974 5667764432 334444443
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.+.+..+++++.++|.+||..||.+|||+.+++++..
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 272 (281)
T 1mp8_A 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 272 (281)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 3455679999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=353.30 Aligned_cols=246 Identities=25% Similarity=0.460 Sum_probs=205.3
Q ss_pred hhhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+.++..+ +||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDG 99 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEecCC
Confidence 457888999999999999999874 45589999998754 3445556789999999999 8999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCT------------------------FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPA 246 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~------------------------l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~ 246 (480)
..|+|||||++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 99999999999999999986533 899999999999999999999999999999999
Q ss_pred cEEEeccCCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh
Q psy14702 247 NILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS 320 (480)
Q Consensus 247 NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~ 320 (480)
|||+ +.++.+||+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+
T Consensus 180 NIli------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~ 246 (314)
T 2ivs_A 180 NILV------------AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIV 246 (314)
T ss_dssp GEEE------------ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHH
T ss_pred eEEE------------cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHH
Confidence 9999 55678999999998654322 223477889999999877554 7899999999999974
Q ss_pred --CCCCCCCCcc--chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 321 --GVTPLPKNGP--MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 321 --~~~p~~~~~~--~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
|..||..... ....+..+. ...+..+++++.+||.+||..||.+|||+.+++++..
T Consensus 247 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~ 307 (314)
T 2ivs_A 247 TLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLE 307 (314)
T ss_dssp TTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 6677765432 334444443 3445678999999999999999999999999998753
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=349.68 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=202.1
Q ss_pred hhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeec
Q psy14702 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEY 198 (480)
Q Consensus 119 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~ 198 (480)
|.....||+|+||.||+|.+..+++.||||.+.... ......+.+|+.++..+ +||||+++++++...+..++||||
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHL-KHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEeCCcEEEEEEe
Confidence 334568999999999999999999999999987643 23345688999999999 889999999999999999999999
Q ss_pred cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 199 CNGGNLENIIQERC---TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 199 ~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.. .++.+||+|||+
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~-----------~~~~~kl~Dfg~ 169 (295)
T 2clq_A 101 VPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT-----------YSGVLKISDFGT 169 (295)
T ss_dssp CSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-----------TTCCEEECCTTT
T ss_pred CCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEEC-----------CCCCEEEeeccc
Confidence 99999999998652 5679999999999999999999999999999999999942 256899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccC-CCCCcccHHHHHHHHHHH-hCCCCCCCCccch----H-HHhcCCCCcCC
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNF-DNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW----H-HIRDGNIEKLS 344 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~----~-~i~~~~~~~~~ 344 (480)
+..... .....||+.|+|||++.+.. ..+.++|||||||++|+| +|..||....... . .........+.
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 2clq_A 170 SKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE 249 (295)
T ss_dssp CEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCT
T ss_pred ccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccc
Confidence 865433 23346899999999997653 234689999999999996 6777775432211 1 11222334456
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+++++.+||.+||..||++|||+.++++||||...
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 789999999999999999999999999999999643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=366.80 Aligned_cols=246 Identities=23% Similarity=0.371 Sum_probs=205.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.++..+ +||||+++++++...+.+|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEecCCCcEEE
Confidence 45788899999999999999999889999999998754 3344455688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~------------~~~~~~kl~DfG 258 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV------------TEKNVLKISDFG 258 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCCEEECCGG
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE------------cCCCcEEECcCC
Confidence 99999999999997653 69999999999999999999999999999999999999 566789999999
Q ss_pred cccccCCCc------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCcC
Q psy14702 275 HVIADNDFE------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEKL 343 (480)
Q Consensus 275 ~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~~ 343 (480)
++....... ...+++.|+|||++.+..+. .++|||||||++|||+ |..||..... ....+..+ ..+.+
T Consensus 259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 337 (377)
T 3cbl_A 259 MSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCP 337 (377)
T ss_dssp GCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCC
T ss_pred CceecCCCceeecCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 987543321 12246789999999876554 6899999999999974 6667765432 22333333 34455
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..+++++.+||.+||+.||++|||+.++++...
T Consensus 338 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 370 (377)
T 3cbl_A 338 ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370 (377)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 678999999999999999999999999987653
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=354.40 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=199.6
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe-----
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS----- 187 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~----- 187 (480)
.....+|.+.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.++..+ +||||+++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCB
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhc-CCCCeeEEEEeccccccc
Confidence 34567899999999999999999999999999999998753 345556788999999999 8999999999873
Q ss_pred ---------eCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCC
Q psy14702 188 ---------DQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELN 258 (480)
Q Consensus 188 ---------~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~ 258 (480)
....+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~------ 155 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT------ 155 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET------
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcC------
Confidence 4578999999997 699999864 57999999999999999999999999999999999999942
Q ss_pred CCCCccccceEeCccCcccccCC-------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADND-------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP 330 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~ 330 (480)
.++.+||+|||++..... .....+|+.|+|||++.+....+.++|||||||++|+| +|..||.....
T Consensus 156 -----~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 156 -----EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp -----TTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred -----CCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 346899999999865432 22345789999999987644445789999999999996 67777765442
Q ss_pred c--hHHHhcCC-------------------------C-----CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 331 M--WHHIRDGN-------------------------I-----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 331 ~--~~~i~~~~-------------------------~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
. ...+.... . ..++.++.++++||.+||+.||.+|||+.++++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 310 (320)
T 2i6l_A 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310 (320)
T ss_dssp HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred HHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence 1 11111100 0 01246899999999999999999999999999999998
Q ss_pred Hh
Q psy14702 379 RN 380 (480)
Q Consensus 379 ~~ 380 (480)
..
T Consensus 311 ~~ 312 (320)
T 2i6l_A 311 IY 312 (320)
T ss_dssp TT
T ss_pred cc
Confidence 54
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=370.65 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=200.6
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-------CCceeEEeeEE
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-------VPHIVNYFSSW 186 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-------hpnIv~l~~~~ 186 (480)
.+..+|.+.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.++..+.+ ||||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3456899999999999999999999999999999999743 3445668899999988842 78999999998
Q ss_pred e----eCCEEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCC----
Q psy14702 187 S----DQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDIKPANILIVKAQG---- 255 (480)
Q Consensus 187 ~----~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~IvHrDlKp~NILl~~~~~---- 255 (480)
. +...+|+||||| +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+...+.
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 7 556899999999 66776666544 4699999999999999999999998 9999999999999964320
Q ss_pred ---------------------------------CCCCCCCccccceEeCccCcccccCC-CcccCCCcccchhhhhcccC
Q psy14702 256 ---------------------------------ELNEPMNTEKLHYKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNF 301 (480)
Q Consensus 256 ---------------------------------~~~~~~~~~~~~vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~ 301 (480)
....+.+.....+||+|||++..... .....||+.|+|||++.+..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~ 269 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSG 269 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSC
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCC
Confidence 00000011234799999999865443 34457999999999998876
Q ss_pred CCCCcccHHHHHHHHHHH-hCCCCCCCCcc--c------hHHHh------------cCCC--------------------
Q psy14702 302 DNLSKVDIFALGLTLYEA-SGVTPLPKNGP--M------WHHIR------------DGNI-------------------- 340 (480)
Q Consensus 302 ~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~------~~~i~------------~~~~-------------------- 340 (480)
+. .++|||||||++|+| +|..||..... . ...+. .+..
T Consensus 270 ~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 348 (397)
T 1wak_A 270 YN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPW 348 (397)
T ss_dssp CC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCC
T ss_pred CC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCc
Confidence 55 789999999999996 67777764321 0 00000 0000
Q ss_pred ----------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 341 ----------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 341 ----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
......+.++.+||.+||+.||.+|||+.|+++||||.
T Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 349 GLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred chhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 01122346788999999999999999999999999985
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=354.11 Aligned_cols=248 Identities=26% Similarity=0.444 Sum_probs=203.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEE--EEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTY--AVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~v--AvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+|.+.+.||+|+||.||+|.+..++..+ |+|.++.. ........+.+|+.++..+.+||||+++++++.+.+.+|+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 46778999999999999999999999865 99988753 2233445688999999999889999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCC
Q psy14702 195 QLEYCNGGNLENIIQERC----------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELN 258 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~ 258 (480)
|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~-------- 175 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV-------- 175 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE--------
Confidence 999999999999997653 69999999999999999999999999999999999999
Q ss_pred CCCCccccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--c
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--M 331 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~ 331 (480)
+.++.+||+|||++..... .....+++.|+|||++.+..+. .++|||||||++|+|+ |..||..... .
T Consensus 176 ----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 250 (327)
T 1fvr_A 176 ----GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 250 (327)
T ss_dssp ----CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ----cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHH
Confidence 5677899999999864322 2234578899999999876554 6899999999999974 6677765432 2
Q ss_pred hHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 332 WHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 332 ~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
...+..+ ....+..+++++.+||.+||..||.+|||+.+++++..-.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 298 (327)
T 1fvr_A 251 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298 (327)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3344443 2344567899999999999999999999999999986543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=343.29 Aligned_cols=243 Identities=23% Similarity=0.312 Sum_probs=201.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+. ++..||+|+++...... ..+.+|+.++..+ +||||+++++++.+.+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKL-SHPKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhC-CCCCEeeEEEEEccCCceEEE
Confidence 457888999999999999999654 67789999997654333 4488999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~------------~~~~~~~l~Dfg 149 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV------------DRDLCVKVSDFG 149 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE------------CTTCCEEECCTT
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE------------CCCCCEEEccCc
Confidence 99999999999997654 59999999999999999999999999999999999999 567789999999
Q ss_pred cccccCCCc-----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCcCC
Q psy14702 275 HVIADNDFE-----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEKLS 344 (480)
Q Consensus 275 ~a~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~~~ 344 (480)
++....... ...+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+. ...+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 228 (268)
T 3sxs_A 150 MTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH 228 (268)
T ss_dssp CEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred cceecchhhhhcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCC
Confidence 986543322 23466789999999876554 6899999999999974 6667654432 223334433 33445
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.+++.+.++|.+||+.||.+|||+.+++++..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (268)
T 3sxs_A 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIE 260 (268)
T ss_dssp TSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHG
T ss_pred cChHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 67999999999999999999999999998753
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=357.86 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=202.8
Q ss_pred hhhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.++..+.+||||+++++++...+
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 457888999999999999999873 356789999997532 23334668899999999988999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCc
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC-----------------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPAN 247 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~N 247 (480)
.+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 202 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 202 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence 9999999999999999997643 27899999999999999999999999999999999
Q ss_pred EEEeccCCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-
Q psy14702 248 ILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS- 320 (480)
Q Consensus 248 ILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~- 320 (480)
||+ +.++.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+|+
T Consensus 203 Ill------------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t 269 (344)
T 1rjb_A 203 VLV------------THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFS 269 (344)
T ss_dssp EEE------------ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTT
T ss_pred EEE------------cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHc
Confidence 999 55678999999998644322 123467889999999877654 7899999999999985
Q ss_pred -CCCCCCCCcc---chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 321 -GVTPLPKNGP---MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 321 -~~~p~~~~~~---~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
|..||..... ....+..+ ....+..+++++.+||.+||..||.+|||+.+++++..-.
T Consensus 270 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 270 LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 6667765432 22233333 2334566899999999999999999999999999987643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.34 Aligned_cols=251 Identities=19% Similarity=0.251 Sum_probs=203.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC-----
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ----- 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~----- 189 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.++..+ +||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccCcc
Confidence 345788899999999999999999999999999999653 3444556688999999999 799999999987654
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~------------~~~~~~k 152 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI------------NSNCDLK 152 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------CTTCCEE
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE------------cCCCcEE
Confidence 67999999996 699999876 479999999999999999999999999999999999999 5667899
Q ss_pred eCccCcccccCCC--------------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--h
Q psy14702 270 LGDFGHVIADNDF--------------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--W 332 (480)
Q Consensus 270 L~DFG~a~~~~~~--------------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~ 332 (480)
|+|||++...... ....||+.|+|||++.+....+.++|||||||++|+| +|..||...... .
T Consensus 153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 232 (353)
T 2b9h_A 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL 232 (353)
T ss_dssp ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 9999998654321 1236899999999987644445789999999999996 666676554321 0
Q ss_pred HHHh------------------------cC--CC------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 333 HHIR------------------------DG--NI------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 333 ~~i~------------------------~~--~~------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..+. .. .. ..++.+++++.+||.+||..||.+|||+.++++||||...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0000 00 00 0124688999999999999999999999999999999864
Q ss_pred C
Q psy14702 381 Y 381 (480)
Q Consensus 381 ~ 381 (480)
.
T Consensus 313 ~ 313 (353)
T 2b9h_A 313 H 313 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=350.97 Aligned_cols=245 Identities=23% Similarity=0.341 Sum_probs=198.6
Q ss_pred hhhhhhheeecccCceEEEEEE----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--C
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCL----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD--Q 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~ 189 (480)
..+|++.+.||+|+||+||+|. +..+++.||||++... .....+.+.+|+.++..+ +||||+++++++.. .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCC
Confidence 4578889999999999999998 5668999999998753 444556789999999999 78999999999854 4
Q ss_pred CEEEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
..+|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~------------~~~~~~ 153 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV------------ENENRV 153 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------EETTEE
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE------------cCCCeE
Confidence 56899999999999999998654 59999999999999999999999999999999999999 556789
Q ss_pred EeCccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc----------
Q psy14702 269 KLGDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---------- 330 (480)
Q Consensus 269 kL~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---------- 330 (480)
||+|||++...... ....+++.|+|||++.+..+. .++|||||||++|+| +|..|+.....
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 232 (295)
T 3ugc_A 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232 (295)
T ss_dssp EECCCCSCC-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTC
T ss_pred EEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCcc
Confidence 99999998654321 223477789999999887654 789999999999997 55555543211
Q ss_pred --------chHHHhc-CCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 331 --------MWHHIRD-GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 331 --------~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
....+.. ...+.+..+++++.+||.+||+.||++|||+.++++...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~ 287 (295)
T 3ugc_A 233 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVD 287 (295)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 0111222 234556679999999999999999999999999987653
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.70 Aligned_cols=246 Identities=19% Similarity=0.197 Sum_probs=198.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.++..+.+||||+++++++...+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 45788899999999999999999999999999998754322 23778999999998899999999999999999999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+...+. .....+||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~-------~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN-------KTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG-------TCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC-------CCCceEEEEEcc
Confidence 9999 99999999863 57999999999999999999999999999999999999943220 112239999999
Q ss_pred cccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHhc
Q psy14702 275 HVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIRD 337 (480)
Q Consensus 275 ~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~~ 337 (480)
++...... ....||+.|+|||++.+..+. .++|||||||++||| +|..||..... .+..+..
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 98653221 245699999999999887654 789999999999996 67788865332 1222222
Q ss_pred CCCCcC-----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 338 GNIEKL-----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 338 ~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
.....+ ..++ ++.++|..||..||.+||++++|++..
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l 276 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLF 276 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHH
Confidence 221111 2244 999999999999999999999998743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.58 Aligned_cols=262 Identities=21% Similarity=0.316 Sum_probs=203.2
Q ss_pred hhhhhhhhheeecccCceEEEEEEE-eeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----CCCceeEEeeEEe
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLK-YMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS-----RVPHIVNYFSSWS 187 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~-~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~-----~hpnIv~l~~~~~ 187 (480)
.+..+|.+.+.||+|+||.||+|.+ ..+++.||||+++.. ......+.+|+.++..+. .|++|+++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3456899999999999999999988 568899999998642 344556788988888773 2346999999999
Q ss_pred eCCEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCC-------C
Q psy14702 188 DQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL-------N 258 (480)
Q Consensus 188 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~-------~ 258 (480)
..+.+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+... .
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 889999998765 689999999999999999999999999999999999995421000 0
Q ss_pred CCCCccccceEeCccCcccccCCC-cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHH
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADNDF-EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHH 334 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~ 334 (480)
......++.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 000001567999999998765433 345799999999999877654 789999999999996 677787654321 111
Q ss_pred Hhc--CCC------------------------------------------CcCCCCCHHHHHHHHHhhccCCCCCCChhH
Q psy14702 335 IRD--GNI------------------------------------------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSS 370 (480)
Q Consensus 335 i~~--~~~------------------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~e 370 (480)
+.. +.. ......++++.+||.+||+.||.+|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 100 000 001123567899999999999999999999
Q ss_pred HHHHHHHHHh
Q psy14702 371 LRRSAQLARN 380 (480)
Q Consensus 371 ll~h~~~~~~ 380 (480)
+++||||...
T Consensus 326 ll~hp~f~~~ 335 (339)
T 1z57_A 326 ALKHPFFDLL 335 (339)
T ss_dssp HTTSGGGGGG
T ss_pred HhcCHHHHHH
Confidence 9999999753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=345.17 Aligned_cols=244 Identities=23% Similarity=0.275 Sum_probs=201.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+. ++..||+|+++...... ..+.+|+.++..+ +||||+++++++.+.+.+|+|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcC-CCCCEeeEEEEEecCCCeEEE
Confidence 457888999999999999999664 77889999998654333 4588999999999 789999999999999999999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili------------~~~~~~kl~Dfg 165 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV------------NDQGVVKVSDFG 165 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE------------CTTSCEEECSTT
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE------------cCCCCEEEcccc
Confidence 999999999999976 4579999999999999999999999999999999999999 566789999999
Q ss_pred cccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCcCC
Q psy14702 275 HVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEKLS 344 (480)
Q Consensus 275 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~~~ 344 (480)
++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+. ...+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T 3gen_A 166 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244 (283)
T ss_dssp GGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT
T ss_pred ccccccccccccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCC
Confidence 98654332 223467889999999877654 7899999999999974 6667764432 334444443 33445
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
.+++.+.+||.+||+.||.+|||+.++++|..-
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~ 277 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 277 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 678999999999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=369.51 Aligned_cols=249 Identities=20% Similarity=0.272 Sum_probs=194.2
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG-- 190 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 190 (480)
.....+|.+.+.||+|+||+||+|.+..+++ ||+|++...... ..+|+.+++.+ +||||++++++|...+
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~------~~~E~~il~~l-~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF------KNRELQIMRIV-KHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS------CCHHHHHHHTC-CCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch------HHHHHHHHHhC-CCCCcceEEEEEEecCCC
Confidence 3345679999999999999999998876665 888887643221 23689999999 7999999999985433
Q ss_pred ----EEEEEeeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 191 ----VLYLQLEYCNGGNLENII---QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 191 ----~~~lv~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
.+|+|||||.++.+.... .....+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~-----------~ 176 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD-----------P 176 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE-----------T
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc-----------C
Confidence 489999999765433322 2245799999999999999999999999999999999999993 1
Q ss_pred cccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc
Q psy14702 264 EKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD 337 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~ 337 (480)
.++.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+..
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~ 256 (394)
T 4e7w_A 177 PSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256 (394)
T ss_dssp TTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 466899999999865432 23456899999999998765555799999999999996 677777665421 111110
Q ss_pred -------------------CCCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 -------------------GNIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 -------------------~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..++ ....+++++.+||.+||+.||.+|||+.++++||||...
T Consensus 257 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 257 VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp HHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred HhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 1111 123478999999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=365.06 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=203.1
Q ss_pred CcchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCC-----ceeEEeeE
Q psy14702 111 DHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP-----HIVNYFSS 185 (480)
Q Consensus 111 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-----nIv~l~~~ 185 (480)
....+..+|.+.+.||+|+||+||+|.+..+++.||||+++.. ......+.+|+.++..+.+|+ +|++++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 3445667899999999999999999999999999999999742 334455778888888876566 49999999
Q ss_pred EeeCCEEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEeccCCCCCCCC
Q psy14702 186 WSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMH--EMRMIHMDIKPANILIVKAQGELNEPM 261 (480)
Q Consensus 186 ~~~~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH--~~~IvHrDlKp~NILl~~~~~~~~~~~ 261 (480)
+...+.+|+|||||. |+|.+++... ..+++..++.++.||+.||.||| +.||+||||||+|||+..
T Consensus 125 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~--------- 194 (382)
T 2vx3_A 125 FMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN--------- 194 (382)
T ss_dssp EEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS---------
T ss_pred eccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec---------
Confidence 999999999999995 5999999865 36999999999999999999999 579999999999999943
Q ss_pred CccccceEeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc
Q psy14702 262 NTEKLHYKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD 337 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~ 337 (480)
+..+.+||+|||++..... .....||+.|+|||++.+..++ .++|||||||++|+| +|..||...... ...+..
T Consensus 195 -~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~ 272 (382)
T 2vx3_A 195 -PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE 272 (382)
T ss_dssp -TTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred -CCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2356799999999876543 3445799999999999887655 789999999999996 677777654321 111111
Q ss_pred C-------------------------CC------------CcC--CC-------------------------CCHHHHHH
Q psy14702 338 G-------------------------NI------------EKL--SN-------------------------VSDDLHTL 353 (480)
Q Consensus 338 ~-------------------------~~------------~~~--~~-------------------------~s~~~~~l 353 (480)
. .+ ..+ .. .++++++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 352 (382)
T 2vx3_A 273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352 (382)
T ss_dssp HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence 0 00 000 00 01378999
Q ss_pred HHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 354 IKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 354 i~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
|.+||+.||++|||+.|+++||||...
T Consensus 353 i~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 353 ILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHhcCCChhhCCCHHHHhcCcccccC
Confidence 999999999999999999999999653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.86 Aligned_cols=246 Identities=20% Similarity=0.268 Sum_probs=195.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee------C
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------Q 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------~ 189 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++..... ...+|+.++..+ +|||||+++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHc-CCCCccceeeEEeccCCCCcc
Confidence 4468899999999999999999999999999999865322 134699999999 89999999998853 2
Q ss_pred CEEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccc
Q psy14702 190 GVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEK 265 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~ 265 (480)
..+++||||+.+ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+.. +.
T Consensus 126 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~-----------~~ 193 (420)
T 1j1b_A 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-----------DT 193 (420)
T ss_dssp EEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEET-----------TT
T ss_pred eeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeC-----------CC
Confidence 247799999975 6766654 2457999999999999999999999999999999999999942 23
Q ss_pred cceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--
Q psy14702 266 LHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD-- 337 (480)
Q Consensus 266 ~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~-- 337 (480)
..+||+|||+++.... .....||+.|+|||++.+....+.++|||||||++||| +|..||...... ...+..
T Consensus 194 ~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~l 273 (420)
T 1j1b_A 194 AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 273 (420)
T ss_dssp TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 5689999999975432 23456899999999997754445799999999999996 677777665421 111110
Q ss_pred ------------C-----CCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 ------------G-----NIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 ------------~-----~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
. .++ ....+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 274 g~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 274 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 0 111 123568999999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=362.51 Aligned_cols=249 Identities=20% Similarity=0.340 Sum_probs=203.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE----
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV---- 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~---- 191 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.++..+ +||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence 4578889999999999999999999999999999987666666677889999999999 79999999999987653
Q ss_pred --EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 192 --LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 192 --~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
+|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~------------~~~~~~k 166 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV------------NEDCELK 166 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE------------CTTCCEE
T ss_pred eeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE------------CCCCcEE
Confidence 599999996 588887743 59999999999999999999999999999999999999 5667899
Q ss_pred eCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--------
Q psy14702 270 LGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD-------- 337 (480)
Q Consensus 270 L~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~-------- 337 (480)
|+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ...+..
T Consensus 167 l~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 167 ILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246 (353)
T ss_dssp ECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHH
T ss_pred EeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999999865443 23356899999999998744445789999999999996 677777654321 111100
Q ss_pred -------------------C---C-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 -------------------G---N-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 -------------------~---~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
. . ...++.+++++.+||.+||..||.+|||+.++++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 0 11234678999999999999999999999999999999754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=368.10 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=208.5
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH---------------HHHHHHHHHHHHHHhcCCCCc
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT---------------AQEKIFKKEIHAHALLSRVPH 178 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~---------------~~~~~~~~Ei~~l~~l~~hpn 178 (480)
.+..+|.+.+.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.++..+ +|||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCC
Confidence 3456789999999999999999987 99999999986421111 0115688999999999 7999
Q ss_pred eeEEeeEEeeCCEEEEEeeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEE
Q psy14702 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENI------IQE--RCTFTEMALKQLLFQVSEGLRCMHE-MRMIHMDIKPANIL 249 (480)
Q Consensus 179 Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~------l~~--~~~l~~~~~~~i~~qi~~aL~yLH~-~~IvHrDlKp~NIL 249 (480)
|+++++++.+.+.+|+|||||++|+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 655 4679999999999999999999999 99999999999999
Q ss_pred EeccCCCCCCCCCccccceEeCccCcccccCC--CcccCCCcccchhhhhccc-CCCCCcccHHHHHHHHHHH-hCCCCC
Q psy14702 250 IVKAQGELNEPMNTEKLHYKLGDFGHVIADND--FEVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYEA-SGVTPL 325 (480)
Q Consensus 250 l~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~k~DiwSlGvilyel-~~~~p~ 325 (480)
+ +.++.+||+|||++..... .....||+.|+|||++.+. .+...++|||||||++|+| +|..||
T Consensus 185 ~------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 185 M------------DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp E------------CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred E------------cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9 5667899999999865433 2345699999999999876 3332389999999999996 677777
Q ss_pred CCCcc---chHHHhcCCCCcC-------------------CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 326 PKNGP---MWHHIRDGNIEKL-------------------SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 326 ~~~~~---~~~~i~~~~~~~~-------------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
..... ....+..+....+ ..++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 253 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred CCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 65433 3444555544433 568999999999999999999999999999999865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=354.62 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=206.6
Q ss_pred hhhhhhheeecccCceEEEEEE-----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~-----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|. +..+++.||||++... ........+.+|+.++..+ +||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQSL 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcCCC
Confidence 4578899999999999999998 5567889999999753 3445556788999999999 8999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC-------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
..|+|||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+... .
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~---------~ 177 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP---------G 177 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS---------S
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC---------C
Confidence 9999999999999999998653 48999999999999999999999999999999999999532 1
Q ss_pred cccceEeCccCcccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chH
Q psy14702 264 EKLHYKLGDFGHVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWH 333 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~ 333 (480)
....+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ...
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 256 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE 256 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence 345799999998853321 2234578899999999877654 7899999999999975 5567654432 233
Q ss_pred HHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 334 HIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 334 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
.+..+. ...+..++..+.+||.+||..||.+|||+.++++++|.....+.
T Consensus 257 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 257 FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 344433 34456789999999999999999999999999999998775443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=347.26 Aligned_cols=249 Identities=18% Similarity=0.233 Sum_probs=203.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.++..+.+|+||+++++++......|+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 345788999999999999999999999999999998754322 2367899999999889999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+. .....+||+||
T Consensus 84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~-------~~~~~~kl~Df 155 (298)
T 1csn_A 84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS-------KNANMIYVVDF 155 (298)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------TTTTCEEECCC
T ss_pred EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-------CCCCeEEEEEC
Confidence 99999 999999998654 6999999999999999999999999999999999999954321 23445999999
Q ss_pred CcccccCC-----------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHh
Q psy14702 274 GHVIADND-----------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIR 336 (480)
Q Consensus 274 G~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~ 336 (480)
|++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred ccccccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 99864432 1234699999999999877654 789999999999996 67778765332 112222
Q ss_pred cCCC-----CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 337 DGNI-----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 337 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.... .....+++++.+||.+||..||.+|||+.++++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~ 279 (298)
T 1csn_A 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 279 (298)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence 2111 123468999999999999999999999999987643
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=348.88 Aligned_cols=247 Identities=23% Similarity=0.358 Sum_probs=204.6
Q ss_pred hhhhhhheeecccCceEEEEEEE-----eeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLK-----YMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~-----~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+ ..+++.||||+++.. ......+.+.+|+.++..+.+||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 45788899999999999999985 346789999999764 334455778999999999988999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC------------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK 252 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~ 252 (480)
..|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~-- 178 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL-- 178 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE--
Confidence 9999999999999999997653 48999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccceEeCccCcccccCCCc------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCC
Q psy14702 253 AQGELNEPMNTEKLHYKLGDFGHVIADNDFE------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTP 324 (480)
Q Consensus 253 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p 324 (480)
+.++.+||+|||++....... ...+|+.|+|||++.+..+. .++|||||||++|+|+ |..|
T Consensus 179 ----------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 179 ----------THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp ----------ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCS
T ss_pred ----------cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCC
Confidence 556789999999986544322 23467889999999877554 7899999999999974 6667
Q ss_pred CCCCcc---chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 325 LPKNGP---MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 325 ~~~~~~---~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
|..... ....+... ....+..++.++.++|.+||..||.+|||+.+++++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 303 (313)
T 1t46_A 248 YPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303 (313)
T ss_dssp STTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 654432 22223322 22334668999999999999999999999999998753
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=343.36 Aligned_cols=243 Identities=15% Similarity=0.234 Sum_probs=202.2
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC--CEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ--GVLYL 194 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~--~~~~l 194 (480)
.+|.+.+.||+|+||.||+|.+ +++.||||+++.........+.+.+|+.++..+ +||||+++++++.+. ...|+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSSCEE
T ss_pred HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCCeEe
Confidence 4677899999999999999986 589999999987666666677899999999999 799999999999876 78999
Q ss_pred EeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 195 QLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
|||||++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.++|
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~------------~~~~~~~l 154 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI------------DEDMTARI 154 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE------------CTTSCEEE
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE------------cCCcceeE
Confidence 999999999999998764 4899999999999999999999999 9999999999999 55667888
Q ss_pred CccCcccccCCCcccCCCcccchhhhhcccCCCC--CcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHh-cC-CCCcC
Q psy14702 271 GDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNL--SKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIR-DG-NIEKL 343 (480)
Q Consensus 271 ~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~-~~-~~~~~ 343 (480)
+|||++..... ....||+.|+|||++.+..... .++|||||||++|+| +|..||...... ...+. .+ ....+
T Consensus 155 ~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 155 SMADVKFSFQS-PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp EGGGSCCTTSC-TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred Eeccceeeecc-cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 88877644322 3356899999999998764432 279999999999996 677777654431 12222 22 33445
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..+++++.++|.+||+.||.+|||+.++++..
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 67899999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=361.14 Aligned_cols=247 Identities=22% Similarity=0.319 Sum_probs=196.6
Q ss_pred hhhhhhheeecccCceEEEEEEEe---eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY---MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+|.+.+.||+|+||.||+|.+. .++..||||+++... .....+.+.+|+.++..+ +||||+++++++...+.+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 121 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTKSKPV 121 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSC
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCce
Confidence 457888999999999999999876 467789999997643 445566799999999999 899999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 193 YLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
|+|||||++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll------------~~~~~~kl~ 189 (373)
T 2qol_A 122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI------------NSNLVCKVS 189 (373)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCEEEC
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE------------cCCCCEEEC
Confidence 99999999999999998654 69999999999999999999999999999999999999 567789999
Q ss_pred ccCcccccCCCc-------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcC-C
Q psy14702 272 DFGHVIADNDFE-------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDG-N 339 (480)
Q Consensus 272 DFG~a~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~-~ 339 (480)
|||++....... ...+++.|+|||++.+..+. .++|||||||++||| + |..||..... ....+..+ .
T Consensus 190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~ 268 (373)
T 2qol_A 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYR 268 (373)
T ss_dssp CC----------------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEE
T ss_pred cCccccccccCCccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999986543221 12356789999999877655 789999999999995 4 6777765432 22333333 2
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
.+.+..++..+.+||.+||+.||.+||++.++++...-
T Consensus 269 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~ 306 (373)
T 2qol_A 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306 (373)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence 34456789999999999999999999999999986543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.58 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=189.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++............+.++..++..+ +||||+++++++...+.+|+|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecCCcEEEE
Confidence 4578889999999999999999999999999999986544333334444444455555 899999999999999999999
Q ss_pred eeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 196 LEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~-~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+||
T Consensus 103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~------------~~~~~~kl~df 169 (318)
T 2dyl_A 103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL------------DERGQIKLCDF 169 (318)
T ss_dssp ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE------------CTTSCEEECCC
T ss_pred Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE------------CCCCCEEEEEC
Confidence 9999 6666666654 46799999999999999999999995 99999999999999 56678999999
Q ss_pred CcccccCC---CcccCCCcccchhhhhcc----cCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCCCc
Q psy14702 274 GHVIADND---FEVEEGDCRYLPKELLNN----NFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNIEK 342 (480)
Q Consensus 274 G~a~~~~~---~~~~~gt~~y~aPE~~~~----~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~~~ 342 (480)
|++..... .....||+.|+|||++.. ....+.++|||||||++|+| +|..||..... .+..+.....+.
T Consensus 170 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL 249 (318)
T ss_dssp TTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC
T ss_pred CCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC
Confidence 98864432 223469999999999952 22334689999999999996 67777765332 233344443332
Q ss_pred ---CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 343 ---LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 343 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
...++.++.+||.+||..||.+|||+.++++||||...
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 250 LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 24589999999999999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=350.70 Aligned_cols=247 Identities=21% Similarity=0.343 Sum_probs=204.6
Q ss_pred hhhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+. .+++.||||+++... .......+.+|+.++..+.+||||+++++++...+
T Consensus 26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 467889999999999999999853 467899999997643 34445678999999999988999999999987654
Q ss_pred -EEEEEeeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecc
Q psy14702 191 -VLYLQLEYCNGGNLENIIQERCT----------------FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKA 253 (480)
Q Consensus 191 -~~~lv~E~~~gg~L~~~l~~~~~----------------l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~ 253 (480)
.+|+|||||++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~--- 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL--- 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE---
Confidence 58999999999999999986543 8999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCC
Q psy14702 254 QGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPL 325 (480)
Q Consensus 254 ~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~ 325 (480)
+.++.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+|+ |..||
T Consensus 182 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~ 251 (316)
T 2xir_A 182 ---------SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 251 (316)
T ss_dssp ---------CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ---------CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCC
Confidence 56778999999998654322 123478899999999877655 7899999999999974 66677
Q ss_pred CCCcc---chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 326 PKNGP---MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 326 ~~~~~---~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..... ....+..+. ...+..+++++.++|.+||..||.+|||+.++++|..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 55432 233344433 3445668999999999999999999999999999865
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.60 Aligned_cols=247 Identities=22% Similarity=0.402 Sum_probs=204.4
Q ss_pred hhhhhhheeecccCceEEEEEEEe-------eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKY-------MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~-------~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
..+|.+.+.||+|+||.||+|.+. .++..||||+++... .......+.+|+.++..+.+||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 457888999999999999999875 467889999997643 444556788999999999889999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEec
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERC----------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVK 252 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~ 252 (480)
.+.+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 190 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV-- 190 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE--
Confidence 999999999999999999998643 38999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCC
Q psy14702 253 AQGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTP 324 (480)
Q Consensus 253 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p 324 (480)
+.++.+||+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..|
T Consensus 191 ----------~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 191 ----------TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp ----------CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCS
T ss_pred ----------cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCC
Confidence 56678999999998654332 223477889999999876554 7899999999999974 6667
Q ss_pred CCCCcc--chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 325 LPKNGP--MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 325 ~~~~~~--~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
|..... ....+..+. ...+..++.++.++|.+||..||.+|||+.+++++..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 314 (334)
T 2pvf_A 260 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314 (334)
T ss_dssp STTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred cCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 765432 233344443 3445678999999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=352.61 Aligned_cols=249 Identities=24% Similarity=0.390 Sum_probs=183.5
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.+..+|+.||||+++.... ......+..|+..+....+||||+++++++...+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 467788999999999999999999999999999986533 3334456666664444448999999999999999999999
Q ss_pred eccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 197 EYCNGGNLENIIQE-----RCTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 197 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~-~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
|||.+ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||+ +.++.+||
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll------------~~~~~~kl 167 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL------------DRSGNIKL 167 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE------------ETTTEEEE
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE------------cCCCCEEE
Confidence 99975 88887763 45799999999999999999999999 99999999999999 55678999
Q ss_pred CccCcccccCCC---cccCCCcccchhhhhc----ccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchHH---HhcCC
Q psy14702 271 GDFGHVIADNDF---EVEEGDCRYLPKELLN----NNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHH---IRDGN 339 (480)
Q Consensus 271 ~DFG~a~~~~~~---~~~~gt~~y~aPE~~~----~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~~---i~~~~ 339 (480)
+|||++...... ....||+.|+|||++. +..+ +.++|||||||++|+| +|..||......... +..+.
T Consensus 168 ~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 168 CDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp CCCSSSCC------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred ccCCCceecccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 999998654332 2336999999999984 3333 4789999999999996 677787654332222 22222
Q ss_pred CCcC-----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 340 IEKL-----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 340 ~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+.+ ..+++++.+||.+||..||.+|||+.++++||||...
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 2222 3588999999999999999999999999999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.44 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=201.0
Q ss_pred hhhhhhhhheeecccCceEEEEEEEe-eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCCceeEEeeEEe---
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKY-MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS--RVPHIVNYFSSWS--- 187 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~-~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~--- 187 (480)
+...+|.+.+.||+|+||.||+|.+. .+|+.||+|+++...........+.+|+.++..+. +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45568999999999999999999985 67899999998653222211223556777766654 7999999999987
Q ss_pred --eCCEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 188 --DQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 188 --~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
....+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili------------~ 154 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV------------T 154 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------C
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE------------c
Confidence 5678999999997 69999998653 49999999999999999999999999999999999999 5
Q ss_pred cccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc
Q psy14702 264 EKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD 337 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~ 337 (480)
.++.+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+..
T Consensus 155 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 155 SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp TTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 667899999999865432 2335689999999999877654 789999999999997 566676554321 111111
Q ss_pred C-------C--------------------CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 G-------N--------------------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 ~-------~--------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
. . ...+..++..+++||.+||..||.+|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0 0 01224688999999999999999999999999999999754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=352.45 Aligned_cols=245 Identities=20% Similarity=0.296 Sum_probs=194.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMT----YAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
..+|.+.+.||+|+||+||+|.+..+++. ||+|.+.... .....+.+.+|+.++..+ +||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC-
Confidence 35688899999999999999998877765 4777765422 223345688999999999 7899999999998765
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.++|+||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll------------~~~~~~kl 158 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV------------KTPQHVKI 158 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------EETTEEEE
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE------------CCCCCEEE
Confidence 78999999999999999864 579999999999999999999999999999999999999 55678999
Q ss_pred CccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcC-C
Q psy14702 271 GDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDG-N 339 (480)
Q Consensus 271 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~-~ 339 (480)
+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+| + |..||..... ....+..+ .
T Consensus 159 ~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 237 (327)
T 3poz_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237 (327)
T ss_dssp CCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ccCcceeEccCCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCC
Confidence 999998654322 123468899999999887665 789999999999996 4 6677754432 22333333 3
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.+.+..++.++.+++.+||+.||.+|||+.+++++..
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~ 274 (327)
T 3poz_A 238 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 4455678999999999999999999999999998754
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=348.32 Aligned_cols=248 Identities=19% Similarity=0.328 Sum_probs=196.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEee---CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC-
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYM---DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG- 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 190 (480)
...+|.+.+.||+|+||.||+|.... ++..||+|+++...........+.+|+.++..+ +||||+++++++....
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC---
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeeccc
Confidence 34578889999999999999998765 456899999987666666667799999999999 7999999999987654
Q ss_pred ----EEEEEeeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCC
Q psy14702 191 ----VLYLQLEYCNGGNLENIIQE------RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEP 260 (480)
Q Consensus 191 ----~~~lv~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~ 260 (480)
..|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---------- 180 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---------- 180 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE----------
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----------
Confidence 35999999999999999853 2469999999999999999999999999999999999999
Q ss_pred CCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--
Q psy14702 261 MNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP-- 330 (480)
Q Consensus 261 ~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~-- 330 (480)
+.++.+||+|||++...... ....+++.|+|||++.+..+. .++|||||||++|+|+ |..||.....
T Consensus 181 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~ 257 (313)
T 3brb_A 181 --RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257 (313)
T ss_dssp --CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred --cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHH
Confidence 56678999999998654321 223478899999999877554 7899999999999975 4456654332
Q ss_pred chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 331 MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 331 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
....+..+. ...+..+++++.++|.+||..||.+|||+.+++++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 304 (313)
T 3brb_A 258 MYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304 (313)
T ss_dssp HHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 333444443 3445678999999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=362.21 Aligned_cols=255 Identities=20% Similarity=0.296 Sum_probs=202.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC----------CCceeEEeeE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR----------VPHIVNYFSS 185 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~----------hpnIv~l~~~ 185 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||++.. .......+.+|+.++..+.+ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 3478899999999999999999999999999999874 33445567889988887742 7999999999
Q ss_pred EeeCC----EEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEeccCCCCC
Q psy14702 186 WSDQG----VLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEM-RMIHMDIKPANILIVKAQGELN 258 (480)
Q Consensus 186 ~~~~~----~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~-~IvHrDlKp~NILl~~~~~~~~ 258 (480)
+...+ .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||+...+..
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~-- 171 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-- 171 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT--
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC--
Confidence 88654 799999999 89999999863 4599999999999999999999998 99999999999999643210
Q ss_pred CCCCccccceEeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------ 330 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------ 330 (480)
+..+.+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||.....
T Consensus 172 ----~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 246 (373)
T 1q8y_A 172 ----ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246 (373)
T ss_dssp ----TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred ----cCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence 3455899999999865543 3345799999999999887654 789999999999996 67777764321
Q ss_pred --chHHHh------------------------------------------cCCCCcCCCCCHHHHHHHHHhhccCCCCCC
Q psy14702 331 --MWHHIR------------------------------------------DGNIEKLSNVSDDLHTLIKLMIDKDPTKRP 366 (480)
Q Consensus 331 --~~~~i~------------------------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 366 (480)
....+. .........++.++.+||.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 326 (373)
T 1q8y_A 247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 326 (373)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence 000000 001111223467889999999999999999
Q ss_pred ChhHHHHHHHHHHhC
Q psy14702 367 STSSLRRSAQLARNY 381 (480)
Q Consensus 367 s~~ell~h~~~~~~~ 381 (480)
|+.++++||||....
T Consensus 327 t~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 327 DAGGLVNHPWLKDTL 341 (373)
T ss_dssp CHHHHHTCGGGTTCT
T ss_pred CHHHHhhChhhhccc
Confidence 999999999998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.17 Aligned_cols=243 Identities=23% Similarity=0.289 Sum_probs=198.5
Q ss_pred hhhhhhe-eecccCceEEEEEEE--eeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 117 LEFLEEE-LLGSGDFGEVFKCLK--YMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 117 ~~y~~~~-~LG~G~fg~V~~~~~--~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+|.+.+ .||+|+||.||+|.. ..+++.||||+++.........+.+.+|+.++..+ +||||+++++++ ..+..|
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEE-ESSSEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEE-CCCCcE
Confidence 4566777 999999999999954 45678999999987554455567799999999999 799999999999 567789
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~------------~~~~~~kl~Df 161 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL------------VTQHYAKISDF 161 (291)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------EETTEEEECCC
T ss_pred EEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE------------eCCCcEEEccC
Confidence 999999999999999988889999999999999999999999999999999999999 55668999999
Q ss_pred CcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CC
Q psy14702 274 GHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IE 341 (480)
Q Consensus 274 G~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~ 341 (480)
|++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 240 (291)
T 1xbb_A 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 240 (291)
T ss_dssp TTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred CcceeeccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 998654322 123467889999999876554 6899999999999974 6677765432 333444443 33
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
.+..+++++.++|.+||..||.+|||+.++++.
T Consensus 241 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 241 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 456789999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=360.08 Aligned_cols=253 Identities=22% Similarity=0.279 Sum_probs=187.5
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG-- 190 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-- 190 (480)
.....+|.+.+.||+|+||.||+|.+..+|+.||||++....... ..+.+++..+..+ +||||+++++++...+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVL-HHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHH-CCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhc-CCCCcccHHHhhhccccc
Confidence 344567999999999999999999999999999999986543222 2245677777777 8899999999986533
Q ss_pred -----EEEEEeeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCceecCCCCCcEEEeccCCCCCC
Q psy14702 191 -----VLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSEGLRCMH--EMRMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 191 -----~~~lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH--~~~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
.+|+|||||.+ +|...+. ....+++..++.++.||+.||.||| ++||+||||||+|||++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~------- 166 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE------- 166 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEET-------
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeC-------
Confidence 38999999976 5544443 4457999999999999999999999 999999999999999932
Q ss_pred CCCccccceEeCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hH
Q psy14702 260 PMNTEKLHYKLGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WH 333 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~ 333 (480)
.++.+||+|||++...... ....||+.|+|||++.+....+.++|||||||++|+| +|..||...... ..
T Consensus 167 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 242 (360)
T 3e3p_A 167 ----ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242 (360)
T ss_dssp ----TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ----CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH
Confidence 2568999999998754432 2356899999999997765555799999999999996 677777654321 11
Q ss_pred HHhc---------------CC-----------------CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 334 HIRD---------------GN-----------------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 334 ~i~~---------------~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
.+.. .. .......++++.+||.+||+.||.+|||+.|+++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp HHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred HHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 1111 00 001122567899999999999999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=371.45 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=191.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|...++||+|+||+||. ....+|+.||||++...... .+.+|+.++..+.+|||||++++++.+...+||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 4577889999999999764 35678999999998754322 24579999999878999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||. |+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+. +....+||+|||+
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~-------~~~~~~kL~DFG~ 169 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA-------HGKIKAMISDFGL 169 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBT-------TTBCCEEECCTTE
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCC-------CCceeEEEecccc
Confidence 9995 69999997653 4666677899999999999999999999999999999954321 3455788999999
Q ss_pred ccccCC-------CcccCCCcccchhhhhccc--CCCCCcccHHHHHHHHHHHh--CCCCCCCCccchHHHhcCCC--C-
Q psy14702 276 VIADND-------FEVEEGDCRYLPKELLNNN--FDNLSKVDIFALGLTLYEAS--GVTPLPKNGPMWHHIRDGNI--E- 341 (480)
Q Consensus 276 a~~~~~-------~~~~~gt~~y~aPE~~~~~--~~~~~k~DiwSlGvilyel~--~~~p~~~~~~~~~~i~~~~~--~- 341 (480)
+..... .....||+.|+|||++.+. ...+.++|||||||++|+|+ |..||.........+..... .
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~ 249 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTT
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccc
Confidence 865432 2235699999999999742 23346899999999999974 45555433322222222211 1
Q ss_pred --cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 342 --KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 342 --~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.....+..+++||.+||+.||.+|||+.++++||||+.
T Consensus 250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 11224566899999999999999999999999999854
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=347.56 Aligned_cols=246 Identities=19% Similarity=0.316 Sum_probs=204.1
Q ss_pred hhhhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 189 (480)
...+|.+.+.||+|+||.||+|.+. .+++.||||.+... ........+.+|+.++..+ +||||+++++++.+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQG 100 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEccC
Confidence 3567889999999999999999877 46789999998754 3344556788999999999 789999999999999
Q ss_pred CEEEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCC
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER----------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
+..|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli--------- 171 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--------- 171 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---------
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---------
Confidence 9999999999999999999752 357999999999999999999999999999999999999
Q ss_pred CCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc-
Q psy14702 260 PMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP- 330 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~- 330 (480)
+.++.+||+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||.....
T Consensus 172 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 172 ---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp ---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred ---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 56678999999988644322 123468899999999877654 7899999999999974 5566654432
Q ss_pred -chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 331 -MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 331 -~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
....+..+. ...+..++..+.+||.+||..||.+|||+.+++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L 294 (322)
T 1p4o_A 248 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294 (322)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 233344443 344567899999999999999999999999999874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=340.46 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=192.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH--HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT--AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+|.+.+.||+|+||.||+|.+ +++.||||+++...... ...+.+.+|+.++..+ +||||+++++++...+..|+
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECCC--CEE
T ss_pred hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEecCCceEE
Confidence 4677899999999999999985 58999999987543222 2235688999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR---MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~---IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
|||||++++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||+...... .....+.+||+
T Consensus 84 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~----~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN----GDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS----SCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc----ccccCcceEEc
Confidence 999999999999885 457999999999999999999999999 9999999999999542110 00136789999
Q ss_pred ccCcccccCCC--cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhcC--CCCcCC
Q psy14702 272 DFGHVIADNDF--EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDG--NIEKLS 344 (480)
Q Consensus 272 DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~~--~~~~~~ 344 (480)
|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+... ..+.+.
T Consensus 159 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 159 DFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp CCCC-------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred cCCcccccccccccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 99998654332 235699999999999877554 789999999999996 677787654432 1222222 234456
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
.+++++.++|.+||+.||.+|||+.+++++.
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L 268 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 7899999999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.08 Aligned_cols=250 Identities=24% Similarity=0.373 Sum_probs=186.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe--------
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS-------- 187 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~-------- 187 (480)
..+|.+.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.++..+.+||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 44788999999999999999999999999999998653 34445678899999999977999999999983
Q ss_pred eCCEEEEEeeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCC
Q psy14702 188 DQGVLYLQLEYCNGGNLENIIQE---RCTFTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMN 262 (480)
Q Consensus 188 ~~~~~~lv~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~ 262 (480)
....+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||++| |+||||||+|||+
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~------------ 171 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL------------ 171 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE------------
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE------------
Confidence 4456899999995 699998864 457999999999999999999999999 9999999999999
Q ss_pred ccccceEeCccCcccccCCCc----------------ccCCCcccchhhhhc--ccCCCCCcccHHHHHHHHHHH-hCCC
Q psy14702 263 TEKLHYKLGDFGHVIADNDFE----------------VEEGDCRYLPKELLN--NNFDNLSKVDIFALGLTLYEA-SGVT 323 (480)
Q Consensus 263 ~~~~~vkL~DFG~a~~~~~~~----------------~~~gt~~y~aPE~~~--~~~~~~~k~DiwSlGvilyel-~~~~ 323 (480)
+.++.+||+|||++....... ...||+.|+|||++. .....+.++|||||||++|+| +|..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 556789999999986543321 335899999999984 222334689999999999996 6777
Q ss_pred CCCCCccchHHHhcCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 324 PLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 324 p~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
||...............+.....+..+.+||.+||+.||.+|||+.+++++.+-...
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 252 PFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp CC------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcchhHHHhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 775443221111112233445678889999999999999999999999999876554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.10 Aligned_cols=247 Identities=22% Similarity=0.365 Sum_probs=203.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCc-----EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGM-----TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.++..+.+||||+++++++...+
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 4568889999999999999999876654 79999987643 34455678999999999988999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC
Q psy14702 191 VLYLQLEYCNGGNLENIIQER--------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE 256 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~ 256 (480)
.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~------ 197 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL------ 197 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE------
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE------
Confidence 999999999999999999743 358999999999999999999999999999999999999
Q ss_pred CCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCC
Q psy14702 257 LNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKN 328 (480)
Q Consensus 257 ~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~ 328 (480)
+.++.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+|+ |..||...
T Consensus 198 ------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 198 ------TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp ------EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ------CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 55678999999998643221 123467889999999877655 7899999999999985 55676543
Q ss_pred cc---chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 329 GP---MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 329 ~~---~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.. ....+..+ ....+..+++++.+||.+||+.||.+|||+.+++++..
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 322 (333)
T 2i1m_A 271 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQ 322 (333)
T ss_dssp CSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred chhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHH
Confidence 32 22222322 23344568999999999999999999999999998654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=341.92 Aligned_cols=249 Identities=20% Similarity=0.318 Sum_probs=199.7
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHH-----HHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE-----KIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~-----~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.+.||+|+||.||+|.+..+++.||+|++.......... +.+.+|+.++..+ +||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEETTTT-
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeecCCC-
Confidence 46788999999999999999999999999999987543322111 5688999999999 7999999999997665
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
++||||+++|+|.+++... ..+++..++.++.|++.||.|||++| |+||||||+|||+...+. +....+
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~-------~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE-------NAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT-------TCSCCE
T ss_pred -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC-------CCceeE
Confidence 6999999999999988654 47999999999999999999999999 999999999999954321 223459
Q ss_pred EeCccCcccccCCC-cccCCCcccchhhhhccc-CCCCCcccHHHHHHHHHHH-hCCCCCCCCccc----hHHHhcC--C
Q psy14702 269 KLGDFGHVIADNDF-EVEEGDCRYLPKELLNNN-FDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM----WHHIRDG--N 339 (480)
Q Consensus 269 kL~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~----~~~i~~~--~ 339 (480)
||+|||++...... ....||+.|+|||++... ...+.++|||||||++|+| +|..||...... ...+... .
T Consensus 169 kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 169 KVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp EECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred EeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 99999998754443 345699999999998432 2233689999999999996 677787654321 2222222 2
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
...+..+++++.+||.+||+.||.+|||+.++++..
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 284 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 334567899999999999999999999999998753
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.83 Aligned_cols=244 Identities=22% Similarity=0.343 Sum_probs=204.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|+.++..+ +||||+++++++.+.+.+|+
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 86 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYI 86 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhC-CCCCEeeEEEEEccCCCEEE
Confidence 3457888999999999999999999999999999997532 2345688999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~------------~~~~~~~l~D 154 (288)
T 3kfa_A 87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV------------GENHLVKVAD 154 (288)
T ss_dssp EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE------------CGGGCEEECC
T ss_pred EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE------------cCCCCEEEcc
Confidence 99999999999999864 359999999999999999999999999999999999999 5667899999
Q ss_pred cCcccccCCCc-----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCc
Q psy14702 273 FGHVIADNDFE-----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEK 342 (480)
Q Consensus 273 FG~a~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~ 342 (480)
||++....... ...+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+... ....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 3kfa_A 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 233 (288)
T ss_dssp CCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC
T ss_pred CccceeccCCccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC
Confidence 99987554322 22367889999999877654 7899999999999974 5566654432 22333333 3445
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
+..+++++.+||.+||..||.+|||+.++++..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l 266 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHH
Confidence 567899999999999999999999999998754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=360.58 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=198.5
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC---------CHHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---------NTAQEKIFKKEIHAHALLSRVPHIVNYF 183 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------~~~~~~~~~~Ei~~l~~l~~hpnIv~l~ 183 (480)
.....+|.+.+.||+|+||.||+|.+. +|+.||||++..... .....+.+.+|+.++..+ +||||++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~ 95 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGLR 95 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCS
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCcccee
Confidence 345567899999999999999999875 599999999865322 223346789999999999 799999999
Q ss_pred eEEee-----CCEEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCC
Q psy14702 184 SSWSD-----QGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGEL 257 (480)
Q Consensus 184 ~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~ 257 (480)
+++.. ...+|+|||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~------- 167 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL------- 167 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE-------
T ss_pred eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE-------
Confidence 99843 347899999997 6888888754 379999999999999999999999999999999999999
Q ss_pred CCCCCccccceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--
Q psy14702 258 NEPMNTEKLHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM-- 331 (480)
Q Consensus 258 ~~~~~~~~~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~-- 331 (480)
+.++.+||+|||++..... .....||+.|+|||++.+....+.++|||||||++|+| +|..||......
T Consensus 168 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 242 (362)
T 3pg1_A 168 -----ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ 242 (362)
T ss_dssp -----CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred -----cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 5567899999999864332 23356899999999998744455789999999999996 677777654321
Q ss_pred hHHHhc-----------------------CCC---------CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 332 WHHIRD-----------------------GNI---------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 332 ~~~i~~-----------------------~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
...+.. ... ...+.+++.+.+||.+||+.||.+|||+.++++||||..
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 322 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence 111100 000 112456889999999999999999999999999999987
Q ss_pred hCCCC
Q psy14702 380 NYPQL 384 (480)
Q Consensus 380 ~~~~~ 384 (480)
.....
T Consensus 323 ~~~~~ 327 (362)
T 3pg1_A 323 LFDPL 327 (362)
T ss_dssp TCCGG
T ss_pred ccCcc
Confidence 65443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=340.46 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=201.9
Q ss_pred hhhhhhe-eecccCceEEEEEEEe--eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 117 LEFLEEE-LLGSGDFGEVFKCLKY--MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 117 ~~y~~~~-~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+|.+.+ .||+|+||.||+|.+. .++..||||+++.. ......+.+.+|+.++..+ +||||+++++++ ..+..|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~-~~~~~~ 85 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQL-DNPYIVRLIGVC-QAEALM 85 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEE-ESSSEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhC-CCCCEeEEEEEe-cCCCcE
Confidence 3455555 9999999999999753 46889999999864 3445567789999999999 899999999999 556689
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili------------~~~~~~kl~D 153 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL------------VNRHYAKISD 153 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------EETTEEEECC
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE------------cCCCCEEECc
Confidence 999999999999999644 469999999999999999999999999999999999999 5567899999
Q ss_pred cCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-C
Q psy14702 273 FGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-I 340 (480)
Q Consensus 273 FG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~ 340 (480)
||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+. .
T Consensus 154 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~ 232 (287)
T 1u59_A 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 232 (287)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred ccceeeeccCcceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcC
Confidence 9998654321 223468899999999876554 6899999999999974 6777765432 334444443 3
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
..+..+++++.++|.+||..||.+|||+.+++++++-.
T Consensus 233 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 233 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 44567999999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=363.20 Aligned_cols=240 Identities=22% Similarity=0.350 Sum_probs=200.1
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC-EEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG-VLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-~~~l 194 (480)
..+|.+.+.||+|+||.||+|.. .|+.||||+++... ..+.+.+|+.++..+ +||||+++++++.... .+|+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~i 264 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 264 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----TSHHHHHHHHHHHTC-CCTTBCCEEEEEECTTSCEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----HHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCCCceEE
Confidence 35688899999999999999975 58899999998643 234588999999999 8999999999987655 7999
Q ss_pred EeeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQERCT--FTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||++|+|.+++..... +++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill------------~~~~~~kl~D 332 (450)
T 1k9a_A 265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV------------SEDNVAKVSD 332 (450)
T ss_dssp EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------CTTSCEEECC
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE------------CCCCCEEEee
Confidence 9999999999999987643 7999999999999999999999999999999999999 5667899999
Q ss_pred cCcccccCCC-cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCc--cchHHHhcC-CCCcCCCC
Q psy14702 273 FGHVIADNDF-EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNG--PMWHHIRDG-NIEKLSNV 346 (480)
Q Consensus 273 FG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~--~~~~~i~~~-~~~~~~~~ 346 (480)
||++...... ....+++.|+|||++.+..+. .++|||||||++|||+ |..||.... .....+..+ ..+.+..+
T Consensus 333 fG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~ 411 (450)
T 1k9a_A 333 FGLTKEASSTQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 411 (450)
T ss_dssp CTTCEECC------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred CCCcccccccccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcC
Confidence 9998754332 234578899999999877655 7899999999999974 677776543 234445554 34556779
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
++++.+||.+||..||.+|||+.++++..
T Consensus 412 ~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 412 PPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 99999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=342.83 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=197.1
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-VANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .........+.+|+.++..+ +||||+++++++...+..|+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCcEEE
Confidence 34688999999999999999999999999999998753 23455567789999999999 78999999999999999999
Q ss_pred EeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 195 QLEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~------------~~~~~~kl 177 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI------------TATGVVKL 177 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEE
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE------------cCCCCEEE
Confidence 9999999999999864 3569999999999999999999999999999999999999 55678999
Q ss_pred CccCcccccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc----chHHHhcCCCC
Q psy14702 271 GDFGHVIADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP----MWHHIRDGNIE 341 (480)
Q Consensus 271 ~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~----~~~~i~~~~~~ 341 (480)
+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.....+
T Consensus 178 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 178 GDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256 (310)
T ss_dssp CCC------------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC
T ss_pred EeccceeeecCCCccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC
Confidence 999988654332 234689999999999877554 789999999999996 67777765432 22334444443
Q ss_pred cC--CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 342 KL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 342 ~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.. ..+++++.+||.+||..||.+|||+.+++++..
T Consensus 257 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~ 293 (310)
T 2wqm_A 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAK 293 (310)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 32 568999999999999999999999999998754
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=341.71 Aligned_cols=246 Identities=18% Similarity=0.198 Sum_probs=199.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++....... .+.+|+.++..+.+|+++..+..++......|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCC----HHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchh----HHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4567889999999999999999999999999999987643332 377899999999665666666666678889999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.. +.++.+||+||
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~---------~~~~~~kl~Df 152 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG---------KKGNLVYIIDF 152 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG---------GGTTCEEECCC
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC---------CCCCeEEEeeC
Confidence 99999 9999999974 4579999999999999999999999999999999999999421 34668999999
Q ss_pred CcccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHh
Q psy14702 274 GHVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIR 336 (480)
Q Consensus 274 G~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~ 336 (480)
|++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+.
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 3uzp_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred CCcccccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc
Confidence 998654322 334699999999999887654 789999999999996 77778765321 222333
Q ss_pred cCCCCc-----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 337 DGNIEK-----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 337 ~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
...... ...+|+++.+||.+||+.||.+|||+.++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 275 (296)
T 3uzp_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred ccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence 222222 256899999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=341.31 Aligned_cols=249 Identities=20% Similarity=0.290 Sum_probs=202.9
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGM---TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ 189 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 189 (480)
......|...+.||+|+||.||+|.+..++. .||+|.+... ......+.+.+|+.++..+ +||||+++++++.+.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 94 (298)
T 3pls_A 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGL-NHPNVLALIGIMLPP 94 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCS
T ss_pred cccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEecC
Confidence 3445567778999999999999998766554 7999998763 3445566789999999999 799999999999866
Q ss_pred CEE-EEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 190 GVL-YLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 190 ~~~-~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
+.. ++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 95 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili------------~~~~~ 162 (298)
T 3pls_A 95 EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML------------DESFT 162 (298)
T ss_dssp SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CTTCC
T ss_pred CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE------------cCCCc
Confidence 554 999999999999999986 3578999999999999999999999999999999999999 56678
Q ss_pred eEeCccCcccccCC--------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHH
Q psy14702 268 YKLGDFGHVIADND--------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHI 335 (480)
Q Consensus 268 vkL~DFG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i 335 (480)
+||+|||++..... .....+|+.|+|||++.+..+. .++|||||||++|+| +|+.|+..... ....+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~ 241 (298)
T 3pls_A 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL 241 (298)
T ss_dssp EEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH
T ss_pred EEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh
Confidence 99999999864322 2234578899999999877554 789999999999997 54666554332 22333
Q ss_pred hcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 336 RDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 336 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..+. .+.+..+++.+.+||.+||..||.+|||+.++++...
T Consensus 242 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 242 AQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 3333 3445668999999999999999999999999987643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=334.85 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=202.7
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.+. +++.||+|++....... +.+.+|+.++..+ +||||+++++++.+.+..|+||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhC-CCCCEeeEEEEEccCCCeEEEE
Confidence 46788999999999999999875 77899999998654332 4588999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili------------~~~~~~kl~dfg~ 150 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV------------GENQVIKVSDFGM 150 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE------------CGGGCEEECCTTG
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE------------CCCCCEEEccccc
Confidence 999999999999865 468999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCcCCC
Q psy14702 276 VIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEKLSN 345 (480)
Q Consensus 276 a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~~~~ 345 (480)
+...... ....+++.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+. ...+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 229 (267)
T 3t9t_A 151 TRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 229 (267)
T ss_dssp GGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred ccccccccccccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCcc
Confidence 8654322 233477889999999876554 7899999999999974 5666654432 333444443 334456
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
++..+.++|.+||..||.+|||+.+++++..
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~ 260 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 260 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 8999999999999999999999999998754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=368.26 Aligned_cols=242 Identities=21% Similarity=0.348 Sum_probs=204.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+..++..||||+++..... .+.+.+|+.++..+ +||||+++++++.....+|||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhc-CCCCEeeEEEEEecCCcEEEE
Confidence 45688899999999999999999988999999999764332 35588999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 196 LEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll------------~~~~~~kl~DF 362 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV------------GENHLVKVADF 362 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CGGGCEEECCT
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE------------CCCCcEEEeec
Confidence 9999999999999864 358999999999999999999999999999999999999 56778999999
Q ss_pred CcccccCCCc-----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCcC
Q psy14702 274 GHVIADNDFE-----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEKL 343 (480)
Q Consensus 274 G~a~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~~ 343 (480)
|++....... ...+++.|+|||++.+..+. .++|||||||++|||+ |..||..... ....+..+ ..+.+
T Consensus 363 G~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 441 (495)
T 1opk_A 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 441 (495)
T ss_dssp TCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC
T ss_pred ccceeccCCceeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 9987543321 23356789999999877654 6899999999999974 5667765432 23334433 33456
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
..+++++.+||.+||+.||.+|||+.++++.
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 6799999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=343.57 Aligned_cols=245 Identities=22% Similarity=0.328 Sum_probs=197.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
-.+|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +||||+++++++...+.+|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEeeCCeEEE
Confidence 3568889999999999999999999999999999876432 334456788999999999 88999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~------------~~~~~~kl~Dfg 179 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV------------SADDFAYLVDFG 179 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTSCEEECSCC
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE------------cCCCCEEEecCc
Confidence 99999999999999988889999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhcCCC---CcC
Q psy14702 275 HVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDGNI---EKL 343 (480)
Q Consensus 275 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~~~~---~~~ 343 (480)
++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+..... ...
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (309)
T 2h34_A 180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR 258 (309)
T ss_dssp C----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTS
T ss_pred cCccccccccccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccC
Confidence 88654332 234689999999999877554 689999999999996 677777654431 122222211 223
Q ss_pred CCCCHHHHHHHHHhhccCCCCCC-ChhHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRP-STSSLRRS 374 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rp-s~~ell~h 374 (480)
+.++.++.++|.+||..||++|| |++++++.
T Consensus 259 ~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp TTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred CCCCHHHHHHHHHhccCCHHHHHHhHHHHHHH
Confidence 56899999999999999999999 78888754
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=345.62 Aligned_cols=247 Identities=24% Similarity=0.325 Sum_probs=199.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe----eCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS----DQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~----~~~~ 191 (480)
..+|.+.+.||+|+||.||+|.+..+|+.||||++... .......+.+|+.++..+ +||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCce
Confidence 34688999999999999999999999999999998653 345566789999999999 8999999999986 3457
Q ss_pred EEEEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 192 LYLQLEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
.|+|||||.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~------------~~~~~ 172 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL------------GDEGQ 172 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE------------cCCCC
Confidence 8999999999999999975 3579999999999999999999999999999999999999 55678
Q ss_pred eEeCccCcccccCCC-------------cccCCCcccchhhhhcccCC--CCCcccHHHHHHHHHHH-hCCCCCCC----
Q psy14702 268 YKLGDFGHVIADNDF-------------EVEEGDCRYLPKELLNNNFD--NLSKVDIFALGLTLYEA-SGVTPLPK---- 327 (480)
Q Consensus 268 vkL~DFG~a~~~~~~-------------~~~~gt~~y~aPE~~~~~~~--~~~k~DiwSlGvilyel-~~~~p~~~---- 327 (480)
+||+|||++...... ....||+.|+|||++.+... .+.++|||||||++|+| +|..||..
T Consensus 173 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 252 (317)
T 2buj_A 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252 (317)
T ss_dssp EEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHT
T ss_pred EEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcc
Confidence 999999987543321 12347999999999875431 23689999999999996 67777642
Q ss_pred CccchHHHhc-CCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 328 NGPMWHHIRD-GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 328 ~~~~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
.......+.. ...+....++.++.+||.+||+.||.+|||+.+++++..-
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp TSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 1112222222 2234446789999999999999999999999999998653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=346.67 Aligned_cols=247 Identities=20% Similarity=0.332 Sum_probs=200.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDG----MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
..+|.+.+.||+|+||.||+|.+..++ ..||||+++... .......+.+|+.++..+ +||||+++++++...+.
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 120 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKP 120 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSS
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCC
Confidence 346777899999999999999876553 469999997643 445556789999999999 88999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------~~~~~~kl 188 (333)
T 1mqb_A 121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV------------NSNLVCKV 188 (333)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCEEE
T ss_pred cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE------------CCCCcEEE
Confidence 99999999999999999765 579999999999999999999999999999999999999 56778999
Q ss_pred CccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcC-
Q psy14702 271 GDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDG- 338 (480)
Q Consensus 271 ~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~- 338 (480)
+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+| + |..||..... ....+..+
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~ 267 (333)
T 1mqb_A 189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF 267 (333)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred CCCCcchhhccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCC
Confidence 999998654322 122367889999999876554 689999999999996 4 6777765432 33444444
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
..+.+..++..+.++|.+||+.||.+||++.+++++..-
T Consensus 268 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 306 (333)
T 1mqb_A 268 RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 306 (333)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 344556789999999999999999999999999987653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=343.81 Aligned_cols=245 Identities=21% Similarity=0.271 Sum_probs=196.1
Q ss_pred hhhhhhheeecccCceEEEEEE----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC--
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCL----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ-- 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-- 189 (480)
..+|.+.+.||+|+||.||+|. +..+++.||+|++..... ......+.+|+.++..+ +||||+++++++...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG 97 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc-chhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence 3457889999999999999998 567899999999875432 22235688999999999 789999999999876
Q ss_pred CEEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
..+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~------------~~~~~~ 165 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV------------ESEHQV 165 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------EETTEE
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE------------cCCCCE
Confidence 6789999999999999999544 579999999999999999999999999999999999999 556689
Q ss_pred EeCccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC-CCCCCCCc-----------
Q psy14702 269 KLGDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG-VTPLPKNG----------- 329 (480)
Q Consensus 269 kL~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~-~~p~~~~~----------- 329 (480)
||+|||++...... ....||..|+|||++.+..+. .++|||||||++|+|++ ..|+....
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 244 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCC
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcc
Confidence 99999998654332 234578889999999877555 68999999999999754 44432110
Q ss_pred -c-----chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 330 -P-----MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 330 -~-----~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
. ....+..+ ..+.+..+++++.+||.+||..||.+|||+.++++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 297 (302)
T 4e5w_A 245 GQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297 (302)
T ss_dssp GGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 0 11122222 3445567899999999999999999999999998754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=352.61 Aligned_cols=244 Identities=18% Similarity=0.250 Sum_probs=196.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcE----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMT----YAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~----vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
.+|.+.+.||+|+||+||+|.+..+++. ||+|.+..... ......+.+|+.++..+ +||||+++++++. ....
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~-~~~~ 89 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSL-DHAHIVRLLGLCP-GSSL 89 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTC-CCTTBCCEEEEEC-BSSE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcC-CCCCcCeEEEEEc-CCcc
Confidence 4688899999999999999998888765 77777654321 11123366789999998 8999999999886 4568
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 193 YLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
|+|||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 90 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~------------~~~~~~kl~ 157 (325)
T 3kex_A 90 QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL------------KSPSQVQVA 157 (325)
T ss_dssp EEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE------------SSSSCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE------------CCCCeEEEC
Confidence 9999999999999999764 479999999999999999999999999999999999999 566789999
Q ss_pred ccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcCC-C
Q psy14702 272 DFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDGN-I 340 (480)
Q Consensus 272 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~~-~ 340 (480)
|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| + |..||..... ....+..+. .
T Consensus 158 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 236 (325)
T 3kex_A 158 DFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERL 236 (325)
T ss_dssp SCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBC
T ss_pred CCCcccccCcccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC
Confidence 99998754322 234578899999999877655 789999999999996 4 6777765432 333444443 3
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..+..++.++.++|.+||..||.+|||+.+++++..
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~ 272 (325)
T 3kex_A 237 AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFT 272 (325)
T ss_dssp CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHH
T ss_pred CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 445568889999999999999999999999998854
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=351.10 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=203.4
Q ss_pred CcchhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 111 DHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 111 ~~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
+......+|.+.+.||+|+||.||+|.+ .+++.||||++...... ..+.+.+|+.++..+ +||||+++++++...+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQ--GIEEFETEIETLSFC-RHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSS--HHHHHHHHHHGGGSC-CCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChH--HHHHHHHHHHHHHhC-CCCCEeeEEEEEcCCC
Confidence 3344556788899999999999999985 47899999998764333 345688999999998 7999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC----TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
..|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~------------~~~~ 176 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL------------DENF 176 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE------------CTTC
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE------------CCCC
Confidence 9999999999999999986542 58999999999999999999999999999999999999 5677
Q ss_pred ceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--h-----
Q psy14702 267 HYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--W----- 332 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~----- 332 (480)
.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||....+. .
T Consensus 177 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 177 VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CEEEeecccccccccccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 8999999998653321 223489999999999877655 789999999999996 677777644321 0
Q ss_pred --HHHhcCCCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 333 --HHIRDGNIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 333 --~~i~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.....+... ..+.++..+.+++.+||+.||++|||+.+++++......
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp THHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 011111111 112245678999999999999999999999999875543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=340.86 Aligned_cols=246 Identities=18% Similarity=0.197 Sum_probs=195.5
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..+.+|++|..+..++......|+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 456789999999999999999999999999999987653222 2367899999999666667677667788899999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||| +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+||
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~---------~~~~~~kL~Df 152 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG---------KKGNLVYIIDF 152 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG---------GGTTCEEECCC
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc---------CCCCeEEEecC
Confidence 99999 9999999975 4579999999999999999999999999999999999999421 34668999999
Q ss_pred CcccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHh
Q psy14702 274 GHVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIR 336 (480)
Q Consensus 274 G~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~ 336 (480)
|++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... ....+.
T Consensus 153 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 231 (296)
T 4hgt_A 153 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231 (296)
T ss_dssp TTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH
T ss_pred ccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh
Confidence 998654321 234699999999999887654 789999999999996 67788865322 122222
Q ss_pred cCCCCc-----CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 337 DGNIEK-----LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 337 ~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
...... ...+++++.+||.+||+.||++|||+.++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 275 (296)
T 4hgt_A 232 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 275 (296)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred cccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence 222222 256899999999999999999999999998743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=336.93 Aligned_cols=245 Identities=22% Similarity=0.316 Sum_probs=200.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
..+|.+.+.||+|+||.||+|.+... +..||+|.+... ......+.+.+|+.++..+ +||||+++++++.++ ..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~ 87 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE-PT 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSS-SC
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC-CC
Confidence 45788899999999999999986543 456999998764 2344567789999999999 799999999998754 56
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 193 YLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~------------~~~~~~kl~ 155 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV------------ASPECVKLG 155 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE------------EETTEEEEC
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE------------CCCCcEEeC
Confidence 8999999999999999765 469999999999999999999999999999999999999 556689999
Q ss_pred ccCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCC
Q psy14702 272 DFGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIE 341 (480)
Q Consensus 272 DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~ 341 (480)
|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+ ..+
T Consensus 156 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (281)
T 3cc6_A 156 DFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234 (281)
T ss_dssp CCCGGGCC---------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred ccCCCcccccccccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC
Confidence 99998654332 223478899999999876554 7899999999999974 6777764332 33333333 344
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.+..+++.+.++|.+||..||.+|||+.+++++..
T Consensus 235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 269 (281)
T 3cc6_A 235 KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLS 269 (281)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHH
Confidence 55678999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=351.11 Aligned_cols=263 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCC-cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-----CCceeEEeeEE
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDG-MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR-----VPHIVNYFSSW 186 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~-~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~-----hpnIv~l~~~~ 186 (480)
..+..+|.+.+.||+|+||+||+|.+..++ +.||+|+++.. ......+.+|+.++..+.+ |++++.+++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 345678999999999999999999988776 78999999742 3445667889988888732 23399999999
Q ss_pred eeCCEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC-------C
Q psy14702 187 SDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE-------L 257 (480)
Q Consensus 187 ~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~-------~ 257 (480)
...+.+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+.. .
T Consensus 92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence 9999999999999 667777776543 69999999999999999999999999999999999999432100 0
Q ss_pred CCCCCccccceEeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hH
Q psy14702 258 NEPMNTEKLHYKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WH 333 (480)
Q Consensus 258 ~~~~~~~~~~vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~ 333 (480)
.....+..+.+||+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred ccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 000013467899999999875443 3345799999999999877655 789999999999996 677777654321 11
Q ss_pred HHhc--CCCC------------------------------------------cCCCCCHHHHHHHHHhhccCCCCCCChh
Q psy14702 334 HIRD--GNIE------------------------------------------KLSNVSDDLHTLIKLMIDKDPTKRPSTS 369 (480)
Q Consensus 334 ~i~~--~~~~------------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~ 369 (480)
.+.. +..+ .....+.++.+||.+||+.||.+|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 1100 0000 0011245789999999999999999999
Q ss_pred HHHHHHHHHHh
Q psy14702 370 SLRRSAQLARN 380 (480)
Q Consensus 370 ell~h~~~~~~ 380 (480)
++++||||...
T Consensus 330 e~l~hp~f~~~ 340 (355)
T 2eu9_A 330 EALLHPFFAGL 340 (355)
T ss_dssp HHTTSGGGGGC
T ss_pred HHhcChhhcCC
Confidence 99999999763
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.38 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=189.9
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC----E
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG----V 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----~ 191 (480)
..+|.+.+.||+|+||+||+|.+ .++.||||++... ......+.+|+.++..+ +||||+++++++.... .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecC---chHHHHHHHHHHHHhcC-CCCCchhhcceeccCCCCCce
Confidence 34688899999999999999975 4899999998643 33344466788888888 7999999999998743 4
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceecCCCCCcEEEeccCCCCCCCC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM----------RMIHMDIKPANILIVKAQGELNEPM 261 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~----------~IvHrDlKp~NILl~~~~~~~~~~~ 261 (480)
+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill----------- 164 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL----------- 164 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE-----------
T ss_pred EEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE-----------
Confidence 79999999999999999764 699999999999999999999999 99999999999999
Q ss_pred CccccceEeCccCcccccCC------CcccCCCcccchhhhhcccCC----CCCcccHHHHHHHHHHH-hCCCCCCCCcc
Q psy14702 262 NTEKLHYKLGDFGHVIADND------FEVEEGDCRYLPKELLNNNFD----NLSKVDIFALGLTLYEA-SGVTPLPKNGP 330 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~----~~~k~DiwSlGvilyel-~~~~p~~~~~~ 330 (480)
+.++.+||+|||++..... .....||+.|+|||++.+... .+.++|||||||++||| +|..||.....
T Consensus 165 -~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 243 (322)
T 3soc_A 165 -KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243 (322)
T ss_dssp -CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred -CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence 5677899999999864332 222469999999999986422 12478999999999997 56666654321
Q ss_pred --------------chH----HHhcCC-CCcCC------CCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 331 --------------MWH----HIRDGN-IEKLS------NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 331 --------------~~~----~i~~~~-~~~~~------~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
... .+.... .+.+. ..++++.+||.+||+.||++|||+.++++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 314 (322)
T 3soc_A 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314 (322)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 001 111111 11111 12355999999999999999999999998754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=364.70 Aligned_cols=255 Identities=27% Similarity=0.404 Sum_probs=190.5
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E 197 (480)
.|...+.||+|+||+||.+ ...+|+.||||++.... ...+.+|+.++..+.+|||||++++++.+.+.+|||||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4556789999999999875 56789999999986521 23467899999887789999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC-CCCCCCccccceE
Q psy14702 198 YCNGGNLENIIQERCTF-------TEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE-LNEPMNTEKLHYK 269 (480)
Q Consensus 198 ~~~gg~L~~~l~~~~~l-------~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~-~~~~~~~~~~~vk 269 (480)
||. |+|.+++...... ++..++.++.||+.||.|||++||+||||||+|||++..+.. ......+....+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 995 6999999865432 233456799999999999999999999999999999643100 0000013456899
Q ss_pred eCccCcccccCCC--------cccCCCcccchhhhhccc------CCCCCcccHHHHHHHHHHHh--CCCCCCCCccchH
Q psy14702 270 LGDFGHVIADNDF--------EVEEGDCRYLPKELLNNN------FDNLSKVDIFALGLTLYEAS--GVTPLPKNGPMWH 333 (480)
Q Consensus 270 L~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~------~~~~~k~DiwSlGvilyel~--~~~p~~~~~~~~~ 333 (480)
|+|||++...... ....||+.|+|||++.+. ...+.++|||||||++|||+ |..||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999998754332 234699999999999751 23347899999999999974 5667654433333
Q ss_pred HHhcCCCC--cC-----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 334 HIRDGNIE--KL-----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 334 ~i~~~~~~--~~-----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.+..+... .+ ..+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 249 ~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 34433322 11 124678999999999999999999999999999954
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=339.35 Aligned_cols=247 Identities=21% Similarity=0.274 Sum_probs=198.5
Q ss_pred hhhhhhhhheeecccCceEEEEEEEeeC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEE-eeC
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSW-SDQ 189 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~-~~~ 189 (480)
....+|.+.+.||+|+||.||+|.+..+ +..||+|.+... ......+.+.+|+.+++.+ +||||+++++++ ..+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 99 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSE 99 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEECCSS
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhC-CCCCEeeeeeEEEcCC
Confidence 3445688899999999999999986543 346899998763 3445566789999999999 799999999985 456
Q ss_pred CEEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
+..|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~------------~~~~~~ 167 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML------------DEKFTV 167 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CTTCCE
T ss_pred CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE------------CCCCCE
Confidence 7889999999999999999754 468999999999999999999999999999999999999 567789
Q ss_pred EeCccCcccccCCC--------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC-CCCCCCCcc---chHHHh
Q psy14702 269 KLGDFGHVIADNDF--------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG-VTPLPKNGP---MWHHIR 336 (480)
Q Consensus 269 kL~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~-~~p~~~~~~---~~~~i~ 336 (480)
||+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|++ +.|+..... ....+.
T Consensus 168 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T 3f66_A 168 KVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246 (298)
T ss_dssp EECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH
T ss_pred EECcccccccccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence 99999998644321 223477889999999877655 78999999999999743 555443322 233344
Q ss_pred cCCC-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 337 DGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 337 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
.+.. ..+..+++.+.++|.+||..||.+|||+.++++..
T Consensus 247 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 286 (298)
T 3f66_A 247 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286 (298)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 4433 33456899999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=346.97 Aligned_cols=245 Identities=20% Similarity=0.302 Sum_probs=195.6
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEE----EEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTY----AVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~v----AvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
..+|.+.+.||+|+||.||+|.+..+++.| |+|.+.... .......+.+|+.++..+ +||||+++++++....
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTST- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC-
Confidence 356888999999999999999988887655 666665432 222345688999999999 7899999999998765
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~------------~~~~~~kL 158 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV------------KTPQHVKI 158 (327)
T ss_dssp EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------EETTEEEE
T ss_pred ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE------------cCCCCEEE
Confidence 78999999999999999764 579999999999999999999999999999999999999 55668999
Q ss_pred CccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcC-C
Q psy14702 271 GDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDG-N 339 (480)
Q Consensus 271 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~-~ 339 (480)
+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+| + |..||..... ....+..+ .
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~ 237 (327)
T 3lzb_A 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER 237 (327)
T ss_dssp CCTTC----------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred ccCcceeEccCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999998654322 123467889999999887665 789999999999996 4 6667765432 23333333 3
Q ss_pred CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 340 IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 340 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.+.+..++.++.+||.+||..||.+|||+.++++...
T Consensus 238 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 274 (327)
T 3lzb_A 238 LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274 (327)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 4455678999999999999999999999999997654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=345.32 Aligned_cols=245 Identities=24% Similarity=0.357 Sum_probs=201.4
Q ss_pred hhhhhhheeecccCceEEEEEE----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe--eC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCL----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS--DQ 189 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~--~~ 189 (480)
..+|.+.+.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++..+ +||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCC
Confidence 3578889999999999999998 4678999999999764 344556789999999999 8899999999886 56
Q ss_pred CEEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
..+|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~------------~~~~~~ 166 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV------------ESEAHV 166 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------EETTEE
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE------------CCCCCE
Confidence 7799999999999999999763 469999999999999999999999999999999999999 556789
Q ss_pred EeCccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc----------
Q psy14702 269 KLGDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---------- 330 (480)
Q Consensus 269 kL~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---------- 330 (480)
||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||.....
T Consensus 167 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~ 245 (327)
T 3lxl_A 167 KIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245 (327)
T ss_dssp EECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC---
T ss_pred EEcccccceecccCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc
Confidence 99999998654322 223578889999999877554 689999999999997 55556543221
Q ss_pred -------chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 331 -------MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 331 -------~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
....+..+ ..+.+..+++++.+||.+||+.||.+|||+.+++++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 299 (327)
T 3lxl_A 246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299 (327)
T ss_dssp -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11112222 23445678999999999999999999999999987753
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=360.17 Aligned_cols=242 Identities=22% Similarity=0.335 Sum_probs=200.9
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|... ++..||||+++..... .+.+.+|+.++..+ +||||+++++++. ...+|+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMS---VEAFLAEANVMKTL-QHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHTTC-CCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCcc---HHHHHHHHHHHhhC-CCCCEeeEEEEEe-CCccEE
Confidence 3557888999999999999999764 5788999999864332 45689999999999 8999999999986 567899
Q ss_pred EeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill------------~~~~~~kl~D 327 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV------------SASLVCKIAD 327 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE------------CTTCCEEECS
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE------------CCCCcEEEee
Confidence 99999999999999753 368999999999999999999999999999999999999 5677899999
Q ss_pred cCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCc
Q psy14702 273 FGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEK 342 (480)
Q Consensus 273 FG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~ 342 (480)
||++...... ....+|+.|+|||++....+. .++|||||||++|||+ |..||..... ....+..+ ..+.
T Consensus 328 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 406 (454)
T 1qcf_A 328 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 406 (454)
T ss_dssp TTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC
T ss_pred CCCceEcCCCceeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9998765432 223467789999999877654 7899999999999974 6677765432 33344443 3455
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
+..+++++.+||.+||..||++|||+.+|++..
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L 439 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 677999999999999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=341.62 Aligned_cols=241 Identities=24% Similarity=0.388 Sum_probs=187.1
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEee----C
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-SRVPHIVNYFSSWSD----Q 189 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~~hpnIv~l~~~~~~----~ 189 (480)
...+|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++... .+||||+++++++.. .
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 456788999999999999999975 7999999998642 123355566666653 289999999998654 3
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEeccCCCCCCCC
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH--------EMRMIHMDIKPANILIVKAQGELNEPM 261 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~IvHrDlKp~NILl~~~~~~~~~~~ 261 (480)
..+|+|||||++|+|.++++. ..+++..++.++.||+.||.||| ++||+||||||+|||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill----------- 146 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV----------- 146 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE-----------
T ss_pred ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE-----------
Confidence 568999999999999999954 47999999999999999999999 9999999999999999
Q ss_pred CccccceEeCccCcccccCCC--------cccCCCcccchhhhhcccCCC-----CCcccHHHHHHHHHHHh-C------
Q psy14702 262 NTEKLHYKLGDFGHVIADNDF--------EVEEGDCRYLPKELLNNNFDN-----LSKVDIFALGLTLYEAS-G------ 321 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~-----~~k~DiwSlGvilyel~-~------ 321 (480)
+.++.+||+|||++...... ....||+.|+|||++.+.... +.++|||||||++|||+ |
T Consensus 147 -~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~ 225 (301)
T 3q4u_A 147 -KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGI 225 (301)
T ss_dssp -CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred -cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccc
Confidence 56678999999998543321 223699999999999876322 14899999999999975 4
Q ss_pred ----CCCCCCCc---cchHHHh-----cCCCCcCC------CCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 322 ----VTPLPKNG---PMWHHIR-----DGNIEKLS------NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 322 ----~~p~~~~~---~~~~~i~-----~~~~~~~~------~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..||.... ..+..+. ....+.++ .+++++.+||.+||+.||.+|||+.++++..
T Consensus 226 ~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L 297 (301)
T 3q4u_A 226 VEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297 (301)
T ss_dssp CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHH
T ss_pred cccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHH
Confidence 45664322 1111111 11111111 2457799999999999999999999998764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=360.57 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=199.9
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC--EE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG--VL 192 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--~~ 192 (480)
...+|.+.+.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.++..+ +||||+++++++.... ..
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCCE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCee
Confidence 34578899999999999999999999999999999875322 12234577899999999 7899999999998655 78
Q ss_pred EEEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 193 YLQLEYCNGGNLENIIQERC---TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+.... +..+.+|
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~--------~~~~~~k 156 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE--------DGQSVYK 156 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT--------TSCEEEE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC--------CCceeEE
Confidence 99999999999999997543 399999999999999999999999999999999999984432 4566899
Q ss_pred eCccCcccccCCC---cccCCCcccchhhhhccc-------CCCCCcccHHHHHHHHHHH-hCCCCCCCCc------cch
Q psy14702 270 LGDFGHVIADNDF---EVEEGDCRYLPKELLNNN-------FDNLSKVDIFALGLTLYEA-SGVTPLPKNG------PMW 332 (480)
Q Consensus 270 L~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-------~~~~~k~DiwSlGvilyel-~~~~p~~~~~------~~~ 332 (480)
|+|||++...... ....||+.|+|||++.+. ...+.++|||||||++|+| +|..||.... ...
T Consensus 157 L~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~ 236 (396)
T 4eut_A 157 LTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236 (396)
T ss_dssp ECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred EecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence 9999998654432 235699999999998752 1223589999999999996 6777875321 122
Q ss_pred HHHhcCCCC---------------------cC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 333 HHIRDGNIE---------------------KL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 333 ~~i~~~~~~---------------------~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
..+..+..+ .. ..++..+.++|.+||+.||++|||+.+++++..-
T Consensus 237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~ 306 (396)
T 4eut_A 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306 (396)
T ss_dssp HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence 233332211 11 1234578899999999999999999999887643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.57 Aligned_cols=247 Identities=18% Similarity=0.217 Sum_probs=189.7
Q ss_pred hhhhhhheeecccCceEEEEEEEeeC-----CcEEEEEEecCCCCCHHHHH---------HHHHHHHHHHhcCCCCceeE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMD-----GMTYAVKRTKRPVANTAQEK---------IFKKEIHAHALLSRVPHIVN 181 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~-----~~~vAvK~~~~~~~~~~~~~---------~~~~Ei~~l~~l~~hpnIv~ 181 (480)
..+|.+.+.||+|+||.||+|.+..+ ++.||||++.........+. .+..|+..+..+ +||||++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~ 112 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL-KYLGVPK 112 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC-SCCCSCC
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc-cCCCCCe
Confidence 45788999999999999999988664 58899999876432111111 122334444555 6999999
Q ss_pred EeeEEeeC----CEEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC
Q psy14702 182 YFSSWSDQ----GVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE 256 (480)
Q Consensus 182 l~~~~~~~----~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~ 256 (480)
+++++... ...||||||| |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~---- 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY---- 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES----
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec----
Confidence 99998764 5689999999 99999999876 57999999999999999999999999999999999999942
Q ss_pred CCCCCCccccceEeCccCcccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCC
Q psy14702 257 LNEPMNTEKLHYKLGDFGHVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTP 324 (480)
Q Consensus 257 ~~~~~~~~~~~vkL~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p 324 (480)
+..+.+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++||| +|..|
T Consensus 188 ------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~P 260 (364)
T 3op5_A 188 ------KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLP 260 (364)
T ss_dssp ------SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCT
T ss_pred ------CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCC
Confidence 15678999999998543221 223499999999999887654 799999999999996 77778
Q ss_pred CCCCccc--hHHHhc----CCCC-------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 325 LPKNGPM--WHHIRD----GNIE-------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 325 ~~~~~~~--~~~i~~----~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
|...... +..... .... ....+++++.++|..||..||.+||++.+|++..
T Consensus 261 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l 324 (364)
T 3op5_A 261 WEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDIL 324 (364)
T ss_dssp TGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred ccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Confidence 7643211 110000 0110 1256799999999999999999999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=352.51 Aligned_cols=247 Identities=17% Similarity=0.200 Sum_probs=190.5
Q ss_pred hhhhhhheeecccCceEEEEEEEee---CCcEEEEEEecCCCCCHHHH---------HHHHHHHHHHHhcCCCCceeEEe
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYM---DGMTYAVKRTKRPVANTAQE---------KIFKKEIHAHALLSRVPHIVNYF 183 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~vAvK~~~~~~~~~~~~---------~~~~~Ei~~l~~l~~hpnIv~l~ 183 (480)
..+|.+.+.||+|+||.||+|.+.. ++..||+|++.........+ ..+.+|+..+..+ +||||++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h~ni~~~~ 114 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DYLGIPLFY 114 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SCCCCCCEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cccCcceee
Confidence 3568889999999999999999887 78899999987653322111 2355677888888 889999999
Q ss_pred eEEee----CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCC
Q psy14702 184 SSWSD----QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 184 ~~~~~----~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
+++.. ...+|+||||| +++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~------ 187 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK------ 187 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS------
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC------
Confidence 99987 78899999999 99999999877789999999999999999999999999999999999999432
Q ss_pred CCCccccceEeCccCcccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCC
Q psy14702 260 PMNTEKLHYKLGDFGHVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPK 327 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~ 327 (480)
....+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..
T Consensus 188 ----~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 ----NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp ----STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred ----CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 1238999999998643211 234699999999999887554 789999999999996 67778754
Q ss_pred Cccc---hHHHhc---CCCC-------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 328 NGPM---WHHIRD---GNIE-------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 328 ~~~~---~~~i~~---~~~~-------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
.... ...... ...+ ....+++++.++|.+||..||++|||+.++++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L 323 (345)
T 2v62_A 263 NLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKIL 323 (345)
T ss_dssp GTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred cccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHH
Confidence 2211 111111 1111 1127899999999999999999999999998754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=351.37 Aligned_cols=247 Identities=24% Similarity=0.351 Sum_probs=196.2
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.. .+|+.||||++...... .....+.+|+.++..+ +||||+++++++...+..|+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMA-VHRNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTC-CCTTBCCCCEEECCSSCCEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhc-cCCCccceEEEEecCCceEE
Confidence 345788899999999999999974 47899999998753221 1122578899999998 79999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 195 QLEYCNGGNLENIIQERC----TFTEMALKQLLFQVSEGLRCMHEM---RMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
|||||.+|+|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||+ +.++.
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~------------~~~~~ 172 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL------------DEEFE 172 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE------------CTTCC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE------------CCCCC
Confidence 999999999999998643 499999999999999999999999 99999999999999 56678
Q ss_pred eEeCccCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCC------ccchHHH
Q psy14702 268 YKLGDFGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKN------GPMWHHI 335 (480)
Q Consensus 268 vkL~DFG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~------~~~~~~i 335 (480)
+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||... .......
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 251 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHH
Confidence 999999998654322 223599999999999877654 789999999999996 677777411 1111111
Q ss_pred hcC-----CCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 336 RDG-----NIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 336 ~~~-----~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
... ... .....+.++.+++.+||+.||.+|||+.++++|.+-
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 252 VKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 111 111 111234679999999999999999999999999863
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=338.85 Aligned_cols=242 Identities=24% Similarity=0.378 Sum_probs=190.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||.||+|.+ +..||+|+++.........+.+.+|+.++..+ +||||+++++++ .....++|
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEES---SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEE-CSSSCEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEE---cCceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeec-cCCccEEE
Confidence 44678899999999999999963 34699999987666677778899999999999 789999999965 55668999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~------------~~~~~~kl~Dfg 165 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL------------HEDNTVKIGDFG 165 (289)
T ss_dssp EECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------ETTTEEEECCCC
T ss_pred EEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE------------CCCCCEEEccce
Confidence 9999999999999643 469999999999999999999999999999999999999 556789999999
Q ss_pred cccccCC------CcccCCCcccchhhhhc---ccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCCC
Q psy14702 275 HVIADND------FEVEEGDCRYLPKELLN---NNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNIE 341 (480)
Q Consensus 275 ~a~~~~~------~~~~~gt~~y~aPE~~~---~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~~ 341 (480)
++..... .....||+.|+|||++. +..+ +.++|||||||++|+| +|..||..... ....+..+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccC
Confidence 8864332 22346899999999986 3323 3689999999999996 67778765432 22233333222
Q ss_pred -----cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 342 -----KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 342 -----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
....+++++.+||.+||..||.+|||+.++++..
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L 283 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 2246889999999999999999999999998754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.31 Aligned_cols=233 Identities=24% Similarity=0.410 Sum_probs=187.6
Q ss_pred hhhhhhhhh-eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----
Q psy14702 114 RYALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD---- 188 (480)
Q Consensus 114 ~~~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~---- 188 (480)
.+..+|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++..+.+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 344556666 7899999999999999999999999998642 2366788888677799999999999887
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCcccc
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~ 266 (480)
...+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+... ..++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~---------~~~~ 157 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK---------RPNA 157 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS---------STTC
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC---------CCCC
Confidence 678999999999999999998754 69999999999999999999999999999999999999432 1256
Q ss_pred ceEeCccCcccccCCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc------hHHHhcCC
Q psy14702 267 HYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM------WHHIRDGN 339 (480)
Q Consensus 267 ~vkL~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~------~~~i~~~~ 339 (480)
.+||+|||++..... ..+ +.++|||||||++|+| +|..||...... ...+....
T Consensus 158 ~~kl~Dfg~a~~~~~------------------~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 218 (299)
T 3m2w_A 158 ILKLTDFGFAKETTG------------------EKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 218 (299)
T ss_dssp CEEECCCTTCEECTT------------------CGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTC
T ss_pred cEEEecccccccccc------------------ccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhcc
Confidence 899999998854331 112 2589999999999996 677777544321 11112222
Q ss_pred CCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 340 IEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 340 ~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
...+ ..+++++.+||.+||..||.+|||+.++++||||....
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 2222 46899999999999999999999999999999998754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.41 Aligned_cols=239 Identities=25% Similarity=0.441 Sum_probs=190.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.. .++.||||++... ...+.+.+|+.++..+ +||||+++++++.+ ..|+||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~lv~ 78 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE----SERKAFIVELRQLSRV-NHPNIVKLYGACLN--PVCLVM 78 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST----THHHHHHHHHHHHHHC-CCTTBCCEEEBCTT--TTEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh----hHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC--CcEEEE
Confidence 4677889999999999999975 5889999998643 2345688999999999 89999999998874 478999
Q ss_pred eccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceecCCCCCcEEEeccCCCCCCCCCcccc-ceE
Q psy14702 197 EYCNGGNLENIIQERC---TFTEMALKQLLFQVSEGLRCMHE---MRMIHMDIKPANILIVKAQGELNEPMNTEKL-HYK 269 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~-~vk 269 (480)
|||++|+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+|||+. .++ .+|
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~------------~~~~~~k 146 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV------------AGGTVLK 146 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE------------TTTTEEE
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe------------CCCCEEE
Confidence 9999999999998654 47899999999999999999999 8999999999999994 333 489
Q ss_pred eCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc----hHHHhcC-CCCc
Q psy14702 270 LGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM----WHHIRDG-NIEK 342 (480)
Q Consensus 270 L~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~----~~~i~~~-~~~~ 342 (480)
|+|||++..... .....||+.|+|||++.+..+. .++|||||||++|+| +|..||...... ...+..+ ..+.
T Consensus 147 l~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
T 2eva_A 147 ICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225 (307)
T ss_dssp ECCCCC------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred EcccccccccccccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence 999999865433 2345699999999999877554 789999999999996 677777643321 1122233 3344
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
+..++..+.++|.+||+.||.+|||+.+++++..-
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~ 260 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 56789999999999999999999999999987653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=351.10 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=193.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe-eCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDG---MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS-DQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~-~~~~ 191 (480)
...|.+.+.||+|+||.||+|....++ ..||+|.++.. ........+.+|+.++..+ +||||+++++++. .++.
T Consensus 88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEECCCSSC
T ss_pred hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEEcCCCC
Confidence 345777899999999999999876543 46899998753 3344556789999999999 7999999999865 4568
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll------------~~~~~~kL 233 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML------------DEKFTVKV 233 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCEEE
T ss_pred eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE------------CCCCCEEE
Confidence 89999999999999999764 368999999999999999999999999999999999999 56778999
Q ss_pred CccCcccccCCC--------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC-CC-CCCCCcc--chHHHhcC
Q psy14702 271 GDFGHVIADNDF--------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG-VT-PLPKNGP--MWHHIRDG 338 (480)
Q Consensus 271 ~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~-~~-p~~~~~~--~~~~i~~~ 338 (480)
+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|||++ +. ||..... ....+..+
T Consensus 234 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~ 312 (373)
T 3c1x_A 234 ADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 312 (373)
T ss_dssp CCC---------------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred eeccccccccccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence 999998643221 223477889999999877655 78999999999999743 44 4443322 23344444
Q ss_pred CC-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 339 NI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 339 ~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
.. ..+..+++.+.++|.+||..||.+|||+.+++++..-
T Consensus 313 ~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~ 352 (373)
T 3c1x_A 313 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 352 (373)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 33 3456689999999999999999999999999987653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=372.33 Aligned_cols=238 Identities=23% Similarity=0.293 Sum_probs=197.3
Q ss_pred eeecccCceEEEEEEEe--eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeeccC
Q psy14702 123 ELLGSGDFGEVFKCLKY--MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCN 200 (480)
Q Consensus 123 ~~LG~G~fg~V~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~~~ 200 (480)
+.||+|+||.||+|... .+++.||||+++.........+.+.+|+.++..+ +|||||++++++.. +.+|+|||||+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~-~~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEA-ESWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEec-CCEEEEEEccC
Confidence 47999999999999553 5678999999986544444456799999999999 79999999999865 45899999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccC
Q psy14702 201 GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADN 280 (480)
Q Consensus 201 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 280 (480)
+|+|.+++.....+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||++....
T Consensus 453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl------------~~~~~~kL~DFGla~~~~ 520 (635)
T 4fl3_A 453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL------------VTQHYAKISDFGLSKALR 520 (635)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------EETTEEEECCTTHHHHTT
T ss_pred CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE------------eCCCCEEEEEcCCccccc
Confidence 99999999988889999999999999999999999999999999999999 556789999999986543
Q ss_pred CC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCcCCCCCH
Q psy14702 281 DF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEKLSNVSD 348 (480)
Q Consensus 281 ~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~~~~~s~ 348 (480)
.. ....+|+.|+|||++.+..+. .++|||||||++|||+ |..||..... ....+..+. ...+..+++
T Consensus 521 ~~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 599 (635)
T 4fl3_A 521 ADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 599 (635)
T ss_dssp C-------------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccccccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 21 123467889999999877655 7999999999999974 6777765443 344455543 345567999
Q ss_pred HHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
++.+||.+||..||++|||+.+|++..
T Consensus 600 ~l~~li~~cl~~dP~~RPs~~~l~~~L 626 (635)
T 4fl3_A 600 EMYDLMNLCWTYDVENRPGFAAVELRL 626 (635)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 999999999999999999999998653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=341.89 Aligned_cols=248 Identities=20% Similarity=0.310 Sum_probs=190.9
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEeeC--
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-SRVPHIVNYFSSWSDQ-- 189 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~~hpnIv~l~~~~~~~-- 189 (480)
.....+|.+.+.||+|+||.||+|.+ +++.||||++... . ...+.+|.+++..+ .+||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT---E--EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc---c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 34567899999999999999999975 5999999998642 1 12234455554443 2899999999999877
Q ss_pred --CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceecCCCCCcEEEeccCCCCCC
Q psy14702 190 --GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM--------RMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 190 --~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--------~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
..+|+|||||++|+|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill--------- 175 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV--------- 175 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---------
T ss_pred CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---------
Confidence 7899999999999999999764 799999999999999999999998 99999999999999
Q ss_pred CCCccccceEeCccCcccccCCC--------cccCCCcccchhhhhcccCCCCC-----cccHHHHHHHHHHHhCC----
Q psy14702 260 PMNTEKLHYKLGDFGHVIADNDF--------EVEEGDCRYLPKELLNNNFDNLS-----KVDIFALGLTLYEASGV---- 322 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~-----k~DiwSlGvilyel~~~---- 322 (480)
+.++.+||+|||++...... ....||+.|+|||++.+...... ++|||||||++|||+++
T Consensus 176 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~ 252 (337)
T 3mdy_A 176 ---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252 (337)
T ss_dssp ---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred ---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcc
Confidence 56678999999998544322 13469999999999987655422 38999999999997543
Q ss_pred -------CCCCCCc---cchHHH----hcCC-CC-cC-----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 323 -------TPLPKNG---PMWHHI----RDGN-IE-KL-----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 323 -------~p~~~~~---~~~~~i----~~~~-~~-~~-----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.||.... ..+..+ .... .+ .+ ..+++++.+||.+||+.||.+|||+.+++++..-...
T Consensus 253 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 4443221 111111 1111 11 11 1356779999999999999999999999998764443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.88 Aligned_cols=241 Identities=22% Similarity=0.358 Sum_probs=191.9
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-CCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-QGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~~l 194 (480)
..+|.+.+.||+|+||.||+|.+ +|+.||||+++... ..+.+.+|+.++..+ +||||+++++++.. .+.+|+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~l 92 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYI 92 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEcCCCceEE
Confidence 35688899999999999999975 58999999987542 234588999999999 78999999998654 457899
Q ss_pred EeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~------------~~~~~~~l~D 160 (278)
T 1byg_A 93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV------------SEDNVAKVSD 160 (278)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CTTSCEEECC
T ss_pred EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE------------eCCCcEEEee
Confidence 999999999999997654 38999999999999999999999999999999999999 5567899999
Q ss_pred cCcccccCCC-cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCcCCCC
Q psy14702 273 FGHVIADNDF-EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEKLSNV 346 (480)
Q Consensus 273 FG~a~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~~~~~ 346 (480)
||++...... ....+++.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+ ....+..+
T Consensus 161 fg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (278)
T 1byg_A 161 FGLTKEASSTQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGC 239 (278)
T ss_dssp CCC------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTC
T ss_pred ccccccccccccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccC
Confidence 9988654432 234578899999999876554 7899999999999974 6666654432 23334443 23445678
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
++.+.++|.+||..||.+|||+.++++...
T Consensus 240 ~~~l~~li~~~l~~~p~~Rps~~~l~~~L~ 269 (278)
T 1byg_A 240 PPAVYEVMKNCWHLDAAMRPSFLQLREQLE 269 (278)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHHHHHH
Confidence 999999999999999999999999987543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.15 Aligned_cols=250 Identities=20% Similarity=0.194 Sum_probs=189.2
Q ss_pred hhhhhhheeecccCceEEEEE-----EEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CCceeEEeeEEee
Q psy14702 116 ALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSR--VPHIVNYFSSWSD 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~-----~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~--hpnIv~l~~~~~~ 188 (480)
..+|.+.+.||+|+||+||+| .+..+++.||||+++... ...+.+|+.++..+.+ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 456888999999999999999 467789999999997532 2346778888877742 8999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQE-----RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
.+..|||||||++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||++....... ....
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~-~~~~ 217 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD-DEDD 217 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc-cccc
Confidence 9999999999999999999974 457999999999999999999999999999999999999954100000 0012
Q ss_pred cccceEeCccCcccccC------CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchHHHh
Q psy14702 264 EKLHYKLGDFGHVIADN------DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHHIR 336 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~~i~ 336 (480)
..+.+||+|||++.... .....+||+.|+|||++.+..++ .++|||||||++||| +|..||......... .
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~-~ 295 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECK-P 295 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEEE-E
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCcee-e
Confidence 26789999999995432 12335699999999999887655 799999999999996 676777533221100 1
Q ss_pred cCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 337 DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 337 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
....... ..++.+.+++..||+.+|.+|++..+.+.+
T Consensus 296 ~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 296 EGLFRRL-PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp CSCCTTC-SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred chhcccc-CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 1111111 246788999999999999999766555544
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=342.08 Aligned_cols=245 Identities=23% Similarity=0.321 Sum_probs=198.3
Q ss_pred hhhhh-hhheeecccCceEEEEEE----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-
Q psy14702 115 YALEF-LEEELLGSGDFGEVFKCL----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD- 188 (480)
Q Consensus 115 ~~~~y-~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~- 188 (480)
+..+| .+.+.||+|+||+||+|. +..+++.||||+++.. ........+.+|+.++..+ +||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecC
Confidence 34455 789999999999998875 3457899999999864 3445566789999999999 68999999999987
Q ss_pred -CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 189 -QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 189 -~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
...+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~------------~~~~~ 172 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL------------DNDRL 172 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE------------cCCCC
Confidence 46899999999999999999764 59999999999999999999999999999999999999 56678
Q ss_pred eEeCccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---------
Q psy14702 268 YKLGDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--------- 330 (480)
Q Consensus 268 vkL~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--------- 330 (480)
+||+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+| +|..||.....
T Consensus 173 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~ 251 (318)
T 3lxp_A 173 VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251 (318)
T ss_dssp EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred EEECCccccccccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence 999999998655432 223578889999999876554 689999999999997 55556543211
Q ss_pred --------chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 331 --------MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 331 --------~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
....+..+ ..+.+..+++++.+||.+||+.||.+|||+.++++..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 305 (318)
T 3lxp_A 252 QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305 (318)
T ss_dssp CHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 01112222 3345567899999999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=331.55 Aligned_cols=241 Identities=25% Similarity=0.386 Sum_probs=197.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+ .++..||+|.+...... ...+.+|+.++..+ +||||+++++++.. +..|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCccc---HHHHHHHHHHHHhC-CCcCcceEEEEEcC-CCcEE
Confidence 345788899999999999999975 46778999998764333 34588999999999 88999999998864 45899
Q ss_pred EeeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~------------~~~~~~kl~D 152 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV------------SDTLSCKIAD 152 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTSCEEECC
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE------------cCCCCEEECC
Confidence 999999999999986432 69999999999999999999999999999999999999 5667899999
Q ss_pred cCcccccCCCc-----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCc
Q psy14702 273 FGHVIADNDFE-----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEK 342 (480)
Q Consensus 273 FG~a~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~ 342 (480)
||++....... ...+++.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+..+ ....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (279)
T 1qpc_A 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231 (279)
T ss_dssp CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CcccccccCcccccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCC
Confidence 99986554322 23467889999999876554 6899999999999975 5566654432 33344443 2334
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
+..+++++.++|.+||..||++|||+.++++.
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 263 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSV 263 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 56789999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.79 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=196.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+. .+..||||+++..... .+.+.+|+.++..+ +||||+++++++.+ +.+|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCC---HHHHHHHHHHHHhC-CCCCEeeEEEEEcC-CceEE
Confidence 3457888999999999999999865 4567999999864332 34588999999999 78999999999876 67899
Q ss_pred EeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill------------~~~~~~kl~D 323 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV------------GENLVCKVAD 323 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CGGGCEEECC
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE------------CCCCCEEECC
Confidence 99999999999999643 469999999999999999999999999999999999999 5677899999
Q ss_pred cCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCc
Q psy14702 273 FGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEK 342 (480)
Q Consensus 273 FG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~ 342 (480)
||++...... ....+++.|+|||++.+..+. .++|||||||++|||+ |..||..... ....+..+ ..+.
T Consensus 324 fG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 402 (452)
T 1fmk_A 324 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 402 (452)
T ss_dssp CCTTC--------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred CccceecCCCceecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9998654322 123467889999999877554 7899999999999974 5667765432 33444444 3445
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
+..+++.+.+||.+||..||++|||+.++++.
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 67799999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=335.71 Aligned_cols=241 Identities=25% Similarity=0.376 Sum_probs=194.0
Q ss_pred hhhheeecccCceEEEEEEEeeCCcEEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV--ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 119 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
|...+.||+|+||.||+|.. +++.||||++.... ........+.+|+.++..+ +||||+++++++.+.+..|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEecCCceEEEE
Confidence 44558999999999999974 78999999987532 2233456789999999999 7899999999999999999999
Q ss_pred eccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 197 EYCNGGNLENIIQE---RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 197 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili------------~~~~~~kl~Df 177 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL------------DEAFTAKISDF 177 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------CTTCCEEECCC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE------------cCCCcEEEeec
Confidence 99999999999974 3469999999999999999999999999999999999999 56778999999
Q ss_pred CcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--ch----HHHhcC--
Q psy14702 274 GHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MW----HHIRDG-- 338 (480)
Q Consensus 274 G~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~----~~i~~~-- 338 (480)
|++...... ....||+.|+|||++.+.. +.++|||||||++|+| +|..||..... .. ..+...
T Consensus 178 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (307)
T 2nru_A 178 GLARASEKFAQTVMTSRIVGTTAYMAPEALRGEI--TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255 (307)
T ss_dssp TTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEE--CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred ccccccccccccccccccCCCcCcCChHHhcCCC--CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence 998654331 2246899999999987753 3689999999999996 66677754332 11 111111
Q ss_pred --------CCC-cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 339 --------NIE-KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 339 --------~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
... .....+..+.++|.+||..||.+|||+.+++++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~ 302 (307)
T 2nru_A 256 TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302 (307)
T ss_dssp CHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred hhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 111 11234567899999999999999999999998754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=347.01 Aligned_cols=239 Identities=15% Similarity=0.215 Sum_probs=192.3
Q ss_pred hhhhhhheeecccCceEEEEEEEee--------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeE------
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYM--------DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN------ 181 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~------ 181 (480)
..+|.+.+.||+|+||.||+|.+.. .++.||||++... ..+.+|+.++..+ +||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l-~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRA-AKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHH-CCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHh-cccchhhhhhhhc
Confidence 3578899999999999999999887 4889999998754 2477899999999 7888887
Q ss_pred ---------EeeEEee-CCEEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEE
Q psy14702 182 ---------YFSSWSD-QGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANIL 249 (480)
Q Consensus 182 ---------l~~~~~~-~~~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NIL 249 (480)
+++++.. ....|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5667665 78899999999 99999999875 68999999999999999999999999999999999999
Q ss_pred EeccCCCCCCCCCcccc--ceEeCccCcccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHH
Q psy14702 250 IVKAQGELNEPMNTEKL--HYKLGDFGHVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTL 316 (480)
Q Consensus 250 l~~~~~~~~~~~~~~~~--~vkL~DFG~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvil 316 (480)
++ .++ .+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++
T Consensus 192 ~~------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il 258 (352)
T 2jii_A 192 VD------------PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCM 258 (352)
T ss_dssp EE------------TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHH
T ss_pred Ec------------CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHH
Confidence 93 444 8999999998643321 223699999999999887554 789999999999
Q ss_pred HHH-hCCCCCCCCccchHH-------HhcCCCCc------CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 317 YEA-SGVTPLPKNGPMWHH-------IRDGNIEK------LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 317 yel-~~~~p~~~~~~~~~~-------i~~~~~~~------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
|+| +|..||......... +....... +..+++++.+||.+||..||.+|||+.++++...
T Consensus 259 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~ 332 (352)
T 2jii_A 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLE 332 (352)
T ss_dssp HHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHH
T ss_pred HHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHH
Confidence 996 677787654321111 11111111 1357899999999999999999999999987653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=355.32 Aligned_cols=245 Identities=18% Similarity=0.190 Sum_probs=201.4
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+..+++.||||++....... .+.+|+.++..+.+|++|..+..++......||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 4567889999999999999999999999999999887543322 267899999999887888888888889999999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||| +++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||+... +..+.+||+||
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~---------~~~~~vkL~DF 150 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG---------RRANQVYIIDF 150 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG---------GGTTCEEECCC
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC---------CCCCeEEEEeC
Confidence 99999 9999999975 4579999999999999999999999999999999999999431 35678999999
Q ss_pred CcccccCCC-----------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-----chHHHh
Q psy14702 274 GHVIADNDF-----------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-----MWHHIR 336 (480)
Q Consensus 274 G~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-----~~~~i~ 336 (480)
|++...... ....||+.|+|||++.+..+. .++|||||||+|||| +|..||..... .+..+.
T Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (483)
T 3sv0_A 151 GLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (483)
T ss_dssp TTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHH
T ss_pred CcceeccCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHh
Confidence 998654322 145699999999999887654 789999999999996 67788865332 112222
Q ss_pred cCCC-----CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 337 DGNI-----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 337 ~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
.... .....++.++.+||..||..||.+||++.+|++.
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~ 272 (483)
T 3sv0_A 230 EKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRL 272 (483)
T ss_dssp HHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred hccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1111 1125689999999999999999999999998764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=338.14 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=197.7
Q ss_pred hhhhhhheeecccCceEEEEEE----EeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC-
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCL----KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG- 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~- 190 (480)
..+|.+.+.||+|+||.||+|. +..+++.||||++... .....+.+.+|+.++..+ +||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC---
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCC
Confidence 3467889999999999999998 4568999999998763 334456689999999999 7899999999886543
Q ss_pred -EEEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 191 -VLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 191 -~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
.+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli------------~~~~~~ 184 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV------------ENENRV 184 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------EETTEE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE------------cCCCcE
Confidence 789999999999999999875 469999999999999999999999999999999999999 556689
Q ss_pred EeCccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc----------
Q psy14702 269 KLGDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---------- 330 (480)
Q Consensus 269 kL~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---------- 330 (480)
||+|||++...... ....++..|+|||++.+..+. .++|||||||++|+| +|..|+.....
T Consensus 185 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~ 263 (326)
T 2w1i_A 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 263 (326)
T ss_dssp EECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTC
T ss_pred EEecCcchhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhcccc
Confidence 99999998654332 123467789999999876554 689999999999997 55555432210
Q ss_pred --------chHHHhc-CCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 331 --------MWHHIRD-GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 331 --------~~~~i~~-~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
....+.. ...+.+..+++++.+||.+||..||.+|||+.++++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L 317 (326)
T 2w1i_A 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317 (326)
T ss_dssp CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0111222 23445567899999999999999999999999998754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=332.49 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=191.2
Q ss_pred hhhhhhheeecccCceEEEEEEEee-CC--cEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYM-DG--MTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~-~~--~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
..+|.+.+.||+|+||.||+|.+.. ++ ..||||+++.... .....+.+.+|+.++..+ +||||+++++++....
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~- 94 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLTPP- 94 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSSS-
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEccCC-
Confidence 4578889999999999999998653 33 3689998875432 234456789999999999 7999999999998765
Q ss_pred EEEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili------------~~~~~~kl 162 (291)
T 1u46_A 95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL------------ATRDLVKI 162 (291)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------EETTEEEE
T ss_pred ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE------------cCCCCEEE
Confidence 89999999999999999764 569999999999999999999999999999999999999 55668999
Q ss_pred CccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-
Q psy14702 271 GDFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG- 338 (480)
Q Consensus 271 ~DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~- 338 (480)
+|||++...... ....+|+.|+|||++.+..+. .++|||||||++|+|+ |..||..... ....+...
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~ 241 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEG 241 (291)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSC
T ss_pred ccccccccccccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccC
Confidence 999988654322 123477889999999876554 6899999999999974 6667765432 23333333
Q ss_pred -CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 339 -NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 339 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
..+.+..++.++.++|.+||..||.+|||+.+++++..
T Consensus 242 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 280 (291)
T 1u46_A 242 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280 (291)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 23445678999999999999999999999999997643
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=364.97 Aligned_cols=240 Identities=23% Similarity=0.337 Sum_probs=194.5
Q ss_pred hhhhe-eecccCceEEEEEEEee--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 119 FLEEE-LLGSGDFGEVFKCLKYM--DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 119 y~~~~-~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
+.+.+ .||+|+||.||+|.... ++..||||+++.... ....+.+.+|+.++..+ +|||||++++++.. +.+|+|
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTC-CCTTBCCEEEEEES-SSEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc-CCeEEE
Confidence 33344 79999999999998763 567799999976432 23345689999999999 89999999999976 568999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 414 ~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl------------~~~~~vkL~DFG 481 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL------------VNRHYAKISDFG 481 (613)
T ss_dssp EECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------EETTEEEECCCS
T ss_pred EEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE------------cCCCcEEEeecc
Confidence 9999999999999654 469999999999999999999999999999999999999 556789999999
Q ss_pred cccccCCCc-------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCc
Q psy14702 275 HVIADNDFE-------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEK 342 (480)
Q Consensus 275 ~a~~~~~~~-------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~ 342 (480)
++....... ...+|+.|+|||++.+..+. .++|||||||++|||+ |..||..... ....+..+. .+.
T Consensus 482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~ 560 (613)
T 2ozo_A 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560 (613)
T ss_dssp TTTTCC--------------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC
T ss_pred CcccccCCCceeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 987543211 12356889999999877655 7899999999999974 6778765432 344555554 345
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
+..+++++.+||.+||..||++|||+.++++.
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~ 592 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQR 592 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 56799999999999999999999999998643
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.65 Aligned_cols=241 Identities=24% Similarity=0.332 Sum_probs=199.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||.||+|.+. .+..||||+++..... .+.|.+|+.++..+ +||||+++++++.+ +.+||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l-~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCC---HHHHHHHHHHHHhC-CCCCEeeEEEEEee-ccceE
Confidence 3457888999999999999999865 4567999999864332 34588999999999 78999999999876 67899
Q ss_pred EeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 195 QLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll------------~~~~~~kl~D 406 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV------------GENLVCKVAD 406 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CGGGCEEECC
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE------------cCCCcEEEcc
Confidence 99999999999999643 469999999999999999999999999999999999999 5677899999
Q ss_pred cCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-CCCc
Q psy14702 273 FGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-NIEK 342 (480)
Q Consensus 273 FG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-~~~~ 342 (480)
||++...... ....++..|+|||++.+..+. .++|||||||+||||+ |..||..... ....+..+ ..+.
T Consensus 407 FG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~ 485 (535)
T 2h8h_A 407 FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 485 (535)
T ss_dssp TTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cccceecCCCceecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9998755432 223467889999999877554 7899999999999985 5667765432 33444444 3445
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
+..+++++.+||.+||+.||++|||+.+|++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 56799999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=340.05 Aligned_cols=239 Identities=23% Similarity=0.314 Sum_probs=179.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHH--HHhcCCCCceeEEeeEEe-----eC
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA--HALLSRVPHIVNYFSSWS-----DQ 189 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~--l~~l~~hpnIv~l~~~~~-----~~ 189 (480)
.+|.+.+.||+|+||.||+|. .+++.||||++... .. ..+..|..+ +..+ +||||+++++.+. ..
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~---~~--~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFA---NR--QNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEE--ETTEEEEEEEEEGG---GH--HHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSC
T ss_pred HHhheeeecccCCCeEEEEEE--ECCeEEEEEEeecc---ch--hhHHHHHHHHHHHhc-cCcchhhheecccccccCCC
Confidence 467889999999999999996 47999999998642 12 223334333 3335 8999999998553 23
Q ss_pred CEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceecCCCCCcEEEeccCCCCCCC
Q psy14702 190 GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM---------RMIHMDIKPANILIVKAQGELNEP 260 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------~IvHrDlKp~NILl~~~~~~~~~~ 260 (480)
..+|+|||||++|+|.+++... ..++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---------- 153 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---------- 153 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE----------
T ss_pred ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE----------
Confidence 4689999999999999999765 568999999999999999999999 99999999999999
Q ss_pred CCccccceEeCccCcccccCC------------CcccCCCcccchhhhhcccC------CCCCcccHHHHHHHHHHH-hC
Q psy14702 261 MNTEKLHYKLGDFGHVIADND------------FEVEEGDCRYLPKELLNNNF------DNLSKVDIFALGLTLYEA-SG 321 (480)
Q Consensus 261 ~~~~~~~vkL~DFG~a~~~~~------------~~~~~gt~~y~aPE~~~~~~------~~~~k~DiwSlGvilyel-~~ 321 (480)
+.++.+||+|||++..... .....||+.|+|||++.+.. ..+.++|||||||++||| +|
T Consensus 154 --~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 231 (336)
T 3g2f_A 154 --KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231 (336)
T ss_dssp --CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred --cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhc
Confidence 5567899999999865432 11345999999999998631 122579999999999997 45
Q ss_pred CCCCCCCcc----------------chHH----Hhc-CCCCc-CC------CCCHHHHHHHHHhhccCCCCCCChhHHHH
Q psy14702 322 VTPLPKNGP----------------MWHH----IRD-GNIEK-LS------NVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373 (480)
Q Consensus 322 ~~p~~~~~~----------------~~~~----i~~-~~~~~-~~------~~s~~~~~li~~~L~~dP~~Rps~~ell~ 373 (480)
..|+..... .... +.. ...+. +. .+++++.+||.+||..||++|||+.++++
T Consensus 232 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 232 CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp BGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 466543221 0000 000 11111 11 13457999999999999999999999987
Q ss_pred HHH
Q psy14702 374 SAQ 376 (480)
Q Consensus 374 h~~ 376 (480)
...
T Consensus 312 ~L~ 314 (336)
T 3g2f_A 312 RMA 314 (336)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=334.06 Aligned_cols=246 Identities=20% Similarity=0.346 Sum_probs=194.6
Q ss_pred chhhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCCceeEEeeEEeeCC-
Q psy14702 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL-SRVPHIVNYFSSWSDQG- 190 (480)
Q Consensus 113 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l-~~hpnIv~l~~~~~~~~- 190 (480)
.....+|.+.+.||+|+||.||+|.+ +|+.||||++... ....+.+|..++..+ .+||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 34567899999999999999999975 6999999998642 234467788888773 38999999999998776
Q ss_pred ---EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceecCCCCCcEEEeccCCCCCC
Q psy14702 191 ---VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH--------EMRMIHMDIKPANILIVKAQGELNE 259 (480)
Q Consensus 191 ---~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH--------~~~IvHrDlKp~NILl~~~~~~~~~ 259 (480)
.+|+|||||++|+|.+++... .+++..++.++.||+.||.||| ++||+||||||+|||+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll--------- 180 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV--------- 180 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---------
T ss_pred ccceeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---------
Confidence 899999999999999999764 7999999999999999999999 8999999999999999
Q ss_pred CCCccccceEeCccCcccccCCC--------cccCCCcccchhhhhcccCCCC-----CcccHHHHHHHHHHHhCC----
Q psy14702 260 PMNTEKLHYKLGDFGHVIADNDF--------EVEEGDCRYLPKELLNNNFDNL-----SKVDIFALGLTLYEASGV---- 322 (480)
Q Consensus 260 ~~~~~~~~vkL~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~-----~k~DiwSlGvilyel~~~---- 322 (480)
+.++.+||+|||++...... ....||+.|+|||++.+..... .++|||||||++|+|+++
T Consensus 181 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 181 ---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp ---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred ---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 56678999999998644322 2346999999999998753321 479999999999998543
Q ss_pred -------CCCCCCcc-------chHHHhcCCC-CcCC------CCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 323 -------TPLPKNGP-------MWHHIRDGNI-EKLS------NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 323 -------~p~~~~~~-------~~~~i~~~~~-~~~~------~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
.||..... ....+..... +.++ .+++.+.+||.+||+.||++|||+.+++++..-.
T Consensus 258 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp TBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 56644321 1112222211 1111 2345789999999999999999999999986543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=338.92 Aligned_cols=242 Identities=19% Similarity=0.315 Sum_probs=193.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||.||+|.+.. .||+|+++.........+.+.+|+.++..+ +||||+++++++.+.+.+|+||
T Consensus 33 ~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 33 EQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp SCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECSSCEEEEC
T ss_pred HHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecCCceEEEe
Confidence 467789999999999999997643 499999876433333334467899999988 7899999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+||+|||+
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~------------~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY------------D-NGKVVITDFGL 175 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE------------C---CCEECCCSC
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE------------e-CCCEEEeecCC
Confidence 9999999999997654 69999999999999999999999999999999999999 3 35799999998
Q ss_pred ccccC---------CCcccCCCcccchhhhhccc--------CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHH
Q psy14702 276 VIADN---------DFEVEEGDCRYLPKELLNNN--------FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHI 335 (480)
Q Consensus 276 a~~~~---------~~~~~~gt~~y~aPE~~~~~--------~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i 335 (480)
+.... ......||+.|+|||++.+. ...+.++|||||||++|+| +|..||..... ....+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 255 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM 255 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 75432 12234589999999999752 2234689999999999996 67777765432 23334
Q ss_pred hcCCCCcC--CCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 336 RDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 336 ~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..+..+.. ..++.++.++|.+||..||.+|||+.++++..
T Consensus 256 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l 297 (319)
T 2y4i_B 256 GTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297 (319)
T ss_dssp HTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHH
T ss_pred ccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 44433332 35889999999999999999999999998753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=361.09 Aligned_cols=246 Identities=23% Similarity=0.369 Sum_probs=201.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
...+|.+.+.||+|+||.||+|.+..+ +..||+|.++.. ......+.+.+|+.++..+ +||||+++++++. ++.
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEC-SSS
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEe-cCc
Confidence 346788999999999999999987653 467999998753 3344556789999999999 8999999999985 456
Q ss_pred EEEEeeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 192 LYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
+|+|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl------------~~~~~vkL 532 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV------------SSNDCVKL 532 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------EETTEEEE
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE------------eCCCCEEE
Confidence 899999999999999998654 69999999999999999999999999999999999999 55678999
Q ss_pred CccCcccccCCCc-----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-C
Q psy14702 271 GDFGHVIADNDFE-----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-I 340 (480)
Q Consensus 271 ~DFG~a~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~ 340 (480)
+|||++....... ...+|+.|+|||++.+..+. .++|||||||++|||+ |..||..... ....+..+. .
T Consensus 533 ~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~ 611 (656)
T 2j0j_A 533 GDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 611 (656)
T ss_dssp CCCCCCCSCCC----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC
T ss_pred EecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9999987554322 23467899999999877554 7899999999999974 5667765432 333444443 4
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
+.+..+++.+.+||.+||..||.+|||+.++++...
T Consensus 612 ~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~ 647 (656)
T 2j0j_A 612 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 647 (656)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 456779999999999999999999999999987643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=369.14 Aligned_cols=243 Identities=20% Similarity=0.272 Sum_probs=196.9
Q ss_pred hhhhhhhhheeecccCceEEEEEEEee-CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE-
Q psy14702 114 RYALEFLEEELLGSGDFGEVFKCLKYM-DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV- 191 (480)
Q Consensus 114 ~~~~~y~~~~~LG~G~fg~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~- 191 (480)
....+|.+.+.||+|+||.||+|.+.. +|+.||||++... ........+.+|+.++..+ +||||+++++++...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTT
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCC
Confidence 345789999999999999999999876 7899999998753 3344556788999999999 79999999999987654
Q ss_pred ----EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 192 ----LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 192 ----~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
.|||||||+|++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++ .+ .
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~------------~~-~ 219 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT------------EE-Q 219 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC------------SS-C
T ss_pred CCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe------------CC-c
Confidence 7999999999999988765 799999999999999999999999999999999999993 32 7
Q ss_pred eEeCccCcccccCCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCCCCCCCCccchHHHhcCCCCcCCCCC
Q psy14702 268 YKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVS 347 (480)
Q Consensus 268 vkL~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~~p~~~~~~~~~~i~~~~~~~~~~~s 347 (480)
+||+|||++..........||+.|+|||++.+.+ +.++|||||||++|+|+++.|...... ...+. ........+
T Consensus 220 ~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~-~~~~~--~~~~~~~~~ 294 (681)
T 2pzi_A 220 LKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY-VDGLP--EDDPVLKTY 294 (681)
T ss_dssp EEECCCTTCEETTCCSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEE-CSSCC--TTCHHHHHC
T ss_pred EEEEecccchhcccCCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccc-ccccc--ccccccccC
Confidence 9999999998777666778999999999998765 468999999999999865544322211 00000 000111246
Q ss_pred HHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 348 ~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
+.+.+||.+||+.||.+||++.+.+.|+|+.
T Consensus 295 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 295 DSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred HHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 7899999999999999999999999998875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.81 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=200.1
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee------CC
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------QG 190 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------~~ 190 (480)
.+|.+.+.||+|+||.||+|.+..+|+.||||+++.. ........+.+|+.++..+ +||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhC-CCCCCCceeeeecccccccCCC
Confidence 5788999999999999999999899999999998764 3455567789999999999 89999999998765 67
Q ss_pred EEEEEeeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccc
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC---TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~ 267 (480)
..|+|||||+||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+...+ ....
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g---------~~~~ 162 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP---------QRLI 162 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS---------SSCE
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC---------Ccee
Confidence 7899999999999999998643 599999999999999999999999999999999999995432 3446
Q ss_pred eEeCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchH----------
Q psy14702 268 YKLGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWH---------- 333 (480)
Q Consensus 268 vkL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~---------- 333 (480)
+||+|||++...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||........
T Consensus 163 vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 163 HKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp EEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred EEEcccccccccccccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 999999998764432 335699999999999877665 689999999999996 56677754321100
Q ss_pred ------HHhcCC------CCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 334 ------HIRDGN------IEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 334 ------~i~~~~------~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
....+. .+.+ ..+++.+.+||.+||..||.+|||+.++++||||..
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 000011 1111 235688999999999999999999999999999976
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=344.83 Aligned_cols=252 Identities=17% Similarity=0.182 Sum_probs=185.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC------HHHHHHHHHHHHHHHhcC--------CCCceeE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN------TAQEKIFKKEIHAHALLS--------RVPHIVN 181 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~------~~~~~~~~~Ei~~l~~l~--------~hpnIv~ 181 (480)
..+|.+.+.||+|+||+||+|++ +|+.||||++...... ....+.+.+|+.+++.+. .|||||+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999986 7899999998764321 112245778888888775 4677777
Q ss_pred EeeEE-----------------ee-------------CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q psy14702 182 YFSSW-----------------SD-------------QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231 (480)
Q Consensus 182 l~~~~-----------------~~-------------~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ 231 (480)
+.+++ .+ .+.+|||||||++|++.+.+.+ ..+++..++.++.||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 76654 22 6889999999999977666643 57899999999999999999
Q ss_pred HHH-hCCceecCCCCCcEEEeccCCCCC--------CCCCccccceEeCccCcccccCCCcccCCCcccchhhhhcccCC
Q psy14702 232 CMH-EMRMIHMDIKPANILIVKAQGELN--------EPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNNNFD 302 (480)
Q Consensus 232 yLH-~~~IvHrDlKp~NILl~~~~~~~~--------~~~~~~~~~vkL~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~~ 302 (480)
||| ++||+||||||+|||+...+.... .........+||+|||+++..... ...||+.|+|||++.+..
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~gt~~y~aPE~~~g~~- 253 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-IVVFCDVSMDEDLFTGDG- 253 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-EEECCCCTTCSGGGCCCS-
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-cEEEeecccChhhhcCCC-
Confidence 999 999999999999999965321000 000011238999999999765543 447999999999998775
Q ss_pred CCCcccHHHHHHHHH-HH-hCCCCCCCCc---cchHHHh-cCCCC------cCCCCCHHHHHHHHHhhccCCCCCCChhH
Q psy14702 303 NLSKVDIFALGLTLY-EA-SGVTPLPKNG---PMWHHIR-DGNIE------KLSNVSDDLHTLIKLMIDKDPTKRPSTSS 370 (480)
Q Consensus 303 ~~~k~DiwSlGvily-el-~~~~p~~~~~---~~~~~i~-~~~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~e 370 (480)
+.++||||||++.. ++ .|..||.... .....+. ..... .++.+|+++++||.+||++| |+.|
T Consensus 254 -~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e 327 (336)
T 2vuw_A 254 -DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATD 327 (336)
T ss_dssp -SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHH
T ss_pred -ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHH
Confidence 36899999988844 44 4556653210 0111222 11111 12347889999999999987 9999
Q ss_pred HH-HHHHHH
Q psy14702 371 LR-RSAQLA 378 (480)
Q Consensus 371 ll-~h~~~~ 378 (480)
++ +||||+
T Consensus 328 ~l~~Hp~f~ 336 (336)
T 2vuw_A 328 LLCQHSLFK 336 (336)
T ss_dssp HHHHCGGGC
T ss_pred HHhcCCCcC
Confidence 99 999973
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=347.85 Aligned_cols=246 Identities=16% Similarity=0.185 Sum_probs=184.3
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCcee----------------
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIV---------------- 180 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv---------------- 180 (480)
.|...+.||+|+||+||+|.+..+|+.||||++..... .....+.+.+|+.++..+.+++|..
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 46677899999999999999999999999999874322 2222456889999998885433211
Q ss_pred -----EEeeEEee-----CCEEEEEeeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy14702 181 -----NYFSSWSD-----QGVLYLQLEYCNGGNLENIIQE-------RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDI 243 (480)
Q Consensus 181 -----~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDl 243 (480)
.+..++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11111111 23467888877 6799998851 224778889999999999999999999999999
Q ss_pred CCCcEEEeccCCCCCCCCCccccceEeCccCcccccCCC-cccCCCcccchhhhhc----------ccCCCCCcccHHHH
Q psy14702 244 KPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDF-EVEEGDCRYLPKELLN----------NNFDNLSKVDIFAL 312 (480)
Q Consensus 244 Kp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-~~~~gt~~y~aPE~~~----------~~~~~~~k~DiwSl 312 (480)
||+|||+ +.++.+||+|||++...... ...+| +.|+|||++. +..+ +.++|||||
T Consensus 238 Kp~NILl------------~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL------------DQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTL 303 (413)
T ss_dssp CGGGEEE------------CTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHH
T ss_pred ccceEEE------------ecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHH
Confidence 9999999 56678999999998655433 33567 9999999994 2223 368999999
Q ss_pred HHHHHHH-hCCCCCCCCccchHHHhcCCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 313 GLTLYEA-SGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 313 Gvilyel-~~~~p~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
||++|+| +|..||....... ...........+|+++.+||.+||+.||.+|||+.++++||||...
T Consensus 304 Gvil~elltg~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALG--GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGS--CSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHHHHHHCCCCCCCcchhh--hHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999996 6778876543211 1111122335689999999999999999999999999999999763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=318.05 Aligned_cols=224 Identities=13% Similarity=0.077 Sum_probs=183.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
...+|.+.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+..+..+ +||||+++++++...+..|
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEETTEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEECCcEE
Confidence 345788999999999999999999999999999999865443 44456789999999998 8899999999999999999
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||+|++|.+++... ....++..++.||+.||.|||++||+||||||+|||+ +.++.+||+++
T Consensus 108 lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll------------~~~g~~kl~~~ 173 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV------------SIDGDVVLAYP 173 (286)
T ss_dssp EEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE------------ETTSCEEECSC
T ss_pred EEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE------------cCCCCEEEEec
Confidence 999999999999999543 4666788999999999999999999999999999999 55668899855
Q ss_pred CcccccCCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch-----HHHhcCCCC----cC
Q psy14702 274 GHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW-----HHIRDGNIE----KL 343 (480)
Q Consensus 274 G~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~-----~~i~~~~~~----~~ 343 (480)
| |++| .+.++|||||||++|+| +|..||....... .....+... ..
T Consensus 174 ~----------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 174 A----------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229 (286)
T ss_dssp C----------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred c----------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence 4 3443 23689999999999996 6777887654311 011122221 22
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
..+++++.+||.+||+.||.+| |+.++++...-.
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 5689999999999999999999 999999876543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-35 Score=310.65 Aligned_cols=229 Identities=12% Similarity=0.074 Sum_probs=160.4
Q ss_pred eecccCceEEEEEEEeeCCcEEEEEEecCCCCC--------HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 124 LLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN--------TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 124 ~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~--------~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.++.|++|.+..++....|+.||||++.+.... ....+.|.+|+.+|+.+.+|+||+++++++++++.+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 467888888888888889999999998764211 223456999999999999999999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+|++|.++|.+.+++++. .|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL------------~~dg~vKL~DFGl 385 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV------------DARQHARLIDFGS 385 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE------------CCCCCEEEeeccc
Confidence 9999999999999988888875 488999999999999999999999999999 5677899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCCCCCCCCccchHHHhcCCCCcCCCCCHHHH
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLH 351 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~~p~~~~~~~~~~i~~~~~~~~~~~s~~~~ 351 (480)
|+.... ....+||+.|||||++.+... .++|+||+|+++|++....+ .....+..... ....+.
T Consensus 386 Ar~~~~~~~~~~t~vGTp~YmAPE~l~g~~~--~~~d~~s~g~~~~~l~~~~~-----~~~~~l~~~~~-----~~~~~~ 453 (569)
T 4azs_A 386 IVTTPQDCSWPTNLVQSFFVFVNELFAENKS--WNGFWRSAPVHPFNLPQPWS-----NWLYAVWQEPV-----ERWNFV 453 (569)
T ss_dssp EESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH-----HHHHHHHTSCG-----GGCSHH
T ss_pred CeeCCCCCccccCceechhhccHHHhCCCCC--Ccccccccccchhhhccccc-----hhHHHhhcCCC-----CCCcHH
Confidence 875543 234579999999999987654 47999999999887532110 11111111111 111356
Q ss_pred HHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 352 TLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 352 ~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.+...+...+|..||.......++|...
T Consensus 454 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 481 (569)
T 4azs_A 454 LLLALFEKKAKLPSAEQQRGATEQWIIA 481 (569)
T ss_dssp HHHHHHHTGGGSCCGGGSSCCHHHHHHH
T ss_pred HHHHHHhCCCCCCCCChhhhccchhHHH
Confidence 7778888899999999888888888654
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=261.97 Aligned_cols=173 Identities=17% Similarity=0.171 Sum_probs=133.9
Q ss_pred hhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-H-----HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-T-----AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 120 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~-----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
...+.||+|+||.||+| ...+..+|+|+....... . ...+.+.+|+.++..+ +||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeCCccE
Confidence 44678999999999999 457889999986543222 1 1235589999999999 8899996555555677779
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||+ +. .+||+||
T Consensus 416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl------------~~--~~kL~DF 473 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF------------DK--DLYIIDF 473 (540)
T ss_dssp EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE------------SS--SEEECCC
T ss_pred EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE------------CC--eEEEEEC
Confidence 99999999999999865 56899999999999999999999999999999 44 8999999
Q ss_pred CcccccCCC-----------cccCCCcccchhhhhcc--cCCCCCcccHHHHHHHHHH
Q psy14702 274 GHVIADNDF-----------EVEEGDCRYLPKELLNN--NFDNLSKVDIFALGLTLYE 318 (480)
Q Consensus 274 G~a~~~~~~-----------~~~~gt~~y~aPE~~~~--~~~~~~k~DiwSlGvilye 318 (480)
|+++..... ....||+.|||||++.. ..|. ..+|+||..+-..+
T Consensus 474 Gla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~ 530 (540)
T 3en9_A 474 GLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMK 530 (540)
T ss_dssp TTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHH
T ss_pred ccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHH
Confidence 999776542 24569999999999986 3333 46899999887776
|
| >3ecr_A Porphobilinogen deaminase; heme biosynthesis, porphobilinogen hinge, alternative splicing, cytoplasm, disease mutation, porphyrin biosynthesis; HET: DPM; 2.18A {Homo sapiens} PDB: 3eq1_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=234.16 Aligned_cols=94 Identities=63% Similarity=0.935 Sum_probs=70.8
Q ss_pred CCcCCcccccccCcccCCccchHHHHHHHHhcCCcceeecccCCCCCCCCCCcccceeccCCCcccceeecccCCCcccc
Q psy14702 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILEREDPRDALILNKKWSGKTLA 80 (480)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~s~kd~p~~~~~~~~~~a~~~r~~p~d~~~~~~~~~~k~l~ 80 (480)
|+|+||+++|+||++||||||||||||.||++|+||+|||||||||+.+|+|+.++|+++|+||||+||++..+.++++.
T Consensus 59 i~T~GD~ild~pL~~iGgKGlFtkELe~ALl~g~iDiAVHSlKDvPt~lp~gl~l~av~~ReDprDalV~~~~~~~~~l~ 138 (364)
T 3ecr_A 59 MSTTGDKILDTALSKIGEKSLFTKELEHALEKNEVDLVVHSLKDLPTVLPPGFTIGAICKRENPHDAVVFHPKFVGKTLE 138 (364)
T ss_dssp C-------------------CCHHHHHHHHHTTSCSEEEEEGGGSCSSCCTTEEEEEECCCCCCCEEEEECTTCTTCCTT
T ss_pred eeccCccccCCcHHHcCCceeeHHHHHHHHhcCCCCEEEECcccCCCCCCCCcEEEEEcCCCCcceEEEEcCccCCCChh
Confidence 78999999999999999999999999999999999999999999999999999999999999999999999766678999
Q ss_pred cCCCCCccCCCCCC
Q psy14702 81 TLPSGSVIDEDSGD 94 (480)
Q Consensus 81 slpsgs~~~~~s~~ 94 (480)
.+|.++++.++|..
T Consensus 139 ~LP~Ga~VGTSSlR 152 (364)
T 3ecr_A 139 TLPEKSVVGTSSLR 152 (364)
T ss_dssp TSCTTCEEECCCHH
T ss_pred HCCCcCEEeCCcHH
Confidence 99999999998753
|
| >1gtk_A Porphobilinogen deaminase; lyase, biosynthesis of linear tetrapyrrole, all alpha/beta; HET: DPM; 1.66A {Escherichia coli} SCOP: c.94.1.1 d.50.2.1 PDB: 1ah5_A* 2ypn_A* 1ypn_A* 1pda_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-28 Score=230.83 Aligned_cols=90 Identities=52% Similarity=0.803 Sum_probs=69.2
Q ss_pred CCcCCcccccccCcccCCccchHHHHHHHHhcCCcceeecccCCCCCCCCCCcccceeccCCCcccceeecccCCCcccc
Q psy14702 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILEREDPRDALILNKKWSGKTLA 80 (480)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~s~kd~p~~~~~~~~~~a~~~r~~p~d~~~~~~~~~~k~l~ 80 (480)
|+|+||+++|+||++||||||||||||.||++|+||+|||||||||+.+|+|+.++|+++|+||||+||++. +.++.
T Consensus 41 i~T~GD~i~d~pL~~iGgkGlFtkELe~aLl~g~iDiAVHSlKDvPt~lp~gl~l~av~~RedprDalV~~~---~~~l~ 117 (313)
T 1gtk_A 41 MVTRGDVILDTPLAKVGGKGLFVKELEVALLENRADIAVHSMKDVPVEFPQGLGLVTICEREDPRDAFVSNN---YDSLD 117 (313)
T ss_dssp CC-----------------CTTHHHHHHHHHTTSCSEEEEEGGGSCSCCCTTEEEEEECCCCCCCEEEECSS---CSSGG
T ss_pred eecCCcccccccHHHcCCccchHHHHHHHHHcCCCcEEEecCCCCCCCCCCCcEEEEEecCCCcceEEEECC---CCChh
Confidence 789999999999999999999999999999999999999999999999999999999999999999999886 46789
Q ss_pred cCCCCCccCCCCC
Q psy14702 81 TLPSGSVIDEDSG 93 (480)
Q Consensus 81 slpsgs~~~~~s~ 93 (480)
.+|.++++.++|.
T Consensus 118 ~LP~Ga~VGTSSl 130 (313)
T 1gtk_A 118 ALPAGSIVGTSSL 130 (313)
T ss_dssp GCCTTCEEECCCH
T ss_pred hCCCCCEEecCCH
Confidence 9999999999875
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=217.15 Aligned_cols=146 Identities=16% Similarity=0.121 Sum_probs=115.0
Q ss_pred hhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----------------HHHHHHHHHHHHHHhcCCCCceeEE
Q psy14702 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----------------AQEKIFKKEIHAHALLSRVPHIVNY 182 (480)
Q Consensus 119 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----------------~~~~~~~~Ei~~l~~l~~hpnIv~l 182 (480)
|.+.+.||+|+||.||+|.+ .+|+.||||+++...... .....+.+|+.++..+. |+++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v--- 166 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAV--- 166 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSS---
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCc---
Confidence 44569999999999999998 889999999986432111 13456889999999996 4444
Q ss_pred eeEEeeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCC
Q psy14702 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMN 262 (480)
Q Consensus 183 ~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~ 262 (480)
.+++.. +..|+|||||+|++|.+ +. . .....++.||+.||.|||++||+||||||+|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl------------ 226 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VR----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV------------ 226 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE------------
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cc----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE------------
Confidence 444433 45699999999999987 32 1 2345799999999999999999999999999999
Q ss_pred ccccceEeCccCcccccCCCcccCCCcccchhhhhcc
Q psy14702 263 TEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELLNN 299 (480)
Q Consensus 263 ~~~~~vkL~DFG~a~~~~~~~~~~gt~~y~aPE~~~~ 299 (480)
+ ++.+||+|||++.. +..|+|||++..
T Consensus 227 ~-~~~vkl~DFG~a~~---------~~~~~a~e~l~r 253 (282)
T 1zar_A 227 S-EEGIWIIDFPQSVE---------VGEEGWREILER 253 (282)
T ss_dssp E-TTEEEECCCTTCEE---------TTSTTHHHHHHH
T ss_pred E-CCcEEEEECCCCeE---------CCCCCHHHHHHH
Confidence 5 66899999999863 456789998853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=8.9e-22 Score=187.30 Aligned_cols=139 Identities=17% Similarity=0.221 Sum_probs=105.5
Q ss_pred hhhheeecccCceEEEEEEEeeCCcE--EEEEEecCCCCC----------------------HHHHHHHHHHHHHHHhcC
Q psy14702 119 FLEEELLGSGDFGEVFKCLKYMDGMT--YAVKRTKRPVAN----------------------TAQEKIFKKEIHAHALLS 174 (480)
Q Consensus 119 y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~~~----------------------~~~~~~~~~Ei~~l~~l~ 174 (480)
|.+.+.||+|+||.||+|.+..+|+. ||||+++..... ......+.+|+.++..+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l- 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA- 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH-
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH-
Confidence 55678999999999999998789999 999987543211 01123578899999988
Q ss_pred CCCc--eeEEeeEEeeCCEEEEEeeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCC
Q psy14702 175 RVPH--IVNYFSSWSDQGVLYLQLEYCNG-G----NLENIIQERCTFTEMALKQLLFQVSEGLRCMH-EMRMIHMDIKPA 246 (480)
Q Consensus 175 ~hpn--Iv~l~~~~~~~~~~~lv~E~~~g-g----~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH-~~~IvHrDlKp~ 246 (480)
+|++ +...+.. +..|||||||.+ | +|.++... .++..+..++.||+.||.||| +.||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 4454 3333332 246899999942 3 77766432 345577899999999999999 999999999999
Q ss_pred cEEEeccCCCCCCCCCccccceEeCccCccccc
Q psy14702 247 NILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD 279 (480)
Q Consensus 247 NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 279 (480)
|||+ +. .++|+|||+|...
T Consensus 201 NILl------------~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 201 NIMY------------ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SEEE------------SS--SEEECCCTTCEET
T ss_pred HEEE------------cC--cEEEEECcccccC
Confidence 9999 44 7999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.7e-18 Score=171.73 Aligned_cols=147 Identities=12% Similarity=0.090 Sum_probs=98.8
Q ss_pred hhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC---------------CHHH-----HHHHHHHHHHHHhcCCCCc
Q psy14702 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA---------------NTAQ-----EKIFKKEIHAHALLSRVPH 178 (480)
Q Consensus 119 y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~---------------~~~~-----~~~~~~Ei~~l~~l~~hpn 178 (480)
|.+...||+|+||.||+|.+ .+|+.||||+++.... .... .....+|...+..+ ++.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HHTT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-HhcC
Confidence 77889999999999999986 4799999998753211 0000 11124566666666 3233
Q ss_pred e--eEEeeEEeeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCC
Q psy14702 179 I--VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGE 256 (480)
Q Consensus 179 I--v~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~ 256 (480)
+ ...++. .. .+|||||++|++|.++. ....+..++.||+.+|.|||+.|||||||||.|||+..++..
T Consensus 175 v~vp~p~~~--~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ--SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE--ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec--cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 2 222221 22 37999999998886542 223456789999999999999999999999999999764321
Q ss_pred CCCCCCccccceEeCccCccccc
Q psy14702 257 LNEPMNTEKLHYKLGDFGHVIAD 279 (480)
Q Consensus 257 ~~~~~~~~~~~vkL~DFG~a~~~ 279 (480)
. ........+.|+||+.+...
T Consensus 245 ~--d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 E--DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp S--CTTSEEEEEEECCCTTCEET
T ss_pred c--cccccccceEEEEeCCcccC
Confidence 0 00011235889999976543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=1.3e-12 Score=123.79 Aligned_cols=139 Identities=14% Similarity=0.107 Sum_probs=108.2
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
..|.+...++.|+++.||++. ..+..+++|+........ ...+.+|+.++..+..+.++.++++++...+..|+||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~--~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEE--CCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 346677888999999999985 347899999986421111 1237789999999876778889999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy14702 197 EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE----------------------------------------- 235 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~----------------------------------------- 235 (480)
||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999987521 223344788999999999998
Q ss_pred ------------------CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 236 ------------------MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 236 ------------------~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
..++|+|++|.|||+ +....+.|+||+.+
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~------------~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV------------KDGKVSGFIDLGRS 211 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE------------ETTEEEEECCCTTC
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE------------ECCcEEEEEEchhc
Confidence 458999999999999 33345679999865
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=4e-11 Score=113.04 Aligned_cols=126 Identities=15% Similarity=0.125 Sum_probs=92.3
Q ss_pred cccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCC-ceeEEeeEEeeCCEEEEEeeccCCCCH
Q psy14702 126 GSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP-HIVNYFSSWSDQGVLYLQLEYCNGGNL 204 (480)
Q Consensus 126 G~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-nIv~l~~~~~~~~~~~lv~E~~~gg~L 204 (480)
+.|..+.||++. ..+|..+++|....... ..+.+|+.++..+.++. .+.+++.+....+..|+||||++|.+|
T Consensus 29 ~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~-----~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 29 IGCSDAAVFRLS-AQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp CTTSSCEEEEEE-CTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCCCceEEEEe-cCCCCeEEEEeCCcccc-----hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 466679999984 35677899998765311 23667888888885552 266788888887889999999999888
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------------
Q psy14702 205 ENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR----------------------------------------------- 237 (480)
Q Consensus 205 ~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~----------------------------------------------- 237 (480)
. .. ... ...++.+++..|..||+..
T Consensus 103 ~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 174 (264)
T 1nd4_A 103 L--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 174 (264)
T ss_dssp T--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred C--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHH
Confidence 4 11 122 2256777888888888643
Q ss_pred -----------ceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCccc
Q psy14702 238 -----------MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI 277 (480)
Q Consensus 238 -----------IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~ 277 (480)
++|+|++|.|||+ +....+.|+|||.+.
T Consensus 175 ~~~~~~~~~~~l~HgDl~~~Nil~------------~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 175 KARMPDGEDLVVTHGDACLPNIMV------------ENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEE------------ETTEEEEECCCTTCE
T ss_pred HHhcCCCCCeEEECCCCCCCcEEE------------ECCcEEEEEcchhcc
Confidence 9999999999999 334456799999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-10 Score=112.99 Aligned_cols=142 Identities=15% Similarity=0.224 Sum_probs=102.3
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEec--CCCCCHHHHHHHHHHHHHHHhcCC-CCceeEEeeEEeeC---CEEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTK--RPVANTAQEKIFKKEIHAHALLSR-VPHIVNYFSSWSDQ---GVLYLQ 195 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~~~Ei~~l~~l~~-hpnIv~l~~~~~~~---~~~~lv 195 (480)
.+.|+.|.++.||++.. .+..+++|+.. ... .......+.+|..++..+.. +..+.+++.++.+. +..|+|
T Consensus 43 ~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEEC--SSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred EEEcCCcccceEEEEEE--CCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 57799999999999753 45678898765 221 11123457789999998854 34578888887766 458999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE---------------------------------------- 235 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~---------------------------------------- 235 (480)
|||++|..+.+.. ...++..+...++.+++..|..||+
T Consensus 120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9999998774321 1247788888999999999999997
Q ss_pred ------------------CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccc
Q psy14702 236 ------------------MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA 278 (480)
Q Consensus 236 ------------------~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 278 (480)
..++|+|++|.|||+... ....+.|+||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~----------~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT----------EPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS----------SSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC----------CCcEEEEECcccccc
Confidence 358999999999999431 112468999997653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=1e-09 Score=106.26 Aligned_cols=138 Identities=14% Similarity=0.156 Sum_probs=98.7
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCc--eeEEeeEEeeCC---EEEEEe
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH--IVNYFSSWSDQG---VLYLQL 196 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpn--Iv~l~~~~~~~~---~~~lv~ 196 (480)
.+.++.|.+..||++. ..+++|+... ......+.+|...+..+..+.. +.+.+....... ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 3568999999999852 4588998643 2334568889999988754332 344444433332 358999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy14702 197 EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE----------------------------------------- 235 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~----------------------------------------- 235 (480)
++++|.+|...... .++..+...++.|++..|..||+
T Consensus 96 ~~i~G~~l~~~~~~--~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN--NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHHH--TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCccccc--cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999888754332 47788888889999999988886
Q ss_pred -----------------CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccC
Q psy14702 236 -----------------MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADN 280 (480)
Q Consensus 236 -----------------~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 280 (480)
..++|+|++|.|||+... ....+.|+||+.+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~----------~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE----------KNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT----------TTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCC----------CCCEEEEEeCCCCccCC
Confidence 137999999999999431 14467899999875543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=9.8e-07 Score=85.30 Aligned_cols=103 Identities=18% Similarity=0.168 Sum_probs=69.0
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-C-ceeEEeeEEe-eCCEEEEEeec
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-P-HIVNYFSSWS-DQGVLYLQLEY 198 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-p-nIv~l~~~~~-~~~~~~lv~E~ 198 (480)
.+.++.|....||+. |..+++|+.. .......+.+|..++..+.+| + .|.+.+.+.. ..+..|+||||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 466889999999986 5678888743 223345688999999998654 2 2555555553 45567899999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q psy14702 199 CNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE 235 (480)
Q Consensus 199 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~ 235 (480)
++|.+|....- ..++..+...++.|+...|..||+
T Consensus 95 i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~ 129 (306)
T 3tdw_A 95 VQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSA 129 (306)
T ss_dssp CCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhc
Confidence 99988876322 134555555556666666655554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.6e-06 Score=81.84 Aligned_cols=134 Identities=14% Similarity=0.093 Sum_probs=94.1
Q ss_pred eecccCce-EEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeeccCCC
Q psy14702 124 LLGSGDFG-EVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGG 202 (480)
Q Consensus 124 ~LG~G~fg-~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~~~gg 202 (480)
.+..|..| .||+......+..+.+|+-... ....+.+|...+..+..+--|.+++.++.+.+..|+|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 34445444 7998766666778999986531 23457789999988866545778888888899999999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------------
Q psy14702 203 NLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM---------------------------------------------- 236 (480)
Q Consensus 203 ~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~---------------------------------------------- 236 (480)
++.+..... ......+..++...|.-||+.
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887765431 122234555566666666520
Q ss_pred ------------CceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccc
Q psy14702 237 ------------RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA 278 (480)
Q Consensus 237 ------------~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 278 (480)
.++|+|+.|.|||+ +....+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~------------~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIF------------DEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEE------------ETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEE------------ECCeEEEEEECccccc
Confidence 27899999999999 4444567999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=8.5e-06 Score=81.60 Aligned_cols=79 Identities=15% Similarity=0.096 Sum_probs=48.1
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCC--CH---HHHHHHHHHHHHHHhcCCC-C-ceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA--NT---AQEKIFKKEIHAHALLSRV-P-HIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~--~~---~~~~~~~~Ei~~l~~l~~h-p-nIv~l~~~~~~~~~~~l 194 (480)
.+.||.|.++.||++....+++.|+||....... .. .....+..|..++..+..+ | .+.+++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 4679999999999996555678899998653211 00 0112356687787776432 3 34455543 3444689
Q ss_pred EeeccCCC
Q psy14702 195 QLEYCNGG 202 (480)
Q Consensus 195 v~E~~~gg 202 (480)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=5.2e-06 Score=81.78 Aligned_cols=83 Identities=8% Similarity=0.025 Sum_probs=51.5
Q ss_pred heee-cccCceEEEEEEEee------CCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeeC--
Q psy14702 122 EELL-GSGDFGEVFKCLKYM------DGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQ-- 189 (480)
Q Consensus 122 ~~~L-G~G~fg~V~~~~~~~------~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~-- 189 (480)
.+.| +.|....+|+..... ++..+++|+...... .......+.+|..++..+..+ -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 889999999875421 266788997643210 000012355677777766443 2466777766554
Q ss_pred -CEEEEEeeccCCCCH
Q psy14702 190 -GVLYLQLEYCNGGNL 204 (480)
Q Consensus 190 -~~~~lv~E~~~gg~L 204 (480)
+..|+||||++|..+
T Consensus 105 ~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVP 120 (357)
T ss_dssp TSSCEEEEECCCCBCC
T ss_pred cCCceEEEEecCCCCh
Confidence 356899999988654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=0.00016 Score=70.19 Aligned_cols=75 Identities=20% Similarity=0.298 Sum_probs=41.1
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC----CCCceeEEe-e--EEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS----RVPHIVNYF-S--SWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~----~hpnIv~l~-~--~~~~~~~~~l 194 (480)
.+.|+.|..+.||++.. .+..+++|+.... .. .+..|..++..|. ..|.++... + +....+..|+
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~~---~~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~ 108 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHRP---EK---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFV 108 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECSC---HH---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEE
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCCC---HH---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEE
Confidence 45677778899999853 3445999988752 11 1233444444332 224444311 1 1234677899
Q ss_pred EeeccCCCCH
Q psy14702 195 QLEYCNGGNL 204 (480)
Q Consensus 195 v~E~~~gg~L 204 (480)
+|+|++|.++
T Consensus 109 l~~~i~G~~~ 118 (346)
T 2q83_A 109 VYDWIEGRPF 118 (346)
T ss_dssp EEECCCCBCC
T ss_pred EEEeecCccC
Confidence 9999998643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00015 Score=72.98 Aligned_cols=76 Identities=12% Similarity=0.121 Sum_probs=43.5
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCC-----CC-C-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP-----VA-N-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~-----~~-~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+.||.|..+.||++. .++..++||..... .. . ......+..|+..+..-.....+.+++.+. .+..++
T Consensus 39 i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 4678999999999984 35678999943211 00 0 001122333433322111223456666554 456789
Q ss_pred Eeecc-CC
Q psy14702 195 QLEYC-NG 201 (480)
Q Consensus 195 v~E~~-~g 201 (480)
||||+ +|
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00032 Score=67.59 Aligned_cols=76 Identities=26% Similarity=0.291 Sum_probs=58.2
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeeCCEEEEEeecc
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEYC 199 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~~~lv~E~~ 199 (480)
.+.|+.|....+|+.. .++..+++|+.... ....+..|...+..|..+ ..+.+.+.+....+..|+||||+
T Consensus 41 ~~~l~gG~~n~~y~v~--~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIN--DEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEE--SSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEE--ECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 4678999999999975 35778899987532 134577888888877433 56778888877778899999999
Q ss_pred CCCCH
Q psy14702 200 NGGNL 204 (480)
Q Consensus 200 ~gg~L 204 (480)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.56 E-value=0.00085 Score=60.30 Aligned_cols=135 Identities=18% Similarity=0.150 Sum_probs=82.1
Q ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCccccc
Q psy14702 202 GNLENIIQER-CTFTEMALKQLLFQVSEGLRCMH-EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIAD 279 (480)
Q Consensus 202 g~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH-~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 279 (480)
-+|.++|+.. .+++|+++|.++.|.+.+|.-+- ...-..+=+-|..|++. .+|.|.+.+ +.+
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~------------~dG~V~f~~-~~s--- 96 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW------------RDGAVTLAP-AAD--- 96 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE------------TTSCEEECC-C-----
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe------------cCCceeccc-ccc---
Confidence 4899999754 58999999999999999987662 11111233345777773 344455442 110
Q ss_pred CCCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhCCCCCCCCccchHHHhcCCCCcCCCCCHHHHHHHHHhhc
Q psy14702 280 NDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMID 359 (480)
Q Consensus 280 ~~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~~~p~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 359 (480)
......+.|||.... ..+.+.=|||||+++|..+...- +. .....+|+++..||..|..
T Consensus 97 -----~~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL-~e-------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 97 -----DAGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGL-KE-------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------------CCSSS--SSCHHHHHHHHHHHHHHHHTTTC-CT-------------TEEECCCHHHHHHHHHHTT
T ss_pred -----cccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCC-Cc-------------ccchhhCHHHHHHHHHHHh
Confidence 012335678887642 22256789999999998543211 11 1124589999999999986
Q ss_pred c-------------------------CCCCCCChhHHHH
Q psy14702 360 K-------------------------DPTKRPSTSSLRR 373 (480)
Q Consensus 360 ~-------------------------dP~~Rps~~ell~ 373 (480)
- .+..|++..+|++
T Consensus 156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp CCC--------------------CCSCCCCCCSHHHHHH
T ss_pred cccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 5 2457888888864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00098 Score=63.72 Aligned_cols=72 Identities=8% Similarity=-0.068 Sum_probs=41.9
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeecc-C
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYC-N 200 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~~-~ 200 (480)
.+.|+.|....+|++ ..+++|+........ ....+|...+..+..+.-..+++... ...-++++||+ +
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~---~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~ 91 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY---INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAG 91 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----C---CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccce---eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCC
Confidence 577899999999997 458888875421110 11234666666554332224555443 32346899999 6
Q ss_pred CCCH
Q psy14702 201 GGNL 204 (480)
Q Consensus 201 gg~L 204 (480)
|.+|
T Consensus 92 g~~l 95 (301)
T 3dxq_A 92 AQTM 95 (301)
T ss_dssp CEEC
T ss_pred CccC
Confidence 6544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.001 Score=64.11 Aligned_cols=76 Identities=9% Similarity=-0.055 Sum_probs=42.0
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC----CceeEEe-e--EEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV----PHIVNYF-S--SWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h----pnIv~l~-~--~~~~~~~~~l 194 (480)
.+.|+.|....+|++.. .+| .+++|....... ...+..|+.++..|..+ |.++... + +....+..++
T Consensus 27 ~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEECC---EEEEEEEE-SSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eeccCCCcccceEEEEe-CCc-cEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 46688898899999853 233 688998765211 12244566666655332 3333211 1 1123467899
Q ss_pred EeeccCCCC
Q psy14702 195 QLEYCNGGN 203 (480)
Q Consensus 195 v~E~~~gg~ 203 (480)
+|+|++|..
T Consensus 101 l~~~l~G~~ 109 (322)
T 2ppq_A 101 LISFLEGMW 109 (322)
T ss_dssp EEECCCCBC
T ss_pred EEEeCCCcC
Confidence 999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0016 Score=63.18 Aligned_cols=78 Identities=9% Similarity=0.016 Sum_probs=36.7
Q ss_pred eeecccCceE-EEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-CceeEEeeEEeeCCEEEEEeeccC
Q psy14702 123 ELLGSGDFGE-VFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-PHIVNYFSSWSDQGVLYLQLEYCN 200 (480)
Q Consensus 123 ~~LG~G~fg~-V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~~~~~~~~lv~E~~~ 200 (480)
+.|+.|+... +|+.. ..+|..+++|....... ..+..|+.++..+..+ -.+.+++.+....+ +++||++.
T Consensus 24 ~~l~gg~s~~~~~r~~-~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLR-SPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEE-CTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEE-cCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCC
Confidence 4565555444 56653 22366777876543210 1133455555555332 23455555433334 68999997
Q ss_pred CCCHHHHH
Q psy14702 201 GGNLENII 208 (480)
Q Consensus 201 gg~L~~~l 208 (480)
+..+.+.+
T Consensus 96 ~~~l~~~l 103 (333)
T 3csv_A 96 DALFTEVI 103 (333)
T ss_dssp SCBHHHHH
T ss_pred CcchHHHh
Confidence 76665443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0044 Score=58.66 Aligned_cols=76 Identities=16% Similarity=0.180 Sum_probs=51.2
Q ss_pred hheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeeCCEEEEEeec
Q psy14702 121 EEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYLQLEY 198 (480)
Q Consensus 121 ~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~~~lv~E~ 198 (480)
..+.+|.|..+.||+.. ..+|+.|.+|+........ ...|..|...|+.|... --+.+.+.+ .. -++||||
T Consensus 19 ~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~ 91 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW 91 (288)
T ss_dssp EEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred EEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence 35779999999999985 4688999999865432211 23467888888887543 124444443 22 3789999
Q ss_pred cCCCC
Q psy14702 199 CNGGN 203 (480)
Q Consensus 199 ~~gg~ 203 (480)
+.++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 88764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.004 Score=60.03 Aligned_cols=76 Identities=13% Similarity=0.065 Sum_probs=45.6
Q ss_pred eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-CceeEEeeE-----EeeCCEEEEEe
Q psy14702 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-PHIVNYFSS-----WSDQGVLYLQL 196 (480)
Q Consensus 123 ~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~-----~~~~~~~~lv~ 196 (480)
..|+ |....||++. ..+|+.+++|......... ..+..|...+..+..+ -.+.+++.. ....+..+++|
T Consensus 32 ~~l~-g~~n~~y~v~-~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQ-DEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEEC-CTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEE-cCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 4577 7788999864 2356679999986332222 2355576666665432 123333332 22356778999
Q ss_pred eccCCCC
Q psy14702 197 EYCNGGN 203 (480)
Q Consensus 197 E~~~gg~ 203 (480)
++++|..
T Consensus 107 ~~i~G~~ 113 (328)
T 1zyl_A 107 PSVGGRQ 113 (328)
T ss_dssp ECCCCEE
T ss_pred EecCCCC
Confidence 9998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0035 Score=63.22 Aligned_cols=74 Identities=16% Similarity=0.078 Sum_probs=48.3
Q ss_pred heeecccCceEEEEEEEee-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYM-------DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+.|+.|....||++.... .+..+.+|+.... .. ...+.+|..++..|..+.-..++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 5678889999999986432 2578999987432 11 12244688888777554334566665542 28
Q ss_pred EeeccCCCC
Q psy14702 195 QLEYCNGGN 203 (480)
Q Consensus 195 v~E~~~gg~ 203 (480)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.68 E-value=0.0025 Score=63.12 Aligned_cols=140 Identities=14% Similarity=0.112 Sum_probs=78.3
Q ss_pred heeecccCceEEEEEEEee-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYM-------DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+.|..|-...+|++.... .+..|.+|+....... ...+.+|..+++.|..+.-..++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 4667778888899986431 3478999985321111 23355788888877654444566666543 28
Q ss_pred EeeccCCCCHH--------------HHH---Hhc-C----CC--CHHHHHHHHHHHHH-------------------HHH
Q psy14702 195 QLEYCNGGNLE--------------NII---QER-C----TF--TEMALKQLLFQVSE-------------------GLR 231 (480)
Q Consensus 195 v~E~~~gg~L~--------------~~l---~~~-~----~l--~~~~~~~i~~qi~~-------------------aL~ 231 (480)
||||++|.+|. +.| +.- . .. -+.++..++.++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 99999875442 111 111 0 11 23455556554422 233
Q ss_pred HHH----h----CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 232 CMH----E----MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 232 yLH----~----~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
.|. . ..++|+|+.+.|||+.... +....+.|+||..+
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~--------~~~~~~~~IDwE~a 252 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEP--------ENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC-----------CCEEECCCTTC
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCC--------CccCcEEEEecccC
Confidence 333 2 2599999999999995321 12357899999765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.47 E-value=0.017 Score=56.19 Aligned_cols=69 Identities=10% Similarity=0.066 Sum_probs=40.1
Q ss_pred cccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCCceeEEeeE------EeeCCEEEEEee
Q psy14702 126 GSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS--RVPHIVNYFSS------WSDQGVLYLQLE 197 (480)
Q Consensus 126 G~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~------~~~~~~~~lv~E 197 (480)
|.|....||++.. .+| .+++|+...... ..|+..+..|. .-|++.+.+.. ....+..+++|+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~ 101 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYP 101 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEE
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEe
Confidence 3444678999752 345 899998765331 12333343332 22334444432 234577899999
Q ss_pred ccCCCCH
Q psy14702 198 YCNGGNL 204 (480)
Q Consensus 198 ~~~gg~L 204 (480)
|++|..+
T Consensus 102 ~i~G~~~ 108 (339)
T 3i1a_A 102 FIHAPNG 108 (339)
T ss_dssp CCCCCBT
T ss_pred ccCCCcC
Confidence 9998755
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0048 Score=60.73 Aligned_cols=75 Identities=12% Similarity=0.016 Sum_probs=41.7
Q ss_pred heeecccCceEEEEEEEee--------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYM--------DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~--------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+.|+.|....+|++.... .+..+++|+........ .....|..++..+..+.-+.++++.+ .+ +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~---~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL---YNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT---SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce---ecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 4678888889999986432 12678888765421110 01245777776664432244555544 22 6
Q ss_pred EEeeccCCCC
Q psy14702 194 LQLEYCNGGN 203 (480)
Q Consensus 194 lv~E~~~gg~ 203 (480)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.30 E-value=0.013 Score=59.42 Aligned_cols=76 Identities=11% Similarity=0.085 Sum_probs=47.1
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeeccCC
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNG 201 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~~~g 201 (480)
.+.|+.|-...+|++.....+..|++|+......... ...+|..++..|..+.-..++++.+. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i---dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII---NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS---CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc---CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4678889899999986433347888998643211110 01468888888866544467777663 2 259999987
Q ss_pred CCH
Q psy14702 202 GNL 204 (480)
Q Consensus 202 g~L 204 (480)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.62 E-value=0.12 Score=51.80 Aligned_cols=75 Identities=15% Similarity=0.050 Sum_probs=45.9
Q ss_pred heeecccCceEEEEEEEee-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYM-------DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+.|..|-...+|++.... .+..|++|+........ ....+|..++..+..+.-..++++.+ .+ ++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---YDSKVELDVFRYLSNINIAPNIIADF--PE--GR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence 5678888889999986532 15789999864321111 11245777776664433345555533 22 68
Q ss_pred EeeccCCCC
Q psy14702 195 QLEYCNGGN 203 (480)
Q Consensus 195 v~E~~~gg~ 203 (480)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999998865
|
| >3ecr_A Porphobilinogen deaminase; heme biosynthesis, porphobilinogen hinge, alternative splicing, cytoplasm, disease mutation, porphyrin biosynthesis; HET: DPM; 2.18A {Homo sapiens} PDB: 3eq1_A* | Back alignment and structure |
|---|
Probab=92.70 E-value=0.045 Score=52.45 Aligned_cols=96 Identities=41% Similarity=0.571 Sum_probs=69.8
Q ss_pred CCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHHhhHHHhcccccccccccccCCCceeeeee
Q psy14702 363 TKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMAVFSEYKPGSLSMTGA 442 (480)
Q Consensus 363 ~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 442 (480)
..+...+.+.+..++...+|.+.+..++.|+++||+|++++..+++++|+.+|+.|+.|..++...|..-.--..-.+|.
T Consensus 143 Ga~VGTSSlRR~aQL~~~rPdL~i~~lRGNV~TRL~KL~~gg~~DAiILA~AGL~RLgl~~~i~~~l~~~~~lPA~gQGa 222 (364)
T 3ecr_A 143 KSVVGTSSLRRAAQLQRKFPHLEFRSIRGNLNTRLRKLDEQQEFSAIILATAGLQRMGWHNRVGQILHPEECMYAVGQGA 222 (364)
T ss_dssp TCEEECCCHHHHHHHHHHCTTSEEECCCSCHHHHHHHHHHSSSCSEEEEEHHHHHHTTCGGGCCEECCTTTCCBCTTTTC
T ss_pred cCEEeCCcHHHHHHHHHHCCCCEEEECCCCHHHHHHHhhcCCCcCEEEehhhHHhhcCCchheeEecChhhcCCccccce
Confidence 34555566777788888899999999999999999999886679999999999999999999887766533222222333
Q ss_pred E--eecCchhhHHHHHHh
Q psy14702 443 V--WSLDGRETLQDAMER 458 (480)
Q Consensus 443 ~--~~~~~~~~~~~~~~~ 458 (480)
+ ....+.+.+.+++..
T Consensus 223 LaIe~R~~D~~~~~ll~~ 240 (364)
T 3ecr_A 223 LGVEVRAKDQDILDLVGV 240 (364)
T ss_dssp EEEEEETTCHHHHHHHHT
T ss_pred eEEEEecCCHHHHHHHHH
Confidence 2 234444555555543
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.68 E-value=0.53 Score=46.55 Aligned_cols=34 Identities=32% Similarity=0.426 Sum_probs=24.9
Q ss_pred ceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCccc
Q psy14702 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI 277 (480)
Q Consensus 238 IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~ 277 (480)
++|+|+.+.|||+..... ++....+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~------~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRE------NSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGG------GCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcc------cCcCCeEEEechHhcc
Confidence 679999999999954221 1345679999997653
|
| >1gtk_A Porphobilinogen deaminase; lyase, biosynthesis of linear tetrapyrrole, all alpha/beta; HET: DPM; 1.66A {Escherichia coli} SCOP: c.94.1.1 d.50.2.1 PDB: 1ah5_A* 2ypn_A* 1ypn_A* 1pda_A* | Back alignment and structure |
|---|
Probab=91.45 E-value=0.092 Score=49.59 Aligned_cols=96 Identities=38% Similarity=0.487 Sum_probs=70.6
Q ss_pred CCCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHHhhHHHhcccccccccccccCCCceeeee
Q psy14702 362 PTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMAVFSEYKPGSLSMTG 441 (480)
Q Consensus 362 P~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 441 (480)
+..+...+.+.+..++...+|.+.+..++.|+++||+|++++. +++++|+.+|+.|++|..++...|..-.-...-.+|
T Consensus 121 ~Ga~VGTSSlRR~aQL~~~rPdl~i~~lRGNV~TRL~KL~~g~-~DaiiLA~AGL~RLgl~~~i~~~l~~~~~lPA~gQG 199 (313)
T 1gtk_A 121 AGSIVGTSSLRRQCQLAERRPDLIIRSLRGNVGTRLSKLDNGE-YDAIILAVAGLKRLGLESRIRAALPPEISLPAVGQG 199 (313)
T ss_dssp TTCEEECCCHHHHHHHHHHCTTSEEECCCSCHHHHHHHHHTTS-CSEEEEEHHHHHHTTCGGGCSEECCTTTSCCCTTTT
T ss_pred CCCEEecCCHHHHHHHHHHCCCCEEEeCCCCHHHHHHHhhCCC-CCEEEHhhhHHHHcCCccccceeeChhhcCCCcCCc
Confidence 3456666777888888999999999999999999999998864 899999999999999999887766553322222233
Q ss_pred eEe--ecCchhhHHHHHHh
Q psy14702 442 AVW--SLDGRETLQDAMER 458 (480)
Q Consensus 442 ~~~--~~~~~~~~~~~~~~ 458 (480)
.+. ..++.+.+.+++..
T Consensus 200 alaIe~r~~d~~~~~ll~~ 218 (313)
T 1gtk_A 200 AVGIECRLDDSRTRELLAA 218 (313)
T ss_dssp CEEEEEETTCHHHHHHHGG
T ss_pred eEEEEEccCcHHHHHHHHH
Confidence 332 34444555555544
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.83 E-value=0.082 Score=53.61 Aligned_cols=62 Identities=10% Similarity=0.052 Sum_probs=17.0
Q ss_pred heeecccCceEEEEEEEeeCCcEEEE------EEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEe
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAV------KRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWS 187 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAv------K~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~ 187 (480)
.+.|| ||.||++.......+||+ |..+...........+.+|..++..+ .|||+++.+.+-.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~-~H~niv~~h~f~~ 214 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENE-QIPKYEKIHNFKV 214 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccc-cccccCCCcceEE
Confidence 45676 999999987655568888 66554322223334567777777777 7899999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 480 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-46 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-42 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-41 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-41 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-41 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-39 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-38 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-38 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-37 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-36 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-36 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-36 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-35 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-35 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-34 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-33 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-30 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-30 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-29 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-29 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-28 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-11 | |
| d1pdaa1 | 217 | c.94.1.1 (A:3-219) Porphobilinogen deaminase (hydr | 9e-09 | |
| d1pdaa1 | 217 | c.94.1.1 (A:3-219) Porphobilinogen deaminase (hydr | 2e-08 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-46
Identities = 65/267 (24%), Positives = 108/267 (40%), Gaps = 21/267 (7%)
Query: 114 RYALE-FLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHA 171
++ALE F LG G FG V+ + A+K K + E ++E+ +
Sbjct: 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231
L P+I+ + + D +YL LEY G + +Q+ F E + +++ L
Sbjct: 62 HLRH-PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDC 289
H R+IH DIKP N+L+ K+ DFG + G
Sbjct: 121 YCHSKRVIHRDIKPENLLL------------GSAGELKIADFGWSVHAPSSRRTTLCGTL 168
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNV 346
YLP E++ + KVD+++LG+ YE G P N + I V
Sbjct: 169 DYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFV 227
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSLRR 373
++ LI ++ +P++RP +
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 7e-46
Identities = 64/292 (21%), Positives = 116/292 (39%), Gaps = 21/292 (7%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVP 177
F + +G G FG V+ + A+K+ + + + + KE+ L R P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHP 75
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+ + Y + + +L +EYC G + + + E+ + + +GL +H
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRYLPKELL 297
MIH D+K NIL+ +E KLGDFG G ++ E++
Sbjct: 136 MIHRDVKAGNILL------------SEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVI 183
Query: 298 NNNFDNL--SKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKL--SNVSDDL 350
+ KVD+++LG+T E A PL M +HI L + S+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 351 HTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDE 402
+ + K P RP++ L + + R P + ++ +++LD
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDN 295
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 2e-43
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 21/261 (8%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE-KIFKKEIHAHALLSRV 176
+F+ ++LG G FG+VF +A+K K+ V + + E +L
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P + + F ++ + L+ +EY NGG+L IQ F ++ GL+ +H
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYL 292
+++ D+K NIL + H K+ DFG +++ D G Y+
Sbjct: 123 GIVYRDLKLDNIL------------LDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDD 349
E+L N VD ++ G+ LYE G +P ++H IR N + +
Sbjct: 171 APEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 350 LHTLIKLMIDKDPTKRPSTSS 370
L+ + ++P KR
Sbjct: 230 AKDLLVKLFVREPEKRLGVRG 250
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 3e-43
Identities = 55/277 (19%), Positives = 110/277 (39%), Gaps = 34/277 (12%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI-------FKKEIHAHA 171
+ +E+LG G V +C+ YAVK + + KE+
Sbjct: 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLR 231
+S P+I+ ++ +L + G L + + E+ T +E ++++ + E +
Sbjct: 65 KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVIC 124
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGD 288
+H++ ++H D+KP NIL+ + ++ KL DFG + G
Sbjct: 125 ALHKLNIVHRDLKPENILL------------DDDMNIKLTDFGFSCQLDPGEKLREVCGT 172
Query: 289 CRYLPKELLNNNFDNLS-----KVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI 340
YL E++ + ++ +VD+++ G+ +Y +G P M I GN
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNY 232
Query: 341 E----KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + + SD + L+ + P KR +
Sbjct: 233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 153 bits (387), Expect = 5e-43
Identities = 60/263 (22%), Positives = 108/263 (41%), Gaps = 25/263 (9%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
E LG+G FG V + + G +A K P + + ++ +KEI ++L P +VN
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRH-PTLVN 87
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENII-QERCTFTEMALKQLLFQVSEGLRCMHEMRMIH 240
++ D + + E+ +GG L + E +E + + QV +GL MHE +H
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVH 147
Query: 241 MDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELL 297
+D+KP NI+ KL DFG H+ +V G + E+
Sbjct: 148 LDLKPENIMFT----------TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVA 197
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI----EKLSNVSDDL 350
D++++G+ Y SG++P +++ + S +S+D
Sbjct: 198 EGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256
Query: 351 HTLIKLMIDKDPTKRPSTSSLRR 373
I+ ++ DP R +
Sbjct: 257 KDFIRKLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-43
Identities = 59/270 (21%), Positives = 101/270 (37%), Gaps = 24/270 (8%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRV 176
+F ++LG G F V + YA+K KR + + +E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P V + ++ D LY L Y G L I++ +F E + ++ L +H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE------GDCR 290
+IH D+KP NIL+ E +H ++ DFG + + G +
Sbjct: 128 GIIHRDLKPENILL------------NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNVS 347
Y+ ELL D++ALG +Y+ +G+ P + I +
Sbjct: 176 YVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFF 234
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377
L++ ++ D TKR + L
Sbjct: 235 PKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 6e-43
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 40/293 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
I + + + +GSG FG V+K AVK Q + FK E+
Sbjct: 5 IPDGQITVG----QRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSE 228
R +I+ + +S L + ++C G +L + + F + L + Q ++
Sbjct: 58 LRKT-RHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-- 286
G+ +H +IH D+K NI + E L K+GDFG + +
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFL------------HEDLTVKIGDFGLATVKSRWSGSHQF 163
Query: 287 ----GDCRYLPKELLNNNFDNL--SKVDIFALGLTLYE-ASGVTPLPKNGPM---WHHIR 336
G ++ E++ N + D++A G+ LYE +G P +
Sbjct: 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG 223
Query: 337 DGNI-----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS-AQLARNYPQ 383
G + + SN + L+ + K +RP + S LAR+ P+
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 151 bits (383), Expect = 9e-43
Identities = 69/309 (22%), Positives = 127/309 (41%), Gaps = 26/309 (8%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
++LG+G F EV A+K + + + EI + P+IV
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS-MENEIAVLHKIKH-PNIVA 71
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
+ G LYL ++ +GG L + I E+ +TE +L+FQV + ++ +H++ ++H
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC---RYL-PKELL 297
D+KP N+L E + DFG ++ V C Y+ P+ L
Sbjct: 132 DLKPENLLYY---------SLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLA 182
Query: 298 NNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIE----KLSNVSDDL 350
+ VD +++G+ Y G P ++ I E ++SD
Sbjct: 183 QKPYS--KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240
Query: 351 HTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGII 410
I+ +++KDP KR + + +A + K NI +++ ++KK + +
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK--NIHQSVSEQIKKNFAKSKWKQAF 298
Query: 411 LAVAGIVRM 419
A A + M
Sbjct: 299 NATAVVRHM 307
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-42
Identities = 61/281 (21%), Positives = 113/281 (40%), Gaps = 30/281 (10%)
Query: 119 FLEE----ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS 174
F+E+ + LG G +GEV + + AVK A E KKEI + +L+
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLN 61
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
++V ++ + + YL LEYC+GG L + I+ E ++ Q+ G+ +H
Sbjct: 62 H-ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE------GD 288
+ + H DIKP N+L+ E+ + K+ DFG E G
Sbjct: 121 GIGITHRDIKPENLLL------------DERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGN-----IEK 342
Y+ ELL + VD+++ G+ L +G P + D +
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383
+ L+ ++ ++P+ R + +++ + +
Sbjct: 229 WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-42
Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 33/275 (12%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
++ +G+G +G K + DG K A++++ E++ L P
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-P 63
Query: 178 HIVNYFSSWSDQ--GVLYLQLEYCNGGNLENIIQ----ERCTFTEMALKQLLFQVSEGLR 231
+IV Y+ D+ LY+ +EYC GG+L ++I ER E + +++ Q++ L+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 232 CMHE-----MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEV 284
H ++H D+KPAN+ + K + KLGDFG ++ +
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL------------DGKQNVKLGDFGLARILNHDTSFA 171
Query: 285 EEGDC--RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGN 339
+ Y+ E +N N K DI++LG LYE + + P IR+G
Sbjct: 172 KAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230
Query: 340 IEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
++ SD+L+ +I M++ RPS +
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (376), Expect = 4e-42
Identities = 59/280 (21%), Positives = 110/280 (39%), Gaps = 32/280 (11%)
Query: 108 TSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEI 167
S D R+ L+F E +G G F V+K L + A + ++ + FK+E
Sbjct: 4 MSND-GRF-LKFDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEA 59
Query: 168 HAHALLSRVPHIVNYFSSWSD----QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLL 223
L + P+IV ++ SW + + L E G L+ ++ L+
Sbjct: 60 EMLKGL-QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWC 118
Query: 224 FQVSEGLRCMHEM--RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIAD 279
Q+ +GL+ +H +IH D+K NI I G + K+GD G +
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV-----------KIGDLGLATLKRA 167
Query: 280 NDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP---MWHHI 335
+ + G ++ E+ +D VD++A G+ + E A+ P + ++ +
Sbjct: 168 SFAKAVIGTPEFMAPEMYEEKYD--ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 225
Query: 336 RDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
G ++ +I+ I ++ +R S L
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 4e-42
Identities = 58/288 (20%), Positives = 113/288 (39%), Gaps = 30/288 (10%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
+Y + E LG G+FG V +C++ TY K K + + KKEI +
Sbjct: 6 KYMIA----EDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIA 58
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRC 232
R +I++ S+ L + E+ +G ++ I E + + QV E L+
Sbjct: 59 -RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 233 MHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDC 289
+H + H DI+P NI+ K+ +FG + ++F +
Sbjct: 118 LHSHNIGHFDIRPENIIY----------QTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 290 RYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI----EK 342
Y E+ ++ + + D+++LG +Y SG+ P +I + E
Sbjct: 168 EYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA 226
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIR 390
+S + + ++ K+ R + S + L + ++ + IR
Sbjct: 227 FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIR 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (377), Expect = 7e-42
Identities = 61/273 (22%), Positives = 120/273 (43%), Gaps = 21/273 (7%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRV 176
+F LG+G FG V +G YA+K K V Q + E ++++
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH- 63
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P I+ + ++ D +++ ++Y GG L +++++ F K +V L +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEEGDCRYLPKE 295
+I+ D+KP NIL+ + H K+ DFG + G Y+ E
Sbjct: 124 DIIYRDLKPENILL------------DKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPE 171
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNVSDDLHT 352
+++ N +D ++ G+ +YE +G TP + M + I + + ++D+
Sbjct: 172 VVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 230
Query: 353 LIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
L+ +I +D ++R +L+ + +N+P K
Sbjct: 231 LLSRLITRDLSQRL--GNLQNGTEDVKNHPWFK 261
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (378), Expect = 2e-41
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 25/279 (8%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLS-- 174
+F ++G G FGEV+ C K G YA+K K+ + E + E +L+S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
P IV ++ L L+ NGG+L + + F+E ++ ++ GL MH
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH--VIADNDFEVEEGDCRYL 292
+++ D+KPANIL+ E H ++ D G + G Y+
Sbjct: 125 NRFVVYRDLKPANILL------------DEHGHVRISDLGLACDFSKKKPHASVGTHGYM 172
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP-----MWHHIRDGNIEKLSNV 346
E+L S D F+LG L++ G +P ++ + +E +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
Query: 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
S +L +L++ ++ +D +R L R AQ + P +
Sbjct: 233 SPELRSLLEGLLQRDVNRRL--GCLGRGAQEVKESPFFR 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-41
Identities = 62/283 (21%), Positives = 117/283 (41%), Gaps = 37/283 (13%)
Query: 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHI 179
+ ++LG G G+V + +A+K + ++E+ H S+ PHI
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHI 67
Query: 180 VNYF----SSWSDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCM 233
V + ++ + L + +E +GG L + IQ+R FTE +++ + E ++ +
Sbjct: 68 VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH---VIADNDFEVEEGDCR 290
H + + H D+KP N+L KL DFG + N
Sbjct: 128 HSINIAHRDVKPENLLYTS---------KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 178
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MWHHIRDGNIE-- 341
Y+ E+L + D+++LG+ +Y G P N M IR G E
Sbjct: 179 YVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 342 --KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382
+ S VS+++ LI+ ++ +PT+R + + + ++
Sbjct: 238 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 149 bits (376), Expect = 2e-41
Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 25/291 (8%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E LGSG FG V +C++ G + K P + K EI L P ++N
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHH-PKLINL 91
Query: 183 FSSWSDQGVLYLQLEYCNGGNLEN-IIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ D+ + L LE+ +GG L + I E +E + + Q EGL+ MHE ++H+
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 151
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKELLN 298
DIKP NI+ + K+ DFG + D +V + E+++
Sbjct: 152 DIKPENIMC----------ETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201
Query: 299 NNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI----EKLSNVSDDLH 351
D++A+G+ Y SG++P + +++ + + S+VS +
Sbjct: 202 REPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260
Query: 352 TLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDE 402
IK ++ K+P KR + L ++ L N +K+ E
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKE 311
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-41
Identities = 62/266 (23%), Positives = 108/266 (40%), Gaps = 30/266 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
LG G FG+V+K + A K + + + + EI A P+IV
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSEEELEDYMVEIDILASCDH-PNIVKL 74
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
++ + L++ +E+C GG ++ ++ E TE ++ + Q + L +H+ ++IH
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHR 134
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYLPKELL 297
D+K NIL T KL DFG + + G ++ E++
Sbjct: 135 DLKAGNILF------------TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 182
Query: 298 NNNFDNL----SKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKL---SNVS 347
K D+++LG+TL E A P + PM I L S S
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 242
Query: 348 DDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ +K ++K+ R +TS L +
Sbjct: 243 SNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-41
Identities = 66/303 (21%), Positives = 119/303 (39%), Gaps = 33/303 (10%)
Query: 95 DHHPVFDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPV 154
D + ++SI S +Y E+ +G G G V+ + G A+++
Sbjct: 2 DEEILEKLRSIVSVGDPKKKY--TRFEK--IGQGASGTVYTAMDVATGQEVAIRQMNL-- 55
Query: 155 ANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTF 214
++++ EI + P+IVNY S+ L++ +EY GG+L +++ E C
Sbjct: 56 QQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-M 113
Query: 215 TEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
E + + + + L +H ++IH DIK NIL+ KL DFG
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL------------GMDGSVKLTDFG 161
Query: 275 H----VIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNG 329
+ G ++ E++ KVDI++LG+ E G P
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNEN 220
Query: 330 P---MWHHIRDG--NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA--QLARNYP 382
P ++ +G ++ +S + +D D KR S L + ++A+
Sbjct: 221 PLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
Query: 383 QLK 385
L
Sbjct: 281 SLT 283
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 62/271 (22%), Positives = 107/271 (39%), Gaps = 28/271 (10%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE----KIFKKEI 167
S+Y + LLGSG FG V+ ++ D + A+K ++ + E E+
Sbjct: 3 ESQYQVG----PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 58
Query: 168 HAHALLS-RVPHIVNYFSSWSDQGVLYLQLEYCNGG-NLENIIQERCTFTEMALKQLLFQ 225
+S ++ + L LE +L + I ER E + +Q
Sbjct: 59 VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 118
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFE 283
V E +R H ++H DIK NILI + + KL DFG ++ D +
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILI-----------DLNRGELKLIDFGSGALLKDTVYT 167
Query: 284 VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNIEK 342
+G Y P E + + + +++LG+ LY+ G P + I G +
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFF 223
Query: 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
VS + LI+ + P+ RP+ ++
Sbjct: 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-39
Identities = 63/265 (23%), Positives = 119/265 (44%), Gaps = 24/265 (9%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI----FKKEIHAHALLSRVPH 178
E LGSG F V KC + G+ YA K K+ +++ + ++E+ + P+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PN 74
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRM 238
++ + ++ + L LE GG L + + E+ + TE + L Q+ G+ +H +++
Sbjct: 75 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQI 134
Query: 239 IHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGDCRYLPKE 295
H D+KP NI+++ N K K+ DFG + N+F+ G ++ E
Sbjct: 135 AHFDLKPENIMLLD--------RNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI----EKLSNVSD 348
++N + D++++G+ Y SG +P + ++ N E SN S
Sbjct: 187 IVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 349 DLHTLIKLMIDKDPTKRPSTSSLRR 373
I+ ++ KDP KR + +
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 1e-38
Identities = 54/273 (19%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++ + L+ +G G+FG+V G AVK K N A + F E
Sbjct: 4 LNMKEL--KLLQT--IGKGEFGDVMLG--DYRGNKVAVKCIK----NDATAQAFLAEASV 53
Query: 170 HALLSRVPHIVNYFSSWSDQ-GVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQV 226
L ++V ++ G LY+ EY G+L + ++ R L + V
Sbjct: 54 MTQLRH-SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 227 SEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV-IADNDFEVE 285
E + + +H D+ N+L+ +E K+ DFG A + +
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLV------------SEDNVAKVSDFGLTKEASSTQDTG 160
Query: 286 EGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP----MWHHIRDGN-I 340
+ ++ E L + +K D+++ G+ L+E +P + + G +
Sbjct: 161 KLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM 219
Query: 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ ++ ++K D RPS LR
Sbjct: 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 5e-38
Identities = 59/276 (21%), Positives = 101/276 (36%), Gaps = 24/276 (8%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRV 176
+F +LLG G FG+V + G YA+K K + + E
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH- 64
Query: 177 PHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
P + ++ L +EY NGG L + FTE + ++ L +H
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR 124
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG----HVIADNDFEVEEGDCRYL 292
+++ DIK N+++ + H K+ DFG + + G YL
Sbjct: 125 DVVYRDIKLENLML------------DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 172
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGP--MWHHIRDGNIEKLSNVSDD 349
E+L +N VD + LG+ +YE G P ++ I I +S +
Sbjct: 173 APEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPE 231
Query: 350 LHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
+L+ ++ KDP +R A+ +
Sbjct: 232 AKSLLAGLLKKDPKQRL--GGGPSDAKEVMEHRFFL 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-38
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 37/277 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
+ L E LG+G FGEV+ Y AVK K+ + F E +
Sbjct: 10 VPRETLKLV----ERLGAGQFGEVWMG-YYNGHTKVAVKSLKQ---GSMSPDAFLAEANL 61
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVS 227
L + +V ++ + + +Y+ EY G+L + ++ T L + Q++
Sbjct: 62 MKQL-QHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
EG+ + E IH D++ ANIL+ ++ L K+ DFG +I DN++
Sbjct: 120 EGMAFIEERNYIHRDLRAANILV------------SDTLSCKIADFGLARLIEDNEYTAR 167
Query: 286 EGDCRYL----PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGPM--WHHIRD 337
EG + P+ + F K D+++ G+ L E G P P ++
Sbjct: 168 EGAKFPIKWTAPEAINYGTFT--IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 338 GN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
G + + N ++L+ L++L + P RP+ LR
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-37
Identities = 63/273 (23%), Positives = 112/273 (41%), Gaps = 33/273 (12%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
ID FL+E LG+G FG V K+ A+K K + E F +E
Sbjct: 1 IDPKDL--TFLKE--LGTGQFGVVKYG-KWRGQYDVAIKMIKE---GSMSEDEFIEEAKV 52
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSE 228
LS +V + + Q +++ EY G L N ++ R F L ++ V E
Sbjct: 53 MMNLSH-EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 111
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEE 286
+ + + +H D+ N L+ ++ K+ DFG + D+++
Sbjct: 112 AMEYLESKQFLHRDLAARNCLV------------NDQGVVKVSDFGLSRYVLDDEYTSSV 159
Query: 287 GDC---RYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGPMW--HHIRDGN 339
G R+ P E+L + + SK DI+A G+ ++E + G P + HI G
Sbjct: 160 GSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL 218
Query: 340 -IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ + S+ ++T++ + +RP+ L
Sbjct: 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-37
Identities = 58/275 (21%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
ID S F++E +GSG FG V +++ A+K + E+ F +E
Sbjct: 2 IDPSEL--TFVQE--IGSGQFGLVHLG-YWLNKDKVAIKTIRE---GAMSEEDFIEEAEV 53
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCT-FTEMALKQLLFQVSE 228
L P +V + +Q + L E+ G L + ++ + F L + V E
Sbjct: 54 MMKL-SHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 112
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-- 286
G+ + E +IH D+ N L+ E K+ DFG D +
Sbjct: 113 GMAYLEEACVIHRDLAARNCLV------------GENQVIKVSDFGMTRFVLDDQYTSST 160
Query: 287 ---GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP----MWHHIRDGN 339
++ E+ + + SK D+++ G+ ++E +P + I G
Sbjct: 161 GTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 219
Query: 340 -IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ K S ++ ++ + P RP+ S L R
Sbjct: 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLR 254
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 62/306 (20%), Positives = 117/306 (38%), Gaps = 65/306 (21%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
+F + LG+G+ G VFK G+ A K + A +E+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNS-P 64
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM- 236
+IV ++ ++ G + + +E+ +GG+L+ ++++ E L ++ V +GL + E
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVEEGDCRYLPK 294
+++H D+KP+NIL+ + KL DFG + D+ G Y+
Sbjct: 125 KIMHRDVKPSNILV------------NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSP 172
Query: 295 ELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLP--------------------------- 326
E L + + DI+++GL+L E A G P+P
Sbjct: 173 ERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 327 -----------------KNGPMWHHIRDGNIEKLSN--VSDDLHTLIKLMIDKDPTKRPS 367
+ +I + KL + S + + + K+P +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 368 TSSLRR 373
L
Sbjct: 292 LKQLMV 297
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-36
Identities = 60/287 (20%), Positives = 117/287 (40%), Gaps = 42/287 (14%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVK-RTKRPVANTAQEKIFKKEIH 168
+D + + +++G G+FG+V K DG+ + + A+ + F E+
Sbjct: 7 LDWNDIKFQ----DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 169 AHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC---------------- 212
L P+I+N + +G LYL +EY GNL + +++
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122
Query: 213 TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272
T + L V+ G+ + + + IH D+ NIL+ E K+ D
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV------------GENYVAKIAD 170
Query: 273 FGHVIADNDFEVEE---GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNG 329
FG + + R++ E LN + + D+++ G+ L+E + P G
Sbjct: 171 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCG 229
Query: 330 P----MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
++ + G +EK N D+++ L++ + P +RPS + +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (336), Expect = 3e-36
Identities = 57/277 (20%), Positives = 116/277 (41%), Gaps = 35/277 (12%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
++ + ++ LG G +GEV++ + +T AVK K +T + + F KE
Sbjct: 14 MERTDITMK----HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAV 66
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE--RCTFTEMALKQLLFQVS 227
+ + P++V + + Y+ E+ GNL + ++E R + + L + Q+S
Sbjct: 67 MKEI-KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEE 286
+ + + IH D+ N L+ E K+ DFG + D
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLV------------GENHLVKVADFGLSRLMTGDTYTAH 173
Query: 287 GDCRYL-----PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGP--MWHHIRD 337
++ P+ L N F K D++A G+ L+E G++P P ++ +
Sbjct: 174 AGAKFPIKWTAPESLAYNKFS--IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
Query: 338 G-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+E+ + ++ L++ +P+ RPS + + +
Sbjct: 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 3e-36
Identities = 64/310 (20%), Positives = 124/310 (40%), Gaps = 60/310 (19%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCL-----KYMDGMTYAVKRTKRPVANTAQEKIFK 164
++LGSG FG+V K + AVK K A++++ +
Sbjct: 34 FPRENLEFG----KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE-KADSSEREALM 88
Query: 165 KEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER------------- 211
E+ L +IVN + + G +YL EYC G+L N ++ +
Sbjct: 89 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 212 ----------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPM 261
T L +QV++G+ + +H D+ N+L+
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV----------- 197
Query: 262 NTEKLHYKLGDFGH---VIADNDFEVEEGDC---RYLPKELLNNNFDNLSKVDIFALGLT 315
T K+ DFG +++D+++ V +++ E L K D+++ G+
Sbjct: 198 -THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGIL 255
Query: 316 LYE--ASGVTP---LPKNGPMWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTS 369
L+E + GV P +P + + I++G +++ +++++ +++ D KRPS
Sbjct: 256 LWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 370 SLRR--SAQL 377
+L QL
Sbjct: 316 NLTSFLGCQL 325
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 5e-36
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 34/278 (12%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTAQEKIFKKE 166
I R L +G G FG+V + + + A+K K +++ +EK F +E
Sbjct: 4 IQRERIELG----RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK-FLQE 58
Query: 167 IHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQ 225
PHIV ++ +++ +E C G L + +Q R + +L +Q
Sbjct: 59 ALTMRQFDH-PHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVE 285
+S L + R +H DI N+L+ + KLGDFG D
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLV------------SSNDCVKLGDFGLSRYMEDSTYY 164
Query: 286 E-----GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGPM--WHHIR 336
+ +++ E +N S D++ G+ ++E GV P I
Sbjct: 165 KASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 223
Query: 337 DGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+G + N L++L+ DP++RP + L+
Sbjct: 224 NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (334), Expect = 5e-36
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 36/297 (12%)
Query: 107 STSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTY---AVKRTKRPVANTAQEKIF 163
+ ID S +E +++G+G+FGEV + G A+K + Q + F
Sbjct: 20 AKEIDISCVKIE----QVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDF 74
Query: 164 KKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQL 222
E P++++ + + + E+ G+L++ +++ FT + L +
Sbjct: 75 LSEASIMGQF-DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM 133
Query: 223 LFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI----A 278
L ++ G++ + +M +H D+ NIL+ L K+ DFG
Sbjct: 134 LRGIAAGMKYLADMNYVHRDLAARNILV------------NSNLVCKVSDFGLSRFLEDD 181
Query: 279 DNDFEVEEGDCRYLPKELLNNNFDN----LSKVDIFALGLTLYE--ASGVTPLPKNGP-- 330
+D +P S D+++ G+ ++E + G P
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241
Query: 331 -MWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS-AQLARNYPQLK 385
+ +D + + LH L+ KD RP + + ++ RN LK
Sbjct: 242 VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLK 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-36
Identities = 58/268 (21%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 120 LEEELLGSGDFGEVFKCLKYM--DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVP 177
LE++ LGSG+FG V K M T AVK K + A + E + L P
Sbjct: 10 LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP 68
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+IV + L +E G L +Q+ + + +L+ QVS G++ + E
Sbjct: 69 YIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-------GDCR 290
+H D+ N+L+ + + K+ DFG A E +
Sbjct: 128 FVHRDLAARNVLL------------VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 291 YLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGPMW--HHIRDGNIEKL-SN 345
+ E +N SK D+++ G+ ++E + G P + G +
Sbjct: 176 WYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG 234
Query: 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+++ L+ L D RP +++
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVEL 262
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 2e-35
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 32/281 (11%)
Query: 123 ELLGSGDFGEVFKCLKYMD---GMTYAVK--RTKRPVANTAQEKIFKKEIHAHALLSRVP 177
++LG+G +G+VF K G YA+K + V + + E + + P
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 178 HIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
+V ++ + L+L L+Y NGG L + +R FTE ++ + ++ L +H++
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 149
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVE-----EGDCRYL 292
+I+ DIK NIL+ H L DFG E E G Y+
Sbjct: 150 IIYRDIKLENILL------------DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 293 PKELLNNNFDNLS-KVDIFALGLTLYE-ASGVTPLPKNGP------MWHHIRDGNIEKLS 344
+++ VD ++LG+ +YE +G +P +G + I
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385
+S LI+ ++ KDP KR R A + + +
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRL--GCGPRDADEIKEHLFFQ 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 131 bits (329), Expect = 2e-35
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 29/270 (10%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQ-EKIFKKEIHAHAL 172
RY L E+LG G EV AVK + +A F++E A
Sbjct: 8 RYELG----EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 173 LSRVPHIVNYFSSWSDQ----GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSE 228
L+ P IV + + + + Y+ +EY +G L +I+ T +++ +
Sbjct: 64 LNH-PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-- 286
L H+ +IH D+KPANI+I N K+ + N
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMI--------SATNAVKVMDFGIARAIADSGNSVTQTAAV 174
Query: 287 -GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM---WHHIRDGNI- 340
G +YL E + + ++ D+++LG LYE +G P + P+ + H+R+ I
Sbjct: 175 IGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 233
Query: 341 --EKLSNVSDDLHTLIKLMIDKDPTKRPST 368
+ +S DL ++ + K+P R T
Sbjct: 234 PSARHEGLSADLDAVVLKALAKNPENRYQT 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-35
Identities = 63/299 (21%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFK 164
+R + + LG+G FG+V + +K MT AVK K P A+ + +
Sbjct: 20 FPRNRLSFG----KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK-PSAHLTEREALM 74
Query: 165 KEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ--------------- 209
E+ + L +IVN + + G + EYC G+L N ++
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 210 ---ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266
+ L +QV++G+ + IH D+ NIL+ T
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL------------THGR 182
Query: 267 HYKLGDFG--HVIADNDFEVEEGDC----RYLPKELLNNNFDNLSKVDIFALGLTLYE-A 319
K+ DFG I ++ V +G+ +++ E + N + D+++ G+ L+E
Sbjct: 183 ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELF 241
Query: 320 SGVTP----LPKNGPMWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
S + +P + + I++G + + +++ ++K D DP KRP+ + +
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 58/289 (20%), Positives = 99/289 (34%), Gaps = 51/289 (17%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI---FKKEIHAHALLSRVPHI 179
+ LG G F V+K A+K+ K + A++ I +EI LS P+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNI 62
Query: 180 VNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMI 239
+ ++ + + L ++ I T +K + +GL +H+ ++
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 240 HMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND----FEVEEGDCRYLPKE 295
H D+KP N+L+ E KL DFG + + + Y E
Sbjct: 123 HRDLKPNNLLL------------DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPE 170
Query: 296 LLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNI------------ 340
LL VD++A+G L E V LP + + I +
Sbjct: 171 LLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 341 ----------------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
S DDL LI+ + +P R + + +
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 4e-35
Identities = 58/298 (19%), Positives = 113/298 (37%), Gaps = 52/298 (17%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKC-------LKYMDGMTYAVKRTKRPVANTAQEKI 162
+ R L + LG G FG+V K AVK K
Sbjct: 10 LPRDRLVLG----KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD- 64
Query: 163 FKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC---------- 212
E+ ++ + +I+N + + G LY+ +EY + GNL +Q R
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 213 ------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKL 266
+ L +QV+ G+ + + IH D+ N+L+ TE
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV------------TEDN 172
Query: 267 HYKLGDF------GHVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS 320
K+ DF H+ +++ E L + + D+++ G+ L+E
Sbjct: 173 VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIF 231
Query: 321 GVTPLPKNGP----MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ P G ++ +++G+ ++K SN +++L+ +++ P++RP+ L
Sbjct: 232 TLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 129 bits (325), Expect = 1e-34
Identities = 67/297 (22%), Positives = 115/297 (38%), Gaps = 57/297 (19%)
Query: 117 LEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
+E++ + +G G FG VF+ L Y AVK K A+ + F++E A
Sbjct: 15 IEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMA 71
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-------------------- 211
P+IV + + L EY G+L ++
Sbjct: 72 EF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 212 ----CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLH 267
+ + QV+ G+ + E + +H D+ N L+ E +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV------------GENMV 178
Query: 268 YKLGDFGH--VIADNDFEVEE----GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE--A 319
K+ DFG I D+ + R++P E + N ++ D++A G+ L+E +
Sbjct: 179 VKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFS 237
Query: 320 SGVTPLPKNGPMW--HHIRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
G+ P +++RDGNI N +L+ L++L K P RPS S+ R
Sbjct: 238 YGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-34
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 37/277 (13%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHA 169
I LE LG G FGEV+ + A+K K T + F +E
Sbjct: 14 IPRESLRLE----VKLGQGCFGEVWMG-TWNGTTRVAIKTLKP---GTMSPEAFLQEAQV 65
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC--TFTEMALKQLLFQVS 227
L R +V ++ S++ +Y+ EY + G+L + ++ L + Q++
Sbjct: 66 MKKL-RHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADNDFEVE 285
G+ + M +H D++ ANIL+ E L K+ DFG +I DN++
Sbjct: 124 SGMAYVERMNYVHRDLRAANILV------------GENLVCKVADFGLARLIEDNEYTAR 171
Query: 286 EGDC---RYL-PKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGP---MWHHIR 336
+G ++ P+ L F K D+++ G+ L E G P P + R
Sbjct: 172 QGAKFPIKWTAPEAALYGRFT--IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
Query: 337 DGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ + LH L+ K+P +RP+ L+
Sbjct: 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (321), Expect = 1e-33
Identities = 66/281 (23%), Positives = 118/281 (41%), Gaps = 21/281 (7%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKR-TKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+ LG+G FG V G YA+K K+ V Q + E + P +V
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVK 105
Query: 182 YFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHM 241
S+ D LY+ +EY GG + + ++ F+E + Q+ +H + +I+
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYR 165
Query: 242 DIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEEGDCRYLPKELLNNN 300
D+KP N+LI ++ + ++ DFG G L E++ +
Sbjct: 166 DLKPENLLI------------DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSK 213
Query: 301 FDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM--WHHIRDGNIEKLSNVSDDLHTLIKLM 357
N VD +ALG+ +YE A+G P + P+ + I G + S+ S DL L++ +
Sbjct: 214 GYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272
Query: 358 IDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLK 398
+ D TKR +L+ +N+ + +++
Sbjct: 273 LQVDLTKRF--GNLKNGVNDIKNHKWFATTDWIAIYQRKVE 311
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 2e-33
Identities = 58/275 (21%), Positives = 105/275 (38%), Gaps = 32/275 (11%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYM--DGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
R L + EL G G+FG V + + M + A+K K+ A + +E
Sbjct: 7 RDNLLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMH 64
Query: 172 LLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLEN-IIQERCTFTEMALKQLLFQVSEGL 230
L P+IV + L L +E GG L ++ +R + +LL QVS G+
Sbjct: 65 QLDN-PYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE---- 286
+ + E +H D+ N+L+ + + K+ DFG A +
Sbjct: 123 KYLEEKNFVHRDLAARNVLL------------VNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 287 ---GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGPM--WHHIRDGN 339
++ E +N + S+ D+++ G+T++E + G P K I G
Sbjct: 171 AGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 229
Query: 340 IEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ +L+ L+ RP ++ +
Sbjct: 230 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 125 bits (314), Expect = 3e-33
Identities = 44/282 (15%), Positives = 88/282 (31%), Gaps = 38/282 (13%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
Y + +G G FG +F+ ++ A+K R + + E + LL
Sbjct: 6 HYKVG----RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR----RSDAPQLRDEYRTYKLL 57
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
+ I N + + L ++ + + F+ + Q+ ++ +
Sbjct: 58 AGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE------- 286
HE +++ DIKP N L + P + + DFG V D ++
Sbjct: 118 HEKSLVYRDIKPDNFL-------IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170
Query: 287 ----GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNI- 340
G RY+ + + D+ ALG G P + + I
Sbjct: 171 KNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 341 ---------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
E + ++ + + + P L+
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 8e-33
Identities = 58/288 (20%), Positives = 108/288 (37%), Gaps = 35/288 (12%)
Query: 102 IKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTA 158
++++ I S + F E++G G FG V+ + + AVK R + +
Sbjct: 14 VQAVQHVVIGPSSLIVHF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIG 70
Query: 159 QEKIFKKEIHAHALLSRVPHIVNYFSSWSD-QGVLYLQLEYCNGGNLENIIQ-ERCTFTE 216
+ F E S P++++ +G + L Y G+L N I+ E T
Sbjct: 71 EVSQFLTEGIIMKDFSH-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV 129
Query: 217 MALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276
L QV++G++ + + +H D+ N ++ EK K+ DFG
Sbjct: 130 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML------------DEKFTVKVADFGLA 177
Query: 277 IADNDFEVEE--------GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLP 326
D E + +++ E L +K D+++ G+ L+E G P P
Sbjct: 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYP 236
Query: 327 KNGPM---WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ ++ + + D L+ ++ RPS S L
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSEL 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-32
Identities = 53/284 (18%), Positives = 105/284 (36%), Gaps = 36/284 (12%)
Query: 107 STSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDG----MTYAVKRTKRPVANTAQEKI 162
+T I S ++++G+G+FGEV+K + + A+K K Q
Sbjct: 1 TTEIHPS----CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVD 55
Query: 163 FKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQER-CTFTEMALKQ 221
F E S +I+ S + + EY G L+ ++E+ F+ + L
Sbjct: 56 FLGEAGIMGQFSH-HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG 114
Query: 222 LLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND 281
+L ++ G++ + M +H D+ NIL+ L K+ DFG D
Sbjct: 115 MLRGIAAGMKYLANMNYVHRDLAARNILV------------NSNLVCKVSDFGLSRVLED 162
Query: 282 -------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGP---- 330
+ R+ E ++ S D+++ G+ ++E P
Sbjct: 163 DPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 331 MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ I DG + + ++ L+ ++ +RP + +
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-32
Identities = 56/274 (20%), Positives = 106/274 (38%), Gaps = 35/274 (12%)
Query: 117 LEFLEEELLGSGDFGEVFKC---LKYMDGMTYAVKRTKRPVANTAQE-KIFKKEIHAHAL 172
L LE+ LG G FG V + ++ AVK K V + + F +E++A
Sbjct: 10 LRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLR 231
L +++ + + + E G+L + +++ F L + QV+EG+
Sbjct: 68 L-DHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125
Query: 232 CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEVEEGD 288
+ R IH D+ N+L+ + K+GDFG + ++D V +
Sbjct: 126 YLESKRFIHRDLAARNLLL------------ATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 289 C----RYLPKELLNNNFDNLSKVDIFALGLTLYE--ASGVTPLPKNGP---MWHHIRDGN 339
+ E L + D + G+TL+E G P + ++G
Sbjct: 174 RKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232
Query: 340 -IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ + + D++ ++ P RP+ +LR
Sbjct: 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 4e-31
Identities = 42/273 (15%), Positives = 76/273 (27%), Gaps = 22/273 (8%)
Query: 114 RYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALL 173
RY L +GSG FG+++ G A+K + E + ++
Sbjct: 8 RYRLG----RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMM 59
Query: 174 SRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCM 233
I ++ + +E + F+ + L Q+ + +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 234 HEMRMIHMDIKPANILIV--KAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCRY 291
H IH D+KP N L+ K + Y+ I + + G RY
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 292 LPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHH----------IRDGNI 340
+ + D+ +LG L G P +
Sbjct: 180 ASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
+ T + +P S LR+
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 1e-30
Identities = 48/268 (17%), Positives = 101/268 (37%), Gaps = 28/268 (10%)
Query: 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVK---RTKRPVANTAQEKIFKKEIHAHALLS 174
EF + ++LGSG FG V+K L +G + + R + K E + A +
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV- 68
Query: 175 RVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMH 234
PH+ V + G L+ + + + L Q+++G+ +
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 235 EMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--HVIADND----FEVEEGD 288
+ R++H D+ N+L+ H K+ DFG ++ + E +
Sbjct: 129 DRRLVHRDLAARNVLV------------KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 289 CRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKNGPMWHHI-----RDGNIEKL 343
+++ E + + + D+++ G+T++E P +G I + + +
Sbjct: 177 IKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235
Query: 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
+ D++ ++ D RP L
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFREL 263
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 4e-30
Identities = 67/308 (21%), Positives = 110/308 (35%), Gaps = 53/308 (17%)
Query: 119 FLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPH 178
F + E +G G +G V+K + G A+K+ + +EI L+ P+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PN 62
Query: 179 IVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMAL-KQLLFQVSEGLRCMHEMR 237
IV + LYL E+ + + + T + L K LFQ+ +GL H R
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA----DNDFEVEEGDCRYLP 293
++H D+KP N+LI + KL DFG A + E Y
Sbjct: 123 VLHRDLKPQNLLI------------NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 170
Query: 294 KELLNNNFDNLSKVDIFALGLTLYE---------------------ASGVTPLPKNGPMW 332
E+L + VDI++LG E + TP P
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230
Query: 333 HHIRDGNI-----------EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS---AQLA 378
+ D + + + +D +L+ M+ DP KR S + +
Sbjct: 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290
Query: 379 RNYPQLKV 386
+ P L++
Sbjct: 291 KPVPHLRL 298
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 5e-30
Identities = 48/288 (16%), Positives = 104/288 (36%), Gaps = 45/288 (15%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFK 164
+ + + LG G FG V++ +K A+K A+ + F
Sbjct: 17 VAREKITMS----RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFL 71
Query: 165 KEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQ----------ERCTF 214
E H+V S + +E G+L++ ++
Sbjct: 72 NEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 215 TEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274
+ + Q+ ++++G+ ++ + +H D+ N ++ E K+GDFG
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV------------AEDFTVKIGDFG 178
Query: 275 HVIADNDFEVEE------GDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASGVTPLPKN 328
+ + R++ E L + + D+++ G+ L+E + + P
Sbjct: 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQ 237
Query: 329 GP----MWHHIRDGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL 371
G + + +G + +K N D L L+++ +P RPS +
Sbjct: 238 GLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 6e-30
Identities = 62/306 (20%), Positives = 103/306 (33%), Gaps = 68/306 (22%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
S+Y E L + +G G FGEVFK G A+K+ +EI L
Sbjct: 10 SKY--EKLAK--IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 173 LSRVPHIVNYFSSWSDQ--------GVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLF 224
L ++VN + G +YL ++C + FT +K+++
Sbjct: 66 LKH-ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 225 QVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEV 284
+ GL +H +++H D+K AN+LI T KL DFG A + +
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLI------------TRDGVLKLADFGLARAFSLAKN 172
Query: 285 EEGDCR--------YLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM---- 331
+ + Y P ELL D +D++ G + E + + N
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
Query: 332 -------------WHHIRDGNIE-----------------KLSNVSDDLHTLIKLMIDKD 361
W ++ + + K LI ++ D
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
Query: 362 PTKRPS 367
P +R
Sbjct: 293 PAQRID 298
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 9e-30
Identities = 51/295 (17%), Positives = 98/295 (33%), Gaps = 62/295 (21%)
Query: 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV 176
+ + + +++G+G FG V++ G A+K+ + ++ +E+ L
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDH- 72
Query: 177 PHIVNYFSSWSDQG------VLYLQLEYCNGGNLENI---IQERCTFTEMALKQLLFQVS 227
+IV + G L L L+Y + + T + +K ++Q+
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 228 EGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG---HVIADNDFEV 284
L +H + H DIKP N+ ++ + KL DFG ++
Sbjct: 133 RSLAYIHSFGICHRDIKPQNL-----------LLDPDTAVLKLCDFGSAKQLVRGEPNVS 181
Query: 285 EEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM------------ 331
Y EL+ D S +D+++ G L E G P + +
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241
Query: 332 --WHHIRDGNIEKL-----------------SNVSDDLHTLIKLMIDKDPTKRPS 367
IR+ N + L +++ PT R +
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 114 bits (287), Expect = 2e-29
Identities = 51/281 (18%), Positives = 97/281 (34%), Gaps = 50/281 (17%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E +G G +G V+K + G T+A+K+ + + +EI L +IV
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKL 65
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
+ + L L E+ + + + + K L Q+ G+ H+ R++H D
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEVEEGDCR---YLPKELLN 298
+KP N+LI + K+ DFG + Y ++L
Sbjct: 126 LKPQNLLI------------NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 299 NNFDNLSKVDIFALGLTLYE-ASGVTPLP-----------------KNGPMWHHIRDGNI 340
+ + +DI+++G E +G P N W ++ +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 341 --------------EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
L + + L+ M+ DP +R +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 4e-29
Identities = 49/314 (15%), Positives = 105/314 (33%), Gaps = 67/314 (21%)
Query: 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVN 181
+E +G G FGEV++ G AVK + + EI+ +L R +I+
Sbjct: 8 QESIGKGRFGEVWRG--KWRGEEVAVKIFSS---REERSWFREAEIYQTVML-RHENILG 61
Query: 182 YFSSWSDQG----VLYLQLEYCNGGNLENIIQERCTFTEMALK-------QLLFQVSEGL 230
+ ++ + L+L +Y G+L + + E +K L E +
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 231 RCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE---- 286
+ + H D+K NIL+ + + D G + +
Sbjct: 122 GTQGKPAIAHRDLKSKNILV------------KKNGTCCIADLGLAVRHDSATDTIDIAP 169
Query: 287 ----GDCRYLPKELLNNNFDNLS-----KVDIFALGLTLYEASGVTPLPK---------- 327
G RY+ E+L+++ + + DI+A+GL +E + +
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 328 ----NGPMWHHIRDGNIEKL-----------SNVSDDLHTLIKLMIDKDPTKRPSTSSLR 372
+ P +R E+ + +++ + R + ++
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 373 RSAQLARNYPQLKV 386
++ +K+
Sbjct: 290 KTLSQLSQQEGIKM 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-28
Identities = 52/282 (18%), Positives = 90/282 (31%), Gaps = 50/282 (17%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
E +G G +G VFK A+KR + + +EI L +IV
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRL 66
Query: 183 FSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMD 242
L L E+C+ + +K LFQ+ +GL H ++H D
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126
Query: 243 IKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV----IADNDFEVEEGDCRYLPKELLN 298
+KP N+LI KL +FG I + E Y P ++L
Sbjct: 127 LKPQNLLI------------NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 299 NNFDNLSKVDIFALGLTLYE-ASGVTPL-------------------------------- 325
+ +D+++ G E A+ PL
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 326 PKNGPMWHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ + + ++ L++ ++ +P +R S
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (277), Expect = 7e-28
Identities = 57/314 (18%), Positives = 105/314 (33%), Gaps = 69/314 (21%)
Query: 100 FDIKSISSTSIDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQ 159
+D +S + Y L LG G + EVF+ + + VK K +
Sbjct: 22 WDYESHVVEWGNQDDYQLV----RKLGRGKYSEVFEAINITNNEKVVVKILKP-----VK 72
Query: 160 EKIFKKEIHAHALLSRVPHIVNYFSSWSDQ--GVLYLQLEYCNGGNLENIIQERCTFTEM 217
+K K+EI L P+I+ D L E+ N + + + Q T T+
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDY 129
Query: 218 ALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG--- 274
++ ++++ + L H M ++H D+KP N++I + E +L D+G
Sbjct: 130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI-----------DHEHRKLRLIDWGLAE 178
Query: 275 HVIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNG---- 329
++ V + ELL + +D+++LG L P
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238
Query: 330 ------------PMWHHIRDGNIE------------------------KLSNVSDDLHTL 353
++ +I NIE VS +
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298
Query: 354 IKLMIDKDPTKRPS 367
+ ++ D R +
Sbjct: 299 LDKLLRYDHQSRLT 312
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 3e-27
Identities = 56/297 (18%), Positives = 109/297 (36%), Gaps = 50/297 (16%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKC-----LKYMDGMTYAVKRTKRPVANTAQEKIFK 164
R L + LG G FG+V + K T AVK K ++ +
Sbjct: 10 FPRDRLKLG----KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 165 KEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQE-------------- 210
+ + + + + G L + +E+C GNL ++
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125
Query: 211 --RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268
+ T L FQV++G+ + + IH D+ NIL+ +EK
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL------------SEKNVV 173
Query: 269 KLGDFG--HVIADNDFEVEEGDC----RYLPKELLNNNFDNLSKVDIFALGLTLYEASGV 322
K+ DFG I + V +GD +++ E + + + D+++ G+ L+E +
Sbjct: 174 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSL 232
Query: 323 TPLPKNGP-----MWHHIRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373
P G +++G + + +++ + +P++RP+ S L
Sbjct: 233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 54/297 (18%), Positives = 104/297 (35%), Gaps = 60/297 (20%)
Query: 112 HSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHA 171
+ Y + +GSG +G V + G A+K+ RP + K +E+
Sbjct: 17 RAVYRDL----QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 72
Query: 172 LLSRVPHIVNYFSSWSDQGVL------YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQ 225
+ +++ ++ L YL + + G + + E ++ L++Q
Sbjct: 73 HMRH-ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 226 VSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH-VIADNDFEV 284
+ +GLR +H +IH D+KP N+ + E K+ DFG AD++
Sbjct: 130 MLKGLRYIHAAGIIHRDLKPGNLAV------------NEDCELKILDFGLARQADSEMTG 177
Query: 285 EEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNI--- 340
Y E++ N VDI+++G + E +G T + + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 341 ------------------------------EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
L+N S L++ M+ D +R +
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-26
Identities = 56/288 (19%), Positives = 99/288 (34%), Gaps = 57/288 (19%)
Query: 123 ELLGSGDFGEVFKCL-KYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV--PHI 179
+G G +G+VFK G A+KR + +E+ L P++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 180 VNYF-----SSWSDQGVLYLQLEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCM 233
V F S + L L E+ + + + +K ++FQ+ GL +
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 234 HEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC---R 290
H R++H D+KP NIL+ T KL DFG +
Sbjct: 133 HSHRVVHRDLKPQNILV------------TSSGQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 291 YL-PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM----------------- 331
Y P+ LL +++ + VD++++G E + +
Sbjct: 181 YRAPEVLLQSSYA--TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 332 -----------WHHIRDGNIEKL-SNVSDDLHTLIKLMIDKDPTKRPS 367
+H IEK +++ + L+ + +P KR S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 2e-26
Identities = 46/304 (15%), Positives = 93/304 (30%), Gaps = 64/304 (21%)
Query: 113 SRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHAL 172
RY +G G +G V ++ + A+K+ P + + +EI
Sbjct: 8 PRYTNL----SYIGEGAYGMVCSAYDNVNKVRVAIKKIS-PFEHQTYCQRTLREIKILLR 62
Query: 173 LSRVPHIVNYFSSWSDQGVLYLQ----LEYCNGGNLENIIQERCTFTEMALKQLLFQVSE 228
+I+ + ++ + + G +L +++ + + + L+Q+
Sbjct: 63 FRH-ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILR 120
Query: 229 GLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEE-- 286
GL+ +H ++H D+KP+N+L+ K+ DFG +
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLL------------NTTCDLKICDFGLARVADPDHDHTGF 168
Query: 287 -----GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNI 340
Y E++ N+ +DI+++G L E S P + I
Sbjct: 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228
Query: 341 ---------------------------------EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
N L+ M+ +P KR
Sbjct: 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE 288
Query: 368 TSSL 371
Sbjct: 289 VEQA 292
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 2e-26
Identities = 53/285 (18%), Positives = 100/285 (35%), Gaps = 54/285 (18%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
+GSG +G V G+ AVK+ RP + K +E+ + +++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-ENVIGL 82
Query: 183 FSSWSDQGVL-----YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR 237
++ L + + G +L NI++ + T+ ++ L++Q+ GL+ +H
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSAD 141
Query: 238 MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDCR-YLPKEL 296
+IH D+KP+N+ E K+ DFG +D R Y E+
Sbjct: 142 IIHRDLKPSNLA------------VNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 189
Query: 297 LNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHHIRDGNI--------------- 340
+ N VDI+++G + E +G T P + +
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 341 ------------------EKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ L++ M+ D KR +
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 7e-24
Identities = 50/300 (16%), Positives = 94/300 (31%), Gaps = 73/300 (24%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNY 182
+ +GSG G V + A+K+ RP N K +E+ ++ +I++
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISL 81
Query: 183 FSSWSDQGV------LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEM 236
+ ++ Q +YL +E + + I E + LL+Q+ G++ +H
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSA 138
Query: 237 RMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFEVEEGDC----RYL 292
+IH D+KP+N + K+ DFG +
Sbjct: 139 GIIHRDLKPSN------------IVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 186
Query: 293 PKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPM-------------------- 331
P+ +L + VDI+++G + E P +
Sbjct: 187 PEVILGMGYK--ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 332 ------------------------WHHIRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPS 367
+ + E + L+ M+ DP KR S
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 76.2 bits (186), Expect = 1e-15
Identities = 54/308 (17%), Positives = 101/308 (32%), Gaps = 33/308 (10%)
Query: 110 IDHSRYALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQE----KIFKK 165
+RY L LG G F V+ ++ A+K + T K+ ++
Sbjct: 10 YKDARYILV----RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65
Query: 166 EIHA---HALLSRVPHIVNYFSSWSD--QGVLYLQLEYCNGGN---LENIIQERCTFTEM 217
A HI+ ++ +++ + + G E +
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 218 ALKQLLFQVSEGLR-CMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH- 275
+KQ+ Q+ GL +IH DIKP N+L+ + K+ D G+
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI------VDSPENLIQIKIADLGNA 179
Query: 276 VIADNDFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYE-ASGVTPLPKNGPMWHH 334
D + Y E+L DI++ ++E +G P H
Sbjct: 180 CWYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFE---PDEGH 235
Query: 335 IRDGNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLN 394
+ + ++ + + L L ++ R +S L RN +LK + L
Sbjct: 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSR----GLLRNISKLKFWPLEDVLT 291
Query: 395 TRLKKLDE 402
+ K +
Sbjct: 292 EKYKFSKD 299
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 59.0 bits (142), Expect = 7e-11
Identities = 27/212 (12%), Positives = 59/212 (27%), Gaps = 42/212 (19%)
Query: 123 ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKI--------FKKEIHA----- 169
+L+G G VF C VK K + + K F
Sbjct: 6 KLMGEGKESAVFNC-YSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 170 HALLSRVPHIVNYFSSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEG 229
L ++ + + +E + ++L + E
Sbjct: 65 FRALQKLQGL--AVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115
Query: 230 LRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVI---ADNDFEVEE 286
+ + ++H D+ N+L+ + + DF + + E+ E
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV-------------SEEGIWIIDFPQSVEVGEEGWREILE 162
Query: 287 GDCRYLPKELLNNNFDNLSKVDIFALGLTLYE 318
D R + + + + DI + + +
Sbjct: 163 RDVRNI-ITYFSRTYRT--EKDINSAIDRILQ 191
|
| >d1pdaa1 c.94.1.1 (A:3-219) Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain {Escherichia coli [TaxId: 562]} Length = 217 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Periplasmic binding protein-like II superfamily: Periplasmic binding protein-like II family: Phosphate binding protein-like domain: Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain species: Escherichia coli [TaxId: 562]
Score = 53.5 bits (128), Expect = 9e-09
Identities = 46/88 (52%), Positives = 55/88 (62%), Gaps = 3/88 (3%)
Query: 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILE 60
M T GD ILD L K+G K LF KELE+AL D VHS+KD+P E P GL L I E
Sbjct: 39 MVTRGDVILDTPLAKVGGKGLFVKELEVALLENRADIAVHSMKDVPVEFPQGLGLVTICE 98
Query: 61 REDPRDALILNKKWSGKTLATLPSGSVI 88
REDPRDA + N +L LP+GS++
Sbjct: 99 REDPRDAFVSNNY---DSLDALPAGSIV 123
|
| >d1pdaa1 c.94.1.1 (A:3-219) Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain {Escherichia coli [TaxId: 562]} Length = 217 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Periplasmic binding protein-like II superfamily: Periplasmic binding protein-like II family: Phosphate binding protein-like domain: Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain species: Escherichia coli [TaxId: 562]
Score = 52.7 bits (126), Expect = 2e-08
Identities = 33/64 (51%), Positives = 41/64 (64%), Gaps = 1/64 (1%)
Query: 367 STSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIM 426
TSSLRR QLA P L + ++RGN+ TRL KLD G +D IILAVAG+ R+ + RI
Sbjct: 124 GTSSLRRQCQLAERRPDLIIRSLRGNVGTRLSKLDNGE-YDAIILAVAGLKRLGLESRIR 182
Query: 427 AVFS 430
A
Sbjct: 183 AALP 186
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 480 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1pdaa1 | 217 | Porphobilinogen deaminase (hydroxymethylbilane syn | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.76 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.71 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.58 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.29 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.58 | |
| d1pdaa1 | 217 | Porphobilinogen deaminase (hydroxymethylbilane syn | 89.24 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-60 Score=452.10 Aligned_cols=250 Identities=25% Similarity=0.434 Sum_probs=220.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||+|++.+... .......+.+|+.+++.+ +|||||++++++.+++.+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEECCEEEEE
Confidence 468889999999999999999999999999999864211 111245688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||++|+|.+++.....+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill------------~~~~~~kl~DFG~ 152 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL------------GSAGELKIADFGW 152 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEECCCCS
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee------------cCCCCEeecccce
Confidence 9999999999999988899999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHH
Q psy14702 276 VIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDL 350 (480)
Q Consensus 276 a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~ 350 (480)
+..... .....||+.|+|||++.+..++ .++|||||||++|+| +|..||..... .+..+.+..+..+..+|+++
T Consensus 153 a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 231 (263)
T d2j4za1 153 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231 (263)
T ss_dssp CSCCCCCCCEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred eeecCCCcccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence 975543 3345799999999999987665 789999999999996 77888865543 45667777777778899999
Q ss_pred HHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 351 HTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 351 ~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
++||.+||++||++|||++|+++||||..+
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 999999999999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=456.24 Aligned_cols=253 Identities=22% Similarity=0.385 Sum_probs=213.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|++.+.||+|+||+||+|+++.+|+.||||++...... ...+.+.+|+.+++.+ +|||||++++++.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKML-NHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTC-CCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhC-CCCCEeeEeeeeccCceeEEE
Confidence 45788999999999999999999999999999998764322 2335688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++..+..+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl------------~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL------------DERDNLKISDFGL 149 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------CTTCCEEECCCTT
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE------------CCCCCEEEccchh
Confidence 9999999999999887889999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc---hHHHhcCC--CCcC
Q psy14702 276 VIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM---WHHIRDGN--IEKL 343 (480)
Q Consensus 276 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~---~~~i~~~~--~~~~ 343 (480)
|..... ....+||+.|||||++.+..+++.++|||||||++||| +|..||...... +..+.... ...+
T Consensus 150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (271)
T d1nvra_ 150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229 (271)
T ss_dssp CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTG
T ss_pred heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCcc
Confidence 865321 23457999999999998877665689999999999996 677788654432 22222222 2334
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
..+|+++++||.+||+.||++|||++|+++||||.+..+
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 230 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 578999999999999999999999999999999976543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.8e-59 Score=453.20 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=221.2
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN-TAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...|...+.||+|+||+||+|+++.+|+.||||++...... ....+.+.+|+.+++.+ +|||||++++++.+++.+||
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~i 92 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLREHTAWL 92 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEECCEEEE
Confidence 45688999999999999999999999999999999865443 33456789999999999 79999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||.+|+|..++..+.++++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||
T Consensus 93 v~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl------------~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL------------SEPGLVKLGDFG 160 (309)
T ss_dssp EEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE------------ETTTEEEECCCT
T ss_pred EEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE------------CCCCCEEEeecc
Confidence 99999999998888877899999999999999999999999999999999999999 567789999999
Q ss_pred cccccCCCcccCCCcccchhhhhccc--CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc--CCCCC
Q psy14702 275 HVIADNDFEVEEGDCRYLPKELLNNN--FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK--LSNVS 347 (480)
Q Consensus 275 ~a~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~--~~~~s 347 (480)
++..........||+.|+|||++.+. ..++.++|||||||++||| +|..||..... ....+..+..+. ...+|
T Consensus 161 ~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s 240 (309)
T d1u5ra_ 161 SASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240 (309)
T ss_dssp TCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSC
T ss_pred cccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCC
Confidence 99887777778899999999998643 2234689999999999996 67778765543 233444444433 34589
Q ss_pred HHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCc
Q psy14702 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLK 385 (480)
Q Consensus 348 ~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~ 385 (480)
+++++||.+||+.||.+|||++|+++||||.+..+...
T Consensus 241 ~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~ 278 (309)
T d1u5ra_ 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV 278 (309)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCchh
Confidence 99999999999999999999999999999988665543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-58 Score=450.97 Aligned_cols=278 Identities=23% Similarity=0.376 Sum_probs=214.4
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
....|.+.+.||+|+||+||+|.++.+|+.||||++.+..... ....+.+|+.++..+ +|||||++++++.+++.+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKI-KHPNIVALDDIYESGGHLYL 84 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTC-CCTTBCCEEEEEECSSEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 4466899999999999999999999999999999997653332 245688999999999 89999999999999999999
Q ss_pred EeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 195 QLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||||+||+|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||+... +.++.+||+|||
T Consensus 85 vmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~---------~~~~~vkl~DFG 155 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL---------DEDSKIMISDFG 155 (307)
T ss_dssp EECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS---------STTCCEEECCC-
T ss_pred EEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc---------CCCceEEEeccc
Confidence 99999999999999988899999999999999999999999999999999999999532 346789999999
Q ss_pred cccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC----cCC
Q psy14702 275 HVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE----KLS 344 (480)
Q Consensus 275 ~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~----~~~ 344 (480)
++...... ...+||+.|+|||++.+..++ .++|||||||++|+| +|..||..... .+..+..+... .++
T Consensus 156 ~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (307)
T d1a06a_ 156 LSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTT
T ss_pred eeEEccCCCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCcccc
Confidence 99755432 345799999999999987665 799999999999996 67778765543 44556655443 335
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcc
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVF 406 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 406 (480)
.+|+++++||.+||++||++|||++|+++||||....... .++...+...+++....+.+
T Consensus 235 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 294 (307)
T d1a06a_ 235 DISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALD--KNIHQSVSEQIKKNFAKSKW 294 (307)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCC--CCCHHHHHHHHHHHSCCCTT
T ss_pred CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccc--cccchhHHHHHHHHHHHhhh
Confidence 7899999999999999999999999999999997543211 22334444455554444333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-58 Score=444.81 Aligned_cols=248 Identities=24% Similarity=0.382 Sum_probs=212.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||+||+|.++.+|+.||||+++...... .+.+.+|+.+++.+ +|||||+++++|.+++.+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMREN-KNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhC-CCCCEeeEeEEEEECCEEEEE
Confidence 347889999999999999999999999999999987543332 35689999999999 889999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.+ ..+++.+++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl------------~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL------------GMDGSVKLTDFGF 162 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEECCCTT
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE------------CCCCcEeeccchh
Confidence 999999999998875 479999999999999999999999999999999999999 5567899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHh-cC--CCCcCCC
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIR-DG--NIEKLSN 345 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~-~~--~~~~~~~ 345 (480)
+..... ....+||+.|+|||++.+..++ .++|||||||++|+| +|..||...... ...+. .. .++.+..
T Consensus 163 a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (293)
T d1yhwa1 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK 241 (293)
T ss_dssp CEECCSTTCCBCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGG
T ss_pred heeeccccccccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCccc
Confidence 875432 2345699999999999987665 799999999999996 777888665432 22222 22 2334567
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
+|+++++||.+||++||++|||+.|+++||||+..
T Consensus 242 ~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 89999999999999999999999999999999653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-58 Score=449.18 Aligned_cols=250 Identities=25% Similarity=0.368 Sum_probs=210.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.++|.+.+.||+|+||+||+|+++.+|+.||+|+++.... ......+.+|+.+++.+ +|||||+++++|.+++.+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEE
Confidence 4578899999999999999999999999999999986533 33346688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE-MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
||||+||+|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||
T Consensus 83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl------------~~~~~vkl~DFG 150 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV------------NSRGEIKLCDFG 150 (322)
T ss_dssp EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE------------CTTCCEEECCCC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE------------CCCCCEEEeeCC
Confidence 9999999999999988899999999999999999999997 599999999999999 567789999999
Q ss_pred cccccC--CCcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchH------------------
Q psy14702 275 HVIADN--DFEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWH------------------ 333 (480)
Q Consensus 275 ~a~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~------------------ 333 (480)
+|.... .....+||+.|+|||++.+..++ .++|||||||++||| +|..||........
T Consensus 151 la~~~~~~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 151 VSGQLIDSMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp CCHHHHHHTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred CccccCCCccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 987432 23456899999999999987665 789999999999996 77888865432100
Q ss_pred --------------------------HHhcCCCCcC--CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 334 --------------------------HIRDGNIEKL--SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 334 --------------------------~i~~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.+.....+.. ..+|.++++||.+||+.||.+|||++|+++||||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0111111111 1368899999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=439.64 Aligned_cols=248 Identities=28% Similarity=0.452 Sum_probs=205.8
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--CCEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD--QGVLY 193 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~ 193 (480)
..+|++.+.||+|+||+||+|+++.+|+.||||++..........+.+.+|+.++..+ +|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 3578899999999999999999999999999999987766666677899999999999 89999999999864 56789
Q ss_pred EEeeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceecCCCCCcEEEeccCCCCCCCCCcc
Q psy14702 194 LQLEYCNGGNLENIIQE----RCTFTEMALKQLLFQVSEGLRCMHEMR-----MIHMDIKPANILIVKAQGELNEPMNTE 264 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~-----IvHrDlKp~NILl~~~~~~~~~~~~~~ 264 (480)
||||||+||+|.+++.+ +..+++..++.++.||+.||+|||++| ||||||||+|||+ +.
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll------------~~ 149 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL------------DG 149 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE------------CT
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc------------CC
Confidence 99999999999999864 357999999999999999999999976 9999999999999 56
Q ss_pred ccceEeCccCcccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhc
Q psy14702 265 KLHYKLGDFGHVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRD 337 (480)
Q Consensus 265 ~~~vkL~DFG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~ 337 (480)
++.+||+|||++..... ....+||+.|+|||++.+..++ .++|||||||++||| +|..||..... ....+..
T Consensus 150 ~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~ 228 (269)
T d2java1 150 KQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228 (269)
T ss_dssp TSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence 77899999999875433 2345799999999999887665 799999999999996 67777765443 3455666
Q ss_pred CCCC-cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 338 GNIE-KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 338 ~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
+..+ .+..+|+++++||.+||+.||++|||++|+++|||+
T Consensus 229 ~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 6654 446799999999999999999999999999999994
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-58 Score=444.47 Aligned_cols=248 Identities=23% Similarity=0.393 Sum_probs=215.2
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.+ +|||||+++++|.+++.+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999865211 111235688999999999 889999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 87 mEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll------------~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL------------NEDMHIQITDFGT 154 (288)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred EEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc------------CCCceEEeccccc
Confidence 9999999999999988899999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCC
Q psy14702 276 VIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNV 346 (480)
Q Consensus 276 a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~ 346 (480)
|+.... ....+||+.|+|||++.+..++ .++|||||||++|+| +|..||...+. .+..+.++.+..+..+
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 233 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKF 233 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTC
T ss_pred ceecccCCcccccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccC
Confidence 975432 2235699999999999887665 789999999999996 78888876543 4566778887778889
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
|+++++||.+||++||++|||++|++.|+|+.
T Consensus 234 s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~ 265 (288)
T d1uu3a_ 234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 265 (288)
T ss_dssp CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHH
Confidence 99999999999999999999999976666654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-57 Score=432.45 Aligned_cols=245 Identities=21% Similarity=0.319 Sum_probs=209.2
Q ss_pred hhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----CCEEEEE
Q psy14702 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----QGVLYLQ 195 (480)
Q Consensus 120 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~~~~lv 195 (480)
...+.||+|+||+||+|.+..+++.||+|++..........+.+.+|+++++.+ +|||||+++++|.+ +..+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCCEEEEE
Confidence 456789999999999999999999999999887655666677899999999999 79999999999865 4578999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMR--MIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~--IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||++|+|.+++.+...+++..++.++.||+.||+|||+++ |+||||||+|||++ +.++.+||+||
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~-----------~~~~~~Kl~DF 159 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT-----------GPTGSVKIGDL 159 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES-----------STTSCEEECCT
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee-----------CCCCCEEEeec
Confidence 999999999999998889999999999999999999999999 99999999999993 23568999999
Q ss_pred CcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCCC--cCCC
Q psy14702 274 GHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNIE--KLSN 345 (480)
Q Consensus 274 G~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~~--~~~~ 345 (480)
|++..... ....+||+.|+|||++.+. + +.++|||||||++||| +|..||..... .+..+..+..+ ....
T Consensus 160 Gla~~~~~~~~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 237 (270)
T d1t4ha_ 160 GLATLKRASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237 (270)
T ss_dssp TGGGGCCTTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred CcceeccCCccCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCcc
Confidence 99975443 3346799999999999765 4 3799999999999996 77888865443 33444444332 2345
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
+++++++||.+||++||++|||++|+++||||+
T Consensus 238 ~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 789999999999999999999999999999983
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=437.10 Aligned_cols=248 Identities=24% Similarity=0.326 Sum_probs=210.5
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
..|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+.+++.+ +|||||++++++.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASC-DHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--HHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeCCeEEEEE
Confidence 357889999999999999999999999999999976432 2335688999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll------------~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF------------TLDGDIKLADFGV 156 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE------------CCCCCEEEEechh
Confidence 999999999997654 579999999999999999999999999999999999999 5667899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhccc----CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCC---
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNN----FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIE--- 341 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~--- 341 (480)
|..... ....+||+.|+|||++... ..++.++|||||||++||| +|..||..... ....+..+..+
T Consensus 157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~ 236 (288)
T d2jfla1 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236 (288)
T ss_dssp CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCS
T ss_pred hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 864432 2346799999999998532 2234789999999999996 67778765543 34455555433
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.+..+|+++++||.+||++||++|||++|+++||||..
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 34578999999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-57 Score=435.61 Aligned_cols=255 Identities=24% Similarity=0.381 Sum_probs=218.2
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
...+|.+.+.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+++.+ +|||||+++++|.+.+
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECC
Confidence 4467999999999999999999999999999999987543221 2246689999999999 7999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|||||||+||+|.+++..+..+++..++.++.||+.||+|||++||+||||||+|||+...+ .....+||
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~--------~~~~~vkl 158 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN--------VPKPRIKI 158 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS--------SSSCCEEE
T ss_pred EEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCC--------CcccceEe
Confidence 9999999999999999999888999999999999999999999999999999999999995433 23457999
Q ss_pred CccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc--
Q psy14702 271 GDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK-- 342 (480)
Q Consensus 271 ~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~-- 342 (480)
+|||++..... .....||+.|+|||++.+..++ .++|||||||++||| +|..||..... .+..+..+....
T Consensus 159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1jksa_ 159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237 (293)
T ss_dssp CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred cchhhhhhcCCCccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence 99999876543 3345799999999999987665 789999999999996 77778765543 345566655443
Q ss_pred --CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 343 --LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 343 --~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
++.+|+++++||.+||+.||++|||++|+++||||+.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 2578999999999999999999999999999999964
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-57 Score=443.58 Aligned_cols=249 Identities=24% Similarity=0.339 Sum_probs=219.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++++... .......+.+|+.+++.+ +|||||+++++|.+.+.+|+|
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECSSEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeeccccccccc
Confidence 468899999999999999999999999999999875321 111235578999999999 799999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.+...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl------------~~~g~vkl~DFG~ 151 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML------------DKDGHIKITDFGL 151 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe------------cCCCCEEEeeccc
Confidence 9999999999999998899999999999999999999999999999999999999 6677999999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
|+.... ....+||+.|+|||++.+..++ .++|||||||++||| +|..||...+. ....+..+.+..+..+|+
T Consensus 152 a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~ 230 (337)
T d1o6la_ 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230 (337)
T ss_dssp CBCSCCTTCCBCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccccccCCcccccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCH
Confidence 975432 2346799999999999988775 789999999999996 67777776543 456777788888889999
Q ss_pred HHHHHHHHhhccCCCCCCC-----hhHHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPS-----TSSLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps-----~~ell~h~~~~~ 379 (480)
++++||.+||++||.+||+ +.++++||||..
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999999999995 899999999854
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-56 Score=443.48 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=217.2
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
...+|.+.+.||+|+||+||+|+++.+|+.||||++... .....+.+.+|+.++..+ +|||||+++++|.+++.+||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEE
Confidence 345789999999999999999999999999999999764 344556789999999999 79999999999999999999
Q ss_pred EeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 195 QLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
|||||+||+|.+++.+ .+.+++..++.|+.||+.||.|||++|||||||||+|||+.. +.++.+||+||
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~----------~~~~~vkL~DF 170 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT----------KRSNELKLIDF 170 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------TTSCCEEECCC
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc----------CCCCeEEEeec
Confidence 9999999999999854 457999999999999999999999999999999999999943 23568999999
Q ss_pred CcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc----C
Q psy14702 274 GHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK----L 343 (480)
Q Consensus 274 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~----~ 343 (480)
|++...... ....||+.|||||++.+..++ .++|||||||++|+| +|..||..... .+..+....... +
T Consensus 171 G~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 249 (350)
T d1koaa2 171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249 (350)
T ss_dssp TTCEECCTTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG
T ss_pred chheecccccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 999765433 346799999999999987665 789999999999996 67788865443 455566655432 2
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..+|+++++||.+||+.||++|||++|+++||||...
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 4689999999999999999999999999999999754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-56 Score=428.70 Aligned_cols=252 Identities=22% Similarity=0.376 Sum_probs=216.4
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-------HHHHHHHHHHHHHHhcCCCCceeEEeeEEee
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-------AQEKIFKKEIHAHALLSRVPHIVNYFSSWSD 188 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-------~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~ 188 (480)
..+|.+.+.||+|+||+||+|+++.+|+.||||++++..... ...+.+.+|+.+++.+..|||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 467889999999999999999999999999999987643321 2234688999999999779999999999999
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
++.+|||||||+||+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill------------~~~~~~ 149 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL------------DDDMNI 149 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTCCE
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE------------cCCCCe
Confidence 99999999999999999999988899999999999999999999999999999999999999 667789
Q ss_pred EeCccCcccccCC---CcccCCCcccchhhhhccc-----CCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhc
Q psy14702 269 KLGDFGHVIADND---FEVEEGDCRYLPKELLNNN-----FDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRD 337 (480)
Q Consensus 269 kL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~ 337 (480)
||+|||++..... .....||+.|+|||++.+. ...+.++||||+||++|+| +|..||..... ....+..
T Consensus 150 kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 150 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHh
Confidence 9999999976543 3345699999999998742 2234689999999999996 77788876553 3344555
Q ss_pred CCCC----cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 338 GNIE----KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 338 ~~~~----~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
+... .+.++|+++++||.+||+.||++|||+.|+++||||++
T Consensus 230 ~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 230 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 5443 23479999999999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-56 Score=437.91 Aligned_cols=249 Identities=23% Similarity=0.404 Sum_probs=219.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++++... .....+.+.+|+.+++.+ +|||||++++++.+.+.+|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEeeCCeeeeE
Confidence 468899999999999999999999999999999875321 111235688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|..++.....+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl------------~~~g~vkL~DFG~ 150 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL------------DKNGHIKITDFGF 150 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE------------CTTSCEEECCCSS
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE------------cCCCCEEEecCcc
Confidence 9999999999999998899999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHHH
Q psy14702 276 VIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLH 351 (480)
Q Consensus 276 a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~~ 351 (480)
|..... ....+||+.|+|||++.+..++ .++|||||||++|+| +|..||..... ....+..+....++.+|++++
T Consensus 151 a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 229 (316)
T d1fota_ 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVK 229 (316)
T ss_dssp CEECSSCBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred ceEeccccccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 976544 3456799999999999888766 689999999999996 78888876543 456677788888888999999
Q ss_pred HHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 352 TLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 352 ~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
++|.+||.+||.+|+ |++++++||||..
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 999999999999996 9999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-56 Score=443.37 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=218.1
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|++.+.||+|+||+||+|.++.+|+.||||+++... ......+.+|+.++..+ +|||||+++++|.+++.+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQL-HHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTC-CSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999987643 34456788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+||+|.+++... .++++.+++.|+.||+.||+|||++|||||||||+|||+.. ...+.+||+|||+
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~----------~~~~~vkL~DFGl 175 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET----------KKASSVKIIDFGL 175 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------TTCCCEEECCCTT
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc----------cCCCeEEEeeccc
Confidence 999999999887654 46999999999999999999999999999999999999942 2456899999999
Q ss_pred ccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCc----CCC
Q psy14702 276 VIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEK----LSN 345 (480)
Q Consensus 276 a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~----~~~ 345 (480)
|...... ....||+.|+|||++.+..++ .++|||||||++|+| +|..||..... ....+..+.... +..
T Consensus 176 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 254 (352)
T d1koba_ 176 ATKLNPDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254 (352)
T ss_dssp CEECCTTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred ceecCCCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccC
Confidence 9765433 345799999999999988665 789999999999996 77788876543 345566655432 357
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCCC
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQL 384 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~~ 384 (480)
+|+++++||.+||++||.+|||+.|+++||||......+
T Consensus 255 ~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~ 293 (352)
T d1koba_ 255 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 293 (352)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchh
Confidence 899999999999999999999999999999998655443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-56 Score=435.27 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=217.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||+||+|.++.+|+.||||+++.. ......+.+|+.+|..+ +|||||+++++|.+++.+||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHS-CCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhC-CCCCCCeEEEEEEECCEEEEEE
Confidence 5688999999999999999999999999999999764 23345688999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQERC-TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||+.. +....+||+|||+
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~----------~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT----------RRSSTIKIIEFGQ 150 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS----------SSCCCEEECCCTT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC----------CCceEEEEcccch
Confidence 9999999999998664 7999999999999999999999999999999999999943 2355799999999
Q ss_pred ccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcC----CC
Q psy14702 276 VIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKL----SN 345 (480)
Q Consensus 276 a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~----~~ 345 (480)
+...... ....||+.|+|||++.+..+. .++|||||||++|+| +|..||..... .+..+.++.+..+ +.
T Consensus 151 ~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 229 (321)
T d1tkia_ 151 ARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229 (321)
T ss_dssp CEECCTTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTT
T ss_pred hhccccCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccC
Confidence 8765432 335699999999999887665 799999999999996 77788876543 4556666665433 46
Q ss_pred CCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCCC
Q psy14702 346 VSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYPQ 383 (480)
Q Consensus 346 ~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~~ 383 (480)
+|+++++||.+||.+||++|||+.|+++||||.+..+.
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~ 267 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIER 267 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGG
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCccc
Confidence 89999999999999999999999999999999875443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.6e-56 Score=440.16 Aligned_cols=249 Identities=25% Similarity=0.372 Sum_probs=219.7
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
.+|.+++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+++.+ +|||||++++++.+...+|+|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeecccccccccccccc
Confidence 578999999999999999999999999999999864211 112235688999999999 899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||.||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl------------~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI------------DQQGYIQVTDFGF 187 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTSCEEECCCTT
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc------------CCCCCEEeeecee
Confidence 9999999999999988899999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCHHHH
Q psy14702 276 VIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSDDLH 351 (480)
Q Consensus 276 a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~~~~ 351 (480)
|+.... .....||+.|||||++.+..++ .++|||||||++||| +|..||..... ....+..+....+..+|+++.
T Consensus 188 a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 266 (350)
T d1rdqe_ 188 AKRVKGRTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266 (350)
T ss_dssp CEECSSCBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHH
T ss_pred eeecccccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHH
Confidence 976554 3346799999999999988765 789999999999996 77788876543 456677788888889999999
Q ss_pred HHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 352 TLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 352 ~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
+||.+||++||.+|+ |++++++||||..
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 999999999999994 9999999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.4e-55 Score=437.31 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=207.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH-HHHHHHHHH---HHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT-AQEKIFKKE---IHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~-~~~~~~~~E---i~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
.+|.+.+.||+|+||+||+|+++.+|+.||||++.+..... .....+.+| +.++..+ +|||||+++++|.+.+.+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECSSEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEECCEE
Confidence 36888999999999999999999999999999986421111 112234445 4444444 699999999999999999
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
|||||||+||+|.+++.+...+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl------------~~~g~iKl~D 150 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL------------DEHGHVRISD 150 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CSSSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE------------cCCCcEEEee
Confidence 9999999999999999988899999999999999999999999999999999999999 6677899999
Q ss_pred cCcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc-ch----HHHhcCCCCcCC
Q psy14702 273 FGHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP-MW----HHIRDGNIEKLS 344 (480)
Q Consensus 273 FG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~-~~----~~i~~~~~~~~~ 344 (480)
||+|..... ....+||+.|+|||++..+..++.++|||||||+|||| +|..||..... .. ..+.......+.
T Consensus 151 FGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 230 (364)
T d1omwa3 151 LGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 230 (364)
T ss_dssp CTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCS
T ss_pred eceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 999975543 33467999999999997655445799999999999996 78888865432 11 222333445567
Q ss_pred CCCHHHHHHHHHhhccCCCCCCC-----hhHHHHHHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPS-----TSSLRRSAQLAR 379 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps-----~~ell~h~~~~~ 379 (480)
.+|+++++||.+||++||.+||| ++++++||||..
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 89999999999999999999999 799999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-56 Score=433.64 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=215.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
++|.+.+.||+|+||+||+|.++.+|+.||||++++... .....+.+..|..++....+|||||++++++.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 468889999999999999999999999999999875211 1111234566777766444899999999999999999999
Q ss_pred eeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 196 LEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
||||+||+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+
T Consensus 82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~------------~~~~~~kl~DFG~ 149 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL------------DKDGHIKIADFGM 149 (320)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE------------CTTSCEEECCCTT
T ss_pred EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee------------cCCCceeccccch
Confidence 9999999999999988899999999999999999999999999999999999999 6677899999999
Q ss_pred ccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCCCCcCCCCCH
Q psy14702 276 VIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGNIEKLSNVSD 348 (480)
Q Consensus 276 a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~~~~~~~~s~ 348 (480)
+..... .....||+.|+|||++.+..++ .++|||||||++|+| +|..||..... .+..+..+.+..+..+|+
T Consensus 150 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~ 228 (320)
T d1xjda_ 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK 228 (320)
T ss_dssp CBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred hhhcccccccccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCH
Confidence 864432 2335799999999999988776 799999999999996 67788876543 556777787777788999
Q ss_pred HHHHHHHHhhccCCCCCCChh-HHHHHHHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTS-SLRRSAQLAR 379 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~-ell~h~~~~~ 379 (480)
++++||.+||++||.+|||+. ++++||||..
T Consensus 229 ~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 229 EAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 999999999999999999995 8999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-56 Score=424.24 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=213.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC-CCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANT----AQEKIFKKEIHAHALLS-RVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~----~~~~~~~~Ei~~l~~l~-~hpnIv~l~~~~~~~~ 190 (480)
..+|++.+.||+|+||+||+|+++.+|+.||||++++..... .....+.+|+.+++.+. .|||||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 357889999999999999999999999999999987532111 11223567999999885 3899999999999999
Q ss_pred EEEEEeeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 191 VLYLQLEYCNG-GNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 191 ~~~lv~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
.+|+||||+.+ +++.+++..+..+++..++.++.||+.||+|||++||+||||||+|||++. +.+.+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~-----------~~~~vk 151 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL-----------NRGELK 151 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEET-----------TTTEEE
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEec-----------CCCeEE
Confidence 99999999976 688899988889999999999999999999999999999999999999942 346899
Q ss_pred eCccCcccccCC--CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchHHHhcCCCCcCCCC
Q psy14702 270 LGDFGHVIADND--FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWHHIRDGNIEKLSNV 346 (480)
Q Consensus 270 L~DFG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~~i~~~~~~~~~~~ 346 (480)
|+|||++..... .....||+.|+|||++.+..+++.++|||||||++|+| +|..||... ..+..+.......+
T Consensus 152 l~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~~i~~~~~~~~~~~ 227 (273)
T d1xwsa_ 152 LIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----EEIIRGQVFFRQRV 227 (273)
T ss_dssp ECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----HHHHHCCCCCSSCC
T ss_pred ECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----hHHhhcccCCCCCC
Confidence 999999865433 34467999999999998876665679999999999996 677777543 34666677777889
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
|+++++||.+||++||++|||++|+++||||+..
T Consensus 228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999999999999653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=431.12 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=206.1
Q ss_pred hhhhhhh-eeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee----CC
Q psy14702 116 ALEFLEE-ELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD----QG 190 (480)
Q Consensus 116 ~~~y~~~-~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~----~~ 190 (480)
..+|.+. ++||+|+||+||+|+++.+|+.||||+++.. ..+.+|+.++..+.+|||||+++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 4567766 4699999999999999999999999998742 3367899988777789999999999875 46
Q ss_pred EEEEEeeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 191 VLYLQLEYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
.+|||||||+||+|.+++..+ ..+++.+++.|+.||+.||+|||++||+||||||+|||+... ...+.+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~---------~~~~~~ 153 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK---------RPNAIL 153 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS---------STTCCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc---------cccccc
Confidence 799999999999999999864 369999999999999999999999999999999999999542 235679
Q ss_pred EeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc------chHHHhcC
Q psy14702 269 KLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP------MWHHIRDG 338 (480)
Q Consensus 269 kL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~------~~~~i~~~ 338 (480)
||+|||+++.... ....+||+.|+|||++.+..++ .++|||||||++|+| +|..||..... ....+..+
T Consensus 154 Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 154 KLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp EECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred cccccceeeeccCCCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 9999999865433 3346799999999999887665 789999999999997 66777764432 11223333
Q ss_pred CCCcC----CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 339 NIEKL----SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 339 ~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
.+..+ ..+|+++++||.+||+.||++|||+.|+++||||.+...
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 33222 358999999999999999999999999999999986543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-55 Score=424.01 Aligned_cols=245 Identities=23% Similarity=0.312 Sum_probs=199.2
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHH---HHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeec
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTA---QEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEY 198 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~---~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~ 198 (480)
+++||+|+||+||+|+++.+|+.||||+++....... ..+.+.+|+.+++.+ +|||||++++++.+++.+||||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCTTCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccCCceeehhhh
Confidence 5889999999999999999999999999875432222 134688999999999 899999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccc
Q psy14702 199 CNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIA 278 (480)
Q Consensus 199 ~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~ 278 (480)
|.++++..++..+..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli------------~~~~~~KL~DFG~a~~ 149 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL------------DENGVLKLADFGLAKS 149 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTCCEEECCCGGGST
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe------------cCCCccccccCccccc
Confidence 9998888777666789999999999999999999999999999999999999 6677899999999865
Q ss_pred cCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhcC-------------
Q psy14702 279 DND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDG------------- 338 (480)
Q Consensus 279 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~~------------- 338 (480)
... ....+||+.|+|||++.+...++.++|||||||++||| +|..||...... ...+.+.
T Consensus 150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred cCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 443 22356999999999998765555799999999999997 566666544321 1111110
Q ss_pred ---------CCC------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 339 ---------NIE------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 339 ---------~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
..+ ..+.+++++++||.+||+.||++|||++|+++||||+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 000 12356889999999999999999999999999999974
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-53 Score=411.54 Aligned_cols=240 Identities=21% Similarity=0.303 Sum_probs=204.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||+||+|.++.+|+.||||+++..... .+.|.+|+.++..+ +|||||++++++.+.+.+||||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEI-KHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhC-CCCCEecCCccEeeCCeeEEEe
Confidence 4677889999999999999999999999999998764433 34588999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 197 EYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 197 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl------------~~~~~~Kl~DFG 160 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV------------GENHLVKVADFG 160 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CGGGCEEECCCC
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE------------CCCCcEEEcccc
Confidence 999999999999764 478999999999999999999999999999999999999 667899999999
Q ss_pred cccccCCCc-----ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCcc---chHHHhcC-CCCcCC
Q psy14702 275 HVIADNDFE-----VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGP---MWHHIRDG-NIEKLS 344 (480)
Q Consensus 275 ~a~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~---~~~~i~~~-~~~~~~ 344 (480)
+++...... ...||+.|+|||++.+..++ .++|||||||++|||+ ++.|+..... .+..+..+ ..+.+.
T Consensus 161 ~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 239 (287)
T d1opja_ 161 LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 239 (287)
T ss_dssp CTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ceeecCCCCceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCc
Confidence 997654322 12478899999999887665 7999999999999975 4666654433 23334444 344556
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~ 373 (480)
.+|+++++||.+||+.||++|||++++++
T Consensus 240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 79999999999999999999999999965
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=407.21 Aligned_cols=240 Identities=24% Similarity=0.309 Sum_probs=198.3
Q ss_pred eeecccCceEEEEEEEee--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEeeccC
Q psy14702 123 ELLGSGDFGEVFKCLKYM--DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLEYCN 200 (480)
Q Consensus 123 ~~LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E~~~ 200 (480)
+.||+|+||+||+|.... +++.||||+++....+....+.|.+|+.++..+ +|||||++++++..+ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC-CEEEEEEcCC
Confidence 579999999999997653 457899999976555555567799999999999 899999999998654 5789999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcccccC
Q psy14702 201 GGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHVIADN 280 (480)
Q Consensus 201 gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~ 280 (480)
+|+|.+++.....+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+++...
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill------------~~~~~~kl~DFGla~~~~ 158 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL------------VTQHYAKISDFGLSKALR 158 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------EETTEEEECCCTTCEECC
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc------------cccCcccccchhhhhhcc
Confidence 99999999988899999999999999999999999999999999999999 567789999999986543
Q ss_pred CC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCcCCCCCH
Q psy14702 281 DF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEKLSNVSD 348 (480)
Q Consensus 281 ~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~~~~~s~ 348 (480)
.. ....||+.|+|||++.+..++ .++|||||||++|||+ |..||..... ....+.++. .+.+..+|+
T Consensus 159 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~ 237 (277)
T d1xbba_ 159 ADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPR 237 (277)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred ccccccccccccCCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence 22 124589999999999887665 7999999999999964 5677765432 344555554 445677999
Q ss_pred HHHHHHHHhhccCCCCCCChhHHH---HHHHH
Q psy14702 349 DLHTLIKLMIDKDPTKRPSTSSLR---RSAQL 377 (480)
Q Consensus 349 ~~~~li~~~L~~dP~~Rps~~ell---~h~~~ 377 (480)
++.+||.+||+.||++|||+++|+ +|+|+
T Consensus 238 ~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 238 EMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999999999984 55554
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-54 Score=415.43 Aligned_cols=252 Identities=25% Similarity=0.356 Sum_probs=203.5
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
++|.+.+.||+|+||+||+|.++.+|+.||||+++...........+.+|+.+++.+ +|||||+++++|.+.+.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccccceeEEE
Confidence 468889999999999999999999999999999976543333356788999999999 8999999999999999999999
Q ss_pred eccCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 197 EYCNGGNLENIIQ-E-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 197 E~~~gg~L~~~l~-~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||.++ +.+++. . ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||
T Consensus 81 e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~------------~~~~~~kl~DFG 147 (298)
T d1gz8a_ 81 EFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI------------NTEGAIKLADFG 147 (298)
T ss_dssp ECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTSCEEECSTT
T ss_pred eecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee------------cccCcceeccCC
Confidence 999664 444443 3 3469999999999999999999999999999999999999 566789999999
Q ss_pred cccccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--C-------
Q psy14702 275 HVIADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD--G------- 338 (480)
Q Consensus 275 ~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~--~------- 338 (480)
++..... .....||+.|+|||++....+.+.++|||||||++|+| +|..||...... +..+.. +
T Consensus 148 ~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 227 (298)
T d1gz8a_ 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW 227 (298)
T ss_dssp HHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc
Confidence 9865432 23346999999999988877766899999999999996 788888654421 111110 0
Q ss_pred -----------CCC---------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 339 -----------NIE---------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 339 -----------~~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
..+ ....+|+++++||.+||+.||++|||++|+++||||.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 228 PGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp TTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 000 12356889999999999999999999999999999976433
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=406.98 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=199.8
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||+||+|+. +..||||+++.........+.|.+|+.++..+ +|||||++++++.+ +.+||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS-SSCEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec-cEEEEEE
Confidence 4577789999999999999963 34699999987655556667899999999999 89999999998754 5689999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCc
Q psy14702 197 EYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGH 275 (480)
Q Consensus 197 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~ 275 (480)
|||+||+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 83 Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl------------~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL------------HEDLTVKIGDFGL 150 (276)
T ss_dssp ECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------ETTSSEEECCCCC
T ss_pred ecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE------------cCCCCEEEccccc
Confidence 999999999999754 569999999999999999999999999999999999999 5677899999999
Q ss_pred ccccCC------CcccCCCcccchhhhhcccC--CCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCC---
Q psy14702 276 VIADND------FEVEEGDCRYLPKELLNNNF--DNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNI--- 340 (480)
Q Consensus 276 a~~~~~------~~~~~gt~~y~aPE~~~~~~--~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~--- 340 (480)
|..... .....||+.|||||++.+.. ..+.++|||||||++||| +|..||..... ....+..+..
T Consensus 151 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 151 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp SCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC
T ss_pred eeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc
Confidence 865432 22356999999999997532 234689999999999996 67888875443 2233333322
Q ss_pred --CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 341 --EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 341 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
..+.++|+++.+||.+||..||++|||+.+|+++.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l 270 (276)
T d1uwha_ 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL 270 (276)
T ss_dssp GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 12356899999999999999999999999999996543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=417.12 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=202.3
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCc-----EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGM-----TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~-----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.+.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.++..+.+|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 468889999999999999999876543 69999986532 233445688999999999889999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q psy14702 192 LYLQLEYCNGGNLENIIQERC-----------------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANI 248 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NI 248 (480)
+|||||||++|+|.++++.+. .+++..++.|+.||+.||+|||++|||||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 999999999999999997542 488999999999999999999999999999999999
Q ss_pred EEeccCCCCCCCCCccccceEeCccCcccccCCCc------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--
Q psy14702 249 LIVKAQGELNEPMNTEKLHYKLGDFGHVIADNDFE------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-- 320 (480)
Q Consensus 249 Ll~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-- 320 (480)
|+ +.++.+||+|||+|+...... ...||+.|||||++.+..++ .++|||||||++|||+
T Consensus 196 ll------------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~ 262 (325)
T d1rjba_ 196 LV------------THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSL 262 (325)
T ss_dssp EE------------ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTT
T ss_pred cc------------ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhC
Confidence 99 667799999999986543321 23479999999999887665 7999999999999974
Q ss_pred CCCCCCCCcc---chHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 321 GVTPLPKNGP---MWHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 321 ~~~p~~~~~~---~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
|..||..... +...+..+ .++.+..+|+++++||.+||+.||++|||++||++|.
T Consensus 263 g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L 321 (325)
T d1rjba_ 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321 (325)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 5677765432 22333333 3445677999999999999999999999999999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-53 Score=409.39 Aligned_cols=244 Identities=21% Similarity=0.322 Sum_probs=196.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCc---EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGM---TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~---~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+|.+.+.||+|+||+||+|.++.+++ .||||.+... ......+.|.+|+.++..+ +|||||++++++.+.+.+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKSTPVM 103 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSSSSCE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeCCEEE
Confidence 457778999999999999999876664 6899988653 3445556799999999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
+|||||++|+|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl------------~~~~~~Kl~D 171 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV------------NSNLVCKVSD 171 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCEEECC
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE------------CCCCcEEECC
Confidence 999999999999988764 479999999999999999999999999999999999999 6678999999
Q ss_pred cCcccccCCCc---------ccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC-
Q psy14702 273 FGHVIADNDFE---------VEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG- 338 (480)
Q Consensus 273 FG~a~~~~~~~---------~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~- 338 (480)
||+++...... ...||+.|+|||++.+..++ .++|||||||++|||+ |..||..... ....+..+
T Consensus 172 FGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~ 250 (299)
T d1jpaa_ 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250 (299)
T ss_dssp C-----------------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred cccceEccCCCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 99986543211 13478999999999887665 7899999999999974 5667765433 33445544
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..+.+..+++++.+||.+||+.||++|||+.||+++.
T Consensus 251 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L 287 (299)
T d1jpaa_ 251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 3456677999999999999999999999999999874
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=400.46 Aligned_cols=240 Identities=23% Similarity=0.300 Sum_probs=195.8
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E 197 (480)
+|.+.+.||+|+||+||+|... +++.||||+++..... .+.|.+|+.++..+ +|||||++++++..++.+|+|||
T Consensus 6 ~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKL-SHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp CEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECSSSSCEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc---HHHHHHHHHHHHhc-CCCCcccccceeccCCceEEEEE
Confidence 4667899999999999999764 6788999999764333 34589999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 198 YCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 198 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill------------~~~~~~Kl~DFGla 148 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV------------GENQVIKVSDFGMT 148 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE------------CGGGCEEECSCC--
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee------------cCCCCeEecccchh
Confidence 99999999998754 468999999999999999999999999999999999999 67789999999998
Q ss_pred cccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCcc---chHHHhcCC-CCcCCCC
Q psy14702 277 IADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGP---MWHHIRDGN-IEKLSNV 346 (480)
Q Consensus 277 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~---~~~~i~~~~-~~~~~~~ 346 (480)
+..... ....||+.|+|||++.+..++ .++|||||||++|||+ ++.|+..... ....+..+. ...+..+
T Consensus 149 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 149 RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp ----------------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccCCCceeecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcccc
Confidence 654332 224589999999999987665 7999999999999975 4555544332 344555553 3445668
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
++++.+||.+||+.||++|||++++++|.
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L 256 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQL 256 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 99999999999999999999999999884
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=403.11 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=204.0
Q ss_pred hhhhhhee-ecccCceEEEEEEEee--CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 117 LEFLEEEL-LGSGDFGEVFKCLKYM--DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 117 ~~y~~~~~-LG~G~fg~V~~~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+|.+.+. ||+|+||+||+|.++. ++..||||+++.. ......+.|.+|+.++..+ +|||||++++++.. +.+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES-SSEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeecc-CeEE
Confidence 34556664 9999999999997654 4568999999764 3445567799999999999 89999999999865 4589
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
||||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill------------~~~~~~Kl~D 152 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL------------VNRHYAKISD 152 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------EETTEEEECC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee------------ccCCceeecc
Confidence 999999999999998653 579999999999999999999999999999999999999 5677899999
Q ss_pred cCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcCC-C
Q psy14702 273 FGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDGN-I 340 (480)
Q Consensus 273 FG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~~-~ 340 (480)
||+++..... ....||+.|+|||++.+..++ .++|||||||++||| + |..||..... ....+..+. .
T Consensus 153 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~ 231 (285)
T d1u59a_ 153 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM 231 (285)
T ss_dssp CTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC
T ss_pred chhhhcccccccccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 9998754332 234588999999999877665 799999999999996 4 6778765432 445566664 3
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHH---HHHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSL---RRSAQLAR 379 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~el---l~h~~~~~ 379 (480)
+.++.+|+++.+||.+||+.||++|||+.+| |+|+|+.-
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 4567899999999999999999999999988 56677643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-53 Score=411.90 Aligned_cols=248 Identities=22% Similarity=0.307 Sum_probs=205.5
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
++|.+.+.||+|+||+||+|+++ +|+.||||+++.........+.+.+|+.+++.+ +|||||+++++|.+++..|++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccCCceeEEE
Confidence 36889999999999999999875 889999999976544444456789999999999 7999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 197 EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
||+.++.+..+......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||.+
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll------------~~~~~~kl~DfG~a 147 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI------------NREGELKIADFGLA 147 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTSCEEECCTTHH
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE------------cCCCCEEecccccc
Confidence 999887777777767789999999999999999999999999999999999999 56778999999998
Q ss_pred cccCC----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--C---------
Q psy14702 277 IADND----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD--G--------- 338 (480)
Q Consensus 277 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~--~--------- 338 (480)
..... .....|++.|+|||++.+..+.+.++|||||||++||| +|..||...... ...+.. +
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccc
Confidence 65433 23346899999999998776666899999999999996 777787654321 111110 0
Q ss_pred -----C-------------CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 339 -----N-------------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 339 -----~-------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
. ...+..+++++++||++||++||++|||++|+++||||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred hhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence 0 012345789999999999999999999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=401.79 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=203.1
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|.+.+.||+|+||+||+|.+. +++.||||+++..... .+.|.+|+.++..+ +|||||++++++.+ +.+||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-~~~~iv~ 86 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQL-QHQRLVRLYAVVTQ-EPIYIIT 86 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhC-CCCCEeEEEeeecc-CCeEEEE
Confidence 46778999999999999999864 6789999999764333 34589999999999 89999999998755 5679999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 197 EYCNGGNLENIIQER--CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 197 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||++|+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll------------~~~~~~Kl~DFG 154 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV------------SDTLSCKIADFG 154 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE------------CTTSCEEECCCT
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee------------ecccceeecccc
Confidence 999999999977533 369999999999999999999999999999999999999 667899999999
Q ss_pred cccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCcc---chHHHhcCC-CCcCC
Q psy14702 275 HVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGP---MWHHIRDGN-IEKLS 344 (480)
Q Consensus 275 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~---~~~~i~~~~-~~~~~ 344 (480)
+|+..... ....||+.|+|||++.+..++ .++|||||||++|||+ ++.|+..... ....+..+. ...+.
T Consensus 155 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~ 233 (272)
T d1qpca_ 155 LARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233 (272)
T ss_dssp TCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred ceEEccCCccccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcc
Confidence 99765432 234588999999999877665 7999999999999975 4566554332 334455543 44556
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHH--HHHHHH
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRR--SAQLAR 379 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~--h~~~~~ 379 (480)
.+++++.+||.+||+.||++|||+++|++ ++||..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 79999999999999999999999999998 678764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2e-52 Score=401.70 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=202.4
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC---
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG--- 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~--- 190 (480)
..++|.+.+.||+|+||+||+|.+..+|+.||||+++.... +......+.+|+.+++.+ +|||||++++++...+
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCC
Confidence 45679999999999999999999999999999999987544 344556799999999998 8899999999987643
Q ss_pred -EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceE
Q psy14702 191 -VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYK 269 (480)
Q Consensus 191 -~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vk 269 (480)
.+|||||||+|++|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.++
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll------------~~~~~~~ 151 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI------------SATNAVK 151 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------ETTSCEE
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc------------Cccccce
Confidence 489999999999999999988899999999999999999999999999999999999999 5567899
Q ss_pred eCccCcccccCC-------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc--chHHHhcCC
Q psy14702 270 LGDFGHVIADND-------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP--MWHHIRDGN 339 (480)
Q Consensus 270 L~DFG~a~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~~~~i~~~~ 339 (480)
|+|||.+..... ....+||+.|+|||++.+..++ .++|||||||++|+| +|..||..... ....+....
T Consensus 152 l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 230 (277)
T ss_dssp ECCCTTCEECC----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC
T ss_pred eehhhhhhhhccccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcC
Confidence 999998754322 2234699999999999887665 789999999999996 77778876543 222233322
Q ss_pred C----CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHH
Q psy14702 340 I----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLA 378 (480)
Q Consensus 340 ~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~ 378 (480)
. ...+.+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 2 12357899999999999999999999555555577654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=405.07 Aligned_cols=253 Identities=21% Similarity=0.272 Sum_probs=213.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+++.+ +||||+++++++.+....++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccccceeEEe
Confidence 368899999999999999999999999999999987665556667899999999998 8899999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 197 EYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 197 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
|++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||.+
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli------------~~~~~~kl~DFG~a 148 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI------------NRNGELKLANFGLA 148 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE------------CTTCCEEECCCTTC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc------------ccCCceeeeecchh
Confidence 999999999998888899999999999999999999999999999999999999 55668999999998
Q ss_pred cccCCC----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch---HHHhc-----------
Q psy14702 277 IADNDF----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW---HHIRD----------- 337 (480)
Q Consensus 277 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~---~~i~~----------- 337 (480)
...... ....+++.|+|||++.+..+.+.++|||||||++||| +|+.||....... ..+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp EECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCT
T ss_pred hcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhh
Confidence 755432 2345788999999998776666899999999999997 5777875443211 11110
Q ss_pred ------------------CCCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 338 ------------------GNIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 338 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
........+++.+++||.+||+.||.+||||+|+++||||..-.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 001122457889999999999999999999999999999975443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-52 Score=392.83 Aligned_cols=240 Identities=23% Similarity=0.290 Sum_probs=204.0
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E 197 (480)
+|...+.||+|+||+||+|++ .+++.||||++++..... +.|.+|+.++..+ +|||||++++++.+++.+|+|||
T Consensus 5 ~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 5 DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNL-SHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTC-CCTTBCCEEEEECCSSSEEEEEE
T ss_pred HCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhc-CCCceeeEEEEEeeCCceEEEEE
Confidence 566789999999999999986 478899999998754432 4589999999999 89999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 198 YCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 198 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill------------~~~~~~kl~DfG~a 147 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV------------NDQGVVKVSDFGLS 147 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE------------CTTCCEEECCCSSC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE------------cCCCcEEECcchhh
Confidence 9999999999764 3579999999999999999999999999999999999999 66779999999998
Q ss_pred cccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcCC-CCcCCCC
Q psy14702 277 IADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDGN-IEKLSNV 346 (480)
Q Consensus 277 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~~-~~~~~~~ 346 (480)
...... ....||+.|+|||++.+..++ .++|||||||++|||+ |..||..... ....+.++. .+.+..+
T Consensus 148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 148 RYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp CBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred eeccCCCceeecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 654322 234589999999999987665 7999999999999974 4567665432 344455553 4455678
Q ss_pred CHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 347 SDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 347 s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
++++++||.+||+.||++|||++++++|.
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L 255 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNI 255 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHh
Confidence 99999999999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=409.29 Aligned_cols=252 Identities=21% Similarity=0.266 Sum_probs=199.7
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeC-CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCCceeEEeeEEee---
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMD-GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS--RVPHIVNYFSSWSD--- 188 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~--~hpnIv~l~~~~~~--- 188 (480)
...+|.+++.||+|+||+||+|++..+ ++.||||+++...........+.+|+.+++.|. +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 346899999999999999999998765 678999998654332222233567777777663 79999999999853
Q ss_pred --CCEEEEEeeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccc
Q psy14702 189 --QGVLYLQLEYCNGGNLENIIQE-RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEK 265 (480)
Q Consensus 189 --~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~ 265 (480)
...+|++||||.++++...... ...+++..++.++.||+.||+|||++|||||||||+|||+ +..
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi------------~~~ 152 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV------------TSS 152 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTT
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE------------cCC
Confidence 3578999999988777655443 3479999999999999999999999999999999999999 667
Q ss_pred cceEeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhc--
Q psy14702 266 LHYKLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRD-- 337 (480)
Q Consensus 266 ~~vkL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~-- 337 (480)
+.+||+|||++..... .....||+.|+|||++.+..++ .++|||||||++||| +|..||...... ...+..
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 231 (305)
T d1blxa_ 153 GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 231 (305)
T ss_dssp CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred CCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhh
Confidence 7899999998865432 2346799999999999887665 799999999999996 677777655421 111110
Q ss_pred ---------------------C----CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 338 ---------------------G----NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 338 ---------------------~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
. ....+..+++++++||.+||++||++|||+.|+++||||+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 0 00123457899999999999999999999999999999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=395.37 Aligned_cols=243 Identities=20% Similarity=0.297 Sum_probs=198.6
Q ss_pred hhhhheeecccCceEEEEEEEeeCC----cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDG----MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~----~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.|...++||+|+||.||+|..+.++ ..||||+++.. ........|.+|+.++..+ +|||||++++++.+.+.++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSSSEE
T ss_pred HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEecCCceE
Confidence 4667899999999999999877654 47999999764 3444556789999999999 8999999999999999999
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
+|||||.+|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+|||+ +.++.+||+|
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl------------~~~~~~Kl~D 153 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV------------NSNLVCKVSD 153 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCEEECC
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE------------CCCCeEEEcc
Confidence 999999999999988755 579999999999999999999999999999999999999 6678999999
Q ss_pred cCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCcc---chHHHhcCC-C
Q psy14702 273 FGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGP---MWHHIRDGN-I 340 (480)
Q Consensus 273 FG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~---~~~~i~~~~-~ 340 (480)
||+++..... ....||+.|+|||++.+..++ .++|||||||++|||+ ++.|+..... ....+..+. .
T Consensus 154 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~ 232 (283)
T d1mqba_ 154 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 232 (283)
T ss_dssp CCC-----------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred cchhhcccCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC
Confidence 9998654321 123589999999999887665 7999999999999975 4566554332 344455543 3
Q ss_pred CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 341 EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 341 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
+.+..++.++.+||.+||+.||++|||+.+|++..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L 267 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHH
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHH
Confidence 45567899999999999999999999999998754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=411.54 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=204.6
Q ss_pred hhhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC----
Q psy14702 115 YALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG---- 190 (480)
Q Consensus 115 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~---- 190 (480)
+..+|.+++.||+|+||+||+|.++.+|+.||||++++........+.+.+|+.+|+.+ +|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence 45679999999999999999999999999999999987766667777899999999999 8999999999997654
Q ss_pred --EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 191 --VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 191 --~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
.+|+||||| +++|..+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~------------~~~~~~ 160 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV------------NEDCEL 160 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCE
T ss_pred cceEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc------------cccccc
Confidence 579999999 6788877654 579999999999999999999999999999999999999 667789
Q ss_pred EeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHHh--------
Q psy14702 269 KLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHIR-------- 336 (480)
Q Consensus 269 kL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i~-------- 336 (480)
||+|||++..... .....||+.|+|||++.+..+.+.++||||+||++|+| +|..||....... ..+.
T Consensus 161 kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 161 KILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp EECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 9999999976544 34467999999999998766656799999999999996 6777776543210 0000
Q ss_pred ---------------cC--C------CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 337 ---------------DG--N------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 337 ---------------~~--~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
.. . ...+..+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00 0 01234678999999999999999999999999999999753
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=393.21 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=196.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeC---CcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMD---GMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~---~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
.+|.+.+.||+|+||.||+|.+..+ +..||||.++.. ......+.+.+|+.+++.+ +|||||++++++. ++.+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQF-DHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEe-cCeEE
Confidence 5788899999999999999987654 357899988653 3445566799999999999 8999999999986 46789
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll------------~~~~~~Kl~D 151 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV------------SSNDCVKLGD 151 (273)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------EETTEEEECC
T ss_pred EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee------------cCCCcEEEcc
Confidence 999999999999987654 479999999999999999999999999999999999999 5667899999
Q ss_pred cCcccccCCC-----cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-h-CCCCCCCCcc--chHHHhcCC-CCc
Q psy14702 273 FGHVIADNDF-----EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-S-GVTPLPKNGP--MWHHIRDGN-IEK 342 (480)
Q Consensus 273 FG~a~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~-~~~p~~~~~~--~~~~i~~~~-~~~ 342 (480)
||+++..... ....||+.|+|||++.+..++ .++|||||||++||| + |..||..... ....+.++. .+.
T Consensus 152 fG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~ 230 (273)
T d1mp8a_ 152 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230 (273)
T ss_dssp -------------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC
T ss_pred chhheeccCCcceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 9998754322 234589999999999887665 789999999999996 4 5556654432 345556654 456
Q ss_pred CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 343 LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 343 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
++++|+++.+||.+||..||++|||+.+|+++..
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~ 264 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS 264 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 6789999999999999999999999999998853
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=396.49 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=195.0
Q ss_pred hhhhhheeecccCceEEEEEEEee-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-CC
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYM-----DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-QG 190 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~ 190 (480)
.+|.+.+.||+|+||.||+|.+.. +++.||||+++.. ......+.+.+|...+..+.+|||||++++++.. +.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 568889999999999999998764 3478999998754 3344456688888889888899999999998765 45
Q ss_pred EEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccC
Q psy14702 191 VLYLQLEYCNGGNLENIIQER----------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQ 254 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~ 254 (480)
.+|+|||||++|+|.+++... ..+++.+++.++.||+.||.|||++|||||||||+|||+
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---- 167 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---- 167 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE----
Confidence 689999999999999999753 248899999999999999999999999999999999999
Q ss_pred CCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCC-CCC
Q psy14702 255 GELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVT-PLP 326 (480)
Q Consensus 255 ~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~-p~~ 326 (480)
+.++.+||+|||+|+..... ....||+.|+|||++.+..++ .++|||||||++|||+ +.. ||.
T Consensus 168 --------~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~ 238 (299)
T d1ywna1 168 --------SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYP 238 (299)
T ss_dssp --------CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSST
T ss_pred --------CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCC
Confidence 66789999999998643321 234699999999999987665 7999999999999975 444 454
Q ss_pred CCcc---chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 327 KNGP---MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 327 ~~~~---~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
.... ....+..+. .+.+..+++++++||.+||+.||++|||+.|+++|..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~ 292 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 3322 233444443 3445678999999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-51 Score=403.75 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=201.5
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--CCEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD--QGVLY 193 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~--~~~~~ 193 (480)
..+|++++.||+|+||+||+|+++.+|+.||||+++... .+.+.+|+.+|..+.+||||++++++|.. ...+|
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 357999999999999999999999999999999987532 24578899999999889999999999974 45799
Q ss_pred EEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 194 LQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
+|||||.+++|..+. ..+++..++.++.||+.||+|||++||+||||||+|||++. ++..+||+||
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~-----------~~~~vkl~DF 174 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH-----------EHRKLRLIDW 174 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEET-----------TTTEEEECCG
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcC-----------CCCeeeeccc
Confidence 999999999997763 46999999999999999999999999999999999999942 2346899999
Q ss_pred CcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccchH---HH-----------
Q psy14702 274 GHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMWH---HI----------- 335 (480)
Q Consensus 274 G~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~~---~i----------- 335 (480)
|++..... .....||+.|+|||++.+....+.++||||+||++|+| +|..||........ .+
T Consensus 175 G~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~ 254 (328)
T d3bqca1 175 GLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254 (328)
T ss_dssp GGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHH
T ss_pred ccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhh
Confidence 99865433 34456999999999998766555799999999999996 77788765432110 00
Q ss_pred --hcCC------------------------CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHH
Q psy14702 336 --RDGN------------------------IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLAR 379 (480)
Q Consensus 336 --~~~~------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~ 379 (480)
.... ......+|+++++||.+||.+||.+|||++|+|+||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp HHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 0000 0011237889999999999999999999999999999964
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=403.93 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=199.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee--------
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-------- 188 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-------- 188 (480)
.+|.+.+.||+|+||+||+|++..+|+.||||++............+.+|+.+++.+ +||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeeccccccccc
Confidence 578899999999999999999999999999999876544444445688999999999 78999999998754
Q ss_pred CCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 189 QGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 189 ~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
++.+|+|||||.++.+..+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl------------~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI------------TRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTSCE
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee------------cCCCcE
Confidence 45689999999887776665666689999999999999999999999999999999999999 567789
Q ss_pred EeCccCcccccCC--------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHHhc
Q psy14702 269 KLGDFGHVIADND--------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHIRD 337 (480)
Q Consensus 269 kL~DFG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i~~ 337 (480)
||+|||++..... ....+||+.|+|||++.+...++.++|||||||++||| +|..||....... ..+..
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 9999999854332 22346999999999998765555799999999999997 6777765443211 11111
Q ss_pred --CCC--C---------------cC-------------CCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 338 --GNI--E---------------KL-------------SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 338 --~~~--~---------------~~-------------~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
+.. . .. ...++++++||.+||++||++|||+.|+++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 000 0 00 0136788999999999999999999999999999753
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=396.87 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=200.8
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcE--EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMT--YAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~--vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
.+|.+.++||+|+||+||+|.++.+|.. ||||+++... .....+.+.+|+.++..+.+|||||++++++.+++.+|+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 3567789999999999999999988874 6777775432 233445689999999999789999999999999999999
Q ss_pred EeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCC
Q psy14702 195 QLEYCNGGNLENIIQER----------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELN 258 (480)
Q Consensus 195 v~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~ 258 (480)
|||||++|+|.++++.+ ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~-------- 160 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV-------- 160 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE--------
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE--------
Confidence 99999999999999753 468999999999999999999999999999999999999
Q ss_pred CCCCccccceEeCccCcccccCCC---cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCC-CCCCcc--c
Q psy14702 259 EPMNTEKLHYKLGDFGHVIADNDF---EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTP-LPKNGP--M 331 (480)
Q Consensus 259 ~~~~~~~~~vkL~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p-~~~~~~--~ 331 (480)
+.++.+||+|||++...... ....||+.|+|||.+.+..++ .++|||||||++|||+ ++.| |..... .
T Consensus 161 ----~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 161 ----GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp ----CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ----cCCCceEEccccccccccccccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHH
Confidence 66779999999998654332 234689999999999887665 7899999999999975 4444 433222 3
Q ss_pred hHHHhcC-CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 332 WHHIRDG-NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 332 ~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
...+.++ .++.+..+++++++||.+||+.||++|||+.+|+++.
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 4445554 3445677999999999999999999999999999984
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=405.32 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=210.0
Q ss_pred hhhhhheeecccCceEEEEEEEe---eCCcEEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKY---MDGMTYAVKRTKRPVA--NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~---~~~~~vAvK~~~~~~~--~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.+.||+|+||+||+|.+. .+|+.||||++++... .....+.+.+|+.+++.+.+||||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56889999999999999999874 4689999999865321 111234477899999999777999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|++||||.+|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill------------~~~~~vkL~ 171 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL------------DSNGHVVLT 171 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTSCEEES
T ss_pred eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee------------cCCCCEEEe
Confidence 99999999999999999988899999999999999999999999999999999999999 566789999
Q ss_pred ccCcccccCC-----CcccCCCcccchhhhhcccC-CCCCcccHHHHHHHHHHH-hCCCCCCCCcc--c----hHHHhcC
Q psy14702 272 DFGHVIADND-----FEVEEGDCRYLPKELLNNNF-DNLSKVDIFALGLTLYEA-SGVTPLPKNGP--M----WHHIRDG 338 (480)
Q Consensus 272 DFG~a~~~~~-----~~~~~gt~~y~aPE~~~~~~-~~~~k~DiwSlGvilyel-~~~~p~~~~~~--~----~~~i~~~ 338 (480)
|||++..... .....|++.|+|||.+.+.. +.+.++|||||||+||+| +|..||..... . .......
T Consensus 172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 9999865432 22356999999999997643 344689999999999996 78888865432 2 2233344
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCC-----ChhHHHHHHHHHH
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRP-----STSSLRRSAQLAR 379 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rp-----s~~ell~h~~~~~ 379 (480)
..+.+..+|+++.+||.+||++||.+|| |++|+++||||..
T Consensus 252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 5566678999999999999999999999 5899999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=392.58 Aligned_cols=247 Identities=22% Similarity=0.299 Sum_probs=200.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEe
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQL 196 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~ 196 (480)
.+|++.+.||+|+||+||+|.+. +++.||||+++..... .+.|.+|+.++..+ +|||||++++++.+ +.+|+||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l-~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKL-RHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSC---HHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSCEEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCC---HHHHHHHHHHHHhc-ccCCEeEEEEEEec-CCeEEEE
Confidence 46888999999999999999875 4467999999765433 34589999999999 89999999999855 5579999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 197 EYCNGGNLENIIQE--RCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 197 E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||++|+|..++.. ...+++.+++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll------------~~~~~~kl~DfG 158 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV------------GENLVCKVADFG 158 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CGGGCEEECCCC
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE------------CCCCcEEEcccc
Confidence 99999999988853 3579999999999999999999999999999999999999 667899999999
Q ss_pred cccccCC-----CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCCCCcc---chHHHhcC-CCCcCC
Q psy14702 275 HVIADND-----FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLPKNGP---MWHHIRDG-NIEKLS 344 (480)
Q Consensus 275 ~a~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~~~~~---~~~~i~~~-~~~~~~ 344 (480)
+++.... .....||+.|+|||++....++ .++|||||||++|||+ ++.|+..... ....+..+ ..+.+.
T Consensus 159 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~ 237 (285)
T d1fmka3 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237 (285)
T ss_dssp TTC--------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCT
T ss_pred hhhhccCCCceeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc
Confidence 9865432 1234689999999999887665 7999999999999974 5666654433 33444444 345667
Q ss_pred CCCHHHHHHHHHhhccCCCCCCChhHHHH--HHHHHHhCC
Q psy14702 345 NVSDDLHTLIKLMIDKDPTKRPSTSSLRR--SAQLARNYP 382 (480)
Q Consensus 345 ~~s~~~~~li~~~L~~dP~~Rps~~ell~--h~~~~~~~~ 382 (480)
.+|+++++||.+||+.||++|||+++|++ ++|+....|
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 89999999999999999999999999986 556554433
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=396.44 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=197.3
Q ss_pred hhhhheeecccCceEEEEEEEeeCCc----EEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEE
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGM----TYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLY 193 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~----~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~ 193 (480)
+|++.++||+|+||+||+|.+..+|+ +||+|+++... .....+.+.+|+.++..+ +|||||++++++.++ ..+
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASV-DNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS-SEE
T ss_pred HCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC-Cee
Confidence 58889999999999999999887776 58888876532 222345689999999999 899999999999865 567
Q ss_pred EEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCc
Q psy14702 194 LQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGD 272 (480)
Q Consensus 194 lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~D 272 (480)
++||||.+|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll------------~~~~~~kl~D 154 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV------------KTPQHVKITD 154 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------EETTEEEECC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee------------CCCCCeEeec
Confidence 888999999999888754 579999999999999999999999999999999999999 5677899999
Q ss_pred cCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCc--cchHHHhcCC-CC
Q psy14702 273 FGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNG--PMWHHIRDGN-IE 341 (480)
Q Consensus 273 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~--~~~~~i~~~~-~~ 341 (480)
||++...... ....||+.|+|||++.+..++ .++|||||||++|||+ |..||.... .....+..+. .+
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~ 233 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 233 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC
T ss_pred cccceecccccccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998754321 223589999999999888665 7999999999999985 344554332 2344555554 45
Q ss_pred cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHH
Q psy14702 342 KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQL 377 (480)
Q Consensus 342 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~ 377 (480)
.++.+++++.+||.+||..||.+|||+.++++|...
T Consensus 234 ~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~ 269 (317)
T d1xkka_ 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269 (317)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence 667899999999999999999999999999998654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=404.18 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=200.1
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC-----E
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG-----V 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~-----~ 191 (480)
.+|.+++.||+|+||+||+|.++.+|+.||||++.+.. .....+.+.+|+.+|+.+ +||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccce
Confidence 46889999999999999999999999999999997643 445566789999999999 8899999999987543 3
Q ss_pred EEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 192 LYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
+|++| |+.+|+|.+++..+ .+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+
T Consensus 86 ~~l~~-~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl------------~~~~~~kl~ 151 (345)
T d1pmea_ 86 VYLVT-HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL------------NTTCDLKIC 151 (345)
T ss_dssp EEEEE-ECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE------------CTTCCEEEC
T ss_pred EEEEE-eecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE------------CCCCCEEEc
Confidence 55554 55699999999764 79999999999999999999999999999999999999 567789999
Q ss_pred ccCcccccCC-------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHH------
Q psy14702 272 DFGHVIADND-------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHI------ 335 (480)
Q Consensus 272 DFG~a~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i------ 335 (480)
|||++..... ....+||+.|+|||++.....++.++||||+||++|+| +|..||...... ....
T Consensus 152 DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~ 231 (345)
T d1pmea_ 152 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231 (345)
T ss_dssp CCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCS
T ss_pred ccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccC
Confidence 9999864432 23356999999999987665555789999999999996 677777654321 0000
Q ss_pred ------------------hcC---CC----CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhCC
Q psy14702 336 ------------------RDG---NI----EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNYP 382 (480)
Q Consensus 336 ------------------~~~---~~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~~ 382 (480)
... .. ..++.+|+++++||.+||+.||.+|||++|+++||||.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred CChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 000 00 123467899999999999999999999999999999986543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=403.16 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=195.6
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee------CCE
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------QGV 191 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------~~~ 191 (480)
+|...++||+|+||+||+|+++.+|+.||||++...... ..+|+.+++.+ +|||||+++++|.. ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceE
Confidence 577889999999999999999999999999999764322 34699999999 89999999999853 346
Q ss_pred EEEEeeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccce
Q psy14702 192 LYLQLEYCNGGNLENII---QERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHY 268 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~v 268 (480)
+|||||||+++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++. +...+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~-----------~~~~~ 162 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP-----------DTAVL 162 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECT-----------TTCCE
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEec-----------CCCce
Confidence 89999999766433332 34457999999999999999999999999999999999999932 23479
Q ss_pred EeCccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHh------
Q psy14702 269 KLGDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIR------ 336 (480)
Q Consensus 269 kL~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~------ 336 (480)
||+|||++..... .....||+.|+|||++.+...++.++||||+||++||| +|..||...... ...+.
T Consensus 163 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 163 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp EECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 9999999865432 33457999999999988766556899999999999996 677777654321 11110
Q ss_pred -------------cCCCC----------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 337 -------------DGNIE----------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 337 -------------~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
....+ ....+++++.+||.+||.+||++|||+.|+++||||...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 00111 123578999999999999999999999999999999764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-50 Score=389.08 Aligned_cols=244 Identities=25% Similarity=0.311 Sum_probs=204.2
Q ss_pred hhhhhhheeecccCceEEEEEEEee-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYM-----DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~ 190 (480)
..+|.+.+.||+|+||+||+|+.+. +++.||||+++.. ......+.|.+|+.+++.+ +||||+++++++...+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhc-CCCCcccceeeeccCC
Confidence 3468889999999999999998753 5688999998764 3444567799999999999 8999999999999999
Q ss_pred EEEEEeeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy14702 191 VLYLQLEYCNGGNLENIIQERC------------------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPA 246 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~ 246 (480)
..+++||||++|+|.+++.... .+++..+..|+.||+.||+|||+++||||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 9999999999999999996432 3889999999999999999999999999999999
Q ss_pred cEEEeccCCCCCCCCCccccceEeCccCcccccCC------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-
Q psy14702 247 NILIVKAQGELNEPMNTEKLHYKLGDFGHVIADND------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA- 319 (480)
Q Consensus 247 NILl~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel- 319 (480)
|||+ +.++.+||+|||+++.... .....||+.|+|||++.+..++ .++|||||||++|||
T Consensus 170 NILl------------d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell 236 (301)
T d1lufa_ 170 NCLV------------GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIF 236 (301)
T ss_dssp GEEE------------CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHH
T ss_pred ceEE------------CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHH
Confidence 9999 6678999999999864322 2235688999999999987665 799999999999997
Q ss_pred hCCC-CCCCCcc--chHHHhcCCCC-cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 320 SGVT-PLPKNGP--MWHHIRDGNIE-KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 320 ~~~~-p~~~~~~--~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
++.. ||..... ....+..+..+ .+..+++++.+||.+||+.||++|||+.||++.
T Consensus 237 ~~~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~ 295 (301)
T d1lufa_ 237 SYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 295 (301)
T ss_dssp TTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4544 4544432 34556666654 456799999999999999999999999999653
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=404.19 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=205.3
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC-----C
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ-----G 190 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~-----~ 190 (480)
..+|++.+.||+|+||+||+|+++.+|+.||||++++........+.+.+|+.+++.+ +|||||++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEeeccccccC
Confidence 4679999999999999999999999999999999988777777777899999999999 789999999998632 3
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
..+++|+||.||+|.+++.. .++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi------------~~~~~~kl 162 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV------------NEDCELKI 162 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE------------CTTCCEEE
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc------------cccccccc
Confidence 34566677789999999864 479999999999999999999999999999999999999 66778999
Q ss_pred CccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--hHHHhcC--------
Q psy14702 271 GDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--WHHIRDG-------- 338 (480)
Q Consensus 271 ~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~~~i~~~-------- 338 (480)
+|||++..... .....||+.|+|||++.+..+.+.++|||||||++|+| +|..||...... ...+...
T Consensus 163 ~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 163 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 99999865543 33456899999999988776666799999999999996 677777654421 1111100
Q ss_pred -----------------CCC------cCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHh
Q psy14702 339 -----------------NIE------KLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARN 380 (480)
Q Consensus 339 -----------------~~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~ 380 (480)
..+ .+..+++++++||.+||..||.+|||+.|+++||||++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000 124578999999999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=381.30 Aligned_cols=240 Identities=22% Similarity=0.327 Sum_probs=192.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-CCEEEEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-QGVLYLQ 195 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~~lv 195 (480)
.+|.+.+.||+|+||.||+|.. +|..||||+++... ..+.+.+|+.+++.+ +|||||++++++.+ .+.+|+|
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----TAQAFLAEASVMTQL-RHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC------HHHHHTHHHHTTC-CCTTBCCEEEEECCC--CCEEE
T ss_pred HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH----HHHHHHHHHHHHHhC-CCCCEeeEEEEEEecCCcEEEE
Confidence 3567789999999999999975 68899999997542 234588999999999 89999999998854 5668999
Q ss_pred eeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCcc
Q psy14702 196 LEYCNGGNLENIIQERC--TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDF 273 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DF 273 (480)
||||++|+|.+++..+. .+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+||
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~------------~~~~~~kl~df 147 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV------------SEDNVAKVSDF 147 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CTTSCEEECCC
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee------------cCCCCEeeccc
Confidence 99999999999996543 58999999999999999999999999999999999999 66778999999
Q ss_pred CcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHhC-CCCCCCCcc---chHHHhcC-CCCcCCCCC
Q psy14702 274 GHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEASG-VTPLPKNGP---MWHHIRDG-NIEKLSNVS 347 (480)
Q Consensus 274 G~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~~-~~p~~~~~~---~~~~i~~~-~~~~~~~~s 347 (480)
|++..... .....+|+.|+|||++.+..++ +++|||||||++|||++ +.|++.... ....+.++ ..+.+..++
T Consensus 148 g~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (262)
T d1byga_ 148 GLTKEASSTQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226 (262)
T ss_dssp CC------------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred ccceecCCCCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 99876443 3345689999999999887664 79999999999999853 444433322 34445544 345556789
Q ss_pred HHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 348 DDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 348 ~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
+++++||.+||..||.+|||+.+++++..
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~L~ 255 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 99999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=386.82 Aligned_cols=245 Identities=23% Similarity=0.394 Sum_probs=199.2
Q ss_pred hhhhhheeecccCceEEEEEEEeeCC-------cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeC
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDG-------MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQ 189 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~-------~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~ 189 (480)
.+|.+.+.||+|+||.||+|+...++ ..||||+++... .......+.+|...+..+.+|||||++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 46788899999999999999876554 479999997643 4445567888999999998899999999999999
Q ss_pred CEEEEEeeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecc
Q psy14702 190 GVLYLQLEYCNGGNLENIIQER----------------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKA 253 (480)
Q Consensus 190 ~~~~lv~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~ 253 (480)
+.+|+|||||++|+|.+++..+ ..+++.+++.++.||+.||+|||+++||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--- 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--- 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---
Confidence 9999999999999999999754 248999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCC
Q psy14702 254 QGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPL 325 (480)
Q Consensus 254 ~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~ 325 (480)
+.++.+||+|||++...... ....||+.|+|||++.++.++ .++|||||||++|||+ |..||
T Consensus 169 ---------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 169 ---------TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPY 238 (299)
T ss_dssp ---------CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSS
T ss_pred ---------cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCC
Confidence 66778999999998644322 234689999999999887665 7999999999999974 34455
Q ss_pred CCCcc--chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 326 PKNGP--MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 326 ~~~~~--~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..... .+..+.++. ++.+..+|+++++||.+||+.||++|||+.||++..
T Consensus 239 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHH
Confidence 43332 344455543 445567999999999999999999999999998754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=401.43 Aligned_cols=248 Identities=21% Similarity=0.283 Sum_probs=195.4
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee------CC
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD------QG 190 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~------~~ 190 (480)
.+|++++.||+|+||+||+|+++.+|+.||||++.+..........+.+|+.+++.+ +|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 579999999999999999999999999999999988776777777899999999999 79999999999963 47
Q ss_pred EEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEe
Q psy14702 191 VLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKL 270 (480)
Q Consensus 191 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL 270 (480)
.+|+|||||.++ +.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|+
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~------------~~~~~~kl 160 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV------------KSDCTLKI 160 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE------------CTTCCEEE
T ss_pred eeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc------------ccccceee
Confidence 899999999664 545443 469999999999999999999999999999999999999 56678999
Q ss_pred CccCcccccCC---CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccch--HHH---------
Q psy14702 271 GDFGHVIADND---FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPMW--HHI--------- 335 (480)
Q Consensus 271 ~DFG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~~--~~i--------- 335 (480)
+|||++..... .....||+.|+|||++.+..++ +++||||+||++|+| +|..||...+... ..+
T Consensus 161 ~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCCCC---------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred echhhhhccccccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 99998765433 2345699999999999887665 789999999999996 6777776543211 000
Q ss_pred -------------hcCCCCc--------------------CCCCCHHHHHHHHHhhccCCCCCCChhHHHHHHHHHHhC
Q psy14702 336 -------------RDGNIEK--------------------LSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQLARNY 381 (480)
Q Consensus 336 -------------~~~~~~~--------------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~~~~~~ 381 (480)
....... ....|+++++||++||..||++||||+|+|+||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0111000 011367899999999999999999999999999998743
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=385.97 Aligned_cols=245 Identities=23% Similarity=0.332 Sum_probs=204.6
Q ss_pred hhhhhheeecccCceEEEEEEEe-----eCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKY-----MDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.++||+|+||.||+|... .+++.||||+++... .......+.+|+.++..+.+|||||++++++.+...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 57778899999999999999864 356789999997643 445566789999999999889999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEecc
Q psy14702 192 LYLQLEYCNGGNLENIIQERC------------------TFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKA 253 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~ 253 (480)
+|||||||++|+|.+++.... .+++..+..++.||+.||+|||++|||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~--- 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL--- 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc---
Confidence 999999999999999997543 58999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CCCCCC
Q psy14702 254 QGELNEPMNTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GVTPLP 326 (480)
Q Consensus 254 ~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~~p~~ 326 (480)
+..+.+||+|||+++..... ....||+.|+|||++.+..++ .++|||||||++|||+ ++.|++
T Consensus 179 ---------~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 179 ---------THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp ---------ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSS
T ss_pred ---------cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCC
Confidence 56778999999998754432 224589999999999887665 7899999999999985 466665
Q ss_pred CCcc----chHHHhcCC-CCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 327 KNGP----MWHHIRDGN-IEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 327 ~~~~----~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
.... ....+..+. ...+..+|+++.+||.+||+.||.+|||+++|++..
T Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 4432 223333433 334456899999999999999999999999998743
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=380.82 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=189.6
Q ss_pred hhhhhheeecccCceEEEEEEEeeC-C--cEEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMD-G--MTYAVKRTKRPVA-NTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVL 192 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~-~--~~vAvK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~ 192 (480)
.+|++.+.||+|+||.||+|+...+ + ..||||++++... .....+.|.+|+.++..+ +|||||++++++.+ ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS-SSC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee-cch
Confidence 4688899999999999999986543 2 4789999876433 233456789999999999 89999999999976 467
Q ss_pred EEEeeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeC
Q psy14702 193 YLQLEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLG 271 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~ 271 (480)
++|||||++|+|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll------------~~~~~vkl~ 153 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL------------ATRDLVKIG 153 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE------------EETTEEEEC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc------------ccccceeec
Confidence 8999999999999887654 479999999999999999999999999999999999999 556789999
Q ss_pred ccCcccccCCC-------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh--CCCCCCCCcc--chHHHhcC--
Q psy14702 272 DFGHVIADNDF-------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS--GVTPLPKNGP--MWHHIRDG-- 338 (480)
Q Consensus 272 DFG~a~~~~~~-------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~--~~~p~~~~~~--~~~~i~~~-- 338 (480)
|||++...... ....|+..|+|||++.+..++ .++|||||||++|||+ |..||..... ....+...
T Consensus 154 DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~ 232 (273)
T d1u46a_ 154 DFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE 232 (273)
T ss_dssp CCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC
T ss_pred cchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCC
Confidence 99998754332 123478899999999987665 7899999999999974 5677755433 23444433
Q ss_pred CCCcCCCCCHHHHHHHHHhhccCCCCCCChhHHHH
Q psy14702 339 NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373 (480)
Q Consensus 339 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 373 (480)
.++.++.+|+++++||.+||..||++|||+.+|++
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33456779999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-48 Score=378.91 Aligned_cols=239 Identities=21% Similarity=0.294 Sum_probs=197.7
Q ss_pred heeecccCceEEEEEEEeeCC---cEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEee-CCEEEEEee
Q psy14702 122 EELLGSGDFGEVFKCLKYMDG---MTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSD-QGVLYLQLE 197 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~---~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~-~~~~~lv~E 197 (480)
.++||+|+||+||+|....++ ..||||+++.. ......+.|.+|+.++..+ +|||||++++++.. ++..|+|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEecCCceEEEEE
Confidence 478999999999999876543 46999998753 4555667899999999999 79999999999765 568999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 198 YCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 198 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+ ++++.+||+|||++
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl------------~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML------------DEKFTVKVADFGLA 177 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE------------CTTCCEEECSSGGG
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE------------CCCCCEEEecccch
Confidence 99999999998754 367888999999999999999999999999999999999 66789999999998
Q ss_pred cccCCC--------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCcc---chHHHhcCCC-CcC
Q psy14702 277 IADNDF--------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGP---MWHHIRDGNI-EKL 343 (480)
Q Consensus 277 ~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~---~~~~i~~~~~-~~~ 343 (480)
+..... ....||+.|+|||++....++ .++|||||||++||| +++.||..... ....+..+.. ..+
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC
T ss_pred hhccccccccceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 654322 123589999999999887664 799999999999997 55777765432 3445555543 345
Q ss_pred CCCCHHHHHHHHHhhccCCCCCCChhHHHHHH
Q psy14702 344 SNVSDDLHTLIKLMIDKDPTKRPSTSSLRRSA 375 (480)
Q Consensus 344 ~~~s~~~~~li~~~L~~dP~~Rps~~ell~h~ 375 (480)
..+++++.+||.+||+.||++|||+.||++|.
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 288 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 67899999999999999999999999999884
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=379.28 Aligned_cols=243 Identities=19% Similarity=0.319 Sum_probs=203.6
Q ss_pred hhhhhheeecccCceEEEEEEEee-----CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYM-----DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGV 191 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~-----~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~ 191 (480)
.+|.+.+.||+|+||+||+|.+.. +++.||||+++.. ........+.+|+.++..+ +|||||++++++..++.
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHc-CCCCEeeeeeEEecCCc
Confidence 467788999999999999998753 4578999999764 3455566799999999999 79999999999999999
Q ss_pred EEEEeeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCC
Q psy14702 192 LYLQLEYCNGGNLENIIQER----------CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPM 261 (480)
Q Consensus 192 ~~lv~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~ 261 (480)
.++|||||++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl----------- 166 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV----------- 166 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE-----------
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee-----------
Confidence 99999999999999998642 247899999999999999999999999999999999999
Q ss_pred CccccceEeCccCcccccCCC------cccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHHh-CC-CCCCCCcc--c
Q psy14702 262 NTEKLHYKLGDFGHVIADNDF------EVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEAS-GV-TPLPKNGP--M 331 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel~-~~-~p~~~~~~--~ 331 (480)
+.++.+||+|||+++..... ....||+.|+|||.+.+..+. .++|||||||++|||+ +. .||..... .
T Consensus 167 -d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~ 244 (308)
T d1p4oa_ 167 -AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 244 (308)
T ss_dssp -CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred -cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 67789999999998654322 223589999999999988765 7899999999999974 53 44543332 3
Q ss_pred hHHHhcCCC-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHHH
Q psy14702 332 WHHIRDGNI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRRS 374 (480)
Q Consensus 332 ~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 374 (480)
...+.++.. +.+..+++.+.+||.+||+.||++|||+.+|+++
T Consensus 245 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~ 288 (308)
T d1p4oa_ 245 LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288 (308)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 445555554 4456799999999999999999999999999985
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-48 Score=376.30 Aligned_cols=252 Identities=18% Similarity=0.184 Sum_probs=201.0
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|++.+.||+|+||+||+|++..+|+.||||++...... ..+..|+.+++.+.+|++|+.+..++.+.+..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 45789999999999999999999999999999998764332 23678999999997777788888888999999999
Q ss_pred eeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQ-ERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||| +++|.+.+. ....+++..+..++.|++.||+|||++|||||||||+|||+... +.+..+||+|||
T Consensus 82 me~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~---------~~~~~vkl~DFG 151 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG---------KKGNLVYIIDFG 151 (299)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG---------GGTTCEEECCCS
T ss_pred EEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc---------CCCceeeeeccC
Confidence 9999 556666654 44589999999999999999999999999999999999998532 345679999999
Q ss_pred cccccCC-----------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--h---HHHhc
Q psy14702 275 HVIADND-----------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM--W---HHIRD 337 (480)
Q Consensus 275 ~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~--~---~~i~~ 337 (480)
+|+.... .....||+.|+|||++.+..++ .++|||||||++||| +|..||...... . .....
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred cceeccccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc
Confidence 9865432 1234699999999999987665 799999999999996 677787654321 1 11111
Q ss_pred C----CC-CcCCCCCHHHHHHHHHhhccCCCCCCChhH---HHHHHHHHHhCC
Q psy14702 338 G----NI-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSS---LRRSAQLARNYP 382 (480)
Q Consensus 338 ~----~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~e---ll~h~~~~~~~~ 382 (480)
. .. ....++|+++.+||.+||..||++||++++ +++|+|......
T Consensus 231 ~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 231 KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 1 11 123578999999999999999999999875 477887766544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-46 Score=363.20 Aligned_cols=245 Identities=19% Similarity=0.251 Sum_probs=199.9
Q ss_pred hhhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEE
Q psy14702 116 ALEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQ 195 (480)
Q Consensus 116 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv 195 (480)
..+|.+.+.||+|+||+||+|++..+|+.||||++...... ..+.+|++++..+.+|+||+.+++++......|+|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 35788999999999999999999999999999998654322 23667889999998889999999999999999999
Q ss_pred eeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccC
Q psy14702 196 LEYCNGGNLENIIQER-CTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFG 274 (480)
Q Consensus 196 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG 274 (480)
|||| +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||+..... ...+.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~-------~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS-------KNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------TTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCccc-------ccCCceEEcccc
Confidence 9999 78999998765 47999999999999999999999999999999999999954321 235679999999
Q ss_pred cccccCC-----------CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc-----hHHHhc
Q psy14702 275 HVIADND-----------FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM-----WHHIRD 337 (480)
Q Consensus 275 ~a~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~-----~~~i~~ 337 (480)
+|+.... .....||+.|||||++.+..++ .++|||||||++||| +|..||...... ...+..
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~ 230 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 230 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh
Confidence 9865322 2234699999999999987665 789999999999996 677888643321 122222
Q ss_pred CC----C-CcCCCCCHHHHHHHHHhhccCCCCCCChhHHHH
Q psy14702 338 GN----I-EKLSNVSDDLHTLIKLMIDKDPTKRPSTSSLRR 373 (480)
Q Consensus 338 ~~----~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 373 (480)
.. . ...+++|+++.+++..|+..+|++||+++.+.+
T Consensus 231 ~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 231 KKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11 1 123568999999999999999999999887754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=370.23 Aligned_cols=241 Identities=20% Similarity=0.343 Sum_probs=181.9
Q ss_pred hhhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCC----EE
Q psy14702 117 LEFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQG----VL 192 (480)
Q Consensus 117 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~----~~ 192 (480)
.+|.+.+.||+|+||.||+|+ .+|+.||||+++.. .........|+..+..+ +|||||++++++.+.+ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~--~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSR---EERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEE--ETTEEEEEEEECGG---GHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEE--ECCEEEEEEEECcc---chhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEE
Confidence 467788999999999999997 47999999998642 22222233444444555 7999999999987643 68
Q ss_pred EEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceecCCCCCcEEEeccCCCCCCCCCcc
Q psy14702 193 YLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHE--------MRMIHMDIKPANILIVKAQGELNEPMNTE 264 (480)
Q Consensus 193 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~--------~~IvHrDlKp~NILl~~~~~~~~~~~~~~ 264 (480)
|+|||||++|+|.+++++. .+++..+..++.|++.||.|||+ +|||||||||+|||+ +.
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl------------~~ 143 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV------------KK 143 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE------------CT
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE------------cC
Confidence 9999999999999999865 69999999999999999999996 699999999999999 66
Q ss_pred ccceEeCccCcccccCC--------CcccCCCcccchhhhhcccCC-----CCCcccHHHHHHHHHHHhCCCCCCCCcc-
Q psy14702 265 KLHYKLGDFGHVIADND--------FEVEEGDCRYLPKELLNNNFD-----NLSKVDIFALGLTLYEASGVTPLPKNGP- 330 (480)
Q Consensus 265 ~~~vkL~DFG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~~-----~~~k~DiwSlGvilyel~~~~p~~~~~~- 330 (480)
++.+||+|||++..... .....||+.|+|||++.+... .+.++|||||||+||||+++.+++....
T Consensus 144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 78999999998864422 123569999999999876432 2357999999999999755444321110
Q ss_pred -------------c----hHHHhcCCC-CcCC------CCCHHHHHHHHHhhccCCCCCCChhHHHHHHH
Q psy14702 331 -------------M----WHHIRDGNI-EKLS------NVSDDLHTLIKLMIDKDPTKRPSTSSLRRSAQ 376 (480)
Q Consensus 331 -------------~----~~~i~~~~~-~~~~------~~s~~~~~li~~~L~~dP~~Rps~~ell~h~~ 376 (480)
. ...+..... +.++ ..+..+.+|+.+||+.||++|||+.||+++.-
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~ 293 (303)
T d1vjya_ 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp CCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred cccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 0 111111111 1111 12345889999999999999999999988653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-44 Score=355.00 Aligned_cols=253 Identities=19% Similarity=0.275 Sum_probs=190.0
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcC----------CCCceeEEeeEEe
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLS----------RVPHIVNYFSSWS 187 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~----------~hpnIv~l~~~~~ 187 (480)
+|+++++||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+++.+. .|+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 589999999999999999999999999999999753 233445678888877763 3689999999876
Q ss_pred e--CCEEEEEeeccCCCCHHHH-HH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEeccCCCCCCCC
Q psy14702 188 D--QGVLYLQLEYCNGGNLENI-IQ--ERCTFTEMALKQLLFQVSEGLRCMHE-MRMIHMDIKPANILIVKAQGELNEPM 261 (480)
Q Consensus 188 ~--~~~~~lv~E~~~gg~L~~~-l~--~~~~l~~~~~~~i~~qi~~aL~yLH~-~~IvHrDlKp~NILl~~~~~~~~~~~ 261 (480)
. ....+++|+++..+..... .. ....+++..++.++.||+.||+|||+ +||+||||||+|||+...+..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~----- 165 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP----- 165 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT-----
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcc-----
Confidence 4 4567777777655543322 22 33479999999999999999999998 899999999999999643211
Q ss_pred CccccceEeCccCcccccCC-CcccCCCcccchhhhhcccCCCCCcccHHHHHHHHHHH-hCCCCCCCCccc--------
Q psy14702 262 NTEKLHYKLGDFGHVIADND-FEVEEGDCRYLPKELLNNNFDNLSKVDIFALGLTLYEA-SGVTPLPKNGPM-------- 331 (480)
Q Consensus 262 ~~~~~~vkL~DFG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~k~DiwSlGvilyel-~~~~p~~~~~~~-------- 331 (480)
.....+|++|||.+..... .....||+.|+|||++.+..++ .++||||+||++++| +|..||......
T Consensus 166 -~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 166 -ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp -TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred -cccceeeEeecccccccccccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence 1234589999999865443 3345799999999999987665 799999999999996 677776532210
Q ss_pred -hH-----------HHhcC------------------------------CCCcCCCCCHHHHHHHHHhhccCCCCCCChh
Q psy14702 332 -WH-----------HIRDG------------------------------NIEKLSNVSDDLHTLIKLMIDKDPTKRPSTS 369 (480)
Q Consensus 332 -~~-----------~i~~~------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ 369 (480)
.. ..... ........++++++||.+||.+||.+|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence 00 00000 0001122457899999999999999999999
Q ss_pred HHHHHHHHHHh
Q psy14702 370 SLRRSAQLARN 380 (480)
Q Consensus 370 ell~h~~~~~~ 380 (480)
|+|+||||...
T Consensus 324 e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 324 GLVNHPWLKDT 334 (362)
T ss_dssp HHHTCGGGTTC
T ss_pred HHhcCcccCCC
Confidence 99999999843
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.3e-25 Score=201.92 Aligned_cols=164 Identities=15% Similarity=0.102 Sum_probs=116.6
Q ss_pred hhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCC----------------HHHHHHHHHHHHHHHhcCCCCceeEEe
Q psy14702 120 LEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVAN----------------TAQEKIFKKEIHAHALLSRVPHIVNYF 183 (480)
Q Consensus 120 ~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~----------------~~~~~~~~~Ei~~l~~l~~hpnIv~l~ 183 (480)
.+.++||+|+||+||+|.+ .+|+.||||+++..... ........+|...+..+ .|++++..+
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~~ 80 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKVY 80 (191)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCEE
T ss_pred hhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceEE
Confidence 3578999999999999987 47999999987532110 11123355688888888 678998887
Q ss_pred eEEeeCCEEEEEeeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEeccCCCCCCCCCc
Q psy14702 184 SSWSDQGVLYLQLEYCNGGNLENIIQERCTFTEMALKQLLFQVSEGLRCMHEMRMIHMDIKPANILIVKAQGELNEPMNT 263 (480)
Q Consensus 184 ~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~IvHrDlKp~NILl~~~~~~~~~~~~~ 263 (480)
++.. .+++|||+++..+. .++...+..++.|++.||.|||++||+||||||+|||++.
T Consensus 81 ~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~----------- 138 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE----------- 138 (191)
T ss_dssp EEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEET-----------
T ss_pred EecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeC-----------
Confidence 6532 27999999886553 2556667789999999999999999999999999999942
Q ss_pred cccceEeCccCcccccCCCcccCCCcccch------hhhhcccCCCCCcccHHHHHHH
Q psy14702 264 EKLHYKLGDFGHVIADNDFEVEEGDCRYLP------KELLNNNFDNLSKVDIFALGLT 315 (480)
Q Consensus 264 ~~~~vkL~DFG~a~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~k~DiwSlGvi 315 (480)
..++|+|||.|........ ..|.. .+.+... +. .++|+||+.--
T Consensus 139 --~~~~liDFG~a~~~~~~~~----~~~l~rd~~~~~~~f~r~-y~-~~~d~~s~~~~ 188 (191)
T d1zara2 139 --EGIWIIDFPQSVEVGEEGW----REILERDVRNIITYFSRT-YR-TEKDINSAIDR 188 (191)
T ss_dssp --TEEEECCCTTCEETTSTTH----HHHHHHHHHHHHHHHHHH-HC-CCCCHHHHHHH
T ss_pred --CCEEEEECCCcccCCCCCc----HHHHHHHHHHHHHHHcCC-CC-CcccHHHHHHH
Confidence 2489999999866543221 11221 1223222 33 47899997543
|
| >d1pdaa1 c.94.1.1 (A:3-219) Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Periplasmic binding protein-like II superfamily: Periplasmic binding protein-like II family: Phosphate binding protein-like domain: Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=99.90 E-value=3.1e-25 Score=196.94 Aligned_cols=90 Identities=52% Similarity=0.803 Sum_probs=75.8
Q ss_pred CCcCCcccccccCcccCCccchHHHHHHHHhcCCcceeecccCCCCCCCCCCcccceeccCCCcccceeecccCCCcccc
Q psy14702 1 MNTTGDNILDKALPKIGEKSLFTKELEIALENQSVDFIVHSLKDLPTELPSGLSLGAILEREDPRDALILNKKWSGKTLA 80 (480)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~s~kd~p~~~~~~~~~~a~~~r~~p~d~~~~~~~~~~k~l~ 80 (480)
|+|+||++++.||+++||||+||||||.+|++|++|+||||+||||+.+|+|+.++|+++|++|+|+||++. +.++.
T Consensus 39 i~T~GD~~~~~~l~~~ggkg~Ftkele~~Ll~~~iDiAVHS~KDlP~~~~~~l~i~a~~~R~d~rD~li~~~---~~~l~ 115 (217)
T d1pdaa1 39 MVTRGDVILDTPLAKVGGKGLFVKELEVALLENRADIAVHSMKDVPVEFPQGLGLVTICEREDPRDAFVSNN---YDSLD 115 (217)
T ss_dssp CCCHHHHC---------CCCTTTHHHHHHHHTTSCSEEEEEGGGSCSCCCTTEEEEEECCCCCCCEEEECSS---CSSTT
T ss_pred EeccCCccccccccccchhHHHHHHHHHHHHcCccceehhhhcccccccCCccccccccccCCcchhccccC---cCCHh
Confidence 689999999999999999999999999999999999999999999999999999999999999999999875 46778
Q ss_pred cCCCCCccCCCCC
Q psy14702 81 TLPSGSVIDEDSG 93 (480)
Q Consensus 81 slpsgs~~~~~s~ 93 (480)
.+|.++.+.++|.
T Consensus 116 ~l~~~~~IGTsS~ 128 (217)
T d1pdaa1 116 ALPAGSIVGTSSL 128 (217)
T ss_dssp TSCTTCEEECCCH
T ss_pred hCCCCCEecccch
Confidence 8899998888765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=9.5e-07 Score=80.76 Aligned_cols=86 Identities=12% Similarity=-0.005 Sum_probs=58.3
Q ss_pred hhhhheeecccCceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEEEee
Q psy14702 118 EFLEEELLGSGDFGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYLQLE 197 (480)
Q Consensus 118 ~y~~~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~lv~E 197 (480)
.|+..+..+.++.+.||+.. ..+..+.+|+........ ...+.+|...+..+..+--+.+++.+..+++..|+||+
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 44445554555567899864 567778889875432111 11256688887777655446777788888899999999
Q ss_pred ccCCCCHHHH
Q psy14702 198 YCNGGNLENI 207 (480)
Q Consensus 198 ~~~gg~L~~~ 207 (480)
+++|.++.+.
T Consensus 91 ~l~G~~~~~~ 100 (263)
T d1j7la_ 91 EADGVLCSEE 100 (263)
T ss_dssp CCSSEEHHHH
T ss_pred eccccccccc
Confidence 9999887554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.76 E-value=2.7e-05 Score=75.45 Aligned_cols=81 Identities=15% Similarity=0.074 Sum_probs=47.0
Q ss_pred heeecccCceEEEEEEEeeCCcEEEEEEecCC---CC--CHHHHHHHHHHHHHHHhcCCC--CceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYMDGMTYAVKRTKRP---VA--NTAQEKIFKKEIHAHALLSRV--PHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~~~~~vAvK~~~~~---~~--~~~~~~~~~~Ei~~l~~l~~h--pnIv~l~~~~~~~~~~~l 194 (480)
.+.||.|....||++....+++.|+||.-... .. ......+...|...+..+..+ ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 35689999999999987777889999964320 00 000111234566666655433 235566654 3445578
Q ss_pred EeeccCCCCH
Q psy14702 195 QLEYCNGGNL 204 (480)
Q Consensus 195 v~E~~~gg~L 204 (480)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.71 E-value=6.4e-05 Score=67.72 Aligned_cols=75 Identities=17% Similarity=0.097 Sum_probs=49.0
Q ss_pred eecccC-ceEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC-CceeEEeeEEeeCCEEEEEeeccCC
Q psy14702 124 LLGSGD-FGEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV-PHIVNYFSSWSDQGVLYLQLEYCNG 201 (480)
Q Consensus 124 ~LG~G~-fg~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pnIv~l~~~~~~~~~~~lv~E~~~g 201 (480)
.+..|. .+.||+.. ...+..+.+|........ .+..|...+..+..+ -.+.+++.+..+.+..|+||++++|
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 344454 46889875 345667888986654322 245566666655332 2366777777888889999999988
Q ss_pred CCH
Q psy14702 202 GNL 204 (480)
Q Consensus 202 g~L 204 (480)
-++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 655
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.58 E-value=0.0022 Score=59.70 Aligned_cols=68 Identities=15% Similarity=0.120 Sum_probs=41.1
Q ss_pred eEEEEEEEeeCCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC----CceeEEe--eEEeeCCEEEEEeeccCCC
Q psy14702 131 GEVFKCLKYMDGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRV----PHIVNYF--SSWSDQGVLYLQLEYCNGG 202 (480)
Q Consensus 131 g~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~h----pnIv~l~--~~~~~~~~~~lv~E~~~gg 202 (480)
-.||++. ..+|..|++|+.+...... ..+..|...+..|..+ +..+..- ..+...+..+.+++++.|.
T Consensus 36 N~vy~v~-~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQ-DEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEEC-CTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEE-cCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4799975 3578899999876533222 2355677766665422 1111111 1234567889999998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.29 E-value=0.0064 Score=58.10 Aligned_cols=75 Identities=15% Similarity=0.037 Sum_probs=49.6
Q ss_pred heeecccCceEEEEEEEee-------CCcEEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCCceeEEeeEEeeCCEEEE
Q psy14702 122 EELLGSGDFGEVFKCLKYM-------DGMTYAVKRTKRPVANTAQEKIFKKEIHAHALLSRVPHIVNYFSSWSDQGVLYL 194 (480)
Q Consensus 122 ~~~LG~G~fg~V~~~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpnIv~l~~~~~~~~~~~l 194 (480)
++.|+.|-.-.+|++.... ....|.+++... .... ....+|..+++.+..+.-..++++++.+ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 5678889999999986542 235677776543 2222 2245788888887665445577777643 58
Q ss_pred EeeccCCCCH
Q psy14702 195 QLEYCNGGNL 204 (480)
Q Consensus 195 v~E~~~gg~L 204 (480)
||||++|..|
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.58 E-value=0.083 Score=48.03 Aligned_cols=29 Identities=24% Similarity=0.240 Sum_probs=24.0
Q ss_pred CCceecCCCCCcEEEeccCCCCCCCCCccccceEeCccCcc
Q psy14702 236 MRMIHMDIKPANILIVKAQGELNEPMNTEKLHYKLGDFGHV 276 (480)
Q Consensus 236 ~~IvHrDlKp~NILl~~~~~~~~~~~~~~~~~vkL~DFG~a 276 (480)
.|+||+|+.++||++ +.+...-|.||+.+
T Consensus 183 ~giIHgDl~~dNvl~------------~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF------------LGDELSGLIDFYFA 211 (316)
T ss_dssp EEEECSCCCGGGEEE------------ETTEEEEECCCTTC
T ss_pred cccccCCcchhhhhc------------ccccceeEeccccc
Confidence 579999999999999 44445689999965
|
| >d1pdaa1 c.94.1.1 (A:3-219) Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Periplasmic binding protein-like II superfamily: Periplasmic binding protein-like II family: Phosphate binding protein-like domain: Porphobilinogen deaminase (hydroxymethylbilane synthase), N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=89.24 E-value=0.057 Score=46.15 Aligned_cols=93 Identities=39% Similarity=0.497 Sum_probs=66.2
Q ss_pred CCCChhHHHHHHHHHHhCCCCccccccccHHHHhhhccCCCcchHHHHHHhhHHHhcccccccccccccCCCceeeeeeE
Q psy14702 364 KRPSTSSLRRSAQLARNYPQLKVENIRGNLNTRLKKLDEGNVFDGIILAVAGIVRMKWKDRIMAVFSEYKPGSLSMTGAV 443 (480)
Q Consensus 364 ~Rps~~ell~h~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 443 (480)
-+...+.+.+..++...+|.+.+..++.|+.+|++++.++ .+++++++.+|+.|++...++...|..-.-.....+|.+
T Consensus 121 ~~IGTsS~RR~aql~~~~p~l~~~~iRGNv~TRl~Kl~~g-~~DaiILA~AGL~RL~l~~~i~~~l~~~~~~PA~gQGai 199 (217)
T d1pdaa1 121 SIVGTSSLRRQCQLAERRPDLIIRSLRGNVGTRLSKLDNG-EYDAIILAVAGLKRLGLESRIRAALPPEISLPAVGQGAV 199 (217)
T ss_dssp CEEECCCHHHHHHHHHHCTTSEEECCCSCHHHHHHHHHTT-SCSEEEEEHHHHHHTTCGGGCSEECCTTTSCCCTTTTCE
T ss_pred CEecccchhHHHHHHHhCCCCceeecccchhhHHHHhhcc-CcCEEEeehhHHhhcCcchheeEEcChhhcCChHhhhhe
Confidence 3555566677777788899999999999999999999865 489999999999999988887766653222222223333
Q ss_pred e--ecCchhhHHHHHH
Q psy14702 444 W--SLDGRETLQDAME 457 (480)
Q Consensus 444 ~--~~~~~~~~~~~~~ 457 (480)
. ..++...+.+.+.
T Consensus 200 aIe~r~~d~~~~~il~ 215 (217)
T d1pdaa1 200 GIECRLDDSRTRELLA 215 (217)
T ss_dssp EEEEETTCHHHHHHHG
T ss_pred EEEEcCCCHHHHHHHh
Confidence 2 3444455555554
|